Final Programme World Congress of Cardiology Buenos Aires, Argentina

Final Programme World Congress of Cardiology Buenos Aires, Argentina 18 - 21 May, 2008

congress FLOOR PLAN

CONtent Welcome address

3

Committees

4

Hosting organizations

6



World Heart Federation Argentine Society of Cardiology Argentine Federation of Cardiology

Congress schedule

21

Congress information

24



How to get to the congress venue About the congress venue La Rural Registration Media and press Visual reproduction policy Congress material WCC on-site services

Social programme

34

WCC 2008 Community activities

35

About Argentina

36



Argentina Buenos Aires Climate Language Time difference Banks, currency, credit cards and VAT Electrical power Security Making phone calls Useful phone numbers Opening hours Leaving Argentina

Tours



Sponsorship and exhibition

41

Acknowledgements Exhibition opening hours List of exhibitors Exhibition map Sponsors’ and Exhibitors’ editorial listing

Scientific programme

38

60

Formats CME Accreditation Technical information for sessions Posters & abstracts Acknowledgements Programme-at-a-glance By day and by time

Author and FACULTY index

290

Content / 1

?

? ?

?

?

? ?

?

?

?

? ?

?

?

?

?

?

?

Do they know their risk? Join the global effort to prevent and control cardiovascular disease, the world’s number one killer. Support World Heart Day by giving heart health checks to your patients and their families to make them aware of their risk of cardiovascular disease. Help spread the message: ‘Know Your Risk!’ and have a heart for life. www.world-heart-federation.org

World Heart Day Sunday, 28 September, 2008

WELCOME ADDRESS A warm welcome to the World Congress of Cardiology 2008. It is our pleasure, speaking on behalf of the joint organizers of the World Heart Federation, the Argentine Society of Cardiology and the Argentine Federation of Cardiology, to welcome delegates from the furthest corners of the globe to Buenos Aires. We strongly believe that it is only with each and every one of us working together that we will make a significant difference – and that is what the World Congress of Cardiology seeks to achieve. Our joint focus is on individual, community and patient care interventions and the growing epidemic of cardiovascular disease that could and can be prevented and managed more effectively. We all know the statistics, or a version of it – that cardiovascular disease, primarily heart disease and stroke, is known to be responsible for a staggering 17.5 million deaths a year. A total, 80% of these deaths are in low- and middleincome countries, and we all have a role to play in changing this trend, be it through prevention, education or the sharing of knowledge. These are three key themes that unite the approach of your World Congress Organizers, not to mention many thousands of our participants. And for now – WCC 2008 welcomes world class speakers with topical and wide-ranging sessions under the theme of “From patients to populations” – a theme that offers a rich, diverse and rewarding opportunity to share new and exciting advances in the fields of prevention and management of heart disease and all its inter-related factors. Whether it be part of the official scientific programme, a commercial satellite symposium or a workshop or taking the time to discover the wealth of new devices and pharmaceutical products present in the exhibition hall – the World Congress of Cardiology offers a wide and rich breadth of educational material to enhance your personal learning and career. You will see that the WCC 2008 also offers Continuing Medical Education Credits (CME) – be sure to benefit from this internationally recognized programme. Full details may be found on page 60 of this WCC Final Programme.

As previously communicated, one key objective of the scientific programme is to feature globally relevant topics in the diagnosis, management and treatment of cardiovascular disease, which includes basic clinical and population research and another is to address public policy and advocacy topics related to cardiovascular disease. Whilst these objectives are shared by all three joint organizers, it is of particular importance for the World Heart Federation in its continuing relationships with changing partners to construct your future World Congresses of Cardiology. It is your participation that makes the World Congress of Cardiology what it is and it is your input and feedback that creates an environment in which to exchange science and build stronger and better working practices and procedures for the future. The World Congress of Cardiology, the official congress of the World Heart Federation, is delighted to be back in Argentina for a second time. We encourage you to take the opportunity post congress to visit this beautiful country and experience the famous warmth of the Argentine people. Welcome – we look forward to meeting you over the next few days. Enjoy your World Congress of Cardiology and Buenos Aires.

Horacio Faella, MD

Shahryar Sheikh, MD

President of the WCC 2008

President of the World Heart Federation

Welcome address / 3

CONGRESS MANAGEMENT COMMITTEE (CMC) Presidents: Horacio Faella (Argentina) – Shahryar Sheikh (Pakistan)

International Relationships: Luis María Amuchástegui (Argentina)

Vice-Presidents: Néstor Vita (Argentina) – Trevor Hassell (Barbados) Valentin Fuster (US) Pekka Puska (Finland)

General Secretary: Juan Krauss (Argentina)

National Organizing Committee President: Jorge Lerman (Argentina)

Director Congress Division, World Heart Federation: Adrian Ott (Switzerland)

National Organizing Committee Vice-President: Juan Carlos Linares-Casas (Argentina)

Managing Director, ICS Congresos Internacionales: Mariano Castex (Argentina)

Chief Executive Officer, World Heart Federation: Janet Voûte (Switzerland)

Scientific Committee: Arturo Cagide (Argentina) Felipe Martínez (Argentina) Sidney C. Smith (US)

SCIENTIFIC PROGRAMME COMMITTEE (SPC) Co-Chairmen: Arturo Cagide (Argentina) Felipe Martínez (Argentina) Sidney C. Smith (US) Scientific Advisory Board Council Chairs / Advisers: Jonathan Carapetis (Australia) Edgardo Escobar (Chile) Dong Zhao (People’s Republic of China) National Advisers: (Argentina) Luis Alday Hugo Grancelli Liliana Grinfeld Néstor Pérez Baliño Juan A. Plastino Ricardo Ronderos International Advisers: Mónica Acevedo (Chile) Ayrton Brandão (Brazil) Günter Breithardt (Germany) Valentin Fuster (US)

Runlin Gao (China) Trevor Hassell (Barbados) José López-Sendón (Spain) Mário Maranhão (Brazil) Marco Martínez-Ríos (Mexico) Akira Matsumori (Japan) Bongani Mayosi (South Africa) Sania Nishtar (Pakistan) Churchill Onen (Botswana) Dev Pahlajani (India) Pekka Puska (Finland) Srinath Reddy (India) Carlos Romero (Uruguay) Nizal Sarraf-Zadegan (Iran) Sergio Timerman (Brazil) Tak Fu Tse (China) Andrew Tonkin (Australia) William Wijns (Belgium) Salim Yusuf (Canada) Director Science Operations, World Heart Federation: Marilyn Hunn (US)

SPONSORSHIP COMMITTEE Horacio Faella (Argentina) Shahryar Sheikh (Pakistan) Jorge Lerman (Argentina)

PRESS COMMITTEE Hugo Lastiri (Argentina) Álvaro Sosa-Liprandi (Argentina) Janet Voûte (Switzerland)

Janet Voûte (Switzerland) Helen Alderson (Switzerland) Adrian Ott (Switzerland) Mariano Castex (Argentina)

Victoria Dix (Switzerland) Patricia Blanco (Argentina) Laura Torres (Argentina) Eugenia De la Fuente (Argentina)

IT’S A RED ALERT

Heart disease & stroke is the No.1 killer of women worldwide. Most heart disease & stroke is preventable. Spread the word. Go Red today. www.worldheart.org/grfw

Hosting OrganiZations World Heart Federation

Improving lives by preventing heart disease and stroke The World Heart Federation is a non-governmental organization committed to helping the global population achieve a longer and better life through prevention and control of heart disease and stroke, with a focus on lowand middle-income countries.

The World Heart Federation is comprised of 196 medical societies and heart foundations from more than 100 countries, as well as continental members covering the regions of Africa, the Americas, Asia-Pacific and Europe. Recognized by the World Health Organization, the World Heart Federation is its leading non-governmental partner in cardiovascular disease prevention and control. Our four pillars of activity include: awareness building, advocacy, demonstration projects and sharing science/ building capacity. Together with its members, the World Heart Federation raises awareness of heart disease and stroke, advocates for policy changes, develops projects to educate communities and patients about reducing the risk of cardiovascular disease and shares medical and population health science to build sustainable capabilities at national and regional levels.

www.worldheart.org

AWARENESS BUILDING To raise public awareness of heart disease and stroke, the World Heart Federation develops campaigns and events. With its members and other partners, it encourages individuals and institutions to adopt heart-healthy habits and plays a major role in ensuring that governments implement policies for cardiovascular disease prevention.

World Heart Day is our most important awareness building event. It promotes preventive measures to reduce the incidence of cardiovascular disease worldwide. Today, World Heart Day is actively celebrated in more than 100 countries and on all continents. This global event, which takes place on the last Sunday of September and focuses on a specific theme each year, involves a wide range of activities, including physical exercise sessions, lectures, shows, walking tours, healthy cooking competitions, and health risk assessments including the testing of cholesterol, blood pressure and glucose levels, along with BMI and waist circumference measurement. The Go Red for Women campaign raises awareness of heart disease and stroke as the number one cause of death of women worldwide. It encourages the medical profession to include heart disease and stroke prevention as a core component of women’s health and urges women to recognize their risks and to reduce them by adopting appropriate lifestyle changes.

Hosting OrganiZations World Heart Federation ADVOCACY Tobacco use kills 5.4 million people a year - an average of one person every six seconds - and accounts for one in 10 adult deaths worldwide. The World Heart Federation and its member organizations are intensively involved in advocating for tobacco control and, notably, the ratification and implementation at the national level of the Framework Convention on Tobacco Control, which has been signed by 168 countries and entered into force in 2005. 153 countries have ratified the FCTC and thus become Parties. Our specific focus includes active involvement in the Global Smokefree Partnership and the development of a Youth Advocacy

Network in Latin America. The World Heart Federation also focuses on the current overweight/obesity epidemic. It is playing a lead role in campaigning for the need to protect public health against the hazards associated with unhealthy nutrition habits and physical inactivity. In partnership with the World Economic Forum and the World Health Organization, the World Heart Federation is also leading the movement to improve employee health through working toward wellness in the workplace.

DEMONSTRATION PROJECTS The World Heart Federation aims to measurably impact cardiovascular disease risk, using resource-appropriate demonstration projects implemented at both population and high-risk individual levels. Demonstration projects are a part of the World Heart Federation’s efforts to achieve measurable impact on cardiovascular disease risk levels in low-income countries. Projects are specifically geared towards demonstrating best practice in areas of cardiovascular disease prevention and

control and span several continents. For example, the World Heart Federation is leading the field of secondary prevention for children with rheumatic fever/rheumatic heart disease in Africa and the Asia-Pacific region. A partnership with Sesame Workshop in Colombia is working to instill healthy habits in young viewers and their families. The Grenada Heart Project, implemented in collaboration with the Government of Grenada, uses the World Health Organization STEPwise approach to surveillance of CVD risk factors in order to help communities to tailor prevention programmes to their needs.

Hosting organizations / 7

Hosting OrganiZations World Heart Federation

sharing science/building capacity World Congresses of Cardiology are held every two years during which thousands of cardiologists and other healthcare professionals from all over the world gather to share the latest science on the treatment of patients and the latest thinking in population-based prevention. World Heart Federation Scientific Councils, composed of experts from around the world, carry out international training seminars, research and demonstration projects. Through its Twin Centres programme, the organization sponsors fellowships for young cardiologists and scientists from less advantaged countries to undergo postgraduate training in world-class cardiology centres.

CVD Prevention and Control is a quarterly journal of the World Heart Federation, which focuses especially on cardiovascular disease prevention in low- and middleincome countries. Nature Clinical Practice Cardiovascular Medicine is a monthly publication of the World Heart Federation, which provides physicians with the latest science of patient care. Further information on the World Heart Federation Journals can be found on page 16. For more information about the World Heart Federation, please visit www.worldheart.org

World Heart Federation Board President Shahryar SHEIKH (Pakistan)

Secretary Akira MATSUMORI (Japan)

Vice-President Trevor HASSELL (Barbados)

Treasurer Craig T BEAM (United States)

President Elect Pekka PUSKA (Finland)

Chief Executive Officer Janet VOÛTE (Switzerland)

Vice-President Elect Lyn ROBERTS (Australia)

Chairman, Foundations' Advisory Board Srinath REDDY (India)

Past President Valentin FUSTER (United States)

Chairman, Scientific Advisory Board Sidney SMITH Jr. (USA)

Past Vice-President Laksmiati A. HANAFIAH (Indonesia)

Editor-in-Chief, CVD Prevention & Control Journal Andy WIELGOSZ (Canada)

Continental Representatives Asia-Pacific Tsui-Lieh HSU (Taiwan) Anil Kumar D.M. (India)

Africa Robert de SOUZA (South Africa) Albert AMOAH (Ghana)

Europe Peter HOLLINS (United Kingdom) William WIJNS (Belgium)

Inter-America Oscar Alvarado (Peru) Rafael Shuchleib (Mexico)

World Heart Federation Meetings World Heart Federation Foundations’ Advisory Board (FAB) Meeting Saturday, 17 May, 2008 08.30 –12.30 Room Martin Fierro, Sheraton San Martin, Buenos-Aires World Heart Federation Board Meeting Saturday, 17 May, 2008 13.30 –18.00 Room Martin Fierro, Sheraton San Martin, Buenos-Aires World Heart Federation Members' Workshop Monday, 19 May, 2008 08.30 - 17.30 Sheraton, San Martin, Buenos-Aires World Heart Federation Writers’ Workshop Monday, 19 May, 2008 09.30 –12.30 WHF Meeting Room, La Rural Congress Centre OTHER MEETINGS ISACCD (International Society Adults Congenital Heart Disease) Meeting Wednesday, 21 May, 2008 12.30 - 13.30 Ganges Room, La Rural Congress Centre Argentine Foundation of Cardiology Meeting Wednesday, 21 May, 2008 12.30 - 13.30 Tiber Room, La Rural Congress Centre Workshop: Medical and social issues about women's CV health. Chairperson: Salvatti Ana (ARGENTINA) Speakers: Nanette Wenger (UNITED STATES), Grinfeld Liliana (ARGENTINA) Book Presentation - "Fisiopatología Cardiovascular, bases racionales para la terapéutica" Wednesday, 21 May, 2008 12.30 - 13.30 Tigris Room, La Rural Congress Centre

World Heart Federation 10th General Assembly Sunday, 18 May, 2008

11.30 –13.30 Room Piso 24, Sheraton San Martin, Buenos-Aires

Agenda 1. Introduction of Members of Board Shahryar Sheikh 2*. Adoption of Minutes of last General Assembly Shahryar Sheikh 3. President’s Report Shahryar Sheikh 4*. Report of the Treasurer Craig T BEAM

(including approval by General Assembly of 2006 & 2007 audited reports)

5. Report of the Foundations’ Advisory Board Trevor Hassell (for Srinath Reddy) 6. Report of the Scientific Advisory Board/Demonstration Sidney Smith

Project Reviews

7. Report of the Secretary Akira Matsumori 8*. Report of the Nominating Committee & Elections Valentin Fuster 9. Awards Shahryar Sheikh 10. Future Priorities for Action Pekka Puska 11. Any Other Business

*Requires approval by General Assembly

Hosting organizations / 9

Accepted abstracts are published in the Circulation supplement. Circulation – the journal of choice in the cardiology community, with an impact factor of 10.940.

Submitting Your Research To The American Heart Association Is The Right Choice.

Global leaders in cardiovascular research and instruction will see your science. Discuss your work with the world’s foremost leaders in your field.

Over 450 media attend; their articles create 200 million impressions.

Opportunities exist for Early Career Awards and Travel Stipends.

Featured research can have an immediate global impact.

Awards are available for qualified healthcare professionals.

Submit Your Best Science Today For Sessions In New Orleans, November 8 – 12 The American Heart Association’s Scientific Sessions is the world’s premier cardiovascular conference, with unmatched scientific scope, authority and prestige.

Abstract submissions April 15 to June 6 Late-breaking abstract submission deadline June 30

O N E W O R L D . O N E M I S S I O N . Y O U R S P E C I A LT Y.

scientificsessions.org ©2008, American Heart Association. 4/08LS1704

World Heart Federation Members CONTINENTAL MEMBERS A continental society or foundation which is a group of societies or foundations from one of the continental groupings of countries comprising Europe, North/Central/South America, Asia Pacific, and Africa. Organization name

President/Chairman

Country

African Heart Network (AHN)

Robert de Souza

South Africa

Asia Pacific Heart Network (APHN)

Hsu Tsui-Lieh

China, Taiwan

Asian-Pacific Society of Cardiology (APSC)

Anil Kumar

India

European Heart Network (EHN)

Peter Hollins

United Kingdom

European Society of Cardiology (ESC)

Kim Fox

United Kingdom

InterAmerican Heart Foundation (IAHF)

Rafael Shuchleib

Mexico

Interamerican Society of Cardiology (IASC)

Oscar Alvarado

Peru

Pan-African Society of Cardiology (PASCAR)

Albert Amoah

Ghana

NATIONAL MEMBERS A national society of cardiology or a national heart foundation. Organization name

President/Chairman

Country

Algerian Society of Cardiology

Djamaleddine Nibouche

Algeria

Argentine Heart Foundation

Liliana Grinfeld

Argentina

Argentine Society of Cardiology

Eduardio Mele

Argentina

National Heart Foundation of Australia

Bruce Carter

Australia

The Cardiac Society of Australia & New Zealand

Michael Feneley

Australia

Austrian Heart Foundation

Konrad Steinbach

Austria

Austrian Society of Cardiology

Kurt Huber

Austria

Bangladesh Cardiac Society

Sirajul Haque

Bangladesh

National Heart Foundation of Bangladesh

Justice Chowdury ATM Masud

Bangladesh

Heart and Stroke Foundation of Barbados Inc

Dru Symmonds

Barbados

Belarusian Scientific Society of Cardiologists

N. Manak

Belarus

Belgian Heart League

Jean-Pierre Willaert

Belgium

Belgian Society of Cardiology

Guy Berkenboom

Belgium

Bolivian Society of Cardiology

Edgar Pozo Valdivia

Bolivia

Association of Cardiologists of Bosnia and Herzegovina

Enver Raljevíc

Bosnia and Herzegovina

Foundation of Health and Heart

Slobodan Cvjetic

Bosnia and Herzegovina

Brazilian Society of Cardiology

Antonio Palandri Chagas

Brazil

Funcor – Brazilian Heart Foundation

Alvaro Avezum

Brazil

Bulgarian Society of Cardiology

Tzvetana Katova

Bulgaria

Canadian Cardiovascular Society

Denis Roy

Canada

Heart and Stroke Foundation of Canada

Carol Jillings

Canada

Chilean Heart Foundation

Mario Alvo

Chile

Chilean Society of Cardiology & Cardiovascular Surgery

René Asenjo González

Chile

Hong Kong College of Cardiology

Chu-Pak Lau

China, Hong Kong

The Hong Kong Heart Foundation, Ltd.

Patrick Wu

China, Hong Kong

Macau Association of Cardiology

Mario Lima Evora

China, Macao

Macau Heart Foundation

Jimmy Chac Lam Chu

China, Macao

Chinese Society of Cardiology

Runlin Gao

People’s Republic of China

Taiwan Heart Foundation

Hung-Chi Lue

China, Taiwan

Taiwan Society of Cardiology

Fui-Tien Chiang

China, Taiwan

Colombian Society of Cardiology

Fernando Manzur Jattin

Colombia

World Heart Federation members / 11

World Heart Federation Members Organization name

President/Chairman

Country

A Heart for Life

Nathalie Kaky-Ndembe

Congo

Croatian Cardiac Society

Davor Milicic

Croatia

Cuban Society of Cardiology

Lorenzo Llerena Rojas

Cuba

Cyprus Heart Foundation

Christos Mavrellis

Cyprus

Cyprus Society of Cardiology

Pambis Nicolaides

Cyprus

Czech Society of Cardiology

Michael Aschermann

Czech Republic

Healthy Nutrition Forum

Rudolf Poledne

Czech Republic

Danish Heart Foundation

Henrik Sillesen

Denmark

Danish Society of Cardiology

Henrik Steen Hansen

Denmark

Dominican Heart Foundation

Hector Mateo

Dominican Republic

Dominican Society of Cardiology

Frank Valdez Báez

Dominican Republic

Ecuadorian Foundation of Cardiology

Ernesto Fuentes

Ecuador

Ecuadorian Society of Cardiology

Santiago García Eguez

Ecuador

Egyptian Society of Cardiology

Aly Ramsy

Egypt

Society of Cardiology of El Salvador

Dagoberto Pereira

El Salvador

Estonian Heart Association

Maarit Vaikmaa

Estonia

Finnish Cardiac Society

Saila Vikman

Finland

Finnish Heart Association

Pekka Puska

Finland

French Society of Cardiology

Nicolas Danchin

France

Georgian Association of Cardiology

V. B. Tchumburidze

Georgia

Georgian Heart Foundation

Merab Mamatsashvili

Georgia

German Cardiac Society

Gerd Heusch

Germany

German Heart Foundation

Hans-Jürgen Becker

Germany

Ghana Heart Foundation

Kwabena Frimpong-Boateng

Ghana

Ghana Society of Hypertension and Cardiology

Albert Amoah

Ghana

Hellenic Cardiological Society

Dimitris Kremastinos

Greece

Hellenic Heart Foundation

Metropolitan of Thebes and Levadia Ieronymos

Greece

Guatemala Association of Cardiology

Pablo Montenegro Valdovinos

Guatemala

Honduras Society of Cardiology

Mauricio Varela

Honduras

Hungarian National Heart Foundation

András Nagy

Hungary

Hungarian Society of Cardiology

Tamás Forster

Hungary

Icelandic Heart Association

Gunnar Sigurdsson

Iceland

All India Heart Foundation

Sivaramakrishna Padmavati

India

Cardiological Society of India

S. S. Chatterje

India

Heart Foundation of Indonesia

Firdanerry A. Sani

Indonesia

Indonesian Heart Association

Muhammad Munawar

Indonesia

Iranian Heart Association

Feridoun Noohi

Islamic Republic of Iran

Iraqi Cardio-Thoracic Society

Adil S. Abdul-Ghafour

Iraq

Irish Cardiac Society

David Higginson

Ireland

Irish Heart Foundation

Eoin O'Brien

Ireland

Israel Heart Society

Basil Lewis

Israel

Italian Federation of Cardiology

Giuseppe Di Pasquale

Italy

Italian Heart Foundation

Rodolfo Paoletti

Italy

The Heart Foundation of Jamaica

Knox Hagley

Jamaica

Japan Heart Foundation

Takuji Shidachi

Japan

Japanese Circulation Society

Tetsu Yamaguchi

Japan

Jordan Cardiac Society

M. Al-Naser

Jordan

Association of Cardiologists of Kazakhstan

Alikham K. Jussipov

Kazakhstan

World Heart Federation Members Organization name

President/Chairman

Country

Kenya Cardiac Society

Stephen Ogendo

Kenya

Kenyan-Heart National Foundation

David Githii

Kenya

The Korean Society of Cardiology

Woo Hyung Lee

Republic of Korea

Kuwait Heart Foundation

Jassim M Al-Bahar

Kuwait

Scientific Society of Cardiologists of the Kyrgyz Republic

Mirrachimov Mirhamidovich

Kyrgyzstan

Latvian Society of Cardiology

Andrejs Erglis

Latvia

Lebanese Society of Cardiology

Fouad Farhat

Lebanon

Libyan Cardiac Society

Omar Msalam

Libya

Lithuanian Heart Association

Pranas Serpytis

Lithuania

Lithuanian Society of Cardiology

Remigijus Zaliunas

Lithuania

Macedonia Society of Cardiology

Sasko Kedev

Macedonia

National Heart Association of Malaysia

Hendrick Chia

Malaysia

The Heart Foundation of Malaysia

Tun Omar Ong Yoke Lin

Malaysia

The Heart Foundation

T. K. Gunness

Mauritius

Mexican Society of Cardiology

Jorge Gaspar Hernandez

Mexico

Moldavian Society of Cardiology

Mihai Popovici

Republic of Moldavia

Moroccan Society of Cardiology

Mohamed Saadaoui

Morocco

Cardiac Society of Myanmar Medical Association

May San Khin

Myanmar

Cardiac Society of Nepal

Abani Upadhyaya

Nepal

Nepal Heart Foundation

Abani Upadhyaya

Nepal

Netherlands Heart Foundation

L. E. H. Vredevoogd

The Netherlands

The Netherlands Society of Cardiology

H. J. G. M. Crijns

The Netherlands

Cardiac Society of Australia and New Zealand

Robert Donaldson

New Zealand

The National Heart Foundation of New Zealand

Robert Donaldson

New Zealand

Nicaraguan Society of Cardiology

Daniel Rivas

Nicaragua

Nigerian Cardiac Society

Martin Aghaji

Nigeria

Nigerian Heart Foundation

A. V. M. Mouktar Mohammed

Nigeria

Norwegian Council On Cardiovascular Disease

Mons Lie

Norway

Norwegian Society of Cardiology

Cecilie Risøe

Norway

Pakistan Cardiac Society

Azhar Masood Faruqui

Pakistan

Pakistan Heart Foundation

Muhammad Ilyas

Pakistan

Cardiological Foundation of Panama

Alfredo L. Maduro

Panama

Society of Cardiology of Panama

Baldomero González

Panama

National Heart Foundation of Papua New Guinea Inc.

David Guinn

Papua New Guinea

Paraguayan Heart Foundation

Abdón Villamayor

Paraguay

Paraguayan Society of Cardiology

Maria Paniagua de Decoud

Paraguay

Peruvian Society of Cardiology

Jaime Espinoza S.

Peru

Heart Foundation of the Philippines

Francisco G. Dizon

Philippines

Philippine Heart Association Inc.

Efren Vicaldo

Philippines

Polish Cardiac Society

Andrzej Rynkiewicz

Poland

Portuguese Heart Foundation

Manuel Oliveira Carrageta

Portugal

Portuguese Society of Cardiology

Hugo Madeira

Portugal

Puerto Rican Society of Cardiology

Luis Molinary

Puerto Rico

Foundation for Cardiac Assistance (Ascar)

Costin Carp

Romania

Romanian Society of Cardiology

Radu Capalneanu

Romania

Society of Cardiology of Russian Federation

Rafael G. Oganov

Russian Federation

San Marino Society of Cardiology

Liano Marinelli

San Marino

Saudi Heart Association

Mohammed Arafah

Saudi Arabia

World Heart Federation members / 13

World Heart Federation Members Organization name

President/Chairman

Country

Serbian Heart Foundation

Miodrag Ostojic

Republic of Serbia

Society of Cardiology of Serbia and Montenegro

Miodrag Ostijic

Republic of Serbia

Seychelles Heart and Stroke Foundation

Dolores Pool

Seychelles

Singapore Cardiac Society

Richard Ng

Singapore

Singapore Heart Foundation

Lip-Ping Low

Singapore

Slovak League Heart to Heart

Ján Slezák

Slovak Republic

Slovak Society of Cardiology

Róbert Hatala

Slovak Republic

Slovenian Heart Foundation

Danica Rotar Pavlic

Slovenia

Slovenian Society of Cardiology

Miran Kenda

Slovenia

Heart and Stroke Foundation South Africa

Richard Cramer

South Africa

The South African Heart Association

Bongani Mayosi

South Africa

Spanish Heart Foundation

Eduardo de Teresa Galván

Spain

Spanish Society of Cardiology

Maria Jesús Salvador Taboada

Spain

Sri Lanka Heart Association

S. J. Stephan

Sri Lanka

Swedish Heart Lung Foundation

Anna-Karin Lundin

Sweden

Swedish Society of Cardiology

Anna Engström-Laurent

Sweden

Swiss Heart Foundation

Ludwig von Segesser

Switzerland

Swiss Society of Cardiology

Andres Jaussi

Switzerland

Syrian Cardiovascular Association

Moufid Jokhadar

Syria

The Heart Association of Thailand

Pradistchai Chaiseri

Thailand

The Heart Foundation of Thailand

HRH Princess Maha Chakri Sirindhorn

Thailand

Turkish Heart Foundation

Cetin Yildirimakin

Turkey

Turkish Society of Cardiology

Cetin Erol

Turkey

Ukrainian Society of Cardiology

Volodymir Kovalenko

Ukraine

Emirates Cardiac Society

Wael Almahmeed

United Arab Emirates

British Cardiovascular Society

Nicholas Boon

United Kingdom

British Heart Foundation

Sir Peter Morris

United Kingdom

American College of Cardiology

James T. Dove

United States

American Heart Association

Daniel W. Jones

United States

Uruguayan Society of Cardiology

Alvaro Báez

Uruguay

Venezuelan Heart Foundation

Igor Morr García

Venezuela

Venezuelan Society of Cardiology

Bartolomé Finizola Celli

Venezuela

Vietnam National Heart Association

Pham Gia Khai

Vietnam

World Heart Federation Members ASSOCIATE INTERNATIONAL MEMBER An independent incorporated organization active in some aspect of the prevention and control of heart disease and stroke. Organization name

President/Chairman

Country

Association of Black Cardiologists, Inc

Gerald DeVaughn

United States

Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA)

Avenilo P. Aventura

Philippines

Children's HeartLink

Elizabeth Bickel

United States

Eastern Mediterranean Network on Heart Health

Nizal Sarraf-Zadegan

Islamic Republic of Iran

Heart Friends Around the World

Alessandro Scalzini

Italy

Heartfile

Sania Nishtar

Pakistan

International Chinese Heart Health Network

Tan-Hoong Chu Eng

China, Hong Kong

International Council of Nurses

Hiroko Minami

Japan

International Forum for Hypertension Control and CVD Prevention in Africa

Daniel Lemogoum

Cameroon

International Heart Health Society (IHHS)

David MacLean

Canada

International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP)

Christian Schaefer

Germany

International Society for Heart Research

J. M. Downey

United States

International Society for Holter & Non-Invasive Electrocardiology

Sergio Dubner

Argentina

International Society of Cardiomyopathy and Heart Failure

Akira Matsumori

Japan

International Society of Cardiovascular Pharmacotherapy

Antonio Bayés de Luna

Spain

International Society of Cardiovascular Ultrasound

Navin Nanda

United States

International Stroke Society

Geoffrey A. Donnan

Switzerland

Latin Society of Pediatric Cardiology and Cardiovascular Surgery

Pedro L. Ferrer

Panama

ProCOR/Lown Cardiovascular Research Foundation

Bernard Lown

United States

The International Society on Hypertension in Blacks (ISHIB)

Charles L. Curry

United States

The Society of Chest Pain Centers and Providers

J. Lee Garvey

United States

The World Heart Failure Society

Willem J. Remme

The Netherland

ASSOCIATE NATIONAL A national society devoted to aspects of the prevention and control of heart disease and stroke or with aims similar to those of the World Heart Federation. Organization name

President/Chairman

Country

Academy of Cardiology at Mumbai

Dev. B. Phalajani

India

Cardiovascular Society of India

A. B. Mehta

India

Foundation for Lay Education on Heart Diseases

Adolfo B. Bellosillo

Philippines

Heart Care Foundation Comilla

Abu Hamid

Bangladesh

Heart Research UK

David Watson

United Kingdom

Indonesian Cardiocerebrovascular Society

Lukman Makmun

Indonesia

Norwegian Heart and Lung Patient Organization (LHL)

Svein Erik Myrseth

Norway

World Heart Federation members / 15

WORLD HEART FEDERATION JOURNALS

Nature Clinical Practice Cardiovascular Medicine, a peerreviewed journal for cardiologists, is an official publication of the World Heart Federation. It delivers timely interpretations of key research developments, translating the latest findings into clinical practice. Our Editor-in-Chief, Valentin Fuster, MD, PhD, and the journal’s international Advisory Board ensure comprehensive coverage of topical issues throughout the year, with the highest standards of editorial quality and integrity that are hallmarks of the Nature Publishing Group. Published monthly in print and online, Nature Clinical Practice Cardiovascular Medicine features unique content designed to be of real, practical value in making diagnosis and treatment decisions. Content includes editorial and opinion pieces, highlights from the current literature, commentaries on the application of recent research to practical patient care, comprehensive reviews, original clinical research and in-depth case studies. Content is subject to rigorous peer-review. For more information about the journal, its Advisory Board and its aims and scope, visit www.nature.com/ncpcardio Visit the World Heart Federation booth to collect your free copy of Nature Clinical Practice Cardiovascular Medicine. ­

Valentin Fuster, MD, PhD Editor-in-Chief

As the official journal of the World Heart Federation, CVD Prevention and Control (formerly “Prevention and Control”, now re-launched under a new title) continues to provide a forum for dialogue and education on matters relating to the prevention and control of cardiovascular diseases worldwide, with a special focus on countries with middle and lower economies. Now in its fourth year of publication, the response to this new niche journal has been very encouraging. In line with the mission of the World Heart Federation, CVD Prevention and Control has become a priority journal for all who wish to contribute to the advancement of knowledge in cardiovascular diseases and to help halt the spread of this epidemic worldwide.

CVD Prevention and Control CVD Prevention and Control is organizing a Writers’

Workshop during the World Congress of Cardiology 2008 in Buenos Aires, Argentina. This half day workshop is primarily intended for those from developing countries who want to publish in scientific journals. Participants will receive information on how to organize and write a manuscript for publication as well as information on how manuscripts are processed through the Elsevier Electronic system. The aim and scope of the journal will be discussed and a part of the session will be focused on interactions with a successful writer. This workshop is being held on Monday, May 19, 2008 from 9.30 –12.30. The number of participants is limited to 40. On Monday, 19 May at 13.30, Andy Wielgosz, the Editorin-Chief of CVD Prevention and Control will be holding a “Meet the Editor” session at the World Heart Federation booth. This is an opportunity for you to discuss the journal and find out how you can submit a paper to the journal.

Andy Wielgosz, MSC, MD, PhD Editor-in-Chief

For further details, please visit: www.precon-journal.com

CLINICAL PRACTICE

Calling now for original research submissions

Maximise the visibility and impact of your research by submitting to Nature Clinical Practice Cardiovascular Medicine and be one of the first to be published in our new Clinical Research section.

www.nature.com/ncpcardio/originalresearch

13409-12_WCC final programme ad.indd 1

18/3/08 17:09:55

The Argentine Society of Cardiology (SAC) General information The Argentine Society of Cardiology (SAC), founded in 1937, is a member of the World Heart Federation, the Interamerican Society of Cardiology, the South American Society of Cardiology and is affiliated to the European Society of Cardiology. It is one of the world's oldest cardiology societies. Its members include many prestigious historical figures internationally recognized for their contributions to science, such as the Nobel Prize winner Dr. Bernardo Houssay and Drs Eduardo Braun Menéndez, Pedro Cossio, Alberto Taquini, Mauricio Rosenbaum and Rene Favaloro. Over its 70-year history, it has been responsible for a rich history of scientific achievements – both educational and within the community. Each year, the Argentine Society of Cardiology organizes the Argentine Congress of Cardiology. 10,500 participants attended the 34th meeting in October 2007, including some of the most important international figures in the world of cardiology. In 1974 the SAC jointly hosted the 7th World Congress of Cardiology and in 1999 the 17th International Congress of Cardiology – setting the scene for the partnership this May, once again playing an active role in the World Congress of Cardiology.

The Argentine Society of Cardiology has more than 6,500 members in various categories including doctors, nurses and technicians. It has 36 Regional Districts spread over the entire national territory and 17 scientific councils representing all the subspecialties of cardiology. It conducts continuous and intensive teaching with courses in all subspecialties, grants the certification of “University of Cardiology“ with various universities and conducts a programme of recertification training. Other important areas of its role include research, with epidemiological surveys, clinical research studies and the Consensus which sets standards for diagnosis and treatment of major cardiovascular diseases. The society acts as advisor to both legislative chambers of the national parliament and also established a community programme for the general population, the Argentine Foundation of Cardiology, to educate and prevent cardiovascular disease as well as running and dictating courses on cardiopulmonary resuscitation.

Argentine Society of Cardiology Board President Eduardo Mele, MD 1st Vice-President Ricardo Iglesias, MD 2nd Vice-President Walter Santander, MD Secretary Fernando Sokn, MD Vice Secretary Antonio Pocoví, MD Treasurer Víctor Mauro, MD Vice Treasurer Rodolfo La Greca, MD Members at Large Horacio Pomés Iparraguirre, MD C. Sara Berensztein, MD María Inés Sosa Liprandi, MD Carlos Farinelli, MD Andrés Mulassi, MD Héctor Sequeira, MD Mirta Diez, MD Enrique Pautasso, MD Past President Osvaldo Masoli, MD

Revista Argentina de Cardiología (RAC) (Argentine Journal of Cardiology) The journal was created in 1934, and as of 1937, when the Argentine Society of Cardiology was founded, it became its official publication.

Argentine Society of Cardiology Projects Medical continuous education and investigation are the chief advocacies of the Argentine Society of Cardiology. Current projects include: the organization of the next Argentine Congress of Cardiology and Meeting of the Regional Districts in 2009, the interactive programme for continuous training, PROSAC, and the promotion of clinical investigation, teaching and counselling on different aspects of methodology and biostatistics, among others.

For more information about the Argentine Society of Cardiology, please visit www.sac.org.ar

Many original scientific papers from different specialities, editorials, clinical cases, review articles, controversies, articles of opinion and images in cardiology are published in the Journal. There is also a section devoted to letters from the readers. In the RAC´s web page (www.revista.sac.org.ar ) all editions from 1993 onwards can be found, with all articles available at full free access. It includes English versions of original papers and the English version of the whole Journal will be available soon. It is indexed in SciELO, LILACS, Latindex and DOAJ.

The Argentine Federation of Cardiology (FAC) The Argentine Federation of Cardiology (FAC) is a scientific institution comprised of 37 cardiology organizations and 11 delegations from the Republic of Argentina and currently reaches more than 6’000 members. Its mission is to promote the harmonious and integrated development of Argentine cardiology to promote cardiovascular health. The FAC was founded in 1965 by a group of prominent cardiologists from the following Argentine northeast provinces representing the six cardiology organizations existing at the time: Córdoba, Rosario, Mendoza, San Juan, Tucumán and La Plata. A Society of Societies was formed, structured as a federation, in which every federate society kept their autonomy and independence, with equal representation and decision among the Federal National Council, its leadership body. Its first president and "alma mater" was Prof, Dr, Ricardo Podio from Cordoba, who was then succeeded by members of the Society of Cardiology from Rosario, Mendoza, Córdoba, La Plata, Tucumán, Salta, Buenos Aires and Neuquén. In over 40 years, the organization has carried out intensive work to accomplish its goals in the development and progress of cardiology throughout the country. Since its foundation, many prestigious scientists such as Dr. René Favaloro and others, have joined FAC, thus contributing to its mission.

In this field, FAC has signed several arrangements with different universities and ministers of health across the country, in order to develop a proper process of specialty certification. Annually, FAC organizes the National Cardiology Congress in different provinces, through a predefined rotation system, and the mentioned congress has become one of the most important cardiology events. The next FAC Congress will take place in May 2009, and the usual attendance is about to 7’000 cardiologists, technicians and nurses. Its Center for Teleinformática (CETIFAC) was established in 1995 to develop communication between different federate societies, as well as with several cardiologic centers from abroad. Its achievements include the 5th Congress of Virtual Cardiology, a pioneer activity on the Internet. It also works closely with the CARDIO Foundation dealing with subjects related to the prevention of cardiovascular diseases and health education in the community. Recognized in several worldwide scientific fora, with many of its members participating in international scientific meetings, FAC continues working in pursuit of a range of goals and always under the ideals set by its founders. For more information about the Argentine Federation of Cardiology, please visit www.fac.org.ar

Currently FAC has a total of 22 scientific committees with subspecialties devoted to research and scientific output. It publishes a hierarchical Scientific Magazine, in which prestigious national and foreign authors contribute. Through its educational programmes, it develops regular activity focusing on immediate postgraduate education.

Argentine FEDERATION of Cardiology BOARD President Luis Alberto Guzmán, MD 1st Vice-President Héctor Luciardi, MD 2nd Vice-President Domingo Pozzer, MD Secretary Guillermo Azize, MD Treasurer Miguel Chiappe, MD Vice Secretary Juan Muntaner, MD Vice Treasurer Sergio Chain, MD Members at large Carlos Volonté, MD Eduardo Conci, MD Rodolfo Sarjanovich, MD Graciela Scaro, MD Horacio Sismondi, MD

Hosting organizations / 19

World The World Heart Federation is committed to helping the global population achieve

Heart a longer and better life through prevention and control of heart disease and stroke,

Federation with a particular focus on low and middle-income countries.

Come and visit us at our booth www.worldheart.org

CONGRESS SCHEDULE TIME Sat. 17 May, 2008 Sun. 18 May, 2008 Mon. 19 May, 2008 Tues. 20 May, 2008 Wed. 21 May, 2008 TIME

6:30 6:45

6:30 6:45

7:30 INDUSTRY INDUSTRY INDUSTRY 7:45

7:15 7:30 7:45

7:00 7:15 CLOSED CLOSED CLOSED

8:00 8:15

8:30 8:45 Oral Oral Oral 9:00 Abstract Abstract Abstract 9:15 Sessions Sessions Sessions 9:30 9:45 R R E P R E P P R E P 10:00 E E X O E X O U E X O 10:15 PUBLIC G G H S G H S B G H S 10:30 EVENT I I I T I I T L I T I 10:45 10km run & S B E S S B E I S B E 11:00 SESSIONS T I R C SESSIONS SESSIONS 3km walk T T I R I R T 11:15 R R T S R T S R T S 11:30 E A A I A I I A 11:45 V T T O T O T O 12:00 E I I N I N I N 12:15 N SATELLITE O O O SATELLITE O SATELLITE 12:30 T SCIENTIFIC N N N SCIENTIFIC N SCIENTIFIC 12:45 ACTIVITIES ACTIVITIES ACTIVITIES T PUBLIC 13:00 (INTER(INTER(INTERH EVENT 13:15 SESSIONS) SESSIONS) SESSIONS) E CPR 13:30 M COURSES 13:45 A 14:00 T 14:15 I 14:30 SESSIONS SESSIONS C SESSIONS 14:45

15:00 R E



7:00 8:00

8:15 8:30 8:45

9:00

9:15 9:30 9:45

10:00

10:15 10:30 10:45

11:00

11:15 11:30 11:45

12:00

12:15 12:30 12:45

13:00

13:15 13:30 13:45

14:00

14:15 14:30 14:45

15:00

15:15 E V 15:30 G E 15:45 I N S 16:00 T T 16:15 R SESSIONS SESSIONS SESSIONS 16:30 A 16:45 T 17:00 I 17:15 O 17:30 N 17:45

15:15 15:30 15:45



X 18:15 OPENING H EXHIBITION SATELLITE SCIENTIFIC SATELLITE SCIENTIFIC 18:30 OPENING CEREMONY I ACTIVITIES ACTIVITIES 18:45 B (EVENING SESSIONS) (EVENING SESSIONS) I 19:00

18:15 18:30 18:45

20:00

20:00

E 18:00



T

16:00

16:15 16:30 16:45

17:00

17:15 17:30 17:45

18:00 19:00

19:15 I 19:30 O N 19:45

19:15 19:30 19:45



20:15 20:30 20:45

20:15 20:30 20:45



21:15 GALA DINNER 21:30 (BY PAYMENT OR 21:45 INVITATION ONLY)

21:15 21:30 21:45



22:15 22:30 22:45

21:00

OFF-SITE 22:00

22:15 22:30 22:45

23:00

21:00

22:00 23:00

Congress schedule / 21

Building New Strategies in Acute Tuesday, May 20, 2008 17:30 – 18:00 Reception 18:00 – 19:30 Symposium

Ganges Room

La Rural Convention & Exhibition Centre Av. Sarmiento 2704 Palermo Buenos Aires, Argentina

Organized by

Decompensated Heart Failure Faculty Nadine Clausell, MD, PhD (Co-Chair) Associate Professor of Medicine Federal University of Rio Grande do Sul Porto Alegre, RS, Brazil

Sergio V. Perrone, MD (Co-Chair)

Medical Director — Intrathoracic Transplant & Heart Failure Division FLENI Institute Buenos Aires, Argentina

Uri Elkayam, MD

Professor of Medicine University of Southern California, Keck School of Medicine Los Angeles, California

J. Thomas Heywood, MD, FACC

Clinical Professor of Medicine Loma Linda University School of Medicine Loma Linda, California

Fábio Vilas-Boas, MD, PhD Chief Cardiology Division Hospital Espanhol Salvador, BA, Brazil

Programme Overview Acute decompensated heart failure (ADHF) is associated with prolonged in-hospital lengths of stay, high rates of hospital readmission, and substantial rates of inpatient and outpatient morbidity and mortality. In Latin American countries, the incidence of heart failure is rising, and ADHF has not been as well characterized as chronic heart failure. An awareness of unmet needs in ADHF management is therefore useful to improve the process of care in this patient population. Goals of therapy for ADHF include relieving symptoms, reversing acute hemodynamic abnormalities, initiating evidence-based therapy, reducing length of stay, and preventing rehospitalization. Treatment recommendations are generally based on the patient’s fluid volume status and cardiac output. It is therefore critical for cardiologists to be aware of when to use various intravenous therapies for improving hemodynamics and acute heart failure signs and symptoms. One such agent is the vasodilator nesiritide, a purified preparation of human B-type natriuretic peptide (hBNP), which reduces pulmonary capillary wedge pressure and improves dyspnea in patients with ADHF who have dyspnea at rest or with minimal activity. This program will help Latin American cardiologists understand the challenges in managing ADHF and effective therapeutic strategies for treating patients with different hemodynamic and clinical profiles. In addition, faculty members will describe and demonstrate through case presentation the appropriate use of nesiritide in patients with ADHF.

Agenda 17:30 – 18:00 18:00 – 18:05

18:05 – 18:15

Reception Introduction (Co-chairs) Nadine Clausell, MD, PhD Sergio Perrone, MD

Focus on Latin America: Unmet Needs in Acute Decompensated Heart Failure Management Nadine Clausell, MD, PhD

18:15 – 18:35

Current Treatment Options for Acute Decompensated Heart Failure

18:35 – 18:55

Nesiritide Therapy for the ADHF Patient

18:55 – 19:15

Case Presentation and Panel Discussion

19:15 – 19:30

Question and Answer

Uri Elkayam, MD

J. Thomas Heywood, MD

Moderator: Uri Elkayam, MD Panelists: Nadine Clausell, MD, PhD, Sergio Perrone, MD, Fábio Vilas-Boas, MD, PhD, J. Thomas Heywood, MD

CONGRESS INFORMATION

How to get to the congress venue By shuttle service A shuttle service running every 15 minutes, will be available between the congress venue and the main hotel area at key times. Date

Hours of service

Sunday, 18 May

16.30 – 21.30

Monday, 19 May

07.00 – 10.00 17.00 – 20.00

Tuesday, 20 May

07.00 – 10.00 17.00 – 20.00

Wednesday, 21 May

07.00 – 10.00 16.00 – 18.00

There are four different routes. Please see below the shuttle bus map and the schedule for each route. Please be aware of the following: ••When returning from the La Rural Convention Centre buses will stop on the opposite side of the Avenue due to traffic regulations ••Frequency may vary during rush hour

How to get to the congress venue ROUTE 1 – YELLOW 34

Hotel InterContiental **

35

Reino Del Plata Hotel

37

NH City

38

562 Nogaró Hotel

44

Gran Boulevard Hotel

45

Hotel de las Luces

72

Argentino Hotel **

36

Imperial Park

39

Tribeca

40

Amerian Congreso

41

Apart Hotel & Spa Congreso

42

Castelar

43

Golden Tulip Savoy

48

Sarmiento Palace

67

Hotel Salles

12

Pestana **

7

Sheraton Libertador

8

Regente Palace Hotel

13

El Conquistador

14

Presidente

27

Shuttle service starts Sunday

Mon, Tue & Wed

16.30

7.00

16.35 – 16.40

07.05 – 07.10

16.45 – 16.50

07.15 – 07.20

17.30

7.40

Loi Suites Esmeralda Arrival at La Rural Congress Centre

** Indicates official shuttle pick-up and drop-off location

ROUTE 2 – ORANGE 15

Panamericano **

10

Hostería Posta Carretas

16

Argentina Tango Hotel

17

Art Deco Suites

18

725 Continental Hotel

19

Broadway All Suites

20

NH Latino

21

Obelisco Center

22

Park Central Kempinski

23

Mayflower Suites

46

Intersur Suites

24

Hotel Embajador **

25

Bel Air

26

Carlton

30

Argenta Tower

31

Loi Suites Arenales

33

Impala

47

Design Suites Lenguas Vivas School – Carlos Pellegrini 1515 **

29 62

Shuttle service starts Sunday

Mon, Tue & Wed

16.30

7.00

16.35 – 16.40

07.05 – 07.10

16.45 – 16.50

07.15 – 07.20

17.30

7.40

Four Seasons Emperador Arrival at La Rural Congress Centre

** Indicates official shuttle pick-up and drop-off location

Congress information / 25

How to get to the congress venue ROUTE 3 – BLUE 51

Madero By Sofitel **

52

Faena Hotel

50

Hilton Buenos Aires ** Plaza Roma – Leandro N Alem & Lavalle **

3

Meliá Buenos Aires

4

Holiday Inn Express Puerto Madero

9

Regal Pacific

53

NH Jousten

54

Lafayette

55

Liberty

56

Claridge

57

Amerian Buenos Aires Park

58

NH Lancaster

60

Tryp Buenos Aires

61

Gran Hotel Buenos Aires Arrival at La Rural Congress Centre

Shuttle service starts Sunday

Mon, Tue & Wed

16.30

07.00

16.35 – 16.40

07.05 – 07.10

16.45 – 16.50

07.15 – 07.20

17.30

07.40

** Indicates official shuttle pick-up and drop-off location

ROUTE 4 – RED 1

Sheraton Buenos Aires **

2

Marriott Plaza

5

Howard Johnson Plaza

6

Waldorf

11

Sheltown

28

NH Crillon

59

NH Florida

68

Hotel Promenade

74

Meliá Buenos Aires Hotel

71

Caesar Park **

32

Howard Johnson Recoleta

63

Plaza Francia

64

Alvear Palace

65

Melia Recoleta

66

Ulises Recoleta

70

Shuttle service starts Sunday

Mon, Tue & Wed

16.30

07.00

16.40 – 16.45

07.10 – 07.15

17.30

7.40

Temporary Apartments Arrival at La Rural Congress Centre

** Indicates official shuttle pick-up and drop-off location

How to get to the congress venue By subway There are five “subtes” lines (abbreviated name for subterraneo/subway). Subway lines are connected with the main avenues, railway and bus stations. Each ticket may be used on all the subway lines.

By taxi Taxis can be called by phone or hailed directly in the street. Radio taxis are considered the best option. Taxis can be easily recognized by their colours, black and yellow, and a red light on the taximeter indicates that they are available.

The main subway line from the hotel area to La Rural Convention & Exhibition Centre is the “Subte Linea D” with “Plaza Italia” as the stop. Delegates can buy discounted metro tickets (MONEDERO) at the registration area.

Please see below the recommended radio taxi companies that major hotels work with: EL PORTEÑO: +54 11 4566 5777 PREMIUM: +54 11 4374 6666 SU TAXI: +54 11 4635 6089

It is highly recommended that you use only black and yellow taxis or taxi companies that work with leading hotels.

Congress information / 27

About the congress Centre La Rural Address La Rural Convention & Exhibition Centre Av. Sarmiento 2704 Palermo Buenos Aires, Argentina Exhibition opening hours Sunday, 18 May, 2008 Monday, 19 May, 2008 Tuesday, 20 May, 2008 Wednesday, 21 May, 2008

18.00 – 20.00 09.00 – 18.00 09.00 – 18.00 09.00 – 18.00

Session rooms To highlight the international nature of the World Congress of Cardiology all session rooms have been named after rivers. Session rooms are shown on the WCC 2008 Floor Plan on the inside front cover. Please note that seating in the session rooms is on a first-come, first-served basis. We recommend therefore that you go to the session room well before your session begins. Due to safety policies of La Rural, the access to the session rooms will be denied once the room is filled to its maximum capacity. Language English is the official language of the congress. However, a track line presented during the South American Congress of Cardiology will be held in Spanish. Simultaneous translation (English-Spanish and Spanish-English) will, however, be provided in the following rooms: Main Auditorium “Rio de la Plata”, Danube and Thames.

Tobacco Free Policy Tobacco smoking is a major cause of preventable early death throughout the world. Cigarette smokers have almost double the risk of dying from coronary heart disease compared with non-smokers. Exposure of non-smokers to environmental tobacco smoke is increasingly suspected as being a cause of coronary heart disease. The World Heart Federation aims to promote the reduction in the prevalence of smoking globally. Workplaces, community, health care, educational institutions, food industry, health professionals and governments are important settings for implementing this policy. All premises occupied by the World Heart Federation, including those that are used temporarily by the World Heart Federation, shall be smoke-free. The WCC Congress Committees thank all participants and exhibitors for not smoking in the Congress Centre “La Rural” and its immediate surroundings at all times. Disclaimer The Congress organizers will accept no liability for personal injuries sustained by, or for loss or damage to property belonging to Congress participants, or other unforeseen circumstances either during or as a result of the Congress or during all tours and activities. It is therefore recommended that participants, as well as companies, arrange their own personal health, accident and travel insurance property loss, damage insurance or any other necessary insurance. ICS Congresos Internacionales S.A. and Bounty Travel Service act as agents and cannot be held responsible for any loss, injury or damage to any person or property whatever the cause may be. The liability of persons and companies providing means of transportation or other services, however, remains unaffected.

Registration Registration opening hours To collect your badge in the registration area, please bring a copy of your letter of confirmation, in order to facilitate the process. Participants can register on-site during the following opening hours: On-site registration opening hours: Saturday, May 17, 2008

15.00 – 18.00

Sunday, May 18, 2008

09.00 – 18.00

Monday, May 19, 2008

08.00 – 18.00

Tuesday, May 20, 2008

08.00 – 18.00

Wednesday, May 21, 2008

08.00 – 18.00

Fees Registration fees are payable in US Dollars and are inclusive of VAT. FEE CATEGORY

On-sitE REGISTRATION FEE

Standard Fee

USD 790

Technician/Nurse/Trainee

USD 400

Latin-American and Caribbean Delegate

USD 790

Latin-American and Caribbean Technician/Nurse/Traineea

USD 400

Argentine Delegate

USD 790

a

Argentine Technician/Nurse/Trainee

USD 400

Heart Foundation Professional

USD 400

Accompanying Person’s Programmme

USD 345c

a

b

a. With a letter of approval from your university or hospital. IMPORTANT FOR TRAINEES: Registration will be processed only upon presentation of a copy of your degree/licence sent with the registration form (5 years maximum since graduation) b. With a letter of approval from the World Heart Federation c. According to availability

Delegate registration fees include: ••Congress badge ••Congress bag with the WCC 2008 Final Programme ••Full access to the exhibition and scientific sessions ••Access to the opening ceremony (limited seats available)

ATTENTION ITALIAN DELEGATES Please note that Alijet & Fargo International has been authorized to collect and deliver to the department of Public Health in Rome, Italy, all application forms from these delegates who will attend the WCC 2008.

Accompanying person fees include: ••Access to the exhibition ••Access to the opening ceremony (limited seats available) ••Half day city tour, Tigre Delta Cruise and Cultural tour ••Scientific sessions are not open to accompanying persons.

Contact: Alijet & Fargo International S.r.l. Via Petro Maroncelli 44/46 50137 Firenze – Italy Tel. +39 055 600555 Fax +39 055 609078 Contact person: Fawn Sarkisian [email protected]

Registration / 29

Registration Badges Participants and accompanying persons are kindly asked to wear their badge during all congress activities. Entry will not be permitted without a badge. Replacement of lost badges incurs an administrative charge of USD 100 (+VAT). Name changes Participant names may be changed with a handling fee of USD 50 (+VAT) along with a newly completed registration form for the replacement participant and with a written permission from the original participant that the name change has been approved. Colour code of badges:

Delegate – White Accompanying person – Grey WCC Exhibitor – Green WCC Staff – Red WCC Faculty – Orange Press – Purple

Visitor tracking system All active delegate badges contain a bar code, which acts as an electronic business card. Participants are therefore able to leave their contact details for exhibitors very quickly and easily. Please note that group registration data is subject to corporate companies completing the details of their delegates and whilst WCC encourage this, we cannot guarantee the quality of group registrations provided by industry.

Cancellation and refunds For cancellations received in writing prior to 15 April, 2008 the paid registration fee will be reimbursed, less a 25% administration fee. No refunds will be issued after that date. Reimbursements will be forwarded 60 days after the Congress ends. Choice of journals All delegates of the World Congress of Cardiology 2008 are eligible to receive a special subscription rate to the following journals. Fees stated in USD (US Dollars). ••Nature  Clinical Practice Cardiovascular Medicine Journal at USD 50 for a one-year subscription ••CVD  Prevention and Control Journal at USD 50 for a one-year subscription ••Revista  Argentina de Cardiologia Journal at USD 50 for a one-year subscription ••Revista de la Federacion Cardiologica Argentina Journal at USD 50 for a one-year subscription Please find more information on Nature Clinical Practice Cardiovascular Medicine and CVD Prevention and Control on page 16. Certificate of attendance Attendance certificates for delegates can be found in each congress bag.

Media and press The WCC Press Centre is located in the Ocre Pavillion. It will be open from 15.00 – 18.00 on 17 May, 08.00 – 20.00 on 18 May and on the 19, 20 and 21 May, from 08.00 – 18.00, or later. A press badge is required to enter this facility. This badge also gives access to the scientific sessions. In order to be granted a complimentary press badge for the WCC 2008, journalists have to register beforehand. Your press badge will be available for you to collect on-site at the press registration area. To collect your badge you will be asked to show photo identification such as a passport, so please have this with you. During the Congress you will have the opportunity to learn about the latest science advances on the management of cardiovascular diseases and to review effective approaches to tackling the rising burden of cardiovascular disease

globally. These include, for example public policy and advocacy, the development of the polypill, a focus on women and CVD and youth tobacco advocacy. The scientific programme will feature globally relevant topics in the diagnosis, management and treatment of cardiovascular disease, including basic clinical and population research. The Scientific Programme includes Symposia, Debates How to & Workshop Sessions and Clinical Seminars. Around 250 scientific sessions will be presented in the main programme, abstract based programme, or in one of the special sessions. Another important feature of the WCC programme is the Spanish Sessions track. Press enquiries should be directed to Victoria Dix ([email protected])

Visual reproduction policy The WCC organizers reserve the right to film all presentations during the WCC 2008. Photographing or videotaping scientific sessions is not allowed on the WCC

congress site, except with specific prior permission of the WCC organizers.

Congress material WCC Final Programme Each delegate will receive one copy of the WCC Final Programme with their congress bag. Additional copies can be purchased in the registration area on the final day of the congress, subject to availability, for USD 10 per copy. The WCC Final Programme is also available on the WCC 2008 Website www.worldcardiocongress.org WCC Programme at a Glance Your copy of the WCC Programme at a Glance is given to you with your congress badge. It is your easy instant summary of the key scientific programme activities. Once you have located a session in the WCC Programme at a Glance, refer to the WCC Final Programme for more detailed information.

WEBCASTS Certain official WCC 2008 Scientific Sessions will be webcasted by Prous Science. These sessions will be accessible on the WCC Congress website www.worldcardiocongress.org approximately one week after the congress. WCC 2010 FIRST Announcement Please come and see the World Heart Federation booth on Wednesday, 21 May in order to retrieve the First Announcement for the next WCC in 2010.

WCC Abstracts All abstracts have been published in the online version of the official American Heart Association Journal “Circulation”. For more information, please visit www.circ.ahajournals.org. In addition, all delegates may collect their personal electronic copy of these abstracts on CD Rom from the Boehringer Ingelheim booth in the exhibition hall. To collect your free copy, please go to their booth with your voucher which you will find in your congress bag. The WCC would like to thank Boehringer Ingelheim for their financial support towards the production and distribution of the abstract CD Rom.

Farbe/colour: PANTONE 288 CV Congress information / 31

WCC on-site services Cyber corner Internet access will be provided at selected locations throughout the congress venue. They can be used by all delegates free of charge for a limited time period to access the internet. Business centre Printing, copying and other office requirements can be handled at the business centre located within the exhibition area. Mobile phones For mobile phone rentals, please visit www.phonerental.com.ar or refer to page 33. First aid Delegates in need of medical treatment should contact the First Aid Point located near the registration area. Cloakrooms Cloakroom service for clothing and reasonable-sized items is available during the opening hours of the congress in the exhibition hall. There will be a daily charge of ARS 5 or USD 2 for each item left in the cloakroom. Valuable items should not be left in the cloakroom. Please ensure to collect all your belongings at the end of the day. Food and beverage outlets Please refer to the map to locate different food and beverage points throughout the congress venue. All food and beverage facilities will be open during the day to serve drinks, snacks and lunch. Payments can be made by cash (in ARS and USD) or credit card.

Hotel information desk/Gala dinner and tours desk Desks for information about hotels, Gala dinner ticket sales and tours will be located in the registration area. Message centre A message centre will be located behind the Amazon Room. It can be used by all delegates free of charge for leaving messages for other delegates. Info points WCC info points are located throughout the congress centre. Please refer to the WCC 2008 Floor Plan on the inside front cover for their exact location. Parking Underground parking can be accessed 24 hours from two different entrances: via the Sarmiento Avenue and via the Cerviño Street. Approximately 1,000 cars can be parked at the La Rural Congress Venue. The following rates will apply: 1 hour – USD 2.50, 12 hours – USD 12, 24 hours – USD 15. Future events booth In order to share knowledge and make you aware of other national and international cardiology congresses, please make sure to drop by the future events booth in the exhibition hall. Transport for disabled persons Special transport facilities within La Rural will be provided for disabled persons.

Lost and Found A lost and found office will be available for delegates.

CONTACT INFORMATION Registration, Accommodation, Sponsorship (local and logistics), Tourism and Social Events ICS Congresos Internacionales S.A. C. C. (P. O. Box) 73, C1084ZAA, Buenos Aires, Argentina   Phone: +54 11 4812 3444 Fax: +54 11 4813 0073 E-mail: [email protected] Registration [email protected] Accommodation [email protected]

Scientific Programme World Heart Federation 7 Rue des Battoirs, CP 155­­ 1211 Geneva 4, Switzerland Phone: + 41 22 807 0320 Fax: + 41 22 807 0337 [email protected]

www.worldcardiocongress.org

Social programme

WCC 2008 Opening Ceremony Sunday, 18 May, 2008 – 18.00 – 20.00 – Rio de la Plata, Red Pavillion, La Rural Congress – Exhibition Centre (Overflow in meeting rooms of the Yellow Pavillion)

Also enjoy a unique Argentine tango performance!

Opening speeches by: Horacio Faella, Shahryar Sheikh, Sidney Smith, Felipe Martínez, Arturo Cagide, Eduardo Mele, Luiz Guzman and Argentine authorities

WCC 2008 Opening Reception Sunday, 18 May, 2008 at 20.30 – Room Libertador, Sheraton Buenos Aires Hotel, San Martin 1225/1275, Retiro, Buenos Aires

Buses will depart from the La Rural main entrance (Sarmiento Avenue) immediately after the Opening Ceremony

Entrance by invitation only

Dress code: Smart casual, please wear something red

WCC 2008 Gala dinner Tuesday, 20 May, 2008 at 20.00 – Hilton Buenos Aires, Macacha Guemes 351, Puerto Madero, Buenos Aires

Buses will depart from the Sheraton Buenos Aires Hotel (San Martin Avenue) as of 19.00 up to 19.30

Access to the WCC 2008 Gala Dinner requires an invitation or a pre-purchased ticket. Your tickets can be collected from the registration area from Sunday, 18 May, 2008 from 10.00.

Dress code: Business attire

WCC 2008 Community activities In celebration of the World Congress of Cardiology, there are several public events that will run in parallel to the Congress. These will be coordinated by the Argentine Foundation of Cardiology and the CARDIO Foundation who are pleased to propose the following activity programme. All of the activities are intended for the community and you are invited to join in. On Saturday, May 17, 2008 between 9.00 and 18.00 mass group CPR courses are planned in the park located on Av. Sarmiento and Av. Del Libertador, close to “Monumento a los Españoles”. There will be 40-minute courses running throughout the day – allowing attendees to be trained in Basic Cardiopulmonary Resuscitation procedures. The activity will be carried out in a 200m2 tent and the aim is to make people aware of the importance of knowing the proper basic Cardiopulmonary Resuscitation procedures in case of an emergency situation. (Registration: Argentine Foundation of Cardiology [email protected] - +54 11 4961 6520 / 9388) On Sunday, May 18, 2008 the Argentine Foundation of Cardiology and the Cardio Foundation are organizing a 10 km competitive run and 3 km aerobic walk at the Bosques de Palermo. These activities will take place from 9.00 – 13.00.

The run is expected to gather approximately 3,000 professional runners and the walk about 7,000 people. The aim is to promote the importance of physical exercise in order to prevent cardiovascular disease and to improve the quality of life whilst developing healthy habits from an early age and maintaining them throughout your life. The general goal of these activities is to spread the importance of preventing cardiovascular diseases to the Argentine community, as prevention is one of the major topics being discussed during the World Congress of Cardiology. On Tuesday, May 20, 2008 visit the Thematic tent at Plaza de la República (Obelisco) from 09.00 – 18.00. There will be arterial pressure, waistline, cholesterol and glycemia measurements, with leaflets and brochures containing general tips. There will also be a press area, with armchairs and a backpanel with logos of the societies involved. The media are invited to cover the activity so as to get a strong understanding of the themed agenda. Material for this activity has included donations from laboratories: lancets and reagents for cholesterol control, stethoscopes, tape measure and scales for determining BMI. Media: Press releases, information and invitations for all means of communication: press, radio and television. Publicity, promotional material and flyers have been sent by e-mail to both foundations’ data bases.

WCC 2008 Community Activities / 35

ABOUT ARGENTINA & BUENOS AIRES About Argentina Argentina has a wealth of natural beauty and immensely varied scenery. It covers an area of over 1 million square miles and is the second largest country in South America. In the north there are the hot Chaco grasslands and tropical jungle and in the south the Antarctic ice of Tierra del Fuego. A visit to Iguazu Falls, the largest and most extensive in the world, can be combined with a horseback ride on the Pampas, whale watching in the south, a visit to the amazing Moreno glacier and the capital, Buenos Aires. VISITING BUENOS AIRES The cultural capital of South America, Buenos Aires, is located on the eastern banks of the River Plate, the largest river in the world. The city has a cosmopolitan atmosphere, although being a modern city; it includes turn-of-thetwentieth-century European style buildings. It also has some well preserved districts of typical colonial architecture. Buenos Aires inhabitants are called “porteños” which makes reference to the fact that the city is a port. Buenos Aires has everything to transform your visit into a wonderful experience. We strongly recommend that you make reservations in advance with Bounty Travel, as availability for tours is limited. Further information about Bounty Travel Tours and reservations can be found either at www.bts.com.ar or at the tours information desk in the registration area. CLIMATE The climate of Buenos Aires is mild all year round. The mean annual temperature is 18ºC. Visitors can enjoy walking around the city in any season. On a sunny day in autumn, mornings are chilly; the temperature rises at mid-day and drops again at night. The average temperature for May is 12°C. LANGUAGE The official language in Argentina is Spanish and many locals also easily understand Italian and Portuguese. However, most people involved in tourist activities speak English.

TIME DIFFERENCE The time zone corresponds to GMT-3. BANKS, CURRENCY AND CREDIT CARDS Banks open at 10.00 and close at 15.00 (some banks extend their closing time to 16.00). Cash withdrawals and other transactions may be made at ATMs, 24 hours a day. The tourist subsidiary of Banco Ciudad offers this service to visitors. You can buy and sell US dollars, Euros and travellers’ cheques: Tuesdays to Fridays from 10.00 – 17.00; Saturdays and Sundays from 11.00 – 16.00; Mondays from 10.00 – 18.00. Cashiers are tourist exclusive. The Argentine currency is the peso ($). There are $ 100, $ 50, $ 20, $ 10, $ 5 and $ 2 notes, and 1 peso, 50, 25, 10 and 5 cent coins. The U.S. dollar (USD) is the most common foreign currency. Banks and currency exchange offices (casas de cambio), where you must present your passport, exchange foreign currency. Most of the shops accept credit cards and dollars but it is more convenient to pay by cash with pesos exchanged in casas de cambio or banks. ELECTRICAL POWER Electric power in Argentina is 220 volt, 50-cycle alternating current. Power outlets have two cylindrical holes or two flat holes with ground connection. SECURITY Buenos Aires has the reputation of being a safe city but, as in any other large cities in the world, tourists should take sensible precautions. TOURISM POLICE DEPARTMENT In case of an emergency please call 0800 999 5000 or +54 11 4346 5748 or contact [email protected] English, Italian, French, Portuguese, Ukrainian, Japanese and Spanish are the available languages.

ABOUT ARGENTINA & BUENOS AIRES MAKING PHONES CALLS Buenos Aires has many public telephone booths. Public phones operate with 5, 10, 25, 50-cent and 1-peso coins. Phone cards can be bought at any sweet or tobacco stalls (quiosco). These phones allow local, national and international calls. For international calls, dial 00 + country code + area code + local number. The country code for Argentina is 54, and the area code for Buenos Aires is 11. For example, to call to 4333-6666 from outside the country, you should dial +54 11 4333 6666. USEFUL PHONE NUMBERS ••Police: 101 ••Fire: 100 ••Medical assistance/Emergencies: 107 ••Telephone enquiries: 110 ••Ezeiza International Airport and Jorge Newbery Airport: +54 11 5480 6111

OPENING HOURS Shops are open from Monday through Fridays from 9.00 – 20.00, and Saturdays from 9.00 –13.00; however, shops in main locations are also open on Saturday afternoons. In shopping centres, hours usually extend until 20.00, including Saturdays and Sundays. LEAVING ARGENTINA The VAT rate in Argentina is 21%. As a foreign visitor, you have the right to a refund of the value-added tax included in the price of the articles you export to your country. At the airport you may obtain a VAT reimbursement corresponding to any purchases made within the country for an amount over $70 (per invoice) and in shops operating with the Global Refund system. Please note that your airport tax which is often included in your booking fee may not be included because of Argentinean regulations. You may be asked to pay this in cash at the airport as you are passing through security.

About Argentina & Buenos Aires / 37

TOURS HALF DAY CITY TOUR Half day tour around South America’s most elegant capital, Buenos Aires. On the way you will see Plaza de Mayo and the buildings that surround it: Casa Rosada (Government House), Cabildo Old City Hall, the bustling banking and business district. Then on to see the monumental Congress Building and its square and along 9 de Julio Ave., the widest in the world, the Colon Theatre, the famous Opera House where the most important artists and musicians from all over the world perform. You will also visit San Telmo, la Boca, and its picturesque street “Caminito”, Puerto Madero, Palermo Park with Jacaranda and Palo borracho trees which flower in spring and late summer, the polo field and the race track and the historical Recoleta Cementery with its ornate memorials. Price per person USD 22* TIGRE & DELTA CRUISE Drive through the fashionable riverside suburbs of Olivos, San Isidro, San Fernando to the Tigre district, with its gracious homes, weeping willows, open air restaurants and cafes. With its assorted food vendors and soap-box politics, this is the preferred “playground of the porteños”. Board the ‘Tren de la Costa’ – the Coastal Train – modern train on the old suburban railway line which runs along the coast of the Rio de la Plata towards the delta of the river. All stations have been renovated, keeping the original buildings built by the British. Drive then to San Isidro where a stop will be arranged. Cruise along the waterways and islands of the delta and past "turn-of-the century" stone mansions, English cottages, Italian villas, little wooden shacks painted bright blue and green, ferries, crews practicing in outriggers, lonely canoeists, rowing and yacht clubs. You will enjoy a cruise along innumerable channels before returning to town. Price per person USD 45*

CULTURAL TOUR – MUSEUMS The cultural heritage in Buenos Aires is ever increasing. This tour is a selection of the best art collections of the city. First you will go to the institutional centre, the Fine Arts National Museum. Once you have visited the new and magnificent museum of Latin American modern and contemporary art (MALBA, Costantini Collection), you will go to the tiny and excellent Xul Solar Museum that holds the best works of some of the most prestigious Argentinean artists. Price per person USD 55* FULL DAY FIESTA GAUCHA This tour is the ideal opportunity to absorb the atmosphere of country life at a really colourful Argentine feast in the Pampas. Lunch with renowned Argentine beef and live entertainment by “Gauchos” in their typical dress, dancing to folklore music, will make this a memorable day. Price per person USD 112 *The accompanying person’s programme includes the following local tours: – Half day City Tour – Tigre & Delta Cruise – Cultural Tour Please note that the Fiesta Gaucha Tour is not included. People not participating in the accompanying persons programme will have to pay for all tours.

Tour schedule for Monday, Tuesday and Wednesday TOUR Time

COST PER PERSON

Half day city tour

10.30 – 14.30

USD 22

Tigre and Delta Cruise

10.30 – 15.30

USD 45

Cultural tour

10.30 – 14.30

USD 55

Fiesta Gaucha (Full Day)

09.00 – 17.00

USD 112

We strongly recommend that you make reservations in advance as availability for tours is limited. Further information about the Bounty Travel Tours and their reservation can be found either at www.bts.com.ar or at the tours information desk in the registration area.

SIZING UP THE

H E A RT-H E A LT H Y FA C T S The case for 23 almonds a day. W E ’ R E T H E S N A C K T H AT LO VES HEARTS BACK

should develop.

width: 10mm height: 20mm

It may be news to some, but we’ve known for a long time what a huge difference a handful of California Almonds can make. From being good for your heart to staving off hunger to getting a nutrientrich boost, eating 23 almonds every day (an ounce to be exact) is a hearthealthy habit everyone

O U R G O O D FAT S RUN DEEP Good things happen when you get good fats. And with 9 grams of monounsaturated fat per serving, we’re full of it. In fact, nearly 70 percent of the fat in almonds is monounsaturated, making us one of the leading sources among nuts.

NUTRIENT RICH & EXTRA C R U N C H Y: A TEMPTING C O M B I N AT I O N

WE’RE CHOLESTEROLFIGHTING DYNAMOS

Ounce for ounce almonds are one of the most nutrient-rich nuts around. All nine clinical studies conducted We’d list them all if we had more room. to date indicate that almonds lower But if you’re looking for a tasty snack cholesterol. These groundbreaking { Fig. 1a: Prunus dulcis } that’s an excellent source of three dietary weight: 1/23 oz studies show how a handful of almonds a day nutrients, a good source of three and has consistently lowered LDL cholesterol levels.* 3 grams of fiber, 6 grams of protein per serving while And because people love eating them, almonds packing a heck of a crunch, then we’re your nut. are an ideal way for cholesterol-conscious patients to maintain healthy numbers. If you’ve got time, these clinical studies make fascinating reading. In fact, when the FDA read the research, it influenced their first Qualified

COME VISIT To learn more about almond nutrition research and taste the appeal of almonds, visit the Almond Board of California at booth number 271.

Health Claim for nuts: “Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts, such as almonds, as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease.”

AlmondsAreIn.com

*Find more information at www.AlmondsAreIn.com/9studies

CZlIgZcYh^c8Vi]ZiZg 6WaVi^dcd[6ig^Va;^Wg^aaVi^dc

Workshop Sess�on Objectives

Speakers

To understand today’s role of catheter ablation in patients with atrial fibrillation

Sergio Dubner, MD Professor Buenos Aires, Argentina

To realize the benefit of continuous remote monitoring in these patients

Johannes Brachmann, MD Professor Coburg, Germany

To be familiar with the design of the CASTLE-AF trial for heart failure patients with atrial fibrillation

Location

Date Tuesday, May 20th, 12:45 – 13:30

Room Niger La Rural Convention Center Av. Sarmiento 2704 Buenos Aires

Sponsorship and exhibition Acknowledgements

Exhibition opening hours

The World Congress of Cardiology Buenos Aires 2008 organizers, the World Heart Federation, the Argentine Society of Cardiology and the Argentine Federation of Cardiology, would like to thank all participating organizations for their commitment to the World Congress of Cardiology 2008. This summary overview is correct at time of going to press (17 April, 2008).

Please come and visit the WCC Exhibition in the Blue/Green Pavillion during the following opening hours and discover the wealth of new devices and pharmaceutical products present: Sunday, 18 May, 2008 Monday, 19 May, 2008 Tuesday, 20 May, 2008 Wednesday, 21 May, 2008

18.00 – 20.00 09.00 – 18.00 09.00 – 18.00 09.00 – 18.00

Sponsorship and exhibition information / 41

List of exhibitors in alphabetical order 3M

221

Abbott Laboratories

229

Aché Laboratorios Farmaceuticos S.A

210

Almond Board of California

271

Aloka Co. Ltda. (represented in Argentina by Hittec) American College of Cardiology American Heart Association ANMAT (Dirección Nacional de Medicamentos, Alimentos y Tecnología Médica) Aplicaciones Médicas

CVD Prevention and Control Journal (Elsevier)

186+188 + 215

Daichii Sankyo Brazil Farmaceutica Ltda

307

Dasani

217

Diagnóstico Maipú por Imágenes S.A.

101

270

Digimed S.A.

105

121

Distribuna Editorial y Libreria Medica

162

Driplan

103

123A+123B+ 124A 138B 113

Ecuadorian Foundation of Cardiology

108A

Ecuadorian Society of Cardiology

108A

Edan Instruments, Inc.

236

Argentine Federation of Cardiology (FAC)

313A

Ediciones Journal

194A

Argentine Society of Cardiology (SAC)

315A

Editorial Médica Panamericana

142A

Editorial Mediterráneo Argentina

195B

Astra Zeneca Baptist Health International Center of Miami

309 and 181 108B

Ekosur S.A.

200

Bayer Schering Pharma AG

302

Esaote Latinoamérica S.A.

211

Biolab Farmaceutica Ltda

254

European Society of Cardiology

119

Biosite - an Inverness Medical Company

257

Feas Electrónica

160

Biotronik

301

Fundación Favaloro

Boehringer Ingelheim GmbH

306

Fundación Rusculleda / DAMIC SRL

163

Bolivian Society of Cardiology

136B

Future events

199

Bonus Comunicaciones S.R.L

177

Galix Biomedical Instrumentation

204

Boston Scientific

212+214+252

GE Healthcare

134B

219+243+244

Brazilian Society of Cardiology

128

Gedic - Grupo de Estudio, Docencia e Investigacion Clinica

205

C2C -The eHealth Company

102

GlaxoSmithKline

230

Granix

110

Cambridge Theranostics Ltd.

137B

Cardiology Management

164

Griensu S.A.

207

Cardiotek Bv.

255

Hittec Medical S.A.

270

Hospital Alemán

238

Instramed

161

Chinese Society of Cardiology Colegio Argentino de Cardiologos Intervencionistas

114B 140

Colgate

194B

InterAmerican Society of Cardiology

124B

Colombian Society of Cardiology

138A

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

141A

Congreso Internacional de Medicina Interna del Hospital de Clínicas Content Ed Net Communications

106 139A

Cortex Biophysik GmbH

206

CSL Behring S.A.

183

Iroko Cardio, LLC ISCP (International Society on Cardiovascular Pharmacotherapy) ISHNE (International Society of Holter and Noninvasive Electrocardiology)

179 107B 126

List of exhibitors in alphabetical order IVAX Argentina

201

Paraguay Society of Cardiology

136A

Janssen-Cilag Farmaceutica

197

PCNA (Preventive Cardiovascular Nurses Association)

107A

Japanese Circulation Society

130B

Jota Tec S.A. Karger AG

262 141B

Laboratorio Baliarda S.A.

265

Laboratorios Bagó S.A.

316

Laboratorios Bernabó S.A.

272

Laboratorios Casasco S.A.I.C.

269

Laboratorios Elea S.A.

242

Laboratorios Gador S.A.

317

Laboratorios Lazar

237

Laboratorios Phoenix S.A.I.C.F.

203

Laboratorios Roemmers S.A.I.C.F.

318

Pfizer

148+189

Pfm Medical

159

Philips Healthcare

266+267+268

Polymer Technology Systems, Inc

263

Productos Roche S.A.

180

Prous Science

260

Quaker – a PepsiCo Group Company

145

Raffo S.A.

253

Rozinn by Scottcare

116

Sanofi-aventis

157+182

Schiller

218+220

Siemens

198

Latin American Society of Interventional Cardiology (SOLACI)

114A

Slovenian Society of Cardiology

112B

Libreria AKADIA Editorial

143A

Solvay Pharmaceuticals GmbH

153+ 185+ 151+ 187

Libyan Cardiac Society

134A

Lilis S.A. McGraw-Hill Education

259 143B

Medispec

104

Medley S.A Ind. Farmaceutica

250

South American Society of Cardiology Spacelabs Healthcare

130A 103

Spanish Society of Cardiology

118+115

St Jude Medical

310

Taiwan Society of Cardiology

132

Menarini International Operations Luxembourg S.A.

216+249

Tecnoimagen-Sonosite

Merck KGaA

247+248

Unilever

150

Merck Sharp & Dohme

245+246

UpTo Date

144

Veccsa

231

Vitaphone GmbH

184

Methabolic Syndrome Institute

264

Mexican Society of Cardiology

112A

233+239

Microlife USA

232

V-Patch Medical Systems

Micromed

206

Welch Allyn, Inc.

117

Ministerio de Turismo de la Prov. de Salta

167

Wiley-Blackwell

137A

Molinos Rio de la Plata S.A.

175

Wolters Kluwer

139B

Nature Clinical Practice Cardiovascular Medicine (Nature publishing Group)

186+188+ 215

Novartis Pharma

303

Numed (Omnimédica Argentina)

202

Omron Healthcare, Inc

222

Oxford Journals | Oxford University Press

World Heart Federation

195A

186+188+ 215

World Point

111

Youth for Smoke Free Environments

258

142B

Sponsorship and exhibition information / 43

List of exhibitors by booth number 101

Diagnóstico Maipú por Imágenes S.A.

175

Molinos Rio de la Plata S.A.

102

C2C -The eHealth Company

177

Bonus Comunicaciones S.R.L

103

Driplan

179

Iroko Cardio, LLC

103

Spacelabs Healthcare

180

Productos Roche S.A.

104

Medispec

181

Astra Zeneca

105

Digimed S.A.

182

Sanofi-aventis

106

Congreso Internacional de Medicina Interna del Hospital de Clínicas

183

CSL Behring S.A.

110

Granix

184

Vitaphone GmbH

111

World Point

185

Solvay Pharmaceuticals GmbH

113

Aplicaciones Médicas

186

CVD Prevention and Control Journal (Elsevier)

115

Spanish Society of Cardiology

186

Nature Clinical Practice Cardiovascular Medicine (Nature publishing Group)

116

Rozinn by Scottcare

186

World Heart Federation

117

Welch Allyn, Inc.

187

Solvay Pharmaceuticals GmbH

118

Spanish Society of Cardiology

188

CVD Prevention and Control Journal (Elsevier)

119

European Society of Cardiology

188

Nature Clinical Practice Cardiovascular Medicine (Nature publishing Group)

121

American College of Cardiology

188

World Heart Federation

126

ISHNE (International Society of Holter and Noninvasive Electrocardiology)

189

Pfizer

128

Brazilian Society of Cardiology

197

Janssen-Cilag Farmaceutica

132

Taiwan Society of Cardiology

198

Siemens

140

Colegio Argentino de Cardiologos Intervencionistas

199

Future Events

144

UpTo Date

200

Ekosur S.A.

145

Quaker – a PepsiCo Group Company

201

IVAX Argentina

148

Pfizer

202

Numed (Omnimédica Argentina)

150

Unilever

203

Laboratorios Phoenix S.A.I.C.F.

151

Solvay Pharmaceuticals GmbH

204

Galix Biomedical Instrumentation

153

Solvay Pharmaceuticals GmbH

205

Gedic - Grupo de Estudio, Docencia e Investigacion Clinica

157

Sanofi-aventis

206

Cortex Biophysik GmbH

159

Pfm Medical

206

Micromed

160

Feas Electrónica

207

Griensu S.A.

161

Instramed

210

Aché Laboratorios Farmaceuticos S.A

162

Distribuna Editorial y Libreria Medica

211

Esaote Latinoamérica S.A.

163

Fundación Rusculleda / DAMIC SRL

212

Boston Scientific

164

Cardiology Management

214

Boston Scientific

167

Ministerio de Turismo de la Prov. de Salta

215

CVD Prevention and Control Journal (Elsevier)

List of exhibitors by booth number 215

Nature Clinical Practice Cardiovascular Medicine (Nature publishing Group)

215

World Heart Federation

216

Menarini International Operations Luxembourg S.A.

217

Dasani

218

Schiller

219

GE Healthcare

220

Schiller

221

3M

222

Omron Healthcare, Inc

229

Abbott Laboratories

230

GlaxoSmithKline

231

Veccsa

232

Microlife USA

233

Tecnoimagen-Sonosite

236

Edan Instruments, Inc.

237

Laboratorios Lazar

238

Hospital Alemán

239

Tecnoimagen-Sonosite

242

Laboratorios Elea S.A.

243

GE Healthcare

244

GE Healthcare

245

Merck Sharp & Dohme

246

Merck Sharp & Dohme

247

Merck KGaA

248

260

Prous Science

262

Jota Tec S.A.

263

Polymer Technology Systems, Inc

264

Methabolic Syndrome Institute

265

Laboratorio Baliarda S.A.

266

Philips Healthcare

267

Philips Healthcare

268

Philips Healthcare

269

Laboratorios Casasco S.A.I.C.

270

Aloka Co. Ltda. (represented in Argentina by Hittec)

270

Hittec Medical S.A.

271

Almond Board of California

272

Laboratorios Bernabó S.A.

301

Biotronik

302

Bayer Schering Pharma AG

303

Novartis Pharma

306

Boehringer Ingelheim GmbH

307

Daichii Sankyo Brazil Farmaceutica Ltda

309

Astra Zeneca

310

St Jude Medical

316

Laboratorios Bagó S.A.

317

Laboratorios Gador S.A.

318

Laboratorios Roemmers S.A.I.C.F.

107A

PCNA (Preventive Cardiovascular Nurses Association)

Merck KGaA

107B

ISCP (International Society on Cardiovascular Pharmacotherapy)

249

Menarini International Operations Luxembourg S.A.

108A

Ecuadorian Foundation of Cardiology

250

Medley S.A Ind. Farmaceutica

108A

Ecuadorian Society of Cardiology

252

Boston Scientific

108B

Baptist Health International Center of Miami

253

Raffo S.A.

112A

Mexican Society of Cardiology

254

Biolab Farmaceutica Ltda

112B

Slovenian Society of Cardiology

255

Cardiotek Bv.

114A

Latin American Society of Interventional Cardiology (SOLACI)

257

Biosite - an Inverness Medical Company

114B

Chinese Society of Cardiology

258

Youth for Smoke Free Environments

123A

American Heart Association

259

Lilis S.A.

123B

American Heart Association

Sponsorship and exhibition information / 45

List of exhibitors by booth number 124A

American Heart Association

124B

InterAmerican Society of Cardiology

130A

South American Society of Cardiology

130B

Japanese Circulation Society

134A

Libyan Cardiac Society

134B

Fundación Favaloro

136A

Paraguay Society of Cardiology

136B

Bolivian Society of Cardiology

137A

Wiley-Blackwell

137B

Cambridge Theranostics Ltd.

138A

Colombian Society of Cardiology

138B

ANMAT (Dirección Nacional de Medicamentos, Alimentos y Tecnología Médica)

139A

Content Ed Net Communications

139B

Wolters Kluwer

141A

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

141B

Karger AG

142A

Editorial Médica Panamericana

142B

Oxford Journals | Oxford University Press

143A

Libreria AKADIA Editorial

143B

McGraw-Hill Education

313A

Argentine Federation of Cardiology

315A

Argentine Society of Cardiology

Exhibition floor plan

MAIN ENTRANCE FROM PUBLIC TRANSPORT AND SHUTTLE BUS

A B

104

103

102

CLOAK ROOMS

101

HOSPITALITY SUITES

C

106

D

107 A 107 B 108 A 108 B 112 A 112 B 114 A 114 B 115

105

REGISTRATION

110 167 229

LOST AND FOUND

230

111 165 113 163

@

231

164 175 164 177 B B 162 177

160

117

232

225

236

238

237

180

222

MAIN ENTRANCE FROM THE PARKING

263 233 239

179

159

118

228 161 116

264

242

266

265

221

267

268

269

270

271

272

119

157

182

181

220

219

243

244

245

121

155

184

183

218

217

248

247

246

123 A 123 B 124 A 124 B

153

185

151

187

186

216

249

214

252

250 262 188

@

303

302

301

306

307

309

310

253

215 212

150

126 128 130 A 130 B 132

134 A 134 B 136 A 136 B 138 A 138 B 140

148 145

189

192

210

211 207

206

215

257

197

255

260

258

259

315 A

313 A

316 141 137 A A 139 B 137 B 139 A

141 144 B 142 143 A A 142 143 B B

194 195 A A 194 195 B B

205 204

MEETING POINT

317

ENTRANCE FROM SESSIONS, WORKSHOPS AND SYMPOSIA ROOMS

POSTER AREA

POSTER HELP DESK

318

203 202 201 200

198

FUTURE EVENTS

BUSINESS CENTER

Exhibition floorplan / 47

Exhibitors’ and sponsors’ editorial listing 3M Olga Cossettini 1031 Buenos Aires C1107CEA ARGENTINA www.3m.com Booth 221 Abbott Laboratories 200 Abbott Park Road Abbott Park, IL 60064 UNITED STATES Abbott is a global, broad-based healthcare company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products. www.abbott.com Booth 229 Aché Laboratorios Farmaceuticos S.A BRAZIL www.ache.com.br Booth 210 Almond Board of California 1150 9th Street Suite 1500 Modesto, CA 95354 UNITED STATES www.almondsarein.com The Almond Board of California, a Federal Marketing Order under the United States Department of Agriculture, promotes the best quality almonds. Booth 271 Aloka Co. Ltda. (represented in Argentina by Hittec) JAPAN www.aloka.com See Hittec Booth 270 American College of Cardiology 2400 N Street NW Washington DC, VA UNITED STATES www.acc.org ACC will launch Cardiosource en Espanol, an online cardiovascular information resource, and offer information about ACC membership opportunities and educational products. Booth 121

American Heart Association 7272 Greenville Avenue Dallas, TX 75231-4596 UNITED STATES www.heart.org The American Heart Association offers the latest information on cardiovascular and stroke research. Pick up free CD-ROMs: Core Collection 2008 & Scientific Sessions Abstracts. Receive information on Emergency Cardiovascular Care, Professional Membership, Scientific Publications, Get With the Guidelines, Patient Education and more. Booth 123A+123B+124A ANMAT (Dirección Nacional de Medicamentos, Alimentos y Tecnología Médica) ARGENTINA www.anmat.gov.ar Booth 138B Aplicaciones Médicas Cnel Rosetti 2264 Olivos Buenos Aires ARGENTINA www.aplimed.com.ar Booth 113 Argentine Federation of Cardiology (FAC) Bulnes 1004 C1176ABT Buenos Aires ARGENTINA www.fac.org.ar Booth 313 A Argentine Society of Cardiology (SAC) Azcuenaga 980 (C1115AAD) Buenos Aires ARGENTINA www.sac.org.ar Booth 315 A Astra Zeneca R&D MöIndal SE 43183 MöIndal SWEDEN www.astrazeneca.com Tel: +46 31 7761000 - Fax: +46 31 7763806 Web sites: www.incirculation.net www.astrazeneca.com AstraZeneca is one of the world’s leading research-based pharmaceutical companies. Our mission is to develop innovative and effective new medicines that fulfil unmet medical needs in important areas of healthcare. Booth 309 and 181

Exhibitors’ and sponsors’ editorial listing Baptist Health International Center of Miami Miami, FL UNITED STATES Booth 108B Bayer Schering Pharma AG BU Primary Care S101,9,120 Muellerstrasse 179 13353 Berlin GERMANY www.bayerhealthcare.com Booth 302 Biolab Farmaceutica Ltda Av Do cafe, 277 7 Andar Torre B (04311-900) Sao Paolo BRAZIL www.biolabfarma.com Booth 254 Biosite - an Inverness Medical Company 21 Rue Albert Calmette 78350 Jouy en Josas FRANCE www.biosite.com Inverness Medical is a world leader in diagnostic products to assist laboratory and healthcare professionals in both preventative and interventional medicine, providing qualitative and quantitative results. Our focus is in the broad clinical fields of Women’s Health, Blood Born Pathogens, Oncology, Drugs of Abuse, Respiratory-Infectious Disease and Cardiology. Visit us Booth 257 to discover our product portfolio. Booth 257 Biotronik Woermannkehre 1 12359 Berlin GERMANY www.biotronik.com BIOTRONIK® is a leading European company in the field of biomedical technology. We focus on devices for electrotherapy of the heart and for vascular intervention. Our products help physicians to save lives and to improve their patients’ quality of life. For further information, please visit our booth 301 in the main exhibition hall. Booth 301

Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein GERMANY www.boehringeringelheim.com Booth 306 Bolivian Society of Cardiology Avenida Saavedra 1983 edificio Italia (Mezaninne) Barrio Miraflores La Paz BOLIVIA www.bago.com.bo Booth 136B Bonus Comunicaciones S.R.L Fonrouge 1561 c1440CYO Buenos Aires ARGENTINA Booth 177 Boston Scientific One Boston Scientific Place Natick, MA 1760 UNITED STATES www.bsci.com Taxus™ Liberté™, the only one that has CE mark for use in Diabetic Patients. The proven one. Booth 212+214+252 Brazilian Society of Cardiology Booth 128 C2C -The eHealth Company Republica dominicana 3, bajos local 1 07014 Palma de Mallorca SPAIN www.c2ctsis.com Company specialized in developing Healthcare IT integration solutions, focused mainly on imaging integration solutions. Booth 102 Cambridge Theranostics Ltd. 7 Hills Avenue Cambridge CB1 7UY UNITED KINGDOM CTL has developed AterononR/T, the first clinically proven neutraceutical product able to inhibit the process responsible for atherosclerotic plaque growth. Booth 137B

Exhibitors’ and sponsors’ editorial listing / 49

Exhibitors’ and sponsors’ editorial listing Cardiology Management 28 Rue de la Loi 1040 Brussels BELGIUM www.cardiologymanagement.eu Booth 164 Cardiotek Bv. Amerikalaan 70 (6199AE) Maastricht Airport Maastricht THE NETHERLANDS www.cardiotek.com Amplifier /Stimulator for Electrophysiologic Procedures Booth 255 Chinese Society of Cardiology www.heart.org.cn Booth 114B Colegio Argentino de Cardiologos Intervencionistas Booth 140 Colgate 300 Park Avenue PK 12 New York, NY 10022 UNITED STATES Colgate Total Booth 194B

Cortex Biophysik GmbH Nonnenstrabe 39 04229 Leipzig GERMANY www.cortex-medical.com See Micromed Booth 206 CSL Behring S.A. Fray Justo Sarmiento 2350 Olivos (B1036AKJ) Buenos Aires ARGENTINA www.cslbehring.com Booth 183 CVD Prevention and Control Journal (Elsevier) Radarweg 29 Amsterdam NX 1043 THE NETHERLANDS www.elsevier.com Elsevier publishes leading international medical journals, including Prevention and Control, the official journal of the World Heart Federation. Visit us and collect your free sample copy. Booth 186+188+215

Colombian Society of Cardiology www.scc.org.co Booth 138A

Daichii Sankyo Brazil Farmaceutica LTDA Almeda Xingu, 766 Barueri Sao Paul BRAZIL www.daiichisankyo.com Booth 307

Congreso Internacional de Medicina Interna del Hospital de Clínicas Booth 106

Dasani www.dasani.com Booth 217

Content Ed Net Communications Maetro Lasalle 36 28016 Madrid SPAIN Content Ed Net is a Global Medical Publishing Specialist with 10 offices in Argentina, Brazil, France, Italy, Japan, Mexico, New Zealand, Spain & UK. Booth 139 A

Diagnóstico Maipú por Imágenes S.A. Av Maipu 1668 (1602) Buenos Aires ARGENTINA Booth 101 Digimed S.A Giribone 1002 (C1427CAN) Buenos Aires ARGENTINA www.digimed.com Booth 105

Exhibitors’ and sponsors’ editorial listing Distribuna Editorial y Libreria Medica Booth 162

Eli Lilly www.lilly.com

Driplan Catalina de Boyle 3340 (calle 28) Gral. San Martin (B1650IMD) Buenos Aires ARGENTINA www.driplan.com Booth 103

Esaote Latinoamérica S.A. Buenos Aires ARGENTINA Booth 211

Ecuadorian Foundation of Cardiology Booth 108A Ecuadorian Society of Cardiology www.sec-np.org Booth 108A Edan Instruments, Inc. 3/F-B Nanshan Medical Equipments Park,Nanhai Rd.1019# Shekou, Nanshan Shenzhen Guangdong Province 518067 CHINA www.edaninstruments.com Edan Instruments, Inc. is one of the leading medical equipments manufacturers in China. Booth 236 Ediciones Journal Junin 873 - Piso 4 Depto H Buenos Aires ARGENTINA www.journal.com.ar Publisher and distributor of medical books in both Spanish and English language. Great exhibition and sale of books in the field of cardiology of main US and European publishers: Elsevier, Lippincott Williams & Wilkins and Springer Verlag. Booth 194A Editorial Médica Panamericana Booth 142A Editorial Mediterráneo Argentina Paraguay 2028 4 Piso ofc. 21 Buenos Aires ARGENTINA Booth 195B Ekosur S.A. Buenos Aires ARGENTINA Booth 200

European Society of Cardiology 2035 Route des Colles Les Templiers BP 179 06903 Sophia Antipolis FRANCE www.escardio.org Booth 119 Feas Electrónica Colon 5760 (X5003DFP) Cordoba ARGENTINA Booth 160 Fundación Favaloro Booth 134B Fundación Rusculleda / DAMIC SRL Asistencia, docencia e investigación en Medicina. Independencia 387. Cordoba Argentina Booth 163 Future Events Learn what's happening world wide in the field of cardiology and heart disease. Booth 199 Galix Biomedical Instrumentation Rocamora 4029 Buenos Aires ARGENTINA www.galix-gbi.com Cardiac External Pacemaker, Computerized ECG and Stress Test Systems, ECG Holter Recorders and Analyzers. Simulators for Polygraph and Electrophysiology. Booth 204 GE Healthcare Bouchard 710 3 piso Buenos Aires ARGENTINA Booth 219+243+244

Exhibitors’ and sponsors’ editorial listing / 51

Exhibitors’ and sponsors’ editorial listing

GlaxoSmithKline 980 Great West Road Brentford, Middlesex, TW8 9GS UNITED KINGDOM www.gsk.com GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies, committed to improve the quality of human life.ww.gsk.com Booth 230

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Ch Louis-Dunant 15 PO Box 195 1211 Geneva 20 SWITZERLAND www.ifpma.org IFPMA is the global non-profit NGO representing the research-based pharmaceutical, biotech and vaccine sectors. Its members comprise 26 leading international companies and 46 national and regional industry associations covering developed and developing countries. The IFPMA Clinical Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s Ethical Promotion and its Health Partnerships information help make the industry’s activities more transparent. Booth 141 A

Granix Buenos Aires ARGENTINA Booth 110

Iroko Cardio, LLC Philadelphia UNITED STATES Booth 179

Griensu S.A. Av.Julio A.Roca 636, Pisos 10O. Buenos Aires ARGENTINA www.griensu.com Booth 207

ISCP (International Society on Cardiovascular Pharmacotherapy) A. Bayés de Luna ICCC - Hospital Sant Pau Avda. Sant Antoni Mª Claret, 167 08025 Barcelona SPAIN www.iscpcardio.org Booth 107B

Gedic - Grupo de Estudio, Docencia e Investigacion Clinica Av Rivadavia 2358 PB4 Buenos Aires ARGENTINA Booth 205

Hittec Medical S.A. Mexico 3100 C1223ABL Buenos Aires ARGENTINA Booth 270 Hospital Alemán Buenos Aires ARGENTINA Booth 238 Instramed Av. Protásio Alves, 3371 Porto Alegre 90410-003 BRAZIL www.instramed.com.br Booth 161 InterAmerican Society of Cardiology Juan Badiano No. 1, Edificio Galas, P. B Mexico D.F. MEXICO www.soinca.org Booth 124B

ISHNE (International Society of Holter and Noninvasive Electrocardiology) Monroe County Rochester, NY UNITED STATES www.ishne.org Booth 126 IVAX Argentina JJ Castelli 6701 Munro prov Buenos Aires ARGENTINA www.ivax.com Cardiovascular line of pharmaceutical products, antihypertensives, lipid regulators, platelet aggregation inhibitors. Booth 201

Exhibitors’ and sponsors’ editorial listing Janssen-Cilag Farmaceutica 1900 Charleston Road M10-3111 Mountain View, CA 94043 UNITED STATES NATRECOR® (nesiritide): A recombinant version of human B-type natriuretic peptide, for I.V. treatment of acute congestive heart failure. Booth 197 Japanese Circulation Society 8th Floor, CUBE OIKE Bldg. 599 Bano-cho Karasuma Aneyakoji Nakagyo-ku Kyoto 604-8172 JAPAN www.j-circ.or.jp Booth 130B Jota Tec S.A. Maipu 231 3p of 40 Buenos Aires 1084 ARGENTINA www.jotatec.com We are leaders producing ABPM, Holter, ECG and ergometry equipment. We are certified under ISO 13485, CE mark and ANVISA. Booth 262 Karger AG Allschwilerstrasse 10 4009 Basel SWITZERLAND www.karger.com We are pleased to present the latest publications in Cardiology at the Karger booth including the book ‘Cardiovascular Diabetology’. Pick up a sample copy of the journal CARDIOLOGY. Booth 141B Laboratorio Baliarda S.A. Alberti 1283 Buenos Aires ARGENTINA Booth 265 Laboratorios Bagó S.A. Bernardo de Irigoyen 248 Buenos Aires ARGENTINA www.bago.com.ar Booth 316

Laboratorios Bernabó S.A. Terrada 2346 Buenos Aires ARGENTINA www.laboratoriosbernabo.com Booth 272 Laboratorios Casasco S.A.I.C. Av. Carabobo 22 Buenos Aires ARGENTINA www.casasco.com.ar Booth 269 Laboratorios Elea S.A. Sanabria 2353 - C1417AZE Buenos Aires ARGENTINA www.laboratorioelea.com.ar Booth 242 Laboratorios Gador S.A. Darwin 429 Buenos Aires ARGENTINA www.gador.com.ar Booth 317 Laboratorios Lazar Av. Vélez Sársfield 5855 - B1606ARI Buenos Aires ARGENTINA www.lazar.com.ar Since 1934 manufactoring top quality pharmaceutical products under strict CMP standards. LAZAR, a trustful symbol in the Medical Field. Booth 237 Laboratorios Phoenix S.A.I.C.F. Humahuaca 4065 Buenos Aires ARGENTINA www.phoenix.com.ar Booth 203 Laboratorios Roemmers S.A.I.C.F. Fray Justo Sarmiento 2350 Buenos Aires ARGENTINA www.roemmers.com.ar Booth 318

Exhibitors’ and sponsors’ editorial listing / 53

Exhibitors’ and sponsors’ editorial listing Latin American Society of Interventional Cardiology (SOLACI) Adolfo Alsina 2653 piso 2 departamento H Buenos Aires ARGENTINA www.solaci.org Booth 114A

Medley S.A Ind. Farmaceutica Rua Macedo Costa 55 13080-180 Campinas Sao Paulo BRAZIL www.medley.com.br Booth 250

Libreria AKADIA Editorial Paraguay 2078 Buenos Aires ARGENTINA www.editorialakadia.com.ar Software and medical books in Spanish Booth 143A

Menarini International Operations Luxembourg S.A. Via Sette Santi 1 50131 Firenze ITALY www.menarini.com Booth 216+249

Libyan Cardiac Society Tajura Cardiac Center P.O.Box: 82251 Tripoli LIBYA www.lcs.org.ly Booth 134A Lilis S.A. Pasteur 798 Buenos Aires ARGENTINA www.lilis.com.ar Littmann - Stethocopes - Medical supplies - ECG Electrocardiographs - Patient monitoring - Diagnostic imaging - Blood pressure monitors - Oximeters - Head lights - Binocular loupes heine - Accessories Booth 259 McGraw-Hill Education 148 Princeton-Hightstown Road, N-1 Hightstown, NJ 08520 UNITED STATES www.mheducation.com Booth 143B Medispec 2041 Observation Drive Suite # 102 Germantown, MD 20876 UNITED STATES www.medispec.com Booth 104

Merck KGaA Frankfurter Strasse 250 64293 Darmstadt GERMANY www.merck.de Booth 247+248 Merck Sharp & Dohme One Merck Drive, WS2C-36A Whitehouse Station, NJ 08889 UNITED STATES www.msd.com Merck Sharp & Dohme is a global reseach-driven pharmaceutical company dedicated to putting patients first. Established in 1891, MSD discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company also devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate MSD medicines but help deliver them to the people who need them. MSD also publishes unbiased health information as a not-for-profit service. Booth 245+246 Methabolic Syndrome Institute Booth 264 Mexican Society of Cardiology Juan Badiano #1 Col. Sección XVI, Tlalpan C.P. 14080 C.P. 14080 Mexico D.F. MEXICO www.smcardiologia.org.mx Booth 112A

Exhibitors’ and sponsors’ editorial listing Microlife US 424 Skinner Boulevard Suite B Dunedin, FL 34698 UNITED STATES www.microlifeusa.com Booth 232 Micromed Rua 3 Lotes 15/17 - Polo de Modas Guara II Brasilia DF 71070503 BRAZIL Booth 206 Ministerio de Turismo de la Prov.de Salta Booth 167 Molinos Rio de la Plata S.A Booth 175 Nature Clinical Practice Cariovascular Medicine (Nature publishing Group) The Macmillan Building 4 Crinan Street London N19XW UNITED KINGDOM www.nature.com Booth 186+188+215 Novartis Pharma 5200 Blue Lagoon Drive Suite 690 Miami, FL 33126 UNITED STATES www.novartis.com The Pharmaceuticals Division of Novartis is recognized worldwide for the innovative medicines provided to patients, physicians and healthcare organizations. Our current product portfolio includes more than 45 key marketed products, many of which are leaders in their respective therapeutic areas. The product development pipeline involves nearly 140 projects – including potential new products as well as potential new indications or formulations for existing products in various stages of clinical development. Booth 303 Numed (Omnimédica Argentina) Buenos Aires ARGENTINA Booth 202

Omron Healthcare, Inc 1200 Lakeside Drive Bannockburn, IL 60015 1243 UNITED STATES www.omronhealthcare.com Booth 222 Oxford Journals | Oxford University Press Great Clarendon Street Oxford OX2 6DP UNITED KINGDOM www.oup.co.uk Booth 142B Paraguay Society of Cardiology www.spc.org.py Booth 136A PCNA (Preventive Cardiovascular Nurses Association) 613 Williamson Street Suite 205 Madison, WI 53703 UNITED STATES www.pcna.net PCNA is the leading nursing organization dedicated to preventing cardiovascular disease through assessing risk, facilitating lifestyle changes, and guiding individuals to achieve treatment goals. Booth 107A Pfizer 235 East 42nd Street New York, NY 10017 UNITED STATES www.pfizer.com Booth 148+189 Pfm Medical 2605 Temple Heights Drive Suite A Oceanside, CA 92056 UNITED STATES www.pfm-ag.com Pfm Ag, Cologne, Germany and it affiliates world wide provide innovative products to the medical community. The Nit-Occlud® spiral coil system is designed for transcatheter occlusion of Patent Ductus Arteriosus (PDA) of all shapes. Safety and reliability of this system are the result of a continuous further improvement of the proven Duct-Occlud® system. Booth 159

Exhibitors’ and sponsors’ editorial listing / 55

Exhibitors’ and sponsors’ editorial listing Philips Healthcare Vedia 3892 Buenos Aires ARGENTINA www.medical.philips.com Royal Philips Electronics of the Netherlands is a global leader in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions through the brand promise of “sense and simplicity”. With sales of EUR 2007, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions for personal wellbeing. Booth 266+267+268 Polymer Technology Systems, Inc 7736 Zionsville Road Indianapolis, IN 46268 UNITED STATES www.cardiochek.com Booth 263 Productos Roche S.A. Productos Roche S.A.Q.e I., Rawson 3150 B1610BAL Ricard Rojas, Tigre Buenos Aires ARGENTINA Booth 180 Prous Science Provenza 388 08025 Barcelona SPAIN www.prous.com Prous Science, a Thomson Scientific business, provides information and communication services on drug R&D, pharmacology, medicine and medicinal chemistry. Booth 260 Quaker – a PepsiCo Group Company R&D Quaker Lar Poneiente 116 No 659 Col. Industrial Vallejo Mexico D.F 02300 MEXICO www.pepsico.com Booth 145

Raffo S.A. Av. Cabildo 86 Buenos Aires ARGENTINA www.raffo.com.ar Leaders in the treament of dsylipemias and cholesterol lowering drugs. Booth 253 Rozinn by Scottcare 4791 West 150th Street Cleveland, OH 44135 UNITED STATES www.scottcare.com Rozinn by Scottcare offers holter, pacemaker follow-up, cardiac evnt, ambulatory BP and Telerehab monitoring systems, plus external counterpulsation (ECP)beds. Booth 116 Sanofi-aventis 174, avenue de France 75013 Paris FRANCE www.sanofi-aventis.com Sanofi-aventis is one of the leading pharmaceutical company in the world, ranking number one in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines. The Group is inspired by a powerful vision: - to find new compounds to prevent, combat and eradicate diseases around the world, - to provide therapeutic and preventive solutions geared to populations in both industrialized and developing countries, - to support innovative medicines and vaccines, mature products, OTC medicines and generics. Every day, everywhere sanofi-aventis is working for what really matters: Patients HEALTH. Booth 157+182 Schiller Altgasse 68 6341 Baar SWITZERLAND www.schiller.ch SCHILLER specailizes in cardio-therapy equipment, focusing on resting & exercise ecg, spirometry, patient monitoring and cardiac defibrillation. Booth 218+220

Exhibitors’ and sponsors’ editorial listing Servier 192 Avenue Charles de Gaulle 92578 Neuilly-sur-Seine Cedex FRANCE www.servier.com Siemens Wittelsbacherplatz 2 80333 Munich GERMANY www.siemens.com Booth 198 Slovenian Society of Cardiology Slovenska hiša srca Ulica stare pravde 6 1000 Ljubljana SLOVENIA www.sicardio.org Booth 112B Solvay Pharmaceuticals GmbH Global Product Strategy Department PO Box 220 30002 Hannover GERMANY Solvay Pharmaceuticals Cardiometabolic portfolio includes: Lipanthyl®/Tricor® indicated for the treatment of lipid disorders, Teveten® controlling high blood pressure and Omacor® for the adjuvant treatment in secondary prevention after myocardial infarction. Booth 153+ 185+ 151+ 187 South American Society of Cardiology Booth 130A Spacelabs Healthcare 5150 220th AVE SE Issaquah, WA UNITED STATES Booth 103 Spanish Society of Cardiology Booth 118+115 St Jude Medical One Lillehei Plaza St. Paul, MN 55117 UNITED STATES www.sjm.com Booth 310

Taiwan Scociety of Cardiology 7, Chung-Shan S. Road National Taiwan University Hospital Taipei 100 TAIWAN, ROC www.tsoc.org.tw Booth 132 Tecnoimagen-Sonosite Buenos Aires ARGENTINA Booth 233+239 Unilever Olivier van Noortlaan 120 P.O.Box 114 Vlaardingen 3130 AC THE NETHERLANDS www.unilever.com Unilever is the global food industry leader in heart health nutrition via its products and education services. Booth 150 UpTo Date Boerhaavelaan 24 Zoetermeer 2713 HX THE NETHERLANDS www.uptodate.com Booth 144 Veccsa Juramento 5841 Buenos Aires C1431CLA ARGENTINA Booth 231 Vifor International Inc. P.O.Box, Rechenstrasse 37 9001 St. Gallen SWITZERLAND Vitaphone GmbH Markirchener Strasse 22 68229 Mannheim GERMANY With advanced telemedicine monitoring and care systems, Vitaphone not only provides comprehensive patient care solutions to care suppliers but also to healthcare insurers. Booth 184

Exhibitors’ and sponsors’ editorial listing / 57

Exhibitors’ and sponsors’ editorial listing V-Patch Medical Systems Chemin Long 259 1310 La Hulpe BELGIUM Wireless, waterproof, body worn EVENT/HOLTER device & patch, program to continuously monitor critical events, data automatically sent to WWW. Booth 195A Welch Allyn, Inc. 4341 State Street Rd. PO Box 220 Skaneateles Falls, NY 13153- 0220 UNITED STATES www.welchallyn.com Booth 117 Wiley-Blackwell 350 Main Street Malden, MA 02148 UNITED STATES www.wiley.com Booth 137A Wolters Kluwer Philadelphia, PA 60090 UNITED STATES www.wolterskluwer.com Booth 139B

Unrestricted educational grants In addition to the welcome participation and support from all exhibitors and sponsors listed elsewhere in this programme, the WCC 2008 would like to thank the following companies for their contribution to WCC 2008 with an unrestricted educational grant. •• Otsuka Pharmaceuticals •• St. Jude Medical A special thanks also to the following societies for their support of the WCC 2008: Lawyers Bustamante, Cavallero, Bolo, Tomeo y Asociados 25 de Mayo 267 5º 512 (C 1002 ABE) - Buenos Aires - Argentina Tel./Fax: +54 11 4343 4861 - [email protected] - www.bcbt.com.ar Counter Santiago Sáenz Valiente SSV Paraná 754 Piso 8 Capital (Entre Córdoba y Viamonte) . 4816-6996

World Heart Federation 7 Rue des Battoirs Case postale 155 1211 Geneva 4 SWITZERLAND The World Heart Federation is committed to helping the global population achieve a longer and better life through prevention and control of heart disease and stroke, with a particular focus on low and middle-income countries. www.worldheart.org Booth 186+188+215 World Point 1326 S. Wolf Rd. Wheeling, IL 60090 UNITED STATES www.worldpoint-ecc.com Booth 111 Youth for Smoke Free Environments A display on youth-led activities promoting smoke-free environments, supported by networks linked to the World Heart Federation and its members. Booth 258

Session: Rheumatic Fever/Rheumatic Heart Disease Tuesday, 20 May, 2008 – 16.00-17.30 - Pilcomayo Demonstration: World Heart Federation booth Wednesday, 21 May, 2008 – 10.00-10.30

Scientific Programme Formats

Over 250 sessions will be presented in the following formats: Symposia (SYMP) include a maximum of five presentations on the latest developments in fields such as basic science, clinical cardiology and epidemiology. Debates (DEB) provide a discussion on controversial issues with two statements that will be debated, each with a pro and contra presentation followed by a discussion at the end of each statement.

Clinical Seminars (CS) will highlight various specific subspecialty topics. The sessions do not target exclusively specialists but also a general audience. The South American Congress of Cardiology (SACC) will be held in conjunction with the World Congress of Cardiology and presented in a series of eleven sessions in Spanish. (Session rooms: Amazon, Tigris). Special Featured Joint Sessions (SP) are held by cardiology societies and organizations.

How-to & Workshop Sessions (HTS) will give the opportunity to interact between a limited audience and experts in various fields of clinical cardiology.

Continuing Medical Education (CME) The World Congress of Cardiology is accredited by the European Board for Accreditation in Cardiology (EBAC) for 18 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. One credit may be claimed for each hour of participation in WCC scientific sessions. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS). In compliance with the EBAC guidelines, all speakers and chair persons who are participating in this scientific programme have disclosed or indicated potential conflicts of interest which might case a bias in the presentations. The Organizers are responsible for ensuring that all potential conflicts of interest relevant to the congress are declared to the audience prior to the CME activities.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Under the terms of this agreement, the AMA will convert CME credit certified by the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, to AMA PRA Category 1 Credit™. How do I receive credits? Credits can be received after the congress via our online system. Please make sure to keep a record of the session titles / numbers and save your registration confirmation number and/or access code. After completing the EBAC evaluation you will be taken to the website to input your information for EBAC CME credits. The site is accessible via a direct link you will be provided within due course. ATTENTION: It will take approximately 6-8 weeks to process your enquiry and before you receive confirmation of your accreditation. Please note that no certificates will be given on-site.

Technical information for sessions Speakers preview CENTRE The speakers preview centre is located in the Green Pavilion behind the Seine and the Niger rooms. opening hours: Saturday, 17 May, 2008:

15.00 – 18.00

Sunday, 18 May, 2008:

09.00 – 19.00

Monday, 19 May, 2008

07.00 – 19.00

Tuesday, 20 May, 2008:

07.00 – 19.00

Wednesday, 21 May, 2008:

07.00 – 16.00

IMPORTANT NOTE:  CHECK-IN TO THE SPEAKERS PREVIEW CENTRE IS MANDATORY FOR ALL PRESENTERS! Plan to check-in the day before or no later than 4 hours before your presentation time. Presenters who do not checkin sufficiently in advance of their presentation may give the scheduled talk, but may not have visuals. Speakers who have submitted their presentations in advance via the online website are advised to visit the speakers preview room for a final check. 

PowerPoint presentations All presentations are downloaded on to a single server before the session and sent through a network to the correct session room. Only MS-PowerPoint (2003 and XP) presentations with video formats should be used for this conference. However, technical assistance will be provided in case you are using a MAC computer. You will have NO possibility to upload/change your presentation(s) to/on the computer in the session room. Therefore you must go to the speakers preview room before your presentation starts. Technicians will be available in case you may need assistance. Time limit All speakers are requested to adhere strictly to the time limit indicated in the programme. The indicated lecture times include time for discussions. Overrunning by even a few minutes may impact on the smooth running of the following sessions, so please respect your colleagues and the time slots. All session rooms will be equipped with video projection. Overhead projection and standard 35mm slide projection is not available.

Posters & abstracts The Scientific Programme Committee (SPC) gratefully acknowledges the submission of over 2000 abstracts from all over the world. All abstracts have been graded and reviewed by the Scientific Programme Committee. All accepted abstracts have been published in the online version of the official American Heart Association Journal “Circulation” For more information, please visit www.circ.ahajournals.org. In addition to that, all delegates may collect their personal abstract CD Rom from the Boehringer Ingelheim booth in the exhibition hall. To collect your free copy, please go to their booth with your voucher which you will find in your congress bag. The WCC would like to thank Boehringer Ingelheim for their financial support towards the production and distribution of the abstract CD Rom.

Abstracts will be presented in the following formats: •• Poster •• Oral abstract presentation

Farbe/colour: PANTONE 288 CV

Poster presentations •• Dimensions: 1.8 meters (max) to 1.5 meters (min) high by 0.9 meters wide (70.80 inches by 35.40 inches). ••The title, authors’ detail(s) and affiliation(s) should be printed at the top of the poster. The chosen font should not be smaller than 5 cm (1.95 inches). •• Even at a distance of 1 meter from the poster board, the poster should be easily readable. ••Posters must be placed on the boards (provided by the organizers) with double sided tape (not provided by the organizers). ••Regarding the content structure of the poster, the sections outlined below should be observed: – Introduction – Materials and Methods – Results – Conclusion(s) – Wherever possible, results can be illustrated with picture(s) and chart(s) ••Posters must be put up and dismantled according to the time slots given by the organizers. ••Should you not dismantle your poster at the appropriate time the staff will take the liberty to remove it. The Congress Organizers will accept no liability for your material and poster. Authors will be present at their posters during the coffee breaks either from 10:00-10:30 or 15:30-16:00.

Scientific Programme / 61

Posters & abstracts A poster help-desk is located within the poster area. Please do not hesitate to contact one of the staff members at the poster help desk for any further assistance.

••Pharmacology ••Basic Science ••Cardiac Imaging/Computers

Poster topics Posters will be presented in the following scientific topics:

••Acute Cardiac Care

••Arrhythmias

••Nursing/Technician/Miscellaneous

••Heart Failure/Left Ventricular Function

••Public Policy / Advocacy initiatives

••Valvular Disease/Pulmonary Circulation/Myocardialpericardial ••Ischemia/Coronary Artery Disease ••Interventions/Peripheral Circulation/Stroke

••Paediatric/Congenital Heart Disease

Oral abstract presentations Oral abstract sessions have a dedicated time slot from 8.30 to 10.00 in the morning. All details for oral abstract session can be found in the detailed scientific programme.

••Hypertension ••Exercise/Epidemiology/Prevention

Special featured joint sessions The World Congress of Cardiology 2008 organizers; the World Heart Federation, the Argentine Society of Cardiology and the Argentine Federation of Cardiology, would like to thank the following societies and organizations that have committed to the World Congress of Cardiology 2008.

••Interamerican Society of Cardiology (IASC)

••American College of Cardiology (ACC)

••Metabolic Syndrome Institute (MSI)

••American Heart Association (AHA)

••Mexican Society of Cardiology (SMC)

••American Society of Echocardiography (ASE) and International Society for Cardiovascular Ultrasound (ISCU)

••Pan African Society of Cardiology (PASCAR)

••American Society of Nuclear Cardiology (ASNC) ••Argentine Ministry of Health ••Asian-Pacific Society of Cardiology (APSC)

••International Society of Hypertension (ISH) ••Latin American Society of Interventional Cardiology (SOLACI) and Society for Cardiovascular Angiography and Interventions (SCAI)

••Preventive Cardiovascular Nurses Association (PCNA) ••World Heart Failure Society (WHFS) ••International Society of Cardiovascular & Pharmacotherapy (ISCP)

••Brazilian Society of Cardiology (SBC) ••Heart Rhythm Society (HRS) and International Society for Holter and Noninvasive Electrocardiology (ISHNE)

For further information about these Special Featured Joint Sessions, kindly refer to the detailed scientific programme which follows.

South American Congress of Cardiology The South American Congress of Cardiology will be held in conjunction with the World Congress of Cardiology and presented in Spanish in a series of eleven sessions (Session rooms: Amazon, Tigris).

••Tratamiento actual de la enfermedad coronaria crónica

••Opening Ceremony-XXIII Congreso Sudamericano de Cardiología

••Avances en la insuficiencia cardiaca aguda descompensada

••Factores de riesgo y aterosclerosis subclínica ••Toma de decisiones en valvulopatías ••Fibrilación auricular. Lo viejo y lo nuevo. ••Nuevas fronteras en la hipertensión arterial

••Desafíos actuales de la cardiología sudamericana ••Cómo optimizar el tratamiento de la insuficiencia cardiaca crónica ••Manejo del paciente con síndrome coronario agudo

For further detailed information about the Spanish sessions, please refer to the detailed scientific programme which follows.

••Conferencias : - De los ensayos clínicos a la práctica asistencial - Avances en el manejo de la enfermedad aórtica

Webcasts Certain official WCC 2008 Scientific Sessions will be webcasted by Prous Science. These sessions will be accessible on the WCC Congress website www.worldcardiocongress.org after the congress.

Industry satellite symposia and workshop activities Industry Satellite Symposia and Workshop activities as well as Non-commercial symposia have dedicated time slots: ••before the congress opens in the afternoons (Pre-Congress activities) ••in the middle of the day during the congress (Inter-Sessions) ••at the end of the afternoon (Evening Sessions)

••Non-commercial Symposia tailor-made for institutions such as hospitals, universities and not-for-profit organizations. For further information about these Industry satellite symposia and workshop activities, kindly refer to the detailed scientific programme which follows.

These sessions include: ••Symposia specifically designed for any company active in the field of cardiology as an opportunity to showcase the latest developments and scientific information. ••Workshops  designed for medical device companies, biotechnology companies and the distribution sector related to cardiovascular medicine.

Scientific Programme / 63

Acknowledgements The scientific programme has been prepared in close collaboration with the Scientific Programme Committee (SPC), local advisers and topic group leaders. The WCC 2008 organizers would like to thank everybody for their commitment and contribution to the WCC 2008 Scientific Programme.

Basic science Luis Alday (Argentina) Valentin Fuster (United States) Cardiac imaging/Computers Moníca Acevedo (Chile) Néstor Pérez Baliño (Argentina)

Topic group leaders: Arrhythmias Günter Breithardt (Germany) Alvaro Sosa Liprandi (Argentina) Heart failure/Left ventricular function Hugo Grancelli (Argentina) Akira Matsumori (Japan) Valvular disease/Pulmonary circulation/Myocardialpericardial Edgardo Escobar (Chile) Ricardo Ronderos (Argentina) Ischemia/Coronary artery disease Juan Krauss (Argentina) Dev Pahlajani (India) Interventions/Peripheral circulation/Stroke Liliana Grinfeld (Argentina) William Wijns (Belgium) Hypertension Luis Maria Amuchástegui (Argentina) Ayrton Brandão (Brazil) Churchill Onen (Botswana) Exercise/Epidemiology/Prevention Nizal Sarrafzadegan (Iran) Néstor Vita (Argentina) Pharmacology Jorge Lerman (Argentina) Andrew Tonkin (Australia)

Acute cardiac care Juan Carlos Linares-Casas (Argentina) Marco Martínez-Ríos (Mexico) Paediatric/Congenital heart disease Horacio Faella (Argentina) Trevor Hassell (Barbados) Nursing/Technician Sania Nishtar (Pakistan) Juan Plastino (Argentina) Local advisers (Argentina) Carla Agatiello Carlos Barrero Horacio Capelli Sergio Dubner Irene Ennis Guillermo Fábregues Mariano Falconi Paola Kuschnir Emilio Kuschnir Pedro Lylyk Osvaldo Masoli Eduardo Mele José Moltedo Oscar Oseroff Diego Pérez de Arenaza Daniel Piñeiro María Laura Plastino Fernán Quiroz José Luis Ramos Rodolfo Rothlin

Scientific programme at a glance

Room

8.30-10.00

Rio de la Plata

Vulnerable plaque and registries

HTS

Interpretation of the difficult ECG: Practical approach 

Thames

Coronary and non-coronary endovascular treatment I

CS

Novel concepts in hypertension treatment 

Danube

Acute and chronic Heart Failure

SYMP

Cardiac resynchronisation therapy (CRT) - Part One

Amazon South American Congress of Cardiology

Opening Ceremony XXIII Congreso Sudamericano de Cardiología

Rhine

Arrhythmias I

Missouri

SP

ACC: Regional challenges to the prevention and treatment of CVD in the U.S.

Research in Heart Failure

DEB

Treatment of Chagas disease

Huang He

3D Echocardiography

CS

Common challenges in the everyday practice of nuclear cardiology 

Nile

Lipids, obesity and metabolic syndrome

SYMP

Cardiac rehabilitation programmes 

Pilcomayo

Diet, drugs and cardiovascular disease

CS

Pharmacotherapy in heart failure: New drugs or new benefits? 

Mississippi

Green

Volga

Clinical and experimental atherosclerosis General Cardiology I Pediatric cardiology: From neonates to grown-ups

Scientific sessions

Desafíos actuales de la cardiología sudamericana

Tiber

Ochre

10.30-12.00

SACC

Oral abstract sessions

Yellow

Pavillion

Red

Monday, 19 May 2008

DEB

SP

SACC CS

SP CS

SYMP

SYMP

Advances in genetics 

SYMP

Severe pulmonary insufficiency after congenital heart surgery

SYMP

DEB

CS

Advances in cardiopulmonary resuscitation 

Niger

Hypertrophy and dysfunction of cardiac cells

CS

Acute coronary syndrome in the elderly 

Ganges

Stroke and carotid artery stenting

CS

Unresolved issues on coronary interventions 

Seine

Myocardial infarction

SYMP

Yang Tze

Cardiovascular risk factors in different populations

SYMP

Paraná

Diabetes and cardiovascular risk

Euphrates

Innovations in surgical and percutaneous valvular treatments

Orinoco

Research in hypertension

SYMP

Mekong

Coronary and non-coronary interventions

SYMP

SP

Drugs vs. electrical devices 

SCAI-SOLACI: What we know and what we don’t know about DES

The polypill 

SP

WHFS: The failing heart around the world 

Cardiac resynchronisation therapy (CRT) - Part Two

Cómo optimizar el tratamiento de la insuficiencia cardiaca SACC crónica

Manejo del paciente con síndrome coronario agudo

Non-invasive risk stratification SYMP for sudden cardiac death 

Management of arrhythmias in genetically based diseases 

APSC: Global burden of heart failure

SYMP

Heart failure with normal ejection fraction 

All a cardiologist needs to know Delayed enhancement imaging for SYMP about cardiac MSCT & MRI  evaluation of cardiomyopathies 

Use of 3D echo in clinical day-to-day practice 

Optimum treatment for heart failure 

HTS

New trends in the management HTS of cardiovascular risk: The role of SYMP heart rate

Cellular regenerative therapy in cardiology  Interventional cardiology in congenital heart disease 

SYMP

Fetal cardiology 

Cardiopulmonary resuscitation  SYMP Resuscitation science and survival  ISCU: Update in 3D echocardiography

SP Endovascular heart valve CS interventions: The end of valvular open-heart surgery? - Part One 

Acute decompensated heart SYMP failure 

Advanced heart failure

Atrial fibrillation: Nonpharmacologic treatment   MSI: The Metabolic Syndrome: Growing prevalence in Latin America and treatment needs

SYMP

Are comorbidities a limit Primary and secondary prevention SYMP to cardiovascular prevention in SYMP in atherosclerosis: From theory the elderly?  to daily practice 

SP

Experience with ST and non ST elevation infarction

16.00-17.30

SYMP Electrical therapy in heart failure SYMP

PASCAR - Health Transitions and CVD in Africa: Implications for the 21st Century

Tigris

Arrhythmias

14.00-15.30

CS

All you need to know about carotid stenting 

CS

Surgical treatment for congestive heart failure 

SYMP

Health promotion for children

DEB

The polypill is an effective strategy for reduction of cardiovascular diseases 

SYMP

Cardiovascular risk and human immunodeficiency virus (HIV) infection in Africa 

CS

Anemia and heart failure 

SYMP

Management of asymptomatic valve disease

Treatment of hypertension in SYMP special situations 

Update of treatment of hypertension 

SP

Current treatment of myocardial infarction: From SYMP evidence to clinical practice 

Antithrombotic treatment in non-ST-acute coronary syndrome 

SYMP

ISH: Hot topics in hypertension: An update Revascularization of patients with stable coronary artery disease 

Pharmacology

Heart failure / Left ventricular function

Basic science

SYMP

Symposium

Valvular disease / Pulmonary circulation / Myocardial-pericardial

Cardiac imaging / Computers

DEB

Debate

Ischemia/ Coronary artery disease

Acute cardiac care

HTS

How-to and Workshop session

Interventions / Peripheral circulation / Stroke

Paediatric / Congenital heart disease

Hypertension

Nursing / Technician

SP

Exercise / Epidemiology / Prevention

Public policy / Advocacy initiatives

SACC

CS

Clinical seminar Special featured joint session South American Congress of Cardiology

Scientific Programme / 65

Scientific programme at a glance Tuesday, 20 May 2008

Red

Pavillion

Room

8.30-10.00

10.30-12.00

Rio de la Plata

Atrial flutter and fibrilation

DEB

Controversial issues regarding management and treatment of systolic heart failure

DEB

Thames

Experiences with high risk patients I

SP

IASC: Heart failure with preserved systolic function

SYMP

Danube

Chronic heart failure

CS

ECG, atrial fibrilation and ablation

CS

Missouri

Cardiac transplantation

Huang He

Conferencias

Tratamiento actual de la SACC enfermedad coronaria crónica SACC

AHA: Critical issues and new strategies to manage patients SYMP SP with cardiovascular disease

Echo stress II

SYMP

Nuclear cardiology 2008

Nile

Exercise, lifestyle and ischemic heart disease

SYMP

Women and coronary heart disease

Pilcomayo

Primary and secondary prevention II

SYMP

The class effect dilemma are all drugs within a class created equal?

Volga

Echo stress I

Fetal cardiology

SYMP

SP

Percutaneous pulmonary valve SYMP replacement

Tigris

Acute myocardial infarction

SYMP

Acute heart failure in the emergency department

SYMP

Niger

Research on pharmacology

SYMP

Acute coronary syndrome in diabetes

SYMP

Ganges

Drug eluting stent: Early and late outcomes

CS

Percutaneous heart valve interventions:The end of valvular CS open heart surgery? - Part two

Seine

Acute coronary events

CS

BMS and DES restenosis: How do we treat them in 2008?

Yang Tze

Primary and secondary prevention I

SP

Paraná

Long QT syndrome, heart failure and diabetes

SYMP

Euphrates

Mitral valve disease and pulmonary hypertension

Orinoco

Drugs, diabetes and hypertension

Mekong

Markers in acute syndromes

Arrhythmias

Risk stratification in genetic Health from a gender perspective: SYMP disorders: ICD or not? Implications for CVD

SYMP

SP

SYMP

Factores de riesgo y aterosclerosis subclínica

Adequate management of chronic heart failure

Endothelial dysfunction SYMP detection with cold pressor SYMP test and myocardial perfusion

The global nutrition challenge

SP

Coronary bypass surgery: Contemporary issues

DEB

What is new in heart failure?

Novel treatments for lipids disorders

PCNA: The role of the nurse in preventive cardiology: An area of leadership

SP

SYMP

Mississippi

Green

Promoting smoke-free environments

SYMP Go Red for Women: Going global

CS

Tiber

Ochre

Guiding and optimizing treatment of heart failure

Management of patients with syncope

Scientific sessions

Rhine

16.00-17.30

Late results in cardiovascular Mitral valve repair: What is SYMP interventions the best option?

SACC

Oral abstract sessions

Yellow

Amazon South American Congress of Cardiology

14.00-15.30

Cardiovascular drug therapy in women

Viability imaging

Stress and depression: New risk factors for coronary heart disease Rheumatic Fever/Rheumatic Heart Disease

SP

Inflammation and Cardiovascular Disease: Multi-marker approach Políticas de Salud Congenital heart disease in countries with limited resources

SYMP

Prevention of cardiac disease in childhood

Acute coronary syndrome from pre-hospital to the emergency room

SYMP

Reperfusion in the elderly: Evidence vs. real life An international look at care for patients with acute coronary syndrome

Acute coronary events during SYMP non-cardiac surgery Complex patients and complex decisions - Part one

CS

How to deal with PCI complications?

Lower limb interventions: Stand up and walk

SYMP

Stroke above the carotids

ASNC: The big trials on nuclear cardiology

CS

Understanding hypertrophic cardiomyopathy

Why are we not better in preventing cardiovascular diseases?

SYMP

Diabetes prevention

SYMP Update on mitral regurgitation SYMP

Current topics in infective endocarditis

CS

Exercise in valvular heart disease

SYMP

Hypertension and target organ damage

What are the strategies in the management of mild hypertension?

SYMP

Management of patients with hypertension and comorbidities

CS

Interventional treatment of acute myocardial infarction

CS

HRS & ISHNE: Sudden cardiac death Cardiovascular disease prevention in children

SP

DEB

SYMP

Non-invasive imaging for What should be the antithrombotic SYMP the diagnosis of myocardial SYMP therapy in acute coronary ischemia: Which method? syndrome?

Pharmacology

Heart failure / Left ventricular function

Basic science

SYMP

Symposium

Valvular disease / Pulmonary circulation / Myocardial-pericardial

Cardiac imaging / Computers

DEB

Debate

Ischemia/ Coronary artery disease

Acute cardiac care

HTS

How-to and Workshop session

Interventions / Peripheral circulation / Stroke

Paediatric / Congenital heart disease

Hypertension

Nursing / Technician

SP

Exercise / Epidemiology / Prevention

Public policy / Advocacy initiatives

SACC

CS

Clinical seminar Special featured joint session South American Congress of Cardiology

Scientific programme at a glance ROOM

8.30-10.00

Rio de la Plata

Prognosis, myocardial infarction and stents

Thames

Experiences with high risk patients II

SYMP

Danube

Experimental and clinical interventions with cardiovascular cells

SYMP

Amazon South American Congress of Cardiology

Prevention of cardiovascular disease

SACC

Rhine

ICD and pacemakers

SYMP

Missouri

Kidney and heart failure

Huang He

16.00-17.30

SYMP

Post-graduate cardiology training and recertification

Advanced concepts in critical care nursing

SYMP

Relevant nursing topics

Cardiology in middle- and low-income countries

SYMP

To ablate or not to ablate? Controversial issues

Update in ablation of ventricular arrhythmias

CS

Sudden death

SYMP

Sudden death in heart failure

SYMP

The cardiorenal syndrome in heart failure

CS

Prognostic factors for heart failure in the betablocker era: Who must be listed for heart transplant?

MRI and CT scan

SYMP

How to use CT multislice and magnetic resonance in clinical practice?

SYMP

Tissue doppler imaging: Present and future

SYMP

Echo doppler in r esynchronisation era

Nile

Hypertension and subclinical atherosclerosis

SYMP

Global risk factors for the development of coronary artery disease and stroke

How to reach and HTS maintain LDL below 70 in very SYMP high risk patients

Nutrition, diet and C VD prevention

Pilcomayo

Interventions and cardiac ultrasound

SYMP

Cardiovascular safety of non-cardiovascular drugs

Medical informatics: Applications in cardiology

ISCP: Update on current cardiovascular research in USA and Europe

Volga

Exercise and autonomic nervous system Coronary and non coronary endovascular treatment II

Tigris

Acute coronary syndromes and PTCA

Niger

TC Scan, arrhytmias and orthostatic hypotension

Ganges

Inside the artery, inside the plaque

Seine

Women and coronary disease

Yang Tze

Social and emotional factors in heart disease

Paraná

Scientific sessions

SYMP

Cell therapy

Toma de decisiones en valvulopatías

SYMP Nursing in cardiovascular disease

Atrial fibrillation: From pathogenesis to practice

Mississippi

GREEN

14.00-15.30

Fibrilación auricular. Lo viejo y lo nuevo.

Tiber

OCHRE

10.30-12.00

SACC

Oral abstract sessions

YELLOW

PAVILLION RED

Wednesday, 21 May 2008

SYMP

SP

MSC: Interventional cardiology in adults with congenital heart disease

HTS

BSC: Coronary artery disease 2008

SP

SYMP

Novel cellular mechanisms in cardiac hypertrophy and ischemia

CS

Contemporary factors in cardiology

SYMP

Prevention of cardiovascular disease in asymptomatic patients

SYMP

Adult congenital heart disease: Hot issues

SYMP

Management of obesity today

CS

The cardiovascular hazards of air pollution

SYMP

The chest pain centre: Evolving concept

SP

DEB

SACC

Avances en la insuficiencia cardiaca aguda descompensada

Cardiovascular disease in diabetes: Controversies and opportunities

CS

Women and cardiovascular disease

CS

The high-risk asymptomatic patient with coronary artery disease

PCI in chronic CHD has no proven long-term safety and benefit

CS

New Strategies for PCI

CS

Complex patients and complex decisions - Part two

Metabolic syndrome in youth: Is it SYMP the beginning of the cardiovascular SYMP disease continuum?

Haemodynamics, heart and hypertension

SYMP

Endothelial function and dysfunction: Assessment, therapy and outcome

SYMP

Stress echocardiography in difficult patients

Advances in nursing topics

HTS

How to assess ventricular dysynchrony for RCT?

CS

Euphrates

Cardiomyopathies

SYMP

Orinoco

Hypertension and other risk factors

DEB

Mekong

Antiplatelets in PTCA

CS

Arrhythmias

Nuevas fronteras en la hipertensión arterial

SACC

Management of acute pulmonary embolism and pulmonary SYMP hypertension

Echodoppler as the main tool in assessing left ventricular SYMP function

Growing practice of nonpharmacological treatment in congestive heart failure Myocarditis and dilated cardiomyopathies: How are they related?

CS

Chagas disease

Management of pre-hypertension SYMP Management of hypertension SYMP and metabolic syndrome Management of acute myocardial SYMP infarction in the 21st century

Scaling-up secondary prevention

Hot topics in hypertension Hyperglycemia, inflammation and coronary artery disease: New relationships?

CS

Pharmacology

Heart failure / Left ventricular function

Basic science

SYMP

Symposium

Valvular disease / Pulmonary circulation / Myocardial-pericardial

Cardiac imaging / Computers

DEB

Debate

Ischemia/ Coronary artery disease

Acute cardiac care

HTS

How-to and Workshop session

Interventions / Peripheral circulation / Stroke

Paediatric / Congenital heart disease

Hypertension

Nursing / Technician

SP

Exercise / Epidemiology / Prevention

Public policy / Advocacy initiatives

SACC

CS

Clinical seminar Special featured joint session South American Congress of Cardiology

Scientific Programme / 67

Scientific programme by day and by time Sunday, 18 May 2008

R io de la P lat a - R e d P avillion - 1 8 .0 0 - 20. 00 Overflow in meeting rooms of the Yellow Pavillion

Op e n i n g Ce re mony W o r l d C o ngre s s of C ardi o lo g y 2008

We l c o m e A d dr es s by Argentinean Authorities

Ope n i n g A d dr e s s Horacio Faella (ARGENTINA) President of the World Congress of Cardiology 2008 Shahryar Sheikh (PAKISTAN) President of the World Heart Federation Sidney Smith (UNITED STATES), Felipe Martínez (ARGENTINA), Arturo Cagide (ARGENTINA) Co-Chairmen of Scientific Programme Committee of the World Congress of Cardiology 2008 Eduardo Mele (ARGENTINA) President of the Argentine Society of Cardiology Luíz Guzman (ARGENTINA) President of the Argentine Federation of Cardiology Hugo Grancelli (ARGENTINA) President of the XXIII Congress of the South American Society of Cardiology

The Opening Address is followed by T h e I g n a c i o Cháve z L e c tur e Fuster Valentin (UNITED STATES) Simultaneous translation Spanish-English / English-Spanish provided in Rio de la Plata – Thames – Danube

Monday, 19 May 2008 Se ine - Gr e e n P avillion - 0 8 :3 0 - 10: 00 Oral abstract session M yo card i a l In f arc t i o n Chairs: Eduardo Morales Briceño (VENEZUELA), Carlos Boissonet (ARGENTINA) 08:30 Are clinical characteristics, therapeutic interventions and in hospital outcome different in women with non ST-segment elevation acute coronary syndromes? H. Pomés Iparraguirre, P. Santander, G. Calderón, W. Santander, G. Andersen, O. Paredes, L. Ferrer, R. Aguero, G. Guthman, J. C. Olmos 08:43

Early and late cardiogenic shock during acute myocardial infarction A. Charask, V. Mauro, L. Rodriguez, J. Zimmermann, M. Ferrer, E. Fairman, Y. Castillo Costa, H. Gomez Santamaria, J. Leguizamon, C. Barrero

08:56 Role of embolic protection devices in acute myocardial infarction. Is their routine use of clinical benefit at 6 months? M. Masotti, H. Salazar, X. Freixa, N. Bellera, R. Kiamco, C. Fernández, M. Jiménez, S. Argiró, A. Betriu 09:09 Late Recovery of Myocardial Blush 24 Hours After a Primary PCI Predicts Long Term Left Ventricular Function (LVF) Improvement. M.A. Riccitelli, J. Szarfer, P. Arce, A. García Escudero, G. Gigena, F. Blanco, R. Neme, R. Sarmiento, M. Gaito, L. Vidal 09:22 Genetic Variability Of Platelet Glycoprotein Ia Regulates The Release Of Soluble CD40-Ligand And P Selectin During Acute ST-Elevated Myocardial Infarction C. Antoniades, D. Tousoulis, C. Vasiliadou, K. Marinou, N. Koumallos, E. Stefanadi, A. Antonopoulos, C. Tentolouris, K. Bakoyiannis, C. Stefanadis 09:35

ST-T Elevation Myocardial Infarction Called By The Emergency Department: How Often Is It True? T. Vagaonescu, A. Hussain, A. Mehra, J. Plate, G. Batsides, A. Wilson, A. Moreyra

09:48 Are women at risk for poor outcomes after percutaneous coronary intervention for acute myocardial infarction? M. Masotti, X. Freixa, N. Bellera, M. Jiménez, R. Kiamco, S. Argiró, C. Fernández, A. Betriu.

Scientific Programme / 69

Monday, 19 May 2008 R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00 Oral abstract session Vu l n e r a bl e p l a q u e a n d r egis tr i e s Chairs: Conci Eduardo (ARGENTINA), Romero Carlos (URUGUAY) 08:30 Managing ACS patients in 2004 and 2007: does practice makes perfection? C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Goncalves, P. Monteiro, L. Gonçalves, M. Freitas, L. Providência 08:43 Vulnerable Plaque: Presence and characteristics in patients who died because of an acute stroke or cerebral trauma M. J. Vera Janavel, C. Vigliano, E. Gurfinkel 08:56

Multicentric inflammation in coronary arteries in ischemic acute syndromes R. A. Sarmiento, C. Parisi, F. Blanco, R. Blanco, L. Romeo, S. Fandiño, E. Bit Chacock, M. Riccitelli, L. Vidal

09:09

High Molecular Weight Adiponectin Is a Good Predictor for the Coronary Artery Soft Plaque R. Nakazato, M. Moroi, T. Furuhashi, H. Fukuda, K. Sugi

09:22 Importance of the magnitude of cardiac troponin T and natriuretic peptide release for long-term riskstratification in decompensated heart failure. A report from the CIAST-HF (Collaborative Italo - Argentinean Study On Troponin-T In Heart Failure) Studies E. Perna, N. Aspromonte, J. P. Cimbaro Canella, G. Di Tano, S. M. Macin, L. Milani, M. L. Coronel, M. Milli, J. Parra Moreno, R. Valle 09:35 Computed discharge report (Epi-Cardio) as a tool for a prospective multicenter registry of in-hospital cardiology activity. A GEDIC-ARIAM collaboration M. De Abreu, Horacio Pomes Iparraguirre, J. Benitez, S. Salzberg, A. Reina, I. Slimobich, P. Gitelman, J. Gagliardi, H. Doval, C. Tajer 09:48 Clinical profiles and outcomes of Acute Aortic Dissection from 2000 to 2006, “Instituto Nacional del Corazón” ESSALUD, Lima – Peru. Gálvez Caballero, David Germán, Rosales Vidal, Maritza, Franco Escobar, David Lenin, Rodriguez Villegas, Jorge Morales Azcona, Rosa Maria, Zelaya Castro, Pio Daniel, Chacon Diaz, Manuel

Monday, 19 May 2008 Me kong - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract session Cor o n ary a n d n o n c o r o n a r y i n t erventions Chairs: Raúl Bretal (ARGENTINA), Roxana Mehran (UNITED STATES ) 08:30 Which is the best strategy to treat patients with concomitant hypertrophic obstructive cardiomyopathy and coronary artery disease? SILVIA Judith Fortunato De Cano, MANUEL Nicolas Cano, ADRIANA C. Moreira, JAIRO Alves Pinheiro Jr., RICARDO Pavanello, VERA Marcia Lopes Gimenes, AMANDA Moraes R. Sousa, JOSE Eduardo Mr Sousa, ADIB Domingos Jatene 08:43

The microvascular rheology of ultrasound contrast in ischemia-reperfusion injury, diabetes and sepsis A. Camarozano, F. Cyrino, E. Bouskela, A. Siqueira-Filho, K. Camarozano, R. Noe

08:56 Multiple Coronary-Left Ventricle Communications: angiographic and clinical characteristics in 20 patients A. Dini, G. Tamashiro, C. Rando, M. Villegas, J. Diaz, J. Gomez, A. E. Ballestrini, A. Tamashiro 09:09 A retrospective analysis of Contrast Induced Nephropathy (CIN) in 501 consecutive patients undergoing coronary angiograms done in a secondary centre I. Ternouth, C. Tibbatts, J. Sleigh 09:22 StentBoost-A Novel Angiographic Technique to Evaluate Stent Expansion: Validation with Caliper Measurement M. Albertal, A. Candiello, F. Cura, L. T. Padilla, P. Perez Balino, S. Jozami, J. A. Belardi 09:35 Extent and Patterns of Neointimal Hyperplasia Distribution after Drug-Eluting Stent Implantation in Diabetic Patients assessed by Intravascular Ultrasound L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen 09:48 Evaluation of Collateral Circulation by Fractional Flow Reserve in Patients with Previous Myocardial Infarction: Relation to Chest Pain and ECG Changes B. Beleslin, M. Ostojic, S. Stojkovic, V. Vukcevic, G. Stankovic, D. Orlic, M. Nedeljkovic, A. Arandjelovic, J. Kostic, M. Dikic

Scientific Programme / 71

Monday, 19 May 2008 Tigris - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Exp e r i e n c e w it h ST and n o n ST ele vat ion infarc t ion Chairs: Mònica Masotti (SPAIN), Juan Gagliardi (ARGENTINA) 08:30 Significant decline in the age adjusted mortality rate from acute ST elevation myocardial infarction (STEMI) in the United States M. R. Movahed, M. Hashemzadeh, M. M. Jamal 08:43 Impact of Combination Evidence-Based Medical Therapy Used at Admission on In-Hospital Mortality in Patients With Non-ST-Elevation Myocardial Infarction Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky 08:56 HDL-Cholesterol Improves Prediction of In-hospital Events in Individuals with Unstable Angina or Non-ST-Elevation Acute Myocardial Infarction L. C. L. Correia, M. S. Rocha, J. P. Esteves 09:09 Correlation between serum markers of inflammation, myocardial injury and thrombosis with coronary angiographic findings in patients with non-ST elevation acute coronary syndromes. Cyntia Karla Magalhães, Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura, Vitor Manuel Pereira Azevedo, Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier 09:22

Nationwide trends in the incidence of non ST elevation myocardial infarction (NSTEMI) in the United States M. R. Movahed, M. Hashemzadeh, M. M. Jamal

09:35 Heart-kidney connection: Renal fibrosis and activation of renal molecular remodeling after myocardial infarction in the absence of heart failure F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett 09:48 Bisoprolol and standard therapy combination in patients with ischemic cardiomyopathy on long-term outcome K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan R hine - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Arr h y t m i a s I Chairs: Ivan Mendoza (VENEZUELA), Alberto Giniger (ARGENTINA) 08:30 Reperfusion arrhythmias: Are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction? G. Heper, M. E. Korkmaz 08:43

Cardiac palpitations in menopausal women due to non-sustained right atrial tachycardia (NSRAT) E. Sclarovsky

08:56

The left-middle (septal) fascicular block P. Sanches, P. Moffa, A. Riera

09:09

Clinical use of microvolt T wave alternans test in risk stratification of dilated cardiomyopathy G. Molon, A. Costa, T. De Santo, G. Ligorio, E. Barbieri

09:22 NT-Pro-BNP decreases rapidly following cardioversion in patients with persistent atrial fibrillation and preserved ventricular function. C. Higa, J. Gambarte, G. Ciambrone, S. Donato, A. Escobar, P. D. Comignani, F. Novo, A. Macchia 09:35

Therapeutic limitations conducts in octogenarians in Intensive Care Unit J. Silva, M. Fervenza, T. Asmann, R. Azevedo, R. Della Pasqua, L. Peixoto, A. Tors, E. Marques, J. Freitas, A. Macedo

09:48

Intravenous digoxin for the cardioversion of recent-onset atrial fibrillation: meta-analysis of randomized studies H. H. Veloso, A. V. De Paola

Monday, 19 May 2008 Euphrat e s - Ochre P avillion - 0 8 :3 0 - 10: 00 Oral abstract session Inno v a t i o n s i n s u r g i c a l a n d p ercutaneous valvula r tr eatments Chairs: Agatiello Carla (ARGENTINA), Borracci Raúl (ARGENTINA) 08:30

Repair of anomalous left coronary artery from pulmonary artery. Early survival, outcomes and follow up. M. Pilan

08:43

First UK experience of percutaneous aortic valve replacement H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac

08:56

Percutaneous aortic valve replacement for severe aortic stenosis by core valve bioprosthesis G. Schuler, A. Linke, S. Möbius-Winkler, F. Mohr, T. Walther, J. Fassl

09:09 Minimally invasive mitral valve surgery without aortic cross-clamping: An excellent solution for re-operative cardiac surgery S. S. Eagle, R. Umakanthan, M. Leacche, M. R. Petracek, R. M. Ahmad, J. M. Balaguer, J. P. Greelish, S. K. Ball, S. J. Hoff, J. G. Byrne 09:22

Aortic root surgery: Ten-Year experience at the Favaloro Foundation R. Favaloro, P. Roura, C. Salvatori, J. Diaz, H. Raffaelli, E. Dulbecco, J. Abud, C. Lopez, H. Casabe, E. Guevara

09:35 The Ross procedure for the treatment of aortic valve disease in adult patients: mid and long term results at a single referral surgical center R. Favaloro, P. Roura, C. Salvatori, J. Diaz, E. Guevara, F. Vaisbuj, C. Rodriguez Correa, F. Salmo, C. Gomez, M. Bustamante Labarta 09:48

Atherosclerotic burden among patients with acute aortic artery syndrome M. J. Fosco, M. P. Marturano, G. Procopio, R. Merbilháa, L. Cicco, R. Favaloro, F. Klein

Yangt z e - Ochre P avillion - 0 8 :3 0 - 10: 00 Oral abstract session Card i o v a scu l ar r i s k f ac t or s i n diffe r ent p op ulations Chairs: Jorge Vilarino (ARGENTINA), Fernando Manzur Jattin (COLOMBIA) 08:30

An assessment of cardiovascular disease risk factors and behavior in Pakistani adolescents S. I. Hassan, K. Kazmi, F. Jahan, S. H. Badruddin, S. Ahmed

08:43 Impact of cardiovascular risk factors on the relationship between education and mortality. A Chilean prospective cohort study: the San Francisco Project. E. Koch, T. Romero, C. Akel, C. Diaz, L. Manriquez, M. Paredes, A. Taylor, C. Roman 08:56

Factors associated with the cord blood lipid profile: Baseline data of a birth cohort study R. Kelishadi, Z Badiei

09:09 EUROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and rehabilitation programme share the same risk factors? Do they change together? C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood 09:22

Development of a valid cardiovascular risk model that aims to stimulate lifestyle changes in the population M.R. Cobain, P. Murray, J. Massaro, R. B. D'Agostino

09:35

National Keshan Disease Surveillance 2007 T. Wang, J. Hou, L. Zhang, J. Pei, H. Feng, Q. Li, B. Xu

09:48 Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in a low and intermediate Framingham risk cohort J. Postley, A. Perez, N. D. Wong, M. Chan, J. Gardin

Scientific Programme / 73

Monday, 19 May 2008 Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Res e a rch i n H e a r t F ail ur e Chairs: Marcelo Montera (BRAZIL), Gimeno Graciela (ARGENTINA) 08:30 Assessment of contractility and afterload mismatch as determinants of reduced ejection fraction in severe aortic stenosis with heart failure R. Migliore, M. Adaniya, M. Bruzzece, F. Saliva, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi 08:43 Invasive and non-invasive evidences of cardiac function and morphology improvement in trained infarcted rats L. Jorge, B. Rodrigues, J. Paulini, K. Rosa, K. De Angelis, M. C. Irigoyen 08:56 Inspiratory muscle training improves distribution of blood flow to resting and exercising limbs in heart failure (WITHDRAWN)

G. R. Chiappa, B. T. Roseguini, P. J. C. Vieira, C. N. Alves, A. Tavares, E. R. Winkelmann, E. L. Ferlin, R. Stein, J. P. Ribeiro 09:09 Physical training improves haemodynamic function, muscle oxidative stress and plasmatic levels of IL-10 in chronic heart failure rats P. Dall'Ago, R. B. Nunes, M. Tonetto, N. McHado, M. Chazan, T. G. Heck, A. B. G. Veiga 09:22

Association of oxygen uptake efficiency slope with other prognostic variables in heart failure S. Miriuka, D. Delgado, M. Walker, S. Carson, H. Ross

09:35 Changes of endogenic intoxication during ivabradin and beta blockers therapy at patients with decompensated CHF N. A. Bylova, G. P. Arutyunov, A. G. Arutyunov, A. L. Volkova 09:48

Assessment of cardiotoxicity of imatinib mesylate in chronic myeloid leukemia patients - a cross-sectional study M. S. Marcolino, H. N. S. Bittencourt, N. C. D. Clementino, M. M. Barbosa, M. C. P. Nunes, V. F. Xavier, A. L. P. Ribeiro

Acu t e a n d c hr o n ic H e a rt F a i l ur e Chairs: Roberto Ricca (URUGUAY), Eduardo Sampo (ARGENTINA)

Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session

08:30 Immediate reversion of myocardial ischemic dysfunction after coronary angioplasty. Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura, Vitor Manuel Pereira Azevedo, Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier 08:43

Metabolic syndrome does not imply worse prognosis in systolic heart failure (WITHDRAWN) J. Thierer, N. Vainstein, A. Acosta, J. Marino, D. Ametrano, A. Francesia, V. Mezzalira, M. Trivi, M. Sutton, F. Brites

08:56 Acute myocardial infarction in patients with prior coronary artery bypass surgery; 19-year experience P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic, M. Ostojic 09:09 Safety and efficacy of the utilization of continuous I.V. infusion of Levosimendan out of the Coronary Care Unit setting. L. A. Guzman, G. Moré, R. Sarjanovich, G. B. Scaro, A. Vanella 09:22

Comparison of the effects on plasma neutrophils count of two ARBs in hypertensive patients J. Said Nisi, M. Benderski, J. Martinez, F. Martinez

09:35 Thrombolysis in patients with myocardial infarction after previous coronary artery bypass surgery; 19-year experience P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic, M. Ostojic 09:48 Structural alterations of large intestinal wall role in development of chronic heart failure N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, N. A. Savelov, Y. A. Pokrovskiy, N. V. Kokosadze, A. V. Risnenko, Z. A. Chernaya, T. K. Chernyavskaya, M. I. Korsunskaya

Monday, 19 May 2008 Lip i d s , o b e s i t y a n d m e t a b o l i c s y ndrome Chairs: Carlos Cuneo (ARGENTINA), Masao Sano (PARAGUAY) 08:30

Nile - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract session

Significant differential metabolic effects of lipophilic and hydrophilic statins in hypercholesterolemic patients K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin

08:43 Prevalence of metabolic syndrome and associated risk factors and the impact of acculturation among multiethnic U.S adolescents S. L. Bassin, A. Perez, V. Lopez, N. D. Wong 08:56 Relationship between race/ethnicity, education and household income, and the prevalence of metabolic syndrome: impact of education in the burden of cardiovascular disease in women S. Yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina 09:09 Spleen derived vascular progenitor cell transfer restores metabolic and vascular insulin sensitivity in high-fat diet insulin resistant mice J. Bloch, M. Schwab, P. Dessen, C. Mathieu, A. Monney, H. Duplain, P. Nicod, C. Sartori, U. Scherrer 09:22

Waist circumference and its association with classic cardiovascular risk factors in healthy women. Maria Teresa Lira, S. Kunstmann, E. Caballero, D. Gainza, J. C. Molina

09:35 Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition (WITHDRAWN)

A. Pouta, J. Pirkola, T. Tammelin, A. Bloigu, J. Laitinen, A. Ruokonen, P. Tapanainen, M. R. Järvelin, M. Vääräsmäki 09:48 Accuracy of anthropometric measures of adiposity to predict cardiovascular risk factors in Chilean men and women. The San Francisco Project. E. Koch, T. Romero, C. Diaz, L. Manriquez, M. Paredes, C. Roman, A. Taylor P ilcomayo - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract session Diet , d r u g s and c a r diovas c u l a r dis e as e Chairs: J Fernandes (BRAZIL), Ricardo Esper (ARGENTINA) 08:30

 ipid-altering efficacy and safety profile of co-administered extended release Niacin/Laropiprant and L Simvastatin in patients with dyslipidemia L. Ose, M. Farnier, G. Gleim, N. Liu, S. Thompson-Bell, K. Beckey, A. O. Johnson-Levonas, C. Ballantyne, J. F. Paolini

08:43

 two-year study to assess the efficacy, safety, and tolerability of Taranabant in obese patients: 52 week results A M. Moreno, I. Gantz, N. Erondu, S. Suryawanshi, B. Musser, J. Nayee, A. O. Johnson-Levonas, S. Heymsfield, J. Amatruda

08:56

 omparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina C as compared to a fish-eating population in Norway. R. Leòn De La Fuente, H. Aarsetoey, S. Kiserud, H. Grundt, E. Lovaglio, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, D. W. T. Nilsen

09:09

 lant sterol-enriched spread enhances the cholesterol-lowering potential of ezetimibe in coronary patients P already taking statins but not reaching lipid goals G. B. Gomes, A. D. Zazula, L. S. Shigueoka, R. A. Fedato, J. R. Faria Neto

09:22

Low levels of antibodies against phosphorylcholine predict development of atherosclerosis J. Frostegård, B. Sjöberg, J. Su, H. Grönlund, I. Dahlbom, B. Hedblad, G. Berglund, U. De Faire

09:35 Green and black tea are equally potent stimuli of NO production and vasodilation: New insights into tea ingredients involved V. Stangl, N. Jochmann, M. Lorenz, J. Urban, G. Baumann, M. Laule, K. Stangl 09:48

Development of atherosclerosis: role of systemic inflammation and endotoxin N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya

Scientific Programme / 75

Monday, 19 May 2008 R es e a rch i n hyp er te n s ion Chairs: Brandão Ayrton (BRAZIL), Cristina Arranz(ARGENTINA)

Or inoco - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract session

08:30

 omparison of abdominal obesity and total obesity in predicting risk of prehypertension status C with reference to economic development in the south-west of Congo Kinshasa B. Longo-Mbenza, J. B. Kasiam Lasi On’kin, A. Nge Okwe, D. Vangu Ngoma, S. Mbungu Fuele, G. Milongo Dipa

08:43

Left ventricular mass and diastolic function in patients undergoing renal artery stenting T. Przewlocki, D. Rzeznik, A. Kablak-Ziembicka, M. Kostkiewicz, A. Roslawiecka, A. Kozanecki, W. Tracz

08:56

Baroreflex dysfunction by sinoaortic denervation increases cardiac damage in hypertension K. Flues, I. C. M. Silva, J. Paulini, R. N. De La Fuente, E. D. Moreira, C. Mostarda, K. De Angelis, M. C. Irigoyen

09:09

 holinergic stimulation with Pyridostigmine improves the chronotropic response during exercise C and heart rate recovery in heart failure patients A. Nobrega, S. Serra, R. Vivacqua, S. Xavier

09:22

Association between Consumption of a DASH-type diet and blood pressure in adults from southern Brazil S. C. Fuchs, A. Celestini, L. B. Moreira, R. L. Henn, F. C. Fuchs, F. D. Fuchs

09:35

Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin

09:48 The presence of nitric oxide synthase genetic polymorphism decreases arterial baroreflex sensitivity after maximal exercise F. Neves, B. Silva, A. Sales, N. Rocha, T. Barbosa, V. Stelet, R. Gonçalves, P. Soares, A. Nobrega Volga - Yello w Pavillion - 08:30-10:00 Oral abstract session Ped i a t r i c C a r d io l o g y: Fr om ne o n at e s t o grown-up Chairs: Alberto Sciegata (ARGENTINA), John Cheatham (UNITED STATES ) 08:30 Levosimendan for cardiac failure in postoperative management of cardiac surgery for congenital heart disease in neonates C. R. Ferreiro, M. A. O. Barbosa, M. B. Jatene, I. Jatene, L. C. B. Souza, E. R. Romano, E. T. Egito, S. F. Pedra, V. Fontes, J. E. Sousa 08:43 Outcomes of 124 consecutive congenital heart surgical procedures. Analysis through a variable life adjusted display. E. Juaneda, B. Vega, R. De Rossi, O. Lazzarín, E. Banille, I. Azar, L. Alday 08:56

Anomalous origin of left coronary artery from pulmonary artery: outcome after surgical repair. I. Lugones, M. Cazalas, A. Sardella, M. I. Roman, C. Kreutzer, J. L. Simon, A.J. Schlichter

09:09

Spectrum of conotruncal congenital heart malformations in patients with 22q11.2 chromosome microdeletion E. Juaneda, N. Rossi, A. Sturich, C. Montes, R. Schumiachkin, A. Chávez, B. Vega, L. Alday

09:22

Stenting coarctation of the aorta with Cheatham platinum stent: initial results R. Gamboa, F. P. Mollon, R. E. Rios Mendez, D. Antoni, G. M. Arro

09:35

Optimal programming of the ICD in children and young adults on the basis of long term follow-up. M. Lewandowski, A. Przybylski, P. Syska, M. Sterlinski, A. Maciag, H. Szwed

09:48 Grown-up congenital heart disease treated in pediatric catheterization laboratory R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, H. Mon, H. E. Montero Monar, L. R. Valdivieso Cedeño, O. A. Mendiz, A. Fogel

Monday, 19 May 2008 Nige r - Gr e e n P avillion - 0 8 :3 0 - 10: 00 Oral abstract session Hype r tro p h y a n d d y s f u n ct i o n o f car diac cells Chairs: Horacio F. Cingolani F (ARGENTINA), Kelly David T (AUSTRALIA) 08:30 Ovarian hormones deprivation induces cardiovascular autonomic dysfunction associated with cholesterol levels in LDL knockout mice J. Paulini, K. Flues, M. Heeren, C. Mostarda, E. D. Moreira, K. De Angelis, M. C. Irigoyen 08:43

Endothelial function in healthy subjects exposes to hypobaric hypoxia D. Iglesias, N. Vainstein, F. Brites, L. Rosso, C. Pesce, C. Lezon

08:56

Functional role of the arginase II in modulating cardiac contractility in mice with and without pressure overload C. H. M. Azevedo, D. Gonzales, G. Joseph, A. M. Benjo, H. C. Champion, D. Nyhan, A. A. Shoukas, J. M Hare, D. Berkowitz

09:09 Diagnosis of acute cellular cardiac allograft rejection by endomyocardial biopsy performed in a teaching hospital from 1984 to 2007 S. Bordignon, E. Horowitz, M. Barra, L. Lima, J. Vieira, P. Ruschell, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla 09:22

Angiotensin AT2 receptor mediates cardiac c-kit+ cell proliferation and supports survival of cardiomyocyte W. Altarche-Xifró, C. Birka, E. Kaschina, M. Timm, A. Grzesiak, C. Curato, M. Brinckmann, T. Unger, J. Li

09:35

 enome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy G in families with hypertension B. M. Mayosi, P. J. Avery, M. Farrall, B. Keavney, H. Watkins

09:48

Echocardiographic study of left ventricular geometry in spontaneously hypertensive rats O. A. Pinilla, V. B. Carranza, E. M. Escudero

Tib e r - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Clin i c a l a n d exp er im e n tal a the r os cle ros is Chairs: Luis De La Fuente (ARGENTINA), Zeljko Reiner (CROATIA) 08:30 Simvastatin improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients independent of doses K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin 08:43 Effects of Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) stimulation in hypercholesterolemic rabbits with induced vascular lesion A. Alessi, L. Baroncini, O. França, C. Prim, D. Précoma 08:56

Is hereditary thrombophilia a contributing factor in premature myocard infarction? M. Kayikcioglu, C. Hasdemir, M. Ildizli, L. Can, S. Payzin, Z. Eroglu, E. Y. Sozmen, B. Saygi, H. Kultursay

09:09

EP2300 compounds, novel squalene synthase inhibitors, reduce atherosclerosis in vivo A. Tavridou, L. Kaklamanis, A. P. Kourounakis, P. N. Kourounakis, A. Charalambous, V. G. Manolopoulos

09:22 Aatorvastatin inhibits the RHO A/RHO kinase pathway and, reduces blood pressure and the expression of vascular remodeling genes in rats with genetically high levels of angiotensin II P. Rivera, M. Ocaranza, J. Jalil 09:35

Overall atherosclerosis burden in patients with end-stage renal disease who are receiving hemodialysis. W. Masson Juarez, I. Bluro, R. Ricardo, G. Rosadiez, V. Aliperti, A. Elizalde, J. Krauss, A. Cagide

09:48 Rosiglitazone effects on counterlateral iliac artery after vascular injury in hypercholesterolemic rabbits O. R. França Neto, A. Alessi, C.R. Prim, R. F. K. Caetano Da Silva, L. De Noronha, A. Caporal, L. A. V. Baroncini, D. B. Precoma

Scientific Programme / 77

Monday, 19 May 2008 G ange s - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session Str o k e a n d c ar o tid a r t er y s te n t ing Chairs: Fernando Vinuela (UNITED STATES ), Jorge Bluguerman (ARGENTINA) 08:30

ENERI experience in carotid artery stenting. Lesson learned and current practice in 1013 patients. P. Lylyk, A. Musacchio, A. Ferrario, C. Miranda, R. Ceratto, J. Vila, P. Angelani, J. Manterola, C. Ingino

08:43

Siriraj subtypes stroke and validation study in Kinshasa B. Longo-Mbenza, J. C. Mbete Tsasa, M. Lelo Tshikwela, P. Mbuilu, D. Vangu Ngoma, S. Mbungu Fuele

08:56

 ong-term survival after ‘tailored’ carotid artery stenting: Results from an academic registry L of 555 consecutive procedures P. Pieniazek, L. Tekieli, P. Musialek, A. Kablak-Ziembicka, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka, W. Tracz

09:09

Initial experience and mid term follow up with intracranial endovascular reconstruction aneurysm treatment with a new stent pipeline P. Lylyk, C. Miranda, A. Berez, K. Nelson, E. Scrivano, R. Romero, C. Ingino

09:22 Percutaneous closure of patent foramen ovale with Amplatzer® device for secondary cryptogenic stroke prevention. immediate results and middle term follow-up analysis M. Borges, P. Machado, E. Horowitz, L. François, J. Silva, R. Rossi 09:35

Risk factors of stroke among Congolese black hypertensive diabetics B. Longo-Mbenza, R. Mombo Ngimbi, D. Vangu Ngoma, S. Mbungu Fuele, B. Buassa-Bu-Tsumbu

09:48

Quality of stroke care in Argentina. Insights from The Argentinian National Stroke Registry (ReNACer) L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustoni, G. Saposnik

Thame s - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Co r o n a r y a n d n o n c or o n a r y endovas cular t re at me nt I Chairs: Deborah Nercolini (BRAZIL), Fernando Cura (ARGENTINA) 08:30 Revival of percutaneous balloon aortic valvuloplasty in non surgical patients with degenerative aortic stenosis as bridge for percutaneous aortic valve replacement C. Agatiello, H. Eltchaninoff, C .Tron, D. Nercolini, C. Rojas Matas, D. Berrocal, A. Cribier, L. Grinfeld 08:43

Abdominal Aortic Aneurysm Evolution after Endovascular Repair. G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, J. Scaglia, P. Mollon

08:56

Descending aorta endovascular repair: Dissection vs. non dissection disease G. Lev, O. Mendiz, L. Valdivieso, C. Fava, L. Villagra, J. Scaglia, P. Mollon

09:09 Contribution to the clinical recognition of severe coronary disease in women C. Serra MD, P. H. M. Del Sueldo, MD, S. Joekes, Magister, G. Pacheco, MD, J. Floridia, MD, H. Cuezo, MD, P. Grosse, MD, A. Righetti, Magister, J. Sala, MD, C. Balestrini, MD 09:22

Therapeutic interventions based on findings in stored electrographs of patients with definitive pacemakers. G. M. M. Pellegrino, D. F. Ortega, L. D. Barja, N. Mangani, L. Mari

09:35 Effects of the late reperfusion of the infarct-related artery on mortality, morbidity and left ventricular remodelling. A metaanalysis of randomised controlled trials. J. Mariani, H. Cohen Arazi, C. Tajer 09:48 Are we treating the right non-ST acute coronary syndrome patients with an invasive strategy? R. Teixeira, C. Lourenço, S. Monteiro, N. Antonio, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, L. A. Providencia

Monday, 19 May 2008 Huang He - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract session 3D Ec h o c a r d i o g r ap hy Chairs: Eduardo Guevara (ARGENTINA), Jose Fernando Guadalajara (MEXICO) 08:30 Utility of the real time 3D echocardiography for assessment of left ventricular mass in patients with hypertrophic cardiomyopathy. Comparison with cardiac magnetic resonance G. Avegliano, M. Huguet, P. Kuschnir, J. Thierer, C. Tobon, D. Capdeferro, C. Burnikoff, A. Frangi, M. Petit, R. Ronderos 08:43

 on invasive estimation of end-diastolic pressure in patients with preserved and reduced ejection fraction. N A new single method using stroke volume and deceleration time. R. Migliore, M. Adaniya, D. Duarte, M. Barranco, J. Poch, J. Lloveras, A. Greco, D Pisano, H. Tamagusuku, A. Sinisi

08:56

Left ventricular systolic performance, function and contractility in patients with severe sepsis or septic shock D. Chejtman, A. Hita, S. Baratta, P. Pratesi, J. Bilbao, H. Fernandez, D. Bernardez, D. Turri

09:09

 eal-time three dimensional echocardiographic left ventricular systolic evaluation: comparison between R dyssynchrony indexes and ejection fraction M. L. C. Vieira, V. M. L. Gimenes, W. A. Oliveira, G. Naccarato, A. Cury, J. Pinheiro Jr, M. M. Andrade, S. F. P Pedra, C. H. Fischer, S. S. Morhy

09:22

Epicardial fat as a contributing factor to diastolic dysfunction S. B. Yoon, S. J. Eum, E. J. Lee, P. K. Min, Y. W. Yoon, B. K. Hong, H. M. Kwon, H. S. Kim, S. J. Rim

09:35

Systolic aortic regurgitation: Pathogenesis, doppler hemodynamic mechanisms and natural history J. Mohan, D. Tomar, C. Shekhar

09:48 Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome: prevalence in patients with liver transplantation indication F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle, H. A. Prezioso, L. A . Vidal, O. C. Imventarza Diabe t e s a n d c ar d io va s c ul ar r is k Chairs: Guzman L (ARGENTINA), Raul Pisabarro (URUGUAY)

P araná - Ochr e Pavillion - 08:30-10:00 Oral abstract session

08:30

Type 2 Diabetes mellitus is strongly associated with third degree AV-block M. R. Movahed, M. Hashemzadeh, M. M. Jamal

08:48

Relationship between Acute Myocardial Infarction and Glycemic Status L. Ribeiro, P. Nogueira, R. Berber, R. Ramos, A. Timerman, C. Gun, L. Piegas

09:06 The impact of diabetes mellitus on outcomes in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction. L. O. Jensen, M. Maeng, P. Thayssen, A. Kaltoft, H. Tilsted, M. Bottcher, J. F. Lassen, L. Pedersen, S. P. Johnsen, L. Thuesen 09:24 Are all forms of pre-diabetes born equal regarding acute coronary syndromes outcome? N. Antonio, C. Lourenco, P. Monteiro, S. Monteiro, S. Costa, R. Teixeira, F. Goncalves, L. Goncalves, M. Freitas, L. A. Providencia 09:42 Multiethnic prevalence of abdominal obesity and associated cardiometabolic risk factor burden in U.S. adults 2003-2004 H. Ghandehari, V. Le, S. Kamal-Bahl, S. L. Bassin, N. D. Wong

Scientific Programme / 79

Monday, 19 May 2008 Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session GENERAL C A RDIOLOGY I Chairs: Victor Sinisi (ARGENTINA), Eduardo Roura (ECUADOR) 08:30

Fuzzy logic. A new internet tool for heart rhythm classification. M. Lewandowski, A. Przybylski, W. Kuzmicz, J. Ollitrault, A. Blinowska, H. Szwed

08:43

Different methods for mechanical dyssynchrony assessment and prognosis in heart failure M. Trivi, J. Thierer, R. Ronderos, P. Kuschnir, R. Guglielmone, A. Acosta, A. Hirshon Prado, V. Mezzalira, M. Sultán, J. Marino

08:56 Preliminary evaluation of the safety and effect of pancreatic adult stem cell implantation in Diabetes Mellitus type 1 patients. A. Mesples, B. Pertiné, R. Bellomo 09:09

Is fibrinogen a predictive factor for albuminuria in type 2 diabetes ? A. C. Cordeiro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr, L. Lotaif, L. S. Piegas, C. Amodeo

09:22 Left and right atrial appendage function after percutaneous mitral valvuloplasty in mitral stenosis and sinus rhythm. T. F. Cianciulli, M. C. Saccheri, J. A. Lax, R. A. Sarmiento, A. M. Bermann, J. E. Guerra, J. A. Gagliardi, A. N. Dorelle, H. A. Prezioso, L. A. Vidal 09:35

Carotid intima-media thickness predicts cardiovascular events in patients with atherosclerosis A. Kablak-Ziembicka, T. Przewlocki, W. Tracz, I. Stopa, P. Pieniazek, P. Musialek, A. Kozanecki

09:48

Age evaluation with cardiac doppler of the heart in young sportsmen category amateur soccer D. Avayu, D. Morisse, J. Goral, J. Fuse, C. Seidler, C. Froimovich, L. Rodas, I. Diaz, L. Cimerman

Amaz on - Ye llow P avillion - 0 8 :3 0- 10: 00 South American Congress of Cardiology Op e n i n g C ere m o n y XXIII C o n g r e s o S u d a m e r ic ano d e Cardiología 08:30

Opening Ceremony - XXIII Congreso Sudamericano de Cardiología

Co n f e r e n c i a : Presidente: Sergio Varini (ARGENTINA) 09:00

Imagen y genoma como estrategias de prevención en el futuro. The HRP Study. Fuster Valentin (UNITED STATES )

R io de la P lat a - R e d P avillion - 1 0 :3 0- 12: 00 How-to & Workshop Session Int e rpre t a t i on o f t he d if f ic u l t ECG: P ract ical appr oach Chairs: Alberto Giniger (ARGENTINA), Dario Sobral (BRAZIL) 10:30

Supraventricular tachycardia Ivan Mendoza (VENEZUELA)

11:15

Ventricular tachycardia Günter Breithardt (GERMANY)

Monday, 19 May 2008 Yangt z e - Och r e Pavillion - 10:30 -12:00 Symposium Atr i a l f i br i l l a t i o n : N o n - p h ar m acologi cal tr eatment Chairs: Carlos Labadet (ARGENTINA), Galvao Silas (BRAZIL) 10:30

Management of atrial fibrillation in patients with heart failure: From drug therapy to ablation Shih-Ann Chen (CHINA, TAIWAN)

10:52

Catheter ablation of atrial fibrillation in brady-tachy syndrome Yunlong Xia (CHINA, PEOPLE'S REPUBLIC OF)

11:14

Strategies and results of catheter ablation of atrial fibrillation Andrea Natale (UNITED STATES )

11:36

Where are we going with management of atrial fibrillation Adrian Baranchuk(CANADA)

Danub e - Gr e e n P avillion - 1 0 :3 0 - 12: 00 Symposium Card i ac re s y nc hr o n i s a t i o n t h era py (CR T) - Pa r t One Chairs: Ramos José Luis (ARGENTINA), Ricardo Miglino (BRAZIL) 10:30

Left ventricular dyssynchrony: Impact on function and structure John Gorcsan III (UNITED STATES )

10:52

Right ventricular pacing: The unwanted model of dyssynchrony? Jose Carlos Pachon Mateos (BRAZIL)

11:14

How to assess left ventricular dyssynchrony? Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF)

11:36

Impact of CRT on atrial fibrillation and atrial function Michael Gold (UNITED STATES )

Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00 Symposium Acu t e d ec o mp e n s a t e d h e art f a i l ur e Chairs: John Cleland (UNITED KINGDOM), Carlos García (COLOMBIA) 10:30

Neurohumoral aspect of acute heart failure Mihai Gheorghiade (UNITED STATES )

10:52

Clinical aspect of acute heart failure: The ADHERE registry Guillermo Torre Amione (UNITED STATES )

11:14

When to use inotropic therapy Fabio Vilas-Boas (BRAZIL)

11:36

New perspectives in the treatment of acute heart failure Faiez Zannad (FRANCE)

Scientific Programme / 81

Monday, 19 May 2008 Mis s is s ippi - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium Ad v a nc e s i n g e n e t i cs Chairs: Alicia MattiazzI (ARGENTINA), Walter Reyes Caorsi (URUGUAY) 10:30

The genetics of atrial fibrillation Johannes Brachmann (GERMANY)

11:00

Clinical correlates of long QT syndrome mutations Christian Wolpert (GERMANY)

11:30

Role of obesity and adiponectin in heart disease Kwang Koh (KOREA, REPUBLIC OF)

Volga - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium Severe pulmonary insufficiency after congenital heart surgery Chairs: Ademar Atik(BRAZIL), Pilar Arnaiz (CHILE) 10:30

The impact of pulmonary insufficiency on GUCHS patients Alex Javois (UNITED STATES )

10:48

Evaluation of right ventricular function David Sahn (UNITED STATES )

11:06

Timing of pulmonary valve replacement Miguel L Barbero Marcial (BRAZIL)

11:24

Transcatheter pulmonary valve insertion Ziyad Hijazi (UNITED STATES )

11:42

Surgeon's perpsective Christian Kreutzer (ARGENTINA)

Thame s - Yello w Pavillion - 10:30-12:00 Clinical Seminar No v e l c o nc e p t s i n h y p e rt e n s i o n t reatment Chairs: Carlos Ferrario (UNITED STATES ), Oscar Carretero (UNITED STATES ) 10:30

The Renin Inhibition in hypertension? Alberto Villamil (ARGENTINA)

10:52

Betablockers in Hypertension today Lars Lindholm (SWEDEN)

11:14

Which combination of anti-hypertensive drugs is the most effective to reduce blood pressure? Marcelo Orias (ARGENTINA)

11:36 Gap between patients and physicians attitudes and awareness toward hypertension and its complication in cardiovascular diseases Luis Ruilope (SPAIN)

Monday, 19 May 2008 Nile - Ye llow P avillion - 1 0 :3 0 - 12: 00 Symposium Card i a c re h a b i l i t a t i o n pr o gr a m mes Chairs: Erika S Froelicher (UNITED STATES ), Puska Pekka (FINLAND) 10:30

Cardiac Rehabilitation in Latin America: Survey results Hermes Ilarraza-Lomeli(MEXICO)

10:48

Simplified Methods of cardiac rehabilitation programs Marian Worcester (AUSTRALIA)

11:06

Risk benefits of exercise Alan Goble (AUSTRALIA)

11:24

Models of cardiac rehabilitation programs for low and middel income countries Sarraf-Zadegan Nizal (IRAN, ISLAMIC REPUBLIC OF)

11:42

Cardiac Rehabilitation: the Cuban Model Eduardo Rivas Estany (CUBA)

P ilcomayo - Ye llow P avillion - 1 0 :3 0 - 12: 00 Clinical Seminar Pharmacotherapy in heart failure: New drugs or new benefits? Chairs: Kelly David T (AUSTRALIA), Cesare Orlandi (UNITED STATES ) 10:30

What is new in aldosterone blockage? Willem Remme (NETHERLANDS)

10:52

Vasopressin receptor antagonists in heart failure Marvin Konstam (UNITED STATES )

11:14

New beta blockers: New actions? Juan Gonzalez Juanatey (SPAIN)

11:36

New drugs in heart failure: What is really new? Philip A Poole-Wilson (UNITED KINGDOM)

Huang He - Ye llow P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Common challenges in the everyday practice of nuclear cardiology Chairs: Claudio Meneghetti (BRAZIL), Adel Allam (EGYPT) 10:30

How to study obese patients? Joao Vitola (BRAZIL)

10:48

Patients referred for viability assessment Erick Alexanderson (MEXICO)

11:06

Patients with 50% stenosis in multi-slide computed tomography studies Marcelo Goldstein (BELGIUM)

11:24

Patients with chest pain and negative ECG Anibal Mele (ARGENTINA)

11:42

Clinical use of cardiac PET Barry Zaret (UNITED STATES )

Scientific Programme / 83

Monday, 19 May 2008 Mis s ouri - Ye llow P avillion - 1 0 :3 0- 12: 00 Debate Tr e a t m e n t o f Cha g a s d is e a s e Chairs: Roberto Blandon Calderon (PANAMA), Fernando Aguirre (ECUADOR) 10:30

Statement 1: Treatment of chronic Chagas disease with current anti-parasitic drugs Pro: Rosalia Morais Torres (BRAZIL) Contra: Jose Milei (ARGENTINA)

11:15

Statement 2: Treatment of asymptomatic ventricular arrhythmias Pro: Jorge Mitelman (ARGENTINA) Contra: Juan Justiniano Encina (BOLIVIA)

Me kong - Ochre P avillion - 1 0 :3 0- 12: 00 Symposium Cu rr e n t t r e a t m e n t o f m yo c a r dial infarc t ion: Fr o m e v i d e n c e to c l inic al prac t ice Chair: Fuster Valentin (UNITED STATES ) 10:30

Un-treated patients: How to reduce lost opportunities? Faiez Zannad (FRANCE)

10:52

Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction Oscar Bazzino (ARGENTINA)

11:14

Predictors of one year mortality in high risk patients Frans Van De Werf (BELGIUM)

11:36

Guidelines revised Rafael Diaz (ARGENTINA)

Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Unr e so l v e d is s ue s o n c or o n a r y int e rve nt ions Chairs: Raúl Bretal (ARGENTINA), Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF) 10:30

Late and very late stent thrombosis: New classification and outcomes Donald Cutlip (UNITED STATES )

10:52

Clinical trials: Long-term follow-up regarding DES safety Bonnie Weiner (UNITED STATES )

11:14

LIMA showed 30 years effectiveness: What happened with stent PCI in the last 30 years? Julio Palmaz (UNITED STATES )

11:36

Which benefits does DES have shown in comparison with BMS at long-term follow-up? Carlos Macaya (SPAIN)

Monday, 19 May 2008

Nige r - Gr e e n P avillion - 1 0 :3 0 - 12: 00 Clinical Seminar Acu t e c o r o n a r y s yndr o m e in the e lde rly Chairs: Jose Antonio Francisco Ramires (BRAZIL), Eduardo Roura (ECUADOR) 10:30

Risk stratification and management strategy in the elderly with non-ST ACS Mauricio Cohen (UNITED STATES )

10:52

Is the aggressive medical treatment beneficial in the elderly? Rodolfo Pizarro (ARGENTINA)

11:14

Antithrombotic treatment in St. miocardial infarction Acevedo Monica (CHILE)

11:36

Prognosis and presictors of survival in St. miocardial infarction Satyavan Sharma (INDIA)

Tigris - Y ellow Pavillion - 10:30 -12:00 Clinical Seminar Adva n c e s i n c a r diop u l m onar y r es us cit at ion Chairs: Alejandro Barbagelata (UNITED STATES ), Eduardo Hasbani (ARGENTINA) 10:30

Pathophysiology evolution of the RCP in the last 10 years Kern Karl B (UNITED STATES )

10:52

Vasopressin: Is it an alternative or a better option than ephinefrine? Ari Timerman (BRAZIL)

11:14

Post-resuscitation care: Induced hypothermia to whom, how and when? Jorge Neira (ARGENTINA)

11:36

In hospital resuscitation: Outcomes and prediction of survival Timerman Sergio (BRAZIL)

Or inoco - Ochr e Pavillion - 10:30-12:00 Symposium Tr ea t m e n t o f h y p er t e n s i o n i n s p ecial situations Chairs: Hugo Baglivo (ARGENTINA), Sokn Fernando (ARGENTINA) 10:30

Hypertension in pregnancy Gloria S. Valdes (CHILE)

10:52

Pediatric and adolescent hypertension Andrea Brandão (BRAZIL)

11:14

In elderly, 80 years and above Kjeldsen Sverre E (NORWAY)

11:36

In resistant hypertension Antonio Coca (SPAIN)

Scientific Programme / 85

Monday, 19 May 2008 P araná - Ochre P avillion - 1 0 :3 0- 12: 00 Special Featured Joint Session MSI: T h e M e t a b o l ic S y n dro m e : Gr ow i n g prev a l e nce i n La t i n A m er ica and t reatment needs Chairs: Romero Carlos (URUGUAY), Piñeiro Daniel (ARGENTINA) 10:30

The emerging obesity problem in Latin America Ada Cuevas (CHILE)

10:52

Drug therapy for the dyslipidemia of the Metabolic Syndrome Jean Charles Fruchart (FRANCE)

11:14

The Metabolic Syndrome as a risk factor for diabetes Pablo Aschner (COLOMBIA)

11:36

The Metabolic Syndrome as a risk factor for cardiovascular disease Scott Grundy (UNITED STATES )

R hine - Ye llow P avillion - 1 0 :3 0- 12: 00 Special Featured Joint Session ACC : Re g i o n a l Cha l l enge s to the pr e v e n t i on a n d t r e a tm ent of CVD in t he U.S. Chairs: W. Douglas Weaver (UNITED STATES ), Mele Eduardo (ARGENTINA) 10:30

Cardiovascular imaging for prevention and treatment of CV disease in the U.S.: Challenges and opportunities George Beller (UNITED STATES )

10:52

The quality - first vision: building a learning health care system Jack Lewin (UNITED STATES )

11:14

Challenges in maximizing functional capacity in elderly patients with valvular heart disease Navin Nanda (UNITED STATES )

11:36

State of the art perspectives in heart failure: A Fantastic Voyage Hector Ventura (UNITED STATES )

Tib e r - Ye llow P avillion - 1 0 :3 0- 12: 00 Special Featured Joint Session PAS C A R - H e al t h Trans itions and CVD in Africa: Imp l ica t i o n s f or t h e 2 1 s t C e n t u ry Chairs: Robert Fagard (BELGIUM), Amoah Albert (GHANA) 10:30 Epidemiologic and Nutritional Transitions in Africa - The Evidence from Obesity, Diabetes, and the Metabolic Syndrome. Krisela Steyn (SOUTH AFRICA) 10:52

Spectrum of CVD and risk factors in Africa today - The Heart of Soweto Study Karen Sliwa (SOUTH AFRICA)

11:14

Addressing Rheumatic Fever and CVD in children and young adults - beyond the Drakensberg Declaration Mayosi Bongani (SOUTH AFRICA)

11:36

Health Transitions in Africa: Policy and Resource Implications for International Health Organizations George A. Mensah (UNITED STATES )

Monday, 19 May 2008 Amaz on - Ye llow P avillion - 1 0 :3 0 - 12: 00 South American Congress of Cardiology Desafíos actuales de la cardiología sudamericana Coordinadores: Gilson Feitosa(BRAZIL), Grancelli Hugo (ARGENTINA) 10:30

Epidemiología de las enfermedades cardiovasculares en sudamérica Bartolome Finizola (VENEZUELA)

10:45

¿ Las guías internacionales son aplicables en nuestra realidad sanitaria? Edgardo Sandoya (URUGUAY)

11:00

Tecnología y alta complejidad cardiovascular. Limitaciones e inequidades en la región Jaime Goich (CHILE)

11:15

¿Cómo desarrollar investigación independiente en nuestros países? Hernan Doval (ARGENTINA)

R hine - Ye llow P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Non-invasive risk stratification for sudden cardiac death Chairs: Luis Alcocer (MEXICO), Martinelli Martino (BRAZIL) 14:00

Microvolt t-wave alternants Gioia Turitto (UNITED STATES )

14:22

ECG and heart rate variability and turbulence Dubner Sergio (ARGENTINA)

14:44

Signal average electrocardiogram Nabil El-Sheriff(UNITED STATES )

15:06

Putting this all together: Is an individualized decision possible? John Camm (UNITED KINGDOM)

R io de la P lat a - R e d P avillion - 1 4 :0 0 - 15: 30 Debate Dr u g s v s . e l e c tr ic a l d e v ice s Chairs: Günter Breithardt (GERMANY), Oseroff Oscar (ARGENTINA) 14:00

Statement 1: Atrial fibrillation: Catheter ablation as first line treatment? Pro: Andrea Natale ( UNITED STATES ) Contra: Shih-Ann Chen (CHINA, TAIWAN)

14:45

Statement 2: All patients with cardiomyopathy and an ejection fraction below 35% should receive an ICD Pro: Sergio Pinski (UNITED STATES ) Contra: José Luis López-Sendón (SPAIN)

Scientific Programme / 87

Monday, 19 May 2008 Danub e - Gr een Pavillion - 14:00-15:30 Symposium Ele c t ric a l t h er a py i n h e a r t f a i lure Chairs: Aleksandras Laucevicius (LITHUANIA), Diego Vanegas (COLOMBIA) 14:00

Cardiac contractility modulation to improve left ventricular function María José Sancho Tello (SPAIN)

14:30

How to prevent pacing in pacemakers: Role of new algorithms Jorge Gonzalez ZUelgaray (ARGENTINA)

15:00

Monitoring of heart failure by implanted devices Michael Gold (UNITED STATES )

Ane m i a a n d h ear t f a il u r e Chairs: Miguel Adorno (PARAGUAY), Bocchi E.A (BRAZIL)

Euphrat e s - Ochre P avillion - 1 4 :0 0- 15: 30 Clinical Seminar

14:00

Heart failure and anemia: Mechanisms and pathophysiology Alejandro Macchia (ARGENTINA)

14:30

Prevalence of anemia in heart failure and its effects on prognosis Cesar Belziti (ARGENTINA)

15:00

Use of EPO and Iron in the Treatment of Anemia in Heart Failure Philip A Poole-Wilson (UNITED KINGDOM)

Se ine - Gr een Pavillion - 14:00-15:30 Symposium Ad v a n c e d h ear t f a il u r e Chairs: Norberto Vulcano (ARGENTINA), Ricardo Levin (UNITED STATES ) 14:00

Advanced dysfunction without advanced symptoms: Pathophysiology and clinical profile Santiago Miriuka (ARGENTINA)

14:18

The time for assistance: Clinical decisions for VAD implantation Hector Ventura (UNITED STATES )

14:36

The future is here: New devices for the failing heart Diego Delgado (CANADA)

14:54

Heart transplantation in 2008 Guillermo Torre Amione (UNITED STATES )

Monday, 19 May 2008

Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Endo v a sc u l ar he a r t val ve int er v e nt ions : The e n d o f v a l v u l a r op e n h e ar t surge ry? - Pa r t one Chairs: Rubén Piraino (ARGENTINA), Ramón Quesada (UNITED STATES ) 14:00

Results with a new valve Alexander Abizaid (BRAZIL)

14:18

How to select patients for endovascular balloon expandable aortic bioprosthesis? Agatiello Carla (ARGENTINA)

14:36

Innnovative approaches in surgical valve replacement Timothy Gardner (UNITED STATES )

14:54

Further applications for percutaneous aortic valve biosprosthesisr: For all patients? Deborah Nercolini (BRAZIL)

15:12

South American experience Jose Condado (VENEZUELA)

P araná - Ochre P avillion - 1 4 :0 0 - 15: 30 Debate The p o l y p i l l i s an ef f e c tive s tr a te gy fo r re d uct i o n o f ca r d i o v a sc u l ar diseases Chairs: Fuster Valentin (UNITED STATES ), Ricardo Esper (ARGENTINA) 14:00

Statement 1: The polypill is an effective strategy for reduction of cardiovascular diseases Pro: Gines Sanz (SPAIN) Contra: Satyavan Sharma (INDIA)

14:45

Statement 2: The statin pleotrophic effect is very important Pro: Nanette Wenger (UNITED STATES ) Contra: TBD

Mis s is s ippi - Ye llow P avillion - 1 4 :0 0- 15: 30 How-to & Workshop Session New trends in the management of cardiovascular risk: The r o l e o f h e a r t r at e Chairs: Kumar Anil (INDIA), Jose Luis Vukasovic (CHILE) 14:00

Heart rate and prognosis in cardiovascular diseases José Luis López-Sendón (SPAIN)

14:30

Heart rate reduction: Evidence of clinical benefit Sheikh Shahryar A (PAKISTAN)

15:00

Heart rate and heart failure: Partners or enemies? Willem Remme (NETHERLANDS)

Scientific Programme / 89

Monday, 19 May 2008 Fet a l c ard i o l o g y Chairs: Miguel Granja (ARGENTINA), Loreta Jara (CHILE) 14:00

Interventional cardiology in newborns John Cheatham (UNITED STATES )

14:22

Management outcome of congenital AV block Paulo Zielinsky (BRAZIL)

14:44

Advances in fetal diagnosis, including MRI David Sahn (UNITED STATES )

15:06

Aortic valvuloplasty in HLHS Pablo Marantz (ARGENTINA)

Volga - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium

Me kong - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium Antithrombotic treatment in non-ST-acute coronary syndrome Chairs: Mònica Masotti (SPAIN), Barrero Carlos (ARGENTINA) 14:00

Usefulness of antithrombin agents in non-ST-acute coronary syndrome Jose Nicolau (BRAZIL)

14:22 Contemporary issues in clopidogreltherapy for non-ST segment elevation infarction: New evidence for clinical practice I. Coma-Canella (SPAIN) 14:44

Optimal pharmacological treatment of non-ST -elevation acute coronary syndrome without PTCA Radke P (GERMANY)

15:06

Rate of complications and management of antithrombotic treatment in non-ST -acute coronary syndrome Jose Navarro Estrada (ARGENTINA)

Or inoco - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium Up - d a t e o f t r e a t m e n t o f h y p e r t ension Chairs: Alberto Re (ARGENTINA), Oscar Carretero (UNITED STATES ) 14:00

Polypill: Which component and to whom? Nicholas Wald (UNITED KINGDOM)

14:22

Meta-analysis in hypertension Carlos Ferrario (UNITED STATES )

14:44

Clinical trials for hypertension: Expectation fulfilled and unfulfilled Alberto Zanchetti (ITALY)

15:06 How strong is the evidence for the use of beta-blockers as a first-line therapy for hypertension? Systematic review and meta-analysis Giuseppe Mancia (ITALY)

Monday, 19 May 2008 Huang He - Ye llow P avillion - 1 4 :0 0 - 15: 30 Clinical Seminar All a c a r d i o logis t n ee d s to kn o w ab out cardiac MSCT& MR I Chairs: Horacio Dinunzio (ARGENTINA), David Vetcher (ARGENTINA) 14:00

Actual role of cardiac MSCT: Where are we? Marcelo Goldstein (BELGIUM)

14:22

Coronary calcium score: Applications in clinical practice (UNITED STATES )

14:44 Non-invasive coronary computed tomographic angiography for patients with low and high pre-test probability for having coronary artery disease: Is it still an indication? Anibal Damonte (ARGENTINA) 15:06

Dual source computed tomography: Is it the real advantage in MSCT? Ernest Garcia (UNITED STATES )

Nile - Ye llow P avillion - 1 4 :0 0 - 15: 30 Symposium Are comorbidities a limit to cardiovascular prevention in the elderly? Chairs: Pasquale Abete (ITALY), Mariano Giorgi (ARGENTINA) 14:00

Cardiovascular Prevention in the Elderly Mario Garcia-Palmieri (PUERTO RICO)

14:22

Acute coronary syndromes/myocardial infarction at advanced age Faiez Zannad (FRANCE)

14:44

Polypharmacy in the elderly Nedina Mendez (VENEZUELA)

15:06

Cardiac rehabilitation and its limits Mauricio Wajngarten (BRAZIL)

Tigris - Ye llow P avillion - 1 4 :0 0 - 15: 30 Debate Car d i o p u l m o n ar y r es u s c it a tion Chairs: T. P. Aufderheide (UNITED STATES ), Ari Timerman (BRAZIL) 14:00

Statement 1: Cardiocerebral resuscitation: Is ventilation not necessary in cardiac arrest? Pro: Karl B. Kern (UNITED STATES ) Contra: Timerman Sergio (BRAZIL)

14:45

Statement 2: Metabolic Resuscitation: Hibernation or hypothermia in CPR? Pro: Soon Joo Wang(Seoul, KOREA, REPUBLIC OF) Contra: Flavio Marques (BRAZIL)

Scientific Programme / 91

Monday, 19 May 2008 P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium U se o f 3 D ec h o i n c l i n ica l d a y - t o-day pr acti ce Chairs: Mario Garcia (UNITED STATES ), Fernando Manzur Jattin (COLOMBIA) 14:00

Quantitation of valvar heart disease Navin Nanda (UNITED STATES )

14:22

Differentiation of cardiac masses Juan Carlos Plana (UNITED STATES )

14:44

Assessment of adult congenital heart disease Mani Vannan (UNITED STATES )

15:06

Assesment of LV ejection fraction, volume and mass Marcelo Trivi (ARGENTINA)

Thame s - Ye llow P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session S C AI-SOLACI: Wh a t w e k n o w a n d w h a t w e d o n 't kno w about DES Chairs: Carlos Mendiz (ARGENTINA), Ziyad Hijazi (UNITED STATES ) 14:00

Interventional cardiologist institute Manish Parikh (UNITED STATES )

14:14

Worldwide impact of DES and worldwide impact of late sten thrombosis Christopher Cates (UNITED STATES )

14:28

Is late stent thrombosis a main concern? Bonnie Weiner (UNITED STATES )

14:42

What do we know and what we don't know about DES in off label indications Daniel Berrocal(ARGENTINA)

14:56

The future of DES Alexander Abizaid (BRAZIL)

15:10 Panel: D. Echeverri (Columbia), F. Brito (Brazil), C. Cates (UNITED STATES), B. Weiner (UNITED STATES), A. Abizaid (Brazil) Mis s ouri - Ye llow P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session A P S C : Gl o b a l b urd e n o f h e a r t f ailu re Chairs: Hisayoshi Suma (JAPAN), Takeshi Nakatani (JAPAN) 14:00

Idiopathic Heart Failure: Contribution of cardiomyopathy and the global alert and response network Matsumori Akira (JAPAN)

14:22

Etiological diagnosis of Heart Failure Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF)

14:44

Heart Failure: Epidemiology, pathophysiology and treatment worldwide David T. Kelly(AUSTRALIA)

15:06

Valvular heart diseases in developed and undeveloped countries Robert Bonow (UNITED STATES )

Monday, 19 May 2008 Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30 South American Congress of Cardiology Cómo optimizar el tratamiento de la insuficiencia cardiaca crónica Coordinadores: Graciela González Bogado (PARAGUAY), José Luis Barisani (ARGENTINA) 14:00 Tratamiento farmacológico actual. Interrogantes no resueltos Miguel Gonzalez (ARGENTINA) 14:15

¿Cómo adecuar el tratamiento en el paciente con comorbilidades? Waldo Fernández Durand (PERU)

14:30

¿Cómo seleccionar a los candidatos para resincronización ventricular? Walter Reyes Caorsi (URUGUAY)

14:45

Estrategias de manejo en el paciente chagásico. ¿Son diferentes? Harry Acquatella (VENEZUELA)

15:00

Alternativas terapéuticas en la IC refractaria Fernando Bacal (BRAZIL)

R hine - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium M an a g e m e n t o f a rr h y t h m i a s i n geneti cally based diseases Chairs: Walter Reyes Caorsi (URUGUAY), Pablo ChiAle (ARGENTINA) 16:00

Brugada syndrome Marcelo Elizari (ARGENTINA)

16:22

Short and long QT syndrome Christian Wolpert (GERMANY)

16:49

Right ventricular dysplasia Nestor Galizio (ARGENTINA)

17:11

Catecholamine-induced polymorphic ventricular tachycardia Riccardo Cappato (ITALY)

Danub e - Gr e e n P avillion - 1 6 :0 0 - 17: 30 Symposium Car d i a c r e sy nc hr o n is at io n t her apy (CR T) - P art Two Chair: Saúl Drajer (ARGENTINA) 16:00

Reasons for failure of CRT Luis Molina (MEXICO)

16:22

Emerging indications for CRT Michael Gold (UNITED STATES )

16:44

Should all patients with an indication for CRT also receive an ICD? John Camm (UNITED KINGDOM)

17:06

Cost-effectiveness of CRT: Implications for developing countries John Gorcsan III (UNITED STATES )

Scientific Programme / 93

Monday, 19 May 2008 P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30 How-to & Workshop Session Op t i m u m tr e a t m e n t f or h e ar t f ailur e Chairs: Krauss Juan (ARGENTINA), Roberto Ricca (URUGUAY) 16:00

How to prevent heart failure? Jay Cohn (UNITED STATES )

16:45

How to achieve guidelines recommendations in patients with heart failure? Philip A Poole-Wilson. (UNITED KINGDOM)

Se ine - Gr een Pavillion - 16:00-17:30 Clinical Seminar S u r g ica l t r e a t m e n t f or c o n g e s tive hea rt failu r e Chairs: Hector Ventura (UNITED STATES ), Ernesto Weinschelbaum (ARGENTINA) 16:00

Surgical correction of mitral regurgitation in end stage cardiomyopathy Enio Buffolo (BRAZIL)

16:22

Surgical strategy for non-ischaemic cardiomyopathy Hisayoshi Suma (JAPAN)

16:44

Ventricular restoration for ischaemic heart failure Noedir Groppo Stolf (BRAZIL)

17:06

Left ventricular assist device José Luis Navia (UNITED STATES )

Mis s ouri - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium Hea r t f a i l u r e w ith n o r m a l e j ec t ion fract ion Chairs: Mihai Gheorghiade (UNITED STATES ), Miguel Gonzalez(ARGENTINA) 16:00

Diastolic heart failure: Is it a disease? Marvin Konstam (UNITED STATES )

16:22

Prevalence and etiologies

16:44

How to diagnose in clinical practice Jorge Thierer (ARGENTINA)

17:06

How to treat John Cleland (UNITED KINGDOM)

Thame s - Yello w Pavillion - 16:00-17:30 Special Featured Joint Session WHFS : T h e f a i l ing hear t a r ound the world Chairs: Shahryar A. Sheikh (PAKISTAN), Grancelli Hugo (ARGENTINA) 16:00

Chagas' disease, or hypertension and IHD: Which are the driving factors of heart failure in Latin America? Bocchi E. A. (BRAZIL)

16:22

HIV-related heart failure in Africa Mayosi Bongani (SOUTH AFRICA)

16:44

Heart failure due to virus infection in Asia Matsumori Akira (JAPAN)

17:06

What we have learned from heart failure registries in Europe Willem Remme (NETHERLANDS)

Monday, 19 May 2008 Huang He - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium Delayed enhancement imaging for evaluation of cardiomyopathies Chairs: Wilson Mathias (BRAZIL), Lorenzo Montserrat (SPAIN) 16:00

Currents status, indications and limitations of MSCT angiography Marcelo Goldstein (BELGIUM)

16:18

Myocardial perfusion imaging by MSCT: Is it possible to use in clinical practice? Joanne D. Schuijf (NETHERLANDS)

16:36

MSCT and molecular imaging: New advances Milind Desai (UNITED STATES )

16:54

Non-invasive diagnostic of vulnerable plaque: the eternal challenge Mario Garcia (UNITED STATES )

17:12

Relationships between CT, PET, SPECT and MR Daniel Berman (UNITED STATES )

Or inoco - Och r e Pavillion - 16:00 -17:30 Special Featured Joint Session ISH : Ho t t op ics i n h y p er t e n s i o n : an u p date Chairs: Gilson Feitosa(BRAZIL) 16:00

Is time to say good-bye to beta-blockers as first line treatment for primary hypertension? Lars Lindholm (SWEDEN)

16:22

Ambulatory blood pressure and prediction of risk: do we need the night? Robert Fagard (BELGIUM)

16:44

Heart remodelling in hypertension Daniel Piskorz (ARGENTINA)

17:06

Salt sensitive hypertension: genetics pathophysiology and management Ramiro Sánchez (ARGENTINA)

Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Man a g e m e n t o f a s y m p t o m a t ic v alve disease Chairs: Jose Antonio Francisco Ramires (BRAZIL), Jorge Lopez Sosa (ARGENTINA) 16:00

Aortic regurgitation Escobar Edgardo (CHILE)

16:22

Aortic stenosis Jeffrey Borer (UNITED STATES )

16:44

Mitral valve prolapse Tomás Cianciulli (ARGENTINA)

17:06

Criteria for early intervention in asymptomatic patients Robert Bonow (UNITED STATES )

Scientific Programme / 95

Monday, 19 May 2008 Me kong - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Revascularization of patients with stable coronary artery disease Chairs: Cossio Pedro (ARGENTINA), Shirish Hiremath (INDIA) 16:00

Optimal medical treatment in patients with stable coronary artery disease Karina Rey García (CUBA)

16:22

Is ischemia enough to select patients for PCI? Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF)

16:44

PCI outcomes with drug eluting stents Jose Alejandro Martinez Sepulveda (CHILE)

17:06

How to select the best strategy for managing patients with stable coronary artery disease?

Volga - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium Int e r v e n t i o n al c a r diol ogy in c onge nit al he art dis e as e Chairs: Zabal Carlos (MEXICO), Mariano Ithuralde (ARGENTINA) 16:00

ASD Closure Ziyad Hijazi (UNITED STATES )

16:18

VSD Closure new developments Trong Phi Le (GERMANY)

16:36

Hybrid procedures John Cheatham (UNITED STATES )

16:54

Use of stents Carlos Pedra (BRAZIL)

17:12

Cutting balloon results Neil Wilson (UNITED KINGDOM)

Mis s is s ippi - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium Cell u l a r r e g e n er a tive t her a p y in cardiology Chairs: Jorge Trainini (ARGENTINA), David T. Kelly(AUSTRALIA) 16:00

Role of stem- and progenitor cells in coronary artery disease Luis De La Fuente (ARGENTINA)

16:22

Which cells and which route of administration? Julio Argentieri(ARGENTINA)

16:44

For which patients? Juan Carlos Chachques (FRANCE)

Monday, 19 May 2008 P araná - Ochre P avillion - 1 6 :0 0 - 17: 30 Symposium Cardiovascular risk and human immunodeficiency virus (HIV) infection in Africa Chairs: Jean-Rene M’buyamba (CONGO, THE DEMOCRATIC REPUBLIC OF THE), Karen Sliwa (SOUTH AFRICA) 16:00

Cardiovascular risk in HIV-infected patients: Global overview and implication for action Sergio Lupo (ARGENTINA)

16:22

Cardiovascular risk in African HIV patients: Situation analysis and implication for action Onen Churchill (BOTSWANA)

16:44

Cost-effective approaches for management and prevention of HIV infection induced cardiomyopathie in Africa Amoah Albert (GHANA)

17:06

Mechanisms of cardiovascular diseases in HIV-infected patients: Is there an ethnic difference? Daniel Lemogoum (CAMEROON)

Yangt z e - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Hea l t h pr o m o t io n f or c hil d r e n Chair: Diego Esandi (ARGENTINA), Volqvartz Susanne (DENMARK) 16:00

Relation between CVD risk factors in children and their parents: Smoking and Rayuela Project Maria Ines Sosa Liprandi (ARGENTINA)

16:22

The role of the paediatrician in school-based health education programmes Soon Joo Wang Ernesto Juaneda (ARGENTINA)

16:44

Protecting children from marketing Anita Saxena (INDIA)

17:06

The Colombia experience Beatriz Londoño (COLOMBIA)

R io de la P lat a - R e d P avillion - 1 6 :0 0- 17: 30 Symposium The po l y pi l l Chairs: Angeles Alonso Garcia (SPAIN), Alfonso Perez (UNITED STATES ) 16:00

Why a polypill? Nicholas Wald (UNITED KINGDOM)

16:22

Clinical considerations Fuster Valentin (UNITED STATES )

16:44

Regulatory issues Martin Seoane (ARGENTINA)

17:06

Cost benefit considerations Gianni Tognoni (ITALY)

Scientific Programme / 97

Monday, 19 May 2008 R es u sc i t a t i o n s c ie n c e a n d s u r vival Chairs: Timerman Sergio (BRAZIL), Ana Salvati (ARGENTINA)

Tigris - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium

16:00

International collaboration on resuscitation guidelines Soon Joo Wang (KOREA, REPUBLIC OF)

16:22

Quality CPR Manoel Fernandes Canesin (BRAZIL)

16:44

The history of how resuscitation techniques have been developed Fabián Gelpi (ARGENTINA)

17:06

Public access to defibrillation: Why, when and where? Alessandro Capucci (ITALY)

Nile - Yello w Pavillion - 16:00-17:30 Symposium Pri m a r y a n d s e c o n d a r y preve n tion in at he ros cle ros is : Fro m t h e o r y t o dail y prac t ic e Chairs: Masao Sano (PARAGUAY), Guzman L. (ARGENTINA) 16:00

International guidelines: Can they be extrapolated and implemented in our countries? Gianni Tognoni (ITALY)

16:22

Control and prevention of cardiovascular disease around the world Ponte N Carlos I. (VENEZUELA)

16:44

Statins and other cardiovascular drugs in developing countries: Are the usual doses useful? Carlos Cuneo (ARGENTINA)

17:06

Cardio-protection through promotion of physical activity in mega cities Mario Garcia-Palmieri (PUERTO RICO)

Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30 Clinical Seminar All y o u n e e d to kn o w a b out c arot id s t e nt ing Chairs: Martínez Rios Marco A (MEXICO), Roxana Mehran (UNITED STATES ) 16:00

Current practice and multicentric trial with the "TwinOne" cerebral protection system Jacques Theron (FRANCE)

16:22

Protection devices: Are all the same? José Gabay (ARGENTINA)

16:44

Why should we treat asymptomatic patients with severe carotid stenosis? Lylyk Pedro (ARGENTINA)

17:06

Carotid stenting: Level of evidence: Where are we? Where are we going? Hugo Londero (ARGENTINA)

Monday, 19 May 2008 Nige r - Gr e e n P avillion - 1 6 :0 0 - 17: 30 Special Featured Joint Session IS CU: Up d a t e i n 3 D Ec h o c ar d i o gr ap hy Chairs: Nelson Pizzano (URUGUAY), Amuchástegui Luis Maria (ARGENTINA) 16:00

Basics of 3-D echocardiography Ronderos Ricardo (ARGENTINA)

16:22

3-D TTE /TEE in the evaluation of valvular heart disease Juan Carlos Plana (UNITED STATES )

16:44

3-D transesophageal echocardiography Mani Vannan (UNITED STATES )

17:06

3-D echocardiography in the assessment of intracardiac masses and adult congenital heart disease Navin Nanda (UNITED STATES )

Amaz on - Ye llow P avillion - 1 6 :0 0 - 17: 30 South American Congress of Cardiology Manejo del paciente con síndrome coronario agudo Coordinadores: Gabriel D’empaire Yanes (VENEZUELA), Daniel Isaza (COLOMBIA) 16:00

SCA sin supra ST: ¿Cómo identificar al paciente de alto riesgo clínico? Miguel Quintana (PARAGUAY)

16:15

SCA sin supra ST: Estrategia invasiva ¿Sistemática o electiva? Carlos Tajer (ARGENTINA)

16:30

SCA con supra ST: ¿Cómo lograr la reperfusión óptima? Francisco Benítez (ECUADOR)

16:45

Terapia antiplaquetaria combinada post SCA ¿A quién, cómo y durante cuánto tiempo? Jose Nicolau (BRAZIL)

Scientific Programme / 99

Scientific programme by day and by time Tuesday, 20 May 2008

Acu t e c o ro n ar y e v e n t s Chairs: Manuel IrarrazAbal (CHILE), Ernesto Ferreiro (ARGENTINA)

Se ine - Gr een Pavillion - 08:30-10:00 Oral abstract Session

08:30 Differences in mobilization of mesenchymal and endothelial progenitors cells by early ischemic preconditioning in porcine myocardial ischemia-reperfusion M. Gyongyosi, N. Pavo, A. Posa, R. Hemetsberger, S. Steiner-Boker, C. Kopp, I. Pavo Jr., Z. Petrasi, Ö. Petnehazy, D. Glogar 08:43 Effect of dietary restriction in the mitochondrial function in an EX-VIVO animal model of diabetes submitted to global myocardial ischemia-reperfusion P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia 08:56 Recurrent angina after admission may partially explain some discrepancies between initial risk stratification and the selection for invasive evaluation in Non ST elevation Acute Coronary Syndromes. Results of the multicentre registry Epi-Cardio M. De Abreu, J. Mariani, A. Charask, E. Zuanich, C. Pellegrini, M. Trevisan, E. Forte, J. Gagliardi, C. Tajer, H. Doval 09:09 Long-term prognosis of patients with acute chest pain, normal electrocardiogram, and non detectable cardiac troponin R. Merbilháa, M. P. Marturano, G. F. Procopio, L. Pfister, M. Piraino, G. A. Ontiveros, M. J. Fosco 09:22 Utility of the Global Registry of Acute Coronary Events Risk Score in Mild or Severe Obstructive Coronary Artery Disease in Non-ST-segment Elevation Acute Coronary Syndromes E. Gurfinkel, E. Duronto, F. Guerloy, B. M. Kennelly, J. López-Sendón, Á. Avezum, E. Beck, K. A. Eagle, G. Fitzgerald, J. M. Gore 09:35 White Blood Cell Subtypes Predicting Diagnosis in a Chest Pain Unit: Diagnostic Value of an Elevated Neutrophil to Lymphocyte Ratio in Patients with Suspected Acute Coronary Syndrome D. Precoma Neto, A. D. Zazula, G. F. Barbieri, A. M. Gomes, H. Kruklis, M. Conforto, G. Facin, R. Y. Forte, J.R. Faria Neto 09:48 Distinguishing Features of Mild vs Severe Coronary Artery Disease in Patients With Acute Coronary Syndromes. The Global Registry of Acute Coronary Events E. Duronto, E. P. Gurfinkel, K. A. Eagle, R. J. Goldberg, D. Brieger, B. Freedman, M. Jelinek, G. Fitzgerald, J. M. Gore

Tuesday, 20 May 2008

Me kong - Och r e Pavillion - 08:30 -10:00 Oral abstract Session

Ma r k ers i n a c u t e s y n dr o m e s Chairs: Sokn Fernando (ARGENTINA), Luis Molinary (PUERTO RICO) 08:30 Clinical correlates of acute myocardial infarction recurrence in patients presenting at a tertiary care hospital in the US. I. Singla, A. Sunil, H. Hreybe, S. Samir 08:43 Creatinine Level or Estimated Creatinine Clearance as Predictors of Cardiovascular Mortality in Patients Undergoing CABG – Do We Really Need the Math? L. H. W. Gowdak, J. J. G. De Lima, J. A. F. Ramires, L. A. M. Cesar 08:56 Cystatin c plasma concentration in patients with multivessel coronary artery disease and hypertension predicts cardiovascular events during the follow-up observation Z. Dzielinska, A. Januszewicz, A. Prejbisz, J. Chudek, M. Makowiecka-Ciesla, M. Demkow, P. Tyczynski, A. Wiecek, W. Ruzyllo 09:09 Reviewing the American Society of Transplantation Guidelines for Cardiovascular Risk Stratification in Renal Transplant Candidates L. H. W. Gowdak, R. L. Arantes, F.J. De Paula, L. A. M. Cesar, L. E. Ianhez, E. M. Krieger, J. J. G. De Lima 09:22

Prognostic value of the QTc prolongation in patients with Acute Coronary Syndrome J. Siccha Martinez, M. Carrion Chambilla

09:35 Can the creatinine clearance predict bleeding complications in acute coronary syndrome patients? N. Antonio, S. Monteiro, C. Lourenco, R. Teixeira, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia 09:48 Prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease T. Przewlocki, A. Kablak-Ziembicka, W. Tracz, G. Kopec, P. Rubis, A. Kozanecki, T. Stompor, M. Kostkiewicz, A. Sokolowski, M. Pasowicz

Scientific Programme / 101

Tuesday, 20 May 2008 Tigris - Yello w Pavillion - 08:30-10:00 Oral abstract Session Acu t e m y o c a r dial in f a rc t io n Chairs: Jorge Leguizamon (ARGENTINA), Sismondi Horacio (ARGENTINA) 08:30 Direct Transport of MI Patients to Interventional Cardiology Centre Following ECG Teletransmission Increases Percentage of Patients Treated within the Timeframe Set by Guidelines M. Karcz, P. Bekta, M. Skwarek, M. Dabrowski, K. Kukula, J. Kadziela, M. Ciszewski, A. Debski, M. Demkow, W. Ruzyllo 08:43 Outcomes in ST Elevation Acute Myocardial Infarction patients poorly included in randomized controlled clinical trials C. Higa, F. Botto, J. Fuselli, P. Blanco, E. Fairman, A. Fernandez, H. Cohen Arazi, R. Merbilhaa, R. Sarmiento, J. Gagliardi 08:56 The Chilean Health Reform and its impact in the Management and Mortality of ST Segment Elevation Myocardial Infarction (STEMI) in Chilean Hospitals. C. N. Carolina Nazzal, P. C. Pabla Campos, R. C. Ramon Corbalan, J. B. Jorge Bartolucci, P. S. Patricio Sanhueza, J. C. P. Juan Carlos Prieto, F. L. Fernando Lanas 09:09

Nationwide trends in the incidence of acute ST elevation myocardial infarction (STEMI) in the United States M. R. Movahed, M. Hashemzadeh, M. M. Jamal

09:22

Acute Myocardial Infarction With ST-Segment Elevation W. Quiroga Castro, E. Conci, F. Zelaya, M. Isa, J. Sala, G. Pacheco, C. Balestrini, C. Serra, C. Quiroga, A. Bossi

09:35

Contribution of each subinterval to door-to-balloon time in primary angioplasty. I. Gomes, A. Correa, M. Makdisse, M. Perin, S. F. Brito Jr., A. Abizaid, B. Almeida, M. A. Magalhães, T. C. Nascimento

09:48 Women with acute myocardial infarction are more likely than men to have delayed door-to-ECG time M. Makdisse, A. G. Correa, A. Pfeferman, L. M. A. Forlenza, M. Knobel, V. Oliveira, S. Ellovitch, C. O. Berlowitz Fo, M. Vaidotas, E. Knobel R hine - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session ECG , a tr i a l f i br i l a t i o n a n d a b l ation Chairs: Carlos Labadet (ARGENTINA), Adrian Baranchuk(CANADA) 08:30

Isolated areas of electrical remodeling: electrocardiographic characteristics and clinical aspects. S. Sclarovsky

08:43 Electro-vectorcardiographic patterns in patients with severely symptomatic hypertrophic obstructive cardiomyopathy submitted to percutaneous ethanol septal ablation: immediate and late follow up Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Andrés Ricardo Pérez Riera, Jairo Alves Pinheiro Jr., Ricardo Pavanello, Amanda Moraes R. Sousa, Jose Eduardo Mr Sousa, Adib Domingos Jatene 08:56

Symptomatic repetitive monomorphic premature ventricular ectopy. Results of radiofrequency ablation. A. Bochoeyer, R. Rabinovich, L. Enciso, R. Costello, R. Ferreyra

09:09 Radiofrequency catheter ablation of incessant ventricular tachycardia in a patient with isolated noncompaction of the left ventricle. L. Citta, E. Sosa, M. Scanavacca, N. Citta 09:22 Findings of sustained ventricular tachycardia in stored electrograms and their correlation with syncope in patients with definitive pacemakers G. M. M. Pellegrino, D. Ortega, L. Barja, N. Mangani, L. Mari 09:35

MUSAFTA : MUlticenter Study Atrial Fibrillation Transcatheter Ablation ) – Ablation Characteristics. Follow-up L. Barja, D. Ortega, N. Mangani, M. Kenar, A. Hita, F. Ditomaso, S. Baratta, J. Bilbao, H. Fernadez, D. Turri

09:48

Advantages of the catheter ablation of nodal slow pathway during atrioventricular nodal tachycardia R. Speranza, G. Costa, O. Perez Mayo, A. Stefani, D. Deluso, A. Alfie, A. Balestrini, C. De Zuloaga

Tuesday, 20 May 2008 R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00 Oral abstract Session At ri a l f l u t t er a n d f i b r i l a t i o n Chairs: Oseroff Oscar (ARGENTINA), Jose Carlos Pachon Mateos (BRAZIL) 08:30 D  oes Timing of Atrial Fibrillation Onset or Ventricular Rate Relate to the Development of In-Hospital Ventricular Fibrillation in Patients with Acute Myocardial Infarction R. Sankaranarayanan, H. Gonna, B. Nuta, S. Burtchaell, R. Holloway, M. A. James 08:43

Feasibility of Common Atrial Flutter Radiofrequency Catheter Ablation in Outpatients E. Marijon, S. Boveda, N. Combes, A. Bortone, J. Najjar, J. P. Donzeau, S. Jacob, J. P. Albenque

08:56 Omega 3 Fatty Acid Supplementation reduces One-Year Risk of Atrial Fibrillation in Patients Hospitalized with Myocardial Infarction A. Macchia, S. Monte, M. Romero, F. Pellegrini, A. P. Maggioni, A. Dettorre, G. Tognoni 09:09

 ifferent medical pretreatment strategies in persistent atrial fibrillation after successful cardioversion. D From Bisoprolol to Ivabradin? K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan

09:22 New insights of segmental pulmonary vein isolation by irrigated catheter ablation and the mesh mapper technique A. Meissner, M. Christ, M. Von Bracht, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn 09:35

CaMKII-dependent phosphorylation of defective RyR2 predisposes to atrial fibrillation (WITHDRAWN) X. H. Wehrens, M.G. Chelu, S. Sood, R. Van Oort, D. Skapura, D. Dobrev

09:48 Predictive factors of atrial systole recovery after left MAZE III surgery by radiofrequency ablation MD Tinetti Matias, MD Lescano Adrian, MD Costello Ramiro, MD Daru Victor, MD Cardenas Cesar, MD Piazza Antonio, MD Iglesias Ricardo Euphrat e s - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Mitr a l v a l v e dis eas e a n d p u l m onary hype rt e ns ion Chairs: Ricardo Migliore (ARGENTINA), Jane Somerville (UNITED KINGDOM) 08:30

Changes of myocardial function after mitral valve downsizing in patients with ischemic mitral regurgitation J. Ostermeyer, S. Geidel, M. Lass, K. H. Kuck

08:43

Mechanisms underlying dyspnea in patients with Rheumatic Mitral Stenosis C. Palaniswamy, R. Guleria, R. Narang, S. Ramamurthy, A. Mohan

08:56

Rheumatic heart disease prevalence in Fiji A. C. Steer, J. Kado, N. Wilson, L. Waqatakirewa, T. Tuiketei, E. K. Mulholland, M. Good, A. J. W. Jenney, J. R. Carapetis

09:09

Pulmonary hypertension in patients with ankylosing spondylitis D. A. Poddubnyy, N. A. Karoli, A. P. Rebrov

09:22

Oxidative stress-induced fetal programming of hypoxic pulmonary hypertension J. Bloch, P. Y. Jayet, C. Mathieu, P. Dessen, A. Monney, M. Schwab, H. Duplain, J. F. Tolsa, C. Sartori, U. Scherrer

09:35 Demographic, clinical and functional characteristics of outpatients with different stages of Chagas´disease in a prospective registry R. Agüero, L. Ferrer, V. Volberg, M. Leonardi, M. Sancineti, A. Sancineti, Horacio Pomes Iparraguirre, G. Calderon 09:48

 xercise-induced abnormal pulmonary arterial pressure response in adolescents and adults with atrial E or ventricular septal defect T. Möller, E. Pettersen, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow

Scientific Programme / 103

Tuesday, 20 May 2008 Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Card i ac tra n s p l a n t a t i o n Chairs: Diez Mirta (ARGENTINA), Hector Ventura (UNITED STATES) 08:30 Influence of regeneration of heart muscle on mobilization of BM-CPCs by intracoronary autologous bone marrow cell transplantation in patients with AMI as well as with Chronic Myocardial Infarction R. G. Turan, M. Brehm, S. Yokus, M. Koestering, S. Steiner, T. Zeus, T. Bartsch, C. M. Schannwell, B. E. Strauer 08:43 Phenotype Characterization Through Cellular Network Reconstruction. A Systems Biology Approach to the Discovery of Candidate Molecular Targets for Phenotype Characterization and Compound Discovery in Heart Transplantation M. Cadeiras, A. Sinha, M. Bayern, F. Latiff, W. K. Lim, R. Dedrick, T. Palomero, C. C. Marboe, A. Califano, M. C. Deng 08:56

NT-proBNP is not useful in early follow up of heart transplant patients D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric

09:09 Improving Diagnostic Accuracy of Acute Cellular Cardiac Allograft Rejection Applying Non-Linear Algorithms to Whole Genome Microarrays in Peripheral Blood Mononuclear Cells of Heart Transplant Recipients E. Tabak, M. Cadeiras, C. Turner, F. Latif, P. Lal, C. C. Marboe, A. Califano, M. C. Deng 09:22 Temporal trends of sex disparity in the referral of patients to heart function clinic, transplant listing, and cardiac transplantation. V. Micevski, F. Gustafsson, D. H. Delgado, H. J. Ross 09:35

Role of probiotics in multimodality therapy of chronic heart failure N. A. Bylova, G.P. Arutyunov, L. I. Kafarskaya, T. K. Chernyavskaya, Z. A. Chernaya

09:48 Outcomes in Patients with Advanced Heart Failure and Left Ventricular Ejection Fraction 30% or Less Referred for Orthotopic Heart Transplantation: The Gender Paradox. S. M. Yala, M. Cadeiras, R. Henquin, D. M. Mancini, Y. Naka, E. V. Giardina, M. C. Deng

Tuesday, 20 May 2008 Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Chr o n ic h e a rt f a i l ur e Chairs: Rafael Porcile (ARGENTINA), Ileana Piña (UNITED STATES) 08:30 Location of Wall Motion Abnormality as a Determinant of Rapid Diastolic Filling: Role of Left Ventricular Ejection Fraction I. P. Clements, D. O. Hodge, C. G. Scott 08:43

Progression of chronic heart failure possible role of gram-negative flora N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, Y. A. Pocrovskiy, T. K. Chernyavskaya, Z. A. Chernaya

08:56 Do Cholesterol Levels Influence Long-Term Heart Failure Outcome in Post-Infarct Patients with Moderate to Severe Left Ventricular Systolic Dysfunction? R. Sankaranarayanan, M. A. James, H. Gonna, S. Burtchaell, R. Holloway 09:09 The Heart Failure Survival Score is a Useful Method in Predicting Cardiovascular Mortality in Severe Heart Failure Patients E. Acarturk, M. Koc, T. Yildiran, O. Sen, D. Y. Sahin 09:22 Influence of cardiologist and non-cardiologist in the management of outpatients with chronic heart failure in Argentina. Preliminary results from Argentinean HOSPICAL II Registry E. Perna, J. P. Cimbaro Canella, C. Poy, F. Diez, R. Colque, L. Lobo Marquez, M. L. Coronel, P. Barrios, S. Perrone 09:35 In-hospital and Long-Term Prognosis of Women Compared with Men with Heart Failure and Acute Myocardial Infarction after Previous Coronary Artery Bypass Surgery; 19-Year Experience P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic, M. Ostojic 09:48 Non-transplant surgical treatment of primary dilated cardiomyopathy and congestive heart failure RADO operation N. Radovanovic, S. Popovic, M. Radovanovic, M. Cenanovic, M. Ignjatovic, S. Potic, N. Pejcic, S. Grujic, M. Zorc

Scientific Programme / 105

Tuesday, 20 May 2008 Or inoco - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Dr u g s, d i a be te s a n d hyp er te n s ion Chairs: Dagnovar Aristizabal (COLOMBIA), Jorge Resk (ARGENTINA) 08:30 Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide: a double-blinded randomized trial with ambulatory blood pressure measurement P. Guerrero, F. D. Fuchs, L. B. Moreira, V. M. Martins, C. Bertoluci, S. C. Fuchs, M. Gus 08:43 The combination of Amlodipine 5 mg and Valsartan 160 mg lowers blood pressure effectively and safely in hypertensive patients not controlled by monotherapy with calcium channel blockers J. Brachmann, R. Handrock, S. Klebs 08:56 Anti-hypertensive drug treatment and the effect over different variability indexes of systolic blood pressure measured by 24-hour Ambulatory Blood Pressure Monitoring M. Gus, F. F. Vianna, A. L. Ferreira, F. C. Fuchs, J. L. Neyeloff, C. Schneider, M. B. Moreira, L. B. Moreira, S. C. Fuchs, F. D. Fuchs 09:09 Inverse association between ankle-brachial index and blood pressure variability estimated by the rate of systolic blood pressure variation derived from 24-hour Ambulatory Blood Pressure Monitoring (ABPM) L. B. Moreira, E. Wittke, F. T. Cichelero, C. M. Moreira, R. Picon, J. S. Varela, T. Bassani, S. C. Fuchs, F. D. Fuchs, M. Gus 09:22 Depressive syndrome prevalence in hypertensives patients and its association with higher pulse pressure and nondipping pattern S. Obregon, C. Kotliar, P. Forcada, G. Iacometti, D. Chejtman, G. Vallejos, C. Bellido, A. Hita, D. Turri 09:35

Type 1 Diabetes mellitus is strongly and independently associated with essential hypertension M. R. Movahed, M. Hashemzadeh, M. M. Jamal

09:48 Cardiovascular risk assessment by SCORE System in Romania and Poland. Data from two National studies: SEPHAR and NATPOL III PLUS M. Dorobantu, T. Zdrojewski, E. Badila, S. Ghiorghe, P. Bandosz, R. O. Darabont, M. Olteanu, P. Flondor P araná - Oc hr e Pavillion - 08:30-10:00 Oral abstract Session Lon g QT s y n dr o m e , h e art f a i l ur e and diabetes Chairs: Manuel Vazquez-Blanco (ARGENTINA), Miguel Adorno (PARAGUAY) 08:30

The Long QT syndrome in pediatric age: prognosis and risk factor G. Fazio, S. Pipitone, L. D'Angelo, P. Palazzolo, G. Di Gesaro, L. Sutera, G. Novo, S. Novo

08:43

Exercise training in patients with left ventricular systolic dysfunction G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, L. Favaloro, M. Diez, R. Favaloro

08:56 A Single Submaximal Exercise Session Enhances Systemic Endothelial Function Independently of Changes in Blood Flow in Patients with Chronic Heart Failure D. Umpierre, J. P. Ribeiro, P. J. C. Vieira, R. S. Moraes, E. L. Ferlin, R. Stein 09:09

Heart failure mortality in three Brazilian states from 1999 to 2004: an analyis of death certification E. Gaui, G. Oliveira, C. Klein

09:22

Age related renine and aldosterone status in 430 essential hypertensives C. Kotliar, P. Forcada, S. Obregon, E. Arcani, J. Bustamante, A. Hita, S. Baratta, D. Turri

09:35 Early detection of right ventricular systolic dysfunction by tissue Doppler derived isovolumic myocardial acceleration (IVA) in Type II diabetes mellitus Y. Tayyareci, Z. Bugra, Y. Nisanci, B. Umman, A. Oncul, I. Altun, S. Yurdakul, N. Polat, K. Adalet 09:48

Pancreatic islets xenotransplantation in dogs with diabetes type 1 A. Abalovich, M. A. Müller, V. Castillo, A. Pisarevsky, G. Ottaviano, R. Gomez Figueroa, D. R. Grana, J. Milei

Tuesday, 20 May 2008 Yangt z e - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract Session P rim a r y a n d s ec ondar y pre vent i on I Chairs: Rodolfo Daniel La Greca (ARGENTINA), Mario Bey Lombana (PANAMA) 08:30

Cardiovascular rehabilitation in patients with peripheral artery disease G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, C. Capano, M. Cisterna, R. Favaloro

08:43 EUROACTION: Changes in smoking, diet and physical activity over one-year in a family based preventive cardiology programme in hospital and general practice. J. L. Jones, A. Mead, C. S. Jennings, A. Holden, S. B. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer, D. A. Wood 08:56 EUROACTION: Achieving Blood Pressure, Lipid and Glucose targets in a 16 week Multidisciplinary Cardiovascular Prevention and Rehabilitation Hospital Programme – One Year Results K. Kotseva, S. Connolly, C. Jennings, A. Mead, J. Jones, A. Holden, D. De Bacquer, G. De Backer, T. Collier, D Wood 09:09 EUROACTION: The Achievement of Blood Pressure, Lipid and Glucose Targets in a Cardiovascular Prevention Programme in General Practice – One Year Results S. Connolly, K. Kotseva, C. Jennings, A. Mead, J. Jones, A. Holden, T. Collier, D. De Backer, G. De Bacquer, D. Wood 09:22

Cardiovascular Risk in Women: The Link Between Framingham Risk Score and Education Inequalities S. Yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina

09:35

Follow up of patients undergoing cardiovascular surgery, compliance with secondary prevention measures S. Kerbage, E. Gallucci, G. Giunta, R. Bianco, J. Figal, J. Abud, E. Dulbecco, H. Raffaelli, R. Favaloro, B. Mautner

09:48 Lack of Cardiac Rehabilitation Programs in Latin America and the Caribbean A. Montero-Gómez, C. Terzic, C. Mendoza, L. Saavedra, F. Kuniyoshi, R. Thomas, S. Kopecky, R. Squires, J. Vallejos, F. López-Jiménez P ilcomayo - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session P rim ary a n d s e co n d a r y pr e v e n t ion II Chairs: Palmira Pramparo (ARGENTINA), Mauricio Wajngarten (BRAZIL) 08:30 Dance-Hall dancing in patients with cardiovascular disease: Experience of 2 years P. Quiroga, MD Rius Suárez, Hermes Ilarraza-Lomel, Y. Prior, MA Viveros, I. Montero, M. Chen, A. Halabe, A. López, D. Flores 08:43 EUROACTION: Achieving lifestyle targets in a hospital and primary care multidisiplinary cardiovascular prevention and rehabilitation programme. Results at 1 year. A. Mead, J. Jones, C. Jennings, A. Holden, S. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer, D. Wood 08:56 Global mortality and relationship with cardiovascular risk factors in a cohort of public employees medical service mendoza argentina. Optimal Systematic Evaluation Program (OSEP STUDY) in Cardiovascular Risk O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, L. Cammi, S. Depine, S. Gimenez 09:09

Clinical reality of coronary prevention in Europe: a comparison of Euroaspire I, II and III surveys K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood

09:22

Profile and High Prevalence of Cardiovascular Risk Factors in an Urban Black African Population K. Tibazarwa, L. Ntyintyane, K. Sliwa, T. Gerntholtz, D. Wilkinson, S. Stewart

09:35

High Prevalence of Cardiovascular Risk Factors Among Brazilian Cardiologists M. S. Rocha, L. C. L. Correia, J. P. Esteves

09:48 Cardiovascular disease prevention and risk factors control: Evaluation of educational community level intervention and communicational strategies for primary prevention S. Kunstmann, Maria Teresa Lira, D. Gainza, J. A. Degrazia, J. C. Molina

Scientific Programme / 107

Tuesday, 20 May 2008 Nige r - Gr een Pavillion - 08:30-10:00 Oral abstract Session R es e a rch o n p har m ac ol ogy Chairs: Lerman Jorge (ARGENTINA), Angeles Alonso Garcia (SPAIN) 08:30 A novel orally active BNP possesses chronic natriuretic actions and decreases mean arterial pressure and activates cGMP in a model of acute hypertension A. Cataliotti, H. H. Chen, J. A. Schirger, F. L. Martin, G. Boerrigter, L. C. Costello-Boerrigter, K. D. James, J. C. Burnett 08:48 Clinical Utility of Single-Pill Amlodipine Besylate/Atorvastatin Calcium to Reduce Predicted 10-Year Coronary Heart Disease Risk by Lowering Blood Pressure and Lipids to Meet Therapeutic Goals in Latin American Patients with Hypertension/Dyslipidemia H. Chaves, Y. Ro, H. F. Tse, L. Howes, C. Aguilar-Salinas, S. Erdine, R. Guindy, P. Chopra, R. A. Moller, I. M. Schou 09:06 Enoxaparin and unfractionated heparin for inpatient initial treatment of venous thromboembolism: an utilization study and cost-minimization analysis L. Moreira, C. Argenta, M. A. P. Ferreira 09:24 Correlation Between Plasma Concentration Of Aldosterone And Neutrophils And The Effect With Aldosterone Blockade In Patients With Heart Failure Following Ami J. Martinez, J. Said Nisi, F. Martinez, M. Bendersky, F. Zaanad, B. Pitt 09:42 Correlation of highly sensitive C reactive protein with Acute Coronary Syndromes and effects of Statin therapy Y. Varma, R. Gupta, A. Kuchwaha, B. S. Yadav, G. Singh, R. K. Shrivastava, V. K. Sharma, T. N. Dube, R. K. Jain, R. S. Meena Nile - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Exe rci s e , l i fe s t y l e a n d i s ch e m ic hea rt disease Chairs: Hermes Ilarraza-Lomeli(MEXICO), Roberto Peidro (ARGENTINA) 08:30

Subacute effects of maximal exercise on heart rate variability in patients with chronic heart failure P. Soares, P. Moreira, F. Neves, N. Rocha, A. Nobrega

08:45

Invasive exercise testing improves the early diagnosis of pulmonary arterial hypertension R. Fowler, A. Maiorana, S. Jenkins, M. Thomas, E. Gabbay, G. O'Driscoll

09:00

Relationship of Exercise Heart Rate Responses to 10-Year Mortality in CHD T. G. Allison, R. W. Squires, B. J. Johnson, F. H. Kuniyoshi, R. J. Thomas

09:15 Circulatory responses to walking test of 50 m in coronary unit in unstable angina and acute myocardial infarction of acute phase C. Dias, A. Maiato, K. Baqueiro, A. Figueiredo, F. Rosa, J. Pitanga, L. Catão, A. Guimarães 09:30 Monitoring myocardial infarction (diagnostic combination, prodromal period, behavioral characteristics) using the WHO program "Registry of Acute Myocardial Infarction", “MONICA” during the period of 22 years in Russia V. Gafarov, A. Gafarova 09:45 EUROASPIRE III: Lifestyle and risk factor management and use of drug therapies in coronary patients from 22 countries in Europe. K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood

Tuesday, 20 May 2008 Feta l ca rd i o l o g y Chairs: Pablo Marantz (ARGENTINA), Areias Carlos (PORTUGAL) 08:30

Volga - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract Session

Histology of Umbilical Blood Vessels J. Milei, H. Ruda Vega, R. Guerri Guttenberg, D. R. Grana, F. Azzato, M. Vazquez Blanco

08:43 The severity of pulmonary regurgitation - what impact it may have on regional right ventricular function in patients after Tetralogy of Fallot repair E. Kowalik, M. Kowalski, M. Kusmierczyk, J. Rozanski, P. Hoffman 08:56 Fetal ductal arteriosus flow velocities and right ventricular size are influenced by maternal ingestion of polyphenol-rich common beverages P. Zielinsky, J. Manica, A. Piccoli Jr., L. Nicoloso, R. Frajndlich, H. Menezes, A. Busato, T. Behrens, J. Huber, M. Silva 09:09 Maternal ingestion of herbal teas and grape juice during pregnancy may cause fetal ductal constriction P. Zielinsky, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, A. Busato, L. Hagemann, M. Moraes J. Silva 09:22 An experimental study of the role of maternal ingestion of green tea, mate tea and grape juice as cause of fetal ductal constriction P. Zielinsky, J. Areias, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, M. Moraes, J. Silva, M. Allievi 09:35

Pulmonary venous flow and its relation with fetal respiratory movements P. Zielinsky, K. Chemello, L. Nicoloso, M. Morais

09:48

Study of left atrium shortening fraction in fetuses of diabetic mothers P. Zielinsky, S. Luchese, J. Manica, A. Piccoli Jr., L. Nicoloso, M. Leite, L. Hagemann, A. Busato, M. Moraes

Nov e l t r e a t m ent s f o r l ip ids dis o rde rs Chairs: Mele Eduardo (ARGENTINA), Zampelas A (GREECE)

Tib e r - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract Session

08:30 Effectiveness of Trimetazidine treatment and Mediterranean-type diet in postinfarction overweight patients with borderline serum cholesterol K. G. Adamyan, A. V. Astvatsatryan, A. L. Chiningaryan 08:43 A treatment algorithm for statin dose selection enables the majority of Latin-American patients with a range of cardiovascular-risk profiles to reach LDL-C targets. A. M. Valderrama, R. Vinueza, and The La-Atgoal Study Group 08:56 Transfer of lipids to High Density Lipoprotein (HDL) in age groups and the effect of Coronary Artery Disease: a study using an artificial nanoemulsion. C. H. M Azevedo, A. C. Lo Prete, C. G. Puk, T. M. Seydell, F. Maniero, M. Wajngarten, J. Diament, R. C. Maranhao 09:09

Simultaneous transfer of lipids from an artificial model lipoprotein (LDE) to high-density lipoprotein. A. C. Lo Prete, C. H. M. Azevedo, C. G. Puk, R. C. Maranhao

09:22 Paradoxical and curvilinear relationship between components of metabolic syndrome, atherosclerosis, and HDL-cholesterol in africans with type 2 diabetes mellitus: Proposition of metabolic syndrome definition for B. Longo-Mbenza, J. B. Kasiam Lasi On’ki, A. Kasiam Lasi On’ki, N. Kangola Kabangu 09:35

Lipid transfer to the HDL fraction in patients with type 2 diabetes T. M. Seydell, G. S. Feitosa-Filho, A. C. Lo Prete, F. Maniero, C. H. Azevedo, C. Alberto Silva, R. Cavalcante Maranhão

09:48 Increased P-Selectin and Fibrinogen Levels After Maximal Stress Test Are Not Modified by a High Dose Atorvastatin D. Lindefjeld, M. Acevedo, G. Chamorro, E. Riedemann, D. Mezzano, C. Aranis, J. Oporto, O. Panes

Scientific Programme / 109

Tuesday, 20 May 2008 Gange s - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Dr u g e l u t i n g s t e n t : E a r l y a n d late out c omes Chairs: Omar Santaera (ARGENTINA), Costantino Costantini (BRAZIL) 08:30

Novel Drug Eluting Stent System with a Polymer Free, On-Site Stent Coating: Single Centre Experience N. Sinha, S. Kumar, A. Kapoor, S. Tewari, H. Rai, N. Singh

08:43

Long term Follow-up of Bare Metal and Drug Eluting Stents in Coronary Angioplasty. G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia

08:56

The Fate Of Coronary Artery Aneurysm Developed After Drug-eluting Stent Implantation B. Hong, C. Ahn, Y. Yoon, P. Min, S. Rim, H. Kwon, D. Choi, Y. Jang, D. Jeon, J. Yang

09:09 Long-term Outcome Following Primary Percutaneous Coronary Intervention with Drug-Eluting and Bare Metal Stent in Patients with ST-Segment Elevation Myocardial Infarction P. Thayssen, L. O. Jensen, M. Maeng, A. Kaltoft, H. Tilsted, M. Bottcher, K. E. Pedersen, L. Pedersen, S. O. Johnsen, L. Thuesen 09:22

Can Disproportionality Analysis Play a Role in Monitoring Drug-Eluting Stent Safety? H. Duggirala, X. Yang, R. Van Manen

09:35 Treatment of bifurcation lesions with two drug eluted stents: Clinical follow up of "Crush" versus "T" stenting techniques I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski 09:48 Cost-effectiveness of the percutaneous treatment strategy of multivessel disease with Taxus stents in comparison with bypass surgery 3 years after treatment M. Gyongyosi, F. Leisch, R. Karnik, S. Harb, P. Siostrzonek, M. Heigert, G. Zenker, I. Lang, G. Christ, D. Glogar Ech o st r e ss I Chairs: Jorge Lax(ARGENTINA)

Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session

08:30 Prognostic Value of Exercise Stress Test and Pharmacological Myocardial Scintigraphy in Diabetic Women Without Cardiac Symptom P. Smanio, A. Thom, A. Carvalho, L. Mastrocolla, R. Meneghelo, S. Tebexreni, A. De Paola, L. Piegas 08:43 Risk stratification of patients with chest pain suspected to be due to acute cardiac ischemia in the emergency department: can rest myocardial perfusion imaging add value to the traditional risk stratification tools? M. Ferreira, A. Ferrer-Antunes, V. Rodrigues, F. Santos, J. Lima, M. D. Cerqueira, L. A. Providência 08:56

Prevalence of myocardial ischemia in patients with syncope. P. Smanio, J. Poeys, G. Monteiro, G. Moscardi, R. Teixeira, D. Moreira, A. Thom, L. Piegas

09:09 Determinants of dipyridamole-induced hypotension in patients undergoing gated myocardial perfusion single-photon emission computed tomography A. De Lorenzo, R. S. L. Lima, M. P. Pellini, J. B. Pereira, L. M. B. Fonseca 09:22

Aortic stiffness is related to the extent of aortic structural damage detected by hybrid PET/CT L. Joly, W. Djaballah, A. Kearney-Schwartz, A. Zervoudaki, P. Olivier, P. Jolivet, P. Y. Marie, A. Benetos

09:35 Imaging of coronary artery fistulas by multidetector computed tomography: Is Multidetector computed tomography sensitive? F. Kacmaz, N. Isiksalan Ozbulbul, O. Alyan, O. Maden, A. D. Demir, R. Atak, A. R. Erbay, Y. Balbay, T. Olcer, E. Ilkay 09:48 Parameters associated with development of myocardial ischemia during mental stress test J. Stepanovic, M. Ostojic, D. Lecic-Tosevski, O. Vukovic, A. Djordjevic-Dikic, I. Nedeljkovic, B. Beleslin, V. Giga, I. Nedeljkovic, M. Nedeljkovic

Tuesday, 20 May 2008 Ech o s tre s s II Chair: Shay Livschiz (ISRAEL)

Huang He - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract Session

08:30 Prevalence of ischemia in diabetic women with multiple risk factors. Comparison between myocardial perfusion scintigraphy, exercise stress test and cardiopulmonary test in the assessment of severe coronary artery disease P. Smanio, C. Carvalho, A. Tebexreni, A. Thom, L. Mastrocolla, R. Meneghelo, A. Alves, L. Piegas 08:43 Incremental Prognostic Value of Left Atrial Volume over Dobutamine Stress Echocardiography Results in Patients with Known or Suspected Coronary Artery Disease J. Tsutsui, P. Dourado, A. Elhendy, S. Falcão, A. Chagas, P. Daluz, J. Ramires, W. Mathias Jr. 08:56

New and faster protocol of stress echocardiography with dobutamine and atropine L. Rocha Lopes, P. Cordeiro, O. Simoes, M. J. Loureiro, S. Almeida, C. Cotrim, M. Carrageta

09:09

Prognostic value of exercise echocardiography in diabetic patients T. S. Aragão, J. L. M. Oliveira, F. D. Anjos-Andrade, E. O. Alves, A. C. Nascimento-Junior, T. J. S. Goes, A. D'Oliveira-Junior, J. A. S. Barreto-Filho, A. C. S. Sousa

09:22 Which is the target heart rate to achieve with dobutamine to consider sufficient an assessment of coronary flow reserve. Is it a feasible test? J. Lowenstein, E. Forte, A. Garcia, G. Peñaloza, A. Lescano, M. Amor, A. Panaro, C. Quiroz, O. Montaña, V. Darú 09:35 Effects of myocardial viability assessed by strain stress echocardiography on diastolic function in Acute Myocardial Infarction W. J. Chung, M. S. Shin, E. O. Shim, W. C. Kang, S. H. Han, C. I. Moon, K. K. Koh, T. H. Ahn, I. S. Choi, E. K. Shin 09:48 Mitral regurgitation and exercise capacity in heart failure patients with left ventricular systolic dysfunction M. Trivi, J. Thierer, R. Guglielmone, A. Adriana, P. Huschnir, J. Marino, M. Sultán, V. Mezzalira, A. Hirshon Prado, R. Ronderos Thame s - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract Session Exp e r i e n c e s w it h high r is k p a tie n t s I Chairs: José Gabay (ARGENTINA), Luis Guzman (UNITED STATES) 08:30

Nationwide Trends in the utilization Of Percutaneous Coronary Intervention (Pci) in the United States. M. R. Movahed, M. Hashemzadeh, M. M. Jamal

08:43 "Deep" Plasma Proteomic Assessment Reveals Increased Amyloidogenic Proteins in Patients With Extensive Atherosclerosis A. Wilson, A. Rafie, K. Beck, N. Balasubramanian, E. Fung, J. Olin, J. Cooke 08:56 In-Hospital Mortality after Acute Ischemic Stroke in an Emerging Country. The Argentinian National Stroke Registry (ReNACer) L. A. Sposato, M. M. Esnaola, M. C. Zurru, J. J. Cirio, R. Zamora, O. Fustinoni, G. Saposnik 09:09 Are there any Gender Differences in First-Ever Ischemic Strokes in Emerging Countries?. The Argentinian National Stroke Registry (ReNACer) Experience L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustinoni, G. Saposnik 09:22

Effects of Carbamazepine on Spinal Cord Ischemia M. Sirlak, S. Eryilmaz, B. Inan, L. Yazicioglu, E. Ozcinar, R. Akar, B. Kaya, Z. Egileten, R. Tasoz, U. Ozyurda

09:35

Early experience in mechanical cardiac support with Berlin heart as bridge to transplant in pediatrics H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, L. Quiroga, G. Burlli, E. Carmona, D. Haag, M. De La Riba

09:48

Intraaortic Balloon Pump in High-Risk Cardiac Patients Undergoing Non-Cardiac Surgery R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, A. Botbol, N. Blanco, E. Tanus

Scientific Programme / 111

Tuesday, 20 May 2008 R hine - Ye llow P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Ma n a g e m e n t o f p a tie n ts w it h s y ncope Chairs: Dario Sobral (BRAZIL), Riccardo Cappato (ITALY) 10:30

Inappropriate sinus node tachycardia Carlos A. Morillo (CANADA)

10:52

Management strategies Rafael Rabinovich (ARGENTINA)

11:14

Syncope and falls in the elderly Antonio Gonzalez Hermosillo(MEXICO) Mis s ouri - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium

Wha t ’ s n e w i n he a r t f ail ur e? Chairs: Jay Cohn (UNITED STATES), Shigetake Sasayama (JAPAN) 10:30

New pharmacotherapies for chronic heart failure Philip A Poole-Wilson. (UNITED KINGDOM)

10:52

What is new with currents agents Henry Krum (AUSTRALIA)

11:14

Cardiac resynchronization therapy John Cleland (UNITED KINGDOM)

11:36

New pharmacotherapies for decompensated heart failure Mihai Gheorghiade (UNITED STATES)

R io de la P lat a - R e d P avillion - 1 0 :3 0- 12: 00 Debate Co n t r o v er s i a l i s s u e s r e g a rd i n g management and t reatment of sy st o l i c h ear t f a il u r e Chairs: Sergio Varini (ARGENTINA), Hori Masatsugu (JAPAN) 10:30

Statement 1: Patients with systolic heart failure in the New York Heart Class Association II should be treated with aldosterone antagonist Pro: Willem Remme (NETHERLANDS) Contra: José Luis López-Sendón (SPAIN)

11:15

Statement 2: Patients with heart failure and LV ejection fraction < 25% and sinus rhythm should receive anticoagulant therapy Pro: Guillermo Torre Amione (UNITED STATES) Contra: Barry Massie (UNITED STATES)

Tuesday, 20 May 2008 Huang He - Ye llow P avillion - 1 0 :3 0 - 12: 00 Symposium Nuc l e a r c a r d io l o g y 2 00 8 Chairs: Alia Abdelfattah (EGYPT), Angel Sandrin (ARGENTINA) 10:30

Molecular imaging Barry Zaret (UNITED STATES)

10:48

Utility of images of the evaluation of vulnerable asymptomatic patients George Beller (UNITED STATES)

11:06

Pharmacological stress: New agents Manuel Cerqueira (UNITED STATES)

11:24

Complementary techniques: Computed tomography and nuclear medicine Ernest Garcia (UNITED STATES)

11:42

Coronary artery disease: Do women constitute a special group? Joao Vitola (BRAZIL) Euphrat e s - Ochre P avillion - 1 0 :3 0- 12: 00 Symposium

Up d a t e o n m i t r al r e g u r git a tion Chairs: Marcia Barbosa(BRAZIL), Carlos Nojek (ARGENTINA) 10:30

Asymptomatic mitral regurgitation, intervene or wait? TBD

10:52

Mitral valve reconstruction: What have we learned during the past 40 years? David Adams(UNITED STATES)

11:14

Percutaneous repair of mitral regurgitation William E. Cohn E. (UNITED STATES)

11:36

Three-dimensional echo evaluation of mitral regurgitation Bernhard Mumm (GERMANY)

Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Perc u t a n e o u s he a r t val ve int er v e nt ions : The e n d o f v a l vu l a r o p e n he a r t s urge ry? - P art t wo Chairs: Alejandro Palacios (ARGENTINA), Felipe Heusser Risopatró (CHILE) 10:30

Innovation in percutaneous mitral valve repair and replacement Jose Condado (VENEZUELA)

10:52

Percutaneous pulmonary valve replacement: An update Neil Wilson (UNITED KINGDOM)

11:14

Balloon mitral valve dilation for mitral stenosis disease from low income countries: Has it replaced surgery forever? Deborah Nercolini (BRAZIL)

11:36

Surgery vs. percutaneous procedures A. A. Shafi Majumder (BANGLADESH)

Scientific Programme / 113

Tuesday, 20 May 2008 Me kong - Ochre P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Int e r v e n t i o n al tr eat m e n t o f acut e myocardial infarc t ion Chairs: Fabio Sandoli De Brito (BRAZIL), Riccitelli Miguel (ARGENTINA) 10:30

Strategies to reduce door-to-balloon times Daniel Berrocal(ARGENTINA)

10:52

Adjunctive drug treatment for primary PCI Dudek Ricardo Lluberas (URUGUAY)

11:14

Multivessel disease management in ST-segment elevation myocardial infarction Satyavan Sharma (INDIA)

11:36

Transfer for PCI: Controlled studies and the real world P. Radke (GERMANY) Nile - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium

Wo m e n a n d c o r onar y he a r t dis eas e Chairs: Juan Justiniano Encina (BOLIVIA), Angeles Alonso Garcia (SPAIN) 10:30

Cardiovascular risk factors in women: Is there a real gender difference? Nanette Wenger (UNITED STATES)

10:52

Diagnostic assessment of IHD in women Noel Bairey Merz (UNITED STATES)

11:14

Therapeutic interventions in women: How can we improve outcomes? Rose Marie Robertson (UNITED STATES)

11:36

Gender differences in angina and acute coronary Acevedo Monica (CHILE)

Danub e - Gr e e n P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Late r e su l t s in Car d io va s c ul ar Int e rve nt ions Chairs: Luis Guzman (UNITED STATES), Ramón Quesada (UNITED STATES) 10:30

Internal thoracic artery over 30 years of experience Sabik III Joseph F (UNITED STATES)

11:00

Composite graph: Radial, gastroepiploic artery and SVG Roque Cordoba (ARGENTINA)

11:30

Preservative surgery of the aortic valve: In hospital and long-term outcomes Daniel Navia (ARGENTINA)

Tuesday, 20 May 2008 P ilcomayo - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium The c l a ss e f f e c t d il em m a: Ar e a ll drugs wit hin a clas s cr e at e d e qual? Chairs: Lerman Jorge (ARGENTINA), Luis Vidal (ARGENTINA) 10:30

Beta blockers Corbalan Ramon (CHILE)

11:00

Nonsteroidal anti-inflammatory drugs Frank Thomas Ruschitzka (SWITZERLAND)

11:30

Statins Antonio Chagas (BRAZIL)

Volga - Ye llow P avillion - 1 0 :3 0 - 12: 00 Symposium Perc u t a n e o u s p ul m o n a r y va l ve re place me nt Chairs: Guillermo Kreutzer (ARGENTINA), Valmir Fontes (BRAZIL) 10:30

Opportunity of pulmonary valve replacement Michael Landzberg (UNITED STATES)

10:52

Point of view of a surgeon Andrés Schlichter (ARGENTINA)

11:14

Experience with Edwards valve Ziyad Hijazi (UNITED STATES)

11:36

Results with Bonhoffer valve Neil Wilson (UNITED KINGDOM)

Or inoco - Ochre P avillion - 1 0 :3 0- 12: 00 Symposium Hyp e r t e n si o n and tar g et or g a n damage Chairs: Luis Alcocer (MEXICO), Luis Molinary (PUERTO RICO) 10:30

Cognitive dysfunction and hypertension Antonio Coca (SPAIN)

10:52

Specific cardiac complications Richard Devereux (UNITED STATES)

11:14

The kidney’s role in hypertension Luis Juncos (ARGENTINA)

11:36

Hypertension, inflammation and organ target damage Oscar Carretero (UNITED STATES)

Scientific Programme / 115

Tuesday, 20 May 2008 Nige r - Gr e e n P avillion - 1 0 :3 0- 12: 00 Symposium Ac u t e c o r o n a r y s yndr o m e in d ia b e t e s Chairs: Mehta A. B (INDIA), Pomes Iparraguirre Horacio (ARGENTINA) 10:30

Diabetes and acute coronary syndromes: An overview Jose Nicolau (BRAZIL)

10:52

Management of ACS in diabetics: An European perspective and lessons from the MIDAS registry Marco Roffi (SWITZERLAND)

11:14

Diabetes and ACS in India: Magnitude of the disease burden and optimal pharmacotherapy Shirish Hiremath (INDIA)

11:36

When perform surgical revascularization in patients with stable coronary artery disease? Robert Califf (UNITED STATES)

P araná - Ochre P avillion - 1 0 :3 0- 12: 00 Symposium Ca r d i o v a sc ul ar dis eas e pre vent ion in childre n Chairs: Pilar Arnaiz (CHILE), Veronica Ines Volberg (ARGENTINA) 10:30

Prevention of cardiovascular diseases from childhood: The EDUCANDO Project Rodolfo Daniel La Greca (ARGENTINA)

10:52

Excercise as a tool in prevention for children Patricia Sangenis (ARGENTINA)

11:14

Pharmacologic treatment of hypertension in adolescents Giuseppe Ambrosio (ITALY)

11:36

Cardiovascular risk factors in childhood: A growing international problem Roya Kelishadi (ISLAMIC REPUBLIC OF IRAN)

Tigris - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium Ac u t e h e a r t f ail ur e in t he em er g e ncy de part me nt Chairs: Gines Sanz (SPAIN), Victor Mauro (ARGENTINA) 10:30

Biochemical diagnosis: How much better than clinical diagnosis? Carlos Martinez-Sanchez (MEXICO)

10:52

Echocardiogram in acute heart failure: When to indicate it in the emergency department? Pablo Oberti (ARGENTINA)

11:14

Heart failure units: Rationale for their implementation Juan José Fuselli (ARGENTINA)

11:36

Nesiritide and levosimedan: Do they have any role in the emergency department? Fernando Bacal (BRAZIL)

Tuesday, 20 May 2008 Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00 Clinical Seminar BMS a n d DES r e s t enos is : H ow do we t re at t he m in 2 0 0 8 ? Chairs: Christopher Cates (UNITED STATES), Antonio Pocovi (ARGENTINA) 10:30

Critical assessment of the outcomes of in-stent restenosis Expedito Ribeiro (BRAZIL)

10:52

High risk lesions for restenosis: Bifurcations, long lesions, small vessels, etc. Spencer King III (UNITED STATES)

11:14

Different paterns and solutions for in-segment/stent restenosis for BMS and DES Carlos Mendiz (ARGENTINA)

11:36

Are there any new devices for avoiding in-stent restenosis? Mario Pieroni (ARGENTINA) Tib e r - Ye llow P avillion - 1 0 :3 0 - 12: 00 Special Featured Joint Session

IS CP T h e G l o bal N ut r it io n Chal l e nge Chairs: Scott Grundy (UNITED STATES), Palmira Pramparo (ARGENTINA) 10:30

Nutrition transition in the developing world Barry Popkin (UNITED STATES)

10:52

Nutrition and health status in China Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF)

11:14

Nutrition and health status in Brazil

11:36

Nutrition and health status in Mexico

Thame s - Ye llow P avillion - 1 0 :3 0 - 12: 00 Special Featured Joint Session IASC : H e a r t f a il u r e w it h pre s e r ve d s ys t olic funct ion Chairs: Oscar Alvarado C (PERU), Maria Paniagua (PARAGUAY) 10:30

A new worldwide epidemic? Wistremundo Dones (PUERTO RICO)

10:52

Pathophysiological mechanisms Piñeiro Daniel (ARGENTINA)

11:14

How to make the diagnosis? Miguel Quiñones (UNITED STATES)

11:36

How to treat it? Diego Delgado (CANADA)

Scientific Programme / 117

Tuesday, 20 May 2008 Yangt z e - Ochre P avillion - 1 0 :3 0- 12: 00 Special Featured Joint Session HRS & ISHNE: S u d d en c a r diac d eat h Chairs: Oseroff Oscar (ARGENTINA), Branco Mautner (ARGENTINA) 10:30

High risk stratification for ICD implantation - clinical approach Gioia Turitto (UNITED STATES)

10:52

High risk stratification for ICD implantation - non-invasive assessment Nabil El-Sheriff(UNITED STATES)

11:14

ICD - primary prevention of SD Luis Molina (MEXICO)

11:36

ICD indication for secondary prevention and genetic arrhytmic disorders Carlos A. Morillo (CANADA) Amaz on - Ye llow P avillion - 1 0 :3 0- 12: 00 South American Congress of Cardiology

Co n f e r e n c i a s Pesidentes: Javier Bustamante (BOLIVIA), Eduardo Roura (ECUADOR) 10:30

De los ensayos clínicos a la práctica asistencial Cagide Arturo (ARGENTINA)

11:15

Avances en el manejo de la enfermedad aórtica Noedir Groppo Stolf (BRAZIL)

Volga - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium Co n g e n i t a l h e ar t d i s e a s e i n co unt ries with limited r esou rc es Chairs: Alberto Sciegata (ARGENTINA), Rodolfo Neirotti (SWITZERLAND) 14:00

Epidemiology and cost-effective practices for congenital heart disease in the developing world Masood Sadiq (PAKISTAN)

14:22

Reality of Chagas Disease in 2008 Ademar Atik(BRAZIL)

14:44

Congenital cardiac surgery in the less privileged regions of the world Anita Saxena (INDIA)

15:06

Congenital cardiac survey in Central America Joaquín Barnoya (GUATEMALA)

Tuesday, 20 May 2008 R hine - Ye llow P avillion - 1 4 :0 0 - 15: 30 Clinical Seminar Ris k st r a t i f i c a tion in ge n et ic dis orde rs : ICD or not ? Chairs: Branco Mautner (ARGENTINA), Yunlong Xia (CHINA, PEOPLE’S REPUBLIC OF) 14:00

Genomic of sudden death: A new approach to risk stratification? Peter Spooner (UNITED STATES)

14:22

Long QT Syndrome pathophysiological background Gabriel Vanerio (URUGUAY)

14:44

ARVCs Guy Fontaine (FRANCE)

15:06

Polymorphic ventricular tachycardia Víctor Arregui (ARGENTINA)

R io de la P lat a - R e d P avillion - 1 4 :0 0- 15: 30 Debate Guid i n g a n d o p t im iz in g t r e a tm ent of he art failure Chairs: José Luis Barisani (ARGENTINA), V. Mareev (RUSSIAN FEDERATION) 14:00

Statement 1: The medical treatment of heart failure should be guided and optimized with measurement of BNP levels Pro: Henry Krum (AUSTRALIA) Contra: Jay Cohn (UNITED STATES)

14:45

Statement 2: The medical treatment of heart failure should be guided and optimize with echocardiogram parameters Pro: Miguel Quiñones (UNITED STATES) Contra: Marvin Konstam (UNITED STATES)

Nige r - Gr e e n P avillion - 1 4 :0 0- 15: 30 Symposium Acu t e c o r o n ar y e vent s d u r ing n on-cardiac s urge ry Chairs: Hernán Cohen Arazi (ARGENTINA), Edgar Pozo Valdivia (BOLIVIA) 14:00

Epidemiology of acute coronary events in non-cardiac surgery Falconi Mariano (ARGENTINA)

14:22

How should we stratify patients before non-cardiac surgery? Victor Sinisi (ARGENTINA)

14:44

Are scores really useful in cardiac risk assessment before non-cardiac surgery?

15:06

Prevention of acute coronary events in non-cardiac surgery: Revascularization or betablocker therapy? Don Poldermans (NETHERLANDS)

Scientific Programme / 119

Tuesday, 20 May 2008 Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Co m pl e x pa t i e n t s a n d c o mp l e x de cisions - Pa rt one Chairs: Martínez Rios Marco A. (MEXICO), Miguel Rubio (ARGENTINA) 14:00

The left main trunk PCI, anatomy related strategies and outcomes TBD

14:22

Elderly patients PCI: Clinical and anatomical risk factors Christopher Cates (UNITED STATES)

14:44

Outcomes in sapheneous vein graft’s interventions: DES and BRS with/without distal protection Roxana Mehran (UNITED STATES)

15:06

The patient with very low ejection fraction Costantino Costantini (BRAZIL)

Euphrat e s - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium Cu rr e n t t o p ic s in inf e c tive e n d o cardit is Chairs: Hector Delgado Osorio (PUERTO RICO), Peter Liu (CANADA) 14:00

World epidemiology of infective endocarditis/experience of ICE study Adam Torbicki (POLAND)

14:22

Epidemiology, clinical characteristics and evolution of infective endocarditis in under-developed countries: Results of the Latino-American registries (EIRA) José Horacio Casabé (ARGENTINA)

14:44

New advances in prognostics stratification of patients with infective endocarditis Miguel Gomez Sanchez (SPAIN)

15:06

Which should be the therapeutic approach of the multi-disciplinarian health team of a patient with infective endocarditis in the new millennium? Francisco Nacinovich (ARGENTINA)

Huang He - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium End o t h e l i a l d y s f u nct i o n d e t ec tion w ith c old pr esso r test and m y o c a r d ia l p e r f us io n Chairs: Plastino Juan A. (ARGENTINA), Acevedo Monica (CHILE) 14:00

Prognostic impact of coronary vasodilator dysfunction Dimitri Tousoulis (UNITED STATES)

14:22

Endothelial dysfunction on moderate risk patients Perez Baliño Nestor (ARGENTINA)

14:44

PET utility on the analyses of the coronary vasomotion Heinrich Schelbert (UNITED STATES)

15:06

Endothelia dysfuction treatment Giuseppe Ambrosio (ITALY)

Tuesday, 20 May 2008 Danub e - Gr e e n P avillion - 1 4 :0 0- 15: 30 Symposium Mitr a l v a l v e r e p air : W ha t is the be s t opt ion? Chairs: Julio Palmaz (UNITED STATES), Alberto Domenech (ARGENTINA) 14:00

How to select patients for surgical mitral valve repair Jaime Calderón Herrer (COLOMBIA)

14:22

In-hospital and long-term follow-up on surgical valve repair David Adams(UNITED STATES)

14:44

When mitral valve repair is not possible: What prosthetic valve should be preferred and for which patient? José Luis Navia (UNITED STATES)

15:06

Up-date on percutaneous mitral valve repair Igor Palacios (UNITED STATES)

P araná - Ochre P avillion - 1 4 :0 0- 15: 30 Debate Why a r e w e n o t b e tt er in pre vent ing cardiovas cular dis e as e s ? Chairs: Shanthi Mendis (SWITZERLAND), Hernán Delmonte (ARGENTINA) 14:00

Statement 1: It is the fault of the doctors that we are not better in preventing cardiovascular disease Pro: Hassell Trevor (BARBADOS) Contra: Zeljko Reiner (CROATIA)

14:45

Statement 2: Is the general publics’ erroneous perception the reason why we are not better in preventing cardiovascular disease? Pro: Daniel W. Jones (UNITED STATES) Contra: Ulrich Keil(GERMANY) Thame s - Ye llow P avillion - 1 4 :0 0 - 15: 30 Symposium

Pro m o t i n g smoke -f r e e envir o n m e nt s Chairs: Ana Tambussi (ARGENTINA), Federico Giachello (ARGENTINA) 14:00

Health impact of passive tobacco smoke: New evidence Joaquín Barnoya (GUATEMALA)

14:22

Policy change for smoke-free environments in Latin America and the Caribbean Beatriz Champagne (UNITED STATES)

14:44

Implementation of the framework convention on tobacco control Eduardo Bianco (URUGUAY)

15:06

Counteracting the tobacco industry’s strategies Ernesto Sebrie (UNITED STATES)

Scientific Programme / 121

Tuesday, 20 May 2008 Me kong - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium Non - i n v a si v e im a g in g f or t he d ia gnos is of myocardial is che mia: Whi c h m e t h o d ? Chairs: Kuschnir Paola (ARGENTINA), Wielgosz Andy (CANADA) 14:00

Nuclear medicine Francisco Benítez (UNITED STATES)

14:22

Echocardiography Walter Stoermann (ARGENTINA)

14:44

MRI and CT multi-slice Mario Garcia (UNITED STATES)

15:06

Looking at the images: Why, when and which one? Pérez De Arenaza Diego (ARGENTINA)

P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium Ca r d i o v a sc ul ar dr u g t her a p y in wome n Chairs: César Serra (ARGENTINA), Pedro Lipszyc (ARGENTINA) 14:00

Treatement during pregnancy and post-partum Manuel Vazquez-Blanco (ARGENTINA)

14:22

Reperfusion therapy Jose Antonio Francisco Ramires (BRAZIL)

14:44

Hormone replacement therapy Nanette Wenger (UNITED STATES)

15:06

Primary and secondary recommendations for Aspirin therapy in women Smith Sidney (UNITED STATES)

Tigris - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium Ac u t e c o r o n ar y s yn d r om e f r om pre -hos pit al t o t he e me rge ncy room Chairs: Karl B. Kern (UNITED STATES), Alfredo Piombo (ARGENTINA) 14:00

Right ventricular myocardial infarction Corbalan Ramon (CHILE)

14:22

Reducing the door-to-balloon time for myocardial infarction Alia Abdelfattah (EGYPT)

14:44

Pre-hospital 12-lead EKG Mario Lado (URUGUAY)

15:06

Antithrombotic therapy in pre-hospital and emergency room Ernesto Paolasso (ARGENTINA)

Tuesday, 20 May 2008 Or inoco - Ochre P avillion - 1 4 :0 0 - 15: 30 Symposium What a r e t h e s tr a te g ies in the m a nage me nt of mild hype rt e ns ion? Chairs: Luis Acosta (VENEZUELA), Pablo Rodriguez (ARGENTINA) 14:00

Lifestyle modifications? Celso Amodeo (ARGENTINA)

14:22

Anti-hypertensive drugs? Alberto Zanchetti (ITALY)

14:44

Anti-platelets agents? Luis Ruilope (SPAIN)

15:06

Lipid lowering agents? Richard Devereux (UNITED STATES)

Se ine - Gr e e n P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Low e r l i m b i n t er vent io n s : S tand up and walk Chairs: Miguel Chiape (ARGENTINA), Joseph F. Sabik III (UNITED STATES) 14:00 Patency vs clinical outcomes in complex infrapopliteal interventions: Does use of DES change the story? Mariano Ferreira (ARGENTINA) 14:22 Percutaneuous treatment of total oclussions of SFA and iliac arteries: Long term follow-up Fernando Cura (ARGENTINA) 14:44 Critical overview of endovascular treatment of aortic aneurysms Patricio Zaefferer (ARGENTINA) 15:06 Long term results in superficial Femoral arteries stenting Jorge Bluguerman (ARGENTINA) Mis s ouri - Yello w Pavillion - 14:00-15:30 Special Featured Joint Session AHA : C r i t ic a l i s s u e s a n d n e w s tr ategies to manage pati e n t s w i t h c ar d io va s c ul ar dis e as e Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Kumar Anil (INDIA) 14:00

New imaging strategies to assess cardiovascular risk Fuster Valentin (UNITED STATES)

14:22

Critical issues in the new secondary prevention guidelines Smith Sidney (UNITED STATES)

14:44

Evolving strategies for the treatment of hypertension - is it time to change the guidelines? Daniel W. Jones (UNITED STATES)

15:06

New guidelines for the management of patients with valvular heart disease Robert Bonow (UNITED STATES)

Scientific Programme / 123

Tuesday, 20 May 2008 Tib e r - Ye llow P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session Inf l a m m a t i o n a n d Car d io va s c ular Dis e as e : Mult i-marke r appr oach Chair: Conci Eduardo (ARGENTINA) 14:00

From inflammation biology to cardiovascular Biomarkers Peter Libby (UNITED STATES)

14:22

Dyslipidemic risk factors which are clinically important Tonkin Andrew (AUSTRALIA)

14:44

Adiponectin and Coronary Heart Disease

15:06

Brain natriurectic peptide as a marker of cardiovascular risk Dimitri Tousoulis (UNITED STATES)

Yangt z e - Ochre P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session ASN C : T h e bi g t r ial s on n u c l ear cardiology Chairs: Barry Zaret (UNITED STATES), Néstor Alejandro Vita (ARGENTINA) 14:00

COURAGE Trial Leslee Shaw (UNITED STATES)

14:22

INSPIRE Trial John Mahmarian (UNITED STATES)

14:44

DIAD Trial George Beller (UNITED STATES)

15:06

ADVANCE MPI Manuel Cerqueira (UNITED STATES) Mis s is s ippi - Ye llow P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session

Polí t i c a s d e S a l u d Chairs: Graciela Ocaña (ARGENTINA), Perez Baliño Néstor Abel (ARGENTINA) 14:00

Políticas públicas en prevencíon cardiovascular: rol de los gobiernos provinciales Oscar González (ARGENTINA)

14:22

Prevencíon cardiovascular en un sistema de atencíon primaria de la salud Claudio Zin (ARGENTINA)

14:44

Políticas Públicas de Salud en la ciudad de Buenos Aires Jorge Lemus(ARGENTINA)

15:06

Promocíon y programas de salud en la Argentina Juan Carlos Nadalich (ARGENTINA)

Tuesday, 20 May 2008 Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30 South American Congress of Cardiology Tr a t a m i e n t o ac t u a l de l a enf e r me dad coronaria cr ónica Coordinadores: Patricia Rebaza (PERU), Edgar Pozo Valdivia (BOLIVIA) 14:00

Impacto del tratamiento médico en la enfermedad coronaria crónica Sanhueza Patricio (CHILE)

14:15

¿Cuándo y cómo evaluar isquemia y viabilidad miocárdica? Masoli Osvaldo (ARGENTINA)

14:30

¿Qué pacientes deben ser revascularizados? Protasio Da Luz (BRAZIL)

14:45

Seleción de la estrategia de revascularización ¿Cuándo utilizar stent con drogas? Ricardo Lluberas (URUGUAY)

Mis s ouri - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium Ade q u a t e m a n age m e n t o f c hr onic he art failure Chairs: Miguel Quintana (PARAGUAY), Cuesta Silva Manuel (ARGENTINA) 16:00

Optimizing diuretic treatment in ambulatory patients Barry Massie (UNITED STATES)

16:18

Frequent difficulties and mistakes with ACEI and beta blockers therapy José Luis López-Sendón (SPAIN)

16:36

Careful Manage in patents with high comorbidity Gilson Feitosa(BRAZIL)

16:54

Prevention of thromboembolic events Ileana Piña (UNITED STATES)

17:12

How to implement a simple and effective disease programme in heart failure? Grancelli Hugo (ARGENTINA) Huang He - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium

Viabi l i t y i m a g in g Chairs: Victor Balestrini (ARGENTINA), Gustavo Acosta (PARAGUAY) 16:00

Is dobutamine echo the best test? Milind Desai (UNITED STATES)

16:18

Recent outcomes in Nuclear Cardiology Francisco Benítez (UNITED STATES)

16:36

Is Pet the gold standard? Heinrich Schelbert (UNITED STATES)

16:54

New kids on the block: Magnetic resonance Masoli Osvaldo (ARGENTINA)

17:12

Is there room for spect nowadays? George Beller (UNITED STATES)

Scientific Programme / 125

Tuesday, 20 May 2008 Or inoco - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Ma n a g e m e n t o f p at ient s w ith hy pe rt e ns ion and comorb idit ie s Chairs: Sverre E. Kjeldsen (NORWAY), Jaime Espinosa (PERU) 16:00

Heart failure and hypertension: Just an overload? Jay Cohn (UNITED STATES)

16:22

Diabetes and hypertension Antonio Coca (SPAIN)

16:44

Hypertension in the very elderly Alberto Zanchetti (ITALY)

17:06

Microalbuminuria Luis Ruilope (SPAIN) Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30 Clinical Seminar

Exe rci se i n v al vul ar he a r t dis eas e Chairs: Mario Bey Lombana (PANAMA), Harry Acquatella (VENEZUELA) 16:00

Aortic stenosis Roberto Peidro (ARGENTINA)

16:22

Aortic regurgitation Daniel Areco (URUGUAY)

16:44

Mitral regurgitation Jairo Pedraza (COLOMBIA)

17:06

Mitral stenosis Pedro Gutierrez Fajardo (MEXICO)

P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30 Special Featured Joint Session Rhe u m a t i c F e ver /R he u m at ic H eart Dis e as e Chairs: Amoah Albert (GHANA), Aloyzio Achutti (BRAZIL) 16:00

It is still around? Edward L. Kaplan (UNITED STATES)

16:18

Primary prevention and the ASAP Program in Africa Mayosi Bongani (SOUTH AFRICA)

16:36

Pathogenesis of rheumatic heart disease Luiza Guilherme (BRAZIL)

16:54

Rheumatic fever vaccines Carapetis Jonathan (AUSTRALIA)

17:12

Rheumatic heart disease and its control in the Pacific Andrew Steer (AUSTRALIA)

Tuesday, 20 May 2008 Yangt z e - Ochre P avillion - 1 6 :0 0 - 17: 30 Clinical Seminar Und e r st a n d i ng hyp e r t r op hic c ardiomyopat hy Chairs: Lastiri Hugo (ARGENTINA), Eduardo Moreyra (ARGENTINA) 16:00

HCM in children Alday Luis (ARGENTINA)

16:22

Pathogenesis beyond gene mutations Matsumori Akira (JAPAN)

16:44

Missense mutations and prognosis of hypertrophic cardiomyopathy Lorenzo Montserrat (SPAIN)

17:06

Treatment approach Peter Liu (CANADA)

Nige r - Gr e e n P avillion - 1 6 :0 0- 17: 30 Symposium An in t e r n a t i o nal l o o k at c ar e f o r pat ie nt s wit h acut e coronary s yndro me Chairs: Mauricio Cohen (UNITED STATES), Ricardo López Santi (ARGENTINA) 16:00

EUROPE Juan Kaski (UNITED KINGDOM)

16:18

ASIA

16:36

LATIN AMERICA Andres Orlandini (ARGENTINA)

16:54

USA Leslee Shaw (UNITED STATES)

17:12

What did we learn from international registries? P. Gabriel Steg (FRANCE)

Me kong - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium What sh o u l d b e t he a n tit hr om b ot ic t he rapy in acut e coronary s yndrome? Chairs: Luis Mercado (BOLIVIA), P. Radke (GERMANY) 16:00

Should fondaparinux be the first choice in ACS? Yusuf Salim (CANADA)

16:22

PCI in ACS: When to indicate and which antithrombotic agent should be used? Enrique Fairman (ARGENTINA)

16:44

Low molecular heparin is the first choice Robert Califf (UNITED STATES)

Scientific Programme / 127

Tuesday, 20 May 2008 P araná - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Dia be t e s pr eve n tion Chairs: Isaac Sinay (ARGENTINA), Shirish Hiremath (INDIA) 16:00

Interventions in diabetes prevention in Europe: Experiences from development of European guidelines Marco Roffi (SWITZERLAND)

16:22

Diabetes prevention in Uruguay Raul Pisabarro (URUGUAY)

16:44

Diabetes prevention programmes in China Qing Qiao (FINLAND)

17:06

Diabetes prevention: A global strategy Mehta A. B (INDIA)

Nile - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium St re s s a n d d e pr e s s i o n : Ne w r i s k facto r s for c orona ry hea rt disease Chairs: Bernardo Boskis (ARGENTINA), Adel Allam (EGYPT) 16:00

Psychosocial interventions in coronary heart disease Matthew Burg (UNITED STATES)

16:18

Depression and cardiovascular disease Acevedo Monica (CHILE)

16:36

Work stress and its impact on coronary artery disease Noel Bairey Merz (UNITED STATES)

16:54

Myocardial ischaemia detection during mental stress: Is it prognostic? Néstor Alejandro Vita (ARGENTINA)

17:12

Type D personality: a chronic risk factor in heart disease Angelique Schiffer (NETHERLANDS)

R hine - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium Hea l t h f r o m a ge n d er p er s p ec t iv e : Implicat ions for CVD Chairs: Fernando De La Serna (ARGENTINA), Robert J. De Souza (SOUTH AFRICA) 16:00

A focus in gender Nishtar Sania (PAKISTAN)

16:22

The implications for the PHC sector: Strengthening core competencies of PHC workers to deal with CVD among women Denise Eldemire Shearer (JAMAICA)

16:44

Policies that work: Examples from Canada Wielgosz Andy (CANADA)

17:06

The WHO response Shanthi Mendis (SWITZERLAND)

Tuesday, 20 May 2008 Volga - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium Pre v e n t i o n o f c ar d ia c dis eas e in childhood Chairs: Alfonso Buendia-Hernandez (MEXICO), Alex Javois (UNITED STATES) 16:00

Childhood origins of vascular disease: New insights and future developments Horacio Zylbersztejn (ARGENTINA)

16:22

Cardiovascular implications of childhood obesity Michael Landzberg (UNITED STATES)

16:44

Metabolic Syndrome as risk factor in children Irina Kovalskys(ARGENTINA)

17:06

Epidemiology of rheumatic fever Anita Saxena (INDIA)

Danub e - Gr e e n P avillion - 1 6 :0 0- 17: 30 Debate Cor o n a r y by p a s s s u r ge r y: Co n te mporary is s ue s Chairs: Daniel Bracco (ARGENTINA), Expedito Ribeiro (BRAZIL) 16:00

Statement 1: Extra-corporeal circulation in coronary surgery is preferred Pro: Roberto Favaloro (ARGENTINA) Contra: Enio Buffolo (BRAZIL)

16:45

Statement 2: Patients with multiple vessel disease should have surgery Pro: Manuel IrarrazAbal (CHILE) Contra: Alfredo Rodriguez (ARGENTINA)

Tigris - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium Repe r f u si o n i n t he el de r l y: E vid ence vs . re al life Chairs: Fernando Botto (ARGENTINA), M. Nahir (ISRAEL) 16:00

Reperfusion in developed countries Xavier Bosch (SPAIN)

16:22

Reperfusion in the rest of the world Álvaro Avezum (BRAZIL)

16:44

Comorbidity and reperfusion strategies John Field (UNITED STATES)

17:06

Cardiac care after myocardial infarction Mauricio Wajngarten (BRAZIL)

Scientific Programme / 129

Tuesday, 20 May 2008 Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30 Clinical Seminar Ho w t o d e a l w ith P CI c om p l ic at i ons ? Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Jorge Leguizamon (ARGENTINA) 16:00

PCI: Lethal or near lethal complications: Predictions and solutions Grinfeld Liliana (ARGENTINA)

16:22

New antithrombotic strategies for avoiding stent thrombosis Marcelo Casey (ARGENTINA)

16:44

Bleeding in PCI: How much of a problem? Carlos Macaya (SPAIN)

17:06

Post-procedural renal failure: An unnecessary complication Roxana Mehran (UNITED STATES) R io de la P lat a - R e d P avillion - 1 6 :0 0- 17: 30 Symposium

Go Re d f o r Wom en: G oing g l o b al Chairs: Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF), Volqvartz Susanne (DENMARK) 16:00

Women and heart disease in Argentina Florencia Rolandi (ARGENTINA)

16:18

Africa: The data gaps Krisela Steyn (SOUTH AFRICA)

16:36

Go Red for Women in the USA Nancy Brown (UNITED STATES)

16:54

Go Red for Women Singapore style Sun Yee Ho (SINGAPORE)

17:12

Women & heart disease in low- and middle-income countries Nishtar Sania (PAKISTAN) Se ine - Gr e e n P avillion - 1 6 :0 0- 17: 30 Symposium

Str o k e a bo v e t he c ar o tids Chairs: Omar Santaera (ARGENTINA), Chain Sergio (ARGENTINA) 16:00

Incidence, prevalence of ischemic and hemorrhagic strokes: Demographic and geographic differences Sebastián Ameriso (ARGENTINA)

16:22

Therapeutic window: Diagnosis and management based on neuro-imaging, CT vs. MRI Gilberto Gonzalez (UNITED STATES)

16:44

Medical treatment beyond aspirin and IV rtpa Tonkin Andrew (AUSTRALIA)

17:06

Endovascular treatment in intracranial ischemic stroke Fernando Vinuela (UNITED STATES)

Tuesday, 20 May 2008 Thame s - Ye llow P avillion - 1 6 :0 0 - 17: 30 Special Featured Joint Session PCNA: The role of the nurse in preventive cardiology: An a r e a o f l e ade r s hip Chairs: Joanna Sikkema (UNITED STATES), Lira Maria Teresa (CHILE) 16:00

The role of the nurse on cardiovascular prevention programmes Veronica Kramer (CHILE)

16:22

Secondary Prevention: Are we able to improve the results? Catriona Jennings (UNITED KINGDOM)

16:44

Role of nursing in cardiac rehabilitation Nancy Houston Miller (UNITED STATES)

17:06

Behavioral changes in cardiovascular diseases: Tools for success Laura Hayman (UNITED STATES)

Amaz on - Ye llow P avillion - 1 6 :0 0 - 17: 30 South American Congress of Cardiology Fac t o r e s d e r ies g o y a te r os c l er os is s ub clínica Coordinadores: Mario Lado (URUGUAY), Santiago García Egüez (ECUADOR) 16:00

¿Es suficiente el score de Framinghan para establecer el riesgo cardiovascular? Hernández Edson (VENEZUELA)

16:15

Aterosclerosis subclínica y riesgo cardiovascular. ¿Cómo evaluarla y como tratarla? Antonio Chagas (BRAZIL)

16:30

Cambios en el estilo de vida: Beneficios clínicos y fallas en su implimentación Victoria Chaparro Cristaldo (PARAGUAY)

16:45

¿Cómo detectar y como tratar el metabolismo anormal de la glucosa? José Drago Silva (PERU)

17:00

Objetivos terapéuticos de los trastornos lipídicos en prevención primaria y secundaria Rey Ricardo (ARGENTINA)

Scientific Programme / 131

Scientific programme by day and by time Wednesday, 21 May 2008

Me kong - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract session Ant i p l a t e l e t s in P T CA Chairs: Ricardo Lluberas (URUGUAY), Barrero Carlos (ARGENTINA) 08:30

Prognostic value of myocardial perfusion Gated SPECT after myocardial infarction P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguadé-Bruix, J. Castell-Conesa, J. Candell-Riera

08:43 Can haemoglobin at admission predict short-term prognosis in acute coronary syndrome patients? N. Antonio, S. Monteiro, C. Lourenco, S. Costa, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia 08:56 Efficacy and Safety of Abciximab in Conjunction with Aspirin, Heparin and Clopidogrel in High Risk Indian Patients Undergoing Percutaneous Coronary Intervention N. Sinha, S. Kumar, K. Parikh, P. Chandra, A. Srinivas 09:09 Safety and Efficacy of Bivalirudin in High-Risk Indian Patients Undergoing Percutaneous Coronary Intervention: The Bivaflo® Registry A. Seth, N. Sinha, K. Parikh, T. Patel, M. S. Hiremath, A. B. Mehta, P. Chandra, B. Pinto, K. K. Sethi, S. Kumar 09:22

Bleeding during warfarin therapy: an alert to concomitant diseases P. L. Lavitola, G. Spina, F. Tarasoutchi, R. O. Sampaio, M. Grinberg

09:35 Traditional cardiovascular risk factors in unselected patients with acute myocardial infarction – impact on short-term mortality Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky 09:48 Interaction between inflammation, glucose plasma levels and left ventricular function in postmenopausal women with coronary arterial disease U. Rushentsova, Y. Ekimova Ac u t e co r o n ar y s y n dr o m e s a n d P TCA Chairs: P. Gabriel Steg (FRANCE), Hita Alejandro (ARGENTINA)

Tigris - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session

08:30 Time to reperfusion and myocardial salvage achievement in Primary PCI J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, G. Gigena, B. Federico, A. Alonso, R. Sarmiento, R. Blanco, R. Neme, L. Vidal 08:43

Brazilian Registry of Acute Coronary Syndromes L. Piegas, H. Guimarães, A. Avezum, H. Reis, A. Muniz, E. Santos, M. Knobel, I. Santos, L. Ritt, J. Braga

08:56

Factors That Impact The Door-To-Electrocardiogram Time In Patients With Acute Myocardial Infarction A. Correa, M. Makdisse, V. F. Oliveira, L. M. A. Forlenza, R. B. Magaldi, L. F. Lisboa, M. Vaidotas, M. Knobel, E. Knobel

09:09 Patients undergoing rescue PCI with selective drug-eluting stent use can achieve similar mortalities to primary PCI, and low rates of target vessel revascularisation Q. Lo, V. Hsieh, N. Wouters, R. Van Der Vijver, D. Tobing, A. Hopkins, S. Lo, D. Leung, C. Juergens, J. French 09:22 ST segment resolution after a successful PTCA: clinical and angiographic associated factors R. Blanco, J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, S. Affatato, G. Gigena, F. Blanco, R. Sarmiento, A. Rodriguez, L. Vidal 09:35

Predictors for lack of reperfusion after primary angioplasty in ST-elevation acute myocardial infarction F. Cura, A. Garcia Escudero, M. Trivi, M. Albertal, J. Thierer, P. Perez Baliño, L. Padilla, J. Belardi

09:48

Prognosis of acute myocardial infarction in the elderly in Chile from 1993 to 2006 F. Lanas, J. C. Prieto, C. Nazzal, P. Seron, P. Campos, J. Bartolucci, R. Corvalan, Gemi Group

Wednesday, 21 May 2008 Wom e n a n d co r o n a r y d i s e a s e Chairs: Masotti Mónica (SPAIN), Rodolfo Pizarro (ARGENTINA)

Se ine - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session

08:30 Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery disease, a WENBIT substudy Ø. Bleie, E. Strand, P. M. Ueland, S. E. Vollset, H. Refsum, J. Igland, J. E. Nordrehaug, O. Nygård 08:43 Prognostic Value Of Myocardial Perfusion Defects With Cold Pressor Testing As An Indicator Of Endothelial Dysfunction In Asymptomatic Moderate Risk Patients.Paradigma Multicenter Study N. Perez Baliño, S. Traverso, L. Grynberg, M. Redruello, N. Maciel, C. Rapallo, D. Rosa, L. Vidal, J. Gagliardi, O. Masoli 08:56 Atorvastatin Improved Endothelial Dysfunction To Supranormal Level After 9 Months Of Treatment In Familial Hypercholesterolaemia Patients A. Rapaee, H. Nawawi, K. Yusoff 09:09

Flow mediated vasodilation in women at risk for preeclampsia F. A. Casas, H. A. Avaca, C. R. Majul, B. Lopez Ledesma, O. D. Manuale, G. M. Ferrari

09:22

Effects of Long-Term Estrogen Replacement Therapy in Postmenopausal Women with Coronary Risk Factors R. Campisi, T. H. Schindler, J. O. Prior, X. L. Zhang, D. Dorsey, H. R. Schelbert

09:35 Endothelial Dysfunction in dyslipidemia: pre and post-treatment assessment using 64-multislice PET/CT, C Reactive Protein and Lipid Profile E. Alexanderson, G. Alexanderson, L. García-Rojas, M. Rodríguez, P. A. Lamothe, J. A. Talayero, J. G. Juárez-Rojas, H. Rodríguez-Zanella, J. Almada, A. Meave 09:48 Ultrafiltration To Remove Inflammatory Mediators During Cardiopulmonary Bypass In Coronary Artery Bypass Graft Surgery O. Petrucci, N. Antunes, P. P. M. Oliveira, C. Kosour, M. H. S. L. Blotta, D. M. Braile, R. W. Vieira

Scientific Programme / 133

Wednesday, 21 May 2008 Nige r - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session TC Sca n , a rr hytm ia s a n d or thos t at ic hypot e ns ion Chairs: Dubner Sergio (ARGENTINA), Nabil El-Sheriff(UNITED STATES) 08:30 Mutation screening of PKP2 gene in severe form of arrhythmogenic right ventricular cardiomyopathy in Polish population E.K. Wlodarska, G. Beffagna, O. Wozniak, E. Czarnowska, C. Basso, K. Pilichou, P. Hoffman, G. Thiene, G. A. Danieli, A. Rampazzo 08:43 Noncalcified Coronary Plaques Evaluated by 64 Slice Computed Tomography in Patients With Low Risk for Coronary Artery Disease A. Bayol, J. Vallejos, R. Peloso, J. Mazucco, R. Obregon, M. Romero, W. Harvey, R. Gonzalez, A. Zarza, J. Parras 08:56 Diagnostic Accuracy of 64-Slice Computed Tomography To Identify Coronary Artery Disease. A Single Center Comparison with Invasive Coronary Angiography L. Lasave, E. Picabea, F. Kozak, A. Damonte, M. Rossi, C. Bonini, E. Arias, M. Gamen, A. Dauria, R. Villavicencio 09:09

Influence of paroxysm of atrial fibrillation on the left atrial and left ventricular functional parameters L. Tunyan

09:22 The significance of short time Poincare plot analysis in assessment of sudden cardiac death risk in patients with alcoholic liver disease B. M. Branislav Milovanovic, N. M. Nikola Milinic, M. K Mirjana Krotin, B. F. Branka Filipovic, V. B Vesna Bisenic 09:35

Association Between Orthostatic Hypotension And Results Of The Head-Up Tilt Table Testing L. Smidt, M. Morais, J. Barbisan, C. Nicoletti, L. Biason, J. Paiva

09:48

Circulatory variables related to the clinical syndrome of Postural Orthostatic Hypotension C. Podoleanu, R. Maggi, M. Brignole, D. Podoleanu, E. Carasca, K. Orban, I. Craciunescu, C. Ginghina

Wednesday, 21 May 2008 R hine - Ye llow P avillion - 0 8 :3 0 - 10: 00 Oral abstract session ICD a n d p a c e make r s Chairs: Luis Alcocer (MEXICO), Jorge Gonzalez ZUelgaray (ARGENTINA)  08:30 Clinical value of a simple RR interval holter monitoring as a predictor of life-threatening arrhythmias in patients with defibrillator discharge. M. Lewandowski, H. Szwed, I. Kowalik. 08:41

Identification of patients who benefit from implantable cardioverter defibrillators (ICDs) by combining the genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1 receptor (AT1R) L. Woie, L. Wee, H. Vefring, J. T. Kvaløy, D. W. T. Nilsen.

08:52

 on-pharmacological prevention of atrial fibrillation after off-pump CABG: temporary atrial external stimulation N F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza.

09:03 T  he Successful Use of Extracorporeal Membrane Oxygenation and Drotrecogin alfa in Patients with Acute Life Threatening Myocarditis T. Tsai, S. Tsao, Y. Wu, J. Yu, K. Chan, K. Ueng, H. Wong, Y. Sun, S. Huang. 09:14 Effectiveness and Feasibility of a Transtelephonic Monitoring Program A. Baranchuk, D. Campbell, K. Stuart, W. Hopman, J. McMillan, K. Aldworth-Gaumond, R. Witjes, D. Clark, D. P. Redfearn, C. S. Simpson. 09:25 Biventricular Pacing Using Conventional Dual-Chamber Pacemakers in Patients with Permanent Atrial Fibrillation and Heart Block S. Pinski, B. Kuo, F. Arnaldo, M. Helguera. 09:36 Where Are The Left Ventricular Leads Really Implanted? A Study of 90 Consecutive Patients C. D'Ivernois, J. Lesage, A. Lagrange, P. Blanc.     09:47 Antiarrhythmic effect of H1-histamine receptors blocker – Phencarol O. N. Uchevatkina, L. M. Makarov, L. A. Balykova, V. N. Komolyatova, V. P. Balashov. 

Scientific Programme / 135

Wednesday, 21 May 2008 Euphrat e s - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract session Card i o m y opa t h i e s Chairs: Eduardo Moreyra (ARGENTINA), Hector Delgado Osorio (PUERTO RICO) 08:30

Surgical treatment of primary dilated cardiomyopathy (the role of endomyocardial biopsy analysis) M. Zorc, D. Petroviè, R. Zorc-Pleskoviè, A. Pleskoviè, N. Radovanoviæ

08:43 New insight into the pathogenesis of the hypertrophic cardiomyopathy: benign tumour secreting inappropriately high amount of BNP during stress N. Nranyan 08:56 Short and long term follow-up of patients with hypertrophic cardiomyopathy treated with percutaneous alcohol septal myocardial ablation L. A. Malek, M. Klopotowski, L. Chojnowska, M. Demkow, A. Witkowski, M. Dabrowski, B. Kusmierczyk, M. Konka, R. Maczynska, W. Ruzyllo 09:09

Seven years follow-up of metoprolol for treatment of dilated cardiomyopathy S. Xue

09:22 Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Ultra-Low Dose of Alcohol (1 ml) is Still Effective J. Veselka, D. Zemánek, P. Tomašov, R. Duchoňová, K. Linhartová 09:35 Echocardiographic And Pathological Assessment Of Cardiac Myxomas: A 14-Year Retrospective Review. T. F. Cianciulli, L. A. Cosarinsky, J. A. Lax, M. C. Saccheri, J. A. Gagliardi, H. J. Redruello, S. D. Llanos Dethinne, S. Fandiño Lound, C. E. Parisi, L. A. Vidal 09:48 Value of real-time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Comparison with two-dimensional echocardiography and magnetic resonance imaging. L. Bicudo, J. Tsutsui, A. Shiozaki, C. Rochitte, E. Arteaga, C. Mady, W. Mathias Mis s ouri - Ye llow P avillion - 0 8 :3 0- 10: 00  Oral abstract session Kid n e y a n d he a r t f ail ur e Chairs: Daniel Nul (ARGENTINA), Barry Massie (UNITED STATES)  08:30 Kidney-Heart Connection: Cardiac Fibrosis and Differential Ventricular Gene Profiles after One Kidney Nephrectomy in the Absence of Heart Failure F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett. 08:45 Experimental Diabetic State Attenuated Left Ventricular Dysfunction after Myocardial Infarction B. Rodrigues, A. Medeiros, G. Orsi Candido, K. Teodoro Rosa, R. Nitrosi De La Fuente, P. Chakur Brum, K. De Angelis, M. C. Irigoyen. 09:00 Influence of glomerular filtration rate and age in the accuracy of Brain Natriuretic Peptide B. Fabricio, L. Armini, J. Kezen, S. Gomes Jr., F. Alvim, P. P. Sampaio, I. Gotlib, J. Mansur. 09:15 High serum adiponectin as a marker of severity and bad prognosis in systolic heart failure J. Thierer, A. Acosta, N. Vainstein, J. Marino, A. Hirchson Prado, M. Sultan, A. Francesia, M. Sutton, L. Boero, F. Brites. 09:30 Left atrial size and prognosis in patients with heart failure. An individual patient meta-analysis study of longitudinal data (MeRGE Heart Failure) A. Rossi, M. Quintana, P. L. Temporelli, G. Hillis, N. A. Marsan, D. Prior, C. Yu, K. Poppe, R. Doughty, G. Whalley. 09:45 C  omparison of prognostic value of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide levels in patients with different functional classes of chronic systolic heart failure A. B. Nargizyan, L. R. Tumasyan, K. G. Adamyan.

Wednesday, 21 May 2008

Hyp e rt e n s i o n a n d o t h e r ri s k f ac tor s Chairs: Wistremundo Dones (PUERTO RICO)

Or inoco - Ochre P avillion - 0 8 :3 0 - 10: 00 Oral abstract session

08:30 Cardiovascular autonomic control improvement induced by exercise training in an experimental model of menopause associated with Dyslipidemia M. Heeren, C. Mostarda, J. Paulini, K. Flues, L. De Souza, E. Moreira, M. C. Irigoyen, K. De Angelis 08:43

Impact of Age-related Elongation of the Aorta on Pulse Wave Velocity Measurement J. Sugawara, K. Hayashi, T. Yokoi, H. Tanaka

08:56

Atrial Fibrillation And Isolated Systolic Hypertension: The Shep And Shep-X Study T. Vagaonescu, A. C. Wilson, J. B. Kostis

09:09

The use of oscillometric blood pressure devices in children for fieldwork in resource poor settings J. J. Miranda, S. Stanojevic, A. Bernabe-Ortiz, R. H. Gilman, L. Smeeth

09:22 Rho Kinase Inhibition Reduces Blood Pressure And Activates The Vasodilator Pathway Of The Renin Angiotensin System In The Aortic Wall Of Hypertensive Rats. M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad 09:35 Impact of combined hypertension and dyslipidemia on risk of coronary heart disease events in the elderly: the Cardiovascular Health Study N. D. Wong, V. A. Lopez, R. Tracy, D. Yanez, L. Kuller, G. Burke, C. Roberts, H. Solomon, B. Psaty 09:48

Heart Rate Recovery After Mental Stress Test Is Impaired In Healthy Relatives Of Hypertensive Patients A. Nobrega, A. Coimbra, M. Magalhaes, R. Castro, P. Silva, S. Pedrosa

Nile - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Hyp e r t e n si o n and s ub c l in ic a l at he ros cle ros is Chairs: Alberto Lorenzatti (ARGENTINA), Protasio Da Luz (BRAZIL) 08:30

Cardiovascular Morbimortality in End Stage Renal Disease patients: Effect of Spironolactone D. Gainza, S. Kunstmann, E. Marusic, A. Vukusich, L. Michea, C. Varela, D. Sepulveda, S. Bravo

08:43

Salt reduction in processed foods to reduce population sodium consumption D. Ferrante, B. Linetzky, M. Virgolini, N. Apro

08:56 Prevalence, and smoking behaviour among university students, and the impact of medical education in their attitudes, towards tobacco control in Chile. J. A. De Grazia, D. Faivovich, F. Falcón, R. Díaz, G. Yentzen, Maria Teresa Lira, S. Kunstmann 09:09 Is there an association between impaired clock drawing test and hypertension in ambulatory communitydwelling elderly? M. Schapira, M. Bellomo, J. Benchimol, M. Bechelli, S. Maggi, J. Pollan, M. Perazzoli, D. Seinhart, L. Cámera 09:22 Impact of obesity and overweight on left ventricle mass, systolic and diastolic function in children and adolescents I. Schusterova, J. Saligova, L. Potocnakova, M. Kuchta, I. Riecansky 09:35 The Relationship of Adiponectin to C-Reactive Protein Levels, Anthropometric Parameters of Obesity and Subclinical Atherosclerosis in Children P. Arnaiz, M. Acevedo, S. Barja, M. Aglony, B. Guzman, B. Cassis, J. Carvajal, M. Moreno, X. Berrios 09:48 The Impact of Age on the Identification of Pre-clinical Atherosclerosis by Screening Vascular Ultrasound (WITHDRAWN)

J. Postley

Scientific Programme / 137

Wednesday, 21 May 2008 Mis s is s ippi - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session Exe rci se a n d a u tonom ic ne r vous s ys t e m Chairs: José Spolidoro (ARGENTINA), Eduardo Rivas Estany (CUBA) 08:30 Strength And Flexibility Measurement In Patients In Phase II Cardiovascular Rehabilitation S. Kerbage Soraya, Gallucci Emilce, Angelino Arnaldo, Brion Graciela, Morozovsky Veronica, Burgos Sebastian, Diaz Lidia, Castañeda Luis, Roberto Peidro, Lirio Carlos 08:43 Exercise-induced cardiopulmonary reflex increase is related to autonomic improvement in spontaneously hypertensive rats I. C. M. Silva, R. N. De La Fuente, K. Flues, C. Mostarda, K. De Angelis, M. C. Irigoyen 08:56

Carotid Chemoreceptors And Antihypertensive Agents D. R. Grana, R. Guerri Guttenberg, N. Paglia, F. Azzato, J. E. Toblli, J. Milei

09:09 An Integrative Evaluation Of Vascular Structure And Function In Patients With Essential Hypertension. Early Detection Of Subclinical Vascular Disease. P. Forcada, C. Kotliar, C. D´amico, J. Guerrieri, G. Millet, S. Obregon, O. Montaña, C. Schulte, A. Hita, D. Turri 09:22

Resistance arm exercise with vascular occlusion acutely improves recovery calf blood flow in older subjects P. J. C. Vieira, G. R. Chiappa, C. N. Alves, R.S. Moraes, R. Stein, J. P. Ribeiro

09:35 Effects of an acute inspiratory muscle training session on haemodynamic control of patients with heart failure and inspiratory muscle weakness. P. Mello, S. Borile, M. C. Irigoyen, G. M. Guerra, C. E. Negrão, MU P.B.Rondon, P. Dall´ago, E. Moacyr Krieger, F. M. Consolim-Colombo 09:48 Recovery Of Heart Rate Variability And Baroreflex Sensitivity After Maximal Exercise Is Correlated To Exercise Capacity A. Nobrega, P. Soares, K. Bousquet-Santos, L. Protasio, J. Figueiredo, E. Silva Junior, M. Souza Yangt z e - Ochre P avillion - 0 8 :3 0- 10: 00 Oral abstract session Soc i a l a n d em o tional f a c tor s in he art dis e as e Chairs: Carlos Tajer (ARGENTINA), Angelique Schiffer (NETHERLANDS) 08:30 Substantial Gaps in Myocardial Infarction Care and Outcomes Across Socioeconomic Groups in the Contemporary Era of Evidence-Based Medicine M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, C. Patterson 08:43

Burnout syndrome, perceived stress and depression in cardiology residents S. Waldman, J. C. Lopez Diez, B. Linetzky, H. Cohen Arazi, S. Guinjoan, H. Grancelli

08:56 10 years investigation of influence of depression on myocardial infarction risk in the population of men of 25-64 years old in Russia: epidemiological views V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova 09:09

Association between Depression, Anxiety and Quality of Life In Post Acute Myocardial Infarction Patients C. Lemos, C. Gottschall, L. Smidt

09:22

High Rates of Depression and Cardiovascular Risk Factors in Rural Mexico L. A. Temming, K. A. Olson, C. R. Clover, B. D. Skinner, S. C. Clark, A. Krishnarao, S. M. Skinner, M. G. Cohen

09:35 Effects of geographical area of residence & deprivation on access to coronary angiography and on mortality after acute myocardial infarction in Quebec, Canada C. B. Claudia Blais, D. H. Denis Hamel 09:48 Alarming Prevalence of Metabolic Risk for Cardiovascular Diseases in a Physician Population of Southern India A. Mathavan, A. Chockalingam, S. Chockalingam, B. Bilchik, V. Saini

Wednesday, 21 May 2008 Cell t h er a py Chairs: Jorge Trainini (ARGENTINA)

Tib e r - Ye llow P avillion - 0 8 :3 0- 10: 00 Oral abstract session

08:30 Mononuclear Stem Cells Implant In Chronic Ischemic Cardiomyopathy J. C. Trainini, N. Lago, J. Bordone, J. C. Chachques, J. De Paz, O. Masoli, C. Collaud, A. Christen, J. C. Barisani, J. Mouras 08:43 Sustained clinical improvement after Autologous Bone Marrow Mononuclear Cell Transplantation (ABMMC) in Humans With Severe Ischemic Heart Failure- Four years follow up H. Dohmann, A. Haddad, R. C. Moreira, S. A. Silva, F. A. Tuche, J. A. Assad, R. Verney, C. M. Rutherford, A. S. Souza, R. Borojevick 08:56 Mesothelial Cells Transplantation For Myocardial Vascularization And Regeneration M. Cortes Morichetti, B. Bourahla, O. Meilhac, I. Elmadbouh, E. Chachques, A. Carpentier, J. B. Michel, J. C. Chachques 09:09

Cellular Therapy In Cardiology: Analysis of Research at the Last 10 Years G. Carvalho, A. Silva, P. Mota, P. Silva, L. Campos, D. Santoro, T. Guimarães, A. Câmara, R. Barreiro Filho, V. Lima

09:22

Bioartificial matrix and bone marrow stem cells in ischemic cardiomyopathy J. Trainini, N. Lago, J. L. Barisani, A. Christen, J. Mouras, G. Ruiz Deza, M. Redruello, O. Masoli, S. Chada, J. Bordone

09:35 Combining Granulocyte Colony-Stimulating Factor Treatment With Cellular Cardiomyoplasty induces Myocardial Regeneration In Patients With Acute Or Chronic Ischaemic Heart Disease J. Senior Sanchez, C. Saldarriaga, F. Cuellar, O. Velásquez, J. Gomez, J. Delgado, G. Blanco, C. Navas, F. Jaimes 09:48

Intracoronary Bone Marrow Stem Cell Transplantation: Feasibility, Safety, And Effect On Ventricular Function And Myocardial Perfusion In Chronic Myocardial Infarction Patients. Recuperar Study. L. Grynberg, N. Perez Baliño, M. Riccitelli, J. Dupont, R. Caccione, S. Traverso, M. Redruello, J. Szarfer, O. Masoli, L. Vidal

Scientific Programme / 139

Wednesday, 21 May 2008 Danub e - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session Exp e r i m e n t a l and c l in ic a l int erve nt ions wit h cardiovas cular ce lls Chairs: Juan Carlos Chachques (FRANCE), Kwang Koh (KOREA, REPUBLIC OF) 08:30

Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System K. Stangl, H. Dreger, M. Fechner, G. Baumann, V. Stangl, S. Meiners

08:43

 rogressive Ventricular Remodeling Occurring After Alcohol Septal Ablation In Severely Symptomatic P Patients With Hypertrophic Obstructive Cardiomyopathy Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Jairo Alves Pinheiro Jr., Vera Marcia Lopes Gimenes, Creso Benedito Conceição Oliveira, Mercedes Maldonado Andrade, Amanda Moraes R. Sousa, Jose Eduardo Mr Sousa, Adib Domingos Jatene

08:56

Physiologic cardiac hypertrophy : impact of its development upon a model of pathologic hypertrophy I. Ennis, M. B. Nolly, O. A. Pinilla, C. D. Garciarena, V. B. Carranza, M. R. Piaggio, E. M. Escudero, H. E. Cingolani

09:09 Time Course of Angiogenesis, Arteriogenesis and Peripheral Conductance After Plasmid VEGF Delivery in Rat Model of Hind Limb Ischemia S. Mishra, S. S. Chauhan, S. K. Maulik, R. Ray, S. Sharma, S. C. Manchanda, V. K. Bahl 09:22

 ransendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter, T Two Year Follow-up in an Open-Label, Non-Randomized, Pilot Study (the TABMMI study) L. M. De La Fuente, S. H. Stertzer, E. Peñaloza, J. Argentieri, J. Miano, B. Koziner, C. Bilos, L. Battaglia, J. Stertzer, P. A. Altman

09:35 Reduction of cardiac output: diagnosis of nursing in patients with cardiomyopathy wide undergone cell therapy A. Camara, A. Silva, D. Santoro, G. Carvalho, L. Campos, P. Silva, P. Mota, T. Guimarães, V. Lima, R. Barreiro Filho 09:48 Cardiac 123I-MIBG Scintigraphy in a Chagasic Patient: Alterations induced by intracoronary injection of autologous bone marrow mononuclear cells L. M. B. Fonseca, S. S. Xavier, R. S. L. Lima, P. H. C. Castro, R. C. S. Goldenberg, M. C. Landermann, B. Gutfilen, R. C. Pedrosa, A. Hasslocher-Moreno, A. C. Campos De Carvalho

Wednesday, 21 May 2008 Huang He - Yello w Pavillion - 08:30 -10:00 Oral abstract session MR I a n d C T sc an Chairs: Marcelo Goldstein (BELGIUM), Campanelli Hugo (ARGENTINA) 08:30

Evaluation of Pulmonary Vein anomalies by Cardiovascular Magnetic Resonance A. Ithuralde, J. P. Gallo, J. Moltedo, C. Seara, P. Garcia De Lucis, C. Nojec, M. Ithuralde

08:43 Detection of Myocardial Fibrosis by Cardiovascular Magnetic Resonance Imaging in Patients with Chagas’ Disease: Correlation with Clinical Presentation and Risk Stratification M. Uellendahl, D. Sobral Filho, C. Ribeiro, S. Martins, W. Oliveira Jr., C. Medeiros, C. Rochitte 08:56

Diagnostic accuracy of 64-row Gadolinium-enhanced CT coronary angiography P. Carrascosa, A. Deviggiano, C. Capuñay, M. Bettinotti, A. Goldsmit, J. Carrascosa, M. Garcia

09:09

Steep learning curve of exclusion significant coronary stenosis with DSCT coronary angiography assessment T. Adla, J. Neuwirth, J. Veselka, R. Duchonova, L. Martinkovicova, V. Suchanek

09:22 The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients with Chronic Kidney Disease Undergoing Abdominal Computed Tomography C. M. Erley, H. S. Henrik S., S. K. Morcos, L. Grazioli, Z. Ni, L. Romano 09:35 Multidetector CT coronary angiography: Importance of the previous appointment for the management of the heart rate in our daily practice. P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa 09:48 Clinical Characteristics and stress tests results of the patients derived to our centre for a CT coronary angiography: The real world. P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa P ilcomayo - Yello w Pavillion - 08:30-10:00 Oral abstract session Inte r v e n t i o n s and c ar d ia c ul t r as ound Chairs: Roxana Campisi (ARGENTINA), Sharaf Abd El Rahman Abd El Gawad Sharaf (EGYPT) 08:30

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events N. D. Wong, H. Gransar, J. Narula, L. J. Shaw, D. Polk, J. Moon, L. Miranda-Peats, D. S. Berman

08:43 Long-term results and factors influencing outcome of subclavian and innominate artery angioplasty T. Przewlocki, A. Kablak-Ziembicka, P. Pieniazek, P. Musialek, A. Kozanecki, I. Stopa, A. Roslawiecka, D. Rzeznik, K. Zmudka, W. Tracz 08:56

Anomalies In The Origin Of Coronary Artery In Chile. Frequency In 10.000 Consecutive Angiographies. H. Ugalde, A. Ramirez, D. Ugalde, F. Ayala, S. Garcia, G. Dussaillant, A. Silva, E. Farias

09:09

Color Doppler Echocardiography Guided Transradial Coronary Interventions S. Chugh, R. Kasliwal, N. Trehan

09:22 Relationship between carotid intima-media thickness and atherosclerotic renal artery stenosis in hypertensive patients. S. Chain, H. Luciardi, G. Feldman, A. Breitgand, S. Berman, J. Ochoa, E. Escudero 09:35 Endothelium dysfunction assessment with high-resolution ultrasound in patients with impaired left ventricle function O. Savenko, V. Vikentyev 09:48 Kinking and coiling of the carotid arteries: Embryiogenic or acquired? A study by color Doppler ultrasonography. R. Beigelman, A. Izaguirre, M. Robles, D. R. Grana, G. Ambrosio, J. Milei

Scientific Programme / 141

Wednesday, 21 May 2008 Gange s - Gr e e n P avillion - 0 8 :3 0- 10: 00 Oral abstract session Ins i d e t h e a r t er y , i n s i d e t h e pl aque Chairs: Daniel Berrocal(ARGENTINA), Igor Palacios (UNITED STATES) 08:30 Intravascular Ultrasound Assessment of Sirolimus-eluting or Paclitaxel-eluting Stent Expansion in Diabetic Patients. L. O. Jensen, M. Maeng, G. S. Mintz, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen, P. Thayssen 08:43

Safety and feasibility of same day discharge after Percutaneous Coronary Intervention using left radial access S. Chugh, S. Chugh, R. Kasliwal, N. Trehan

08:56

Contrast-Induced Nephropathy (CIN) During PCI or Angiography in Patients at the Highest Risk A. E. Moreyra, J. Reiner, C. Staniloae, S. K. Sharma, R. E. Katholi, R. J. Solomon

09:09

Are drug eluting stents an attractive strategy to treat the diffuse in-stent restenosis? O. Carlevaro, S. Centeno, L. De Candido, H. Maffeo, R. Kevorkian

09:22

Effect of the Stent Design Properties on Restenosis in Stented Human Coronary Artery V. Dehlaghi, S. Najarian, M. Tafazzoli-Shadpour, A. Rai

09:35 The value of invasive functional parameters in prediction of restenosis in patients with previous myocardial infarction B. Beleslin, M. Ostojic, A. Djordjevic-Dikic, V. Vukcevic, S. Stojkovic, M. Nedeljkovic, D. Orlic, G Stankovic, V. Giga, J. Stepanovic 09:48

Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study Ø. Bleie, E. Strand, K. H. Løland, P. M. Ueland, S. E. Vollset, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. Nygård

Volga - Y ellow Pavillion - 08:30-10:00 Oral abstract session Co r o n a r y a n d non c o r onar y e n dovas cular t re at me nt II Chairs: Carlos Mendiz (ARGENTINA), Alexander Abizaid (BRAZIL) 08:30

Biodegradable Synthetic Small Calibre Vascular Prostheses: Potential as Coronary Bypass Grafts (WITHDRAWN) B. Walpoth, M. Cikirikcioglu, D. Mugnai, J. C. Tille, E. Pektok, A. Kalangos, G. Bowlin

08:43 Impact of glycemic control on postoperative complications in type II diabetic patients undergoing elective coronary bypass surgery. M. Santos, D. Lowenstein, H. Sanabria, A. Ciccale Smit, R. Favaloro, E. Gabe 08:56 Expiratory positive airway pressure associated with incentive spirometry reduces pulmonary complications and improves functional capacity in patients undergoing coronary artery bypass graft surgery P. Dall'Ago, M. P. Haefner, G. M. Ferreira, S. S. M. Barreto 09:09

Prognostic impact of early asymptomatic coronary graft stenosis or occlusion A. De Lorenzo, M. S. Felix, C. C. Zeno, F. J. M. Pittela, A. S. C. Rocha

09:22

Early and late clinical outcomes after off pump are better than after on pump coronary surgery? J. M. Vrancic, J. Thierer, F. Piccinini, G. Vaccarino, H. Raich, S. Florit, D. Navia

09:35

New Technology: Valvuloplasties with Biodegradable Rings R. Neirotti, M. Cikirikcioglu, A. Kalangos

09:48 Midterm Outcomes After Aortic Valve Replacement With Homograft Implantation. H. J. Redruello, T. F. Cianciulli, M. L. Talavera, J. A. Lax, M. C. Saccheri, R. Blanco, H. A. Prezioso, V. P. Picone, O. A. Schwint, H. Vogelfang

Wednesday, 21 May 2008

Thame s - Yello w Pavillion - 08:30 -10:00

Ex pe ri e nc e s w i t h h i g h r i s k p a t i e nts II Chairs: Carlos Macaya (SPAIN), Alejandro Palacios (ARGENTINA) 08:30

Percutaneous Left Ventricular Assist in Ischaemic Cardiac Arrest V. Tuseth, M. Salem, R. Pettersen, S. Rotevatn, K. Grong, J. E. Nordrehaug

08:52

Open vs. Close Cells Stent Designs in Carotid Angioplasty. G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia

09:14

Percutaneous Mitral Valvuloplasty during Pregnancy H. M. Pham, H. L. Nguyen, Q. N. Nguyen, O. N. Pham, L. D. Do, V. L. Nguyen, K. G. Pham

09:36

Carotid artery stenting with neuroembolic cerebral protection filter vs endarterectomy . Long term follow-up. B. Tedeschi, A. Tedeschi, B. Gonçalves, M. De Sena, R. Peixoto

P araná - Ochre P avillion - 0 8 :3 0- 10: 00 Adv a nc e s i n n u r s i n g t op ic s Chairs: Amparo Peiró (SPAIN), José Antonio Boggiano (ARGENTINA) 08:30

Early transfer preparation for discharge patient from ICCU to a general ward. Anna Lider, Sigalit Dayan, Miroslava Yardenova, Tatyana Gopshtein, Yafim Irgo

09:00 Six minute walking test in cardiac rehabilitation: factors related to performance. M. Bustamante, V. Krämer, D. Guidi, A. Guajardo, F. Marques, F. Yañez, M. Acevedo 09:30 “Does he live to take his medications or to fish?” Values, identity, and context as determinants of compliance during heart failure A. M. Clark, N. Freyberg, L. Strain, M. Chan, R. Tsuyuki, P. Armstrong, F. A. McAlister P rev e n t i o n o f c ar d i o v a sc u l ar d isease Chairs: Herman Schargrodsky (ARGENTINA), Denise Eldemire Shearer (JAMAICA)

Amaz on - 08:30-10:00 Oral abstract session

08:30 Regional demonstration for sustained community based prevention of CVD: From North Karelia Project to North Karelia Center of Public Health V. Korpelainen, P. Puska 08:52 Consumption of fruits and vegetables in adolescents of Porto Alegre, Southern Brazil: Association with age, gender, and education S. C. Fuchs, M. A. Rieth, L. B. Moreira, R. L. Henn, M. B. Moreira, P. Stoll, F. Ghizzoni, F. D. Fuchs 09:14 EUROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and rehabilitation programme share the same smoking habits? Do they stop smoking together? C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood 09:36 Palpitations in menopausal women without structural heart disease: a cross sectional prospective study with 12 leads holter system recording E. Sclarovsky

Scientific Programme / 143

Wednesday, 21 May 2008 R io de la P lat a - R e d P avillion - 0 8 :3 0- 10: 00 Oral abstract session Pro g n o si s, M yoc ar d ia l inf arc tion and s t e nt s Chairs: Riccitelli Miguel (Argentina), Karina Rey García (Cuba) 08:30 Long-term prognosis in Mexican patients with silent myocardial ischemia: results of a cohort study with 10 years of follow-up A. Unzueta, M. A. Villasis, G. Ordoñez, N. Zamorano, F. David 08:43 Prognostic significance of N-terminal pro B-type natriuretic peptide in asymptomatic severe aortic regurgitation: Incremental value over clinical and echocardiographic variables R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, S. Tewell, J. Krauss, A. Cagide 08:56

Pseudo-aneurysm of VE - a complication of myocardial infarction E. Marum, A. Soares, M. Amoedo, M. Patricio, M. Socorro, V. Cordeiro, R. Fitaroni, R. Russo, J. Buono, H. Abensur

09:09 Patients with acute myocardial infarction receiving drug eluting stents have better survival compared to patients receiving bare metal stents. A new jersey statewide database study T. Vagaonescu, A. E. Moreyra, A. C. Wilson, N. M. Cosgrove, J. B. Kostis 09:22 Significant differential metabolic effects of atorvastatin, atorvastatin combined with amlodipine, and amlodipine therapy in hypertensive patients K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin 09:35

Low body mass index and body surface area are independently associated with aortic regurgitation M. R. Movahed, A. Martinez, R. Ebrahimi

09:48 Diagnostic usefulness and prognostic implications of tissue Doppler imaging and E/Vp ratio in patients with aortic stenosis P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide R hine - Yello w Pavillion - 10:30-12:00 Symposium At r i a l f i b r i ll a t i o n : Fr o m p a t h o genesis to pr acti ce Chairs: Rene Asenjo (CHILE), Enrique Retyk (ARGENTINA) 10:30

Mechanism of atrial fibrillation: From electrical to structural remodeling. Johannes Brachmann (GERMANY)

10:52

Rate versus rhythm control: Still a matter of discussion? Martinelli Martino (BRAZIL)

11:14

Old and new anti-arrhythmic drugs: Revised concepts Ricardo Pesce (ARGENTINA)

11:36

Antithrombotic therapy: Revised guidelines Ali Oto (TURKEY)

Wednesday, 21 May 2008

Mis s our - Yello w Pavillion - 10:30 -12:00 Symposium

Sudd e n d e a t h in hear t f a il u r e Chairs: Iglesias Ricardo (ARGENTINA), Luis Molina (MEXICO) 10:30

Epidemiology of sudden death in heart failure V. Mareev. (RUSSIAN FEDERATION)

10:52

Risk stratification for sudden death in heart failure Adrian Baranchuk(CANADA)

11:14

ICD indications in primary prevention: The arrhythmia specialists’ vision Sergio Pinski (UNITED STATES)

11:36

ICD indications in primary prevention: The clinical cardiologist specialists’ vision Hernan Doval (ARGENTINA)



Yangt z e - Och r e Pavillion - 10:30 -12:00 Symposium End o t h e l i a l fu n c tion a n d dys f u n ct ion: As s e s s me nt , t he rapy and out come Chairs: Roberto César Esper (ARGENTINA), Luis Mercado (BOLIVIA) 10:30

Biomarkers in detection of endothelial function Dimitri Tousoulis (UNITED STATES)

10:48

Methods for the non-invasive evaluation of endothelial function in humans. Jorge Vilarino (ARGENTINA)

11:06

Detection of vulnerable plaque by coronary angioscopy Kyoichi Mizuno (JAPAN)

11:24

Does correcting endothelialdysfunction make a difference? Juan Kaski (UNITED KINGDOM)

11:42

Are inflammatory markers good cardiovascular risk Peter Libby (UNITED STATES)



Or inoco - Ochre P avillion - 1 0 :3 0 - 12: 00 Debate Mana g e m e n t o f pre -hyp e r t ens io n and me t ab olic s yndrome Chairs: Leonardo Ribeiro (BRAZIL), Onen Churchill (BOTSWANA) 10:30

Statement 1: Pre-hypertension should be treated with anti-hypertensive drugs Pro: Gianfranco Parati (Milano, ITALY) Contra: Dagnovar Aristizabal (COLOMBIA)

11:15

Statement 2: Metabolic syndrome: A collection of risk factors or a true syndrome? Pro: Wahida Karmally (New York, UNITED STATES) Contra: Ricardo Horacio Rey (ARGENTINA)

Scientific Programme / 145

Wednesday, 21 May 2008 Euphrat e s - Ochre P avillion - 1 0 :3 0- 12: 00| Symposium Ma n a g e m e n t of a c u te p ul m o n a ry e mb olis m and pulmonary hype rt e ns io n Chairs: Piñeiro Daniel (ARGENTINA), Corbalan Ramon (CHILE) 10:30

Current classification and diagnostic strategies Adam Torbicki (POLAND)

10:52

Imaging and monitoring right ventricle function Miguel Gomez Sanchez (SPAIN)

11:14

Present and future in the pulmonary hypertension treatment Sergio Perrone (ARGENTINA)

11:36

Diagnostic strategy in acute pulmonary embolism Jorge Ubaldini (ARGENTINA)

P aranA - Ochre P avillion - 1 0 :3 0- 12: 00 How-to & Workshop Session Ho w t o a sse s s vent r ic ul ar dys y nchrony for R CT? Chairs: Heinrich Schelbert (UNITED STATES), Ricardo Martellotto (ARGENTINA) 10:30

How to assess ventricular-dysynchrony? Ronderos Ricardo (ARGENTINA)

11:15

How to optimise CRT? John Gorcsan III (UNITED STATES)

Nile - Yello w Pavillion - 10:30-12:00 Symposium Global risk factors for the development of coronary artery disease and stroke Chairs: Santiago García Egüez (ECUADOR), Maranhão Mario (BRAZIL) 10:30

International prevalence, recognition and treatment of CV risk factors in out-patients with atherothrombosis Deepak Bhatt (UNITED STATES)

11:00 Risk factors for the development of strokes in multiple populations Gilberto Gonzalez (UNITED STATES) 11:30 Risk factors for heart disease globally: An up-date from the Inter-Heart Study Yusuf Salim (CANADA) Tigris - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium The c h e st p ain c e n tr e: E vol ving conce pt Chairs: M. Nahir (ISRAEL), Sergio Hauad (ARGENTINA) 10:30

New injury markers Peter Libby (UNITED STATES)

10:52

The chest pain centre concept: Scientific rationale and clinical results Hugo Ramos (ARGENTINA)

11:14

Exercise testing vs. images tests Ezra Amsterdam (UNITED STATES)

11:36

What happens to patients who are descharged from the chest pain centre in the follow-up? Muntaner Juan (ARGENTINA)

Wednesday, 21 May 2008 Gange s - Gr e e n P avillion - 1 0 :3 0- 12: 00 Debate PCI i n c h r o n i c CHD ha s n o pro ven long-t e rm s afe t y and b e ne fit Chairs: Roxana Mehran (UNITED STATES), José Antonio Rodríguez (CHILE) 10:30

Statement 1: PCI in chronic CHD has no proven long-term safety and benefit Pro: Yusuf Salim (CANADA Contra: Igor Palacios (UNITED STATES)

11:15

Statement 2: Conventional risk factors control is sufficient to prevent past intervention CVD progression Pro: Spencer King III (UNITED STATES) Contra: Robert Superko

Huang He - Ye llow P avillion - 1 0 :3 0 - 12: 00 Symposium How t o u s e C T m u l t i s l ic e a n d m a gneti c r esonan ce in c linical pr acti ce? Chairs: James Moon (UNITED KINGDOM), Ricardo Baeza (CHILE) 10:30

How to implement CT multislice in the emergency department to assess patients with chest pain? Enrique Gurfinkel (ARGENTINA)

10:52

How to estimate cardiovascular risk using coronary CT multislice? Andre Ricardo Valle (BRAZIL)

11:14

Cardiovascular magnetic resonance for assessing myocardial ischaemia and viability Gustavo Avegliano (ARGENTINA)

11:36

Delayed enhancement imaging for evaluation of cardiomyopathy Scott Flamm(UNITED STATES)

P ilcomayo - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium Car d i o v a sc u l ar s a f e t y o f n o n - c ardiovas cular dr ugs Chairs: Rothlin Rodolfo (ARGENTINA), Jeffrey Borer (UNITED STATES) 10:30

Anti-cancer therapies Diego Rosso (ARGENTINA)

10:52

Erythropoietin Henry Krum (AUSTRALIA)

11:14

Antipsychotics Silvia Wikinski (ARGENTINA)

11:36

NSAIDs/Coxibs Frank Thomas Ruschitzka (SWITZERLAND)

Scientific Programme / 147

Wednesday, 21 May 2008 Mis s is s ippi - Ye llow P avillion - 1 0 :3 0- 12: 00 Symposium No v e l c e l l u la r m e c ha n is m s in c ardiac hype rt rophy and is chae mia Chairs: Kwang Koh (KOREA, REPUBLIC OF) 10:30

NHE-I and myocardial hypertrophy Ennis Irene (ARGENTINA)

10:52

Regulation of pHi in the heart Richard Vaughan-Jones (UNITED KINGDOM)

11:14

PDE-5 inhibition and NHE-I Néstor Gustavo Pérez (ARGENTINA)

11:36

UNREP effect Paolo Tucci (BRAZIL)

Volga - Yello w Pavillion - 10:30-12:00 Symposium Ad u l t co n g e n i t a l h e ar t d i s e a s e: H ot issues Chairs: Patricia Frangini (CHILE), Capelli Horacio (ARGENTINA) 10:30

Asymtomatic Patients with ASD and Moderated/ Severe Pulmonary Hypertension Alfonso Buendia-Hernandez (MEXICO)

10:52

Serious arrhythmia and sudden death after surgery Jose Moltedo (ARGENTINA)

11:14 Mistakes and Disasters in Medical Care GUCH Patients Jane Somerville (UNITED KINGDOM) 11:36

The perspective of patients Michael Landzberg (UNITED STATES)

Thame s - Yello w Pavillion - 10:30-12:00 Symposium Ad v a n c e d c o nc e p t s in cr itic al care nurs ing Chairs: Nancy Houston Miller (UNITED STATES), Marcelo Alvarez (ARGENTINA) 10:30

Advantages and disadvantages of open critical care units Nancy Bravo (ARGENTINA)

10:52

Prevalence of infections in patients post-cardiovascular surgery Stella Maimone (ARGENTINA)

11:14

Contrapulsation balloon Amparo Peiró (SPAIN)

11:36

Hemodynamic monitoring Marcela Ferrada (CHILE)

Wednesday, 21 May 2008 Me kong - Ochre P avillion - 1 0 :3 0- 12: 00 Clinical Seminar Man a g e m e n t of a c u te m yo c a r dial infarc t ion in t he 2 1 s t Ce nt ury Chairs: Conci Eduardo (ARGENTINA), Eduardo Rivas Estany (CUBA) 10:30

Epidemiology of acute myocardial infarction in the 21st century: Is it changing? Carlos Tajer (ARGENTINA)

10:52

Management of AMI in developing countries Eduardo Morales Briceño (VENEZUELA)

11:14

Significance of Q-wave in myocardial infarction in the era of cardiac magnetic resonance imaging Antoni Bayés De Luna (SPAIN)

11:36 Multi-slice computed tomography after acute myocardial infarction: Can we use this technique to establish prognosis? Michael Lim (SINGAPORE) Se ine - Gr e e n P avillion - 1 0 :3 0 - 12: 00 Symposium M et a b o l ic s y n d r o m e i n y o u t h : Is it the beginning of the c ardiovas c ular dise a se c o n t inuum ? Chairs: Gabriel D. Waisman (ARGENTINA) 10:30

Bogalusa heart study

10:52

The Rio de Janeiro study Brandao Ayrton (BRAZIL)

11:14

Risk score predictions of atherosclerotic lesions in young people: The PDAY study Wistremundo Dones (PUERTO RICO)

11:36

How early does the cardiovascular disease continuum begin? Mario Bey Lombana (PANAMA)

Danub e - Gr e e n P avillion - 1 0 :3 0- 12: 00 Symposium Ca rd i o l o g y i n m i d d l e - a n d l o w - i ncome count ries Chairs: Antonio Chagas (BRAZIL), Hassell Trevor (BARBADOS) 10:30

Prevention is better than cure Nishtar Sania (PAKISTAN)

10:52

The research perspective Reddy Srinath (INDIA)

11:14

Models of service delivery Howard Spencer (BAHAMAS)

11:36

Economic impact of cardiology services George A. Mensah (UNITED STATES)

Scientific Programme / 149

Wednesday, 21 May 2008 Amaz on - Y ellow Pavillion - 10:30-12:00 South American Congress of Cardiology T om a d e d e ci s i o n e s e n v a l v u l o patías Coordinadores: Plastino Juan A (ARGENTINA), Luis Moya (COLOMBIA) 10:30

¿Cirugía de la insuficiencia aórtica ¿Cuándo es demasiado precoz y cuándo demasiado tarde? Juan Gonzalez Moreno (URUGUAY)

10:45

¿Cuándo intervenir la estenosis aórtica asintomática? Octavio Aparicio (BOLIVIA)

11:00

La insuficiencia mitral severa con factibilidad de reparación. ¿Siempre es quirúrgica? Gustavo Restrepo (COLOMBIA)

11:15

¿Cuándo operar la insuficiencia mitral funcional? Zalaquett Ricardo (CHILE)

11:30

Procedimientos percutáneos de reparación y remplazo valvular Jose Condado (VENEZUELA)

R hine - Yello w Pavillion - 14:00-15:30 Symposium S ud d e n d e a t h Chairs: Ladislao Endrei (ARGENTINA), María José Sancho Tello (SPAIN) 14:00

Sudden cardiac death, a changing problem Ali Oto (TURKEY)

14:22

Role of pharmacological therapy to prevent sudden death Jorge Garguichevich (ARGENTINA)

14:44

Role of ICD in primary prevention of sudden cardiac death Luis Molina (MEXICO)

15:06 Role of the ICD in rare disorders Andres Caeiro (ARGENTINA) Danub e - Gr e e n P avillion - 1 4 :0 0- 15: 30 Symposium To a bl a t e o r not t o ab l a te ? Cont rove rs ial is s ue s Chairs: Pozzer Domingo (ARGENTINA), Sabine Ernst (UNITED KINGDOM) 14:00

To ablate or not to ablate in asymptomatic WPW Riccardo Cappato (ITALY)

14:22

Should atrial flutter always be ablated? Rolando Gonzalez (CHILE)

14:44

To ablate or not to ablate idiopathic ventricular tachycardia Mauricio Scanavacca (BRAZIL)

15:06

Atrial tachycardia Teruhisa Tanabe (JAPAN)

Wednesday, 21 May 2008 Mis s ouri - Ye llow P avillion - 1 4 :0 0 - 15: 30 Symposium The c a r d i o r e n a l s yn d r om e in he a rt failure Chairs: Roberto Colque (ARGENTINA), Barry Massie (UNITED STATES) 14:00 T  he cardiorenal syndrome: Pathophysiology of the crosstalk Daniel Nul (ARGENTINA)   14:22 Prognosis in patients with chronic renal failure Diego Delgado (CANADA)    14:44 Emerging therapies in acute heart failure Mihai Gheorghiade (UNITED STATES)   15:06 Continuous ambulatory Ultrafiltrations in chronic heart disease Victor Gura (UNITED STATES)   Se ine - Gr een Pavillion - 14:00 -15:30 Symposium Hae m o d y n a m i c s , hear t a n d hyp ert e ns ion Chairs: Kuschnir Emilio (ARGENTINA), Eduardo Moreyra (ARGENTINA) 14:00

The role of collagen in the development of left ventricular dysfunction Richard Devereux (UNITED STATES)

14:30

Hypertensive cardiopathy and coronary reserve. Is it always diminished? Robert Califf (UNITED STATES)

15:00

Pulse wave velocity and prognosis Gianfranco Parati (ITALY)



Mis s is s ippi - Ye llow P avillion - 1 4 :0 0 - 15: 30 Clinical Seminar Con t e m p o r a r y f ac t o r s in c ar d io logy Chairs: Horacio F. Cingolani F (ARGENTINA), Maranhão Mario (BRAZIL) 14:00

Up-date in the functions of natriuretic peptides Adolfo De Bold (CANADA)

14:18

Vascular NADPH oxidases as drug targets for novel antioxidant strategies Tj. Guzik (POLAND)

14:36

The growing role of inflammatory markers Juan Kaski (UNITED KINGDOM)

14:54

The cellular pathophysiology of oxidative stress Carlos Ferrario (UNITED STATES)

15:12

Apoptosis in myocardial ischaemia Ricardo Gelpi (ARGENTINA)

Scientific Programme / 151

Wednesday, 21 May 2008 Nige r - Gr e e n P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Wo m e n a n d c a r diovas c u l a r d is e as e Chairs: Romero Carlos (URUGUAY), Susana Zeffiro (ARGENTINA) 14:00

Explanation for the higher mortality in women Noel Bairey Merz (UNITED STATES)

14:22

Clinical presentation and differences in pathophysiology of CAD in women Judith Zilberman (ARGENTINA)

14:44

What is the best method for the non invasive investigation of CAD in my female patients? Roxana Campisi (ARGENTINA)

15:06

Are there any differences in results from revascularization between genders? Leslee Shaw (UNITED STATES) Euphrat e s - Ochr e Pavillion - 14:00-15:30 Symposium

Cha g a s d i s e a s e Chairs: Antonio Chagas (BRAZIL), Javier Bustamante (BOLIVIA) 14:00

Pathogenesis of chagas disease: Is there now a consensus? José Antônio Marin-Neto (BRAZIL)

14:18

Chagas heart disease: Clinical work up at initial presentation and prognosis Anis Rassi Jr. (BRAZIL)

14:36

Echocardiography approach for diagnosis and prognosis Ricardo Migliore (ARGENTINA)

14:54

Periodic parasitemias in the development of Chagas’ cardiomyopathy Oscar Salomone (ARGENTINA)

15:12

Antiparasitic treatments of chagas disease: An update Arturo Arribada (CHILE) Volga - Yello w Pavillion - 14:00-15:30 Symposium

Ma n a g e m e n t o f ob es ity today Chairs: Norberto Pallavicini (ARGENTINA), Gerardo Uceda (ARGENTINA) 14:00

Obesity in the Americas Luis Molinary (PUERTO RICO)

14:18

Which Diet Is Best for Obesity? Jorge Braguinsky (ARGENTINA)

14:36

Exercise for the Management of Obesity Palmira Pramparo (ARGENTINA)

14:54

Gastric bypass: patient selection and perioperative management Claudio Zin (ARGENTINA)

15:12

Central obesity or viceral obesity? Scott Grundy (UNITED STATES)

Wednesday, 21 May 2008 Me kong - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium



Sca l i n g - u p sec ondar y preve n tion Chairs: Eduardo Rivas Estany (CUBA), Álvaro Sosa Liprandi (ARGENTINA) 14:00

Lessons from prevention programs in Europe David Wood (UNITED KINGDOM)

14:22

Secondary prevention in stroke J. Fernandes (BRAZIL)

14:44

Field testing of fixed dose combinations TBD

15:06

Gaps in secondary prevention and access to essential medicines Reddy Srinath (INDIA) Thame s - Ye llow P avillion - 1 4 :0 0 - 15: 30 Symposium

Rele v a n t n u r s in g t o p ic s Chairs: Veronica Kramer (CHILE), Imelda Perdomo (ARGENTINA) 14:00

Evidences of nursing cares in cardiovascular surgery Aina Lauga (ARGENTINA)

14:22

Advances in pre-hospitalization treatment of acute coronary syndromes with ST segment elevation José Luis Araya (ARGENTINA)

14:44

Reaches and competences of nursing in catheter handling Martín Toranzo (ARGENTINA)

15:06

Handling of cardiogenic shock in a public hospital emergency ward Mabel Medina (ARGENTINA) Nile - Ye llow P avillion - 1 4 :0 0 - 15: 30 How-to & Workshop Session

How t o r e a c h a n d m a in tain LDL b e low 7 0 in v e ry h i g h r i s k p a t i e n t s Chairs: Francisco Fonseca(BRAZIL), Alberto Lorenzatti (ARGENTINA) 14:00

With mixed dyslipidemia George Steiner (CANADA)

14:45

With severe hypercholesterolemia Ada Cuevas (CHILE)

Scientific Programme / 153

Wednesday, 21 May 2008 Yangt z e - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium Str e ss e c h o c ar d io g r ap hy in d ifficult pat ie nt s Chairs: Eduardo Escudero (ARGENTINA), Horacio Vazquez (URUGUAY) 14:00

Stress echo in patients with LBBB, atrial fibrillation or left ventricular hypertrophy Manuel Pinto (CHILE)

14:22

Stress echo after heart transplant Wilson Mathias (BRAZIL)

14:44

Stress echo for aortic valvulopathy Gustavo Restrepo (COLOMBIA)

15:06

Assessment of coronary flow reserve during stress echo Jorge A. Lowenstein (ARGENTINA)

P araná - Ochre P avillion - 1 4 :0 0- 15: 30 Clinical Seminar Echo d o pp l e r a s the m a in t o o l in as s e s s ing le ft ve nt ricular funct ion Chairs: Susan Acosta Castillo (BOLIVIA), Takeshi Nakatani (JAPAN) 14:00

Global and regional systolic function: The classic and the new Miguel Quiñones (UNITED STATES)

14:22

Dyastolic ventricular function at rest and during exercise Nelson Pizzano (URUGUAY)

14:44

Role of echodoppler in the diagnosis of heart failure Mani Vannan (UNITED STATES)

15:06

Heart failure treatment based on the echocardiography findings Bjoy Khandheria (UNITED STATES) Gange s - Gr e e n P avillion - 1 4 :0 0- 15: 30 Clinical Seminar

New S t r a t e g ies f or P CI Chairs: Ricardo Sarmiento (ARGENTINA), Jose Alejandro Martinez Sepulveda (CHILE) 14:00

Stents platforms, polymers and gene therapies: Where are we? Igor Palacios (UNITED STATES)

14:22

New drugs for drug eluting stents Alexander Abizaid (BRAZIL)

14:44

New approached for bifurcation lesions: One, two or dedicated stents? Expedito Ribeiro (BRAZIL)

15:06

New non-stent devices Jorge Belardi (ARGENTINA)

Wednesday, 21 May 2008 R io de la P lat a - R e d P avillion - 1 4 :0 0- 15: 30 Symposium Pos t - g r a d u a te c a r diol ogy tr a in ing and re ce rt ificat ion Chairs: Hector Luciardi (ARGENTINA), Abel Moreyra (UNITED STATES) 14:00

The training of cardiology in developing countries Reddy Srinath (INDIA)

14:22

Sub-specialty training in cardiology Günter Breithardt (GERMANY)

14:44

Promoting international medical education Tudor Vagaonescu (UNITED STATES)

15:06

The training of a cardiac surgeon Radu Deac (ROMANIA) Or inoco - Ochre P avillion - 1 4 :0 0- 15: 30 Symposium

Man a g e m e n t of hyp e r t ens io n Chairs: Fernando Manzur Jattin (COLOMBIA), Mayosi Bongani (SOUTH AFRICA) 14:00

ACE inhibition and ARB, mechanisms of cardiovascular and renal protection: Are they the same? Oscar Carretero (UNITED STATES)

14:22

Benefits of hypertensive therapy beyond lowering blood pressure Jorge Jalil (CHILE)

14:44

Diuretics: Are they the same? Daniel Piskorz (ARGENTINA)

15:06

Choosing the right drug for the right patient or socio ethnic considerations in selection of hypertensive therapy GuilleRmo Fabregues (ARGENTINA)

Huang He - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium Tissu e d o pp l e r im aging: P r es ent and fut ure Chairs: Jorge Cachero (ARGENTINA), Ricardo Castro (ARGENTINA) 14:00

Strain 2D non-doppler for quantifying regional ventricular function Bjoy Khandheria (UNITED STATES)

14:22

Speckle tracking: A toy or a tool? Carlos Eduardo Suaide Silva (BRAZIL)

14:44

Tissue doppler imaging: A new diagnostic and prognostic tool Juan Carlos Plana (UNITED STATES)

15:06

Tissue doppler and strain rate during stress echo Miguel Bustamante-Labarta (ARGENTINA)

Scientific Programme / 155

Wednesday, 21 May 2008 P ilcomayo - Ye llow P avillion - 1 4 :0 0- 15: 30 Symposium Me d i c a l i n f o r m a tic s : App l ic a tions in cardiology Chairs: Ortego Raul (ARGENTINA), Fernán Quirós (ARGENTINA) 14:00

Clinical decision support to improve cost and quality: Valve and practical use Leslee Shaw (UNITED STATES)

14:18

Medical Informatics at Distance: Continuing Learning in Cardiology Armando Pacher (ARGENTINA)

14:36

Tele electrocardiography in Chile: Impact on the national care system Escobar Edgardo (CHILE)

14:54

Ambulatory blood pressure monitoring: Teletransmission: The Latin American experience Jose Andres Octavio (VENEZUELA)

15:12

Knowledge Translation: from data to clinical practice Alvaro Margoglis (URUGUAY)

Tib e r - Ye llow P avillion - 1 4 :0 0- 15: 30 Special Featured Joint Session SM C : I n t e r v e n tional c ar d io l o g y in adult s wit h conge nit al he art dis e ase Chairs: J. C. Linares-Casas (ARGENTINA), Carlos Zabal (MEXICO) 14:00

Patent ductus arteriosus in the adult. Interventional treatment versus surgical repair Zabal Carlos (MEXICO)

14:22

Interventioan treatment of the coarctation of the aorta in adults Alejandro Peirone (ARGENTINA)

14:44

Percutaneous closure with amplatzer device of atrial septal defects with pulmonary hypertension in adults more than 40 years old Alfonso Buendia-Hernandez (MEXICO)

15:06

Interventional cardiology in adults: State of the Art Faella Horacio (ARGENTINA)

Amaz on - Ye llow P avillion - 1 4 :0 0- 15: 30 South American Congress of Cardiology Fib r i l a c i ó n a u r ic ul ar . L o vie j o y lo nue vo. Coordinadores: Dario Sobral (BRAZIL), Ronald Cuellar (BOLIVIA) 14:00

Activación neurohormonal e inflamación en la FA Corbalan Ramon (CHILE)

14:15

¿Cómo diagnosticar y cómo tratar la FA intermitente? Alberto Giniger (ARGENTINA)

14:30

¿Cómo optimizar el control del ritmo y la frecuencia? Javier Galeano (PARAGUAY)

14:45

Prevención de la complicación embólica: ¿Cuándo y cómo? René Vicuña Mariño (ECUADOR)

15:00

Ablación con radiofrecuencia como terapia de la FA Rene Asenjo (CHILE)

Wednesday, 21 May 2008 Tigris - Ye llow P avillion - 1 4 :0 0 - 15: 30 South American Congress of Cardiology Ava n c e s e n l a in s uf ic ie n c ia c ar d iaca aguda-de s compe ns ada Coordinadores: Enrique Oropeza (BOLIVIA), Fernando Aguirre (ECUADOR) 14:00

Impacto de la descompensación en la evolución de la enfermedad Juan Cimbaro Canella (ARGENTINA)

14:15

Asistencia respiratoria no invasiva en el manejo inicial Solon Navarrete (COLOMBIA)

14:30

Estrategia actual del manejo farmacológico Fabio Vilas-Boas (BRAZIL)

14:45

¿Cómo proteger la función renal? Alberto Fernández (ARGENTINA) Thame s - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium

Nur si n g i n c a r diovas c u l a r D is e a s e Chairs: - Daniel Maggio (ARGENTINA), Virginia Argibay Pitlyk(SPAIN) 16:00

How can the Nursing Team work in the Prevent Coronary Risk Factors Monica Soto Vertchert (ARGENTINA)

16:22

Academical Formation In Cardiovascular Nursing. What is the laboral status around the world? Rosana Andreoli (ARGENTINA)

16:44

Cardiovascular Emergency: Importance of the Interrelation Doctor-Nurse in reducing Patients Morbimortality Boggiano José Antonio (ARGENTINA)

17:06

Participation of Nurses in Bioethical Committees Nancy Houston Miller (UNITED STATES)

Danub e - Gr e e n P avillion - 1 6 :0 0 - 17: 30 Clinical Seminar Up -d a t e i n a bl a tion o f ve n tr ic u lar arrhyt hmias Chairs: Ivan Mendoza (VENEZUELA), José Luis Serra (ARGENTINA) 16:00

Ventricular tachycardia: Epi- and endocardial approach Adrian Baranchuk(CANADA)

16:22

Ventricular tachycardia ablation results Teruhisa Tanabe (JAPAN)

16:44

Right & left ventricular outflow tract tachycardia Sabine Ernst (UNITED KINGDOM)

17:06

Hemodynamically stable VT Guy Fontaine (FRANCE)

Scientific Programme / 157

Wednesday, 21 May 2008 P araná - Ochre P avillion - 1 6 :0 0- 17: 30 Symposium Growing practice of non-pharmacological treatment in congestive heart failure Chairs: Barry Massie (UNITED STATES), Javier Marino (ARGENTINA) 16:00

Exercise I therapy: Application to mild to severe heart failure Ileana Piña (UNITED STATES)

16:22

Treatment of heart failure patients with central sleep apnea syndrome by nasal oxygen Shigetake Sasayama (JAPAN)

16:44

Waon Therapy : soothing warmth therapy Chuwa Tei (JAPAN)

17:06

Device monitoring of heart failure Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF)

Mis s ouri - Ye llow P avillion - 1 6 :0 0- 17: 30 Clinical Seminar Pro g n o st i c f a c tor s f o r hear t f a ilure in t he b e t ab locke r e ra: Who m u st be l is te d f or he a r t t r ans plant Chairs: Marcos Amuchastegui (ARGENTINA), Marcelo Montera (BRAZIL) 16:00

How to predict sudden death? Guillermo Bortman (ARGENTINA)

16:22

Are scores useful in advance heart failure? Nadine Clausell (BRAZIL)

16:44

Biomarkers for risk stratification Eduardo Perna (ARGENTINA)

17:06

State of the art of VO2 max exercise test Ileana Piña (UNITED STATES)

Euphrat e s - Ochre P avillion - 1 6 :0 0- 17: 30 Clinical Seminar Myo c a r d i t i s a n d dil at ed c a r diomyopat hie s : How are t he y re lat e d? Chairs: Hector Delgado Osorio (PUERTO RICO), Mitsuaki Isobe (JAPAN) 16:00

Difference in presentation timing of pregnancy-related heart failure Karen Sliwa (SOUTH AFRICA)

16:30

Characterization of post part time cardiomyopathy Carlos Dumont (ARGENTINA)

17:00

Pathogenesis of myocarditis Peter Liu (CANADA)

Wednesday, 21 May 2008 Nige r - Gr e e n P avillion - 1 6 :0 0- 17: 30 Clinical Seminar The h i g h - r i sk a s ym p t o m at ic p a tie nt wit h coronary art e ry dis e as e Chairs: Tak-Fu Tse (CHINA, PEOPLE’S REPUBLIC OF), Zeljko Reiner (CROATIA) 16:00

Clinical characteristics of high-risk asymptomatic patients with coronary artery disease Mele Eduardo (ARGENTINA)

16:22

Non-classical markers of risk in patients with asymptomatic coronary artery disease T. Omland (NORWAY)

16:44

Optimal treatment of coronary heart disease to prevent heart failure Diego Delgado (CANADA)

17:06

Dietary Lipids and Coronary Heart Disease A. Zampelas (GREECE)

Volga - Ye llow P avillion - 1 6 :0 0 - 17: 30 Clinical Seminar The c a r d i o v as c u l a r ha zar d s o f air pollut ion Chairs: Ali Oto (TURKEY), Rose Marie Robertson (UNITED STATES) 16:00

The cardiovascular effect of air pollution: the AHA scientific statement Smith Sidney (UNITED STATES)

16:22

The acute cardiovascular effects of air pollution Hermes Ilarraza-Lomeli(MEXICO)

16:44

Mechanisms of cardiovascular disease induced by air pollution: Basic science studies Shuchleib Rafael (MEXICO)

17:06

Mechanisms of cardiovascular disease induced by air pollution: Clinical science studies David Newby (UNITED KINGDOM) Nile - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium

Nut r i t i o n , d i e t a n d CVD pre vent io n Chairs: Maranhão Mario (BRAZIL), Maria Inés Somoza (ARGENTINA) 16:00

Risk factors in the developing world

16:18

Healthy life style vs. medications in CVD prevention Satyavan Sharma (INDIA)

16:36

Portofolio eating plan and antioxidants Wahida Karmally (UNITED STATES)

16:54

Red wine: Experimental and clinical basis for its recomendations Protasio Da Luz (BRAZIL)

Scientific Programme / 159

Wednesday, 21 May 2008 Me kong - Ochre P avillion - 1 6 :0 0- 17: 30 Clinical Seminar Hyp e r g l y c e mia, in f l a m m a tion a n d coronary art e ry dis e as e : New r e l a t i o n s hip s ? Chairs: Jose Sala (ARGENTINA), Corbalan Ramon (CHILE) 16:00

Hyperglycemia as a risk factor in AMI: New insights Jose Nicolau (BRAZIL)

16:30

Do biomarkers change pharmacological interventions in Stable Coronary Artery Disease? Cagide Arturo (ARGENTINA)

17:00

The role of lipids in chronic coronary disease Ada Cuevas (CHILE)

Mis s is s ippi - Ye llow P avillion - 1 6 :0 0- 17: 30 Symposium Pre v e n t i o n o f c a r diovas c u l a r d is e as e in as ympt omat ic pat ie nt s Chairs: Carlos Nijensohn (ARGENTINA), Alejandro Gómez Monroy (ARGENTINA) 16:00

The impact of policies to reduce salt consumption on cardiovascular health Hassell Trevor (BARBADOS)

16:30

Experience in developing national policy frameworks for prevention and control of CVD Herman Schargrodsky (ARGENTINA)

17:00

Cost effectiveness of cardiovascular prevention programmes Shah Ebrahim (UNITED KINGDOM)

Gange s - Gr e e n P avillion - 1 6 :0 0- 17: 30 Clinical Seminar Co m p l e x p a t ient s a n d c om p l e x de cis ions - P art t wo Chairs:C. Vozzi (ARGENTINA), Miguel Ballarino(ARGENTINA) 16:00

When do gender differences exist in patients undergoing planned PCI? Spencer King III (UNITED STATES)

16:22

When does a bifurcation lesion require more than one stent? Costantino Costantini (BRAZIL)

16:44

An old concept a new approach. Autoretroperfusion of the coronary sinus in no-option patients Jose Navia (ARGENTINA)

17:06

PCI in the diabetic patient: Outcomes for focal and diffuse disease Alexander Abizaid (BRAZIL)

Wednesday, 21 May 2008 Huang He - Ye llow P avillion - 1 6 :0 0 - 17: 30 Symposium Echo d o pp l e r in r e s ync hr o n is at i on e ra Chairs: Jesus Vargas Baron (MEXICO), Amuchastegui Luis Maria (ARGENTINA) 16:00

Left ventricular dynamics in heart failure Jeffrey Borer (UNITED STATES)

16:22

Myocardial? Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF)

16:44

Role of tissue doppler imaging in RCT Eduardo Guevara (ARGENTINA)

17:06

Myocardial syndrome assessment by 3D Bernhard Mumm (GERMANY) Or inoco - Ochre P avillion - 1 6 :0 0 - 17: 30 Symposium

Hot t o p i c s i n hyp er te n s ion Chairs: Jorge Jalil (CHILE), Fernando Peliche (ARGENTINA) 16:00

Home measurement of blood pressure: Does it work? Gianfranco Parati (ITALY)

16:18

Obstructive sleep apnea: Where are we? Luciano Drager (BRAZIL)

16:54

Silent white matter lesions, blood pressure variability and cognitive deterioration in elderly hypertensive patients Ramiro Sánchez (ARGENTINA)

17:12

Ambulatory blood pressure for all? Mario Bendersky (ARGENTINA)  Tib e r - Ye llow P avillion - 1 6 :0 0- 17: 30 Special Featured Joint Session

SB C : C o r o n a r y Ar te r y D is e a s e 2 00 8 Chairs: Antonio Chagas (BRAZIL), Faella Horacio (ARGENTINA) 16:00

Clinical approaches for treatment: drugs vs lifestyle Protasio Da Luz (BRAZIL)

16:22

The utility of inflammatory markers in the management of the disease Enrique Gurfinkel (ARGENTINA)

16:44

Current views in PCI Luiz Piva Mattos (BRAZIL)

17:06

The roll of surgical management Kalil Renato Ak (BRAZIL)

Scientific Programme / 161

Wednesday, 21 May 2008 P ilcomayo - Ye llow P avillion - 1 6 :0 0- 17: 30 How-to & Workshop Session ISC P : Upd a t e o n c urr e n t ca r d i o vasc ular r esea rch in USA and Eur ope Chairs: Jay Cohn (UNITED STATES), Antoni Bayés De Luna (SPAIN) 16:00

Strategies toward advances in research: Perspective from the US National Heart Lung and Blood Institute Marvin Konstam (UNITED STATES)

16:45

Most important clinical cardiovascular research in Europe Angeles Alonso Garcia (SPAIN)

Amaz on - Ye llow P avillion - 1 6 :0 0- 17: 30 South American Congress of Cardiology Nue v a s f r o n te r as e n l a hip e r t ens ión art e rial Coordinadores: Claudia Anchique (COLOMBIA), Masao Sano (PARAGUAY) 16:00

La reducción de la presión arterial ¿es suficiente? Felix Medina (PERU)

16:15

Hipertensión arterial en el anciano ¿Son distintos los objetivos y el tratamiento? Fernando Manzur Jattin (COLOMBIA)

16:30

¿Cómo prevenir y tratar el daño de órgano blanco? GuilleRmo Fabregues (ARGENTINA)

16:45

Objetivos terapéuticos en el paciente diabético Espinoza Jaime (PERU)

17:00 Manejo de la hipertensión arterial en el paciente con insuficiencia renal Hilton Chaves (BRAZIL)

PosterS AND ABSTRACTS Poster Listing

P1 Changing of monocyte chemoattractant protein-1 (MCP-1) in patients with type 2 diabetes mellitus and acute coronary syndrome T. Golitsyna, T. Chazova, K. Zykov.

P3 The presence of C allele for -765g>c common variant of cox-2 gene constitutes a protector factor against coronary disease in Chilean individuals L. A. Salazar, A. Hernandez, A. Cuevas, P. Jaramillo, C. Lanas, F. Lanas.

P4 Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads N. Kucukarslan, A. Kirilmaz, E. Ulusoy, M. Yokusoglu, N. Gramatnikovski, E. Ozal, H. Tatar .

P5

Is allen test safe for radial artery graft in cabg surgery? N. Kucukarslan, E. Ozal, E. Kuralay, M. Arslan, H. Tatar .

P6 Two factors effecting the morbidity and mortality in surgery of vascular injuries due to gunshot: Missed arterial injury, ignored vein repair N. Kucukarslan, B. Oz, E. Ozal, V. Yildirim, M Sahin, H. Tatar . P7 Atherothrombotic risk factors correspond to the appearance of internal inflammation and erythrocyte adhesiveness/aggregation in the peripheral blood I. Shapira, O. Rogowski, D. Zeltser, S. Berliner . P8 Low grade inflammation in individuals with the hypertriglyceridemic waist phenotype. Another feature of this atherogenic dysmetabolism I. Shapira, O. Rogowski, S. Toker, S. Melamed, A. Shirom, S. Berliner . P9 Liver enzymes and inflammation - sensitive biomarkers. Relevance for apparently healthy individuals and those with atherothrombotic risk I. Shapira, O. Rogowski, R. Oren, S. Berliner . P10 Effects of Efferent Sympathetic Nerve Stimulation on Ischemia-Induced Ventricular Arrhythmias by Modulating Connexin43 Protein in Rats X. R. Hu, H. Jiang, Z. B. Lu, H. Z. Wen, M. Ghias, D. D. Zhao, Q. Z. Tang, C. X. Huang. P11 Communication Devices Produce Electromagnetic Interference on ECG machines: Does it really matter? A. Baranchuk, J. Kang, C. Shaw, D. Campbell, H. Alanazi, W. Hopman, D. P. Redfearn, C. S. Simpson.

Scientific Programme / 163

PosterS AND ABSTRACTS Poster Listing

P12 Prognosis of heart rate control on decompensated heart failure patients. G. P. Aroutunov, Professor, A. G. Aroutunov, A. L. Volkova, N. A. Bylova.

P15 Determination of Vascular Wall Shear Stress by High-Resolution Ultrasound as a Method of Assessment of Endothelium-Dependent Vasodilatation in Patients with Arterial Hypertension A. Rekhviashvili, B. Tsinamdzgvrishvili, A. Tsiskaridze, M. Chkhetia, N. Archvadze, G. Labakhua . P16 Measurements in imaging: Are internal or external reference systems better in detecting eary stage heart failure? R. Asbot.

P17 Quantitative electrocardiac parameters can predict impaired systolic heart function G. Simonyi, E. Szûcs, T. Bauernfeind, K. Szakolczai, J. R. Bedros, I. Préda, M. Medvegy. P18

Endovascular therapy of chronic mesenteric ischaemia A. Silva, R. Barros Wanderley, L. Carvalho Pereira, I. Kury Nunes, R. Luis Favero, L. Henrique Kanashiro.

P19 Clinical Feasibility and angiographic follow-up of Endovascular Stent-Graft for Type B Dissection (Stantford). Experience of a single center A. Silva, R. Barros Wanderley, L. Carvalho Pereira, L. Henrique Kanashiro, R. Luis Favero, I. Abilio Kury Nunes. P20 Prevalence of Changes in Undiagnosed Glucose Intolerance According to Age and Gender in Japanese Middle Aged Working People H. Kawano, H. Soejima, H. Fujii, Y. Nagayoshi, Y. Tanaka, S. Nakayama, Y. Kinoshita, H. Ogawa.

P21 Dehydroepiandrosterone Levels Vary According as Heart Failure Condition in Patients with Idiopathic Dilated Cardiomyopathy H. Kawano, Y. Nagayoshi, H. Soejima, Y. Tanaka, H. Yamabe, Y. Kinoshita, H. Ogawa. P22 Intermediate Outcome of Percutaneous Coronary Interventions for Single Remaining Coronary Artery S. Mishra, V. K. Bahl . P23 Frequency of diarrhoea as a predictor of elevated blood pressure in children J. J. Miranda, A. R. Davies, G. Davey Smith, L. Smeeth, L. Cabrera, R. H. Gilman, H. H. Garcia, Y. R. Ortega, V. A. Cama. P24

Is being an immigrant a risk factor for CVD in Australia? J. Dassanayake, L. Gurrin, W. R. Payne, V. Sundararajan, S. C. Dharmage .

Poster Listing P25 Percutaneous femoral closure following thoracic aorta stent graft placement: Preliminary results and 6 month follow up P. Avanzas, M. Martin, I. Lozano, J. M. Llaneza, F. Vega, F. Fernandez, J. M. De La Hera, J. M. Vegas, J. M. Valle, C. Moris. P26 Predictive value of coronary artery stenoses and c-reactive protein levels in patients with stable coronary artery disease P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski. P27

A/a’: A New Correlate of Left Ventricular End Diastolic Pressure? R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy.

P28 Univariable and Multivariable Correlates of E/e’: can we get closer to noninvasive left ventricular end-diastolic pressure estimation? R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy. P29 Investigating the European Society of Cardiology Diastology Guidelines in a Practical Scenario W. T. Emery, I. Jadavji, J. B. Choy, R. A. Lawrance . P30 E/e’ Ratio Derived From Septal and Lateral Annuli and its Correlation With Left Atrial Volume Index W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy. P31 Echocardiographic Correlates of left atrial size: inter-relationships with other diastolic measures. I. Jadavji, W. T. Emery, R. A. Lawrance, I. Vondermuhl, J. B. Choy. P32 Discrepant Mitral Annular Doppler Velocities: Implications For The Assessment Of Diastolic Function W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy. P33 C-reactive protein correlates with left ventricular ejection fraction and predicts functional status in patients with chronic stable angina P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski.

P34 The incidence of acute rheumatic fever in the world: a systematic review of population-based studies K. B. Tibazarwa, J. A. Volmink, B. M. Mayosi. P35 Patent ductus arteriosus closed with Nit-Occlud system: mid term follow-up. R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, D. M. Villa.

Scientific Programme / 165

Poster Listing P39 Effects of Taranabant, a Novel Cannabinoid 1 Receptor (CB-1R) Inverse Agonist, on Weight Reduction in Obese Patients Over 12 Weeks C. D. Gonzalez, N. Erondu, B. Gumbiner, B. Musser, K. Lu, R. A. Capece, S. Klein, E. Ravussin, J. M. Amatruda, S. B. Heymsfield.

P40 The prognostic value of NT-proBNP in patients with chronic coronary heart disease but without clinically manifest heart failure. O. Mayer Jr., J. Šimon, M. Galovcová, J. Bruthans, R. Cífková. P41 Cardiac performance in hypertensive versus physiological left ventricular hypertrophy. M. Deljanin Ilic, S. Ilic, V. Stoickov, L. Nikolic. P42 Changes of white blood cell count during stress echocardiography may predict future coronary events. S. Ilic, M. Deljanin Ilic, P. Milosavljevic, L. Nikolic. P43 Use of (all-blood) miniplegia versus crystalloid cardioplegia in an experimental model of acute myocardial ischemia. O. Petrucci, R. W. Vieira, M. R. Carmo, N. Antunes, P. P. M. Oliveira, D. M. Braile. P45 Echocardiography and adenosine test: non invasive method to detect patients with reactive pulmonary hypertension. R. Reinoso, H. Badiola Villa, R. Artigas Garcia, C. Lozano Girol. P46 How often does pressure recovery affect measurement of aortic valve gradients by Doppler echocardiography in patients with aortic stenosis in real-world clinical practice? A. C. Parameswaran, D. Reisner, A. Amanullah. P47 Effect of beta blocker treatment on platelet nitric oxide synthase, cyclic guanosine monophosphate and oxidative stress, in patients with heart failure A. Shah, E. Gkaliagkousi, J. Decourcey, R. Buckley, J. Ritter, A. Ferro. P48

The human serotonin 5-HT4a receptor J. Neumann.

P49 Effects of resistance stress on cardiac biochemical markers in power lifters V. Pönitz, S. P. H. Hjortshoj, G. Espersen, J. Ravkilde.

Poster Listing P50 Clinical features of STEMI-patients with multivessel disease who develop cardiogenic shock after primary percutaneous coronary intervention. A. Dominguez-Rodriguez, M. J. Garcia-Gonzalez, S. Samimi-Fard, A. Sanchez-Grande, G. Yanes-Bowden, I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez. P51 The Correlation Between Augmentation Index and Myocardial Ischemia of Adenosine Stress Myocardial Scintigraphy T. Morishima, T. Hatano, M. Aiga, M. Odaira, M. Nakayama, K. Takeishi, S. Fuse, T. Chikamori, K. Takazawa, A. Yamashina. P52 A Prospective Randomized Trial of a Rapid Fibrinolytic Protocol for Left-sided Prosthetic Valve Thrombosis (RAFT-PVT) G. Karthikeyan, N. Mathew, R. S. Math, P. R. Bhimashankar, S. Singh, M. Kalaivani, V. K. Bahl. P53 Significance of brain natriuretic peptide in the prediction of secondary morbidity and mortality in post-MI patients A. Boskovic, L. Music. P54 Is there difference between daily and nightly heart rate variabilty in patients with acute myocardial infarction A. Boskovic, L. Music.

P55

Clinical efficacy of statins in smokers with coronary artery disease A. Boskovic, L. Music, S. Dragnic.

P56 Clinical efficacy of statins in secondary prevention in patients with coronary artery disease depending on gender A. Boskovic, L. Music. P57

Cardioprotective Effect of Red Wine A. Novakovic, L. J. Gojkovic Bukarica, D. Nezic, M. Peric.

P58 Gender, age and clinical differences of Idiopathic, Hypertrophic and Atypical complete left bundle branch block S. Sclarovsky. P59 Electrical remodeling (ER) as is expressed in the electrocardiogram (ECG), electrical remodeling phenotypes from Neonatal to Sexual maturation, Gender differences. S. Sclarovsky.

Scientific Programme / 167

Poster Listing P60 The accuracy of factors used in assessing the progression of expressed heart failure symptoms A. Chaitoff, H. Kominsky, V. Sumodi, K. Fagnilli, M. Hanna. P62 Impact of Diabetes on mortality of patients with heart failure with reduced Left Ventricular function A. Innasimuthu, G. Rao, B. Naronha, K. Ckarke.

P64 Prognostic value of corrected QT interval and its correlation with cardiac Troponin T in non - ST- elevation acute coronary syndrome S. C. L. Llois Susana Claudia, F. L. G. Gadaleta Francisco Leonardo, V. A. S. Sinisi Víctor Alfredo, P. A. Avanzas Pablo, J. C. K. Kaski, Juan Carlos. P65 Children who fulfil current recommendation for physical activity are slimmer and have higher fitness level M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen.

P66 Body Fat, Abdominal fat and Body fat distribution related to Risk Factors for Cardiovascular Disease in Young Children M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen.

P68 Epidemiological Aspects of the Burnout Syndrome in professional cardiovascular nursing J. Boggiano, R. Miret, D. Maggio, A. Bantar, I. Perdomo, M. Medina, M. Lavalle, E. Moya, N. Bravo, H. Macazana Trucios. P69 Effect of early education on patient anxiety while waiting for cardiac catheterization J. Boggiano, A. Zichert, D. Maggio, H. Macazana Trucios, A. Incarbone, R. D´agosto, R. Dominguez, G. Bulacio, N. Crozzoli, M. Bertoli. P70 Workplace stress factors perceived by the nurses, who work in those areas of the hospital concerned with heart-lung transplants J. Boggiano, R. Miret, D. Maggio, M. Medina, M. E. De La Antonia, N. Acuña, F. Rotemberg, D. Chaparro, C. Ortiz, S. Castelar. P71 Corrected QT interval measurement in patients with non-ST elevation acute coronary syndrome and t-wave abnormalities: Any additional clinical value? F. L. Gadaleta, S. C. Llois, VA Sinisi, P. Avanzas, J. C. Kaski.

P72 Scientific production spilt in symposiums of cardiovascular nursing in Argentina J. Boggiano, R. Miret.

Poster Listing P73 The virtual heart: art and science J. Reynolds, C. Salazar, J. Vega, A. Castellanos.

P74 Determinants of hospital length of stay in patients admitted with acute heart failure. R. Bagnati, P. Ledesma, N. Vulcano, S. Fernandez, C. Belziti .

P75 Predictors of acute impairment in renal function in patients admitted with acute decompensated heart failure. P. Ledesma, R. Bagnati, N. Vulcano, S. Fernandez, C. Belziti .

P76 Influence of atrial natriuretic peptide treatment on cardiovascular and renal nitric oxide system in spontaneously hypertensive rats M. A. Costa, D. Rodríguez Ierace, R. Elesgaray, M. F. Visintini Jaime, C. Caniffi, A. M. Balaszczuk, C. Arranz. P77 Most frequent symptoms and extension of coronary artery disease in women with acute coronary syndromes C. N. Crudo Norma, P. A. Alfredo Piombo, V. L. Luis Vidal. P78 Coronary artery calcification in elderly adults over 80 years old: does it have any role in the pre-operation determination of ischemic heart disease? Masahiro Tamashiro, Yuu Nomura, Toshiya Chinen, Atsushi Kakazu, Kageyuki Ohba, Naoya Maehira, Akira Kakazu, Masanori Kakazu, Osamu Arasaki, Tetsuji Shinjo. P81 Early Outcomes of Direct Carotid Artery Stenting without Predilation in HighRisk Patients: Analysis of a Single-Center Registry J. Veselka, D. Erná, P. Zimolová, M. Šramko, A. Tomek, M. Šrámek.

P84 Relation of ischemia-modified albumin to ST-segment resolution after reperfusion of acute myocardial infarction A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez, J. C. Kaski.

P85 Do diabetic patients with acute myocardial infarction treated with thrombolytic therapy have a worse prognosis during long-term follow-up B. Stefanovic, P. Mitrovic, Z. Vasiljevic, G. Matic, M. Radovanovic, N. Radovanovic, A. Karadzic, A. Milosevic, G. Krljanac, M. Dragovic.

P86

Risk stratification in cardiac surgery: our experience M. Silvero, G. Solari, L. Browne, D. Bergerot, R. Vallejo, E. Badino .

Scientific Programme / 169

Poster Listing P87 Low risk cardiovascular profile patients seems to have high risk atherosclerotic plaques. Identification of atherosclerotic plaques in asymptomatic patients with 64 channel MSCT. A. Bayol, J. Vallejos, R. Obregon, M. Romero, R. Peloso, R. Gonzalez, W. Harvey, A. Zarza, J. Mazucco, J. Parras.

P88

Anterograde Utilization of Intraaortic Balloon Pump R. Levin, M. Degrange, R. Porcile, F. Salvagio, N. Blanco, A. Botbol, C. Del Mazo, E. Tanus.

P89 Relation between the VEGF Level and Myocard Ischemia in Patients with Collateral Vessels and Single-Vessel Chronic Total Occlusion F. Arican Ozluk, O. Badak, A. Sýsman, G. Capa Kaya, H. Bozkurt, S. Guneri .

P90 Metabolic Syndrome Predicts Non-Elderly Onset in Patients with Acute Myocardial Infarction T. Saikawa, M. Hara, T. Takakura, T. Ooie, T. Iwao, S. Shigematsu. P91 Predictors of successful ASA reistance suppression using dose escalation regimen in stable coronary artery disease patients. M. Dominiak, T. Wcislo, A. Rozga, L. Figiel, J. Drozdz, M. Krzeminska - Pakula, J. Kasprzak.

P92 Accuracy of myocardial contrast echocardiography in predicting early and long-term outcome in patients with acute myocardial infarction M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, T. Przewlocki, W. Tracz. P93 NT-proBNP measured on admission is well predictor early and long-term outcome in patients with acute myocardial infarction after primary coronary angioplasty. M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, W. Tracz. P94 The impact of socioeconomic conditions on the evolution of chronic Chagas disease. R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti. P95 The effect of concomitant use of monopril and spironolactone in patients with mild to moderate congestive heart failure N. Krstic, M. Pavlovic, Z. Perisic, L. J. Radevic, M. Lazovic, S. Salinger, A. Stojkovic, D. Milic. P96 Carney’s syndrome: review and report of a case with five intracardiac myxomas M. Silvero, J Boullosa.

Poster Listing P97 Gated SPECT Myocardial imaging in patients with left bundle branch block: comparison with stress echo coronary flow reserve D. Sobic-Saranovic, S. Pavlovic, A. Djordjevic-Dikic, Z. Petrasinovic, N. Kozarevic, D. J. Saranovic, M. Todorovic-Tirnanic, V. Artiko, V. Obradovic, M. Ostojic. P99 Value of Gated SPECT perfusion imaging in patients with previous myocardial infarction and single vessel disease D. Sobic-Saranovic, S. Pavlovic, B. Beleslin, M. Todorovic-Tirnanic, D. J. Saranovic, Z. Petrasinovic, V. Artiko, V. Obradovic, B. Vujisic-Tesic, M. Ostojic. P101

Ischemic Preconditioning in Elderly Patients with first STEMI. M. Giorgi, R. Ahuad Guerrero, P. Schygiel, F. Sokn, H. Farras, M. Voos, J. Tronge .

P102 Can we predict clopidogrel resistance after percutaneous intervention? M. Dominiak, A. Rózga, T. Wcis£o, M. Krzemiñska- Paku£a, J. Kasprzak.

P103 An increased right ventricular overload - how does it influence the tissue? M. Kowalski, E. Kowalik, P. Hoffman. P104 ABO blood group distribution and major cardiovascular risk factors in patients with myocardial infarction I. Sari, O. Ozer, M. Sucu, V. Davutoglu, S. Gorgulu, M. Eren, M. Aksoy.

P105 Clinical value of lead aVR in Acute Coronary Syndromes with non-ST segment elevation H. Juan Gallinari, H. Alviso De Vargas, E. Gonzalez Gonzalez, G. Boccuzzi, S. Colangelo, M. Minelli. P106 Morning peak in the circadian variation of myocardial infarction is not valid for all nations: Afternoon predominance in Turkish population I. Sari, V. Davutoglu, B. Erer, E. Tekbas, E. Ucer, O. Ozer, H. Uyarel, M. Eren, M. Sucu, M. Aksoy. P107 Analysis of timing events in Doppler ultrasound signals from the fetal heart rate J. Zietek, J. Jezewski, K. Horoba, A. Gacek, J. Wrobel.

P108 Septadian Variation In The Occurrance of ST Elevation Myocardial Infarction In Turkish population: Monday Syndrome I. Sari, B. Erer, E. Tekbas, E. Ucer, H. Uyarel, V. Davutoglu, O. Ozer, M. Sucu, S. Soydinc, M. Aksoy.

P109

Antepartum evaluation of fetal cardiac performance J. Zietek, A. Matonia, J. Sikora, K. Horoba, A. Gacek, J. Jezewski.

P110 Left ventricular regional function in adults after aortic coarctation repair M. Kowalski, E. Kowalik, K. Kotlinski, J. Rozanski, P. Hoffman.

Scientific Programme / 171

Poster Listing P112 Relationship between total and differential leukocyte counts and isolated coronary artery ectasia S. A. Kocaman, G. Taçoy, A. Sahinarslan, T. Timurkaynak, A. Çengel. P113 Short-term preoperative treatment with atorvastatin reduces proinflammatory response and the risk of renal failure after cardiopulmonary bypass in patients with diabetes type 2 operated due to aortic valve disease-randomized, placebo controlled study D. Zakrzewski, J. Janas, J. Stepinska.

P114 Peak oxygen uptake is better than Oxygen Uptake Efficiency Slope in quantifying cardiopulmonary functional reserve in patients with Metabolic Syndrome A. Casella-Filho, B. C. G. Nascimento, C. B. Casella, I. C. Trombetta, M. U. Rondon, F. Y. Cesena, D. Favaratto, C. E. Negrao, P. L. Daluz, A. C. P. Chagas. P115

Urbanization of Chagas Disease – A 17-year follow-up F. Sosa.

P116 Pharmacological effect at low dosis of Ezetimibe/Simvastatin combination A. Kavata, B. Martire.

P117 Association Between a Cell-Seeded Collagen Matrix and Cellular Cardiomyoplasty for Myocardial Support and Regeneration M. Cortes Morichetti, J. A. Genovese, E. Chachques, A. F. Carpentier, J. C. Chachques.

P118 “Unoperated univentricular heart with normally related arteries and pulmonary stenosis in a 47 year old woman” J. V. G. N. Juvenal Vaz Guimarães Neto, T. M. G.Q. Tânia Maria Gonçalves Quintão, H. F. M. Helena Furtado Martino, B. M. F. N. Betania De Freitas Nogueira, R. C. A. Roberta Chaves Araújo, G. P. T. Glenda Pataro Teixeira, G. M. R. Gabriela Mendonça Rabello.

P119 Cardiac tissue-reactive autoantibodies. Prevalence of anti-cardiac troponin-I IgG in a BNP positive population. M. Adamczyk, R. J. Brashear, P. G. Mattingly. P120

Depression and heart disease - a cross cultural view A. Nanhay, L. Villano.

P121 Velocity vector imaging for assessment of mechanical dyssynchrony and its comparison to color coded tissue Doppler imaging. A. C. Parameswaran, T. P. Shah, A. Amanullah.

Poster Listing P122 Intraoperative coronary angiography – an approach to quality control and logistic background for emergency simultaneous catheter-based interventions during minimal invasive coronary bypass surgery G. Friedrich, C. Kolbitsch, T. Schachner, N. Bonaros, S. Abbrederis, G. Laufer, O. Pachinger, J. Bonatti .

P123 Metabolic syndrom by new IDF definition and mortality outcomes in patients with manifest coronary heart disease. O. Mayer, J. Šimon, M. Plášková, R. Cífková.

P124 Intraoperative detection of porcelain aorta remains a challenging dilemma in coronary artery bypass surgery H. B. Bittner, R. R. Battellini, A. J. Rastan, F. W. Mohr. P125 Multislice Computer Tomographic Coronary Angiography for Preoperative Risk Stratification in Patients undergoing Liver Transplantation S. Abbrederis, G. Feuchtner, O. Pachinger, W. Vogel, E. Gassner, I. Graziadei, A. Mallouhi, G. Friedrich. P126 An Eight-Week, Multi-center, Randomized, Double-blind, Parallel Group study Comparing The Efficacy and Safety of Amlodipine/Valsartan combination therapy Versus Amlodipine Monotherapy in The Treatment of Stage 2 Hypertension M. Destro, L. Satlin, A. Kandra, P. Brunel.

P127 Value of first-line hypertension treatment with an amlodipine/valsartan regimen for systolic blood pressure control: analyses in difficult-to-treat populations M. Destro, L. Satlin, A. Kandra, P. Brunel.

P128 Efficacy and Safety of amlodipine/valsartan in Hispanic subjects with stage 2 hypertension M. Destro, L. Satlin, A. Kandra, P. Brunel.

P129 Tissue Doppler Imaging and Contrast Echocardiography: new methods in diagnosing intracardiac structures. M. Hlawaty, W. Tracz, M. Olszowska, M. Kostkiewicz, M. Pasowicz, P. Podolec.

P130 Transient myocardial stunning syndrome: Prevalence and clinical features in a population of a general hospital L. Hamity, F. Ramello, A. Moyano, L. Marani, E. Moreyra, L. Alday.

P131

Lengthening of the Aorta with Advancing Age: MRI Study H. Tanaka, K. Hayashi, T. Yokoi, J. Sugawara.

P132

Ischemic Cardiopathology in Cuban Women S. Luis Mario Sollet Lopez, Laura Principe.

Scientific Programme / 173

Poster Listing P133 Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery (ALCAPA). Presentation of two cases. L. M. Sollet Lopez, E. Selman Houssein, A. Naranjo, L. Principe, A. E. Gonzalez Morejon.

P134 Assessment of Patients Operated on Complete Anomalous Drainage of Pulmonary Veins According to the Cuban Program for Children’s Cardiac Rehabilitation S. Luis Mario Sollet Lopez, Francisco Carballes Garcia, Adel Glez Morejon, Laura Principe .

P135 The Role of Abnormal Q Waves and ST-Segment Elevation as a Marker for Disease Progression in Hypertrophic Cardiomyopathy Maky Fabiola Furuki K., Hiroya Kawai, Katsuko Norisada, Mariko Okada, Kazuhiro Tatsumi, Toshiya Kataoka, Tetsuari Onishi, Hidekazu Tanaka, Kenichi Hirata. P136 Heart rate, risk factors, metabolic syndrome and global cardiovascular risk in a working population M. A. Sánchez Chaparro, J. Román García, E. Calvo Bonacho, M. Cabrera Sierra, A. Fernández Meseguer, M. Ruiz Moraga, J. C. Saínz Gutiérrez, C. Fernández-Labandera, A. García García, A. Gálvez Moraleda. P137 Evaluation of heart pumping function by dynamics of oxygen dept in cardiopulmonary exercise test in patients with coronary artery disease. S. V. Ivanov, Y. U. A. Izachik, A. B. Pestova, S. S. Ivanov, N. A. Grablina .

P138 CT Cornary angiography - new perspectives of diagnostic of coronary artery disease. Personal experiences B. Cveticanin, M. Zorc.

P139 Isolated noncompaction is a biventricular disease E. K. Wlodarska, O. Wozniak, B. Lubiszewska, M. Konka, D. Piotrowska-Kownacka, E. Walczak, K. Baranska, W. Ruzyllo, P. Hoffman.

P140 Presence and severity of cerebral white matter lesions associated with an arterial hypertension M. Tundybaeva, A. Jussipov.

P141 Pregnancy in patients with prosthetic and homograft heart valves - maternal and fetal outcome. A. Lesniak-Sobelga, M. Kostkiewicz, W. Tracz. P144 Tissue Doppler post-systolic motion in patients with hypertensive heart disease A. Stevanovic, B. Vujisic-Tesic, M. Dekleva, L. J. Sevic.

Poster Listing P145 Influenza Vaccination Reduces the Frequency of Coronary Events in Patients after Primary PCI A. Ciszewski, Z. T. Bilinska, L. B. Brydak, M. Romanowska, C. Kepka, M. Kruk, W. Piotrowski, W. Ruzyllo.

P146 Effect of fixed antihypertensive combinations on blood pressure, pulse wave veloñity and glucose metabolism in hypertensive patients with metabolic syndrome S. Nedogoda, T. Chalabi, U. Brel, E. Podolskaya, G. Mazina, V. Tzoma, D. Zaremba. P147 Treatment of arterial hypertension with very-small doses of antibodies to C-end fragment of àò1 receptors of angiotensin II. S. Nedogoda, V. Petrov, O. Epstein, T. Chaliabi, U. Brel, N. Chepurina, G. Masina, A. Sabanov, S. Tarasov, A. Kolosova . P148 EFFECT OF INDAPAMIDE SR VS HYDROCHLOROTHIAZIDE ON BLOOD PRESSURE, PULSE WAVE VELOSITY AND GLUCOSE METABOLISM IN OBESE HYPERTENSIVE PATIENTS S. Nedogoda, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina . P149

EFFICACY OF ATORVASTATIN AT PATIENTS WITH METABOLIC SYNDROME S. Nedogoda, V. Tsoma, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina .

P150 THE EFFECT OF AN EDUCATIONAL INTERVENTION ON CARDIOVASCULAR RISK FACTORS IN AN OVERWEIGHT ELDERLY POPULATION. F. Santos, A. Neujahr, E. Veitenheimer, N. Schimidt, B. Santos, R. El-Kik, A. Gustavo.

P152

Normal E/Ea ratio values in healthy individuals according to age. H. Deschle, G. Allende, A. Miranda, A. Lakowsky, D. Sanchez Luceros, J. Carbajales, R. Calviño.

P153 Pediatric cardiovascular rehabilitation program: roll of the aquatic physical therapy. J. Bleiz, C. Serra, M. Venere, G. Guarraccino, G. Rocca, V. Assinnato, I. Souto, P. Campana, J. Rodriguez, S. Prates.

P154 Systolic and Diastolic Left Ventricular Wall motion Dyssynchrony Assessed by 99mTc-sestamibi-Gated-SPECT in patient with hypertension M. Ishikawa, A. Yamamoto, N. Takahashi, T. Shingo, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida, K. Munakata.

P155 Impact Of Angiotensin II Receptor Brockade On Left Ventricular Dyssynchrony In Hypertension N. Takahashi, A. Yamamoto, M. Ishikawa, S. Tezuka, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida, K. Munakata.

P156 Adherence of patients to the antihypertensive treatment in Georgian population D. Trapaidze, B. Tsinamdzgvrishvili, R. Tataradze, T. Abesadze, A. Rekhviashvili.

Scientific Programme / 175

Poster Listing P157

Early and late results of total correction of tetralogy of Fallot K. H. Hashemzadeh, S. H. Hashemzadeh, M. J. Dehdilani, M. Z. Dehdilani.

P158 Acute effects of Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) Stimulation in macrophage cells and highly sensitivity Creactive protein of Hypercholesterolemic Rabbits A. Alessi, O. França Neto, C. Prim, P. R. Brofman, L. Noronha, L. Baroncini, D. B. Précoma. P159

HYPERTENSION DETECTION IN CHILDREN IN SCHOOLARSHIP AGE S. Lopez Cross, L. Dumas, D. Peroni, G. Valenzuela .

P160

Risk Factors For Inadequate Transesophageal Echocardiography B. Flynn, J. Stanley, S. Wang, S. Lam, J. Meltzer, V. Moitra.

P161 Release of calcitonin gene-related peptide from the jugular-nodose ganglion complex in rats T. Strecker, A. Dieterle, K. Messlinger, W. Neuhuber, M. Weyand, S. Koulchitsky.

P162 Stenting of the Vena Cava Superior in a patient with a Total Artificial Heart T. Strecker, M. Uder, R. Tandler, M. Weyand, M. Kondruweit.

P163 Cardiac tumors – 37-year results, surgical experinence and outcome in our heart surgery center T. Strecker, J. Roesch, M. Weyand, M. Kondruweit. P164 Incidence of coronary artery disease in patients with tricuspid versus bicuspid aortic stenosis L. Cook, S. Burger, C. Harden. P165 One-Year Cardiovascular Event Rates in outpatients with slow upsloping ST depression vs. horizontal or downsloping ST depression in Treadmill exercise testing L. Ferro, A. Contreras, P. Pogonza, E. Brenna, F. Urinovsky, R. Bagur, D. Morillo, L. M. Amuchastegui. P166 ASYNCHRONOUS HEMIDISC CLOSURE IN MECHANICAL BILEAFLET PROSTHESES WITH NORMAL FUNCTION. T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, G. E. Gigena, A. N. Dorelle, E. H. Fernandez, J. H. Leguizamon, H. A. Prezioso, L. A. Vidal.

P167 Detection of atherosclerosis in the brachiocephalic trunk: the missing piece of the puzzle? N. Moraes, R. Dias, J. Tsutsui, A. Uchida, M. Vieira, S. Oliveira, P. Da Luz, W. Mathias.

P168 Is Easy-Access Preventive Medicine Necessary in a Social Healthcare System A. Bader, M. Hochleitner.

Poster Listing P169

Prone Imaging is An Effective Method of Attenuation Correction in A. Salacata, J. Mills, S. Keavey .

P170 Diabetic patients undergoing percutaneous coronary intervention using drug-eluting stents: incidence and predictors of very late (> 12 months) stent thrombosis V. Voudris, P. Karyofillis, S. Thomopoulou, S. Patsilinakos, A. Manginas, C. Spargias, G. Pavlides, D. V. Cokkinos.

P171 Long-term clinical outcome of patients with saphenous vein graft lesions treated with drug-eluting stents ; comparison with patients treated with bare metal stents V. Voudris, S. Thomopoulou, P. Karyofillis, C. Kalianos, A. Manginas, G. Pavlides, C. Spargias, D. V. Cokkinos.

P172 Seeking medical advice of patients with myocardial infarction in Russia V. Gafarov, A. Gafarova.

P173 Monitoring myocardial infarction (diagnostic combination, prodromal period, behavioral characteristics) using the WHO program “Registry of Acute Myocardial Infarction”, “MONICA” during the period of 22 years in Russia V. Gafarov, A. Gafarova.

P175 Eco-Cardiographic Ergometric Correlation of Patients L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola, C. Garcia Morejon, E. Fleitas.

P176 Eco-Cardiographic Ergometric Correlation of Patients L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola, C. Garcia Morejon, J. C. Ramiro Novoa, J. Ozores, E. Fleitas.

P177 Correlación Eco cardiográfica-Ergo métrica de pacientes operados de TGV a través de la técnica de Mustard. L. Sollet Lopez, A. Glez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arzola, C. Garcia Morejon, J. C. Ramiro Novoa, E. Fleitas.

P178

Risk Factors of Atherosclerosis in Children H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera.

P179 Factores de riesgos de aterosclerosis en poblacion infantil, area de salud reparto Jesus Menendez, 2006 H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera.

Scientific Programme / 177

Poster Listing P180 OBESITY, PLASMA LIPID PROFILES AND METABOLIC SYNDROME AMONG APPARENTLY HEALTHY ADULT NIGERIANS M. Sani, K. Wahab, B. Yusuf, O. Johnson.

P181 Correlation of ischemic wall motion abnormalities in stress echo with observed morphologic pattern in twelve lead exercise electrocardiography. N. G. Allende, R. Perez De La Hoz, E. Carrasco, G. Marambio, S. Carabajal, C. Vazquez, M. Russo. P182 VALVE REPLACEMENT WITH BILEAFLET HP-BIPLUS MECHANICAL PROSTHESES VERSUS STANDARD PROSTHESES: LONG-TERM RESULTS. T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, L. A. Cozarinsky, F. J. Gadea, A. N. Dorelle, R Guidoin, H. A. Prezioso, L. A. Vidal.

P184 Outcomes of Primary Percutaneous Coronary Intervention for Acute ST-elevation Myocardial Infarction in patients aged over 80 years I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski. P185 The electrical remodeling in the senescent over 90 years old - Gender differences and clinical aspects S. Sclarovsky. P186 Level of knowledge of the impact of cardiovascular disease in women’s mortality, in three population groups: ordinary women, nurses and medical doctors in Santiago, Chile. M. Fernandez, P. Arellano, V. Vera, P. Uriarte, M. Tobar, A. Abufhele.

P187

Noncompaction of the ventricular myocardium (NCVM) A. De Dios, E. Flores, A. Olive, M. Pasquale, M. Vaccari, M. Vidal, M. Zampach, B. Zarlenga, R. Cayre.

P189 Activated Factor XII and B-type natriuretic peptide, but not C-reactive protein, are independent predictors of mortality following admission with suspected myocardial infarction. V. Pönitz, T. Brügger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen.

P190 Activated Factor XII type A is an independent predictor of cardiovascular outcome in coronary patients admitted with troponin T negative chest pain V. Pönitz, T. Brugger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen.

P191

Mitral valve repair surgery V. Bichara, J. Tazar, A. Araujo, R. De Rosa.

P192 BODY COMPOSITION ANALYSIS WITH COMBINATED PHYSICAL TRAINING IN CORONARY PATIENTS M. Resnik, M. Ruffa, S. Taurozzi, L. Maggio, M. Perez Ruffa, E. Abad Monetti.

Poster Listing P193 Head to Head Comparison of Prognostic Value of Dobutamine and Adenosine Real-Time Myocardial Contrast Echocardiography- Preliminary Results A. Alves, I. Kowatsch, J. Tsutsui, A. Osório, L. César, J. Ramires, W. Mathias Jr. P194 THE IMPACT OF PREOPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING MITRAL VALVE SURGERY: 15 YEARS OF EXPERIENCE OF A CARDIAC SURGERY SERVICE R. Santa Ritta, M. Coutinho, E. Varella, F. Di Giovanni, K. Da Correggio, G. Longo, C. Fontana, S. Fadel.

P195

Nurse led heart Failure clinic is cost effective in New Zealand I. Ternouth, B. Lindsay.

P196 IS MULTI SLICE CT ANGIOGRAPHY ADEQUATE AS THE SOLE DIAGNOSTIC CRITERIA TO PROCEED FOR CABG ? H. Bedi, J. Gill, S. Bakshi.

P197 SURGICAL TREATMENT OF CHRONIC SEVERE RIGHT VENTRICULAR CARDIOMYOPATHIES M. Cortes Morichetti, J. L. Hebert, T. Lavergne, R. Frank, G. Fontaine, F. Hidden-Lucet, Y. Lecarpentier, A. Carpentier, J. N. Fabiani, J. C. Chachques.

P198 Late Complications After Drug-Eluting Stent Implantation in “Real-World” Clinical Practice D. R. Ramsdale, A. Rao, O. Asghar, K. A. Ramsdale, E. McKay. P200 Prevalence and Predictors of Carotid Versus Femoral Plaque by Screening Vascular Ultrasound in Asymptomatic Adults J. Postley, J. Gardin, A. Perez, M. Chan, N. D. Wong. P201 ROLE OF PATIENT EDUCATION IN EXERCISE ADHERENCE IN PATIENTS UNDERGOING MYOCARDIAL REVASCULARIZATION G. Giunta, D. Comtesse, H. Sanabria, A. Hershon, R. Mayer, L. Brandani, R. Romero, S. Di Yelsi, C. Commes, S. Kerbage.

P202 Retrieval, Repositioning, Unknotting, and Stripping of Intracardiac Catheters and Foreign Bodies J. Tisnado, D. J. Komorowski, M. K. Sydnor, D. A. Leung, J. Tisnado.

P206 Renal function and evolution of Acute Coronary Sindrome. National Hospital Arzobispo Loayza Lima-Peru M. Carrion Chambilla, A. Hurtado Arestegui, C. Gutierrez Villafuerte, J. Pinto Concha.

P207

Survivin Expression in Cardiac Myxoma P. H. Chu, S. M. Jung.

Scientific Programme / 179

Poster Listing P209 EFFECT OF LEVOSIMENDAN ON DIASTOLIC FUNCTIONS IN PATIENTS WITH HEART FAILURE AND COEXISTING ATRIAL FIBRILLATION O. C. Yontar, M. B. Yilmaz. P210 Elevated triglycerides/HDL ratio predicts extensive coronary artery disease in Cyprus C. Conkbayir, S. Kenan.

P211 Short-term exercise training improves HDL functional characteristics in patients with metabolic syndrome A. Casella-Filho, V. M. Silva, C. B. Casella, I.C. Trombetta, F. Y. Cesena, B. C. G. Nascimento, C. E. Negrao, R. C. Maranhao, P. L. Daluz, A. C. P. Chagas. P213 Prevalence of Rheumatic Heart Disease According to World Health Organization Criteria for Sub-Clinical Valve Lesions E. Marijon, D. S. Celermajer, B. Ferreira, A. O. Mocumbi, D. Sidi, X. Jouven.

P214 ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH DEPENDENT CAVOTRICUSPID ISTHMUS FLUTTER J. García-Seara, L. Martinez-Sande, F. Gude Sampedro, B. Cid Alvarez, R. Vidal Perez, F. Soto Loureiro, J. Gonzalez Juanatey . P216 The effects of general demographic data on the initation and timing of thrombolytic therapy among of STEMI patients O. C. Yontar, A. Erdem, K. Yalta, M. B. Yilmaz, I. Tandogan. P217 Is There a Predictive Pattern of P-Wave Signal Averaged Electrocardiogram for Arrhythmia Recurrence after Cardioversion of Persistent Atrial Fibrillation C. Militaru, A. Giuca, O. Istratoaie, D. D. Ionescu. P218 Cardioprotective Effects of Zofenopril, Enalapril and Valsartan on Doxorubicin Cardiotoxicity E. Bozçali, D. B. Dedeoglu, O. Süzer, H. Karpuz.

P219 PLASMA HOMOCYSTEINE LEVEL IN CARDIAC SYNDROME X AND ITS RELATION WITH DUKE TREADMILL SCORE T. Timurkaynak, S. Balcioglu, U. Arslan, S. A. Kocaman, A. Çengel. P220 Inflammation and Fibrinolytic Dysfunction in Impaired Glucose Tolerance. H. L. Luciardi, S. Chain, S. G. Berman, G. Feldman, J. Muntaner, R. N, Herrera.

Poster Listing P221 ATP-binding cassette transporter G1 Promoter Variant Influences to A Severity of Coronary Artery Disease Y. Uehara, S. Furuyama, S. Abe, S. I. Miura, B. Zhang, K. Saku.

P222 Layperson trainees improve their knowledge of resuscitation in BLS/AED courses and their confidence in providing bystander CPR. P. Cokkinos, N. Nikolaou, T. Papafanis, P. Strebelas, C. Hasikidis, A. Tasouli, D. Kontogianni, G. Gavrielatos, T. Kapadohos, D. Chrysos.

P223 Distribution, Awareness, Control and Benefits of Reduction of Blood Pressure in Yerevan, Armenia P. Zelveian, G. Podosyan, S. Barsamyan, A. Potosyan.

P224 Prognostic value of surface Electrocardiogram (ECG) one-minute heart rate variability (HRV) J. Visperas, O. Bugarin, M. Somera, M. Ramirez, E. Caguioa, M. Yamamoto. P225 Is the cold pressor test useful in the pre-clinical stage of coronary heart disease to predict events? E. Pautasso, M. Koretzky, J. Aiub, C. Borrego, R. Foye, M. Boscaro, M. Battiston, F. De Cecco, J. Panini, A. Marcon Del Point.

P226 EXERCISE ECHOCARDIOGRAPHY WITH CONTRAST FOR THE EVALUATION OF PULMONARY ARTERY SYSTOLIC PRESSURE. NEW METHOD. L. Rocha Lopes, S. Almeida, R. Miranda, M. J. Loureiro, O. Simoes, P. Cordeiro, C. Cotrim, M. Carrageta. P227 Infectious endocarditis associated with permanent implantable electronic devices (PIED): a prospective study. 18 months follow-up. G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Cerón, F. Gonzalez, D. Calcines Huerta, H. Massetti, N. Blanco, A. Botbol, R. Porcile. P228 Pulmonary embolism in infectious endocarditis associated with permanent implantable electronic devices PIED: incidence and outcomes after percutaneous extraction of catheters. G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Nordaby, T. Soria, H. Cruz, F. Sanchez, N. Blanco, A. Botbol, R. Porcile. P229 PREDICTORS OF HIGH HOSPITAL COSTS FOR ELDERLY PATIENTS WITH HEART FAILURE M. Giorgi, M. Voos, R. Borracci, R. Ahuad, H. Farras, S. Balmaceda, M. Fanuele, J. Insua.

P230 PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS OVER 80 YEARS OLD THROUGH THE TRANSRADIAL ACCESS G. Samaja, A. Rodriguez Saavedra, M. Koretzky, R. Costello.

Scientific Programme / 181

Poster Listing P231

Transapical minimally invasive aortic valve implantation T. Walther, R. Battellini, V. Falk, M. Borger, J. Kempfert, J. Fassl, Y. Rückert, A. Linke, G. Schuler, F. W. Mohr.

P232

Cardiac lead vegetations in rhythm devices - transvenous extraction R. Battellini, A. Rastan, M. Uhlemann, N. Lachmann, M. Luduena, T. Walther, N. Doll, F. W. Mohr.

P233

Survival from cardiac arrest in a specialized hospital. P. Cokkinos, E. Papadopoulou, A. Gkouziouta, V. Voudris, D. V. Cokkinos.

P234 Non invasive assesment of coronary artery by pass grafts by VCT 64 multislice. Comparison with conventional coronary angiography. J. Bonelli, C. Cigalini.

P235 Does Carvedilol Therapy Reduce QT Dispersion in Patients with Heart Failure ? E. Tatli, T. Kurum, M. Aktoz, C. Gul, M. Buyuklu. P236 Effect of Carvedilol on P-Wave Duration and P-Wave Dispersion in Patients with Systolic Heart Failure E. Tatli, T. Kurum, M. Aktoz, M. Buyuklu, C. Gul, A. Barutcu.

P237

Non invasive coronary angiography with MSCT 64 slice J. Bonelli, C. Cigalini, P. Pollono.

P238 Clinical and echocardiographic assessment of patients with aortic valve disease - maternal and fetal outcome A. Lesniak-Sobelga, W. Tracz, M. Kostkiewicz.

P239 Information poverty as a risk factor for cardiovascular disease: AshantiProCor Project to Increase CVD Knowledge and Practice Among Health Workers C. Coleman, B. Bilchik.

P240 Implementation measures secundary prevention CHD in Banja Luka Region,Republic of Srpska,B&H D. Vulic, S. Loncar, B. Vulic, D. Roganovic, M. Ostojic, J. Marinkovic.

P241 Awareness, Treatment and Control of the Combination of Hypertension and Hypercholesterolemia in a Primary Prevention Population in Chile M. Acevedo, V. Krämer, R. Tagle, G. Chamorro, M. Fernandez, L. Orellana. P243 Does gender influence postprandial lipaemia in heterozygotes of familial hypercholesterolaemia? G. Kolovou, P. Cokkinos, S. Mavrogeni, G. Hatzigeorgiou, D. V. Cokkinos.

Poster Listing P244

Coronary atherosclerosis in Western Siberia: north-south differences V. Kuznetsov, I. Zyrianov, G. Kolunin, D. Krinochkin, L. Evlampieva, M. Bessonova, E. Gorbatenko.

P245 ASYMPTOMATIC CAROTID ATHEROSCLEROSIS IN PATIENTS WITH CORONARIOPATHY: PREVALENCE, PREDICTORS AND DIAGNOSIS R. Marelli, J. Lopez Camelo, C. Geronés, C. Viscuso, A. Gomez Monroy, G. Godoy, M. Portis, F. Bourdin, I. Rifourcat, R. Sanchez.

P246

ATHEROSCLEROSIS OF CAROTID ARTERIES AND CORONARY ARTERY DISEASE P. Meszaros, N. Cemerlic-Adjic, K. Pavlovic, M. Maletin.

P247 INTERLEUKIN-6 (IL-6): IS A MARKER FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY A. Silva, A. Baptista, P. Neves.

P248 Prevalence of cardiovascular risk factors and metabolic syndrome in a hospital hypertension unit M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Sanchez, L. Lopez Y Juan, B. Saiz, P. Rosique, R. Guerra.

P249 Non-ischemic benefits may be independent of the LDL-lowering properties of atorvastatin J. C. Larosa, J. Shepherd, D. D. Waters, A. Breazna, D. Demicco.

P250 Unravelling Hidden Renal Dysfunction. An unrecognized major problem. M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Suarez, B. Saiz, P. Rosique, R. Guerra, V. Nieto.

P251 Pituitary-adrenal axis hormone adjustment following cardiac surgery M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto.

P252 Determinant factors for temporary hormone changes in cardiac surgery M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto.

P253 Plasmatic levels of apolipoprotein in young subjects without cardiovascular disease. Effects of age, gender and body mass index. D. A. Siniawski, W. M. Masson, P. Sorroche, J. Krauss, A. M. Cagide .

P254 Achievement of Treatment Targets of Cardiovascular Risk Factors in a Pilot Secondary Prevention Program In Chile M. Acevedo, V. Krämer, G. Chamorro, G. Krogh, A. Muñoz, R. Corbalan. P255 ANTIPHOSPHOLIPID SYNDROME AND HYPERTENSIVE DISORDERS OF PREGNANCY (preliminary results). L. S. Voto, M. J. Mattioli, R. Zarate, G. N. Voto, B. E. Grand.

Scientific Programme / 183

Poster Listing P256 Elevated augmentation index but not hsCRP could be related to arterial damage in patients with rheumatoid arthritis A. Cypiene, A. Laucevicius, J. Dadoniene, A. Venalis, Z. Petrulioniene, M. Kovaite, J. Badariene, V. Dzenkeviciute, L. Ryliskyte.

P257 Autologous Bone-Marrow Mononuclear Cell Transplantation after Acute Myocardial Infarction:Comparison of Two Delivery Techniques H. Dohmann, S. A. Silva, R. C. Moreira, A. Haddad, F. A. Tuche, A. S. Souza, C. Peixoto, R. Verney, M. Amorin, R. Borojevick .

P258 IMPLEMENTATION OF EMERGENCY-BASED THROMBOLYSIS; AN ACHIEVABLE OPTION FOR RURAL HOSPITALS IN DEVELOPING COUNTRIES. S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.

P259 COMPLIANCE WITH THE MALAYSIAN NATIONAL CLINICAL PRACTICE GUIDELINES ON THE ADMINISTRATION OF THROMBOLYTIC AGENTS IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.

P260 RISK FACTOR PROFILE OF PATIENTS PRESENTING WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION TO A RURAL HOSPITAL IN MALAYSIA S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh.

P266 SURGICAL THERAPY FOR ISCHEMIC HEART FAILURE: PREDICTORS OF MORTALITY AT LATE FOLLOW-UP I. Butkuviene, L. Ivaskeviciene, G. Nogiene, J. Zidanaviciute.

P267

ARTERIAL HYPERTENSION MULTICENTRIC STUDY IN TYPE 2 DIABETIC PATIENTS M. L. Ruiz Morosini, E. Lopez Gonzalez, A. Garcia, A. Luongo, C. Gonzalez, G. Burlando, M. Ruiz .

P269

MYOCARDIAL PERFUSION SPECT WITH DOUBLE DRUG NEED. V. Martire, D. Portillo, J. M. Dominguez, E. Pis Diez.

P270 SPECT USEFULNESS IN PATIENTS WITH DOUBTFUL ERGOMETRY DUE TO ST-T DEPRESSION V. Martire, M. Cantos, M. Pilato, S. Pilato, C. Vietti, S. Vogogna.

P271 INFLUENCE OF THE COLLATERAL CORONARY CIRCULATION IN THE MODEL OF DOUBLE ERGOMETRIC STRESS TEST V. Martire, A. Arrastia, S. Gonzalez, D. Portillo, J. M. Dominguez.

Poster Listing P272 Clinical outcomes in patient with idiopathic dilated cardiomyopathy or coronary cardiomyopathy and an implantable cardoverter defibrillator. Are they different? R. Aguayo, S. Diangelo, W. De Andrade, E. Costa, L. Azocar, O. Macz, R. Ferreyra, I. Romero, J. Maloney, C. Muratore

P273 PHARMACOLOGICAL EFFECTS OF INAMRINONE LACTATE IN PATIENTS WITH REVERSIBLE PERFUSION DEFECTS INDUCED BY DIPYRIDAMOLE V. Martire, D. Portillo, J. M. Dominguez, A. Kavata.

P274 Implantable Cardioverter Defibrillator Therapy in Patients with Chronic Chagas’ Cardiomyopathy: comparison with Ischemic Cardiomyopathy. L. Aguinaga, C. Muratore, A. Malan, L. Batista, G. Maid, J. Escudero, M. Lanzotti, P. Chiale, J. Maloney . P275 Importance of Blood Flow and Calcification Degree in Results of Carotid Artery Stenting L. Martinez Riera, E. Trucco, M. J. Cabrera Ferreyra, F. Paoletti, H. Londero. P276 Cardiac Myocyte Injury Can Result in Elevated Levels of Choline in Plasma. M. Adamczyk, R. J. Brashear, P. G. Mattingly. P277 Chest symptom classification is useful for identifying cardiac risk in diabetic patients H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, K. Sugi. P278 DES, like BMS, do not influence systemic inflammatory status related with inflammatory cells after PCI in stable angina pectoris T. Timurkaynak, S. A. Kocaman, A. Sahinarslan, A. Cengel. P279 HOSPITALIZATION OF PATIENTS WITH HEART FAILURE. ROLE OF THE PRECIPITATING FACTORS. T. Livieratos, A. Tziovas, A. L. Patsilinakos, P. A. Koustas, F. O. Kontari, G. E. Fagogenis, G. E. Kordosis, A. T. Germanos. P280 CHARACTERISTICS, MANAGEMENT AND IN-HOSPITAL OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES. T. H. Livieratos, A. R. Tziovas, A. L. Patsilinakos, G. E. Fagogenis, F. O. Kontari, P. A. Koustas, G. E. Kordosis, A. T. Germanos. P281 The Effects of Nocturnal Dipping on Cardiovascular Outcome and Proteinuria In Essential Hypertensive Patients Y. Selcoki, B. Uz, N. Baybek, A. Akcay, B. Eryonucu.

P282 Assessment of myocardial viability in chronic ischemic heart disease evaluated by stress echocardiography with dobutamine and gated single photon emission computed tomography (GSPECT) M. Kostkiewicz, A. Lesniak-Sobelga, M. Olszowska, M. Hlawaty, P. Podolec, W. Tracz.

Scientific Programme / 185

Poster Listing P283 cardiopulmonary exercise testing in the estimation of the cardio respiratory efficiency after cardiac rehabilitation in coronary patients A. Stuto, G. Cosentino, A. Ambu, F. Raineri, G. Bottaro, G. Basile, B. Armaro.

P284 Prevalence of Cardiac Events in Patients with Normal Perfusion and Abnormal ST-T Segment During Dipyridamole Infusion P. Smanio, L. Freitas, A. Feldman, A. Mota, C. Collet, F. Penhalves, R. Lopes, M. Oliveira, A. Thom, L. Piegas.

P285 Five Year Results of the Treatment Strategy Based Upon the Fractional Flow Reserve Measurements in Patients with Borderline Coronary Artery Lesions U. Arslan, S. Balcioglu, S. A. Kocaman, T. Timurkaynak. P286 Aortic Sclerosis and Mitral Annular Calcification are Related with Increased Risk Factors and Markers in Acute Coronary Syndrome S. A. Kocaman, G. Taçoy, S. Türkoglu, S. Akinci, M. Erden, S. K. Açikgöz, A. Çengel. P287 Prevalence and Clinical Course of the End Stage Phase of Hypertrophic Cardiomyopathy in Patients Referred to a Tertiary Care Center A. Fernández, J. H. Casabé, R. R. Favaloro, M. Diez, L. Favaloro, C. Vigliano, E. Guevara, F. Landeta, J. Diaz, R. Laguens. P288 Relationship Between Frequency of Ventricular Tachyarrhythmia Episodes and Functional Capacity in Patients Treated with Implantable Cardioverter Defibrillator A. Eksik, A. Akyol, T. Norgaz, S. Sakalli, N. Cakmak, H. Hasdemýr, A. Alper, O. Soylu, D. Oz, I. Erdinler .

P289 Role of a family physician service in lipid control in patients with coronary artery disease O. Korzh, G. Kotchuev, S. Krasnokutskiy. P290 Torsade de Pointes: a cause of Morgagni-Adam-Stokes attacks in patients with atrioventricular block. D. Antonelli, E. Rosner, A. Shurman, N. A. Freedberg, Y. Turgeman. P291 Prognositc value of anemia in patients hospitalized for Acute Coronary Syndrome A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, P. Rigueiro Veloso, F. J. García Seara, A. Virgos Lamela, R. Vidal Perez, A. Díaz Redondo, J. R. Gonzalez Juanatey. P292 Clinic features and prognosis of Acute Coronary Syndrome in the elderly A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, J. Garcia Seara, M. Gutierrez Feijoo, R. Vidal Perez, J. L. Martinez Sande, A. Díaz Redondo, J. R. Gonzalez Juanatey.

Poster Listing P293 Clinical presentation and prognosis of Acute Coronary Syndrome in women A. B. Cid Alvarez, E. Gonzalez Babarro, M. Pedreira Perez, J. M. Garcia Acuña, M. Bastos Fernandez, P. Mazon Ramos, I. Gomez Otero, R. Vidal Perez, A. Diaz Redondo, J. R. Gonzalez Juanatey.

P294 Application of Devereux’s geometric model for the analysis of structure and function in hypertensive patients. D. Chejtman, S. Baratta, A. Hita, F. Tramontini, H. Fernandez, C. Kotliar, P. Forcada, D. Turri . P296 Serum myeloperoxidase level is associated with risk of major cardiovascular events during hospitalization and extent of coronary artery disease in patients with acute coronary syndromes B. Karadag, B. Vatan, N. Karadag, I. Keles, Z. Ongen, V. A. Vural. P297 The prognostics significance of impaired glucose regulation in non-diabetic patients with acute myocardial infarction M. Ilic, I. Mrdovic, T. Jozic, R. Lasica, J. Perunicic, M. Asanin, M. Srdic, S. Stankovic, M. Matic, Z. Vasiljevic .

P298

Lead Intoxication in children: markers of endothelial damage. G. Feldman, S. Chain, H. Luciardi, S. Berman, R. Feldman, N. Martínez Riera.

P299 A Simplified Strategy for the Estimation of the Ventilatory Thresholds During Ramp-Incremental Exercise R. Stein, J. A. Neder.

P300 Brachial-ankle Pulse Wave Velocity is a Marker of Coronary Heart Disease in Subjects without, but not With, Metabolic Syndrome H. Tomiyama, A. Yamashina .

P301 Incidence of patients with isolated noncompaction of left ventricle - single center experiences A. Nikolic, L. J. Jovovic, S. Tomic, M. Vukovic, D. Nikolic.

P302 Achieving Lipid Goals with Rosuvastatin compared to Simvastatin: DISCOVERY BETA Study T. Laks, E. Keba, M. Leiner, E. Merilind, M. Peterson, S. Reinmets, S. Väli, T. Sööt, K. Otter.

P303 The disease of vasa vasorum in endarterectomy sequesters of coronary arteries in patient with Chlamydia pneumoniae infection M. Zorc, R. Zorc Pleskovic, A. Pleskovic, O. Vraspir Porenta, D. Petrovic, N. Radovanovic.

Scientific Programme / 187

Poster Listing P304 Chronic Chlamydia pneumoniae infection and morphology of atherosclerotic process in diffuse and distal coronary artery disease A. Pleskovic, R. Zorc Pleskovic, M. Zorc, O. Vraspir Porenta, D. Petrovic, N. Radovanovic.

P305 PREDICTORS OF BLOOD PRESSURE NON-DIPPING PATTERN IN ACUTE CORONARY SYNDROME A. Zamora, G. Vazquez, M. Vilaseca, J. M. Fernandez-Real, M. Crespo, A. Gibert, G. Paluzuie, S. Corali, D. Bron, J. Massa.

P306 Intracoronary Autologous Bone Marrow Mononuclear Cell Transfer after Large Anterior Acute Myocardial Infarction (AMI M. A. Riccitelli, N. Perez Baliño, J. C. Dupont, J. Szarfer, F. Blanco, L. Grynberg, R. Cacchione, L. A. Vidal, A. García Escudero, O. Masoli.

P307 Coronary endothelial dysfunction is distinct in postmenopausal women with chest pain in the absence of coronary artery disease T. Ashikaga, H. Fujii, S. Niki, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, Y. Kishi, M. Isobe.

P308 PROGNOSTIC VALUE OF PULSE PRESSURE REGISTERED BY 24 HOURS AMBULATORY BLOOD PRESSURE MONITORING IN ACUTE CORONARY SYNDROME G. Vazquez, A. Zamora, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, I. Caballe, V. Fernández, C. Campoamor, S. Coralli.

P309 CORRELATION BETWEEN ACCESS TO INVASIVE CORONARY APPROACH AND COMORBIDITY STATUS IN PATIENTS ADMITTED WITH ACUTE CORONARY SYNDROME IN A COMMUNITY HOSPITAL M. Vilaseca, G. Vazquez, A. Zamora, M. Crespo, A. Gibert, G. Paluzie, R. Cuenca, D. Bron, A. Rivera, R. Massa.

P310 BLOOD PRESSURE VARIATION ACTIVITY/REST IS ASSOCIATED TO A POOR CARDIOVASCULAR PROGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME A. Zamora, G. Vazquez, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, C. Campoamor, S. Coralli, D. Bron, A. Garcia-Flores.

P311

DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE. M. Kowman, T. Sobow, I. Kloszewska, M. Dominiak, M. Klosinska, J. Drozdz.

P312 Syncronous Carotid Artery Stenting and Cardiovascular Surgery. Long Term Evolution C. Fava, L. Valdivieso, G. Lev, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz. P313 Effect of mean platelet volume on post-intervention coronary blood flow in patients with chronic stable angina pectoris H. Duygu, F. Ozerkan, U. Turk, B. Kirilmaz. P314 STATINS MIGHT IMPROVE CORONARY BLOOD FLOW AFTER PERCUTANEOUS CORONARY INTERVENTION H. Duygu, F. Ozerkan, U. Turk, C. Turkoglu.

Poster Listing P315 Latency Non Invasive Evaluation in Implantable Pacemaker Patients Potential Use as Biosensor for Automatic Rate Responsive Pacemaker D. Ortega, L. Barja, N. Mangani, F. Di Tomaso, A. Hita, D. Turri, M. Kenar.

P316

Parahisian Septal Stimulation. Indication Analysis. Results D. Ortega, L. Barja, N. Mangani, E. V. Segura, A. Hita, C. Paladino, N. Paz, M. Kenar, D. Turri.

P317 Cardiac Electrotonic Memory Induction after QRS Normalization by Parahisian Pacing. D. Ortega, L. Barja, N. Mangani, D. Turri, G. M. M Pellegrino, A. Hita, M. Kenar, C. Paladino, V. Kotowicz.

P318 Effect of different right ventricular pacing places on left ventricular electro-mechanical time. D. Ortega, L. Barja, M. Amor, G. M. M. Pellegrino, N. Mangani, A. Hita, D. Turri, M. Kenar.

P319 Uses of Tissue Doppler Imaging for Detection of Subclinical Left Ventricular Dysfunction in Pre- Transplant Renal Hemodialysed Patients C. Dizeo, M. Brito, G. Rey, P. Rossi.

P321 Predictors for silent myocardial ischemia in diabetic patients with myocardial perfusion ischemia H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, N. Joki, H. Hase.

P322 Preoperative Use of Calcium Sensitizer Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Patients with Aortic Stenosis and Left Ventricular Dysfunction R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, E. Tanus, N. Blanco, L. Botbol.

P323 Screening for Primary Hyperaldosteronism in Essential Hypertensive Patients: a Multicentric Study* S. Lupi, S. Belli, D. Cornalo, S. Damilano, R. Gomez, M. Leal, M. Martinez, M. Nofal, G. Ruibal, E. Pardes. P324 ASYMPTOMATIC CAROTID ATHEROSCLEROSIS IN PATIENTS WITH SEVERE AORTIC VALVULAR STENOSIS. R. Marelli, L. Godoy, L. Geronés, N. Napoli, O. Pisano, C. Echeverria, M. Giacomo, V. Marasa, M. Geronés, O. Rastelli.

P325 Determination of the Aldosterone/Plasma Renin Activity Ratio in a Normotensive Population: a Multicentric Study* E. Pardes, S. Belli, L. Contreras, L. Costa, R. Chervin, S. Damilano, C. Fenili, R. Gomez, M. Leal, S. Lupi. P326

Key Role of Reactive Oxygen Species in the Anrep’s Phenomenon. N. G. Pérez, L. P. Novaretto, H. E. Cingolani.

Scientific Programme / 189

Poster Listing P327 In the treatment of the acute myocardial infarction, the primary percutaneous coronary intervention show us better in-hospital results than the rescue percutaneous coronary intervention after thrombolisis. M. Cantarelli, S. Gioppato, J. B. Guimarães, E. P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves, H. Castello . P328 Are there differences in immediate results of percutaneous coronary intervention between elderly population above and under 80 years old? M. Cantarelli, S. Gioppato, J.B. Guimarães, E.P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves, H. Castello . P329 Double chamber right ventricle: diagnosis and treatment. Presentation of two cases C. Viscuso, M. Giacomo, C. Echeverria, L. Cali, M. Antonetti, J. Como Birche, G. Basso, D. Herrera, O. Pisano, R. Marelli .

P330

Quality Control ( QC ) in Anticoagulation Clinic M. G Gonzalez Achaval, M. Hadad, A. Del Val, S. Ghione, S. Gomez, J. P. Sala.

P331

Therapeutic hypothermia after cardiac arrest M. Petrovic, G. Panic, I. Srdanovic, T. Canji, A. Jovelic .

P332 TETRALOGY OF FALLOT: A 1 YEAR OF EXPERIENCE AT THE HOSPITAL CARDIOLOGICO INFANTIL LATINOAMERICANO “DR GILBERTO RODRIGUEZ OCHOA” CARACAS, VENEZUELA. A. Galindo, J. Rengel, J. Figueira, S. Sanchez, A. Sanchez, J. Figueredo, N. Ysturiz, J. Iribarren, E. Parra, H. Mejias .

P333 HOSPITAL CARDIOLOGICO INFANTIL LATINOAMERICANO “DR GILBERTO RODRIGUEZ OCHOA” CARACAS; VENEZUELA. POST OPERATIVE EXPERIENCE OF VENTRICUALR SEPTAL DEFECT. J. Figueira, J. Rengel, A. Galindo, S. Sanchez, J. Iribarren, A. Sanchez, C. Febres, M. Flores, H. Contreras, F. Emperador

P334 ANOMALOUS ORIGIN OF THE LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY (ALCAPA) IN ADOLESCENT: PRESENTATION OF CLINICAL CASE. J. Rengel, J. Figueira, A. Galindo, S. Sanchez, I. Donis, J. Figueredo, J. Gonzalez, F. Guerra, Y. Acosta, I. Tolj .

P335 LONG TERM TIROFIBAN INFUSION BEFORE PCI IN PATIENTS WITH ANGIOGRAPHICALLY MASSIVE INTRACORONARY THROMBUS T. Timurkaynak, U. Arslan, S. Balcioglu, S. A. Kocaman, S. Türkoglu. P336 C- Reactive Protein and its relation with the ventricular mass, in patients with chronic hemodialysis I. Masuda.

Poster Listing P339 C- Reactive Protein and its relation with the ventricular mass, in patients with chronic hemodialysis Masuda Isabel, Ferrero Mónica, Hecker Susana, Ziella Juan Carlos, Marcozzi Amalia, Hansen Ana, Aguirre Gustavo, Eduardo Escudero, Ciprés Miriam .

P341 Early Detection of Right Ventricular Systolic Dysfunction at Tissue Level by Isovolumic Myocardial Acceleration in Patients with COPD Y. Tayyareci, C. P. Tastan, P. Bayazit, Y. Nisanci, A. Oncul, B. Umman, T. Goren, S. Umman, K. Adalet, Z. Bugra.

P342 Management and immediate outcome of elderly patients with acute coronary: A single center experience V. Dias, S. Cabral, F. Soares, A. Luz, C. Gomes, F. Oliveira, L. Gomes . P343

Invasive and anticoagulant threatment of coronary ectasia V. Grigorov.

P344 The Association Between Metabolic Syndrome and its Components and Heart Failure in Patients Referred to a Primary Care Facility F. Coelho, M. Moutinho, M. Rosa, V. Miranda, L. Tavares, E. Mesquita .

P345 Effects of simvastatin on the transfer of lipids to high density lipoprotein in coronary artery disease patients. A. C. Lo Prete, C. H. Dina, C. H. M. Azevedo, T. M. Seydell, W. Hueb, R. C. Maranhao.

P346 Bradykinin released during intense exercise inhibits the expression of gap junction protein in trained mouse hearts. G. C. Tiscornia, E. A. Garcia Gras. P348 THE EFFECTS OF THE CONTROLLED RESPIRATION ON THE AUTONOMIC MODULATION OF THE HEART IN RESISTENT HIPERTENSION: THE IMPACT OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ON CARDIAC AUTONOMIC MODULATION (THE CURUMIM STUDY) G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, A. F. P. Gondar, F. D. Vilela, F. V. Campos, J. Barbosa-Filho, M. V. Barros, A. B. R. Lima, I. Cordovil.

P349 HDL size and ability of acceptance cholesterol and other lipids in heart transplantation patients with treatment C. G. Puk, A. C. Lo Prete, E. A. Bocchi, C. H. Azevedo, S. Ayub, R. C. Maranhão.

P351

UTILITY OF A LOW-RISK SPECT TEST IN UNSTABLE ANGINA Y. Castillo Costa, V. Mauro, A. Charask, R. Pérez, E. Fairman, L. Rodríguez, E. Barrionuevo, C. Barrero.

Scientific Programme / 191

Poster Listing P352 CARDIAC MIXOMAS: CLINICAL PRESENTATION, SURGICAL RESULTS AND LONG-TERM FOLLOW UP OF 60 CASES. E. Gonzalez, N. Pizzi, G. Caponi, J. Shiraishi, M. Varela Otero, Y. Arzani, L. Helman, R. Favaloro.

P353 Compliacation of Cardiothoracic Surgery in the Peruvian National Heart Institute M. Condori. P354 Surgical Treatment of Acute Type A Aortic Dissections. Immediate and LongTerm Results. R. Spampinato Torcivia, H. Cohen Arazi, H. Grancelli, W. Rodriguez, S. Waldman, M. Cáceres, M. Sellanes, C. Pensa, C. Nojek. P355 Evaluation on the risk of target organ damage based on the genetic profile of AGT 235MT, mineralocorticoid receptor GCC5GG4C and ACE I/D in subjects with resistant hypertension F. V. Campos, P. R. Benchimol-Barbosa, F. D. Vilela, C. S. Miranda, G. N. Gobbi, J. Barbosa-Filho, A. F. P. Gondar, M. V. Barros, A. B. R. Lima, I. Cordovil.

P356 Ventricular-Vascular coupling response and Left Ventricular Function Parameters with the Ergo-metric stress J. Tripolone, G. Santiago, M. Garcia.

P357

Right-sided Infective Endocarditis in Singapore Y. Goh, P. Goh, H. Oh.

P358 The effect of long-term beta-blocker treatment on endothelium-dependent hemostasis in patients with chronic heart failure E. V. Shlyakhto, K. A. Khmelnitskaya, M. Y. U. Sitnikova.

P359

NATURAL HISTORY OF RHEUMATIC MITRAL STENOSIS M. Kilickap, B. Candemir, A. O. Ozdemir, S. Turhan, H. Ede, T. Altin, T. Sayin, G. Akgun, C. Erol.

P360 Exercise diastolic left ventricular function in patients with coronary artery disease Y. U. A. Izachik, S. V. Ivanov, A. B. Pestova, N. A. Grablina, S. S. Ivanov.

P361 Improvement in endothelial function with short-term exercise training and without specific diet in patients with metabolic syndrome A. Casella-Filho, S. R. Coimbra, C. B. Casella, I. C. Trombetta, F. Y Cesena, E. Cerqueira, D. Favarato, C. E. Negrao, P. L. Daluz, A. C. P. Chagas.

Poster Listing P363 Mitral and aortic valve dysfunction in maintenance haemodialysis patients echocardiographic findings. M. Hlawaty, M. Olszowska, W. Tracz, P. Podolec, M. Kostkiewicz, A. Liœniak-Sobelga, M. Pasowicz. P364 Medical advice to quit tobacco smoking as a cornerstone in cardiovascular prevention. Reality or fiction. G. Pérez Baztarrica, R. Alonso, H. Cruz, F. Sanchez, F. Ganzalez, M. Cerón, L. Gariglio, F. Salvaggio, R. Cherhousky, R. Porcile. P365

THE POLARISING SOLUTION IN THE TREATMENT OF ACUTE CORONARY SYNDROM R. Matunovic, S. Rafajlovski, M. Rabrenovic, J. Samardzic, R. Spasic.

P367 IMPORTANCE OF CARDIOSURGERY TREATEMENT IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND HEART FAILURE R. Matunovic, Z. Mijailovic, D. Tavciovski, Z. Vucinic, Z. Davicevic, Z. Jovic, V. Begovic, J. Samardzic.

P368 Resting Electrocardiographic Variables of Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Bypass Graft Surgery plus Intramyocardial Bone Marrow Cell Injection: An One-Year Follow Up Study M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira, L. H. W. Gowdak.

P369 Outcomes at Follow-Up of Patients who had Carotid Stenting Periprocedural TIA or Minor Stroke Complications. C. Fava, G. Lev, L. Valdivieso, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz. P370 One Year Follow up of Ambulatory Electrocardiographic Variables of Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Bypass Graft Surgery plus Intramyocardial Bone Marrow Cell Injection M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira, L. H. W. Gowdak. P371 Left Main Coronary Artery Disease is Correlated to the Clinical Characteristics of Stable Coronary Artery Disease Patients. A Study Ajusted to the Coronary Atherosclerotic Burden A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak. P373 Bisoprolol and perindopril combination in post infarction left ventricle remodelling K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan . P374

Cardiac resting metabolism: energetic cost of calcium withdrawal P. Bonazzola, D. Takara.

Scientific Programme / 193

Poster Listing P375 Tissue Doppler Tricuspid Annular study with loading variations: clinical and pronostical interest G. Robles, M. Feissel, R. Khalaky, J. Badie, O. Ruyer, A. Grentzinger, J. P. Faller.

P376 CAN WE USE THE QRS COMPLEX AXIS AS A ELECTROCARDIOGRAPHIC PREDICTOR OF EFFICACY OF CARDIAC RESYNCHRONIZATION THERAPY? J. García-Seara, B. Cid Alvarez, J. L. Martinez Sande, M. Bastos Fernandez, A. Varela Roman, L. Grigorian Shamagian, P. Rigueiro Veloso, E. Gonzalez Babarro, J. R. Gonzalez-Juanatey.

P377 INVERSE REMODELING AFTER DEPENDENT CAVOTRICUSPID ISTHMUS FLUTTER ABLATION J. García-Seara, L. Martinez-Sande, B. Cid Alvarez, F. Soto Loureiro, R. Vidal Perez, M. Bastos Fernandez, M. Gutierrez Feijoo, M. Vega Fernandez, J. R. Gonzalez Juanatey. P378 Echocardiographic assessment of early left diastolic dysfunction and correlation with BNP serum levels estimation in patients without clinical heart failure K. Hristova, S. Milanov, I. Filibev.

P379 ECHOCARDIOGRAPHIC REGIONAL RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM K. Hristova, S. Milanov, I. Filibev, D. Petrov. P380 THE RELATIONSHIP BETWEEN SERUM HBA1C LEVELS AND SEVERITY OF CORONARY ARTERIAL DISEASE IN DIABETIC PATIENTS O. C. Yontar, A. Erdem, M. B. Yilmaz, K. Yalta, I. Tandogan.

P381 Entry – and exitblock as endpoints in segmental pulmonary vein isolation by irrigated catheter ablation and the mesh mapper technique A. Meissner, M. Von Bracht, M. Christ, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn. P382

SCREENING PATIENTS FOR HYPERTENSION IN EMERGENCY DEPARTMENT K. Hristova, S. Milanov, I. Filibev.

P383 PREVENTION ON MORTALITY AND SUDDEN CARDIAC DEATH IN PATIENTS WITH CARDIOVASCULAR DISEASES: EFFECT OF HIGHLY PURIFIED OMEGA – 3 FATTY ACID (OMACOR). K. Hristova, S. Milanov, I. Filibev. P384 Non-invasive assessment of arterial pulse pressure by using automatic analysis of B-mode echographic images S. Graf, R. Armentano.

Poster Listing P385 LONG - TERM EVOLUTION OF R WAVE AMPLITUDE IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MD Di Toro Dario, RCT Lopez Carlos, MD Hadid Claudio, MD Luis Vidal, MD Carlos Labadet.

P387 STUDY OF THE DEGREE OF KNOWLEDGE THAT THE CARDIOLOGISTS IN THE CITY OF SÃO PAULO BRAZIL HAVE ABOUT AN ENTITY WITH LOW PREVALENCE ASSOCIATED TO SUDDEN CARDIAC DEATH: BRUGADA SYNDROME A. R. Perez Riera, C. Ferreira, C. Ferreira Filho, E. Schapachnik, S. Dubner, A. H. Uchida, L. Zhang.

P388 “SHARP-SUVED”… Proved Integrated Management with Indian Systems of medicine for CAD (Coronary Artery Disease) V. Marathe, S. Vaidya.

P389 Right ventricular mechanic analysis and pulmonary distensibility during the ergo-metric effort J. Tripolone, G. Santiago, C. Rollan.

P390

New Left Ventricular Function Index. ¨Miocardic acceleration concept J. Tripolone, G. Santiago, M. Salguero.

P391 Asymptomatic Paroxistic Atrial Fibrillation.“The importance of being silent” J. Gant Lopez, F. Meiller, F. Deketele, A. Garcia Aguirre, A. Morales Lezica, M. Passauer, M. Cabo Fustaret, G. Maid, C. Rivas.

P393 Evaluation of Coronary Arterial Illness Risk Factors in Amazonians Inhabitants of the Mutucal Island, City of Curuçá-Pará. L. Freire, R. Freire, B. Faillace, M. Palmeira, M. Lemes, I. Faillace, H. Azevedo.

P394 Presence of the Cardiovascular Risk Factors in Patients Attended in the Cardiology Clinic of the University of the State of Pará. L. Freire, R. Freire, B. Faillace, M. Palmeira, I. Faillace, M. Lemes, H. Azevedo.

P396 RISK FACTORS FOR CORONARY EVENTS AND BASELINE DEMOGRAPHICS IN JAPANESE MEN. J. Sasaki, K. Fukuyo, K. Shimomura. P397 Cardioprotective Effects of Nigella Sativa on Cyclosporine A-induced Cardiotoxicity in Rats Y. Selcoki, E. Uz, B. Uz, R. Bayrak, A. Kaya, F. H. Turgut, A. Karanfýl, S. Sahýn, N. Baybek, A. Akcay.

P398 The Influence of the Beta-Adrenergic Agonists and Antagonists on T-wave Alternans and late potential in Patients with Ventricular Tachyarrhythmia N. Komiya, S. Fukae, S. Seto.

Scientific Programme / 195

Poster Listing P399 Effect of Carvedilol and Bisoprolol on parameters of quality of life in patients with chronic heart failure U. Kamilova, S. Shukurjanova, S. H. Jurayeva, R. Rahmonov, A. Kevorkov.

P400 EFFECT OF BISOPROLOL AND CARVEDILOL ON PARAMETERS OF LEFT VENTRICLE REMODELLING IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS Z. Shoalimova, U. Kamilova, S. H. Jurayeva, A. Kevorkov, T. Aliyeva.

P401 SUPERIORITY OF LEVOSIMENDAN OVER DOBUTAMINE IN LOW CARDIAC OUTPUT SYNDROME AFTER AORTIC VALVE REPLACEMENT R. Levin, M. Degrange, C. Del Mazo, R. Porcile, E. Tanus, N. Blanco, F. Salvagio, L. Botbol, V. Milman.

P402 Long Time Prognostic Value of CK-MB Mass in Low-Risk Patients with Stable Angina Scheduled for Cardiac Surgery Kjell Vikenes, Knut S. Andersen, Tor Mellberg, Mikael Farstad, Jan Erik Nordrehaug.

P403 EFFECT OF CARVEDILOL ON MYOCARDIAL PERFUSION IN PATIENTS WITH CHRONIC HEART FAILURE U. Kamilova, S. H. Jurayeva, T. Aliyeva, A. Kevorkov, B. Myasnik.

P405 The combination of amlodipine 10mg and valsartan 160mg lowers blood pressure effectively and safely in elderly hypertensive patients not controlled by combination therapy with an ace inhibitor and a calcium channel blocker P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.

P406 Evaluation of Healthcare Provider Inertia in the Management of Cardiovascular Disease (CVD) Risk Factors in Primary Care Settings in Cape Town K. Steyn, N. Levitt, M. N. Hill, C. Dennison, N. Peer, J. Fourie .

P407 SHORT AND LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITHOUT KNOWN DIABETES AND ABNORMAL GLUCOSE REGULATION: CLINICAL IMPLICATIONS J. De La Hera, E. Hernández, J. Vegas, J. García-Ruiz, R. Suarez-Arias, I. Lozano, C. Fernández-Cimadevilla, P. Avanzas, F. Alvarez, C Morís.

P408 IMPACT OF UNKNOWN DIABETES DIAGNOSIS WITH ORAL GLUCOSE TOLERANCE TEST IN CORONARY PATIENTS: IDENTIFICATION OF POSSIBLE IMPROVEMENTS IN SECONDARY PREVENTION MEASURES J. De La Hera, E. Hernández, J. Vegas, P. Avanzas, J. García-Ruiz, R. Suarez-Arias, F. Torres, D. Calvo, E. Delgado, C. Morís.

Poster Listing P409 ORAL GLUCOSE TOLERANCE TEST PERFORMANCE AND MULTIDISCIPLINARY TEAM APPROACH IMPROVE SECONDARY PREVENTION MEASURES IN NON-DIABETIC CORONARY PATIENTS J. De La Hera, E. Hernández, J. Vegas, R. Suarez-Arias, P. Avanzas, J. García-Ruiz, I. Lozano, A. Carro, E. Delgado, C. Morís.

P410 Poly(ADP-ribose) Polymerase (PARP) Inhibitor HO3089 Enhanced Post Ischemic Myocardial Glucose Uptake Mostly By Activation Of AMP-activated Protein Kinase (AMPK) E. Bognar, G. Y. N. Kiss, Z. S. Sarszegi, E. Bartha, I. Solti, B. Sumegi, Z. Berente .

P412

SURGERY DEATH RATE PREDICTORS IN PATIENTS WITH SEVERE AORTIC STENOSIS L. Gerones, L. Godoy, F. Bourdin, J. Como Birche, M. D’Aglio, F. Bravo, J. Aringoli, R. Martinez, P. Flaherty, R. Marelli.

P413 Baseline characteristics in patients with Chagas Heart Disease Implanted with a Defibrillator. Does the presence of a Ventricular Aneurysm make any difference? C. Hadid, C. Lopez, D. Di Toro, L. Vidal, C. Labadet. P414 PREVENTION OF RADIAL ARTERY SPASM IN CORONARY SURGERY WITH IN VITRO OVER-DILATION D. Guastavino, M. Nahin, G. Vizcarra, G. Cozzarin, S. Budelli, A. Zillo, D.R. Grana, J. Milei.

P415 Time-course of regression of the protection conferred by simulated high altitude on rat myocardium. I. Response to calcium and to hypoxia/ reoxygenation. P. La Padula, L. Costa. P416 Clinical 2-year follow-up results in bifurcation lesions with sirolimus-eluting stents and bare-metal stents. T. Ashikaga, S. Niki, H. Fujii, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, M. Isobe.

P417 Time-course of regression of the protection conferred by simulated high altitude on rat myocardium. II. Mitochondrial NOS activity and expression. P. La Padula, J. Bustamante, A. Czerniczyniec, L. Costa.

P418 Self-reported leisure-time physical activity predicts long-term survival in patients with coronary heart disease F. Apullan, M. Bourassa, J. C. Tardif, A. Fortier, M. Gayda, A. Nigam.

P419 The Time of Cardioversion In Patients With Hyperthyroidism and Atrial Fibrillation H. Arý, E. Erdogan, V. Koca, T. Bozat .

Scientific Programme / 197

Poster Listing P420 Long-term outcome of the off-label use of paclitaxel-eluting stents: insights from a cohort of 604 patients X. Flores-Ríos, J. P. Abugattás-De Torres, R. Marzoa-Rivas, R. Campo-Pérez, G. Aldama-López, J. Salgado-Fernández, R. Calviño-Santos, J. M. Vázquez-Rodríguez, N. Vázquez-González, A. Castro-Beiras. P421 THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY COMBINATION THERAPY WITH AN ACE INHIBITOR AND A CALCIUM CHANNEL BLOCKER P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.

P422 THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD PRESSURE EFFECTIVELY AND SAFELY IN OVERWEIGHT AND OBESE HYPERTENSIVE PATIENTS NOT CONTROLLED BY COMBINATION THERAPY WITH AN ACE INHIBITOR AND A CALCIUM CHANNEL BLOCKER P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.

P423 THE COMBINATION OF AMLODIPINE 10 MG AND VALSARTAN 160 MG LOWERS BLOOD PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS WITH METABOLIC RISK FACTORS NOT CONTROLLED BY COMBINATION THERAPY WITH AN ACE INHIBITOR AND A CALCIUM CHANNEL BLOCKER P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs.

P424 Percutaneous Coronary Interventions in Octogenarians: Immediate and Middle-Term Results M. Centemero, O. Belzares, C. E. Soares, F. Maia, R. Staico, F. Feres, I. Pinto, L. A. Mattos, A. G. M. R. Sousa, J. E. Sousa.

P426 TYPE 2 DIABETES AND METABOLIC SYNDROME: LIPID TRANSFER FROM AN ARTIFICIAL LIPIDIC NANOEMULSION TO HIGH DENSITY LIPOPROTEIN V. M. Silva, C. G. C. Vinagre, M. P. Bertato, C. P. Oliveira, A. P. M. Chacra, R. C. Maranhão. P427

ROSUVASTATIN AND AORTIC REMODELING IN NITRIC OXIDE DEFICIENT RATS R. Neto-Ferreira, V. N. Rocha, L. S. R Reis, A. L. R Nascimento, C. A. Mandarim-De-Lacerda, J. J. Carvalho.

P428

Role Of Sildenafil In Eisenmenger Syndrome: A Pilot Study N. Garg, U. Agrawal, N. Sinha .

P429 EXERCISE TRAINING LEFT VENTRICULAR REMODELING IN MALES AND FEMALES RATS V. B. Carranza, O. A. Pinilla, E. M. Escudero. P430 SHORT AND LONG TERM RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS OLDER THAN 80 YEARS OLD S. Bulur, S. Ordu, E. S. Albayrak, A. Kaya, S. Bulur, H. Ozhan, M. Yazici.

Poster Listing P431 Epidemiology in Rheumatic Valvular Disease Surgical Replacement in a Developing Country. Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura, Monica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Carlos Alberto M. Magalhães, José Oscar Reis Brito, Márcia Cristina C. M. Pinheiro, Clara Weksler. P432 SHORT AND LONG TERM FOLLOW-UP RESULTS OF PATIENTS WHO ARE IMPLANTED WITH R-STENT: A SINGLE CENTER EXPERIENCE S. Bulur, A. Kaya, S. Bulur, S. Ordu, H. Özhan, M. Yazici.

P433 Mortality Among Patients Submitted to Valvular Surgical Procedures. Is there any difference between rheumatic and degenerative valvular disease groups? Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura, Monica Moura De Vasconcellos, Carlos Alberto M. Magalhães, Arn Migowski Rocha Dos Santos, Clara Weskler, Vitor Manuel Pereira Azevedo, José Oscar Reis Brito. P434 Systemic vascular resistance measurement by echocardiography in chronic congestive heart failure: a tool to optimize medical prescription of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. L. Florio, G. Vignolo, R. Centurión, J. Pouso. P435 Effect of cardiac arrest induced by cardioverter defibrillator (ICD) testing on ischemia modified albumin (IMA). L. Woie, Ø. Hetland, J. T. Kvaløy, D. W. T. Nilsen.

P436 Epidemiological Profile of the Surgical Interventions in Valvular Diseases in a Developing Country. Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura, Mônica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Arn Migowki Rocha Dos Santos, Clara Weskler, Márcia Cristina C. M. Pinheiro, José Oscar Reis Brito. P437 Intracardiac electrocardiographic (EGM) morphology changes in patients with implantable cardioverter defibrillator (ICD). L. Woie, T. Eftestøl, J. T. Kvaløy, T. Aarsland, K. Tjelta, D. T. W. Nilsen.

P438 The Prevalence of Hypertension and its Association with Body Weight Index in Hungarian Policemen G. Simonyi, J. R. Bedros, K. Szakolczai, M. Medvegy, T. Csatay, L. Halmy.

P439

The Effects of Vegetarian Diets on Chylomicron Metabolism J. C. M. Vinagre, C. G. Vinagre, F. S. Pozzi, E. Slywitch, R. C. Maranhão.

Scientific Programme / 199

Poster Listing P440 Cortical renal volume measurements by using multi-detector row CT and its relationship with primary hypertension J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa. P441 Left ventricle evaluation with 64-row Gadolinium enhanced cardiac CT. P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa, M. Garcia.

P442 Multi-detector computed tomography feasibility´s in calculating the cortical renal volume J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa. P443 Prevalence of myocardial bridging in 64-row MDCT coronary angiographic studies. P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa, M. Garcia.

P444 Risk Stratification in Non-ST Segment Acute Coronary Syndromes Based on Acute and Chronic Risk Scores Derived From the European Guidelines M. Dorobantu, A. G. Fruntelata, M. Stefuriac, M. Chiru, L. Platica, A. Crusitu, A. Scafa-Udriste. P445 Relationship between dietary intake of alcohol and some metabolic and cardiovascular risk factors in healthy men L. Vitek, M. Kalousova, B. Stankova, L. Novotny, P. Schreib, T. Zima, A. Zak.

P446 Elderly patients with STEMI are suboptimally treated with reperfusion therapy Z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky.

P447 Use of not evidence based treatments among elderly real world patients hospitalized with acute heart failure. A. Macchia, G. Ciambrone, N. Laffaye, J. Gambarte, S. Donato, N. Rizzo, F. Novo, C. Higa, P. Comignani. P448 ASSESSMENT OF CAROTID-RADIAL PULSE WAVE VELOCITY CHANGES AFTER INDUCED ISCHEMIA E. Rusak, O. Iavicoli, S. Vazquez, S. Robert, M. Duarte, J. Lerman, C. Bellido. P449 Brain Natriuretic Peptide Increases 24 Hours After Acute Myocardial Infarction Irrespective of Reperfusion and Is a Marker of Early Left Ventricular Remodeling M. Dorobantu, R. Onut, A. Scafa-Udriste, D. Constantinescu, A. Alexandrescu, A. Vasile, E. Gainoiu, A. G. Fruntelata. P450

Effect of repeated coronary angioplasty on QT dispersion E. Z. Soliman, M. Abdel-Salam .

Poster Listing P451 Discrepancy between Troponins T and I in chronic hemodialysis patients H. Trimarchi, M. Dicugno, M. Mongitore, M. Forrester, A. Toscano, F. Lombi, M. Vera, M. Alonso, H. Pereyra, A. Muryan. P452 Correlation between chest pain and acute coronary syndrome diagnosis M. Assad, A. Volschan, M. Diniz, LH. Fonseca, M. Santos, C. Stipp, A. Sa, E. Mesquita. P453 AGE-RELATED CHANGES IN MYOCARDIAL OXIDATIVE STRESS AND THE INTERVENTIONAL EFFECT OF DHEA M. H. V .M. Jacob, D. R. Janner, A. Belló-Klein, M. F. M. Ribeiro.

P454 MORPHOLOGIC PATTERN OF LATE GADOLINIUM ENHANCEMENT IN TAKO-TSUBO SYNDROME. “ANOTHER CLUE TO SOLVE THE ENIGMA”. G. Avegliano, M. Huguet, P. Kuschnir, A. Panaro, F. Botto, G. Oller, D. Capdeferro, A. Frangi, R. Ronderos, M. Petit.

P455 Delayment factors for medical assistance search in patients with chest pain M. Assad, A. Volschan, M. Diniz, L. H. Fonseca, M. Santos, C. Stipp, A. K. Sá, E. Mesquita. P456 Acute effect of sildenafil citrate on pulse wave velocity in middle-aged patients M. Assad, A. Brandão, R. Pozzan, E. Magalhães, A. P. Brandão.

P457

BAROREFLEX FUNCTION ASSESSTMENT BY A NON-INVASIVE PRESSOR TEST M. Duarte, D. R. Grana, C. A. Bellido, J. Milei.

P458

Exercise ventilatory response in diabetic patients R. Peidro, D. Motta, A. Angelino, G. Brión, E. Navia, P. Diaz Uberti, R. Favaloro .

P459 DEMOGRAPHIC CHARACTERISTICS OF OVER SIX HUNDRED RENAL ARTERIES INTERVENTIONS. N. Schechtmann, Md. Facc, E. Polanco Md, S. Karas, Md. Facc. P460 Cardiac Magnetic Resonance Has Advantages Over 2D Echocardiography In Assessment Of Mitral Stenosis Patients. A. Rapaee, C. K. Liew, A. Y. Y. Fong, C. K Ang, H. B Liew, W. M Chin, B. S. P Chin, T. K Ong, K. H Sim.

P461 Impairment of Endothelial Function In Newly Diagnosed Hypertensive and Prehypertensives Patients A. Rapaee, H. Nawawi, K. Yusoff.

P462 Diagnostic and treatment algorithm for sustained ventricular tachycardia in chronic Chagas disease R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti, A. Sinisi.

Scientific Programme / 201

Poster Listing P463

Furosemide induced cardiac alterations in thiamine-deprived rats S. Cunha, J. C. Bastos, J. B. Salles, M. C. C. Silva, V. L. F. C. Bastos, C. A. Mandarim-De-Lacerda.

P464 Risk stratification in asymptomatic severe mitral regurgitation: clinical, biochemical and echocardiographic variables. Is it possible to determine adverse clinical outcome? R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, J. Krauss, A. Cagide.

P465 Isolated coronary artery disease of the diagonal branch of the left anterior descending artery V. Kuznetsov, I. Bessonov, I. Zyrianov, G. Kolunin, D. Krinochkin, M. Semukhin, M. Bessonova, L. Frazin. P466 Association between polymorphisms of the Renin-Angiotensin System genes and essential hypertension: a community-based study in Southern China Y. Zhan, X. Jiang, H. Sheng, J. Li, P. Xun, Y. Cheng, J. Huang, H. Xiao.

P467 Implementation and Results of a Comprehensive Cardiac Rehabilitation Program in a Developing Country. E Rivas Estany, J. Alvarez Gomez, J. Barrera Sarduy, S. Sixto Fernandez, L. Rodriguez Nande, C. Kesser Garcia. P468 Effect of PARP inhibition on young spontaneously hypertensive rat (SHR) hearts E. Bartha, R. Halmosi, I. Solti, E. Bognar, K. Kovacs, T. Habon, T. Kálai, B. Sumegi, K. Hideg, K. Toth.

P469 Significance of determining troponin I levels in the evaluation of patients with isolated form of aortic stenosis before and after aortic valve replacement A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, V. Maravic, D. Brunner .

P470 The effect of aortic valve replacement on B type BNP in patients with isolated form of severe aortic stenosis and not impaired systolic function A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, S. Tomic, D. Brunner. P471 Using of arterial graft (LIMA) in prediction of frequent occurrences of pericardial effusion after CABG A. Nikolic, S. Tomic, L. J. Jovovic, M. Vukovic, L. J. Trkulja, M. Zlatanovic, B. Djukanovic .

P472 Prolactin inhibition improves clinical outcome in peripartum cardiomyopathy patients presenting with subsequent pregnancy O. Forster, D. Hilfiker-Kleiner, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Yip, A. Becker, K. Sliwa.

P473 T-cell mediated autoimmune reaction in peripartum cardiomyopathy might be reflected by activity of pro-inflammatory cytokines O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Becker, K. Sliwa.

Poster Listing P478 Time Course Pattern of Immunoglobulin M in HIV Positive and HIV Negative Peripartum Cardiomyopathy Patients O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, M. J. Nel, A. Becker, K. Sliwa.

P479 acute coronary syndromes in black south african patients with human immunodeficiency virus infection: the clinical and angiographic features A. C. Becker, K. Sliwa, S. Stewart, E. Libhaber, A. R. Essop, M. R. Essop.

P480 Heat shock proteins antibody level and associated disease in patients undergoing cardiac operation. V. Kecskemeti, A. Szebeni, Z. Prohaszka, I. Matko, Z. Szabolcs .

P481 Circadian Rhythm and Risk Factors in Isolated Nocturnal Hypertension G. Simonyi, R. J Bedros, M. Medvegy.

P482 Prevalence of Sleep Related Breathing Disorders in Patients with Chronic Heart failure and their Improvement with cardiac resynchronisation therapy K. Seidl, M. Strauß, T. Kleemann, T. Becker. P483 Prevalence of Complete Electrical Pulmonary Vein Isolation Using an Anatomically Guided Approach Assessed by a Novel High Density Circumferential Mapping Catheter K. Seidl, T. Becker, T. Kleemann, M. Strauß. P484 Interraction in changes of an endothelium status and clinical current in patients with CHF on a background of therapy ACE inhibitors M. Sitnikova, T. Maximova, C. Kchmelnitskaya.

P485 Locally delivered Tetradecylthioacetic acid (TTA) reduces inflammation and collagen formation after coronary balloon injury in a porcine model R. P. Reidar Pettersen, M. S. Mohamed Salem, S. R. Svein Rotevatn, K. K. Karel Kuiper, T. L. Terje Larsen, P. B Pavol Bohov, R. B Rolf Berge, J. E. N. Jan Erik Nordrehaug.

P486 The Age-BNP Survival Model: Prediction of survival in old (>75 years) patients with heart failure E. Shlyakhto, M. Sitnikova, T. Lelyavina. P487 Interaction between the ACE polymorphism genes (insertion/deletion) and the particular clinical features of congestive heart failure, structural and functional indexes of the heart and mortality M. Sitnikova, S. Ivanov, O. Krasnova, E. Shlyakhto.

Scientific Programme / 203

Poster Listing P488 IMPROVEMENT IN SIX-MINUTE WALK TEST PERFORMANCE AFTER A SINGLE DOSE OF SILDENAFIL IN CHRONIC HEART FAILURE PATIENTS J. Curotto Grasiosi, A. Paragano, M. Pelliza, D. Cordero, R. Machado, A. Abdala, G. Bertelle, R. Perez, C. Magallanes, R. Esper. P489 SERUM MATRIX METALLOPROTEINASE-9/TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 AND LEFT VENRICLE PERFORMANCE IN PATIENTS WITH AORTIC STENOSIS N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto.

P490 HYPERTRIGLYCERIDEMIA: AN INDEPENDENT PREDICTOR STRONGLY CORRELATED WITH OTHER CARDIOVASCULAR RISK FACTORS? A. Paragano, J. Curotto Grasiosi, R. Machado, D. Cordero, A. Abdala, P. Merlo, J. Lopez Diez, D. Alasia, C. Magallanes, R. Esper. P491 Right coronary artery morphology by 64-row MDCT in patients with left dominant system. P. Carrascosa, C. Capuñay, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa. P492 Clinical perception of MS vs. Diagnosis according to ATPIII criterion. CARISMA (Characterization and risk analysis of individuals with metabolic syndrome) study group. G. Cerezo, A. Vicario, N. Vainstein, E. Biasin, D. Ricon, D. Piskorz, I. Nocetti, C. Brommer, M. Miragaya.

P493

Estrogen-dependent gene expression in human cardiac tissue G. Kararigas, E. Becher, V. Regitz-Zagrosek.

P494 Dobutamine dynamic intraventricular gradient and hypertrophic cardiomyopathy: morphologic and functional evaluation by cardiac magnetic resonance M. Ferreira, P. Donato, S. Monteiro, T. Pereira, R. Martins, F. Caseiro-Alves, L. A. Providência.

P495 Cardiac magnetic resonance in the study of patients with a dynamic intraventricular gradient during dobutamine stress echocardiography M. Ferreira, P. Donato, S. Monteiro, R. Martins, F. Caseiro-Alves, L. A. Providência. P496 Tumor necrosis factor alpha, interleukin 1 and interleukin 1 receptor antagonist polymorphisms in Mexican patients with myocardial infarction. G. Vargas-Alarcón, J. M. Fragoso, J. M. Rodríguez-Pérez, N. Pérez-Hernández, D. Cruz-Robles, E. Chuquiure, C. Martínez, Marco A. Martínez Ríos, P. A. Reyes. P497 Gender differences in presentation and prognosis in population with acute chest pain suspected to be related with acute cardiac ischemia M. Ferreira, V. Rodrigues, F. Santos, L. A. Providência.

Poster Listing P498 Sudden Cardiac Death and Defibrillators in Latin America. Primary and. Secondary Prevention. Data from the ICD Registry Latin America. R. Keegan, R. Eloy Pereyra, F. Colombo, W. Uribe, J. Cordero Cabra, C. Tentori, V. Moraes, K. Griffith, J. Maloney, C. Muratore . P499 BENEFICIAL EFFECTS OF TRIMETAZIDINE, GIVEN BEFORE PERCUTANEOUS CORONARY INTERVENTION, ON MYOCARIAL DAMAGE DURING THE PROCEDURE A. Yilmaz, A. Erdem, K. Yalta, S. Sarikaya, M. B. Yilmaz, O. O. Turgut, I. Tandogan.

P500 ABDOMINAL OBESITY: AN INDICATOR OF EXTENSIVE CORONARY ARTERIAL DISEASE IN NSTEMI PATIENTS? A. Erdem, O. C. Yontar, S. Sarikaya, A. Yilmaz, K. Yalta, M. B. Yilmaz, I. Tandogan.

P501 EFFECTS OF CHRONIC WATER RESTRICTION ON CARDIOVASCULAR M.P. Da Rosa, P. Arza, A. Fellet, M. Toscani, C. Arranz, M. A Costa, A. M Balaszczuk.

P502 The Interleukin 1B –511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients. G. Vargas-Alarcon, E. Malpica-Miranda, J. M. Fragoso, H. Delgadillo-Rodríguez, J. M. Rodríguez-Pérez, C. GonzálezQuesada, N. Martínez-Rodríguez, M. A. Peña-Duque, Marco A. Martínez Ríos.

P503 ENDOTHELIAL FUNCTION AND HORMONE REPLACEMENT WITH TIBOLONE IN MENOPAUSAL WOMEN J. Gomez-Mancebo, M. Navarrete, L. A. Sanchez, A. Pinzon.

P504 Coronary artery bypass surgery in diabetes E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, R. R. Favaloro.

P505 Relationship between inflammatory biomarkers, oxidative stress and morpho-functional mitochondrial changes in experimental atherogenic model M. C. Baez, M. Tarán, V. Campana, P. Pons, J. C. Simes, D. F. Comay, J. A. Palma, M. Moya.

P506 HYPERTROPHIC CARDIOMYOPATHY AND PREGNANCY RELATED COMPLICATIONS. F. Landeta, A. Fernandez, J. H. Casabe, F. Vaisbuj, C. Lopez, R. Coronel, R. Bianco, E. Guevara.

P507 EFFECTS OF A COX-2 ANTAGANONIST ON VASCULAR INFLAMMATION ASSOCIATED TO A MODEL OF METABOLIC SYNDROME N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello.

P508 Characteristics of Hypertrophic Cardiomyopathy in the elderly J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez, E. Guevara.

Scientific Programme / 205

Poster Listing P509 Early and late outcome in patients with End Stage Renal Failure under chronic dialysis undergoing cardiac valve surgery: mechanical versus biological prosthetic valve A. Hershson, M. Cabello, R. Coronel, G. Stampone, P. Roura, P. Raffaelle, J. Abud, E. Dulbecco, H. Raffaelli, R. Favaloro.

P510 Is there any difference at presentation in infantile dilated cardiomyopathy regarding the age? Vitor Manuel Pereira Azevedo, Marco Auré,lio Santos, Má,rcia Bueno Castier, Maria Cristina C. Kuschnir, José, Geraldo De Castro Amino, Maria Ourinda Mesquita Cunha, Rogé,rio Brant Martins Chaves, Bernardo Rangel Tura, Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier.

P511 Inappropriate ICD shocks: Incidence, predictors and prevention of recurrence. COMPAS registry. N. Galizio, S. Schanz, L. Medesani, P. Montoya, M. Ramirez, L. Soriano, G. Fava, R. Raña, H. Fraguas, J.L. Gonzalez.

P512 Use of a Selective Beta-Blocker in Pediatric Patients with Long QT Syndrome J. Moltedo, N. J Kertesz, M. S Abello, R. A Friedman, A. L Fenrich, B. C Cannon.

P513 Radiofrequency ablation in patients with congenital heart disease J. Moltedo, M. Abello, A. Ithuralde, C. Seara, H. Grancelli, M. Campos, N. Fernandez, S. Waldman, M. Ithuralde.

P514 Predictor factors for death in coronary artery bypass surgery patients. Which could be modified before surgery? Renato Kaufman, Vitor Manuel Pereira Azevedo, Maria Cristina C. Kuschnir, José Geraldo De Castro Amino, Marco Aurelio Santos, Rogério Brant Martins Chaves, Carlos Alberto Moreira Magalhã, Arn Migowski Rocha Dos Santos, Bernardo Rangel Tura, Regina Maria De Aquino Xavier.

P515 The relationship between serum lipids and quartiles of the omega-3 index in a beef eating population in Argentina as compared to a fish eating ACS population in Norway. R. Leòn De La Fuente, H. Aarsetoey, P. Gallo, V. Pönitz, T. Aarsland, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, D. W. T. Nilsen.

P517 Early Arrhythmic Events and Quality of Life after Radiofrequency Catheter Ablation of Atrial Fibrillation T. Balabanski, V. Traykov, T. Shalganov, B. Dinov, M. Protich.

P518 PREVALENCE OF PROLONGED QT INTERVAL IN LEFT VENTRICULAR HYPERTROPHY. M. Orellana, P. Adriazola, F. Bello, P. Trejo, P. Gonzalez, E. Escobar.

P519 Stepwise algorithm. Diagnostic accuracy of the supraventricular tachycardia mechanism. P. Montoya, J. L. Gonzalez, N. Galizio, G. Fava, S. Schanz, L. Medesani, L. Soriano, R. Raña, M. Ramirez.

Poster Listing P520

THE EFECT OF SIMVASTATIN ON THE DECREASE OF INTIMOMEDIAL COMPLEX OF CAROTIDAL ARTERIES IN PATIENTS WITH ARTERIAL HYPERTENSION D. L. Lovic Dragan, B. L. Lovic Branko, M. L. Lovic Milan, D. D. J. Djordjevic Dragan, I.T. Tasic Ivan.

P522 Aspirin resistance and cardiovascular events after Percutaneus Coronary Intervention. I. Santos-Rodriguez, I. Gonzalez-Mendia, C. Alonso-Buron, V. Ramirez-Castro, M. J. Ruiz-Olgado, M. L. Lopez, M. Cascon-Bueno, J. Rodriguez-Collado, M. Diego-Dominguez, I. Alberca.

P523 CARDIAC INVOLVEMENT IN SYSTEMIC SCLEROSIS M. E. Isasi Capelo, E. S. Isasi Capelo.

P524

 AGNETIC RESONANCE EVALUATION OF PULMONARY REGURGITATION M R. Parra, F. Heusser, G. Urcelay, P. Becker, E. Villanueva, J. Otero, C. Toledo, C. Garcia.

P526 Early identification of preserved systolic function in acute decompensated heart failure. E. Fairman, V. Mauro, A. Charask, Y. Castillo Costa, L. Rodriguez, M. Ferrer, C. Barrero.

P527 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IN HIGH RISK PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY. FOLLOW-UP. G. Fava, N. Galizio, J. L Gonzalez, H. Casabe, A. Fernandez, E. Guevara, L. Medesani, P. Montoya, S. Schanz, F. Landeta.

P528 The relationship between BNP and hsCRP and quartiles of the omega-3 index in a beef eating ACS population in Argentina as compared to a coastal ACS population in Norway. R. Leòn De La Fuente, H. Aarsetoey, T. Brügger-Andersen, V. Pönitz, S. A. Dib Ashur, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, D. W. T. Nilsen.

P529 Assessment of Anemia and Renal Function in Patients with Heart Failure: A Comparison of Patients with Left Ventricular Systolic Dysfunction Versus Preserved Systolic Function B. Sáenz, E. Barcellos, H. Villacorta, L. Costa Lima, . Soares, C. Wiefels, R. Steffen, A. Salles, E. Tinoco.

P530 PROGNOSTIC UTILITY OF STRESS (99M)Tc-SESTAMIBI SPECT IN RISK STRATIFICATION OF NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES A. Dos Santos, C. Cortes, M. Daicz, J. Peirano, O. Cendoya, G. Marrero, I. Merlo, E. Duronto, E. Gurfinkel.

P531 GRAVITATIONAL STRESS IN RAYNAUD’S PHENOMENON. M.E. Isasi Capelo, E.S. Isasi Capelo.

Scientific Programme / 207

Poster Listing P532

H eart rate recovery after a cardiovascular rehabilitation program R. Peidro, P. Diaz Uberti, G. Brión, A. Angelino, E. Navia, D. Motta, F. Peidro, M. Santa María, R. Lowenstein, R. Favaloro.

P533 NON-PHARMACOLOGICAL PREVENTION OF ATRIAL FIBRILATTION AFTER OFF-PUMP CABG: TEMPORARY ATRIAL EXTERNAL STIMULATION F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza.

P534 Predicting Elevated C-Reactive Protein Levels by Body Mass Index and Waist Circumference in Type 2 Diabetes Patients A. C. Cordeiro, I. Castro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr., L. Lotaif, L. S. Piegas, C. Amodeo.

P535

 octurnal blood pressure pattern in obese patient with and without sleep N apnea G. Simonyi, J. R. Bedros, M. Medvegy.

P536 Glutathione peroxidase, superoxide dismutase, TNF-alpha, CRP and VCAM-1 are markers of metabolic syndrome T. Francuz, J. Gminski, K. Siemianowicz, M. Goss, J. Kopec.

P537 LDL-c, HDL-c and glucose optimization using phytonutrient combination therapy in diabetes I. Martinez, B. Horne, P. Verdegem.

P538 Influence of myocardial ischemia and the number of obstructed coronaries at major coronary events in patients submitted to medical treatment only. T. Carvalho, M. Benetti, A. L. C. Hallal, A. J. Mansur.

P539 Acute Coronary Sindromes without significant coronary lessions: clinical profile and long term outcome. C. Cabrera, D. Barranco, A. Spinelli, G. Vignolo, J. C. Hiriart.

P540 Surgery for coarctation of the aorta in prematures weighting less than 1.900 kg. R. De Rossi, E. Juaneda, G. Campos.

P541

D etecting subclinical alterations in early stages of Chagas’s disease through Holter D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, G. Ranchilio, P. Velazco, J. Armentano.

P542 A new approach for percutaneous intervention of ostial right coronary artery lesions. Feasibility of the Floating Wire Technique G. Carvalho, V. Daher Vaz, J. M. Dias De Azeredo Bastos, S. Pontes Câmara, S. Rassi, A. Carvalho Leme Neto.

Poster Listing P543 Enhanced basal and exertional isometric diastolic function in resistance training athletes E. Fisman, Y. Adler, N. Koren-Morag, D. Tanne, E Lasry, A. Tenenbaum.

P544 The atrial vulnerability parameters of lone atrial fibrillation patients with subclinical hypothyroidism N. Komiya, S. Seto, S. Fukae.

P545

I nsulin Resistance and Clustering of Cardiometabolic Risk Factors in Brazilian Adolescents: Effect of Body Weight I. C. Guimaraes, A. M. Almeida, R. Rocha, A. G. Bittencourt, A. Guimaraes.

P546 COMPLEX AORTIC COARTATION ANGIOPLASTY WITH PTFE-COVERED BALLOON EXPANDABLE STENT M. Granja, L. Trentacoste, J. Damsky Barbosa, V. Lucini, M. Rivarola.

P547

A meta-analysis of trials of Omega-3 fatty acids supplementation in cardiovascular diseases. A. Macchia, R. Marchioli, R. Marfisi, H. Doval, S. Varini, D. Nul, H. Grancelli, P. D. Comignani, J. J. Fuselli, G. Tognoni.

P548 Antibodies against Trypanosoma cruzi ribosomal P proteins induce apoptosis on HL-1 cardiac cells. G. Levy, M. J. Levin, K. Gomez.

P549 CARDIAC REHABILITATION PROGRAM IN PEDIATRIC PATIENTS P. Quiroga, Hermes Ilarraza-Lomel, M. D. Rius Suárez, I. Miranda, C. Zamora, A. Buendía.

P552 DEFINITIVE HIS BUNDLE PACING IN PATIENTS WITH WIDE QRS R. Barba, P. Moriña, J. Venegas, J. M. Fernández, M. Herrera.

P553 Serum triglycerides may reflect the content of cellular omega-3 fatty acids in CHD populations with a low intake of fish. R. Leòn De La Fuente, P. Gallo, S. A. Dib Ashur, E. Lovaglio, A. Torino, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, D. W. T. Nilsen.

P554 RHEUMATIC HEART DISEASE DATABASE AS A FRAMEWORK TO CONSOLIDATE RHEUMATIC FEVER SURVEILLANCE SYSTEM IN BRAZIL. R. M. A. X. Regina Maria Aquino Xavier, M. C. C .K. Maria Cristina Caetno Kuschnir, V. M. P. A. Vitor Manuel Pereira Azevedo, R. E. M Regina Elizabeth Muller, M. C. P. Márcia Cristina Pnheiro, B. R. T. Bernardo Rangel Tura, D. V. Denizar Vianna, M. A. S. Marco Aurélio Santos, E. L. Eliane Lucas, M. F. P. L. Maria De Fátima Pereira Leite.

Scientific Programme / 209

Poster Listing P555 The strong relationship between age of patients but not polymorphisms of genes encoding G-proteins system components and dominant vasodepressor response to tilting in syncopal young and middle-aged patients M. Lelonek, T. Pietrucha, M. Matyjaszczyk, J. H. Goch.

P556 Primary Hypertension in Adolescents – Rio de Janeiro, Brazil M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça, R. M. A. X. Regina Maria Aquino Xavier, R. E. M. Regina Elisabeth Muller, H. D. Henrique D‘abreu, A. M. Arn. Migowski, R. B. C. Rogério Brant Chaves, M. C. P. Márcia Cristina Pinheiro, C. A. M. Carlos Alberto Magalhães, V. M.P. A. Vitor Manuel Pereira Azevedo.

P557 Comparative value of NT-BNP and Tei index in the estimating of the severity of congestive heart failure J. Celutkiene, V. Grabauskiene, R. Steponeniene, J. Misiura, A. Laucevicius.

P558 Non invasive diagnostic methods in controlling the effectiveness of cardioprotective properties of creatinephosphate and agents on the base of native DNA in young athletes L. A. Balykova, L. M. Makarov, I. A. Markelova, I. A. Gorbunova, V. P. Balashov, S. A. Ivyanskij.

P559 Predictors of abnormal heart rate response to dipyridamole in patients undergoing myocardial perfusion SPECT R. S. L Lima, A. De Lorenzo, M. P. Pellini, L. M. B. Fonseca.

P560 Risk Model for cardiac surgery in Argentina: A Bedside Graphic Score. V. Carosella, W. Rodriguez, M. Caceres, M. Sellanes, J. Bilbao, C. Cardenas, C. Pensa, H. Grancelli, C. Nojek.

P561 Gender differences in the approach of coronary artery heart disease J. Erriest, M. Cornelli, G. Vigo, V. Arregui, M. L. Plastino, L. Cartasegna, J. Camilletti.

P562 Influence of chronic renal failure on the heart rate response to dipyridamole of patients undergoing myocardial perfusion SPECT A. De Lorenzo, R. S. L. Lima, M. P. Pellini, L. M. B. Fonseca.

P563 Defibrillation Threshold in Patients of LABOR Registry L. Jurado, C. Martinengo, A. Martín, F. Colosia, R. Samaniego, C. Garillo, E. Valero.

P564 ICD Experience in a Latin American Pediatric Population J. Scaglione, G. Fernandez, G. Maid, M. Senesi, R. Pesce, F. Dorticós, E. Valero, Icd-Labor Investigators.

P565 Risk stratification in patients post-CABG using stress myocardial perfusion SPECT J. Erriest, A. Mele, V. Severicha, P. Kociubinski, J. Camilletti.

Poster Listing P566

A non-linear HRV index used as an indirect measure of left ventricular function D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, C. De Luca, M. Marcia, P. Velazco.

P567 Role of brain natriuretic peptide as a predictor of Right Ventricular Dysfunction in patients with Pulmonary Embolism B. Fabricio, K. Jose, S. Serafim, A. Flavio, P. P. Sampaio, N. Augusto, B. Alexandre, M. Joao.

P568 Increase in the embedding dimension in electrocardiograms of adult and pediatric patients with ventricular arrhythmia and congestive heart failure D. S. Andres, I. M. Irurzun, M. M. Defeo, J. Bleiz, E. E. Mola, D. Perez Casal, J. Paul.

P569 Arterial stiffness surrogates in black-African human immunodeficiency virusinfected patients D. Lemogoum, C. Kouanfack, L. Van Bortel, M. Leeman, J. P. Degaute, P. H. Van De Borne.

P570

R elationship between plasmatic activity of type 1 plasminogen activator inhibitor and the presence of risk factors in patients with type II diabetes. N. Crespi, A. Scicolone, V. Sanchez, G. Scicolone.

P571 Prevalence of hypertension and other cardiovascular risk factors in postmenopausal women. Data from SEPHAR study. M. Dorobantu, E. Badila, S. Ghiorghe, R. O. Darabont, G. Datcu, M. R. Luca.

P572

I nfluence of an adecuate zinc intake during fetal and posnatal and adult life on arterial blood pressure and cardiovascular nitric oxide system C. Arranz, A. Tomat, S. Finella, R. Elesgaray, L. Veiras, A. Balaszczuk, M. A. Costa.

P573 Chronic Carbon Monoxide Exposure is Associated with Increased Electrocardiographic P-wave and QT Dispersion I. Sari, S. Zengin, O. Ozer, C. Yildirim, V. Davutoglu, M. Aksoy.

P574

 ssociation of Changes in Oxidative and Proinflammatory States with Changes A in Vascular Function after a Lifestyle Modification Trial Among Obese Adolescents R. Kelishadi, M. Hashemi, N. Mohammadifard, S. Asgary, N. Khavarian.

P575 Characteristics of Hypertrophic Cardiomyopathy in the elderly J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez, E. Guevara.

P576 Assessment of Right Ventricular Function in Inferior Myocardial Infarction by Tei Index. M. Barranco, R. Migliore, M. E. Adaniya, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi.

Scientific Programme / 211

Poster Listing P577

 NEW TRANSGENIC LINE FOR IN VIVO ASSESSMENT OF BONE-MARROW CELL HOMING TO A DAMAGED CARDIAC TISSUE G. Barila, D. L. Altschuler, J. A. Genovese.

P579

I n-stent restenosis in coronary arteries evaluated with multislice computed tomography of 64 channels A. Bayol, J. Vallejos, R. Peloso, R. Obregon, M. Aguero, J. Baccaro, J. Mazucco, M. Romero, M. Vera, J. Parras.

P580

I mpact of a supervised exercise rehabilitation program on secondary prevention goals after acute coronary syndromes. I. B. Ignacio Batista, H. F. Horacio Fernandez, M. B. Mariano Berro, F. L. Federico Lipszyc, J. B. Jose Bonorino, L. P. Luciano Pastori, S. B. Sergio Baratta, M. O. Martin O’Flaherty, G. I. Gilbert Iacometti, A. H. Alejandro Hita.

P581 Value of electrophysiological testing and catheter ablation in children and adolescents A. Stefani, O. Perez Mayo, G. Costa, R. Speranza, D. Deluso, C. Zuloaga.

P582 Cardiovascular Risk Factors in Rural Mexico: Results from the Proyecto Puentes de Salud K. A. Olson, L. A . Temming, C. R. Clover, T. D. Snyder, A. D. Nanney, I. JvNelligan, A. L. Rollins, B. D. Skinner, P. Y. Frasier, M. G. Cohen.

P583

I nfluence of Emigration of Rural Mexicans to the United States and Cardiovascular Risk Factors in Close Relatives who Remain in Mexico C. R. Clover, L. A. Temming, K. A. Olson, S. M. Skinner, P. Y Frasier, D. Reuland, B. D. Skinner, A. Krishnarao, M. G Cohen.

P590 Correlation between serum high sensitivity CRP level and inhospital cardiac events in the patients with unstable angina H. Kazerani, A. Rai, V. Dehlaghi.

P593 Analysis of Rate-Pressure Product In South Brazilian Population K.C. Belli, T. Dipp, T.F. Panigas, C.F. Panigas, D.C. Bündchen, C.M. Richter, J.Z. Klafke, R. Killing, P.R.N. Viecili.

P596 Analysis of Maximal Oxygen Consumption-VO2 max of a Brazilian Specific Population K. C. Belli, T. F. Panigas, T. Dipp, D. C. Bündchen, C. F. Paniga, C. M. Richter, J. Z. Klafke, M. A. Silva, J. L. C. Pippi, P. R. N. Viecili.

P597

The role of clinical laboratory in high-risk for death groups selection using classification tree analysis for infantile dilated cardiomyopathy. Vitor Manuel Pereira Azevedo, Marco Aurélio Santos, Márcia Bueno Castier, Maria Cristina C. Kuschnir, José Geraldo Castro Amino, Maria Ourinda M. Cunha, Rogério Brant Martins Chaves, Bernardo Rangel Tura, Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier.

Poster Listing P598 JOB STRESS AND ARTERIAL HYPERTENSION IN PREGNANCY J. Marques Neto, S. A. G. Marques, M. S. Queroz, I. Fonseca, S. Moura, N. Oliveira, T. M. Araujo.

P599 DILATED CARDIOMYOPATHIES: TREATMENT WITH STEM-CELLS : EXPERIENCE DURING 30 MONTHS. O. T. Greco, J. L. B. Jacob, R. V. Ardito, M. R. Lago, A. Parro Junior, R. T. Takeda, F. V. Salis, L. P. Ruiz, M. A. Ruiz, A. C. Abreu.

P600 Intrahospital and long term clinic outcomes of coronary angioplasty with drug eluting stent, in diabetic patients, compared with the no diabetic ones. F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A .C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio.

P601 ACAP™CONFIRM: A NEW ALGORITHM BASED ON EVOKED-RESPONSE DETECTION FOR ATRIAL CAPTURE CONTROL. A SHORT-TIME FOLLOW-UP STUDY J. Olagüe, J. G. Martínez, J. J. García-Cuerrero, J. Fernández De La Concha, C. Llorente, F. Crespo, A. Ibañez, M. J. Sancho-Tello, O. Sanz.

P602 New ECG pattern in young patient with catecholaminergic polymorphic ventricular tachycardia L. Makarov, T. Kyryleva, S. Chuprova, V. Komoliatova.

P603

I ntrahospital and late outcomes a unique centre of treatment with different kinds of drug eluting stents, in patients with “Off Label” coronary angioplasty indication. F. F. O. Fernando Fabian Ordonez, C. A. I. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio.

P604 Intrahospital and long term clinic outcomes of treatment with drug eluting stent, in small vessel with “Off Label” coronary angioplasty indication. F. F. O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio.

P607 Hemodynamic Behavior In Different Periods Of Day In A Physical Exercise Program Subjects T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, J. Z. Klafke, R. Killing, P.R.N. Viecili.

P608 Common Mental Disorders and Hypertension in adolescents – Rio de Janeiro, Brazil M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça.

P609 Prognostic significance of microalbuminuria in non-diabetic patients with ST-segment elevation myocardial infarction. A. Dominguez-Rodriguez, S. Samimi-Fard, M. J. Garcia-Gonzalez, G. Yanes-Bowden, A. Sanchez Grande-Flecha, I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez, J. C. Kaski.

Scientific Programme / 213

Poster Listing P610

 orrelation Between Oxidative Stress, Endothelial Injury And Coagulation C Activation In Advanced Chronic Heart Failure O. Korzh, S. Krasnokutskiy.

P611 The Effect of Ambient Temperature Variability 0n Blood Pressure: Two Years of Observation T. F. Panigas, T. Dipp, C. M. Richter, D. C. Bündchen, J. L. C. Pippi, C. F. Panigas, Z. Klafke, K. C. Belli, P. R. N. Viecili.

P612 Analysis of Cardiorespiratory Fitness in a Brazilian Specific Population K. C. Belli, T. Dipp, T. F. Panigas, C. F. Panigas, C. M. Richter, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili.

P614

LEFT ATRIAL DOPPLER TISSUE IMAGING: CHANGES IN PATIENTS WITH CORONARY ARTERY DISEASE. C. Killinger, G. Cabrejos, M. Del Campo, M. Sun, D. Lozano, S. Ferradas, R. Rosental, G. Mohamed, S. Zymerman, E. Beck.

P615

R eduction Of Exaggerated Exercise Blood Pressure Levels In Normotensive Individuals After Physical Exercise Program. C. M. Richter, C. F. Panigas, D.C. Bündchen, K. C. Belli, T. Dipp, T. F. Panigas, J. L. C. Pippi, J. Z. Klafke, R. M. F. Sampedro, P. R. N. Viecili.

P616 Alzheimer’s Type Dementia Versus Vascular Dementia in Hypertensive Patients A. Vicario, C. D. Martinez, G. H. Cerezo.

P617 SEVERE AORTIC STENOSIS AND NONCARDIAC SURGERY IN THE ELDERLY POPULATION. D. De Mollein, C. Dominguez, G. Lopez Soutric, S. Robert, S. Berensztein, M. Vazquez Blanco, J. Lerman.

P618 RELATION BETWEEN DIABETES, HEART RATE VARIABILITY AND LEFT VENTRICULAR FUNCTION IN PATIENTS AFTER MYOCARDIAL INFARCTION V. Stoickov, S. Ilic, M. Deljanin Ilic.

P619 STUDY OF THE QUALITY OF LIFE (QOL) OF CORONARY PATIENTS, TREATIES WITH AND WITHOUT CARDIAC REHABILITATION (CR). A. Gómez Monroy, A. Amarilla, R. Gonzalez, D. Marelli, C. Herrera, S. Macin, N. Mijailovsky.

P620 Contribution of the aVL lead in the electrocardiographic distinction between AV Nodal Reentrant Tachycardia and AV Reentrant Tachycardia. C. Hadid, D. Di Toro, C. Lopez, L. Vidal, C. Labadet.

P621 CEREBROVASCULAR ACCIDENT PREVALENCE AND PREDICTORS IN MYOCARDIAL REVASCULARIZATION SURGERY R. Marelli, I. Rifourcat, E. Serrano, R. Lolo, J. Como Birche, C. Salomón, L. Ponce, M. David, A. Gomez Monroy, L. Mancini.

Poster Listing P623 Differences in cardiovascular mortality among men and women in the city of Rio de Janeiro, Brazil, during the 1998 and 2002 FIFA Soccer World Cup F. Braga, A. Bahia, J. Kezen, S. Gomes Jr., L. Armini, P. P. Sampaio, G. Oliveira, A. C. Neno, J. Mansur.

P624 FREQUENCY OF COMMON VARIANTS OF ABCB1, CYP3A4 AND CYP3A5 GENES IN CHILEAN SUBJECTS WITH PRIMARY HYPERCHOLESTEROMIA A. Rosales, A. Pacheco, N. Saavedra, F. Lanas, L. A. Salazar.

P625 Endothelial function: Relationship between coronary grafts and brachial artery in patients of coronary artery bypass surgery. V. Proto, C. Joo Turoni, R. Marañon, J. Salinas, J. Muntaner, M. Peral De Bruno.

P626 FAMILY MYXOMATOSIS. PRESENTATION OF THREE CLINICAL CASES. R. Marelli, A. Hauqui, M. Portis, D. Vazquez, C. Viscuso, C. Echeverria, V. Strada, J. Como Birche, F Hauqui, N. Baungartner.

P627 Secondary acute coronary syndromes in older people. G. F. López Soutric, A. Brignoli, S. Swieszkowski, A. Lakowsky, V. Brito, J. M. Caparrós, R. Perez De La Hoz, E. A. Sampó.

P628 TAKAYASU DISEASE. PRESENTATION OF A CLINICAL CASE R. Marelli, L. Bernardini, D. Braziunas, J. Di Siervi, C. Echeverria, C. Viscuso, N. Bangartner, R. Lagos, O. Pisano, O. Rastelli.

P629 ASSOCIATION BETWEEN BIRTH WEIGHT AND CARDIOVASCULAR RISK FACTORS IN BRAZILIAN ADOLESCENTS M. A. C. Sousa, I. C. Guimarães, C. Daltro, A. C. Guimarães.

P630 Usefulness of the rapid test of NT-ProBNP and non-invasive haemodynamic assessment with tissue Doppler for early diagnosis of decompensated heart failure in a cardiovascular emergency room E. Perna, E Garcia, O. Querencio, E. Villegas, P. Pozzer, G. Pereira Zini, R. Sanchez De Coll, W. Garcia, E. Fernandez, J. Parras.

P631 Comparing drug eluted with bare metal stents: Are we treating the same patients in the same way? F. Braga, L. Armini, J. Kezen, S. Gomes Jr., R. Guerreiro, A. Bahia, A. Neno, M. Batista, R. Villela, J. Mansur.

P632 Transradial percutaneous coronary angiography and interventions E. C. Eric J. Carro-Jiménez, H. Q. Humberto O. Quintana-Irazola, J. B. Jonathan Bonilla Díaz, C. A. Claudia Algaze, J. D. R. Juan M. Del Río, J. C. Joaquín Crespo, J. O. José Ortiz Betancourt, E. R. Ernesto Ruiz, M. A. Michelle Arrieta, I. P. Iris Parrilla Boria.

Scientific Programme / 215

Poster Listing P633 Conduct relation comparison betweent cardiac frequency and work load during stress test on patients with cardiopathy N. Pacheco, N. Ceron, J. Alonso, H. Ilarraza.

P634 INCIDENCE OF CORONARY ARTERY STENT THROMBOSIS IN THE “REAL WORLD” EXPERIENCE OF A UNIVERSITARY COLOMBIAN HOSPITAL B. Lombo, C. Satizabal, I. Rendon, D. Sarmiento, C. Carvajal, J. Mor.

P635 The relationship of left atrial size and stress echocardiography S. Enar.

P636 Effects of Amaranthus caudatus L. hydroalcoholic extract on new risk factors of cardiovascular diseases and prevention of fatty streak formation and comparing its effect with lovastatine S. Asgary, N. Kabiri, H. Madani, P. Mahzoni, N. Jafari Dinani.

P637 Effect of hydroalcoholic extracts of Jugulans Regia on blood sugar in diabetes-induced rats S. Asgary, P. Rahimi, H. Madani, P. Mahzouni, N. Jafari Dinani.

P638 Dietary supplementation with Artemisia sieberi reduce atherosclerosis in hypercholesterolemic rabbits S. Asgary, N. Jafari Dinani, P. Mahzouni.

P639 The Utility Rates of Integrated Treatment Strategies for CHD Secondary Prevention among High Risk CHD Patients in China D. Zhao, Q. Liu, M. Hunn, W. Wang, C. M. Yu, J. R. Zhu, J. Liu, S. Smith Jr.

P640 Adipokines In Coronary Artery Disease And Heart Failure: Relationships With Left Ventricle Hemodynamics And Cachexia C. Antoniades, D. Tousoulis, A. Antonopoulos, A. Drolias, N. Koumallos, K. Marinou, K. Bakoyiannis, C. Tentolouris, E. Vavouranakis, C. Stefanadis.

P641 Genetic Polymorphism On Angiotensin Receptor Type 2, Modifies Plasma Levels Of Acute Phase Proteins And Affects Cardiovascular Risk In Hypertensive Subjects D. Tousoulis, N. Koumallos, C. Antoniades, A. Antonopoulos, D. Kardara, D. Mentzikof, C. Vasiliadou, C. Tentolouris, E. Stefanadi, C. Stefanadis.

P642 The Impact Of Acute Consumption Of Corn Oil, Liver Oil, Olive Oil Or Soya Oil On Endothelial Function And Oxidative Stress Status, In Healthy Adults C. Tentolouris, D. Tousoulis, N. Papageorgiou, C. Antoniades, A. Giolis, E. Stefanadi, C. Tsioufis, G. Bouras, K. Marinou, C. Stefanadis.

Poster Listing P643 Oxidative Stress IS Not The Main Regulator Of Asymmetrical Dimethyl-Arginine (ADMA) Synthesis In Experimental Homocysteinemia C. Antoniades, D. Tousoulis, K. Marinou, G. Bouras, E. Stefanadi, C. Vasiliadou, C. Vlachopoulos, A. Antonopoulos, C. Tentolouris, C. Stefanadis.

P644 Gender differences in a population suspected of ischemic heart disease: exercise response, perfusion abnormalities and prognosis M. Ferreira, A. Ferrer-Antunes, J. Lima, L. A. Providência.

P645 The Underlying Disease State As The Main Modifier Of The Relationship Between Inflammatory Status And The Release Of sCD40L In Coronary Atherosclerosis D. Tousoulis, C. Antoniades, C. Tentolouris, A. Nikolopoulou, K. Marinou, N. Koumallos, K. Koniari, C. Vasiliadou, E. Stefanadi, C. Stefanadis.

P646 Value of Myocardial Performance Index in Evaluation of Patients with Hepatoesplenic Mansonic Schistosomiasis V. T. Carvalho, M. M. Barbosa, L. C. S. Silva, J. R. Lambertucci.

P647 Low-Dose Atorvastatin Treatment Suppresses Inflammatory And Thrombotic Processes During Post- STEMI Period C. Tentolouris, D. Tousoulis, C. Antoniades, V. Katsi, E Bosinakou, A. Antonopoulos, K. Marinou, P. Aggelopoulos, E. Stefanadi, C. Stefanadis.

P648 Homocysteine Variations Induce Endothelial Dysfunction By Activating Endothelin-1 Pathway In Hypertensive Patients D. Tousoulis, G. Bouras, C. Antoniades, K. Marinou, C. Tentolouris, C. Vasiliadou, A. Antonopoulos, E. Stefanadi, P. Aggelopoulos, C. Stefanadis.

P649 Role of Telemedicine for the Detection of ST-segment Elevation Acute Myocardial Infarction F. C. Cura, Fernando, R. L. Levi, Regina, L. V. Verruna, Leticia, A. S. Szyszko, Ariel, M. F. Farias, Marcelo, F. O. Olejnik, Francisco, N. V. Navarro Victor, D. D. Drago, Daniel, J. E. Estrella, Javier.

P650 PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ATRIAL FIBRILLATION. ANTITHROMBOTIC THERAPY AND BASELINE CLINICAL CHARACTERISTICS ANALYSIS. J. M. Ruiz-Nodar, T. A. Brouzet, J. Hurtado, J. Valencia, J. R. Jimeno, J. Pineda, M. Valdés, F. Sogorb, G.Y.H. Lip, F. Marín.

P651 CASE REPORT: ASSOCIATION OF 2 VERY UNCOMMON PATHOLOGIES IN THE SAME PATIENT C. Stringi, S. Pereiro Gonzalez, M. Masuelli, A. Bordenave, A. Crespo, G. Sumay, B. Nadinic, C. Poliserpi, J. Modenesi, S Chekherdemian.

Scientific Programme / 217

Poster Listing P652

V alue of TIMI risk Score for predicting mortality and major clinical events in patients with STEMI that underwent Percutaneus Coronary Intervention on admission to hospital. I. Santos-Rodriguez, M. J. Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno, V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez.

P653 Postgraduate and Systematic Distance Learning Experience in Cardiology R. Ortego, A. Pacher, S. Berman, T. Bertuzzi, A. Carli, B. Kennel, R. Lombardo, S. Nanfara.

P654 Expanded Clinical Indications for a Tissue Engineered Blood Vessel L. M. De La Fuente, S. Garrido, A. Marini, J. Antonelli, A. Fiorillo, A. Kocher, I. Gasperovich, N. Dusserre, T. McAllister, N. L’heureux.

P655 Ambulatory Blood Pressure Monitoring In Hypertensive Offsprings J. Knopfholz, A. Ribeiro Langowiski, E. Lima Junior, A. Reichert, M. Oliveira Nogueira, L. C. Guarita-Souza.

P656 Continuous Activity in Telemedicine Focused on Teaching Cardiology A. Pacher, R. Lombardo, R. Ortego, E. Schapachnik, S. Eskenazi, S. Nanfara, J. Sanagua, M. Heñin, S. Berman, Pcvc Group.

P657 ENDOTHELIAL FUNCTION IN RESPONSE TO ORAL LIPIDS AND POSTPRANDIAL LIPEMIA Carlos I. Ponte N., O. Sanchez, R. Melendez, J. Isea-P, J. Feijoo, J. Gomez-M.

P658 Are Lateral or Postero-Lateral Veins The Optimal Site to Implant Left Pacing Leads? A study of 77 consecutive resynchronized patients C. D’Ivernois, J. Lesage, A. Lagrange, P. Blanc.

P659 Echocardiographic evaluation of myocardial contractility in hypertensive left ventricular hypertrophy by a load-independent index A. Tufare, E. Escudero.

P660 Drug-eluting-stent-based percutaneous coronary intervention for treatment of acute coronary syndrome with multivessel disease; Comparison of ‘culpritvessel-only’ and complete revascularization B. Hong, H. Kim, S. Yoon, M. Kim, H. Moon, Y. Yoon, P. Min, S. Rim, H. Kwon.

P661 Proarrhythmic effects of Flecainide during exercise stress test in coronary artery disease detecting K. G Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan.

P662 Antioxidant spectrum changes due to trimetazidine treatment in patients with coronary artery disease and diabetes mellitus type 2. Experience in 44 patients K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan.

Poster Listing P663 Different Effect of DM and Other Cardiovascular Risk Factors on Circulating Monocyte Count in Patients with Stable CAD S. A. Kocaman, A. Sahinarslan, T. Timurkaynak.

P664 Treatments and outcomes of acute myocardial infarction. A three year experience in a progressive care unit. M. Perez, C. Martinez Sagasta, E. Brunel, E. Soloaga, G. Medina, J. Bori, C. Smith, A. Palazzo, M. Veltri, J. Ubaldini.

P665 Drug-eluting-stent-based percutaneous coronary intervention versus coronary artery bypass surgery for treatment of patients with multivessel coronary artery disease B. Hong, H. Mun, N. Chon, M. Kim, C. Ahn, P. Min, Y. Yoon, S. Rim, H. Kwon.

P666 LEFT VENTRICULAR ROTATION AND TORSION AFTER ANTERIOR AND INFERIOR MYOCARDIAL INFARCTION. M. Pinto.

P667 Different levels than proposed in abdominal waist circumference on a latinoamerican population Carlos I. Ponte N., N. Vargas, I. Brajkovich, L. Machado-H, J. Isea-Pérez, J. Gómez.M, C. Mendoza.

P668 SOLITARY PAPILLARY MUSCLE HYPERTROPHY CAN BE A PRECURSOR OF HYPERTROPHIC CARDIOMYOPATHY T. F. Cianciulli, M. C. Saccheri, A. M. Bermann, J. A. Lax, I. V. Konopka, R. S. Acunzo, H. J. Redruello, H. A. Prezioso, M. V. Elizari, L. A. Vidal.

P669 Acute Effects of Non Invasive Ventilation with Continuous Positive Airway Pressure on Pulse Pressure in Chronic Heart Failure M. Quintão, S. Chermont, N. N. Rocha, E. T. Mesquita, A. C. L. Da Nóbrega.

P670 PERCUTANEOUS CORONARY INTERVENTIONS (PCI) FOR UNPROTECTED LEFT MAIN CORONARY ARTERY (ULCMA) M. Strozzi, D. Anic, B. Skoric.

P671 Importante of reperfusion strategy and heart failure in the acute myocardial infarction S. M. Macin, E. R. Perna, P. Barrios, J. Parra Moreno, P. Pozzer, E. Villegas, G. Zini, P. Liva, J. Baccaro, J. R. Badaraco.

P672 HEPATOPULMONARY SYNDROME AND HEMODYNAMIC RESPONSE ON THE LEFT SIZE OF THE HEART F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle, H. A. Prezioso, L. A. Vidal, O. C. Imventarza.

Scientific Programme / 219

Poster Listing P673 Quality of life improvement in stable angina pectoris by combining physical exercise and medical treatment L. Matos, M. Lengyel, J. Szlavov, L. Pál.

P674 Have adherence to guidelines in chronic coronary artery disease? S. M Macin, J. Bono, H. Ramos, A. Romano, M. Balestra, G. Zapata, E. Hasbani, J. Mountaner, H. Luciardi.

P676 DOPPLER TISSUE IMAGING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY M. C. Saccheri, T. F. Cianciulli, S. E. Puga, I. V. Konopka, R. S. Acunzo, J. E. Guerra, D. F. Serans, H. A. Prezioso, M. V. Elizari, L. A. Vidal.

P677

P OSITIVE CORRELATION BETWEEN WAIST CIRCUMFERENCE, HDL-CHOLESTEROL AND TOTAL CHOLESTEROL IN CENTRAL AFRICANS WITH CONGESTIVE HEART FAILURE : REVERSE EPIDEMIOLOGY AND U-RELATIONSHIP IN CARDIOVASCULAR RISK B. Longo-Mbenza, H. F. Agongola Mambune, J. B. Kasiam On’Kin, E. Kintoki Vita, S. Mbungu Fuele, J. Nkondi Nsenga, L. Mabwa, V. Nzuzi.

P678

 eart rate variability after different cardiac surgery procedures and its H prognostic value N. Lakusic, F. Baborski, J. Mirat, L. J. Pavelic, K. Fuckar, D. Cerovec, M. Majsec.

P679 EARLY DETECTION OF MYOCARDIAL DAMAGE IN CHAGAS DISEASE. T. F. Cianciulli, J. A. Lax, M. C. Saccheri, A. Papantoniou, R. J. Mendez, N. G. Prado, A. N. Dorelle, A. R. Riarte, H. A. Prezioso, L. A. Vidal.

P680 ASSOCIATION BETWEEN CORONARY HEART DISEASE, CERTAIN COMPONENTS OF METABOLIC SYNDROME AND THE QTc INTERVAL IN HYPERTENSIVE CENTRAL AFRICANS B. Longo-Mbenza, J. C. Manzala Kumbi, G. Milongo Dipa, A. Nge Okwe, S. Mbungu Fuele.

P681 Evaluation of chest pain with BNP: Do we have a new tool? F. Braga, L. Armine, P. P. Sampaio, A. Bahi, M. Simoes, J. Kezen, S. Gomes Jr., A. C. Neno, F. Alvim, J. Mansur.

P682 Usefulness of Tissue Doppler Imaging alone and with Stress-Dobutamine Echocardiography in cardiotransplanted patients. F. S. Deketele, M. A. Morales Lezica, L. Ahualli, D. Radlovacky, V. Piccone, C. A. Rivas.

P684 Prediction of echocardiography risk factors of thromboembolism using D-dimmer in non-valvular atrial fibrillation F. Braga, P. Medeiros, F. Brasil, F. Nogueira, A. Godomiczer, M. Spelta, A. C. Neno, R. Salomao, R. H. Lins, B. Hellmuth.

P685 Evaluation of physicians´ knowledge on reperfusion therapy for acute myocardial infarction in Argentina: a tool for quality improvement process. R. Iglesias, F. Rolandi, F. Di Tommaso, I. Chaves, M. Strumminger, P. Stuzbach, A. Pocovi.

Poster Listing P686 Aortopulmonary fistula as an unusual complication in the follow-up of an arterial switch operation (ASO) for Transposition of the Great Arteries. B. Chiostri, I. Lugones, M. Grippo, J. L. Simon, A. J. Schlichter.

P687 THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS PULSE PRESSURE EFFECTIVELY AND SAFELY IN ELDERLY AND NON-ELDERLY HYPERTENSIVE PATIENTS NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS J. Brachmann, R. Handrock, S. Klebs.

P688 THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS BLOOD PRESSURE EFFECTIVELY AND SAFELY IN OVERWEIGHT AND OBESE HYPERTENSIVE PATIENTS NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS J. Brachmann, R. Handrock, S. Klebs.

P689 Predictive value of preoperative BNP for adverse outcomes in Coronary Artery Bypass Grafting L. Valtuille, L. Gomez, F. Rolandi, A. Domenech, R. De Miguel, D. Perez De Arenaza, A. Cagide, J. L. Navarro Estrada.

P690 LEFT ATRIAL APPENDAGE FUNCTION AND RISK OF THROMBOEMBOLISM IN MITRAL STENOSIS IN SINUS RHYTHM T. F Cianciulli, M. C. Saccheri, J. A. Lax, F. L. Weich Glogier, J. J. Cirio, R. A. Sarmiento, M. L. Talavera, D. A. Kyle, O. Fustinoni (h), H. A. Prezioso.

P691

 ody Image Analysis In Obeses, Overweight And Eutrophic Subjects B K. C. Guidini, P. M. Lese, K. C. Belli, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, C. M. Richter, M.C. Romero, P. R. N. Viecili.

P692 THE COMBINATION OF AMLODIPINE 5 MG AND VALSARTAN 160 MG LOWERS BLOOD PRESSURE EFFECTIVELY AND SAFELY IN HYPERTENSIVE PATIENTS WITH METABOLIC RISK FACTORS NOT CONTROLLED BY MONOTHERAPY WITH CALCIUM CHANNEL BLOCKERS J. Brachmann, R. Handrock, S. Klebs.

P693 Study of the Periodic Alimentary Compulsion in Individuals with Different Anthropometrics Indexes P. M. Lese, K. C. Guidini, K. C. Belli, C. M. Richter, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, M. C. Romero, P. R. N. Viecili.

P694 Progress of a Cardiac Transplantation Program in a Public Pediatric Hospital in Argentina H. Vogelfang, G. Naiman, A. Villa, M. Disanto, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli, M. De La Riba.

Scientific Programme / 221

Poster Listing P695 CARDIOVERTER-DEFIBRILLATOR THERAPY AND ITS RELATION WITH SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH CARDIOMYOPATHIES C. Killinger, G. Ceconi, L. Shocron, M. Senesi, A. Cueto, M. Del Campo, C. Sun, G. Cabrejos, E. Beck, A. Papadopoulos.

P696 Clopidogrel response in acute coronary syndrome patients: Comparing different loading doses F. Braga, G. Lavall, R. Guerreiro, A. Godomiczer, M. Spleta, C. Segadaes, A. C. Neno, G. Gouvea, R. Villela, R. H. Lins.

P697

 latelet Aggregation and Post Percutaneous Coronary Intervention P Myonecrosis. F. Braga, E. Sophia, G. Lavall, R. Guerreiro, B. Zappa, R. Max, R. Villela, B. Hellmuth, P. Medeiros, R. H. Lins.

P698

 BESITY IN A COHORT OF PUBLIC EMPLOYEES MEDICAL SERVICE OF MENDOZA O ARGENTINA. Optimal Systematic Evaluation Program (OSEP STUDY) in Obesity S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, J . Alvarez, A. Añó, S. Depine, S. Gimenez.

P699

 tructural and funtional alterations of cardiac and skeletal muscle S mitochondria in patients with congestive heart failure. G. Guzman Mentesana, R. Cordoba, A. Baez, R. Dominguez, D. Comay, S. Lo Presti, W. Rivarola, P. Pons, R. Fretes, P. Paglini.

P700 Inflammation/Lipid Score may outperform TIMI score in acute myocardial infarction treated by primary intervention. J. Kasprzak, K. Kolodziej, M. Wraga, J. Z. Peruga, M. Krzeminska-Pakula.

P701

 ontrast Enhancement Score: optimal parameter for predicting local and C global viability after myocardial infarction- a contrast echocardiographic study. J. Kasprzak, M. Ciesielczyk, J. Drozdz, M. Kurpesa, M. Kidawa, M. Krzeminska-Pakula.

P702 Coronary flow reserve in infarct-related artery.is not altered by Intracoronary administration of bone marrow stem cells. J. Kasprzak, M. Plewka, P. Lipiec, K. Wierzbowska-Drabik, T. Robak, A. Korycka, T. Jezewski, J. Z. Peruga, M. Krzeminska-Pakula.

P703 EFFECTS OF WEIGHT LOSS AFTER GASTRIC BYPASS ON LEFT VENTRICULAR FUNCTION ASSESSED BY TISSUE DOPPLER IMAGING T. F. Cianciulli, A. M. Bermann, J. A. Lax, M. C. Saccheri, B. E. Linetzky, L. A. Morita, J. A. Gagliardi, A. N. Dorelle, H. A. Prezioso, L. A. Vidal.

P704 Economic Benefit of Physical Activity Program for Hypertensive Subjects: Variation In Cost-Dose-Medication T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, E. G. Barbosa, J. Z. Klafke, P. R. N. Viecili.

Poster Listing P705 Exercise-induced abnormal pulmonary arterial pressure response in young athletes – normal physiology or precursor of endothelial damage? T. Möller, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow.

P706 ECHOCARDIOGRAPHIC DETECTION OF RENAL CELL CARCINOMA EXTENDING FROM INFERIOR VENA CAVA INTO RIGHT ATRIUM. T. F. Cianciulli, M. C. Saccheri, J. A. Lax, L. A. Morita, H. J. Altube, J. F. Codone, M. T. Lioy Lupis, A. N. Dorelle, H. A. Prezioso, L. A. Vidal.

P707 Peripheral artery disease – still underestimated in diagnostic and pharmacotherapy treatment L. J. Banfic, M. Vrkic Kirhmajer, E. Fucak, I. Sakic.

P708 Carotid artery stenting improves parameters of cerebrovascular haemodynamics D. Cerna, J. Veselka, P. Zimolova, P. Blasko, J. Fiedler, R. Duchonova, D. Zemanek, M. Maly, P. Hajek.

P709 Moderate altitude conditions may cause hypoxia and abnormal pulmonary arterial pressure response at rest and during exercise in patients with atrial or ventricular septal defect T. Möller, P. M. Fredriksen, H. Holmstrøm, J. Hallén, E. Thaulow.

P710 Aspirin and Clopidogrel response in patients with acute coronary syndrome F. Braga, G. Lavall, A. Sterque, F. Albuquerque, G. Gouvea, A. C. Neno, J. Kezen, R. Max, E. Sophia, B. Hellmuth.

P711

P arameters of right ventricular function in predicting exercise capacity as a determinant of VO2max in patients with dilated cardiomyopathy J. Vormbrock, G. Plehn, S. A. Machnick, C. Zuehlke, H. J. Trappe.

P712 The Dose-Response Curve For Exercise And Blood Pressure: How Many Sessions Are Needed? D. C. Bündchen, T. F. Panigas, C. M. Richter, T. Dipp, C. F. Panigas, K. C. Belli, J. L. C. Pippi, J. Z. Klafke, T. Carvalho, P. R. N. Viecili.

P713 ASSESSMENT OF PLANIMETRIC MITRAL VALVE AREA IN PATIENTS WITH RHEUMATIC MITRAL STENOSIS USING 16-ROW MULTIDETECTOR COMPUTED TOMOGRAPHY:COMPARISON WITH TRANSTHORACIC TWO-DIMENTIONAL ECHOCARDIOGRAPHY O. Ucar, M. Vural, Z. Cetin, S. Gokaslan, T. Gursoy, B. Demircelik, A. Selvi, S. Aydogdu.

P714

R adiation dose of dual-source CT is much higher compared to invasive coronary angiography R. Duchonova, T. Adla, J. Veselka, J. Neuwirth, L. Martinkovicova, V. Suchanek, P. Hajek, M. Maly, D. Zemanek, P. Blasko.

Scientific Programme / 223

Poster Listing P715 Management of resistant hypertension by adding a low dose spironolactone E. Badila, C. Tirziu, S. Ghiorghe, D. Bartos, M. Dorobantu.

P716 INCREASED EXPRESSION OF THE HOMOLOGUE ANGIOTENSIN I CONVERTING ENZYME (ACE2) INDUCED BY BOTH CANDESARTAN AND FASUDIL IN RATS WITH GENETICALLY HIGH LEVELS OF ANGIOTENSIN II M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad.

P717 Ischemic or non-ischemic etiology influence on endothelial function in patients with cardiac failure E. Badila, S. Ghiorghe, C. Tirziu, D. Bartos, M. Dorobantu.

P718 Risk factors for Trypanosoma cruzi infection reactivation in Chagas’ heart transplant recipients. T. Theodoropoulos, A. Silva, R. Bestetti.

P719 Single centre experience in patients with left ventricular non-compaction: clinical characteristics and evolution. M. Diez, R. Fernandez, A. Fernandez, J. Casabe, G. Arroyo, E. Guevara, M. Tettamanti, R. Gamboa, C. Rodriguez Correa, L. Favaloro.

P720 Real-time three-dimensional echocardiographic left ventricular systolic assessment: side-by-side comparison with cardiac computed tomography M. L. C Vieira, C. H. Nomura, B. Tranchesi Jr., W. A. Oliveira, G. Naccarato, B. S. Serpa, R. B. D. Passos, M. B. G. Funari, C. H. Fischer, S. S. Morhy.

P721 The role of hemodynamic and non-hemodynamic factors of left ventricular remodeling in patients with ankylosing spondylitis D.A. Poddubnyy, A. P. Rebrov.

P722 Prevalence and Relevance of Extreme Dipping Pattern of Blood Pressure G. Simonyi, J. R. Bedros, M. Medvegy.

P723 Morphological Study of Tachyarrhythmias: Typical Features on Cardiac MRI P. Donato, B. Graça, M. J. Ferreira, F. Caseiro-Alves, L. A. Providência.

P724 Incidence of cocaine use in patients under 45 years presenting to an emergency department with adverse cardiovascular events M. Colmenero, F. Manzano, A. Reina, R. Garcia, M. Rodriguez-Elvira, J. Roca.

P725 Contribution of the diastolic wave to the evaluation of hypertensive subjects F. C. Clara, Fernando, A. C. Casarini, Alfredo, A. T. Tufare, Ana, M. E. Echzu, María, A. S. Escandurra, Adriana, G. M. Meschino, Gustavo, L. C. Clara, Laurencia.

Poster Listing P726 Long-term influence of cardiovascular risk factors in the development of thromboembolic disease. B. Roca, D. Bahamonde, M. Peris.

P727

M ass in the left atrium – A Challenger of Diagnosis A. Soares, E. Marum, A. Silva, R. Russo, C. Chicanelli, H. Abensur.

P728 Stress Doppler Echocardiography for Screening of Patients at Risk for Pulmonary Arterial Hypertension R. Maier, G. Kovacs, S. Scheidl, C. Hesse, W. Salmhofer, R. Stauber, M. Brodmann, E. Aberer, E. Gruenig, H. Olschewski.

P729 Coronary Angioplasty of Bifurcated Lesions M. Albertal, F. Cura, L. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J.. A. Belardi.

P730 Nursing Diagnoses at Rio de Janeiro’s Chest Pain Unit M. A. C. S Marluci Andrade Conceiçãostipp, K. B. A. Karla Biancha Silva De Andrade, V. Z. M. Valéria Zadra De Mattos, A. P. B. P. Ana Paula Brito Pinheiro, M. F. M. Maria De Fátima Muino, J. L. L. Josète Luzia Leite, R. S. S. Renata Silva Dos Santos, A. A. S. Alessandra Andrada De Souza, N. M. C. Natália Machado Da Cunha.

P731 Patch carotid endarterectomy. Follow up results in a selected group J. Cors, C. Schulte, A. Hershson, G. Peltz, M. Nallar, H. Raffaelli.

P732

 ANDOMIZED STUDY OF EVALUATION OF N-ACETYLCYSTEINE AND SODIUM BICARBONATE R IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY A. Salvatierra Ruiz, G. Marchetti, A. Lagioia, M. Bodoira, D. Lavaggi, R. Ferreyra, A. Pocoví, A. Palacios,

P733 Differential Trends in Use of Revascularization Procedures in Myocardial Infarction Patients According to Socioeconomic Status M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, S. C. Smith Jr., C. Patterson.

P734

I nflammation influences late prognosis of patients with STEMI treated with primary PCI M. Pyda, M. Lanocha, K. Korybalska, K. Ksiazek, S. Grajek, M. Lesiak, M. Grygier, A. Katarzynska, W. Skorupski, J. Witowski.

P735 A Comparison between Monophasic and Biphasic Multipulse Biowave® Pulses during E. Trendafilova, A. Alexandrov, E. Kostova, I. Toshev, A. Bankova, P. Tassovska, T. Andreeva, N. Gotcheva.

P736

 ender differences in Left Main Artery Disease Assesed by Intravascular G Ultrasound F. Kozak, L. Lasave, A. Abizaid, A. Damonte, M. Rossi, M. Gamen, F. Feres, E. Sousa, E. Picabea.

Scientific Programme / 225

Poster Listing P737 Need to reinforce the medical concern for smoking cessation. Results from a survey. J. Isea-Pérez, C. I. Ponte, B. Nuñez, J. L. Viloria, A. Reveron, J. Boscan, L. Hernandez, J. Pinto.

P738 Importance of Thrombus Aspiration in intrahospital outcomes from Primary Angioplasty F. F. O. Fernando Fabian Ordonez, C.A.A. Carlos Alejandro Alvarez, A. C. Aberto Cristino, V. H. Veronica Heredia, C. A. I. Carlos Alvarez Iorio.

P739 Does thrombus aspiration with catheter export provide benefits to the intrahospital outcomes of primary angioplasty? F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, V. H. Veronica Heredia, C. A. I. Carlos Alvarez Iorio.

P741

M etabolic syndrome and Hepatic Transaminases Levels: Analysis of 33 Patients J. Knopfholz, J. R. Faria Neto, A. Moser, B. A. Di Rico, G. Moreno Jardim, V. Bernardes, C. L. Pereira Da Cunha.

P743 Circuit Weight Training and Cardiac Morphology: a Trial with Magnetic Resonance Imaging M. Camargo, R. Stein, J. Ribeiro, P. Schvartzman, M. Rizzatti, B. Schaan.

P744 An Emergency Department Observation Unit protocol for Atrial Fibrillation: Proceedings and Outcomes M. D Tinetti Matias, M. D. Gonzalez Miguel, M. D. Castro Florencia, M. D. Costabel Juan Pablo, M. D. Fernando Botto, M. D. Albina Gaston, M. D. Jorge Thierer, M. D. Alberto Giniger, M. D. Marcelo Trivi.

P745 Superior Vena Cava to Pulmonary Artery Oxygen Gradient is a Function of Coronary Sinus Oxygen Saturation J. Giorgini, P. D Comignani, G. Ciambrone, S. Donato, J. Gambarte, C. Higa, A. Macchia, F. Novo.

P746

 stimating achievable benefit from components of a comprehensive heart E disease prevention and treatment program T. Kottke, D. Faith, C. Jordan.

P747 Latino’s Attitudes and Preferences Regarding Treatment of Hypertension M. G. Cohen, B. L. Sleath, S. Blalock, A. R. Cerna, D. E. Bender.

P748 Study of the arterial bypass in delayed postooperative of MR (miocardial revascularization) through Multi-detector Row CT Angiography A. Tangari, G.S. Fernandes, C. A. Cattani, L. Fonseca, R. Castro, A. A. Santos, J. F. Baungratz, J. H. Vila, J. C. Brigante, J. P. Silva.

Poster Listing P749 Mid -Term Follow up in a population who underwent Percutaneous Renal Artery Stenting due to uncontrolled hypertension C. Agatiello, H. Bassani Molinas, A. Pascua, D. Grinfeld, A. Fernandez, J. M. Gabay, C. Rojas Matas, D. Berrocal, L. Grinfeld.

P751 Left Ventricular Function, Evaluated by Means of Myocardial Perfusion GatedSPECT Scintigraphy in a Population of Low Probability of Coronary Heart Disease F. Otero, A. Salvati, R. Geronazzo, V. Crosa, G. Casella, G. Bozovich, S. Traverso, R. Campisi.

P753 Prevalence of Noonan Syndrome in adult patients with Primary Left Ventricular Hypertrophy G. Pereiro, I. Masuda, H. Cola, A. Graziano, O. Serraiocco, O. Cravero, A. Pasca, R. Hoffman, R. Savanti, A. Leon.

P755 EFFECTS OF OVEREXPANSION ON STENTS’ RECOIL, SYMMETRIA-ASYMMETRIA AND NEOINTIMAL HYPERPLASIA IN AORTAS OF HYPERCHOLESTEROLEMIC RABBITS G. E. González, D. H. Berrocal, A. Fernández, L. Wilensky, C. Morales, L. Grinfeld, R. J. Gelpi.

P756 What is the Prevalence of Anemia in ADHF? S. M. Martins, C. Medeiros, F. M.Oliveira, R. Cantarelli, C. Sarteschi.

P757

 BSENCE OF ASSOCIATION BETWEEN FACTOR XII 46C>T GENE POLYMORPHISM AND A CORONARY ARTERY DISEASE IN CHILEAN SUBJECTS J. Caamaño, P. Jaramillo, C. Lanas, F. Lanas, L. A. Salazar.

P758 Enzyme replacement therapy in Fabry’s Disease: Cardiac Analysis A. Escobar, G. Ferrari, C. Kudrle, G. Doxastakis, O. Manuale, F. Casas, L. Dragonetti, S. Makhoul.

P759 Rheumatic Carditis – still a challenge in Brazil! R. E. Müller, B. R. Tura, S. M. Lamy, M. C. C. Kuschnir, C. Weksler, R. M. A. Xavier, M. J. L. M. Silva, F. F. Nascimento.

P760 HEMORRHAGIC COMPLICATIONS OF COMBINED ANTIPLATELET AND ANTICOAGULANT THERAPY IN ELECTIVE PCI PATIENTS F. Baraona.

P761

U nawareness Of Presence For Cardiovascular Disease Risk Factors In A Brazilian Regional Population C. M. Richter, D. C. Bündchen, T. Dipp, K. C. Belli, T. F. Panigas, C. F. Panigas, J. Z. Klafke, M. A. Silva, P. R. N. Viecili.

P762 Glycemic control in patients with type II diabetes mellitus after an acute myocardial infarction – a randomized controlled pilot study comparing glargine insulin plus regular insulin versus insulin pump therapy C. Sampaio, D. Franco, F Eliaschewitz.

Scientific Programme / 227

Poster Listing P763 CLINICALS VARIABLES OF INTERRUPTION IN FOLLOWING OF HYPERTENSIVE PATIENTS R. Altamirano, J. O. Ibañez, J. Kriskovich, R. Perez Rey, B.G. Rovai, C. Martinez, J. Gomez, S. Ibañez.

P764 Blood pressure measurement according to the V Brazilian Hypertension Guideline: does it make difference? V. Guimarães Neto, S. Albuquerque, F. Souza, S. Lima, A. Feitosa, G. Falbo, D. Carvalho, J. Albuquerque.

P765 Heart rate recovery after maximal exercise testing in healthy physically active older women O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, A. Scariot, G. Cavalli, J. M. Baumgarten.

P766

E ARLY VS LATE LOSARTAN EFFECTS ON POST-MYOCARDIAL INFARCTION VENTRICULAR REMODELLING AND EARLY INFLAMMATORY INFILTRATE IN RABITS G. E. González, L. Wilensky, L. Krieger, J. Palleiro, I. Seropian, M. Rodriguez, R. J. Gelpi, C. Morales.

P767 Cardiovascular Events: 10 years of follow-up in a closed population J. Tartaglione, G. Grazioli, M. Sarmiento, L. Goldstraj.

P768 Fraction of the left Ventricle ejection And Auto Declared color and polymorphism of the enzyme Gen Converser of Angiotensin in Heart Failure B. Cavalieri.

P769 Effect of remote ischemic posconditioning on endothelial function after one period of sustained ischemia. J. Álvarez- Gómez, Y. Coto Hernández, E. Roldos Cuza, L. Rodriguez Nandez, E. Rivas Stany, D. García Barreto.

P770

The post menopausal climacteric woman with hypertension: implications to quality of life and functional capacity. O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, G. Cavalli, A. Scariot.

P771 ACUTE CORONARY SYNDROME IN THE VERY ELDERLY: DIFICULT DIAGNOSIS, LATE DIAGNOSIS, LESS GUIDELINES APPLICATIONS AND WORSE PROGNOSIS. A. Lichter, A. L. P. Ribeiro, H. P. M. Pena, M. A. M Andrade.

P772 Ambulatory Blood Pressure (ABPM) in high risk patients. Improvement of 24 h profile with intensive treatment M. Baroni, C. Cruz, M. Gaute, SALA J, C. Balestrini, C. Serra, M. Bendersky.

P773 Improvement of vascular risk factors management through a stroke prevention program. Programa Integral General de ACV (PROTEGE-ACV) M. Zurru, C. Alonzo, L. Brescacin, M. Romano, J. Rojas, MvPiaggio, M. Schneider, L. Camera, G. Waisman, E. Cristiano.

Poster Listing P775 ACUTE MYOCARDIAL INFARCTION IN A NON-PCI HOSPITAL AC Alberto Caccavo, CAA Carlos Alejandro Alvarez, RU Rogelio Urizar, AMC Alicia Maria Carrique, S. A. L. Sergio A. Lasdica, F. H. B. Facundo Horacio Bello, A. E. F. Adriana Elizabeth Ferrari.

P776 Endothelial function in a model of systemic inflammation R. A. Sarmiento, A. Capuccio, R. Solerno, M. Fenucci, A. Perrone, F. Exposito, A. Videla Lynch, L. Balletti, A. Cherro, M. Larroude.

P777 The CHADS 2 Score as predictor of stroke recurrence: gender comparison M. Zurru, J. Rojas, M. Romano, L. Patrucco, E. Cristiano.

P779 RIGHT VENTRICULAR HYPERTROPHY ALONE AS A NEW FORM OF PRESENTATION OF HYPERTROPHIC CARDIOMYOPATHY. M. C. Saccheri, T. F. Cianciulli, I. V. Konopka, R. S. Acunzo, R. J. Mendez, J. A. Gagliardi, L. A. Morita, H. A. Prezioso, M. V. Elizari, L. A. Vidal.

P780 CLINICAL SIGNIFICANCE OF TISSUE DOPPLER IMAGING IN PATIENTS WITH CHAGAS DISEASE. T. F. Cianciulli, J. A. Lax, M. C. Saccheri, M. A. Beck, L. A. Morita, N. G. Prado, A. R. Riarte, A. N. Dorelle, H. A. Prezioso, L. A. Vidal.

P781 Left Ventricular Tachycardia in “Structurally Normal Hearts”: In Search of the Lost Substrate. J. Petriz, O. Souza, A. Casarsa, A. Serra, A. Glavan, L. Pereira, L. Mendonça, J. Moll.

P782 High Sensitivity C - Reactive Protein and Asymptomatic Atherosclerosis Evaluated for Endothelial Dysfunction and Carotid Intima Media Thickness D. E. Lopez, G. Scianca, C. Sturgeon, D. Morisse, D. Avayu.

P783 BETABLOCKERS IN ADMISSIONAL TREATMENT OF ACUTE HEART FAILURE: SECURITY AND CLINICAL BENEFITS M. Montera, S. Bernardez, M. Scofano, V. Barzilai, A. Volschan, E. Mesquita.

P784 Nocturnal Blood Pressure (BP) In Patients With No Antihypertensive Treatment M. Cruz, M. Baroni, J. Sala, C. Balestrini, C. Serra, M. Bendersky.

P785

A qualitative systematic review into helpseeking during heart failure : Barriers and facilitators to prompt treatment A. M. Clark, L. Svard, S. Heath, F. McAlister, J. Spiers.

P786 Quality of Care: Acute Cardiac Failure Treatment in a Cardiac Failure Unit M. Montera, S. Bernardez, V. Barzilai, A. Volshan, M. Scofano, E. Mesquita, A. Ribeiro.

P787 Cost Evaluation of Acute Cardiac Failure Treatment in a Cardiac Failure Unit M. Montera, S. Bernardez, I. Marques, E. Mesquita.

Scientific Programme / 229

Poster Listing P788 Impact of gender on coronary artery bypass results.Differences between men and women. E. Gabe, M. Santos, J. Abud, E. Dulbecco, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, R. R. Favaloro.

P789 Coronary artery bypass surgry. Clinical risk predictors of in-hospital mortality. E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, R. R. Favaloro.

P790 Aspirin resistance recovers in the chronic phase of myocardial infarction B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic, D. Milicic.

P792 LV Remodelling Features in Athletes and Hypertensive Subjects N. Sharashidze, Z Pagava, G Mamaladze, T Kishmareia, G Saatashvili.

P793 Heart failure in population over 50 years in Bulgaria M. Grigorov, J. Uzunangelov, A. Velkova, M. Tsekova, S. Djambazov, V. Bratanova, A. Bajkova.

P795 Short-term effects of a low intensity physical activity program on cardiometabolic profile of sedentary patients with metabolic syndrome C. M. Colombo, R. Macedo, A. M. Caporal, J. R. Faria Neto.

P796 Centralization of Invasive Cardiac Care Results in Less Invasive Treatment in Areas With Only Referral Hospitals A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen.

P797 Characteristics and dynamics of resistance to antiplatelet drugs in patients with acute myocardial infarction treated with standard doses of acetylsalicylic acid and clopidogrel D. Milicic, B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic.

P798 Discriminating value of carotid intima-media thickness in pre- and postmenopausal women with suspected coronary artery disease A. Kablak-Ziembicka, T. Przewlocki, W. Tracz, P. Pieniazek, P. Musialek, A. Sokolowski, D. Rzeznik, R. Drwila.

P799 Does Ambulatory Blood Pressure Predict Left Ventricular Diastolic Dysfunction Independent of Conventional Blood Pressure in Groups of African Descent? E. Libhaber, C. Libhaber, O. H. Majane, M. J. Maseko, M. R. Essop, P. Sareli, G. R. Norton, A. J. Woodiwiss.

P800 Atherosclerotic plaque instability may not be confined to coronary arteries only, but may also involve other arterial districts. A. Drzewiecka-Gerber, A. Rybicka-Musialik, J. Krauze, J. Myszor, M. Trusz-Gluza.

Poster Listing P802 Late gadolinium enhancement predicts all cause mortality in patients with heart failure and systolic dysfunction of uncertain etiology M. Nadal, A. Valle, J. Estornell, C. Soriano, N. Martinez, V. Jacas, A. Laynez, M Corbi, R. Paya, F. Ridocci-Soriano.

P803 Corelation of Hyponatremia with short term (30 days) mortality among the patients of acute ST elevation Myocardial Infarction. Y. Varma, B. S. Yadav, T. Rajarajan, G. Singh, R. Gupta, R. K. Shrivastava, V. K. Sharma, R. S. Meena, T. N. Dube, R. K. Jain.

P804 Late gadolinium enhancement cardiovascular magnetic resonance is useful to diferenciate left ventricular systolic dysfunction related to coronary artery disease from dilated cardiomyopathy in patients with acute new onset congestive heart failure. A. Valle, M. Nadal, J. Estornell, C. Soriano, N. Martinez, A. Trigo, R. Romaguera, J. Perez, R. Paya, F. Ridocci-Soriano.

P805 The Diabetes-Cardiovascular Risk Paradox: Results from a Finnish PopulationBased Prospective Study N. C. Barengo, S. Katoh, V. Moltchanov, N. Tajima, J. O. Tuomilehto.

P806

E arly Surgical Management of Anatomically Complete Vascular Rings T. Tsai, F. Chen, J. Yu.

P807

 ICROALBUMINURIA- CARDIOMETABOLIC SYNDROME; INDEPENDENT MARKER OF M CARDIOVASCULAR RISK V. Raos, T. Katic, O. Jaksic, B. Vitunjski-Englert, M. Raguz, J. Sikic-Vagic, M. Bergovec.

P808 AUTOLOGOUS INTRAMYOCARDIAL TRANSPLANTATION OF BONE MARROW MONONUCLEAR STEM-CELLS FOR DILATED CARDIOMYOPATHY – TECNIQUE AND EARLY RESULTS R. Kalil, D. Ott, R. Sant’Anna, E. Dias, J. Fracasso, A. Cañedo, N. Nardi, J. Sant’Anna, P. Prates, I. Nesralla.

P809 EFFECTS OF HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITORS IN REDUCTION OF INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS G. Teixeira, R. Kalil, P. Prates, J. Sant’Anna, L. Pellanda, A. Neto, I. Nesralla.

P810 Correlation of femoral atherosclerosis and severity of CAD quantified by Gensini score M. Vrkic Kirhmajer, L. J. Banfic, M. Vojkoviæ, M. Strozzi, J. Bulum, K. Putarek, T. Simoncek.

P811 LEFT VENTRICULAR TORSION DYNAMICS IN PATIENTS WITH FABRY’S DISEASE Y. Zocalo, E. Guevara, D. Bia, A. Fernandez, J. Casabe, J. Politei, G. Cabrera, R. Armentano.

P812

The change in fractional flow reserve can predict lesion severity and long term prognosis S. A. Kocaman, A. Sahinarslan, T. Timurkaynak.

Scientific Programme / 231

Poster Listing P813 Prognostic value of left ventricular diastolic disfunction for adverse cardiac events A. Berger-Kucza, K. Wita, M. Turski, M. Trusz-Gluza.

P814

D eterminants of left early and late ventricular remodeling in patients with acute MI treated with primary PCI A. Berger-Kucza, W. Wróbel, M. Nowak, M. Trusz-Gluza.

P815

 IOFIELD (Aura) scanning for preventive and primary investigation B of Heart patients and S. Vaidya, V Marathe.

P816

Thrombus aspiration for microvascular protection in patients with acute MI undergoing early primary PCI. A. Berger-Kucza, M Lelek, K Wita, M Trusz-Gluza.

P817

I mpaired morning arterial distensibility adjustment in hypertensive patients D. Bia, S. Lluberas, Y. Zocalo, M. Zabalza, R. Armentano.

P818

P revalence of Metabolic Syndrome in adolescents of Rio de Janeiro City, Brazil D. G. Denise Giannini, M. S. Moysés Szklo, M. C. K. Maria Cristina Kuschnir.

P819

The impact of diffuse coronary artery disease on fractional flow reserve A. Sahinarslan, S. A. Kocaman, T. Timurkaynak.

P820 Screening of Ischaemic Heart Disease in C hronic Arsenicosis Patients S. Kole, R. Dutta, S. K. Roy, S. K. Biswas, A. Ghosh, A. Kundu, S. Gupta, B. Sarkar.

P821 Cadillac risk score and regional perfusion score index A. Berger-Kucza, M. Turski, K. Wita, M. Trusz-Gluza.

P822

Kissing Ballon Overexpansion in Provisional T-Stenting: Experiences in a Bench Model M. Zehetgruber, B. Pausa, B. Frey.

P823

A meliorating Morbidity and Abolishing Hospital Mortality Associated to Isolated G. Gonzalez-Stawinski, L. Vargas, E. Nowicki, B. Lytle, J. Navia, G. Pettersson, L. Svensson, A. Gillinov, N. Smedira, J. Sabik.

P825 Women receive less invasive treatment after first acute myocardial infarction A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen.

Poster Listing P826

P roximal neuroprotection as the system of choice in high risk carotid artery stenting: Results from an academic center registry of 143 proximal– and 412 distal–neuroprotected CAS P. Pieniazek, P. Musialek, A. Kablak-Ziembicka, L. Tekieli, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka, W. Tracz.

P827

 SYCHOLOGY IN THE CARDIAC TRANSPLANTATION PROGRAM P S. Bordignon, P. Ruschel, L. Lima, S. Wottrich, R. Machado, E. Vigueras, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla.

P828 Early Myocardial Oxidative Stress Profile at 48h Post-Experimental Infarction in Rats and the Effects of Cellular Therapy A. M. V. Tavares, P. C. Schenkel, A. C. Taffarel, R. Dall’ Alba, G. Nicolaidis, G. Baldo, U. Matte, A. Belló-Klein, L. E. Rohde, N. Clausell.

P829 Heart rate recovery on the first minute in the six minutes walk test in patients with chronic heart failure S. Chermont, S. Lindemberg Malfacini, M. Pena Quintão, M. De Rossi, S Guilhon, M. M. Veloso, P. L. C. Teixeira, S. Bernardez, A. C. Lucas Da Nobrega, E. T. Mesquita.

P830 Chronic hepatitis C infection is associated with increased coronary artery atherosclerozis defined by modified Reardon severity score F. Kacmaz, O. Alyan, B. Deveci, O. Ozdemir, R. Astan, A. S. Celebi, E. Ilkay.

P831 SOCIAL INDICATORS OF PATIENTS IN CARDIAC TRANSPLANTATION WAITING LIST ASSISTED BY SOCIAL SERVICE OF IC/FUC S. Bordignon, V. Porto, S. Fonseca, L. Lima, J. Vieira, P. Ruschel, P. Cordeiro, I. Nesralla.

P832

I mpact of angiotensin-converting enzyme inhibitor use on the incidence of atrial fibrillation in the early postoperative period of elective cardiac surgery F. R. França, R. J. Alves, R. N. Campos, R. B. Piveta, N. Kenji.

P833

I NCREASED S100B SERUM LEVELS IN DILATED CARDIOMYOPATHY PATIENTS S. Bordignon, G. Mazzini, D. Schaf, E. Horowitz, F. Bacal, R. Bruch, C. Gonçalves, D. Souza, L. Portela.

P834 Late results of endoventricular patch plasty repair in akinetic and dyskinetic areas after acute myocardial infarction S. Bordignon, P. Prates, A. Homsi-Neto, L. Lovato, G. Teixeira Filho, J. Sant’Anna, L. Yordi, R. Kalil, I. Nesralla.

P835 The Effect ol Valsartan in Patients with Pulmonary Hypertension L. Koldas, F. Ayan, G. Bozkurt, I. Basar.

P836 THE ISCHEMIC RAT HEART RELEASES S100B S. Bordignon, G. Mazzini, D. Schaf, A. Oliveira, C. Gonçalves, A. Belló-Klein, R. Bruch, G. Campos, D. Souza, L. Portella.

Scientific Programme / 233

Poster Listing P837 Gene expression profiling in atrial fibrillation patients with structural heart diseases. M. Kharlap, L. Goryunova, A. Timofeeva, G. Smolyanova, G. Khaspekov, S. Dzemeshkevich, R. Akchurin, V. Ruskin, S. Golitsyn, R. Beabealashvilli.

P838 Angiographic Pulmonary Anatomy in Pulmonary Atresia with Ventricular Septal Defect. A Useful Classification and Surgical Approach. Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda M. Da Cunha, Rogério Brant Martins Chaves, Maria Cristina C. Kuschnir, Renato Kaufman, Bernardo Rangel Tura, Regina Maria De Aquino Xavier.

P839 Reflections on strategies of psychosocial rehabilitation of the transplant patient, from my experience as a volunteer in a supportive house. M. Machado, C. Garcez, M. Tatsch, S. Macin, L. Rosa, N. Antunes, A. Alvim, J. Souza.

P840 Comparison of left ventricular ejection fraction evaluated by dual source CT and two-dimensional echocardiography R. Duchonova, K. Linhartova, L. Martinkovicova, T. Adla, J. Neuwirth, J. Veselka.

P842

E lective Electrical Cardioversion Protocol: Quality Indicator in a Cardiac Emergency Department K. Andrade, A. Pinheiro, A. Volschan, M. F. Muiño, V. Mattos, C. Almeida, G. Trancoso, S. Simas.

P843 Acute Effects from Weaning of Mechanical Ventilation by Holter Analysis G. A. Tinoco, M. P. Quintão, C. L. Oliveira, A. Torrão, J. C. Pereira, J. M. Linhares, L. N. De Barros, R. Tinoco, E. T. Mesquita, S. Chermont.

P845

S ize of myocardial infarction but not transmurality is associated with lower left ventricular ejection fraction and higher sphericity index D. Perez De Arenaza, M. Pietrani, M. Falconi, P. Pollono, J. Moon, FvAbramzon, P. Oberti, L. Grinfeld, R. Garcia-Monaco, A. Cagide.

P846 PYRIDOSTIGMINE INCREASES BAROREFLEX SENSITIVITY AND IMPROVES AUTONOMIC BALANCE AFTER MYOCARDIAL INFARCTION IN RATS R. N. De La Fuente, I. C. M. Silva, L. E. De Souza, G. O. Candido, R. A. Sirvente, B. Rodrigues, E. M. Krieger, S. Lacchini, M. C. Irigoyen.

P847 Comparison between High resolution model and traditional Health System model in an Outpatient Consultation Department of Cardiology. Experience of 5 years G. A. Cortez Quiroga, C. Rus Mansilla, M. M. Martinez Quesada, G. Lopez Moyano, M. Delgado Moreno, E. Ruiz De Temiño De Andres, D. Sevilla Ruiz, M. Gavilan Perez, C. Recuerda Casado.

Poster Listing P848 Calcium-Dependent Tyrosine Kinase PYK2 Plays Crucial Role in Angiotensin IIBut Not Norepineprine-Mediated Activation of Rac/Superoxide Pathway That Differentially Regulates Blood Pressure and Vasoconstriction A. Matsui, M. Okigaki, A. Katsume, H. Yamada, H. Matsubara.

P849 ENDOMYOCARDIAL FIBROSIS – MISSED DIAGNOSIS V. Vaghela, K. Sliwa, R. Mvungi.

P850 Critical aortic stenosis in infancy – how small can left ventricle be, and still be adequate to support the circulation after an aortic valvotomy. Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda Mesquita Cunha, Rogério Brant Martins Chaves, Renato Kaufman, Maria Cristina C. Kuschnir, Bernardo Rangel Tura, Regina Maria De Aquino Xavier.

P853

C ardioprotective Action of Interleukin-1beta in Adaptation to Cardiac Pressure Overload Stress by Activation of IGF-1/Akt Pathway S. Honsho, S. Nishikawa, M. Okigaki, A. Matsui, H. Matsubara.

P855 Effects of Carvedilol on Quality of Life and Clinical Outcomes in Elderly patients with Chronic Heart Failure N. Ganugrava, I. Jashi, B. Kobulia, R. Abashidze, G. Tabidze.

P857 Adherence to selective criteria for the use of drug-eluting stents results in low rates of target vessel revascularisation J. Gohil, K. Kadappu, Q. Lo, D. Tobing, S. Lo, A. P. Hopkins, D. Leung, C. P. Juergens, J. K. French.

P858 Assessment of Myocardial Dysfunction in Patients with non-ST Segment Elevation Myocardial Infarction Using Serum B-type Natriuretic Peptide Level B. Kim, B. Lee, C. Goh, Y. Byun, K. Rhee.

P859

C ost-effectiveness of 64- multislice slice coronary CT angiography at emergency ward compared to standard management in low risk patients with acute chest pain D. Perez De Arenaza, M . Falconi, F. Abramzon, P. Pollono, A. Fernandez, PvOberti, LvGrinfeld, R. Garcia’Monaco, J. Krauss, A Cagide.

P860

 orrelation of heart rate with cardiovascular risk factors C A. Kalvelis, G. Bahs, I. Stukena, A. Lejnieks, U. Teibe.

P862

H uman aorta transcriptome profiles of different atherosclerotic lesions types. A. Timofeeva, L. Goryunova, G. Khaspekov, O. Ilyinskaya, V. Sirotkin, E. Tararak, R. Beabealashvilli.

Scientific Programme / 235

Poster Listing P863 The use of contrast in real-time and in bolus for quantification and qualification of myocardial flow: comparison with Gated-SPECT and angiography. A. Camarozano, A. Soares, D. Bastos, A. Cantisano, C. Oliveira, EvSanson, L. H. Weitzel.

P864

 ODULATION OF MONOCROTALINE INDUCED COR PULMONALE BY GRAPE JUICE M A. Belló-Klein, A. R. Lenhenbauer-Lüdke, R. Caron-Lienert, F. Mosele, T. R. Fernandes, W. Partata, M.F. Ribeiro.

P865 Cost Effectiveness Analysis of Carotid Doppler Ultrasound Examinations in Patients with Significant Left Main Coronary Artery Stenosis A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak.

P866 99 Tc-SESTAMIBI DIPYRIDAMOLE MYOCARDIAL PERFUSION SINGLE-PROTON EMISSION TOMOGRAPHY AND CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY SCANNING IN DETECTION OF ALLOGRAFT CORONARY ARTERY DISEASE AFTER DEART TRANSPLANTTION A. Tangari, G. S. Fernandes, C. A. M. Cattani, J. P. Silva, J. C. Brigante, L. Fonseca, J. A. Bottega.

P867 Predictors of mortality from myocardial perfusion Gated-SPECT in patients without previous myocardial infarction P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguedé-Bruix, J. Castell-Conesa, J. Candell-Riera.

P868

V alsalva maneuver predicts exercise left ventricular outflow tract obstruction in patients with hypertrophic cardiomiopathy F. Vaisbuj, A. Fernandez, J. H. Casabe, M. Bustamante Labarta, G. Bozovich, F. Landeta, R. Peidro, G. Fava, E. Guevara.

P869

C ytokine network genes are associated with susceptibility to essential hypertension in Tatars from Bashkortostan (Russia) Y. R. Timasheva, T. R. Nasibullin, A. N. Zakirova, O. E. Mustafina.

P870 CARDIOVASCULAR REHABILTACION POST CARDIAC TRANSPLANTATION G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, F. Bethencourt, M. Diez, L. Favaloro, R. Favaloro.

P871

 UTRITIONAL PROFILE OF PATIENTS IN THE WAITING LIST FOR HEART TRANSPLANTATION N S. Bordignon, P. Cordeiro, P. Borges, V. Porto, S. Fonseca, E. Horowitz, L. Lima, J. Vieira, P. Ruschel, I. Nesralla.

P872

 ulse Oximetrie in Six Minutes Walk Test Associated With Exercise Tolerance in P Outpatients With Chronic Heart Failure S. Chermont, S. Guilhon, M. P. Quintão, M. De Rossi, P. Teixeira, S. Lindemberg, S. Bernardez, D. A. Bastos, P. P. Soares, E. T. Mesquita.

P873 Quantification of saved myocardium after primary angioplasty with myocardial perfusion gated-SPECT. Preliminary results. P. Pujol, G. De León, S. Aguadé-Bruix, B. García Del Blanco, S. Rossi, R. Falú, J. Figueras, J. Castell-Conesa, J. Candell-Riera.

Poster Listing P875 Clinical characteristics of pain in men and women admitted to a chest pain unit M. F. Larin, E. Ludueña Clos, C. Kudrle, G. M. Ferrari, H. Avaca, B. Lopez Ledesma, M. Gingins, EvBrunel, J. D. Humphreys, O. Manuale.

P876 EFFICACY AND SAFETY OF DRUG ELUTING STENTS FOR THE TREATMENT OF DIFFUSE IN-STENT RESTENOSIS. INFLUENCE OF DIABETES ON LONG-TERM OUTCOME. G. Schipani, F. Azzari, D. Chambre, A. Fernandez, E. Torresani, S. Brieva, R, Nauwerk, Horacio Pomes Iparraguirre, C. Barrero, J. Leguizamon.

P877 Energetics of ischemia-reperfusion in rat neonatal hearts: differences in Ca homeostasis A. E. Consolini, P. Bonazzola.

P878

P rofessional Divers with History of Decompression Sickness Have Much More Higher Prevalence of Right to Left Shunt Than in Those without Such Event and Reaveal Favourable Outcome during Mid-term Follow-up after the Transcatheter Closure J. Fiedler, T. Honìk, K. Linhartová, J. Veselka.

P879 Sub-clinical miocarditis due to Dengue infection J. Galeano, J. Ortellado, M. Paniagua, I. Lovera, C. Rodriguez.

P880 Procalcitonin is a marker of infection after surgery for valvular heart disease in a predominnatly rheumatic population. G. Spina, F. Tarasoutchi, L.F. Moreira, R. O. Sampaio, F. Bertanha, V. M. Jonke, C. Strunz, M. Grinberg.

P881

 ender differences of cardiovascular risk profile in Lithuania G S. Kutkiene, Z. Petrulioniene, J. Badariene, V. Dzenkeviciute.

P882 Misclassification of Ischaemic Heart Disease Mortality in Brazil A. R. N. Migowski Rocha Dos Santos, BERNARDO Rangel Tura, CARLOS Alberto Moreira Magalhães, MÁRCIA Cristina C. Macedo Pinheiro, MARIA Cristina Kuschnir, REGINA Maria Aquino Xavier, ROGÉRIO Brant Chaves, VITOR Manuel Pereira Azevedo.

P883 Relation between patients baseline characteristic and pre-hospital treatment and the occurrence of no-reflow after primary percutaneous intervention in patients with pre-hospital diagnosis by means of ECG teletransmission L. Malek, M. Karcz, P. Bekta, M. Klopotowski, M. Skwarek, M. Dabrowski, K. Kukula, A. Witkowski,. W Ruzyllo.

P884

A STUDY OF THE PERCEPTION OF THE HEART TRANSPLANTATION PATIENT THROUGH THE FAMILY CARETAKER. S. Bordignon, P. Ruschel, L. Lima, A. Souza, C. Thomas, C. Seelig, E. Vigueras, P. Cordeiro, S. Fonseca, I. Nesralla.

Scientific Programme / 237

Poster Listing P885 SPECT Myocardial Perfusion and Pulmonary Ventilation Perfusion Scintigraphy for Differential Diagnosis between Coronary Artery Disease vs. Pulmonary Embolism P. Pujol, S. Valdivielso, G. De León, R. Falú, S. Aiguadé-Bruix, J. Castell-Conesa, J. Candell-Riera.

P886

I mpact of insulin resistance and nonalcoholic fatty liver disease on left ventricular diastolic dysfunction in non-obese patients G. Roytberg, O. Sharkhun, T. Ushakova, D. Sobolev, O. Platonova.

P887 Multislice computed tomographic characteristics of coronary artery lesions and pathophysiology insights to Tako-tsubo like left ventricular dysfunction P. Avellana, C. Tajer, D. Santos, P. Carrascosa, A. Deviggiano, C. Capuñay, A. Pocoví, M. De Abreu, O. Santaera, L. Antonietti.

P888 Antihypertensive efficacy of the direct renin inhibitor aliskiren in patients with diabetes, metabolic syndrome or obesity: a pooled analysis of 10 randomized trials M. R. Weir, M. F. Prescott, C. Bush, V. Arora, D. L. Keefe.

P889 Rhythm control strategy is not different of rate control strategy: a long-term follow up cohort study M. Falconi, P. Oberti, R. Pizarro, A. Arias, F. Achilli, D. Perez De Arenaza, G. Jaimovich, S. Quevedo, J. Krauss, A. Cagide.

P890

V isceral fat in hypertensive and prehypertensive obese patients G. Simonyi, J. R. Bedros, M. Medvegy, L. Halmy.

P891 CARDIOVASCULAR REHABILITATION POST CARDIAC TRANSPLANTATION: FOLLOW UP AND DROP OUT G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, M. Diez, L. Favaloro, R. Favaloro.

P892

 aternal Heart Disease and Pregnancy Outcome: A SingleM V. Stangl, J. Schad, G. Gossing, A. Borges, G. Baumann, M. Laule, K. Stangl.

P893

LONG TERM FOLLOW-UP AFTER SURGICAL TREATMENT FOR IDIOPATHIC DILATATION OF THE RIGHT ATRIUM E. Mesquita, A. C. Rodrigues, V. Schubsky, H. Korkes, M. Barbero-Marcial, S. A. Oliveira, E. Lira, C. Fisher, M. Vieira, S. Morhy.

P895 Prognostic importance of weight loss in patients with heart failure and different pre heart failure body mass P. Rozentryt, J. U Nowak, S. Von Heahling, J. Sikora, A. John, U. Wilczek, L. Polonski, S. D Anker.

Poster Listing P896 ACE INHIBITION REVERTS CARDIAC DAMAGE IN EXPERIMENTAL DIABETES: ROLE OF AUTONOMIC MODULATION C. Malfitano, R. B. Wichi, K. Rosa, C. Mostarda, K. De Angelis, M. C. Irigoyen.

P897 Successful Percutaneous Balloon Fenestration for Aortic Dissection Presenting as Claudication B. Kim, B. Lee, C. Goh.

P900 The effect of living in the high plateau on cardiovascular system G. A. Gamez Aldo, C. N. Cellino Natalia.

P901

P rimary Angioplasty in Patients Presenting Late After Onset of Chest Pain and ST elevation Myocardial Infarction – KAMI registry B. Kim, C. Goh, YvByun, M. H. Jeong, B. Lee.

P902

C ORRELATION BETWEEN PLASMA HOMOCYSTEINE, CARDIOVASCULAR RISK FACTORS AND CARDIOVASCULAR DISEASE IN AN ADULT POPULATION FROM BUENOS AIRES. L. Gariglio, O. Fridman, M. Potenzoni, D. Calcines, G. Perez Baztarrica, I. Bañes, L. Ferrero, J. Schnidt, A. Botbol, R. Porcile.

P903 QUICKOPT®: A NEW ALGORITHM FOR AUTOMATIC ATRIO-VENTRICULAR DELAY OPTIMIZATION IN PACEMAKERS. A SHORT-TIME FOLLOW-UP STUDY J. García Guerrero, J. Fernández De La Concha, J. Olagüe, M. J. Sancho-Tello, J. G. Martínez, A. Ibáñez, C. Llorente, F. Crespo, O. Sanz.

P904

M RI in left ventricular non-compaction. Our experience in eleven patients. C. A. Rivas, L. Dragonetti, F. Corbella, F. S. Deketele, M. A. Morales Lezica, L. Ahualli.

P905 Permanent sinus rhythm is associated with less heart failure hospitalizations in patients with history of atrial fibrillation M. Falconi, P. Oberti, R. Pizarro, F. Sosa, L. Lucas, G. Maid, D. Perez De Arenaza, G. Jaimovich, J. Krauss, A. Cagide.

P906

I ncidence and characteristics of ischemic stroke in patients with atrial fibrillation M. Falconi, P. Oberti, R. Pizarro, G. Maid, D. Perez De Arenaza, S. Quevedo, A. Arias, F. Achilli, J. Krauss, A. Cagide.

P907 The Effect of Telmisartan on Left Ventricular Mass And Renal Function T. Huang, H. Ezumi, Y. Kobayashi.

P908

H omocysteine Levels and Methylentetrahydrofolate Reductase Gene Variant (C677T) are Associated with Increased Risk of Hypertension in a Population of the Buenos Aires City R. P. Porcile, L Gariglio, V. Vanasco, M. Junco, M. Potenzoni, I. Bañes, O. Fridman.

Scientific Programme / 239

Poster Listing P909

 therogenic Index of Plasma as a Determinant of Oxidized LDL in Slovak NonA CHD Subjects. B. Vohnout, P. Blazicek, A. Dukat, G. Fodor, J. Lietava.

P910

S tem cells cardiac transplantation F. Machado, E. Oliveira, F. Machado, V. Lisboa, B. Bessa, D. Gherardi, I. Pinto.

P911

 THEROSCLEROTIC CAROTID PLAQUE IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). A G. Zampi, F. Fini, G. Illuminati, C. Torromeo, F. Barilla, V. Paravati.

P912

R elation between pulse pressure and in-hospital mortality, 30-day rehospitalization and combined events, in patients with decompensated heart failure R. Cantarelli, F. L. Cantarelli, F. M. F. Oliveira, C. A. Medeiros, C. Sarteschi, S. Martins Marinho.

P913

LONG-TERM OUTCOME OF CAROTID ARTERY STENTING WITH DISTAL EMBOLIC PROTECTION G. Andersen, F. Azzari, S. Ludueña, D. Chambre, G. Schipani, A. Fernandez, S. Brieva, E. Torresani, H. Bertoni, J. Leguizamon.

P915

I s stress and depression a prognostic risk factor in unstable angina patients? N. Vita, A. Esquivel, D. Ostera, S. Bonetti, M. Gassmann, F. Diez.

P916 Consistency of the results with a new percutaneous treatment for mitral regurgitation and heart failure through the coronary sinus (CARILLON-CDI). A. Ebner, S. Gallo, E. Alvarez, E. Silva, C. Oviedo.

P917

O lder patients with heart failure are at higher risk of hyperkalemia with spironolactone: results from a heart failure programme C. Belziti, N. Vensentini, N. Vulcano, S. Fernandez, D. Perez De Arenaza.

P920

G LOBAL MORTALITY ON PATIENTS WITH A PREVIOUS CARDIOVASCULAR EVENT AND RELANTIOSHIP WITH CARDIOVASCULAR RISK FACTORS IN A COHORT OF PUBLIC EMPLOYEES MEDICAL SERVICE MENDOZA ARGENTINA. OSEP STUDY (Optimal Systematic Evaluation Program) O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, S. Depine, L. Cammi, S. Gimenez.

P921 Functional Capacity in Children with Congenital Heart Disease C. Hossri, I. Jatene, G. Grecca, R. Meneghelo, H. Arakaki, A. Alves, B. Zaccara, S. Buglia, M. Tomazzi, J. Beutel.

P922 CLINICAL AND METABOLIC CHARACTERIZATION OF METABOLIC SYNDROME IN CHILDREN AND ADOLESCENTS IN ARGENTINA C. Mazza, P. Evangelista, I. Kovalskys, A. Figueroa, P. Digon, S. Lopez, E. Scaiola, N. Perez, G. Dieuzeide.

Poster Listing P923 PROGNOSIS AND PREDICTORS OF LIFE THREATENING ARRHYTHMIAS IN PATIENTS WITH ACUTE CORONARY SINDROMES G. Maid, R. Perez Etchepare, F. Rolandi, J. Navarro Estrada, D. Perez De Arenaza, G. Elizalde, C. Moreno, A. Cagide,

P924 Left Main Coronary Artery angioplasty for stable angina and for acute coronary syndromes. Acute results and long – term clinical outcome of 73 patients. P. Tyczynski, A. Debski, Z. Chmielak, A. Witkowski, K. Cedro, J. Pregowski, W. Ruzyllo.

P925

F requency and distribution of depressive symptoms at a Cardiology Consulting Room J. Tripolone, G. Santiago, R Barin.

P927 Blood pressure level, Lipids profile and cardiovascular risk factors in adults Rwandan health volunteers. Twagirumukiza Marc, Karagirwa Alphonse, Umutesi Hassina, Seminega Benoit, Musafiri Sanctus, Nkeramihigo Emmanuel, Luc Van Bortel.

P928 Cardiovascular Risk Reduction With Single-Pill Amlodipine/Atorvastatin in Diverse Populations R. Blank, S. Erdine, R. Feldman, P. Marques Da Silva, P. Chopra, H. Shi, R. A. Moller, M. Schou.

P929

 OMPLEX CATHETERISM PROCEDURES IN A PUBLIC HOSPITAL IN ARGENTINA. FEASIBILITY C AND RESULTS G. Feltes, M. De La Vega, A. Ittig, C. Leonardi, M. Giraudo, G. Pessah, L. Guzmán.

P931 Higher aortic valve resistance at rest and in response stress in patients with aortic valve sclerosis M. Falconi, P. Oberti, R. Pizarro, A. Arias, L. Lucas, F. Sosa, M. Fernandez, D. Perez De Arenaza, J. Krauss, A. Cagide.

P932

 hort Term Results of Repeat Valve Replacement - Predictive Factors Analysis S S. Beurtheret, H. Feier, V. Gariboldi, D. Grisoli, A. Riberi, A. Mouly-Bandini, D. Metras, F. Collart.

P934 The Prognostic Value of Dypiridamol Stress Echocardiography in Women B. Markman-Filho, M.C. Almeida, M. Markman, M. Moreno, C. Barros, A. Chaves, I. Labanca, M. F. Lobo, W. Souza, S. Montenegro.

P935

R ole of adenosine testing in syncope of unknown origin M. Sammartino, G Albina, R Laiño, A Giniger.

P936 Ventriculoarterial Coupling in Severe Aortic Stenosis With Heart Failure R. Migliore, M. Adaniya, M. Bruzzece, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi.

Scientific Programme / 241

Poster Listing P937 Study of the depressive load on the cardiologic patient J. Tripolone, G Santiago, J Gimenez, JM Tripolone.

P938 Pulse wave velocity in normotensive adolescents M. Bracho, E. Silva, G. Bermudez, J. Villasmil, S. Briceño, C. Esis, J. Chacon.

P939 Histopathological Features of the Resected Left Atrial Appendage in Paroxysmal Atrial Fibrillation in patients without Valvular Heart Disease L. Antonietti, D. Santos, C. Tajer, M. Amat, A. Zapolanski, F. Mastrogiacomo, W. Astorino, E. Domenicchini, J. Lax.

P940 Analysis of Clinical Characteristics and Head-up Tilt Test Responses in Patients Suffering from Unexplained Syncope. K. Alonso, J. Escobar Calderon, R. Sansalone, J. Armentano, L Ferrer, R. Aguero, M. Leonardi, Horacio Pomes Iparraguirre.

P941

 PITHELIOID HAEMANGIOENDOTHELIOMA OF THE AORTA E G. Feltes, M. Losano, N. Bustamante, G. Ghirardi, A Uribe, L. Guzmán.

P942

 articularities of the Cardiovascular Risk in Old Women in an Urban Romanian P Community D. Pop, D. Zdrenghea, A. Sitar-Tautu, M. Cebanu, D. Colcear, B. Borz.

P943

 istopathologic Evaluation of Prophylactic Effects of Zofenopril, Enalapril H and Valsartan against Doxorubicin Cardiotoxicity in Rats E. Bozcali, V. Karpuz, D. B. Dedeoglu, O. Suzer, H. Karpuz.

P944

 requency of Incomplete Stent Apposition Assessed by StentBoost: F a Novel Angiographic Technique A. Candiello, M. Albertal, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi.

P945 Acute aortic regurgitation due to spontaneous rupture of a fenestrated cusp: report in six cases. J. Goral, D. Avayu, J. Mitelman, D. Morisse, C. Froimovich, L. Rodas.

P946

A pplication of Health Informatics for Global Efforts: The Care of Adult Congenital Heart Defects’ Surveillance A. Krishnaswamy, G. Mensah, W. Book, M. McConnell, T. Lyle, A. Correa.

P947 Bisoprolol favorably alters diastolic function and reduces NT-pro-BNP levels in diastolic heart failure with restrictive transmitral flow pattern. K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.

Poster Listing P948 EFFECTS OF SUPPLEMENTATION WITH SATURATED, MONOUNSATURATED OR POLYUNSATURATED RICH-OILS ON FUNCTIONAL ASPECTS OF HIGH-DENSITY LIPOPROTEIN (HDL) IN HAMSTERS. F. Maniero, A. F. Padoveze, T. V. Oliveira, M. H. H. Santos, T. M. Seydell, M. L. Guzzo, C. H. Azevedo, R. C. Maranhão.

P949

 ELATIONS OF QT INTERVALS WITH DIFFERENT DEFINITIONS AND COMPONENTS OF R METABOLIC SYNDROME IN B. Longo-Mbenza, J. B Kasiam On’kin, J. C Manzala Kumbi, A. Nge Okwe, B. Buassa-Bu-Tsumbu, N. Kangola, D. Vangu Ngoma, S. Mbungu Fuele, I. Longo Phemba.

P950 The Effect of Homocysteine-lowering B-vitamin Intervention on Angiographic Coronary Artery Disease May Be Adverse - A WENBIT Sub-Study K. H. Løland, A. J. Blix, Ø. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygård.

P951 Single and delayed defibrillation testing the day after first implantation of cardioverter defibrillator: a reliable and safe strategy H. Bader, N. Delarche, R. Lasserre, G. Flory, G. Estrade.

P952

 Novel Coronary Heart Disease Risk Evaluation and Communication Program A Improves Modifiable Risk Factors and Understanding in Patients With Hypertension: The Risk Evaluation And Communication Health Outcomes And Utilization Trial (REACH OUT) L. Erhardt, J. S. Benner, R. A. Moller, N. Rajicic, S. B. Cherry, Z. Gaciong, E. S. Johnson, M. C. J. M. Sturkenboom, J. Garcia-Puig, X. Girerd.

P953 TOBACCO CONSUMPTION AND PREVALENCY IN THE PERSONNEL OF A HOSPITAL D. Morisse, D. Avayu, G. Lewy, J. Mitelman, J. Goral, C. Martorano, J. Gallo, C. Froimovich.

P954

O besity and Hypertension Z. Brankovic.

P955 HEALTH CAMPAIGN: A METHOD OF SCREENING AND EDUCATION IN CARDIOVASCULAR HEALTH. A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, E. R. Suarez, C. Nagaoka, A. C. Santomauro, C. Ferreira.

P956

 ROGNOSIS INFLUENCE OF LEISURE-TIME PHYSICAL ACTIVITY PRACTICE PRIOR TO P CORONARY ARTERY BYPASS GRAFT SURGERY R. Nery, I. Mahmud, J. Barbisan, L. Smidt.

P957

 ORRELATION BETWEEN EPIDMIOLOGICS FACTORS AND DIABETES MELLITUS IN PATIENTS C SUBMITTED TO MYOCARDIAL REVASCULARIZATION SURGERY A. C. Santomauro Jr., L .Z. P. Oliveira, M. R. Ugolini, I. A. B. Bincoleto, C. Nagaoka, W. A. Amorim, J. Albuquerque, A. C. Santomauro, A. T. Santomauro, F. Fraige Filho.

Scientific Programme / 243

Poster Listing P958 Secondary Prevention of Cardiac Sudden Death with Implantable CardioverterDefibrillator in Patients with Chronic Chagasic Cardiomiopathy and Preserved Left Ventricular Function P. R. Salvador, D. D Nascimento, S. A Fakhouri, A. S Fakhouri, A. C Silva, E. S Resende, C. S Melo, F. R De Fazzio, F. H Silva, E. E Kanaan.

P959

P recise filtered-QRS limits tracking in signal-averaged electrocardiography: Comparison between classical ESC vs. new derivative-based method O. Nasario-Junior, P. R. Benchimol-Barbosa, J. Nadal, C. Miranda, G. N. Gobbi, F. P. Vilela, J. Barbosa-Filho, I. Cordovil.

P960 ELECTROCARDIOGRAPHIC ALTERATIONS OF PREVALENCE IN YOUNG SPORTMEN SOCCER AMATEUR CATEGORY, CORRELATION WITH DOPPLER CARDIAC I. Diaz, D. Avayu, D. Morisse, C. Seidler, J. Fuse, J. Goral, L. Rodas, A. Cardozo, A. Cler Pereyra, C. Froimovich.

P962

E xercise induced elevation of NT-pro-BNP is associated with subsequent coronary events in men with negative stress-test. K.G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan.

P963

 RE CHANGES IN THE ARTERIAL WALL RESPONSIBLE FOR THE DECLINATION OF MENTAL A ACTIVITY IN LONGEVOUS INDIVIDUALS ? E. Izcovich, A. Lescano, A. Izcovich, V. Daru, R. Izcovich, R. Ferreyra.

P964

 ypertrophic cardiomyopathy: Case report H E. R. F. L Moraes, F. S. V. Jardim, G. T. Gama, F. L. Vieira, F. J. B. Silva Filho, D. R. Almeida.

P965

 ssessment of Stent Expansion By a Novel Angiographic Technique: Stentboost A M. Albertal, A. Candiello, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi.

P966 Clinical Features of Patients Undergoing CABG who had Prior Percutaneus Coronary Stenting. A. Vizcarra Diaz, R. Marenchino, L. Diodato, V. Cesareo, A. Domenech, D. Bracco.

P968

A ssessment of left ventricle sublinical dysfunction and surgical outcome in asymptomatic severe Mitral regurgitation. Study of Vector velocity Imaging J. Moreno, M. A. Garcia, V. Celorrio, E. Perez, R. Pereira.

P969

B aseline plasma levels of nitrites/nitrates in patients with vasovagal syncope G. A Ruiz, S. Sinigaglia, R. Hermes, R. Chirife, M. Capula, H. Grancelli, M. Nogues, M. C. Tentori.

P970

 TUDY OF THE HEART RATE VARIABILITY IN TYPE 2 DIABETES MELLITUS S A. C. Santomauro Jr., C. Nagaoka, M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, W. A. Amorim, A. C. Santomauro, F. Fraige Filho.

Poster Listing P971

The combination of different imaging techniques seems to be recommendable in the quantification of pulmonary vein ostia sizes. M. Christ, G. Plehn, M. Van Bracht, H. J. Trappe, A. Meissner.

P972 Cardiotoxic effects of pentavalent antimony in guinea-pig leading to arrhythmia and cardiomyopathy. A. C. A Carvalho, L. F. Rodrigues-Jr., C. C. Lores, M. O. Masuda, A. C. C Carvalho, J. H. M. Nascimento.

P973

 T-proBNP is not useful in early follow-up of heart transplant patients N D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric.

P974

E valuation of the cardiopulmonary resuscitation teaching-learning by the nursing team L. A. B. N. Sampaio, A. M. K. Miyadahira.

P975 Association between pravastatin and enalaprilat in the reversal of left ventricular hypertrophy in rats induced by isoproterenol-preliminary results. I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, A. Meneghini, C. Ferreira Filho, T. R. Theodoro, E. R. Suarez, N. Murad, C. Ferreira.

P976

Takotsubo Syndrome: a cathecolamine cardiomyopathy I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, B. S. Santoro, J. F. Kelendjian, R. Alessi, A. R. P. Rieira, C. Ferreira.

P977

P ercutaneous treatment of chronic total occlusion in routine clinical practice S. Jozami, M. Albertal, F. Cura, L. Padilla, A. Candiello, P. Perez Baliño, J. Thierer, J. Belardi.

P978 CARDIOPULMONARY RESUSCITATION (CPR) IN THE POSTOPERATIVE ONE OF CARDIOVASCULARY SURGERY: CHARACTERIZATION OF THE ACTIVITIES AND NECESSITIES OF TRAINING EVIDENCED BY THE PROFESSIONALS OF NURSING. L. A. B. N. Sampaio, A. M. K. Miyadahira, D. V. Correa.

P979 TGF-B1 MEDIATES THE HYPERTROPHIC CARDIOMYOCYTE GROWTH INDUCED BY ISOPROTERENOL IN RATS. I. A. B. Bincoleto, A. C. Santomauro Jr., L. Z. P. Oliveira, M. R. Ugolini, C. Ferreira Filho, A. Meneghin I, T. R. Theodoro, E. R. Suarez, N. Murad, C. Ferreira.

P980

C ardiac Peptides during Exercise in Heart Failure Patients D. Zdrenghea, M. Ilea, D. Pop, D. Petrovai.

P981

 ction of Memantine in the myocites of rats submitted to cold stress. A I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, C. Ferreira Filho, M. Ferriera, A. R. P. Rieira, A. Meneghini, C. Ferreira, N. Murad.

Scientific Programme / 245

Poster Listing P982

 USPICION OF ACUTE CORONARY ILLNESS IN DIABETIC PATIENTS. CLINICAL S CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, C. Laspiur, S. Araujo, A. Farah, F. Marconetto, H. Velez, N. Barrientos.

P984

The influence of gastric bypass in the improvement of the Metabolic Syndrome factors in the later post-operative (6 months) I. A. B. Bincoleto, F. M. B. Rossi, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, W. A. Amorim, A. Serpa Neto, R. B. F. Silva, M. Rossi, E. Z. Chehter.

P985

I s maximal exercise capacity related to ventricular dyssynchrony in asymptomatic aortic stenosis? M. Bustamante-Labarta, F. Vaisbuj, P. Roura, J. Casas, C. Lopez, M. Diaz, F. Salmo, C. Rodriguez-Correa, G. Marambio, E. Guevara.

P986

C ardiac output monitoring in critical care: Influence of the height of the headboard of the bed in the cardiac output and hemodynamics measurements. V. S. Bulgarelli, L. A. B. N. Sampaio.

P987

I ncidence and risk factors of major bleeding in acute coronary syndrome patients A. Reina, F. Manzano, M. Colmenero, P. Castan, M. Rodriguez-Elvira.

P988

C LINICAL COURSE AND PROGNOSIS OF INFECTIVE ENDOCARDITIS IN THE ELDERLY C. M. Cortés, R. J. San Miguel, P. Roura, C. Nagel, C. Salvatori, A. Arlia Ciommo, E. Dulbecco, J. Abud, R. R. Favaloro, J. H. Casabe.

P989

D RUG TREATMENT OF HEART FAILURE PATIENTS IN A ROMANIAN GENERAL HOSPITAL C. Talos, D. Zdrenghea, D. Pop.

P990

V entricular Tachyarrhythmias and the Impact of ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy F. Duru.

P991

 USPICION OF ACUTE CORONARY DISEASE IN PATIENTS OVER 75 YEARS OLD. CLINICAL S CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, S. Araujo, F. Wayar, C. Laspiur, F. Marconetto, C. Toldo, F. Rassi, E. Aramburu.

P992

A ddition of Ivabradin further improves clinical status in patients with end stage heart failure and intolerance to SS-blockers. K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.

Poster Listing P993

S hould Natriuretic Peptide (BNP) be considered for a marker of symptomatic status in severe aortic stenosis patients? M. Katz, G. Spina, F. Tarasoutchi, C. Strunz, R. O. Sampaio, M. Grinberg.

P994

I ntake of isoflavones-enriched soy product fermented with Enterococcus faecium decrease total and non-HDL cholesterol levels in rats D. C. U. Cavallini, E. A. Rossi, I. Z. Carlos, R. C. Vendramini, R. C Damaso, R. Bedani, G. F. Valdez.

P995

LIPOPROTEIN (a) CONCENTRATION IN THREE AFRO-AMERICAN POPULATIONS IN ZULIA STATE, VENEZUELA D. Aparicio, V. Bermúdez, E. Mengual, J. Faria, F. Finol, X. Guerra, D. Gotera, L. Acosta, E. Rojas, L. Sorell.

P996

 symmetric and symmetric dimethylarginine are weaker predictors than A homocysteine of long-term mortality in both men and women with stable angina G. Svingen, P. M. Ueland, Ø. Bleie, J. E. Nordrehaug, T. Folkestad, K. Kuiper, M. Ebbing, E. R. Pedersen, S. E. Vollset, O. Nygård.

P997 Does the frequency of syncope predict the response to Head-up tilt-table testing in adolescents R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, V. Cerutti, R. Hams, D. Serrano, C. Marques.

P998

Long Term Outcome Of Patients With Type B Aortic Dissection D. Bracco, R. Marenchino, A Domenech, V. Cesareo, L. Diodato.

P999

B -Type Natriuretic Peptide and anemia, are they related? R. A. F. Gomes, L. M. Sena, J. L. Ferreira, C. Sarteschi, S. M. Martins, A. D. M. Feitosa.

P1000 I ncidence of the cardiovascular risk factors in the patients of the Health Campaign in Santo André, Brazil A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, C. Nagaoka, J. F. Kelendjian, E. R. Suarez, C. Ferreira.

P1001 ASSESSMENT OF THE ANALGESIC EFFECTIVENESS OF GENERAL ANESTHESIA AND SPINAL ANESTHESIA USING MORPHINE AND ROPIVACAINE IN PATIENTS SUBMITTED TO MIOCARDIAL REVASCULARIZATION SURGERY V. Pinheiro, R. Diniz, M. Ferreira, J. Costa, E. Pinheiro, M. Cascudo.

P1002 SUSPICION OF ACUTE CORONARY DISEASE IN WOMEN, CLINICAL CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, S. Araujo, P. Kairuz, F. Wayar, N. Marquez, A. Lopez Facchin, M. Geronimo.

Scientific Programme / 247

Poster Listing P1003 Ecologic methods for measuring health disparities attributed to socioeconomic factors: risk of premature CVD mortality across geodemographic areas of Porto Alegre, Brazil S. L. Bassanesi, M. I. R. Azambuja, A. C. Achutti.

P1004 SUSPICION OF ACUTE CORONARY DISEASES, CLINICAL CHARACTERISTICS, TREATMENT AND EVOLUTION AT THIRTY DAYS R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, C. Laspiur, S. Araujo, C. Flores Borja, A. Farah, J. Gomez, J. Zapata, F. Rassi.

P1005 Myocardial infarction : Strategy and results in hospitals with/without PCI chance. L. Herrera-Para, A. Reina-Toral, R. Diaz-Contreras, R. Lirola-Liebanas, G. Moratalla-Cecilia, F. Manzano-Manzano, I. Slimobich, J. Benitez-Parejo, E. Aguayo-De Hoyos, J. C. Luque-Moscoso.

P1007 PAINFUL PROCEDURES IN THE POST-OPERATORY OF CARDIAC SURGERY V. Pinheiro, C. Pimenta.

P1008 ADDITIVE VALUE OF TROPONINE T TO ADMISSION ELECTROCARDIOGRAM IN PATIENTS WITH SUSPICION OF ACUTE CORONARY DISEASE S. Saravia Toledo, P. Gallo, R. Leon De La Fuente, F. Marconetto, C. Laspiur, C. Rodriguez, G. Castillo, F. Gomez Ortega, C. Swarzman.

P1009 Cardiac I Troponin as a Predictor of Normal Coronary Arteries in Association to Gender in Patients with Acute Coronary Syndrome without ST Segment Elevation. D. Di Nanno, L. Lopez, M. Consoli, C. Pasinato, A. Bordenave, J. Tartaglione, S. Chekherdemian.

P1010 LONG TERM FOLLOW UP OF BIFURCATION LESIONS ANGIOPLASTY: OUR EXPERIENCE. D. Grinfeld, D. Berrocal, G. Cugat, J. Gabay, C. Agatiello, P. Pollono, F. Fuertes, A. Fernandez, J. L. Parmisano, L. Grinfeld.

P1011 Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes F. Finol, V. Bermúdez, D. Aparicio, L. Acosta, R. Canelón, E. Rojas, E. Mengual, K. Acosta, R. Cano, M. Cabrera.

P1012 The ratio of apolipoproteins ApoB/ApoA1 as a predictor of angiographic progression of atherosclerosis in patients with coronary artery disease A. J. Blix, K. H. Loland, O. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygard.

P1013 Incremental shuttle walk test in the assessment of functional capacity in chronic heart failure C. Pulz, A. N. F. Alves, R. V. Z. Diniz, A.S. Tebexreni, A. C. C. Carvalho, A. A. V. De Paola, D. R. Almeida.

Poster Listing P1014 Antioxidant therapy improves left ventricular diastolic function and alters remodeling in patients with postinfarction heart failure and impaired renal function. K. G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan.

P1015 Low Frequency Power of Heart Rate Variability Associated With Baroreflex Impairment in Myocardial Infarction in Rats C. Mostarda, E. D. Moreira, B. Rodrigues, M. Vane, K. T. Rosa, E. M. Krieger, K. De Angelis, M. C. Irigoyen.

P1017 Is carvedilol useful for symptomatic heart failure patients with chronic cardiomyopathy due to a Chaga‘s disease? R. V. Z. Diniz, R. F. M Viegas, J. M. L Amorim, A. S. Tebexreni, A. C. C. Carvalho, A. A. V. Paola, D. R. Almeida.

P1018 Minimally-invasive cardiac surgical ablation (Wolf Mini-Maze) of Atrial Fibrillation in patients without concomitant heart disease. Three years follow up. L. Antonietti, A. Zapolanski, D. Santos, F. Mastrogiacomo, A. Villamil, N. Gastaldello, J. Lax, C. Tajer.

P1020 Heart Rate Variability Analysis in Patients with Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome) C. Faria, D. Sobral-Filho, J. Brandão-Neto, A. Rego, S. Egito, F. Baracho.

P1022 PLASMA LEVELS OF NITRIC OXIDE METABOLITES AND VASCULAR ENDOTHELIAL FUNCTION IN MAJOR DEPRESSION SUBJECTS. R. G Garcia, J. G. Zarruk-Serrano, W. Arenas-Borda, C. Barrera, E. Trillos, A. Pinzon, D. Quintero, C. Tomaz, P. Lopez-Jaramillo.

P1024 Orange Juice Synergistic Effects on GemfibrozilTreatment in High Fat Fed Rabbits M. Higuchi, J.J. Raposo, S. A. P. Palomino, M. H. H Santos, R. Ikegami, M. M Reis. P1025 B6 vitamers and long term mortality in patients with stable angina E. R. Pedersen, M. Ebbing, O. Midttun, P.M. Ueland, S.E. Vollset, O. Bleie, H. Schartum-Hansen, J. E. Nordrehaug, O. Nygard.

P1027 Endothelium dysfunction as cardiovascular events risk factor in patients with metabolic syndrome O. Savenko, V. Vikentyev.

P1028 Changes in multifractal parameters of heart rate fluctuations in correlation with circadian differences of heart rate R. Galaska, D. Makowiec, A. Dudkowska, A. Koprowski, M. Fijalkowski, A. Rynkiewicz.

Scientific Programme / 249

Poster Listing P1030 Molecular identification of T. cruzi lineages and populations in endstage Chagas heart disease patients undergoing heart transplantation: predominance of lineage I J. M. Burgos, M. Diez, C. Vigliano, M. Bisio, T. Duffy, L. Favaloro, R. Favaloro, M. J. Levin, A. G. Schijman.

P1032 Percutaneous revascularization in elderly women. Do they have worst prognosis? M. Monteverde, H. Caballero, S. Liotta, E. Barrera, H. Fernandez, S. Berenztein, M. Vazques Blanco, E. Sampo, J. Lerman.

P1034 APICAL HYPERTROPHIC CARDIOMYOPATHY AND APICAL CALCIFIED THROMBUS: A NEW COMPLICATION?. M. C. Saccheri, T. F. Cianciulli, R. J. Mendez, I. V. Konopka, H. J. Redruello, G. E. Gigena, D. F. Serans, R. S. Acunzo, H. A. Prezioso, L. A. Vidal.

P1035 Role of theophylline (adenosine antagonist) or N-acetylcysteine alone and in combination for prevention of contrast induced nephropathy S. Kumar, N. Sinha, K. Chawla, A. Kapoor, S. Tewari, N. Prasad, S. Gambhir, S. Barai. P1036 Does the use of 600 mg Clopidogrel loading dose before percutaneous coronary intervention in acute coronary syndromes increase the risk of bleeding after the procedure? R. Gusmao De Oliveira, A. Figueiredo, J. Petriz, A. Marques, M. Cardoso, A. Glavan, A. Brasileiro, B. Tura, P. Resende. P1038 Bleeding complications in elderly patients with non-ST elevation acute coronary syndromes: predictors and outcomes C. Lourenço, R. Teixeira, A. Natália, S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1039 ACUTE CARDIAC INSUFFICIENCY SECONDARY TO VIRAL MYOCARDITIS: A CASE STUDY C. L. Weksler, R. Alves, F. T. Oliveira, A. L. C. Marins, V. Z. Mattos, V. R. Souza.

P1041 Maintenance of Venous Access as Indicator of Quality of Care for Nursing A. L. C. Marins, R. Mourilhe Rocha, R. Esporcatte.

P1042 THE IMPACT OF CORONARY ARTERY BYPASS GRAFT SURGERY IN THE ABANDON OF SMOKING R. Pietrobon, J. Barbisan, L. Smidt.

P1043 MALE GENDER AND METABOLIC SYNDROME IN YOUNG INDIVIDUALS FOLLOWED-UP FOR A 17 YEARS-PERIOD. THE RIO DE JANEIRO STUDY A. A. Brandao, M. E. C Magalhaes, E. G Campana, F. L Fonseca, O Pizzi, E. V Freitas, R Pozzan, A. P Brandao.

Poster Listing P1045 Anti-streptoccocal vaccination induces lowering of anti-oxLDL antiboties in responding diabetic patients. E. Rzewuska, M. Karynski, K. Jankowski, M. Puchta, A. Lipinska, P. Grzesiowski, D. Liszewska-Pfejfer, P. Pruszczyk.

P1047 Is ankle-brachial index associated with ischemia on myocardial perfusion scintigraphy in elderly patients? L. Machado, P. Smanio, C. Ferreira, J. Borges, M. Castillo, A. Thom, L. Piegas.

P1048 Prevalence of ‘responders’ and ‘non-responders’ to antiplatelet drugs M. G. Gonzalez Achaval, S. Ghione, M. Hadad, S. Gomez, L. A. Del Val, C. Balestrini.

P1049 Homocysteine and markers of immune activation as predictors of mortality in stable angina patients E. R. Pedersen, P. M. Ueland, S.E. Vollset, O. Midttun, G. Svingen, H. Schartum-Hansen, O. Bleie, M. Ebbing, J. E. Nordrehaug, O. Nygard.

P1050 PREVALENCE AND CHARACTERISTICS OF HIGH BLOOD PRESSURE AND ITS ASSOCIATION TO CARDIOVASCULAR RISK FACTORS IN SOUTH SERBIA I. Burazor, M. Burazor, N. Vukadinovic, B. Lovic, Z Burazor, G. Cvetanovic, N. Burazor.

P1051 Tissue synchronization imaging in the localization of the accessory atrioventricular pathways M. Lanocha, A. Szyszka, K. Blaszyk, R. Ochotny, S. Grajek.

P1052 Role Of Pentoxifylline (Non-Specific Anti-Cytokine Agent) On Left Ventricular Ejection Fraction And Functional Class In Patients With Left Ventricular Systolic Dysfunction S. Kumar, N. Sinha, A. Kapoor, S. Tewari, G. S. Gill, V. Agarwal, R. N. Mishra.

P1053 HIGH BLOOD PRESSURE IN A COHORT OF PEOPLE JOINT TO PUBLIC EMPLOYEES MEDICAL SERVICE OF MENDOZA ARGENTINA A. Añó, S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, G. Vega, S. DepineY, S. Gimenez.

P1054 A comparative study of Carotid Intima Media Thickness in Patient of End stage renal disease patients on peritoneal dialysis S. Kumar, N. Sinha, N. Prasad, K. Chawla, A. Kapoor, S. Tewari.

P1055 Effects of flu vaccination of senior citizens (60+) on seasonal trends of morbi-mortality in Brazilian hospitals. M. I. Azambuja, S. L. Bassanesi.

P1056 INTIMAL PROLIFERATION INDUCED BY PERIVASCULAR INFLAMMATION IN MICE: COMPARISON BETWEEN FEMORAL AND CAROTID ARTERIES S. Lacchini, L. F. Borges, J. P. F. Blini, B. S. Yasumura, J. E. Krieger.

Scientific Programme / 251

Poster Listing P1058 Impact of Body Mass Index in the Target Organs Damage in Patients with Resistant Hypertension M. Barros, A.B. Lima, C. A. S. Nascimento, J. R. M. Pereira, F. D. Vilela, V. Verri, P.R. Benchimol-Barbosa, F. E. S. F. Cruz, I. Cordovil.

P1059 Can the progression of endothelium dysfunction be a predictor of cardiovascular events in patients with metabolic syndrome? O. Savenko, V. Vikentyev.

P1060 Myocardial infarction with angiographically normal coronary arteries in an infant A. Sardella, H. Vazquez, I. Abella, C. Viegas, I. Torres, M. Grippo, M. Cazalas, A. Goldsman, A. Slichter, C. Kreutzer.

P1061 Clinical impact of prophylactic use of aprotinin in cardiac surgery. S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa.

P1063 Cardiogenic Shock without Acute Cardiac Syndrome: clinical profile of patients, management strategies and prognosis. I. Wojtkowska, M. Banaszewski, A. Konopka, M. Marona, J. Stepinska.

P1064 Acute Heart Failure With Preserved Systolic Function in Acute Coronary Syndrome Patients: clinical relevance and outcomes C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, L. Providência.

P1065 Ambulatory blood-pressure monitoring in patients with severe aortic regurgitation, before and after treatment with nifedipine F. Gual-Capllonch, A. Evangelista, J. L. Tovar, T. Gonzalez-Alujas, M. Alvarez, P. Mahia, R. Aguilar, P. Tornos.

P1066 The impact of Head-Up Tilt Test (HUT) with nitroglycerine (NTG) provocation on chosen parameters of assessment in the healthy human subject circulation K. Peczalski, P. Sionek, D. Wojciechowski.

P1068 TYPE 2 DIABETICS WITH HIGH LEVELS OF C-REACTIVE PROTEIN PRESENT A REDUCTION OF HEART RATE VARIABILITY E. O. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva.

P1069 ARTERIAL HYPERTENSION AND DYSLIPIDEMIA: COMPARISON AMONG ANAMNESIS AND THE RESULTS GOT FROM DIGITAL SPHYGMOMANOMETER AND BIOCHEMICAL MEASUREMENT FROM PERIPHERAL BLOOD A. L. P. Arnaldo Lemos Porto, D. M. S. N. Douglas M. Silva Nascimento, J. P. H. R. João Paulo Hanel Rorato, E. C. A. R. Eliane Consuelo A. Rabelo, C. C. P. Celmo Celeno Porto.

Poster Listing P1070 THE IMPACT OF NURSING CONSULTATION ON THE CONTROL OF INR F. Silva, A. Camara, R. Filho, C. Barros, S. Figueiredo, T. Guimaraes, I. Santos, I. Oliveira, M. Bosa, R. Silva.

P1071 Lower serum Fetuin-A levels are associated with aortic sclerosis in patients with coronary artery disease and preserved renal function K. Linhartova, J. Veselka, G. Sterbakova, O. Topolcan, R. Cerbak, J. Racek.

P1072 SCIENTIFIC ANALYSIS OF PRODUCTION OF CARDIOVASCULAR NURSING UNDER THE PREVENTION TERTIARY A. Camara, C. Barros, D. Santoro, F. Silva, R. Barreiro Filho, R. Silva, S. Figueiredo, T. Guimarães, I. Santos, L. Campos.

P1073 Peri-stent Remodeling after Sirolimus-eluting or Paclitaxel-eluting Stent Implantation in Diabetic Patients. A Randomized Serial Intravascular Ultrasound Study. L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen. P1074 The multidisciplinary team care to secondary prevention in a group with resistant hypertension treated in a public institute of cardiology in Rio de Janeiro, Brasil. A. B. Lima, M. Barros, V. Verri, J. R. M. Pereira, C. A. S. Nascimento, F. D. Vilela, P. R. Benchhimol-Barbosa, F. E. S. F. Cruz, I. Cordovil. P1075 The relationship between angiotensin converting enzyme gene polymorphism and comorbidities in rural community patients with chronic heart failure. H. Balieiro, E. T. Mesquita, T. L. Balieiro, S. R. Brito, R. B. Moreira, R. K. Osugue, S. B. Pereira, A. M. Domingos, A. P. Moraes, G. Ribeiro.

P1076 Successful treatment of endotension and aneurysm sac enlargement with endovascular stent graft reinforcement. M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi.

P1077 METHIONINE PRODUCED AN IMPAIRMENT OF CARDIOVASCULAR AUTONOMIC MODULATION IN RATS G. O. Candido, R. H. Mendes, R. N. De La Fuente, C. Mostarda, I. C. M. Silva, L. Jorge, M. C. Irigoyen, K. Rigatto.

P1078 IMPACT OF A MANAGED ACUTE MYOCARDIAL INFARCTION (AMI) PROTOCOL IN THE PRESCRIPTION RATE OF ACE INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKER FOR HOSPITALIZED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND LEFT VENTRICULAR SYSTOLIC DYSFUNCTION M. R. P. Makdisse, A. Correa, S. Lagudis, S. S. Morhy, F. Bacal F, M. Knobel, C. H. Fischer, M. L. C. Vieira, P. V. Pires, E. Knobel.

Scientific Programme / 253

Poster Listing P1079 Analysis of possible iPods interference with Pacemakers M. Benassi, E. Valero, R. Pesce, L. Jurado.

P1081 Contemporary management of carotid artery stenosis: carotid endarterectomy is here to stay. Selection of the approach according to patient surgical risk. M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi.

P1082 The resistant hypertension genotypes of the population resident in Rio de Janeiro F. D. Vilela, P. R. Benchimol-Barbosa, C. C. Zeno, A. B. Lima, M. Barros, F. V. Campos, C. S, Miranda, G. N. Gobbi, J. Barbosa-Filho, I Cordovil.

P1083 GLYCAEMIA AT ADMISSION ACCURATELY PREDICTS IN-HOSPITAL OUTCOME IN ACUTE CORONARY SYNDROME PATIENTS S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1084 Usefulness of multislice computed tomography in the detection of non-suspected coronary and myocardial diseases M. Falconi, D. Perez De Arenaza, P. Oberti, P. Pollono, A. Fernandez, F. Abramzon, L. Grinfeld, R. Garcia Monaco, J. Krauss, A. Cagide.

P1085 ASSOCIATION BETWEEN PROGNOSTIC FACTORS IN SEVERE IDIOPATIC DILATED CARDIOMYOPATHY AND FIBROSIS EVALUATED BY CARDIOVASCULAR MAGNETIC RESONANCE M. L. O. Mugnaini, D. B. Précoma, P. R. Schvartzman, L. A. Z. Moura, S. H. Barberato, G. Lemke, P. R. Brofman.

P1086 Does symmetry of the aortic outflow velocity profile reflect contractile function in coronary artery disease ? An automated analysis using mathematical modelling M. Cikes, H. Kalinic, A. Baltabaeva, S. Loncaric, C. Parsai, J. Separovic Hanzevacki, I. Cikes, G. Sutherland, B. Bijnens.

P1087 Absence of electrocadiographic abnormalities in children infected with Trypanosoma cruzi from a rural area of Argentina. C. D. Lacunza, M. Gonzalez, A. Alberti, R. Cimino, V. Pereyra, R. Zacca, V. Orellana, M. A. Basombrío, J. Nasser, P. Diosque.

P1088 HEMODYNAMIC AND AUTONOMIC RESPONSES TO A MENTAL STRESS TEST AND TO AN ISOMETRIC EXERCISE TEST IN OFFSPRING OF HYPERTENSIVE PARENTS. J. V. Francica, M. V. Heeren, C. Mostarda, M. Sartori, M. Tubaldini, R. C. Araújo, M. C. Irigoyen, K. De Angelis.

P1089 Population awareness on cardiovascular risk factors: a developing country experience PrevenAção A. Avezum, H. Guimarães, A. Brasileiro, P. Esteves, A. Neto, M. Bertolami, C. Serrano, L. Maia, A. Marco, F. Nobre.

Poster Listing P1090 264 DAYS ON BIVENTRICULAR MECHANICAL ASSISTANT SUPPORT AS BRIDGE TO TRANSPLANTION IN A 31 MONTH OLD PATIENT H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli, D. Haag, M. De La Riba.

P1091 NORMOTHERMIC CARDIOSURGERY. THE COMPARATIVE ANALYSIS OF HEMODYNAMIC IN AORTO-CORONARY BYPASS SURGERY R. S. Ovchinnikov, L. A. Bockeria, V. A. Lischouk, I. U. Sigaev, D. S. Gazizova, L. V. Sazukina, V. E. Volgushev.

P1092 Hypertension Screening with a New Digital Blood Pressure Device Named “Rastreometer” A. D. M. Feitosa, V. R. Lafayette, L. B. N. C. Magalhaes, M. A. M. Gomes, R. D. Miranda.

P1093 Latvian bifurcation lesion registry – IVUS results A. Erglis, I. Kumsars, I. Narbute, D. Sondore, S. Jegere, A. Dombrovskis, A. Lismanis, I. Olina.

P1094 Amplitude of in-hospital glycaemia variation: a new prognostic marker in acute coronary syndromes? S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1095 THE EFFECTS OF RESISTANCE EXERCISE ON PLASMA KINETICS OF AN ARTIFICIAL NANOEMULSION THAT BINDS TO LOW-DENSITY LIPOPROTEIN RECEPTORS J. L. Silva, C. G. Vinagre, A. T. Morikawa, R. C. Maranhao.

P1096 Cardiac Magnetic Resonance in heterozygotes females with Anderson-Fabry disease L. Dragonetti, C. Rivas, F. Corbella, E. Eyheremendy, Adellfa.

P1097 EXERCISE TRAINING INDUCED AUTONOMIC IMPROVEMENT WAS ASSOCIATED WITH METABOLIC AND RENAL DYSFUNCTIONS ATTENUATION IN AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME AND MENOPAUSE. K. Ponciano, J. Brito, I. Sanches, M. Heeren, M. C. Irigoyen, K. De Angelis.

P1098 BODY MASS INDEX AND IN-HOSPITAL ACS OUTCOME: THE MIDDLE IS THE PLACE TO BE! S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1099 Anaemia and renal failure – a deadly duet in Acute Coronary Syndromes S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1100 Using a fiber and phytonutrient combination therapy to control hypercholesterolemia in an African American community L. Njord, R. Njord, W. Cooper, P. J. E. Verdegem.

Scientific Programme / 255

Poster Listing P1101 CORONARY ACUTE SYNDROME IN PATIENTS ADMITTED TO THE EMERGENCY IN THE CENTRAL HOSPYTAL OF THE SOCIAL INSTITUTE PREVISIÒN F. Fernandez Chamorro, C. Saldivar, L. Fatecha, M. Centurión, J. Paredes, L. Bell, A. Villamayor, V. Marmol, J. Gonzalez, S. Aguirre.

P1102 Predictors and Clinical Relevance of Troponin Elevation following percutaneous Aortic Valve Replacement H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac.

P1103 ENDOVASCULAR RECONSTRUCTION BY MEANS OF STENTS OF SYMPTOMATIC INTRACRANIAL STENOSIS P. Lylyk, C. Miranda, R. Ceratto, A. Ferrario, J. Vila, C. Ingino.

P1104 Diabetes: a coronary artery disease equivalent revisited in acute coronary syndrome patients S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1105 Cardiac abnormalities in patients with HIV-related malignancies in Sub-Saharan Africa C. Onen.

P1106 Angiopoietins mediate monocyte adhesion to endothelial cells and have pro-inflammatory actions independent of VEGF R. Potluri, T. Fujisawa, K. Chudasama, S. Ahmad, P. Hewett, M. Cudmore, A. Ahmed.

P1107 HOW DO PARENTS AND RESPONSIBLE OF SCHOLARS DEAL WITH TONSILLITIS AND RHEUMATIC FEVER IN RIO DE JANEIRO? R. Müller, M. F. M. P. Leite, D. L. Sampaio, M. C. C. Kuschnir, M. J. L. M. Silva, A. S. Souza, R. Thurler, R. Bedim, F. F. Nascimento, R. M. A. Xavier.

P1108 Long-term (up to five years) Clinical Outcomes of On-label versus Off-label Patients in the DESIRE (Drug Eluting Stents In the REal world) Registry J. Costa Jr., A. Sousa, R. Costa, A. Costa, M. Cano, G. Maldonado, O. Berwanger, R. Pavanello, M. Barbosa, J. Eduardo Sousa.

P1109 Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of extracellular signal-regulated kinases (ERK) 1/2 in rat heart in vivo. J. F. Giani, M. M. Gironacci, M. C. Muñoz, D. Turyn, F. P. Dominici.

P1110 MICROVASCULAR DIABETIC COMPLICATIONS ARE MORE PREVALENT IN INDIA COMPARED TO MAURITIUS AND THE UK DUE TO POORER DIABETIC CONTROL R. Potluri, Y. Purmah, N. Sewpaul, M. Dowlut.

Poster Listing P1111 Electrocardiographic patterns and coronariographic correlation in patients with STEMI that underwent Percutaneous Coronary Intervention on admission to hospital. I. Santos-Rodriguez, M. J Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno, V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez.

P1113 “ASSESSMENT OF ATRIAL SYSTOLE WITHIN THE FIRST 24 HOURS AFTER CARDIOVERSION IN PATIENTS WITH ACUTE ATRIAL FIBRILLATION” G. Rodriguez Botta, E. Escudero.

P1114 Obesity as a predictor of mayor cardiovascular risk factors- Chilean policemen cohort. F. Vilchez, P. Varleta, B. Clericus, P. Salvo.

P1115 Predictive Value of Cardiac I Troponin for High Risk Anatomy in Acute Coronary Syndromes without ST Segment Elevation. D. Di Nanno, L. Lopez, A. Torterola, A. Bordenave, M. Consoli, C. Pasinato, R. La Greca, S. Chekherdemian.

P1116 Heart rate variation disturbance followed by right ventricle acute systolic strain after pulmonary embolisms M. Palinsky, J. Petrovicova, P. Mitro, M. Szakacs.

P1117 EXCELLA First-in-Man STUDY : SAFETY AND EFFICACY OF ELIXIR NOVOLIMUS-ELUTING STENT IN THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY LESIONS A. Abizaid, J. Costa Jr., R. Costa, F. Feres, D. Siqueira, P. Fitzgeral, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa.

P1118 Association of alanine aminotransferase with cardiovascular risk factors in 40 years old subject from Slovak general population B. Vohnout, J. Gasparovic, Z. Basistova, S. Wsolova, L. Fabryova, K. Raslova.

P1119 Restenosis of Drug-eluting stents: a Currently Unsolved Issue? J. Costa Jr., A. Sousa, R. Costa, A. Moreira, G. Maldonado, M. Cano, E. Romano, C. Jardim, C. Campo, J. Eduardo Sousa.

P1120 Preliminary Results of the Hydroxyapatite Non-Polymer-Based SirolimusEluting Stent for the Treatment of Single De Novo Coronary Lesions – A FirstIn-Human Analysis of a Third Generation Drug-Eluting Stent (DES) System A. Abizaid, J. Costa Jr., R. Costa, F. Feres, R. Graebin, R. Staico, L. Fernando Tanajura, A. Abizaid, A. Sousa, J. Eduardo Sousa.

P1123 The use of PICC in Infectious Endocarditis Treatment P. Silva, A. Silva, C. Barros, G. Carvalho, L. Campos, P. Mota, P. Marinho, R. Barreiro Filho, R. Silva, T. Guimarães.

Scientific Programme / 257

Poster Listing P1125 Long-term results of drug-eluting stents for the treatment of saphenous vein grafts: What we learned from the DESIRE-SVG (Drug-Eluting Stents In REal world - Saphenous Vein Graft) Registry J. Costa J., A. Sousa, A. Moreira, R. Costa, G. Maldonado, M. Cano, E. Egito, A. Cury, O. Berwanger, J. Eduardo Sousa.

P1126 Tilt test in the investigation of exercise-induced syncope of unknown origin A. Nobrega, R. Castro, A. Souza.

P1127 Differential influences of high fat diet on cardiac remodeling from normotensive and spontaneously hypertensive rats S. A. Oliveira Júnior, A. P. Lima-Leopoldo, P. F. Martinez, D. H. S. Campos, M. M. Sugizaki, M. P. Okoshi, K. Okoshi, C. R. Padovani, M. Dal Pai-Silva, A. C. Cicogna.

P1128 Impact of Invasive Strategy in elderly patients presenting with non-ST elevation acute coronary syndromes C. Lourenço, R. Teixeira, N. António, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, L. A. Providência.

P1129 NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES. ANTECEDENTS, CLINICAL PRESENTATION AND PREDICTORS OF PROGNOSIS BY MULTIVARIATE ANALYSIS H. Pomés Iparraguirre, G. Calderón, W. Santander, J. H. Leguizamón, O. Paredes, G. Kuhn, A. Arias Posada, L. Ferrer, R. Aguero, G. Valeriano.

P1130 Exercise antioxidant protective effect improves cardiovascular and renal function in diabetic hypertensive rats T. S. Cunha, R. H. Mendes, M. Bertagnolli, G. Cândido, J. P. Aguiar, K. Flues, K. De Angelis, F. K. Marcondes, A. Belló-Klein, M. C. Irigoyen.

P1131 Chronic Clopidogrel and Aspirin Therapy for Coronary Artery Disease: A 10 year Clinical Follow-Up S. Krishna, R. Suneja, P. C. Chabot, N. Kleiman.

P1132 Role of M-mode septal to posterior wall motion delay as predictor of response to cardiac resynchronization therapy N. António, L. Coelho, S. Costa, H. Vieira, R. Martins, M. Ventura, J. Cristóvão, L. Elvas, L. Gonçalves, L. A. Providência. P1133 Is an invasive strategy useful in women with non-ST acute coronary syndrome? R. Teixeira, C. Lourenço, N. Antonio, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, L. A. Providencia.

Poster Listing P1134 Very long-term clinical outcomes of a consecutive high-complexity population treated with drug-eluting stents: Results of the DESIRE (Drug Eluting Stents In the REal world) Registry J. Costa Jr., A. Sousa, R. Costa, A. Moreira, M. Cano, G. Maldonado, C. Jardim, M. Helena Dib, C. Campos, J. Eduardo Sousa.

P1135 Vascular risk factors in perimenopausal female physicians in Argentina H. Z. Zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar.

P1136 RISK OF HEMODIALYSIS AFTER HEART SURGERY B. Santos, S. Olival, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa. P1137 SYNCOPE WITH INJURY. DIAGNOSTIC AND OUTCOME N. Galizio, L. Soriano, G. Fava, J. L. Gonzalez, L. Medesani, P. Montoya, S. Schanz, R. Ramon, H. Ramirez. P1139 Diagnosis of the Metabolic Syndrome and its Relation with Insulin Resistance. G. Giunta, L. Cuniberti, C. Escarain, N. Pizzi, S. Lynch, A. Miranda, A. Christen, G. Yannarelli, R. Sanchez, H. Baglivo.

P1140 C Reactive Protein and Cardiac I Troponin. Two Sides of the Same Medal? D. Di Nanno, L. Lopez, M. Consoli, F. Petrolito, A. Costa, L. Saclietti, C. Pasinato, S. Chekherdemian.

P1141 A new Strategy for Rheumatic Fever Prevention through Health Education – PREFERE Program, Rio de Janeiro, Brazil R. E. M. Regina Elizabeth Muller, M. C. K. Maria Cristina Kuschnir, B.R.T. Bernardo Rangel Tura, R. M. A. X. Regina Maria Aquino Xavier, M. J. L. S. Maria José Lucas M. Da Silva, A. L. S. Ana Lucia Schilke, F. F. N. Fabiana F. Nascimento, A. E. A. S. Anna Esther Araújo E Silva, A. B. L. Ana Beatriz Lima, M. F. C. Marcia Fernanda De Carvalho.

P1142 Angiographic and ultrasonographic comparison of Sirolimus and Novolimuseluting stents for the treatment of coronary lesions J. Maia, J. Costa Jr., A. Abizaid, D. Chamie, F. Feres, R. Costa, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa.

P1144 Mitochondrial ATP-Sensitive Potassium Channel Participation in Spironolactone Preconditioning C. C. Lores, L.F. Rodrigues Jr., A. C. A Carvalho, A. C. C. Carvalho, J. H. M. Nacimento.

P1145 RESTRICTIVE CARDIOMYOPATHY: ETIOLOGIES AND OUTCOME IN A SINGLE CENTER EXPERIENCE V. Gregorietti, M. Peradejordi, A. Bertolotti, M. Diez, L. Favaloro, L. Talavera, C. Vigliano, R. Laguens, R. Favaloro.

P1146 EQUIPLANARITY OF ECHOCARDIOGRAPHIC, SPECT AND CARDIAC MAGNETIC RESONANCE IMAGING PLANES. TO WHAT EXTENT ARE THE AHA STATEMENTS FOR SEGMENTATION AND NOMENCLATURE PRACTICABLE? R. Asbot, K. Sugar, I. Balogh.

Scientific Programme / 259

Poster Listing P1147 THE GOOD SCORE´S QUALITY OF LIFE IS A MARKER FOR THE GOOD CONTROL ON BLOOD PRESSURE IN HYPERTENSION PATIENT? G. M. Guerra, E. O. Freitas, P. L. Silva, D. M. A. Giorgi, E. M. Krieger, H. F. Lopes.

P1148 Relationship between ventricle-vascular coupling and the ventricular function parameters. Concept of ventricle-vascular interaction. J. Tripolone, G. Santiago, A. Schott, J. M. Tripolone.

P1149 Racial Distribution Of Nitric Oxide Synthase Polymorphism In A Multi-ethnical Population E. Mesquita, S. Bernardez, O. Tardin, L. Pessoa, S. Chermont, T. Alves, H. Balieiro, L. Amorim, G. Ribeiro, M. Velloso.

P1152 Atherothrombosis in acute coronary syndromes: one size does not fit all! S. Monteiro, N. Antonio, S. Costa, R. Teixeira, C. Negrier, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

P1153 STROKE AFTER CARDIOTHORACIC SURGERY: ANALYSIS OF ASSOCIATED FACTORS S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa.

P1154 Experience with covered stent implantation in congenital heart disease. A. Peirone, A. Guevara, A. Spillmann, E. Juaneda, G. Pessah, G. Guglieri, E. Banille, L. Alday.

P1155 MYOGENIC REGULATORY FACTORS EXPRESSION IN SKELETAL MUSCLE CHANGES DURING VENTRICULAR DYSFUNCTION AND HEART FAILURE P. F. Martinez, K. Okoshi, L. A. M. Zornoff, R. F. Carvalho, S. A. Oliveira Jr, D. H. S. Campos, A. R. R. Lima, C. R. Nogueira, M. Dal Pai-Silva, M. P. Okoshi.

P1156 Precompetitive assessment in young athletes J. Kriskovich, R. Rasmussen, E. Villegas, G. Pereira Zini, M. Avila, M. De La Rosa, E. Tassano.

P1158 emergency service: analysis of chest pain unity J. Silveyra, P. Bayol, O. Querencio, E. Fernandez, S. Manzolillo, R. Zoni, J. Parras, J. Kriskovich, J. Escalante, R. Peloso.

P1159 Evaluation of Aortic Pathology by Cardiac Magnetic Resonance A. Ithuralde, C. Seara, J. Moltedo, J. P. Gallo, C. Nojek, P. Garcia De Lucis, M . Garcia Nani, A. De Elizari, M. Ithuralde. P1160 NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES IN DIABETIC PATIENTS. CLINICAL CHARACTERISTICS, THERAPEUTIC INTERVENTIONS AND INHOSPITAL OUTCOME H Pomés Iparraguirre-, G Kuhn, G Calderón, W Santander, JH Leguizamón, O Paredes, R Aguero, L Ferrer, J. Torres, A. Cejas.

Poster Listing P1161 Exercise testing assessment in active men and their relationship with smoking J. Kriskovich, R. Rasmussen, E. Villegas, M. Avila, G. Pereira Zini, J. Sanagua, H. Martinez, E. Tassano. P1163 Family history of tobacco smoking and attitude towards the patient smoker in female physicians of Argentina H. Z. Zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte, Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar.

P1164 Blood pressure control and prevalence of arterial hypertension in adolescents of a rural population in Argentina. Vela Project. Matias Tringler, Alejandro Diaz, Soledad Saravia, Maria Silvia Grenóvero.

P1165 Analysis of Risk Factors for Cardiovascular Disease among Women in a city in Argentina M. Del Sueldo, Md, C. Serra, Md, Ph, G. Guerrero, Engineer, R. Rodrigo, Md. M. Carasa, Md. S. Castellino, Md. V. Giovinni, Md. I. Vigil Torres, Md. D. Barra, Biochemist, J. Zilberman, Md.

P1166 Anthropometric, Metabolic And Cardiorespiratory Profile Of Subjects Older Than 60 Years-old In Brazil Southern Population K. C. Belli, C. M. Richter, T. F. Panigas, D. C. Bündchen, T. Dipp, J. Z. Klafke, K. C. Guidini, C.F. Panigas, P. R. N. Viecili.

P1167 Angiographic and ultrasonographic results of the SISC (Stent In Small Coronaries) Registry D. Chamie, J. Costa Jr., A. Abizaid, R. Costa, F. Feres, J. Maia, F. Devito, D. Siqueira, A. Sousa, J. Eduardo Sousa.

P1168 Relationship Between Heart Rate Equations and Maximum Oxygen Consumption for Exercise Program Prescription J. L. C. Pippi, T. F. Panigas, T. Dipp, C. M. Richter, K. C. Belli, C. F. Panigas, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili.

P1169 Rehabilitation in coronary patient: follow up J. Kriskovich, R. Rasmussen, G. Amarilla, J. Vallejos, M. Avila, E. Villegas, J. Parra Moreno.

P1170 Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus: Prevalence of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. C. D. C Collaud Carlos, R. M. Redruello Marcela, B. J. Blanco Juan, P. O. Parysow Oscar, M. O. Masoli Osvaldo.

P1171 Analysis of the reflective vasomotor carotid response to the hyperventilation test. Comparative study between normal patients with risk factors and patients with carotid atherosclerotic obstruccion J. Tripolone, G. Santiago, J. M. Tripolone.

Scientific Programme / 261

Poster Listing P1172 Heart failure mortality in three brazilian states from 1999 to 2004: an analysis it´s association with other conditions chosen as underlying cause of death. E. Gaui, G. Oliveira, C. Klein.

P1173 Long-Term Outcomes in Patients with Unstable Angina Evaluated in a Chest Pain Unit T. G. Allison, G. S. Reeder, P. A. Smars.

P1174 PREDICTORS OF MEDIASTINITIS AFTER HEART SURGERY S. Olival, B. Santos, R. Gomes, M. Santos, K. Senna, A. Rouge, M. Freitas, R. Vegni, J. O. R. Brito, O. N. Barbosa.

P1175 Nutritional Profile in Outpatients With Chronic Heart Failure in a Heart Failure Clinic E. Britto, S. Chermont, E. T. Mesquita. P1176 The role of balloon static atrioseptostomy in inter atrial estabilization of infants with complex congenital heart disease L. Simões, P. R. Travancas, C. Lace, J. G. Athayde, W. Paiva, A. Inocenzi, M. Celente, F. Gurgel, A. H. Dorigo, C. C. Assef. P1178 VASCULAR EFFECTS OF CANDESARTAN AND TEMPOL IN A MODEL OF METABOLIC SYNDROME N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello.

P1179 Detection, awareness, counseling and control of hypertension in the US adult age 18 years of more: A NHANES 1999-2004 study. Sunil Kumar Agarwal, Samir Saba.

P1180 Critical Pulmonary Valve Stenosis of the Neonate: Treatment With Balloon Percutaneous Valvoplasty.(BPV) L. Simões, C Lace, P. R. Travancas, P. S. Oliveira, F. Gurgel, W. Paiva, A. Inocenzi, M. Celente, J. G. Athayde, A. H. Lago Dorigo.

P1181 Aortopulmonary window—impact of associated lesions on natural history and in the surgical results L. Simões, C. Gangana, J. Caliani, C. C. Assef, R. Minardi, A. H. Lago Dorigo, P. R. Travancas, C. Lace, M. Celente, F. Gurgel. P1182 PERSPECTIVA DE GÉNERO EN TORNO A LA CARDIOPATÍA ISQUÉMICA Y LA SEXUALIDAD DE LOS PACIENTES CORONARIOS. I. Brevis. P1183 Angiotensin-(1-7) downregulates tyrosine hydroxylase through a proteasomedependent pathway M. A. Lopez Verrilli, M. M. Gironacci.

Poster Listing P1184 Hospital Costs and Effects of Congenital Heart Surgery stratified with Aristotle Score E. Trindade, C. Tanamati, M. Barbero Marcial, R. Assad, M. Jatene, A. Riso, A. A. Lopes, L. Caneo, S. Fujii, C. Yukiko Osato.

P1185 Distribution of beta–adrenergic receptors polymorphisms in a Brazilian Heart Failure Clinic. S. Bernardez, O. Tardin, L. Pessoa, T. Alves, B. Cavaliere, R. Abdalah, S. Chermont, V. Navega, G. Ribeiro, E. Mesquita.

P1186 Ankle brachial index and its associated obesity criteria T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes. P1188 Dilated Cardiomyopathy Registry in Chronic Hemodialys Patients (REMIDIAL) L. Gastaldi, M. Viso, C. Mascheroni, F. Acosta, D. Genova, A. Davila, S. Pezzotto, H. Lastiri, J. Beloscar.

P1189 LIPOPROTEIN(a) PLASMATIC LEVELS AND LIPIDIC PROFILE ON INDIVIDUALS OF THE AÑÚ TRIBE OF THE PAEZ MUNICIPALITY, ZULIA STATE, VENEZUELA L. Acosta, A. Siciliano, V. Bermúdez, E. Mengual, D. Aparicio, R. Canelón, F. Finol, E. Rojas, J. Faría, L. Sorell.

P1190 ENALAPRIL BUT NOT HYDRALAZINE INCREASES ENDOCARDIAL TRANSIENT OUTWARD POTASSIUM CURRENT IN RAT CARDIOMIOCYTES L. F. Rodrigues Jr., C. C. Lores, A. C. A. Carvalho, A. C. C. Carvalho, J. G. Mill, J. H. M. Nascimento.

P1191 Incidence of depressive symptoms on the left ventricular function parameters J. Tripolone, G. A. Santiago, J. M. Tripolone.

P1192 WHICH IS THE LATE EVOLUTION OF SYMPTOMATIC PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY SUBMITTED TO ALCOHOL SEPTAL ABLATION? MANUEL Nicolas Cano, SILVIA Judith Fortunato De Cano, ADRIANA C Moreira, RICARDO Pavanello, JAIRO Alves Pinheiro Jr., AMANDA Gmr Sousa, JOSE Eduardo Mr Sousa, ADIB Domingos Jatene.

P1194 Evaluation of anthropometric measures, clinical, nutritional and physical activity level in subject with different levels of cardiovascular risk A. P. Q. Mello, I.T. Silva, C. A. Sanibal, A. S. Timm, R. D. S. Filho, R. C. Maranhao, N. R. T. Damasceno.

P1195 Does the type of stent influence in-hospital outcome in acute coronary syndrome patients? S. Costa, S. Monteiro, N. Antonio, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia.

Scientific Programme / 263

Poster Listing P1196 WHICH IS THE BEST STRATEGY TO TREAT CONCOMITANT CAROTID AND CORONARY ARTERY DISEASE? MANUEL Nicolas Cano, ANDRÉS Sanchez Esteva, ANTONIO M. Kambara, FAUSTO Feres, ALEXANDRE Abizaid, SAMUEL M. Martins, LEOPOLDO Soares Piegas, AMANDA Guerra Mr Sousa, JOSE Eduardo Mr Sousa, ADIB Domingos Jatene.

P1197 Noninvasive method for assessment of endothelial function based on reflection index obtained with post-occlusive reactive hyperemia A. S. F. Ferreira, Arthur De Sá, J. B. F. Barbosa Filho, José, I. C. Cordovil, Ivan, M. N. S. Souza, Marcio Nogueira.

P1198 Atrial Fibrillation Analysis on the Absence of Cardiac Illness through the Stroke Volume and Echocardiogram J. Morais, T. Diogenes, J. Paes Jr.

P1199 MAIN PULMONARY ARTERY PRESSURE WAVEFORM ANALYSIS: a time-domain approach for complete hemodynamic evaluation during pulmonary hypertension. J. Grignola, L. Devera, F. Ginés.

P1200 THE EFFECTS OF THE BREATH CONTROLLED INCURSION ON THE BLOOD PRESSURE SYSTEM IN SUBJECTS WITH RESISTENT HIPERTENSIVE TO THE TREATMENT: IMPACT OF AUTONOMIC MODULATION ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM C. S. Miranda, P. R. Benchimol-Barbosa, G. N. Gobbi, J. Barbosa-Filho, M. V. Barros, A. B. R. Lima, F. Vilela, F. V. Campos, I. Cordovil.

P1201 The Volumetric Index of the Left Atrium is more Precise than the Limiar Measure by the Echocardiogram J. Morais, T. Diogenes, J. Paes Jr.

P1202 Correlation between the average speed of mitral ring excursion by M-mode and the conventional DP / DT of the mitral regurgitant flow valued by Doppler Echo J. Tripolone, G. A. Santiago, J. M. Tripolone.

P1203 Role of the cardiovascular magnetic resonance in patients with ventricular arrhythmia of unknown cause D. Perez De Arenaza, G. Maid, M. Falconi, M. Pietrani, P. Pollono, F. Abramzon, R. Perez-Etchepare, R. Garcia Monaco, A. Cagide, G. Elizalde.

P1204 Native Infective Endocarditis in 111 children: Changing Patterns M. V. Lafuente, C. Villalba, G. Rossi, E. Lataza, H. Capelli.

P1205 Analysis of DNA polymorphisms in the Endothelin-1 and Superoxide dismutaseMn genes and their relationship with the evolution of the Chagasic Cardiomyopathy O. Lassen, F. Quintiero, S. Tabares, J. Herrera, A. Garutti, G. Dotto, R. Sosa, R. Galerano, A. Sembaj.

Poster Listing P1206 CONTROL OF RISK FACTORS TREATMENT THROUGH CAROTID INTIMA-MEDIA THICKNESS AND ENDOTHELIUM-DEPENDENT BRACHIAL ARTERY VASODILATATION FOR HIGH RISK PATIENTS. C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk.

P1207 Evaluation of the Volumetric Index of the Left Atrium on Diabetics and Hypertensive Patients J. Morais, T. Diogenes, J. Paes Jr.

P1208 PRELIMINARY REPORT AFTER A 7 YEAR FOLLOW-UP IN WOMEN WITH A HIGH RISK SCORE EXERCISE TOLERANCE TEST AND A NORMAL CORONARY PERFUSION SPECT. G. Llamas-Esperon, S. Varela-Ortiz, S. Sandoval-Navarrete, R. Munoz-Sandoval, M. L. Fuantos-Delgado, U. Casas-Juarez, J. Albarran-Dominguez, A. Loera-Pinales, A. Zamora-Muciño.

P1209 WAIST OBESITY - IMPORTANT RELATIONSHIP WITH METABOLIC SYNDROME AND CARDIOVASCULAR EVENTS I. A. B. Bincoleto, A. C. Santomauro Junior, M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, C. Nagaoka, J. F. Kelendjian, A. C. Santomauro, E. R. Suarez, C. Ferreira.

P1210 CHARACTERISTICS, THERAPEUTIC INTERVENTIONS AND INHOSPITAL OUTCOME OF PATIENTS WITH NON ST-ELEVATION ACUTE CORONARY SYNDROMES ACCORDING TO CLINICAL PRESENTATION H. Pomés Iparraguirre, W. Santander, G. Calderón, J. Torres, O. Paredes, M. Leonardi, D. Chambre, J. C. Olmos, L. Ferrer, G. Guglieri.

P1211 Reactive C Protein, Lipid and Anthropometric Profile in Adolescents with Different Nutritional Status L. B. Sanches, I. T. Silva, A. F. S. Paz, M. Fisberg, I. P. Cintra, A. P. Q. Mello, N. R. T. Damasceno.

P1212 The Effect Of Campomanesia Xanthocarpa “Guabiroba” In Hypercholesterolemic Subjects J. Z. Klafke, T. F. Panigas, C. M. Richter, T. Dipp, K. C. Belli, D. C. Bündchen, M. A. Silva, J. C. H. Coracini, P. Bianchi, P. R. N. Viecili.

P1213 Coronary Fistula: treatment by hemodynamic techniques L. Simões, C. Lace, F. Gurgel, P. R. Travancas, J. G. Athayde, C. C. Assef, M. Celente, A. H Lago Dorigo, W. Paiva, M. S. Tagliari.

P1214 Echocardiographic Evaluation of the Left Ventricular Hypertrophy in Patients with Hypertension A. Martinez, A. Esper, D. Holownia, J. Tazar.

Scientific Programme / 265

Poster Listing P1215 Evalution Of Blood Pressure Levels Among Indian Population Of The Upper Rio Negro Basin L. M. Rodrigues, O. E. Soares, T. Dipp, T. F. Panigas, C. F. Panigas, D. C. Bündchen, K. C. Belli, C. M. Richter, P. R. N. Viecili.

P1216 Relationship between depressive symptoms and self cerebral flow regulation J. Tripolone, G. A. Santiago, J. M. Tripolone.

P1217 PREVALENCE OF PERIPHERAL ARTERIAL DISEASE OF LOWER EXTREMITIES, IN PATIENTS WITH CORONARY DISEASE. G. Llamas-Esperon, R. Muñoz-Sandoval, S. Sandoval-Navarrete, A. Zamora Muciño, M. L. Fuantos-Delgado, U. T. Casas Juarez, J. Albarran-Dominguez, S. Varela Ortiz.

P1218 Functional and Structural Alterations on Aortic Calcifications (AC) J. Morais, T. Diogenes, J. Paes Jr.

P1219 CARDIOPULMONARY AND METABOLIC EFFECTS IN PATIENTS SUBMITTED TO A CARDIOPULMONARY AND METABOLIC REHABILITATION PROGRAM C. A. Hossri, M. C. Thomazi, R. Ceolin, G. Shinzato, E. C. Souza, H. Arakaki.

P1220 Electrocardiographical Evidences of Intra-coronary Autologous Stem Cells Implantation: Intraventricular Electrical Transients Study by SignalAveraged Electrocardiogram P. R. Benchimol-Barbosa, H. F. Martino, A. C. Campos-De-Carvalho, F. D. Vilela, C Miranda, R. N. Gobbi, P. S. De Oliveira, L. H. Weitzel, J. Barbosa-Filho, I. Cordovil,.

P1221 Reproducibility of reversible myocardial perfusion defects by cold pressor test myocardial perfusion SPECT imaging. O. Masoli, M. Redruello, N. Maciel, J. Gagliardi, S. Traverso, L. Grynberg, L. Vidal, N. Perez Baliño.

P1222 Is the Rest Echocardiogram is enough to evaluate the contractile recovery after CABG? L. H. Weitzel, A. C. Camarozano, F. J. M. Pitella, C. A. S. Nascimento, L. Belem, A. S. C. Rocha.

P1223 PERCUTANEOUS SEPTAL ABLATION WITH ABSORBABLE GELATIN SPONGE IN HYPERTROPHIC OBSTRUCTIVE CARDIOMIOPATHY G. Llamas-Esperon, S. Sandoval-Navarrete, R. Muñoz-Sandoval, A. Loera Pinales, S. Varela Ortiz, E. Sandoval Rodriguez, M. L. Fuantos-Delgado, U. T. Casas Juarez, J. Albarran-Dominguez, A. Zamora Muciño.

P1224 PREDICTION OF THE INTRAOPERATIVE IMPROVEMENT OF THE RIGHT VENTRICLE STROKE WORK INDEX DURING PULMONARY ENDARTERECTOMY A. Bertolotti, C. Gomez, J. Negroni, M. Diez, L. Favaloro, J. O. Caneva, R. Boughen, F. Klein, R. R. Favaloro.

Poster Listing P1225 Predictive Value of Carotid Intima-Media Thickness, Carotid Plaques and Endothelium-Dependent Vasodilation for Vascular Events in High Risk Patients. C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk.

P1226 Heart failure in a public universitary hospital in Argentina. Characteristics of population and causes of hospitalization. V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro.

P1227 Non-invasive evaluation of local and regional biomechanical properties of post-implanted arterial cryopreserved homografts D. Bia, S. Laza, H. Perez, Y. Zocalo, D. Craiem, S. Lluberas, A. Esperon, I. Alvarez, R. Armentano.

P1228 THE EFFECTS OF THE BREATH CONTROLLED INCURSIONS ON THE AUTONOMIC MODULATION OF THE HEART IN SUBJECTS WITH RESISTENT HIPERTENSIVE TO THE TREATMENT: IMPACT OF AUTONOMIC MODULATION ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (SRAA) (CURUMIM STUDY II) G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, F. D. Vilela, A. F. P. Gondar, J. Barbosa-Filho, M. V. Barros, A. B. R. Lima, F. V. Campos, I. Cordovil.

P1229 Is decrease of left ventricular ejection fraction after stress with normal perfusion associated with cardiac events? R. Berber, P. Nogueira, L. Ribeiro, D. Pareira, R. Lopes, F. Alves, M. Oliveira,. P Smanio.

P1230 CLINICAL IMPLICATIONS OF ANEMIA IN HEART FAILURE PATIENTS M. Descalzo, M. Diez, L. Favaloro, M. Perea, R. Ratto, D. Puente, J. Barra, M. Peradejordi, L Feldman.

P1231 Analysis of the relationship of the presence of the resistance to the insulin and diastolic dysfunction in senior. R. F. M. Viégas, R. V. Z. Diniz, T. M. R. F. Viégas, A. M. R. R. Oliveira, A. C. Schimidt, D. R. Almeida.

P1232 Socioeconomic status, Hospital Volume and Ischemic Stroke Mortality in Canada G. Saposnik, T. Jeerakathil, D. Selchen, V. Hachinski, M. K. Kapral.

P1233 Aortic insufficiency and ventricular septal defect – Analysis of surgical treatment L. Simões, A. F. Malheiros, J. Caliani, L. C. Arongaus, F. Gurgel, F. Lino, J. A. T. Marinho, C. C. Assef, P. R. Travancas, W. Peixoto. P1234 Heart failure in a public universitary hospital in Argentina. Causes of acute decompensation. V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro.

Scientific Programme / 267

Poster Listing P1235 Primary Percutaneous Coronary Intervention. A comparative analisys according to Infarct localization in a General Hospital MANUEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano, CLEBER Do Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra, FLAVIO Antonio De Oliveira Borelli.

P1236 CLINICAL AND ECHOCARDIOGRAPHYCAL FOLLOW-UP AFTER ONE YEAR IN PATIENTS WHO UNDERWENT MITRAL VALVULOPLASTY WITH DOUBLE-BALLOON TECHNIQUE FOR SEVERE MITRAL STENOSIS S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Rosas Cabral, F. J. Serna Vela, M. L. Fuantos Delgado, U. T. Casas Juarez, A. Zamora Muciño, J. Albarran Dominguez.

P1237 The prevalence of risk factors for cardiovascular disease in university hospital T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes. P1238 Ability of aortic atheromas to predict coronary and cerebral events. H. Deschle, A. Salazar, M. Fernandez, R. Pissinis, P. Carrascosa, J. Carrascosa.

P1239 Does Myocardial Perfusion Scintigraphy Help in the Definition of Therapy to Assymptomatic Patients with Myocardial Ischemia? C. Zukowski, R. Leite, C. Albertini, R. Kanthack, R. Lopes, M. Oliveira, FvAlves, P. Smanio.

P1240 Obstetrical and clinical factors related to the mode of delivery in pregnant women with heart disease M. R. F. L. Bortolotto, M. Zugaib. P1241 ISCHEMIA ON RIGHT CORONARY TERRITORY DEMOSTRATED BY MYOCARDIAL PERFUSION SPECT, CONDITIONED BY A UNIQUE LEFT CORONARY ARTERY, CORROBORATED BY CORONARY CT SCAN AND CORONARY ANGIOGRAPHY S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Loera Pinales, E. Sandoval Rodriguez, M. L. Fuantos Delgado, U. T. Casas Juarez, J. Albarran Dominguez. P1242 Fascicular Tachycardia in children and adolescents: Important aspects for tachyarrhythmia aproach R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, R. Hams, V. Cerutti, A. Guimaraes, M. Juliano.

P1243 BEHAVIOR OF THE ATRIOVENTRICULAR PRE-EXCITATION DURING AN EXERCISE TESTING M. C. Thomazi, C. A. Hossri, N. Scarin, R. Meneghelo.

P1244 LIPID PROFILE RESPONSE TO RESISTED PHYSICAL EXERCISE PROGRAM IN TYPE 2 DIABETICS E. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva.

Poster Listing P1245 Planimetric determination of left ventricular outflow tract: diagnostic importance on prosthesis patient mismatch E Castro, M. Cavazzi, A. Curcio, G. Converso, J. Quiroga, S. Chekerdemian.

P1246 CASE FATALITY IN CORONARY ARTERY BYPASS GRAFT ALONG THE FIRST YEAR AFTER HOSPITAL DISCHARGE IN RIO DE JANEIRO STATE, 1999 TO 2003 P. Godoy, N. A. Souza E Silva, G. M. M Oliveira, C. H Klein.

P1247 Amiodarone as a good intervention for patients with heart failure and ventricular arrhythmias L. P. Leopoldo Piegas, A. A. Alvaro Avezum, A. G. Aloyra Guimaraes, I. S. Italo Santos, H. G. Hélio Guimaraes, H. R. Helder Reis, E. S. Elizabeth Santos, A. M. A. Muniz.

P1248 Absence Of Correlation Between The Anthropometric Variables And Blood Pressure In Hypertensive Obese Subjects Submitted To An Exercise Physical Program C. F. Panigas, T. Dipp, T. F. Panigas, K. C. Belli, D. C. Bündchen, C. M. Richter, J. L.C. Pippi, P. R. N. Viecili.

P1249 Influence of depressive symptoms on the parameters of left ventricular function during ergometric test J. Tripolone, G. A. Santiago, J. M. Tripolone, P. Zuliani, M. Salguero.

P1250 CARDIAC HYPERTROPHY AND OXIDATIVE STRESS IN RATS TREATED WITH METHIONINE. R. Sirvente, R. H. Mendes, G. O. Candido, C. Mostarda, L. Jorge, A. Belló-Klein, K. Rigatto, M. C. Irigoyen,.

P1251 EFFECT OF CHRONIC ATORVASTATIN THERAPY IN THE MITOCHONDRIAL FUNCTION P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia.

P1252 MYOCARDIAL PERFUSION SCINTIGRAPHY IN PATIENTS ASSESSED FOR RENAL OR RENOPANCREATIC TRANSPLANTATION. R. Ferrando, M. Lujambio, M. Kapitan, E. Moreira, J. Vilar, R. Hitateguy, C. Lecot, V. Selios, S. Miranda, P. Marichal.

P1253 CASE FATALITY IN PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIES ALONG THE FIRST YEAR AFTER HOSPITAL DISCHARGE IN RIO DE JANEIRO STATE, 1999 TO 2003 P. Godoy, G. M. M. Oliveira, N. A. Souza E Silva, C. H Klein.

P1254 Primary Percutaneous Coronary Intervention during the acute fase of Myocardial Infarction. Are there any differences in the late Evolution of Elderly Vs Younger adult patients? MANUEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano, CLEBER Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra, FLAVIO Antonio Oliveira Borelli.

Scientific Programme / 269

Poster Listing P1255 Risk stratification using myocardial perfusion SPECT in the assessment of ischemic heart disease in symptomatic women. M. Lujambio, R. Ferrando, J. Vilar, M. Kapitan, V. Selios, C. Lecot, R. Hitateguy, G. Lago, R. Lluberas, J. Gaudiano.

P1256 Effect of Sleep Deprivation Partial of the Vascular reactivity J.L. Dettoni, F. M. Consolim-Colombo, H. Moreno-Filho, M. C. Irigoyen, J. C. A. Ferreira-Filho, S. B. C. Souza, S. Borile, L. F. Drager, E. M. Krieger, G. Lorenzi-Filho.

P1257 Influence of PTCA on Mobilization of bone marrow-circulating progenitor cells in peripheral blood R. G. Turan, S. Yokus, M. Brehm, S. Steiner, T. Zeus, T. Bartsch, M. Koestering, C. M. Schannwell, B. E. Strauer.

P1258 Valuation of the Excursion and Average Mitral Ring Speed as Left Ventricular Systolic function indexes J. Tripolone, G. A. Santiago, J. M. Tripolone.

P1259 Optimization of Medical Therapy in African-American Patients with Heart Failure Referred for Cardiac Resynchronization Therapy M. Sardar, J. Shin, A. Kezerashvili, S. Maybaum, M. Galvao, K. Trivedi.

P1260 INCIDENCE OF HOSTILITY IN SUBJECTS FOLLOWING A PROGRAM OF CARDIAC REHABILITATION POST-MYOCARDIAL INFARCTION, PREDICTIVE FACTOR FOR POSSIBLE RELAPSES M. Alcocer, M. Rangel, E. Tirado, N. Pacheco, S. Leon, E. Castro, JvAlvarez De La Cadena, J. Rodriguez, E. Garcia, D. Arroyo.

P1261 Acute Effects of Acupuncture on Hemodynamics Variables in Outpatients With Compensated Chronic Heart Failure S. Chacon, S. Soares, M. Quintão, D. A. Bastos, L. Aragão, E. T. Mesquita, S. Chermont.

P1262 Effect of Daily Versus Alternate Day Therapy With Simvastatin in Reducing LDL-Cholesterol Among South Asian Cohort M. Sardar, S. Nadeem, A. Omer, R. Siddiqui.

P1263 CT Angiogram as Replacement Diagnostic Investigation for Angioplasty of Coronary arteries M. C. L Lim, C. De Larrazabal, T. W. Wong. P1264 Hospital mortality in acute STEMI in greater of 70 years M. Correa, M. Lopez, R. Codutti, M. Sanjurjo. P1265 Long term results of balloon dilation of the mitral valve for pediatric typical mitral valve stenosis. A. Peirone, A. Guevara, A. Spillmann, B. Vega, E. Juaneda, E. Ruiz Lascano, E. Banille, L. Alday.

Poster Listing P1266 In-hospital management of decompensated heart failure: interaction among NT-proBNP, renal function and diuretic response M. L Coronel, P. L. Pozzer, G. A. Pereira Zini, R. P. Laurino, G. V. Lepore, C. R. Zoni, G. D. Olivera, J. P. Cimbaro Canella, S. M. Macin, E Perna.

P1267 Prevalence and treatment of the Arterial Hypertension in the city of Formosa F. Sosa, C. Sosa, D. Hernandez.

P1268 Finds of Miocardy Perfusion in diabetic asymptomatic patients without previous AMI. A. Pallares Farias, Abalsa Agustina, Joo Turoni Claudio, Rovaletti Federico, Castellanos Ramiro.

P1269 PROGNOSTIC VALUE OF ADMISSION ECG IN NON-ST ELEVATION ACUTE CORONARY SYNDROMES H. Pomés Iparraguirre-, G Calderón, W. Santander, G. Guglieri, L. Ferrer, R. Aguero, O. Paredes, F. Brey, J. Torres, G. Guthmann.

P1270 Lack of late enhancement with gadolinium in non compaction cardiomyopathy D. Perez De Arenaza, M. Falconi, M. Pietrani, P. Pollono, G. Maid, P. Oberti, C. Belziti, N. Vulcano, R. Garcia Monaco, A. Cagide.

P1271 Cardiovascular and electrocardiographic abnormalities observed in patients undergoing chronic dialysis P. Nasca.

P1272 Regular and chronic use of statin prevents Atrial Fibrillation in the early postoperative period of elective cardiac surgery R. N. Campos, R. J. Alves, E. S. Hara, K. Nakiri.

P1273 Significant percentage of patients using antihypertensive medication are not presenting adequate levels of blood pressure in the twenty-four hours recording R. N. Campos, R. J. Alves, T. Inada, E. Florido, K. Nakiri.

P1274 Mortality in the STEMI according to the age. Experience in Cordis Institute of the heart. M. Correa, M. Sanjurjo, R. Codutti, M. Lopez.

P1275 RISF FACTORS REDUCCION WITH IMPLEMENTATION OF NUTRICIONAL AND EXERCISE PROGRAM M. Alcocer, A Nava, S. Leon, L. Robles, E. Castro, E. Tirado, E. Garcia, J. Alvarez De La Cadena, L. Mendoza, Y. Prior.

P1276 Discrepancy between Perceived Obesity Status, Self-reported, and measured BMI in the US population; and the strategies employed for weight loss or maintenance: A NHANES 2003-2004 Study. Ruchika Goel, Sunil Kumar Agarwal, Nikhil Gupta.

Scientific Programme / 271

Poster Listing P1277 Evaluation of diastolic function in the elderly: comparison of Echo Doppler parameters in patients with and without hypertension. N. Allende, H. Deschle, A. Lakowsky, A. Miranda, D. Sanchez Lucero, R. Calviño, J. Carabajales.

P1278 Serum Levels of interleukins 1SS, 6, interleukin 2 Receptor and C Reactive Protein for Diagnostic and Prognostic Evaluation in Unstable Angina. J. Petriz, A. Brasileiro, D. Albuquerque, R. Abtibol, R. Gusmão, A. Figueiredo, P. Resende, N. Souza E Silva, J. Moll, F. Albanesi.

P1279 Percutaneous Left Ventricular Assist in Ischaemic Cardiac Arrest V. Tuseth, M. Salem, R. Pettersen, K. Grong, J. E. Nordrehaug.

P1281 ASSOCIATION OF CARDIOVASCULAR EVENTS WITH GLYCOSYLATED HAEMOGLOBIN IN DIABETIC PATIENTS P. Karki, R. K. Deo, S. K. Sharma, P. Acharya.

P1282 Effects of Cilnidipine versus Atenolol on Left Ventricular Diastolic Function and Hypertrophy in Essential Hypertension -CANDLE Trial W. J Chung, B. C. Oh, E. O. Shim, M. S. Shin, W. C. Kang, C. I. Moon, S. H. Han, K. K. Koh, T. H. Ahn, E. K. Shin. P1283 2-Dimensional strain echocardiographic assessment of myocardial function in patients with myocardial bridge. C. Kyoung Im, L. Dong Won, L. Hyeon Gook, K. Tae Ik. P1284 Comparison of Cardiac Structure and Function in Diabetes Mellitus with and without Systemic Hypertension C. Kyoung Im, K. Bohyun, L. Donwon, L. Hyeongook, K. Taeik.

P1285 10 - years investigation of influence of depression on myocardial infarction risk at the population of men of 25-64 years in Russia: epidemiological views. V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova.

P1286 OVERWEIGHT, OBESITY AND OTHER RISK FACTORS FOR ISCHEMIC HEART DISEASE IN 10 TO 18-YEAR OLD SCHOOLCHILDREN S. Barbiero, L. Pellanda, C. Cesa, P. Campagnolo, F. Beltrami, C. Abrantes.

P1287 TYPE OF STRESS FOR MYOCARDIUM PERFUSION STUDIES: REVISION OF THE ADEQUACY OF INDICATIONS. S. Armijo, B Morales, I Luksic, M Peña, J Jensen, P Canales.

P1288 Seeking medical advice of patients with myocardial infarction V. Gafarov, A. Gafarova.

Poster Listing P1289 NATIONWIDE TRENDS IN THE UTILIZATION OF MULTI VESSEL PERCUTANEOUS CORONARY INTERVENTION (MPCI) IN THE UNITED STATES. M. R. Movahed, M. Hashemzadeh, M. M. Jamal.

P1291 In-vitro and in vivo pharmacodynamic properties of metoprolol in fructose hypertensive rats C. Höcht, C. Di Verniero, E. Silberman, M. Mayer, J. A. W. Opezzo, F. Bertera, C. AvTaira. P1292 Modification of some components of the cardiac beta-adrenergic system along the experimental Trypanosoma cruzi infection. M. S. Lo Presti, H. W. Rivarola, A. R. Fernández, J. E. Enders, G. Levin, D. F. Comay, P. A. Paglini-Oliva,.

P1293 MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN URUGUAY M. Stoll, P. Esperón, V. Raggio, M. Lorenzo.

P1294 Aldosterone synthase C344T polymorphisms determine circadian arterial blood pressure variation in resistant systemic arterial hypertension P. R. Benchimol-Barbosa, A. D. Varanda-Rosario, M. Rollin-Ornelas, F. D. Vilela, C. Miranda, G. N. Gobbi, J. Barbosa-Filho, I. Cordovil.

P1295 Cardiovascular disease risk and anaemia in diabetes. What’s the association? A. Silva, A. Baptista, A. Guedes, A. Cabrita, P. Neves.

P1297 Tachycardia-induced cardiomyopathy by fascicular ventricular tachycardia in a patient with left ventricular noncompaction/hypertrabeculation: A Case Report P. Pozzer, E. Perna, I. Reyes, L. Coronel, J. Silveyra, A. Bayol, R. Zoni, C. Babi.

P1298 Prognostic value for CA125 antigen in newly diagnosed, advanced congestive heart failure K. Filipiak, A. Folga, M. Grabowski, S. Szmit, R. Glowczynska, A. Budaj, M. Marchel, A. Serafin, B. Przybysz, G Opolski. P1299 Electrocardiogram (ECG) in acute coronary syndromes - the specific ECG features to predict total mortality K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, Z. Huczek, M. Marchel, A. Serafin, T. Imiela, F. Szymanski, G. Opolski.

P1300 The change in predicitive value of different electrocardiogram (ECG) features in follow-up of acute coronary syndromes patients K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, A. Kaplon, B. Przybysz, A. Serafin, F. Szymanski, J. Olszewski, G Opolski.

P1301 LONG-TERM FOLLOW-UP OF PATIENTS WITH HEART FAILURE AND INDICATION FOR A DEFIBRILLATOR FOR PRIMARY PREVENTION OF SUDDEN DEATH. C. Hadid, P. Avellana, D. Di Toro, C. Fernandez Gomez, M. Visser, N. Prieto.

Scientific Programme / 273

Poster Listing P1302 INSULIN POTENTIATES THE CENTRAL PRESSOR RESPONSE TO ANGIOTENSIN II IN RATS M. Mayer, C. Höcht, J. Giani, F. Dominici, E. Silberman, J. A. W. Oppezzo, M. Gironacci, C. Taira, B. Fernández, A. M. Puyó.

P1303 DISORDERS IN HEART RHYTHM AND DISTURBANCES IN INTRAVENTRICULAR CONDUCTION SYSTEM IN HEART FAILURE G. Vieyra, S. Folino, O. Agri, E. Pautasso, M. Koretzky, H. Bovero, J. Aiub, R. Montecchiesi.

P1304 HEART FAILURE REGISTRY IN THE NORTHERN AREA OF GREATER BUENOS AIRES G. Vieyra, E. Pautasso, S. Folino, O. Agri, M. Koretzky, E. Pardo, M. Rey, M. Chiozza.

P1305 Can Dipyridamole act as a bridge for DES patients undergoing Non cardiac Surgery Off Clopidogrel A. Magd, H. Ragy, I. Attia, A. Zaki, N. Okasha.

P1306 Is Platelet Aggregation Adequately Inhibited by Current Clopidogrel Dosing Regimens? A. Magd, M. Sawasany, A. Ramzy, S. Builtagy, A. Zaki, M. El Badry.

P1307 Estimation of the level of knowledge and adherence to dietary guidelines designed for hypertension treatment in a population of patients under dialysis I. M. Masuda, A. N. Aguirre , M. A. Marcozzi, F. M. Ferrero, Z. C. Ziella, H. A. Hansen , H. S. Hecker, C. M. Ciprés, R. A. Ríos.

P1308 EXERCISE STRESS ECHOCARDIOGRAPHY PRIOR TO DISCHARGE FROM A CHEST PAIN UNIT IN PATIENTS WITH DIABETES MELLITUS B. Lopez Ledesma, E. Ludueña Clos, H. Avaca, G. M. Ferrari, C. Kudrle, M. Gingins, M. F. Larin, P. Pieroni, J. D. Humphreys, O. D. Manuale.

P1309 AIR QUALITY AND RESPIRATORY AND CARDIOVASCULAR DISEASES IN A SOUTHERNS BRAZILIAN CITY FROM 1997 TO 2006 E. O. Fernandes, R. Zumach, G. M. O. Fernandes, J. Müller, S. C. Faria.

P1310 ATRIAL FIBRILLATION IN PATIENTS WITH AORTIC STENOSIS: CLINICAL SIGNIFICANCE OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto.

P1311 Are there clinical and outcome differences in patients with aortic stenosis treated with angiotensin converting-enzyme inhibitors? P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide.

P1312 Kymogram - a new tool for the assessment of heart valve performance M. Kondruweit, R. Cesnjevar, T. Wittenberg, S. Friedl, T. Strecker, M. Weyand.

Poster Listing P1313 Coffe consumption and atrial fibrillation A. Mattioli, E. Tarabini Castellani, S. Bonatti, C. Miloro, D. Lodi, G. Mattioli.

P1314 Pulmonary valvuloplasty in adults using the Inoue Balloon Catheter H.M. Pham, H.L. Nguyen, Q.N Ngoc, H.M Nguyen, H.N Khong, V.L Nguyen, L.D Do, K.G. Pham.

P1315 PHYSICAL AND SEDENTARY ACTIVITIES IN SOUTHERN BRAZILIAN TEENAGERS: A POPULATION BASED CROSS-SECTIONAL STUDY C. Cesa, A. Andreola, T. Santos, R. Petkowics, S. Barbiero, P. Campagnolo, F. Beltrami, E. Vigueras, L. Pellanda.

P1317 Advantages of CT angiography in the planning and follow up of abdominal aortic aneurysm C Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa.

P1318 Multidetector CT features in the follow up of patients with endovascular aortic aneurysm treatment P. Carrascosa, C. Capuñay, A. Deviggiano, J. Vallejos, E. Martin Lopez, J. Carrascosa.

P1319 CT features in pulmonary embolism. Impact of the Multidetector technology C. Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa.

P1320 IVC-SCV Filters. A comprehensive review of the spectrum of complications. J. Tisnado, M. K. Sydnor, D. J. Komorowski, D. A. Leung. P1321 CHEST PAIN UNITS: CLINICAL FEATURES OF THE PATIENTS J. Ibañez, J. Muntaner, V. Mansilla, R. Corbalan.

P1322 Idiopathic ventricular and atrial arrhythmias. Relationship with developmental dismorphogenesis of their involved structures. M. Elizari, S. Lupano, M. Ferreiro, M. Civetta, F. Lubenieki, S. Sicouri.

P1324 PSEUDO INCOMPLETE RIGHT BUNDLE BRANCH BLOCK. ITS RELATIONSHIP WITH THE EMBRYOLOGIC DEVELOPMENT OF THE RIGHT VENTRICULAR OUTFLOW TRACT. M. Elizari, M. F. Lambardi, M. Ferreiro, R. S. Acunzo, P. A. Chiale, M. M. Civetta, R. R. Bonato.

P1326 INTRAMYOCARDIAL OR INTRACORONARY CELL DELIVERY: WHICH IS THE BEST ROUTE FOR CELL THERAPY IN IDIOPATHIC DILATED CARDIOMYOPATHY? A. C. Campos De Carvalho, F. B. Muccillo, P. C. S. Costa, S. N. S. Arvelo, E. Assunção E Silva, P. S. Oliveira, C. M. Gouvêa, C. T. Mesquita, H. F. Martino.

P1327 Early prognosis of patients with valve prosthesis regurgitation immediately after heart surgery. R. O. Sampaio, F. C. S. Silva Jr., I. S. Oliveira, G. S. Spina, F. Tarasoutchi, M. Grinberg.

Scientific Programme / 275

Poster Listing P1328 The Trypanosoma cruzi infection with an isolate obtained from an endemic area produces alterations in the complexes of the cardiac mitochondrial respiratory chain A. Baez, M. S. Lo Presti, H. W. Rivarola, G. Guzmán Mentesana, D. Comay, P. Paglini-Oliva.

P1329 Effectiveness of different ablation methods for paroxysmal atrial fibrillation in randomized study D. Lebedev, E. Mikhaylov.

P1330 P-wave analysis as a clue for optimization of paroxysmal atrial fibrillation ablation D. Lebedev, E. Mikhaylov.

P1331 Misleading interpolated premature atrial contractions in patients with paroxysmal atrial fibrillation: their mechanism and origination E. Mikhaylov, D. Lebedev.

P1332 Arial arrhythmias and their origination in patients with paroxysmal atrial fibrillation according to ambulatory observation E. Mikhaylov, D. Lebedev.

P1333 Adventitial infectious agents in heart transplant accelerated graft coronary atherosclerosis (AGCA) N. V. Sambiase, M. L. Higuchi, M. M. Reis, E. Bocchi, N. Stolf.

P1334 Serum Paraoxonase 1 Activity and Oxidative Markers of LDL in patients with Cardiac Syndrome-X M. Kayikcioglu, S. Saygi, E. Azarsiz, L. H. Can, H. Kultursay, E. Y. Sozmen.

P1335 Does Myocardial Perfusion Scintigraphy Useful in the Detection of Ischemia after Surgical Revascularization? L. Cardenas, H. Herbas, R. Conti, Z. Fichino, A. Thom, R. Lopes, M. Oliveira, P. Smanio.

P1336 COMBINATION OF GENETIC POLYMORPHISMS AND SMOKER STATUS IN HIGH RISK FAMILIES M. Stoll, P. Esperón, V. Raggio, M. Lorenzo, M.C. Artucio, F. Kuster.

P1337 Importance metabolic syndrome on hypertensive patients with left ventricular hypertrophy – an 10 year follow-up study I. Tasic, D. Djordjevic, G. Lazarevic, D. Mijalkovic, M. Lovic, D. Lovic, N. Miladinovic Tasic.

P1338 C  an Eustachian valve be a risk factor for pulmonary embolism? I. Kurt.

Poster Listing P1340 N  oninvasive assessment of coronary flow reserve after percutaneous coronary intervention in patients with previous myocardial infarction: Relation to functional recovery A. Djordjevic-Dikic, M. Ostojic, B. Beleslin, J. Stepanovic, V. Giga, B. Vujisic-Tesic, I. Nedeljkovic, M. Nedeljkovic, S. Stojkovic, Z. Petrasinovic.

P1341 AN ANALYSIS OF LEFT ATRIAL EJECTION FRACTION IN THE DIFFERENT TYPES OF LEFT VENTRICLE DIASTOLIC DYSFUNCTION J. L. F. Jefferson Luís Vieira, T. V. B. Thaís Valenti Branchi, I. K. Ilmar Köhler, L. C. D. Luís Cláudio Danzmann, M. R. T. Marco R. Torres.

P1342 Clinical Outcome after multilesion percutaneous interventions: comparison of a selective and non-selective use of drug-eluting stents M. Albertal, F. Cura, L. T. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J. A. Belardi.

P1343 RESPONSES OF CORONARY FLOW IN POSTMENOPAUSAL WOMEN WITHOUT EVIDENCES OF MYOCARDIAL ISCHEMIA EVALUATED BY TRANSESOPHAGEAL DOBUTAMINE-STRESS-ECHO: A RANDOMIZED, DOUBLE BLIND, CROSSOVER CLINICAL ESSAY, WITH WASH OUT, DURING HORMONE REPLACEMENT AND RALOX M. R. T. Marco R. Torres, J. C. T. João Carlos Tress, T. C. D. E. Tereza Cristina Duque Estrada, L. S. C. Lilian S. Costa, O. C. E. G. O. C. E. Gebara.

P1344 Prevalence of Chagas Disease evaluated by 13 years in the Hospital San Fernando of Buenos Aires M. Galli, E. Alvarez, M. Boscaro, H. Deschle, M. Koretzky, J. Seresi, A. Rubinich.

P1345 Lone Atrial Fibrillation : Comparation with Atrial Fibrillation with Heart Disease. OFFICE FA Study J. Gant Lopez, D. Di Toro, C. Muratore, J. Battista, A. Andina, A. Lucchini, C. Damico, R. Borracci.

P1346 TiTAN2® (Hexacath, France), a titanium-NO coated stent: a drug-eluting-like bare metal stent? L. Van Casteren, P. Debruyne, B. Vankelecom, J. Roosen, E. Raymenants, S. De Ridder, L. Janssens.

P1347 InCor-HCFMUSP’s Cardiovascular Emergency and Simulation Laboratory and ACLS Courses F. Marques, W. Nishizawa, M. Gonzalez, S. Timerman.

P1348 Rationale for an Evidence-Based Intervention to Prevent Risk Factors for the Development of Chronic Disease C. Jordan, M. Slater, T. Kottke.

P1349 Regression of cardiac lupus under immunosuppressive therapy. E. Chammas, A. Hussein, A. Barbari, M. Abou Akl, O. Hamoui, L. Abouzahr.

Scientific Programme / 277

Poster Listing P1350 Multivessel coronary artery disease patients under medical therapy: A 10 year observational study E. Chammas, C. Elbacha, R. Kyrillos.

P1351 TRADITIONAL RISK FACTORS ARE PREDICTIVE ON SEGMENTAL LOCALIZATION OF CORONARY ARTERY DISEASE G. Tacoy, S. Balcioglu, S. Akinci, G. Erdem, S. A. Kocaman, T. Timurkaynak, A. Cengel.

P1352 Evolution of no culprit complex coronary lesions R. Costantini, J. Telayna, F. Graziano.

P1353 A Simple Echocardiographic Method for Left Ventricular Ejection Fraction Calculation Specially Useful in Patients with Prior Myocardial Infarction G. Liniado, J. Gagliardi, S. Schneck, S. Molteni.

P1354 SUBACCUTE EFFECTS OF MAXIMAL EXERCISE ON ENDOTHELIAL FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE P. Moreira, P. Soares, F. Das Neves, N. Rocha, A. Nobrega.

P1355 Predictors of left ventricular remodeling in patients after successful primary percutaneous coronary intervention for acute myocardial infarction: Long term follow-up I. Nedeljkovic, B. Vujisic-Tesic, M. Ostojic, M. Petrovic, B. Beleslin, O. Petrovic, D. Zamaklar-Trifunovic, A. Djordjevic-Dikic, V. Giga, J. Stepanovic.

P1356 Prediction of acute coronary events by myocardial jeopardy score: Five years follow-up patients with natural progression of coronary artery disease I. Nedeljkovic, M. Ostojic, B. Beleslin, A. Djordjevic-Dikic, V. Giga, J. Stepanovic, M. Nedeljkovic, S. Stojkovic, P. Mitrovic, B. Vujisic-Tesic.

P1357 Infectious agents, MMP-9 and PPAR alpha are increased in the adventitia and periadventital fat of aortic aneurysms A. Roggerio, M. L. Higuchi, N. V. Sambiase, N. Stolf. P1358 Sleep-Disordered Breathing: Relation of treatment compliance and the occurrence of cardiovascular disease in severe obstructive sleep apnea patients. J. Santos, B. Gonzales, J. Caneva, J. Oses, R. Boughen, F. Robles, E. Gabe. P1359 Costs and effects: Three-years follow-up of the InCor valve replacements surgeries E. Trindade, P. Pomerantzeff, M. Grinberg, C.M. Brandão, S. Fujii.

Poster Listing P1360 Echocardiographic Characteritics and Surgical Outcome of Mitral Valve Disease In Marfan Syndrome J. M Casas, C. E. Lopez, M. Segura, J. H. Casabe, P. Roura, H. Raffaelli, J. Abud, E. Dulbecco.

P1361 SEVERE RHEUMATIC TRICUSPID REGURGITATION SEVERAL YEARS AFTER MITRAL VALVE REPLACEMENT OR REPAIR H. Silva, A. Bartolomé, V. Picone, C. A. Bruno.

P1362 EMERGENCY DEPARTMENT PREDICTORS OF MORTALITY AND AORTIC INTERVENTION AMONG PATIENTS WITH SYMPTOMATIC ABDOMINAL AORTIC ANEURYSM M. P. Marturano, G. Procopio, R. Merbilháa, G. A. Ontiveros, E. Dulbecco, F. Klein, M. J. Fosco.

P1363 CARDIOPULMONARY (VO2) EXERCISE TEST IN PATIENTS WITH ASYMPTOMATIC AND SYMPTOMATIC SEVERE AORTIC STENOSIS H. Silva, J. Ale, C. A. Bruno, A. Bartolomé, V. Picone.

P1365 LONG-TERM OUTCOME IN PATIENTS WITH SYMPTOMATIC SEVERE AORTIC STENOSIS H. Silva, A. Bartolomé, S. Belforte, V. Picone, C. A. Bruno.

P1366 THE EFFECT OF BODY MASS INDEX ON BLOOD PRESSURE RESPONSE DURING EXERCISE G. E. Yazici, G. Tacoy, B. Alibazoglu.

P1367 TIMI FRAME COUNT AND MYOCARDIAL BLUSH GRADE IN NORMAL CORONARY ARTERIES OF PATIENTS G. Tacoy, G. E. Yazici, S. A. Kocaman, M. Ozdemir, A. Cengel.

Note: For consistency, clarity and ease of interpretation, some abstract titles have had the font of their text amended and minor spelling changes made.

Scientific Programme / 279

Industry satellite symposia and workshop activities Programme at a glace – Satellite symposia table

PAVILLION

ROOM Rio de la Plata

SYMP (IS)

Boehringer Ingelheim GmbH ONTARGET: New Evidence in Total Cardio & Vascular Protection

Thames

SYMP (IS)

Daiichi Sankyo Brazil Blood pressure and beyond - Ancillar effects by AT1 Receptor blockade

YELLOW

12.30 - 13.30 (INTERSESSION)

TUESDAY, 20 MAY, 2008

RED

MONDAY, 19 MAY, 2008

Danube

SYMP (IS)

Astra Zeneca Optimising Outcomes in Acute Coronary Syndromes: Role of New Approaches to Platelet Inhibition

Missouri

SYMP (IS)

Bayer Schering Pharma AG Targeting multiple risk factors to optimise cardiovascular care

Nile

SYMP (IS)

Pilcomayo

SYMP (IS)

18.00 - 19.30 (EVENING SESSION)

Pfizer GlaxoSmithKiline A Remarkable Change in SYMP Clinical evidence of fondaparinux in Smoking Cessation: Approach (IS) thrombosis: From VTE prevention to and Treatment acute coronary syndrome treatment

Novartis Pharma SYMP Emerging Data in the Treatment (IS) of Cardiovascular Disease

IFPMA SYMP Transparency around clinical trials and (IS) data: are we on the right trajectory?

SYMP (IS)

Menarini International Operations Luxembourg S.A. From hypertension to heart failure: the developing role of vasodilating beta-blockers

SYMP (IS)

Colgate Oral Health-Cardiovascular Health: Emerging Evidence of the Relationship

WS (IS)

Biotronik (12.45-13.30) New Trends in Catheter Ablation of Atrial Fibrillation

Mississippi

Solvay Pharmaceuticals GmbH SYMP Retinopathy associated with prevalent (IS) CHD in patients with T2D. What needs to be done?

Tigris

Boehringer Ingelheim GmbH SYMP Acute Myocardial Infarction (IS) Reperfusion Strategies in Real Life and their Potential Benefit for the Patient

Niger

Abbott Laboratories SYMP SYMP Acute Heart Failure Treatment: Doing (IS) (IS) what comes naturally?

American Heart Association Strengthening the Chain of Survival: From bench to community

SYMP (IS)

Merck Sharp & Dohme ER Niacin/Laropiprant: A new Paradigm in Comprehensive Lipid Management

Ganges

Seine

12.30 - 13.30 (INTERSESSION)

Bayer Schering Pharma AG SYMP Management of right ventricular (IS) dysfunction in pulmonary arterial hypertension

GlaxoSmithKline Boston Scientific SYMP Drug Eluting Stent Technology: a Diabetes, Cardiovascular (IS) breakthrough in PTCA patient outcome disease and Thiazelidinediones

Tiber

GREEN

18.00 - 19.30 (EVENING SESSION)

Sanofi-aventis Latin America SYMP Intraabdominal Obesity and SYMP (IS) Cardiometabolic Risk Factors: present (IS) and future

Arrhythmias

Sanofi-aventis Reshaping the future in the management of atrial fibrillation

Janssen-Cilag Farmaceutica SYMP Building New Strategies in Acute (IS) Decompensated Heart Failure Merck KGaA Sanofi-aventis The weight of the evidence: SYMP SYMP LMWHs Across the Spectrum of (IS) setting the standard with beta- (IS) ACS: The Weight of the Evidence blockade

Pharmacology

Heart failure / Left ventricular function

Basic science

Valvular disease / Pulmonary circulation / Myocardial-pericardial

Cardiac imaging / Computers

Ischemia/ Coronary artery disease

Acute cardiac care

Interventions / Peripheral circulation / Stroke

Paediatric / Congenital heart disease

Hypertension

Nursing / Technician

Exercise / Epidemiology / Prevention

Public policy / Advocacy initiatives

SYMP (IS) Symposium WS (IS)

How-to and Workshop session

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION Monday, 19 May 2008

Tigris - Ye llow P avillion - 1 2 :3 0 - 13: 30 Symposium (IS) Boehringer Ingelheim GmbH Acu t e M y o c ar d i a l In f arc t i o n - R e pe r fusion S t rategies in Real Life and t h e i r Po t e n tial B ene f it f o r the P at ie nt Chairs: Frans Van De Werf (BELGIUM), Rafael Diaz (ARGENTINA) 12:30

Thrombolysis: a treatment option for rural areas only? Richard Arntz (GERMANY)

12:45 13:00

Fibrinolysis or Primary PCI: are we living up to the guidelines? Rob Welsh (CANADA) The benefits of gaining time in the treatment of STEMI patients Freek Verheugt (NETHERLANDS)

13:15

Panel Discussion with an outlook to a new trial (STREAM) Frans Van De Werf (BELGIUM) and Rafael Diaz (ARGENTINA) Mis s ouri - Ye llow P avillion - 1 2 :3 0 - 13: 30 Symposium (IS)

Bayer Schering Pharma AG Tar g e t i n g m ul t ip l e r is k f a c tor s t o opt imis e cardiovas cular care Chairs: Smith Sidney (UNITED STATES), Alberto Villamil (ARGENTINA) 12:30

The unique formulation determines the benefits of nifedipine GITS Peter A. Meredith (UNITED KINGDOM)

12:50

Nifedipine GITS - combining intervention and evidence to create a standard in cardiovascular care Giuseppe Mancia (ITALY)

13:10

Low-dose ASA - from secondary to primary prevention Smith Sidney (UNITED STATES) Danub e - Gr e e n P avillion - 1 2 :3 0- 13: 30 Symposium (IS)

Astra Zeneca Op t i m i si n g O u t c o m e s in Acut e Co ronary Syndrome s : Role o f N e w Approac he s to P l at ele t Inhib it ion Chairs: Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES) 12:30

Introduction Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES)

12:40

Implications for Antiplatelet Therapy Post TRITON Nicolau José (BRAZIL)

12:50

Bleeding Complications in Patients Receiving Oral Antiplatelet Therapy: Definitions, Prevalence, Consequences Sunil V. Rao (UNITED STATES)

13:00

Novel Approaches to Platelet Inhibition: New Mechanisms Hans Van Giezen (SWEDEN)

13:10

Novel Approaches to Platelet Inhibition: New Agents Steen Husted (DENMARK)

13:20

Panel Discussion Deepak Bhatt (UNITED STATES)

Scientific Programme / 281

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION Monday, 19 May 2008

Mis s is s ippi - Ye llow P avillion - 1 2 :3 0- 13: 30 Symposium (IS) Solvay Pharmaceuticals GmbH Reti n o p a t h y as s oc iat ed w it h pr e vale nt CHD in pat ie nt s wit h T2 D. Wha t n e e d s to b e done ? Chairs: Alberto Zambon (ITALY), Anthony Keech (AUSTRALIA) 12:30

The eye microvascular complications and the vascular residual risk Xavier Pintó (SPAIN)

12:50

FIELD; Macro- and Microvascular Benefits and the Metabolic Syndrome Profile Anthony Keech (AUSTRALIA)

13:10

Role of Fibrates in Vascular Events Reduction in T2D Patients Alberto Zambon (ITALY) Nige r - Gr e e n P avillion - 1 2 :3 0- 13: 30 Symposium (IS)

Abbott Laboratories Ac u t e H e a r t F a il u r e Tre a tm ent : Doing what come s nat urally? Chairs: Sergio Perrone (ARGENTINA), Fabio Vilas-Boas (BRAZIL)

Welcome Sergio Perrone (ARGENTINA)



ALARM-HF versus Euroheart II: What have we learnt? Ferenc Follath(SWITZERLAND)



ALARM-HF: Factors which impact mortality Fabio Vilas-Boas (BRAZIL)



Acute Heart Failure Hlobal Registry of Standard Treatment (ALARM-HF): Providing answers Ferenc Follath(SWITZERLAND)



Q+A Faculty Se ine - Gr e e n P avillion - 1 2 :3 0- 13: 30 Symposium (IS)

Sanofi-aventis Latin America Int r a a bd o m in a l O b es ity a n d Cardiome t ab olic R is k Fact ors : Pre se n t a n d F ut u r e Chair: Maria Ines Sosa Liprandi (ARGENTINA) 12:30

Reduction of Cardiometabolic Risk: is there room for improvement? Richard W. Nesto (UNITED STATES)

13:00

ECS: New target for patients with multiple cardiometabolic risk factors Rafael Maldonado (SPAIN)

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION Monday, 19 May 2008

P ilcomayo - Ye llow P avillion - 1 2 :3 0- 13: 30 Symposium (IS) International Federation of Pharmaceutical Manufacturers & Associations (Ifpma) Tr a n sp a r e n c y ar o u n d c l in ic a l t rials and dat a: Ar e w e o n t h e r ight t r aj e c tor y? Chairs: Beat Widler (UNITED KINGDOM), Aurora Vila (ARGENTINA) 12:30

Setting the scene Beat Widler (UNITED KINGDOM)

12:50

What does transparency mean for patients in Latin America Aurora Vila (ARGENTINA)

13:10

Appropriate use and communication of public domain data - a case study on meta-analysis Alexander Walker (UNITED STATES) Nile - Ye llow P avillion - 1 2 :3 0- 13: 30 Symposium (IS)

Boston Scientific Dr u g E l u t i n g S t ent T ec hnol ogy: A b re akt hrough in P TCA pat ie nt out com e Chair: Jorge Belardi (ARGENTINA) 12:30

PTCA current indications. PTCA alternative or complementary to surgery / medical treatment? Daniel Berrocal(ARGENTINA)

12:50

DES benefits. On and off label indications Oscar Mendiz (ARGENTINA)

13:10

DES in the daily practice. The influence of the technique, clinical data support and the use of new technology (IVUS) in the outcome. Jorge Belardi (ARGENTINA)

Scientific Programme / 283

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS Monday, 19 May 2008

Tib e r - Ye llow P avillion - 1 8 :0 0- 19: 30 Symposium (IS) Menarini International Operations Luxembourg S.A. Fr o m h yperte n s i o n t o h e a r t f a i lur e: the develo p ing role of va so d i l a t i n g b et a -b l oc ke r s Chairs: Alberto Zanchetti (ITALY), Sanchez Ramiro (ARGENTINA) 18:00

Targets and benefits of blood pressure lowering Brandão Ayrton (BRAZIL)

18:22

Beta-blockers in hypertension: do we know it all? Gabriel D. Waisman (ARGENTINA)

18:44

CHF: from clinical trials to clinical pratice Solon Navarrete (COLOMBIA)

19:06

The road ahead with nebivolol in the treatment of elederly CHF patients: clinical outcomes from SENIORS trial Van Veldhuisen Dirk (NETHERLANDS) R io de la P lat a - R e d P avillion - 1 8 :0 0- 19: 30 Symposium (IS)

Boehringer Ingelheim GmbH ONTA RGET : N e w E vid enc e in T o tal Cardio & Vas cular P rot e ct ion Chairs: Piegas Leopoldo (BRAZIL), Michael Böhm (GERMANY) 18:00

Blood pressure lowering or cardio & vascular protection - what to aim for? Giuseppe Mancia (ITALY)

18:22

Cardio & vascular protection - the value of combining an ARB and an ACE-inhibitor Thomas Unger (GERMANY)

18:44

The ONTARGET results Rafael Diaz (ARGENTINA)

19:06

Translating ONTARGET into clinical practice Michael Böhm (GERMANY) Nige r - Gr e e n P avillion - 1 8 :0 0- 19: 30 Symposium (IS)

American Heart Association (AHA) Str e n g t h e n i n g t he Cha in of S ur v ival: From b e nch t o communit y Chairs: Timerman Sergio (BRAZIL), Robert O’connor (UNITED STATES) 18:00

ECC from bench to community to bench Robert O’connor (UNITED STATES)

18:22

Progress and lessons learned from the «Take Heart America» project Ed Racht (UNITED STATES)

18:44

International Perspective on the Strengthening the Chain of Survival Timerman Sergio (BRAZIL)

19:06

A view from the future Graham Nichol (UNITED STATES)

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS Monday, 19 May 2008

Se ine - Gr e e n P avillion - 1 8 :0 0 - 19: 30 Symposium (IS) Sanofi-aventis Res h a p i n g t h e f u tur e in t he m anage me nt of at rial fib rillat ion Chairs: John Camm (UNITED KINGDOM), Marcelo Elizari (ARGENTINA) 18:00

Rationale for outcomes studies in atrial fibrillation Gerald Nacarelli (UNITED STATES)

18:30

Impact of atrial fibrillation in the prognosis of cardiovascular disease Marcelo Elizari (ARGENTINA)

19:00

ATHENA: a landmark study in atrial fibrillation John Camm (UNITED KINGDOM) Gange s - Gr e e n P avillion - 1 8 :0 0- 19: 30 Symposium (IS)

Merck Sharp and Dohme ER N i a c i n / L a r o p iprant : A n ew P a r adigm in Compre he ns ive Lipid Manage men t Chairs: Pedro Lipszyc (ARGENTINA), Ricardo Horacio Rey (ARGENTINA) 18:00

Epidemiology in Latin America Ricardo Horacio Rey (ARGENTINA)

18:22

The need for Comprehensive Lipid Management Anders G. Olsson (SWEDEN)

18:44

New Insights into Niacin Biology Pedro Lipszyc (ARGENTINA)

19:06

Laropiprant: unlocking the Therapeutic Potential of Niacin Moriguchi Emilio Hideyuki (BRAZIL) Nile - Ye llow P avillion - 1 8 :0 0- 19: 30 Symposium (IS)

GlaxoSmithKline Diab e t e s , C ar d i o v a sc u l a r d i s e a se and Thiazelidinediones Chairs: Isaac Sinay (ARGENTINA), Juan Rosas (MEXICO) 18:00

Diabetes, Metabolic Syndrome & Cardiovascular disease Álvaro Avezum (BRAZIL)

18:22

Rosiglitazone the most widely studied Oral Antidiabetic Medicine Isaac Sinay (ARGENTINA)

18:44

Rosiglitazone FDA final statement Juan Rosas (MEXICO)

19:06

Rosiglitazone Cardiovascular Profile Nesto Richard W (UNITED STATES)

Scientific Programme / 285

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS Monday, 19 May 2008

Thame s - Ye llow P avillion - 1 8 :0 0- 19: 30 Symposium (IS) Daiichi Sankyo Brazil Blo o d pr e ssu r e a n d b eyond - A ncillar e ffe ct s b y AT 1 - R e ce pt or b lockad e Chairs: Antonio Felipe Simão (BRAZIL), Antonio Chagas (BRAZIL) 18:00

HTN in the LA Region Agustin Lara Esqueda (MEXICO)

18:22

RAAS and Drugs Robson Santos (BRAZIL)

18:44

OLM Activity and figures Arthur Ribeiro (BRAZIL)

19:06

Vascular Protection Carlos Ferrario M. (ARGENTINA) Danub e - Ye llow P avillion - 1 8 .0 0- 19. 30 Symposium/Workshop

St. Jude Medical Fir st L a t i n A m e r ic an S ym p o s ium/Works hop on At rial Fib rillat ion President: Oseroff Oscar (Argentina) Chairs: Andrea Natale (UNITED STATES), Arruda Mauricio (UNITED STATES), Morillo Carlos (CANADA) 18:00 Opening remarks on AF "The New Epidemic"AF mechanisms and the role of neural network: Implications on current AF ablation strategies John Camm (UNITED KINGDOM) 18:15

LA and PVs anatomy. The use of CT, MR and Echo to guide AF Ablation Jose Carlos Pachon Mateos (BRAZIL), Mauricio Scanavacca (BRAZIL)

18:30

Current worldwide AF ablation approaches. Is image-guided remote navigation the future of AF ablation? Andrea Natale (UNITED STATES)

18:45

Ablation of long-standing AF: Strategies beyond PV isolation. Future tools to minimize ablation collateral Arruda Mauricio (UNITED STATES)

19:00

AF ablation "Guidelines and Clinical Trials "Are we ready for AF ablation as first line therapy" Morillo Carlos (CANADA)

19:15 Open discussion on: What to do in front of the Atrial Fibrillation patient, with the participation of the Symposium Faculty and invited experts

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION Tuesday, 20 May 2008

Tib e r - Ye llow P avillion - 1 2 :3 0- 13: 30 Symposium (IS) Colgate Or a l H e a l t h - C ard i o v a scu l ar He alth: E me rging Eviden c e of the Relationshi p Chair: Nestor Lopez (CHILE) 12:30

The Oral Cavity and Chronic Inflammation: What is periodontal disease and how might it affect cardiovascular health? David Paquette (UNITED STATES)

12:45

The Global Epidemic of Cardiovascular Disease and Diabetes: What is the evidence of a relationship between periodontal disease and CVD and Diabetes? Smith Sidney (UNITED STATES)

13:00

Discussion: Can the recognition and treatment of periodontal disease make a difference in cardiovascular outcomes? David Paquette (UNITED STATES)

13:15

Discussion: What can a cardiologist do in his/her practice to assist in reducing the risk that periodontal disease might contribute to a patient’s risk for CVD? What’s next for cardiology? Smith Sidney (UNITED STATES) Nile - Ye llow P avillion - 1 2 :3 0 - 13: 30 Symposium (IS)

Novartis Pharma Eme r g i n g D a t a in the Tre a tm ent of Cardiovas cular Dis e as e Chair: Alberto Villamil (ARGENTINA) 12:30

Welcome and Introduction: Understanding the Burden of Hypertension Alberto Villamil (ARGENTINA)

12:45

A New Look at the Cardiovascular Continuum with Valsartan Matthew Weir (UNITED STATES)

13:00

Amlodipine-Valsartan: Changing the Landscape of Blood Pressure Management Kenneth Jamerson (UNITED STATES)

13:15

Evolution in Renin Suppression: the New Frontier Matthew Weir (UNITED STATES) Nige r - Gr e e n P avillion - 1 2 :4 5 - 13: 30 Workshop session (IS)

Biotronik New Tre n d s i n Cat het er A b l a tion of At rial Fib rillat ion 12:45

Catheter ablation of atrial fibrillation: Where do we stand? Dubner Sergio (ARGENTINA)

13:07

Catheter ablation of atrial fibrillation in patients with LV dysfunction Johannes Brachmann (GERMANY)

Scientific Programme / 287

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - INTERSESSION Tuesday, 20 May 2008

Mis s ouri - Ye llow P avillion - 1 2 :3 0- 13: 30 Symposium (IS) Bayer Schering Pharma AG Ma n a g e m e n t of r ight ve n tr ic u l a r dys funct ion in pulm o n a r y a r te r ial hyp e r t ens io n Chairs: Miguel Gomez Sanchez (SPAIN), Sergio Perrone (ARGENTINA) 12:30

RV function in pulmonary hypertension Sandrine Huez (BELGIUM)

12:45

How should we evaluate right ventricular function? Adam Torbicki (POLAND)

13:00

Chronic adaptation of right ventricular function: Eisenmenger syndrome Julio Sandoval (ARGENTINA)

13:15

Management of right ventricular dysfunction Stephan Rosenkranz (GERMANY) Se ine - Gr e e n P avillion - 1 2 :3 0- 13: 30 Symposium (IS)

Merck KGaA The w e i g h t of the e vid enc e : S e tt ing t he s t andard wit h b e t a-b lockade Chair: Norberto Vulcano (ARGENTINA) 12:30

Beta-blockade in chronic heart failure (CHF): past, presence and future of beta-blockers in CHF management Cagide Arturo (ARGENTINA)

12:42

Beta-blockade in chronic heart failure (CHF): CIBIS III - expanding the frontier Piotr Ponikowski (POLAND)

12:54

Cardioprotection in non-cardiac surgery (NCS):perioperative management in NCS - current status Anai Durazzo (BRAZIL)

13:06

Cardioprotection in non-cardiac surgery (NCS): recent advances with beta-blockade in NCS Don Poldermans (NETHERLANDS)

13:18

Closing remarks Piotr Ponikowski (POLAND)

INDUSTRY SATELLITE SYMPOSIA AND WORKSHOP ACTIVITIES - EVENING SESSIONS Tuesday, 20 May 2008

Se ine - Gr e e n P avillion - 1 8 :0 0 - 19: 30 Symposium (IS) Sanofi-aventis LMWH s Acro ss t he Spec t r um of A CS: The We ight of t he Evide nce Chairs: José Luis López-Sendón (SPAIN), Grinfeld Liliana (ARGENTINA) 18:00

Differentiating anticoagulants: Do pharmacologic differences lead to differences in clinical outcomes? Nicolau José (BRAZIL)

18:22

Defining adjunctive anticoagulants therapy in ACS José Luis López-Sendón (SPAIN)

18:44

A decade of GRACE: The real world in STEMI and NSTE ACS P. Gabriel Steg (FRANCE)

19:06

Panel discussion / Q & A Grinfeld Liliana (ARGENTINA) Gange s - Gr e e n P avillion - 1 8 :0 0- 19: 30 Symposium (IS)

Janssen-Cilag Farmaceutica Buil d i n g N e w S t r at egie s in Acut e De compe ns at e d He art Failure Chairs: Nadine Clausell (BRAZIL), Sergio Perrone (ARGENTINA) 18:00

Focus on Latin America: Unmet Needs in Acute Decompensated Heart Failure Management Nadine Clausell (BRAZIL)

18:22

Current Treatment Options for Acute Decompensated Heart Failure Uri Elkayam (UNITED STATES)

18:44

Nesiritide Therapy for the ADHF Patient J. Thomas Heywood (UNITED STATES)

19:06 Case Presentation and Panel Discussion Uri Elkayam (UNITED STATES), Panelists: Nadine Clausell (BRAZIL), Heywood J Thomas (UNITED STATES), Sergio Perrone (ARGENTINA), Vilas-Boas Fábio (BRAZIL) R io de la P lat a - R e d P avillion - 1 8 :0 0- 19: 30 Symposium (IS) GlaxoSmithKline Clin i c a l e v i d enc e of f o n d a p ar in u x in t hromb os is : From VTE pre ve nt ion to a c u t e c o r onar y s yn d r om e tr eat me nt Chairs: Rafael Diaz (ARGENTINA), Álvaro Avezum (BRAZIL) 18:00

VTE Prevention in Surgical Patients: Fondaparinux benefits over Enoxaparin Alexander Turpie (CANADA)

18:22

Factor Xa Inhibition across the spectrum of ACS: Improved anti-thrombin treatment with reduced bleeding risk Yusuf Salim (CANADA)

18:44

Optimising Management of Acute coronary Syndromes from guidelines to clinical practice Álvaro Avezum (BRAZIL)

19:06

Introduction to Fondapariniux Clinical Role Rafael Diaz (ARGENTINA)

Scientific Programme / 289

INDEX

Authors H. Aarsetoey.................................................... 75, 206-207

C. Aguilar-Salinas.......................................................... 108

M. Allievi....................................................................... 109

T. Aarsland............................................................ 199, 206

E. Aguilera.................................................................... 177

T. G. Allison........................................................... 108, 262

A. Abalovich.................................................................. 106

L. Aguinaga................................................................... 185

J. Almada...................................................................... 133

R. Abashidze................................................................. 235

S. Aguirre...................................................................... 256

C. Almeida............................................................ 234, 241

S. Abbrederis................................................................ 173

A. N. Aguirre................................................................. 274

D. R. Almeida..........................................244, 248-249, 267

A. Abdala...................................................................... 204

R. M. Ahmad................................................................... 73

S. Almeida............................................................ 111, 181

R. Abdalah.................................................................... 263

S. Ahmad...................................................................... 256

B. Almeida.................................................................... 102

M. Abdel-Salam............................................................ 200

A. Ahmed...................................................................... 256

A. M. Almeida............................................................... 209

J. Abe........................................................................... 175

S. Ahmed........................................................................ 73

M. C. Almeida............................................................... 241

S. Abe........................................................................... 181

C. Ahn................................................................... 110, 219

K. Alonso...................................................................... 242

I. Abella......................................................................... 252

T. H. Ahn............................................................... 111, 272

A. Alonso...................................................................... 132

M. S. Abello.................................................................. 206

R. Ahuad............................................................... 171, 181

M. Alonso..................................................................... 201

M. Abello...................................................................... 206

L. Ahualli............................................................... 220, 239

J. Alonso....................................................................... 216

H. Abensur............................................................ 144, 225

M. Aiga......................................................................... 167

R. Alonso...................................................................... 193

E. Aberer....................................................................... 225

S. Aiguadé-Bruix........................................................... 238

C. Alonso-Buron............................................................ 207

T. Abesadze.................................................................. 175

J. Aiub................................................................... 181, 274

C. Alonzo...................................................................... 228

S. Z. Abildstrøm.................................................... 230, 232

R. Akar.......................................................................... 111

A. Alper......................................................................... 186

L. Abouzahr................................................................... 277

A. Akcay................................................................ 185, 195

R. Altamirano................................................................ 228

F. Abramzon..................................................235, 254, 264

R. Akchurin................................................................... 234

W. Altarche-Xifró............................................................ 77

C. Abrantes................................................................... 272

C. Akel............................................................................ 73

T. Altin.......................................................................... 192

A. C. Abreu................................................................... 213

G. Akgun....................................................................... 192

P. A. Altman.................................................................. 140

P. Abreu-Gonzalez.........................................167, 169, 213

S. Akinci................................................................ 186, 278

D. L. Altschuler............................................................. 212

R. Abtibol...................................................................... 272

M. Aksoy.............................................................. 171, 211

H. J. Altube................................................................... 223

J. Abud.............................73, 107, 205-206, 230, 246, 279

M. Aktoz....................................................................... 182

I. Altun.......................................................................... 106

A. Abufhele................................................................... 178

A. Akyol........................................................................ 186

M. G. Alvarez........................................................ 170, 201

E. Acarturk.................................................................... 105

H. Alanazi...................................................................... 163

M. Alvarez..................................................................... 252

P. Acharya..................................................................... 272

D. Alasia........................................................................ 204

E. Alvarez.............................................................. 240, 277

F. Achilli..........................................144, 202, 238-239, 274

F. Albanesi.................................................................... 272

F. Alvarez...................................................................... 196

S. K. Açikgöz................................................................. 186

J. Albarran-Dominguez.......................................... 265-266

I. Alvarez....................................................................... 267

A. Acosta...........................................................74, 80, 136

E. S. Albayrak................................................................ 198

J. Alvarez.......................................107, 202, 222, 240, 271

F. Acosta....................................................................... 263

J. P. Albenque............................................................... 103

R. J. Alves............................................................. 233, 271

K. Acosta...................................................................... 248

I. Alberca....................................................................... 207

C. N. Alves.............................................................. 74, 138

Y. Acosta...................................................................... 190

M. Albertal........................71, 132, 225, 242, 244-245, 277

A. N. F. Alves................................................................ 248

N. Acuña....................................................................... 168

A. Alberti................................................................. 53, 254

L. Alves.......................................................... 252, 259-260

R. S. Acunzo...................................219-220, 229, 250, 275

C. Albertini.................................................................... 268

A. Alves.........................................................111, 179, 240

K. Adalet............................................................... 106, 191

C. Alberto.......................................................109, 213, 226

T. Alves................................................................. 260, 263

M. Adamczyk........................................................ 172, 185

G. Albina....................................................................... 241

F. Alves................................................................. 248, 267

K. G. Adamyan................................72, 103, 109, 136, 193,

F. Albuquerque............................................................. 223

E. O. Alves.................................................................... 111

......................................................218, 242, 244, 246, 249

D. Albuquerque............................................................. 272

R. Alves........................................................................ 250

M. E. Adaniya................................................................ 211

S. Albuquerque............................................................. 228

F. Alvim................................................................. 136, 220

T. Adla............................................................141, 223, 234

J. Albuquerque..................................................... 228, 243

A. Alvim........................................................................ 234

Y. Adler......................................................................... 209

M. Alcocer............................................................. 270-271

O. Alyan................................................................ 110, 233

A. Adriana..................................................................... 111

G. Aldama-López.......................................................... 198

A. Amanullah........................................................ 166, 172

P. Adriazola................................................................... 206

K. Aldworth-Gaumond.................................................. 135

A. Amarilla.................................................................... 214

S. Affatato..................................................................... 132

J. Ale............................................................................. 279

G. Amarilla.................................................................... 261

V. Agarwal.................................................................... 251

G. Aleshina........................................................... 204, 274

M. Amat........................................................................ 242

P. Aggelopoulos............................................................ 217

R. Alessi........................................................................ 245

J. M. Amatruda............................................................. 166

M. Aglony..................................................................... 137

A. Alessi.................................................................. 77, 176

J. Amatruda.................................................................... 75

U. Agrawal.................................................................... 198

G. Alexanderson........................................................... 133

G. Ambrosio.................................................................. 141

O. Agri.......................................................................... 274

B. Alexandre................................................................. 211

A. Ambu........................................................................ 186

S. Aguadé-Bruix.................................................... 132, 236

A. Alexandrescu............................................................ 200

D. Ametrano................................................................... 74

R. Aguayo..................................................................... 185

A. Alexandrov............................................................... 225

K. Amitani..................................................................... 175

S. Aguedé-Bruix............................................................ 236

A. Alfie.......................................................................... 102

M. Amoedo................................................................... 144

M. Aguero..................................................................... 212

B. Alibazoglu................................................................. 279

M. Amor............................................................... 111, 189

R. Aguero.........................................69, 242, 258, 260, 271

V. Aliperti........................................................................ 77

J. M. L. Amorim............................................................ 249

R. Agüero...................................................................... 103

T. Aliyeva...................................................................... 196

W. A. Amorim................................................ 243-244, 246

J. P. Aguiar.................................................................... 258

G. Allende............................................................. 175, 178

L. Amorim............................................................. 249, 260

R. Aguilar...................................................................... 252

N. Allende..................................................................... 272

M. Amorin..................................................................... 184

Authors R. Andalaft............................................................ 247, 268

R. Armentano.........................................194, 231-232, 267

F. Ayan.......................................................................... 233

G. Andersen............................................................ 69, 240

A. Armenti............................................................ 170, 201

S. Aydogdu................................................................... 223

L. B. Andersen.............................................................. 168

S. Armijo....................................................................... 272

S. Ayub......................................................................... 191

A. Andina...................................................................... 277

L. Armine...................................................................... 220

M. I. R. Azambuja......................................................... 248

K. Andrade.................................................................... 234

L. Armini............................................................... 136, 215

I. Azar.............................................................................. 76

M. A. M. Andrade......................................................... 228

P. Armstrong................................................................ 143

S. Azarisman................................................................. 184

M. M. Andrade................................................................ 79

A. M. Arn Migowski...................................................... 210

E. Azarsiz...................................................................... 276

M. Andrade............................................................. 79, 228

P. Arnaiz........................................................................ 137

R. Azevedo..................................................................... 72

T. Andreeva.................................................................. 225

F. Arnaldo..................................................................... 135

H. Azevedo............................................109, 191, 195, 243

A. Andreola................................................................... 275

A. Arnedo.............................................................. 205, 230

C. H. M. Azevedo.............................................77, 109, 191

D. S. Andres.......................................................... 208, 211

L. C. Arongaus.............................................................. 267

L. Azocar....................................................................... 185

C. K. Ang....................................................................... 201

V. Arora......................................................................... 238

F. Azzari................................................................ 237, 240

P. Angelani...................................................................... 78

A. G. Aroutunov............................................................ 164

F. Azzato............................................................... 109, 138

A. Angelino.............................106-107, 201, 208, 236, 238

A. Arrastia..................................................................... 184

C. Babi.......................................................................... 273

D. Anic.......................................................................... 219

O. Arrieta...............................................107, 222, 240, 251

T. Babic......................................................................... 202

F. D. Anjos-Andrade...................................................... 111

G. Arroyo...................................................................... 224

F. Baborski.................................................................... 220

S. D. Anker.................................................................... 238

D. Arroyo...................................................................... 270

J. Baccaro............................................................. 212, 219

A. Añó....................................................107, 222, 240, 251

G. M. Arroyo........................................................... 76, 165

O. Badak....................................................................... 170

A. A. Ansari............................................................ 202-203

R. Arroyo-Espliguero..................................................... 165

J. R. Badaraco............................................................... 219

D. Antonelli................................................................... 186

U. Arslan........................................................180, 186, 190

J. Badariene.......................................................... 184, 237 H. Bader........................................................................ 243

J. Antonelli.................................................................... 218

M. Arslan...................................................................... 163

M. Antonetti................................................................. 190

E. Arteaga..................................................................... 136

A. Bader........................................................................ 176

D. Antoni......................................................................... 76

V. Artiko........................................................................ 171

J. Badie......................................................................... 194

C. Antoniades.................................................. 69, 216-217

M. C. Artucio................................................................. 276

Z. Badiei.......................................................................... 73

L. Antonietti...................................................238, 242, 249

G. P. Arutyunov........................................... 74-75, 104-105

E. Badila.........................................................106, 211, 224

N. Antonio............ 78-79, 101, 132, 255-256, 258, 260, 263

A. G. Arutyunov.............................................................. 74

E. Badino...................................................................... 169

N. António........................................................70, 252, 258

S. N. S. Arvelo............................................................... 275

H. Badiola Villa.............................................................. 166

A. Antonopoulos.............................................. 69, 216-217

H. Arý............................................................................ 197

S. H. Badruddin............................................................... 73

N. Antunes.....................................................133, 166, 234

P. Arza.......................................................................... 205

A. Baez................................................................. 222, 276

D. Aparicio..................................................... 247-248, 263

Y. Arzani........................................................................ 192

M. C. Baez.................................................................... 205

N. Apro......................................................................... 137

M. Asanin..................................................................... 187

R. Bagnati..................................................................... 169

F. Apullan...................................................................... 197

R. Asbot................................................................ 164, 259

R. Bagur........................................................................ 176

L. Aragão...................................................................... 270

S. Asgary.............................................................. 211, 216

D. Bahamonde.............................................................. 225

T. S. Aragão.................................................................. 111

O. Asghar...................................................................... 179

A. Bahi.......................................................................... 220

H. Arakaki............................................................. 240, 266

T. Ashikaga........................................................... 188, 197

A. Bahia........................................................................ 215

E. Aramburu.................................................................. 246

T. Asmann...................................................................... 72

V. K. Bahl.......................................................140, 164, 167

A. Arandjelovic................................................................ 71

N. Aspromonte............................................................... 70

G. Bahs......................................................................... 235

C. Aranis....................................................................... 109

M. Assad...................................................................... 201

A. Bajkova..................................................................... 230

R. L. Arantes................................................................. 101

R. Assad....................................................................... 263

K. Bakoyiannis........................................................ 69, 216

A. Araujo....................................................................... 178

J. A. Assad.................................................................... 139

S. Bakshi....................................................................... 179

S. Araujo................................................................ 246-248

A. R. Assali............................................................ 110, 178

T. Balabanski................................................................. 206

T. M. Araujo.................................................................. 213

C. Assef.........................................................262, 265, 267

J. M. Balaguer................................................................. 73

R. C. Araújo................................................................... 254

V. Assinnato.................................................................. 175

V. P. Balashov....................................................... 135, 210

R. C. Araújo................................................................... 254

R. Astan........................................................................ 233

N. Balasubramanian...................................................... 111

E. Arcani....................................................................... 106

W. Astorino................................................................... 242

A. M. Balaszczuk................................................... 169, 205

P. Arce............................................................................ 69

A. V. Astvacatryan................................................. 242, 246

Y. Balbay....................................................................... 110

N. Archvadze................................................................ 164

A. V. Astvatsatryan.......... 72, 103, 109, 193, 218, 244, 249

S. Balcioglu............................................180, 186, 190, 278

R. V. Ardito.................................................................... 213

R. Atak.......................................................................... 110

G. Baldo........................................................................ 233

J. Areias........................................................................ 109

J. G. Athayde........................................................ 262, 265

M. Balestra................................................................... 220

P. Arellano.................................................................... 178

I. Attia........................................................................... 274

A. Balestrini.................................................................. 102

W. Arenas-Borda.......................................................... 249

N. Augusto.................................................................... 211

C. Balestrini......................................78, 102, 228-229, 251

C. Argenta..................................................................... 108

H. A. Avaca................................................................... 133

M. Balevic..................................................................... 202

S. Argiró.......................................................................... 69

P. Avanzas..............................................165, 168, 196-197

H. Balieiro............................................................. 253, 260

E. Arias......................................................................... 134

D. Avayu...................................................80, 229, 242-244

T. L. Balieiro.................................................................. 253

A. Arias...........................144, 202, 238-239, 241, 258, 274

P. Avellana............................................................ 238, 273

S. K. Ball.......................................................................... 73

J. Aringoli...................................................................... 197

P. J. Avery....................................................................... 77

C. Ballantyne................................................................... 75

B. Armaro..................................................................... 186

M. Avila.................................................................. 260-261

A. E. Ballestrini................................................................ 71

J. Armentano........................................................ 208, 242

F. Ayala......................................................................... 141

L. Balletti....................................................................... 229

Index / 291

Authors S. Balmaceda................................................................ 181

J. A. S. Barreto-Filho..................................................... 111

A. C. Becker.................................................................. 203

I. Balogh........................................................................ 259

N. Barrientos................................................................. 246

P. Becker...................................................................... 207

A. Baltabaeva................................................................ 254

E. Barrionuevo.............................................................. 191

K. Beckey........................................................................ 75

L. A. Balykova....................................................... 135, 210

P. Barrios.............................................................. 105, 219

R. Bedani...................................................................... 247

M. Banaszewski........................................................... 252

R. Barros Wanderley..................................................... 164

H. Bedi.......................................................................... 179

P. Bandosz.................................................................... 106

C. Barros........................................................241, 253, 257

R. Bedim....................................................................... 256

I. Bañes......................................................................... 239

M. V. Barros............................................191-192, 264, 267

J. R. Bedros...................................164, 199, 208, 224, 238

L. J. Banfic............................................................ 223, 231

M. Barros............................................................... 252-254

R. J. Bedros.................................................................. 203

N. Bangartner............................................................... 215

S. Barsamyan................................................................ 181

G. Beffagna................................................................... 134

E. Banille..........................................................76, 260, 270

E. Bartha............................................................... 197, 202

V. Begovic..................................................................... 193

A. Bankova.................................................................... 225

A. Bartolomé................................................................. 279

T. Behrens.................................................................... 109

A. Bantar....................................................................... 168

J. Bartolucci.................................................................. 132

R. Beigelman................................................................ 141

A. Baptista............................................................ 183, 273

D. Bartos....................................................................... 224

P. Bekta................................................................ 102, 237

K. Baqueiro................................................................... 108

T. Bartsch............................................................. 104, 270

J. A. Belardi......................................................71, 225, 277

F. Baracho..................................................................... 249

A. Barutcu..................................................................... 182

L. Belem....................................................................... 266

S. Barai......................................................................... 250

V. Barzilai...................................................................... 229

B. Beleslin.................................71, 110, 142, 171, 277-278

K. Baranska................................................................... 174

I. Basar.......................................................................... 233

S. Belforte..................................................................... 279

F. Baraona..................................................................... 227

G. Basile....................................................................... 186

L. Bell............................................................................ 256

R. Barba........................................................................ 209

Z. Basistova.................................................................. 257

N. Bellera........................................................................ 69

A. Barbari...................................................................... 277

M. A. Basombrío........................................................... 254

K. C. Belli..........212-214, 221-223, 227, 261, 265-266, 269

S. H. Barberato............................................................. 254

S. L. Bassanesi..................................................... 248, 251

S. Belli........................................................................... 189

M. Barbero Marcial....................................................... 263

H. Bassani Molinas....................................................... 227

K. C. Belli..........212-214, 221-223, 227, 261, 265-266, 269

M. Barbero-Marcial....................................................... 238

T. Bassani..................................................................... 106

C. Bellido.............................................................. 106, 200

E. Barbieri....................................................................... 72

S. L. Bassin............................................................... 75, 79

C. A. Bellido.................................................................. 201

G. F. Barbieri................................................................. 100

C. Basso....................................................................... 134

G. Bellini............................................................... 247, 268

S. Barbiero............................................................ 272, 275

G. Basso....................................................................... 190

F. Bello.......................................................................... 206

J. Barbisan.....................................................134, 243, 250

M. Bastos Fernandez............................................ 187, 194

A. Belló-Klein.................................201, 233, 236, 258, 269

L. Barbosa............................................................. 135, 208

J. C. Bastos................................................................... 202

M. Bellomo................................................................... 137

M. M. Barbosa........................................................ 74, 217

V. L. F. C. Bastos.......................................................... 202

R. Bellomo...................................................................... 80

M. Barbosa......................................................74, 217, 256

D. Bastos...................................................................... 236

J. Beloscar.................................................................... 263

T. Barbosa....................................................................... 76

L. Batista....................................................................... 185

F. Beltrami............................................................ 272, 275

E. G. Barbosa................................................................ 222

M. Batista..................................................................... 215

O. Belzares................................................................... 198

M. A. O. Barbosa............................................................ 76

G. Batsides..................................................................... 69

M. Benassi.................................................................... 254

O. N. Barbosa.........................................252, 259-260, 262

L. Battaglia.................................................................... 140

P. R. Benchhimol-Barbosa............................................ 253

J. Barbosa-Filho.......191-192, 244, 254, 264, 266-267, 273

R. Battellini........................................................... 173, 182

J. Benchimol................................................................. 137

E. Barcellos................................................................... 207

R. R. Battellini............................................................... 173

P. R. Benchimol-Barbosa.......................191-192, 244, 252,

N. C. Barengo............................................................... 231

J. Battista...................................................................... 277

.......................................................254, 264, 266-267, 273

G. Barila........................................................................ 212

M. Battiston.................................................................. 181

D. E. Bender................................................................. 226

F. Barilla........................................................................ 240

A. Battler............................................................... 110, 178

M. Benderski.................................................................. 74

R. Barin......................................................................... 241

T. Bauernfeind.............................................................. 164

I. Ben-Dor............................................................. 110, 178

J. L. Barisani................................................................. 139

G. Baumann.....................................................75, 140, 238

A. Benetos.................................................................... 110

J. C. Barisani................................................................. 139

J. M. Baumgarten......................................................... 228

M. Benetti..................................................................... 208

L. Barja.................................................................. 102, 189

N. Baungartner............................................................. 215

J. Benitez........................................................................ 70

L. D. Barja....................................................................... 78

J. F. Baungratz.............................................................. 226

J. Benitez-Parejo........................................................... 248

S. Barja......................................................................... 137

P. Bayazit...................................................................... 191

A. M. Benjo..................................................................... 77

L. Baroncini............................................................. 77, 176

N. Baybek............................................................. 185, 195

J. S. Benner.................................................................. 243

L. A. V. Baroncini............................................................ 77

M. Bayern..................................................................... 104

R. Berber................................................................ 79, 267

M. Baroni............................................................... 228-229

A. Bayol.................................................134, 170, 212, 273

C. Berensztein.............................................................. 267

J. Barra......................................................................... 267

P. Bayol......................................................................... 260

S. Berensztein.............................................................. 214

M. Barra.......................................................................... 77

R. Bayrak...................................................................... 195

Z. Berente..................................................................... 197

D. Barra......................................................................... 261

R. Beabealashvilli................................................... 234-235

S. Berenztein................................................................ 250

M. Barranco...............................................74, 79, 211, 241

M. Bechelli.................................................................... 137

A. Berez.......................................................................... 78

D. Barranco................................................................... 208

E. Becher...................................................................... 204

A. Berger-Kucza............................................................ 232

R. Barreiro Filho......................................139-140, 253, 257

M. A. Beck.....................................................176, 178, 229

D. Bergerot................................................................... 169

J. Barrera Sarduy.......................................................... 202

E. Beck..........................................................100, 214, 222

G. Berglund..................................................................... 75

C. Barrera...................................................................... 249

K. Beck......................................................................... 111

M. Bergovec................................................................. 231

E. Barrera...................................................................... 250

T. Becker...................................................................... 203

D. Berkowitz................................................................... 77

S. S. M. Barreto............................................................ 142

A. Becker............................................................... 202-203

S. Berliner..................................................................... 163

Authors C. O. Berlowitz Fo......................................................... 102

H. B. Bittner.................................................................. 173

C. Borrego.................................................................... 181

S. Berman......................................................141, 187, 218

S. Blalock...................................................................... 226

M. R. F. L. Bortolotto.................................................... 268

D. S. Berman................................................................ 141

P. Blanc................................................................. 135, 218

A. Bortone.................................................................... 103

S. G. Berman................................................................ 180

N. Blanco.......................................111, 170, 181, 189, 196

B. Borz.......................................................................... 242

A. M. Bermann................................................80, 219, 222

F. Blanco.....................................................69-70, 132, 188

M. Bosa........................................................................ 253

G. Bermudez................................................................. 242

R. Blanco.........................................................70, 132, 142

J. Boscan...................................................................... 226

V. Bermúdez.................................................. 247-248, 263

P. Blanco....................................................................... 102

M. Boscaro........................................................... 181, 277

A. Bernabe-Ortiz........................................................... 137

G. Blanco...................................................................... 139

E. Bosch....................................................................... 183

V. Bernardes................................................................. 226

B. J. Blanco................................................................... 261

E. Bosinakou................................................................. 217

S. Bernardez..................................229, 233, 236, 260, 263

R. Blank........................................................................ 241

A. Boskovic................................................................... 167

D. Bernardez................................................................... 79

P. Blasko....................................................................... 223

A. Bossi........................................................................ 102

L. Bernardini................................................................. 215

K. Blaszyk..................................................................... 251

A. Botbol................................................111, 170, 181, 239

X. Berrios...................................................................... 137

P. Blazicek.................................................................... 240

L. Botbol............................................................... 189, 196

D. H. Berrocal............................................................... 227

Ø. Bleie..................................................133, 142, 243, 247

G. Bottaro..................................................................... 186

M. Bertagnolli............................................................... 258

J. Bleiz.................................................................. 175, 211

M. Bottcher............................................................ 79, 110

F. Bertanha................................................................... 237

J. P. F. Blini................................................................... 251

J. A. Bottega................................................................. 236

M. P. Bertato................................................................ 198

A. Blinowska................................................................... 80

R. Boughen............................................205, 230, 266, 278

G. Bertelle..................................................................... 204

A. J. Blix................................................................ 243, 248

J. Boullosa.................................................................... 170

F. Bertera...................................................................... 273

J. Bloch................................................................... 75, 103

B. Bourahla................................................................... 139

G. Bertocchi.......................................................... 170, 201

A. Bloigu......................................................................... 75

G. Bouras............................................................... 216-217

M. Bertolami................................................................. 254

M. H. S. L. Blotta.......................................................... 133

M. Bourassa................................................................. 197

M. Bertoli...................................................................... 168

I. Bluro............................................................................ 77

F. Bourdin............................................................. 183, 197

A. Bertolotti.......................................................... 259, 266

E. Bocchi....................................................................... 276

E. Bouskela..................................................................... 71

C. Bertoluci................................................................... 106

E. A. Bocchi.................................................................. 191

K. Bousquet-Santos...................................................... 138

H. Bertoni..................................................................... 240

G. Boccuzzi................................................................... 171

S. Boveda..................................................................... 103

T. Bertuzzi..................................................................... 218

A. Bochoeyer................................................................ 102

H. Bovero...................................................................... 274

O. Berwanger....................................................... 256, 258

L. A. Bockeria................................................................ 255

G. Bowlin...................................................................... 142

B. Bessa....................................................................... 240

M. Bodoira.................................................................... 225

T. Bozat......................................................................... 197

I. Bessonov................................................................... 202

L. Boero........................................................................ 136

E. Bozcali...................................................................... 242

M. Bessonova....................................................... 183, 202

G. Boerrigter................................................................. 108

E. Bozçali...................................................................... 180

R. Bestetti..................................................................... 224

J. Boggiano................................................................... 168

H. Bozkurt..................................................................... 170

F. Bethencourt.............................................................. 236

E. Bognar.............................................................. 197, 202

G. Bozkurt..................................................................... 233

A. Betriu.......................................................................... 69

K. Bohyun..................................................................... 272

G. Bozovich........................................................... 227, 236

M. Bettinotti................................................................. 141

N. Bonaros.................................................................... 173

M. Bracho..................................................................... 242

S. Beurtheret................................................................ 241

R. R. Bonato.................................................................. 275

F. Braga..................................................215, 220, 222-223

J. Beutel....................................................................... 240

J. Bonatti...................................................................... 173

J. Braga......................................................................... 132

P. R. Bhimashankar....................................................... 167

S. Bonatti...................................................................... 275

D. M. Braile........................................................... 133, 166

D. Bia............................................................. 231-232, 267

P. Bonazzola......................................................... 193, 237

I. Brajkovich.................................................................. 219

P. Bianchi...................................................................... 265

J. Bonelli....................................................................... 182

L. Brandani.................................................................... 179

R. Bianco.............................................................. 107, 205

S. Bonetti...................................................................... 240

A. A. Brandao................................................................ 250

E. Biasin........................................................................ 204

C. Bonini....................................................................... 134

A. P. Brandão................................................................ 201

L. Biason....................................................................... 134

J. Bono......................................................................... 220

J. Brandão-Neto............................................................ 249

V. Bichara...................................................................... 178

W. Book........................................................................ 242

B. F. Branka Filipovic..................................................... 134

L. Bicudo....................................................................... 136

E. Borbas.............................................................. 196, 198

Z. Brankovic.................................................................. 243

B. Biernacka............................................................ 78, 233

A. Bordenave.................................................217, 248, 257

R. J. Brashear....................................................... 172, 185

B. Bijnens..................................................................... 254

S. Bordignon.............................................77, 233, 236-237

F. Brasil......................................................................... 220

J. Bilbao...........................................................79, 102, 210

J. Bordone.................................................................... 139

A. Brasileiro...................................................250, 254, 272

B. Bilchik............................................................... 138, 182

F. O. Borelli............................................................. 80, 208

F. Bravo........................................................................ 197

Z. T. Bilinska.................................................................. 175

M. Borger..................................................................... 182

S. Bravo........................................................................ 137

C. Bilos......................................................................... 140

A. Borges...................................................................... 238

D. Braziunas.................................................................. 215

I. A. B. Bincoleto............................................ 243-247, 265

M. Borges....................................................................... 78

A. Breazna.................................................................... 183

C. Birka........................................................................... 77

P. Borges...................................................................... 236

M. Brehm............................................................. 104, 270

M. Bisio........................................................................ 250

J. Borges...................................................................... 251

A. Breitgand.................................................................. 141

S. K. Biswas.................................................................. 232

L. F. Borges.................................................................. 251

U. Brel........................................................................... 175

E. Bit Chacock................................................................. 70

J. Bori........................................................................... 219

E. Brenna...................................................................... 176

H. N. S. Bittencourt......................................................... 74

S. Borile................................................................ 138, 270

L. Brescacin.................................................................. 228

A. G. Bittencourt........................................................... 209

R. Borojevick......................................................... 139, 184

I. Brevis......................................................................... 262

M. S. Bittencourt.................................................. 193, 236

R. Borracci............................................................ 181, 277

F. Brey.......................................................................... 271

Index / 293

Authors S. Briceño..................................................................... 242

G. Burlli..........................................................111, 221, 255

P. Campana.................................................................. 175

D. Brieger..................................................................... 100

J. C. Burnett.....................................................72, 108, 136

D. Campbell.......................................................... 135, 163

S. Brieva............................................................... 237, 240

C. Burnikoff..................................................................... 79

C. Campo...................................................................... 257

J. C. Brigante........................................................ 226, 236

S. Burtchaell......................................................... 103, 105

C. Campoamor.............................................................. 188

M. Brignole................................................................... 134

A. Busato...................................................................... 109

R. Campo-Pérez............................................................ 198

A. Brignoli..................................................................... 215

C. Bush......................................................................... 238

A. C. Campos De Carvalho.................................... 140, 275

M. Brinckmann............................................................... 77

N. Bustamante.............................................................. 242

R. N. Campos........................................................ 233, 271

G. Brion...................................................106-107, 236, 238

M. Bustamante................................................73, 143, 236

M. Campos................................................................... 206

G. Brión................................................................. 201, 208

I. Butkuviene................................................................. 184

G. Campos............................................................ 208, 233

F. Brites.............................................................74, 77, 136

M. Buyuklu................................................................... 182

D. H. S. Campos................................................... 258, 260

S. F. Brito Jr.................................................................. 102

N. A. Bylova.........................................74-75, 104-105, 164

L. Campos..............................................139-140, 253, 257

S. R. Brito...................................................................... 253

J. G. Byrne...................................................................... 73

P. Campos.................................................................... 132

V. Brito.......................................................................... 215

Y. Byun......................................................................... 235

C. Campos.....................................................140, 259, 275

J. O. R. Brito...........................................252, 259-260, 262

J. Caamaño................................................................... 227

F. V. Campos..................................191-192, 254, 264, 267

J. Brito.......................................................................... 255

I. Caballe....................................................................... 188

D. H. S. Campos................................................... 258, 260

M. Brito......................................................................... 189

H. Caballero.................................................................. 250

A. C. Campos-De-Carvalho........................................... 266

E. Britto......................................................................... 262

E. Caballero..................................................................... 75

L. H. Can....................................................................... 276

M. Brodmann................................................................ 225

M. Cabello.................................................................... 206

P. Canales..................................................................... 272

P. R. Brofman....................................................... 176, 254

S. Cabral....................................................................... 191

J. Candell-Riera..............................................132, 236, 238

C. Brommer.................................................................. 204

G. Cabrejos........................................................... 214, 222

B. Candemir.................................................................. 192

D. Bron......................................................................... 188

C. Cabrera..................................................................... 208

G. O. Candido................................................234, 253, 269

D. Brosh................................................................ 110, 178

L. Cabrera..................................................................... 164

G. Cândido.................................................................... 258

T. A. Brouzet................................................................. 217

M. Cabrera............................................................ 174, 248

A. Candiello...............................71, 225, 242, 244-245, 277

L. Browne..................................................................... 169

G. Cabrera..................................................................... 231

A. Cañedo..................................................................... 231

R. Bruch........................................................................ 233

A. Cabrita...................................................................... 273

R. Canelón............................................................ 248, 263

T. Brugger-Andersen.................................................... 178

R. Cacchione................................................................. 188

L. Caneo....................................................................... 263

T. Brügger-Andersen............................................ 178, 207

R. Caccione................................................................... 139

J. O. Caneva................................................................. 266

E. Brunel....................................................................... 219

M. Caceres................................................................... 210

C. Caniffi....................................................................... 169

P. Brunel....................................................................... 173

M. Cáceres................................................................... 192

T. Canji.......................................................................... 190

D. Brunner.................................................................... 202

M. Cadeiras.................................................................. 104

B. C. Cannon................................................................. 206

C. A. Bruno................................................................... 279

A. Cagide.................................77, 144, 202, 221, 234-235,

M. Cano................................................................. 256-259

J. Bruthans................................................................... 166

.......................................238-239, 241, 254, 264, 271, 274

R. Cano......................................................................... 248

M. Bruzzece............................................................ 74, 241

A. M. Cagide................................................................. 183

R. Cantarelli.......................................................... 227, 240

L. B. Brydak.................................................................. 175

E. Caguioa..................................................................... 181

F. L. Cantarelli............................................................... 240

B. Buassa-Bu-Tsumbu............................................ 78, 243

N. Cakmak.................................................................... 186

M. Cantarelli................................................................. 190

R. Buckley..................................................................... 166

D. Calcines............................................................ 181, 239

A. Cantisano................................................................. 236

A. Budaj........................................................................ 273

G. Calderon................................................................... 103

M. Cantos..................................................................... 184

S. Budelli....................................................................... 197

G. Calderón......................................69, 258, 260, 265, 271

C. Capano..................................................................... 107

A. Buendía.................................................................... 209

L. Cali............................................................................ 190

J. M. Caparrós.............................................................. 215

O. Bugarin..................................................................... 181

J. Caliani............................................................... 262, 267

D. Capdeferro......................................................... 79, 201

S. Buglia........................................................................ 240

A. Califano.................................................................... 104

R. A. Capece................................................................. 166

Z. Bugra................................................................ 106, 191

R. Calviño.............................................................. 175, 272

G. Caponi...................................................................... 192

S. Builtagy..................................................................... 274

R. Calviño-Santos.......................................................... 198

A. M. Caporal................................................................ 230

G. Bulacio..................................................................... 168

D. Calvo........................................................................ 196

A. Capuccio................................................................... 229

V. S. Bulgarelli............................................................... 246

V. A. Cama.................................................................... 164

M. Capula..................................................................... 244

J. Bulum....................................................................... 231

A. Camara............................................................. 140, 253

C. Capuñay....................................141, 200, 204, 238, 275

S. Bulur.................................................................. 198-199

A. Câmara..................................................................... 139

S. Carabajal................................................................... 178

D. C. Bündchen...............................212-214, 221-223, 227,

M. Camargo.................................................................. 226

J. Carabajales................................................................ 272

...............................................................261, 265-266, 269

A. Camarozano....................................................... 71, 236

M. Carasa..................................................................... 261

J. Buono....................................................................... 144

K. Camarozano................................................................ 71

E. Carasca..................................................................... 134

I. Burazor...................................................................... 251

A. C. Camarozano......................................................... 266

J. Carbajales................................................................. 175

M. Burazor.................................................................... 251

L. Camera..................................................................... 228

C. Cardenas.................................................................. 210

Z. Burazor..................................................................... 251

L. Cámera..................................................................... 137

L. Cardenas................................................................... 276

N. Burazor..................................................................... 251

J. Camilletti................................................................... 210

M. Cardoso................................................................... 250

S. Burger....................................................................... 176

L. Cammi...............................................107, 222, 240, 251

A. Cardozo.................................................................... 244

J. M. Burgos................................................................. 250

P. Campagnolo..................................................... 272, 275

T. S. Carey............................................................ 138, 225

G. Burke........................................................................ 137

V. Campana.................................................................. 205

O. Carlevaro.................................................................. 142

G. Burlando................................................................... 184

E. G. Campana.............................................................. 250

A. Carli.......................................................................... 218

Authors F. Carlos...........................................................78, 110, 143

P. H. C. Castro.............................................................. 140

A. Chaitoff..................................................................... 168

I. Z. Carlos..................................................................... 247

S. M. R. Castro..................................................... 252, 268

T. Chalabi...................................................................... 175

M. R. Carmo................................................................. 166

A. Castro-Beiras............................................................ 198

T. Chaliabi..................................................................... 175

E. Carmona................................................................... 111

A. Cataliotti......................................................72, 108, 136

D. Chambre...................................................237, 240, 265

R. Caron-Lienert............................................................ 236

L. Catão........................................................................ 108

D. Chamie............................................................. 259, 261

V. Carosella................................................................... 210

C. A. M. Cattani............................................................ 236

E. Chammas.......................................................... 277-278

A. F. Carpentier............................................................. 172

B. Cavaliere................................................................... 263

G. Chamorro.................................................. 109, 182-183

M. Carrageta......................................................... 111, 181

B. Cavalieri.................................................................... 228

H. C. Champion............................................................... 77

V. B. Carranza..................................................77, 140, 198

G. Cavalli....................................................................... 228

K. Chan......................................................................... 135

E. Carrasco................................................................... 178

D. C. U. Cavallini........................................................... 247

M. Chan...........................................................73, 143, 179

P. Carrascosa.........................141, 200, 204, 238, 268, 275

M. Cavazzi.................................................................... 269

P. Chandra.................................................................... 132

J. Carrascosa.................................141, 200, 204, 268, 275

R. Cayre........................................................................ 178

D. Chaparro................................................................... 168

A. Carro......................................................................... 197

M. Cazalas.............................................................. 76, 252

A. Charalambous............................................................ 77

S. Carson........................................................................ 74

M. Cebanu.................................................................... 242

A. Charask...............................................69, 100, 191, 207

L. Cartasegna................................................................ 210

G. Ceconi...................................................................... 222

A. Charroqui...................................................111, 221, 255

C. Carvajal..................................................................... 216

K. Cedro........................................................................ 241

S. S. Chauhan............................................................... 140

J. Carvajal..................................................................... 137

A. Cejas........................................................................ 260

I. Chaves....................................................................... 220

A. C. A. Carvalho............................................245, 259, 263

A. S. Celebi................................................................... 233

H. Chaves..................................................................... 108

A. C. C. Carvalho.............................245, 248-249, 259, 263

M. Celente............................................................ 262, 265

A. Chaves..................................................................... 241

D. Carvalho................................................................... 228

D. S. Celermajer............................................................ 180

A. Chávez........................................................................ 76

R. F. Carvalho................................................................ 260

A. Celestini..................................................................... 76

K. Chawla............................................................... 250-251

G. Carvalho.....................................139-140, 208, 228, 257

V. Celorrio..................................................................... 244

M. Chazan....................................................................... 74

A. C. A Carvalho.............................................245, 259, 263

J. Celutkiene................................................................. 210

T. Chazova.................................................................... 163

T. Carvalho.....................................................208, 217, 223

N. Cemerlic-Adjic.......................................................... 183

E. Z. Chehter................................................................. 246

P. E. G. Carvalho........................................................... 228

M. Cenanovic................................................................ 105

D. Chejtman.....................................................79, 106, 187

A. Carvalho....................................110, 208, 245, 259, 263

O. Cendoya................................................................... 207

S. Chekerdemian.......................................................... 269

C. Carvalho.............................111, 245, 248-249, 259, 263

A. Cengel....................................................... 185, 278-279

S. Chekherdemian.................................217, 248, 257, 259

J. J. Carvalho................................................................ 198

A. Çengel.......................................................172, 180, 186

M. G. Chelu................................................................... 103

V. T. Carvalho................................................................ 217

M. Centemero.............................................................. 198

K. Chemello.................................................................. 109

H. Casabe........................ 73, 205, 207, 211, 236, 246, 279

S. Centeno.................................................................... 142

F. Chen......................................................................... 231

J. Casabe.............................................................. 224, 231

R. Centurión.................................................................. 199

M. Chen........................................................................ 107

A. C. Casarini................................................................ 224

M. Centurión................................................................. 256

H. H. Chen.......................................................72, 108, 136

A. Casarsa..................................................................... 229

R. Ceolin....................................................................... 266

Y. Cheng....................................................................... 202

J. Casas........................................................................ 246

R. Ceratto............................................................... 78, 256

N. Chepurina................................................................. 175

F. Casas........................................................................ 227

R. Cerbak...................................................................... 253

R. Cherhousky.............................................................. 193

J. M. Casas................................................................... 279

G. H. Cerezo................................................................. 214

S. Chermont............219, 233-234, 236, 260, 262-263, 270

F. A. Casas.................................................................... 133

A. R. Cerna.................................................................... 226

Z. A. Chernaya................................................. 74, 104-105

U. Casas-Juarez............................................................ 265

D. Cerna........................................................................ 223

T. K. Chernyavskaya......................................... 74, 104-105

M. Cascon-Bueno..........................................207, 218, 257

D. Černá......................................................................... 169

A. Cherro.......................................................229, 265, 267

M. Cascudo.................................................................. 247

N. Ceron....................................................................... 216

S. B. Cherry................................................................... 243

F. Caseiro-Alves.................................................... 204, 224

M. Cerón............................................................... 181, 193

R. Chervin..................................................................... 189

C. B. Casella...................................................172, 180, 192

D. Cerovec.................................................................... 220

P. A. Chiale................................................................... 275

G. Casella...................................................................... 227

E. Cerqueira.................................................................. 192

G. R. Chiappa.......................................................... 74, 138

A. Casella-Filho..............................................172, 180, 192

V. Cerutti............................................................... 247, 268

C. Chicanelli.................................................................. 225

B. Cassis....................................................................... 137

C. Cesa................................................................. 272, 275

T. Chikamori.................................................................. 167

P. Castan...................................................................... 246

L. A. M. Cesar................................................101, 193, 236

A. L. Chilingarian....................................242, 244, 246, 249

S. Castelar.................................................................... 168

L. César........................................................................ 179

A. L. Chilingaryan.....................................72, 103, 193, 218

A. Castellanos............................................................... 169

V. Cesareo............................................................ 244, 247

D. Chin.................................................................... 73, 256

J. Castell-Conesa...........................................132, 236, 238

F. Y. Cesena...................................................172, 180, 192

W. M. Chin.................................................................... 201

S. Castellino.................................................................. 261

R. Cesnjevar................................................................. 274

B. S. P. Chin.................................................................. 201

H. Castello.................................................................... 190

Z. Cetin......................................................................... 223

B. Chiostri..................................................................... 221

G. Castillo..................................................................... 248

P. C. Chabot.................................................................. 258

M. Chiozza.................................................................... 274

V. Castillo...................................................................... 106

E. Chachques........................................................ 139, 172

R. Chirife....................................................................... 244

M. Castillo..................................................................... 251

J. Chacon...................................................................... 242

R. Chirino...................................................................... 183

R. Castro........................................137, 226, 252, 258, 268

S. Chacon..................................................................... 270

M. Chiru........................................................................ 200

I. Castro........................................................................ 208

A. P. M. Chacra............................................................. 198

M. Chkhetia.................................................................. 164

D. Castro..........................................................75, 107, 226

S. Chada....................................................................... 139

Z. Chmielak................................................................... 241

E. Castro................................................................ 269-271

A. C. P. Chagas..............................................172, 180, 192

A. Chockalingam........................................................... 138

Index / 295

Authors S. Chockalingam........................................................... 138

S. R. Coimbra................................................................ 192

L. C. L. Correia........................................................ 72, 107

D. Choi.......................................................................... 110

A. Coimbra.................................................................... 137

J. Cors.......................................................................... 225

I. S. Choi....................................................................... 111

P. Cokkinos............................................................ 181-182

C. Cortes....................................................................... 207

L. Chojnowska.............................................................. 136

D. V. Cokkinos...................................................... 177, 182

C. M. Cortés................................................................. 246

N. Chon......................................................................... 219

H. Cola.......................................................................... 227

R. Corvalan................................................................... 132

P. Chopra.............................................................. 108, 241

S. Colangelo.................................................................. 171

L. A. Cosarinsky............................................................ 136

J. B Choy...................................................................... 165

D. Colcear..................................................................... 242

G. Cosentino................................................................. 186

M. Christ........................................................103, 194, 245

C. Coleman................................................................... 182

N. M. Cosgrove............................................................. 144

G. Christ........................................................................ 110

F. Collart....................................................................... 241

A. Costa...................................72, 169, 205, 211, 256, 259

A. Christen............................................................ 139, 259

C. Collaud............................................................. 139, 261

G. Costa................................................................ 102, 212

E. H. Christiansen............................................71, 142, 253

C. Collet........................................................................ 186

E. Costa........................................................................ 185

D. Chrysos.................................................................... 181

T. Collier...........................................................73, 107, 143

S. Costa...............................70, 78-79, 101, 132, 250, 252,

P. H. Chu....................................................................... 179

M. Colmenero....................................................... 224, 246

.......................................254-256, 258, 260, 263, 275, 277

K. Chudasama............................................................... 256

F. Colombo................................................................... 205

L. Costa.........................................................189, 197, 207

J. Chudek...................................................................... 101

C. M. Colombo.............................................................. 230

R. Costa......................................................... 256-259, 261

S. Chugh................................................................ 141-142

F. Colosia...................................................................... 210

J. Costa...................................................247, 256-259, 261

W. J. Chung........................................75-77, 111, 144, 272

D. Comay.............................................................. 222, 276

M. A. Costa....................................................169, 205, 211

S. Chuprova.................................................................. 213

N. Combes.................................................................... 103

P. C. S. Costa................................................................ 275

E. Chuquiure................................................................. 204

P. Comignani................................................................ 200

J. Costa Jr...............................................256-257, 259, 261

G. Ciambrone...................................................72, 200, 226

C. Commes................................................................... 179

R. Costantini................................................................. 278

T. F. Cianciulli.....................................79-80, 136, 142, 176,

D. Comtesse................................................................. 179

R. Costello............................................................ 102, 181

.......................................................178, 219-223, 229, 250

M. Condori.................................................................... 192

L. C. Costello-Boerrigter............................................... 108

L. Cicco........................................................................... 73

T. Conforti..................................................................... 190

C. Cotrim.............................................................. 111, 181

F. T. Cichelero............................................................... 106

M. Conforto.................................................................. 100

M. Coutinho.................................................................. 179

A. C. Cicogna................................................................ 258

C. Conkbayir................................................................. 180

L. A. Cozarinsky............................................................ 178

A. B. Cid Alvarez.................................................... 186-187

S. Connolly.......................................................73, 107, 143

G. Cozzarin.................................................................... 197

M. Ciesielczyk............................................................... 222

M. Consoli.....................................................248, 257, 259

I. Craciunescu............................................................... 134

R. Cífková............................................................. 166, 173

F. M. Consolim-Colombo...................................... 138, 270

D. Craiem...................................................................... 267

C. Cigalini...................................................................... 182

A. E. Consolini............................................................... 237

O. Cravero.................................................................... 227

M. Cikes....................................................................... 254

D. Constantinescu........................................................ 200

N. Crespi....................................................................... 211

I. Cikes.......................................................................... 254

R. Conti......................................................................... 276

A. Crespo...................................................................... 217

M. Cikirikcioglu............................................................. 142

A. Contreras.................................................................. 176

F. Crespo.............................................................. 213, 239

L. Cimerman................................................................... 80

L. Contreras.................................................................. 189

M. Crespo..................................................................... 188

R. Cimino...................................................................... 254

H. Contreras................................................................. 190

A. Cribier......................................................................... 78

H. E. Cingolani...................................................... 140, 189

G. Converso.................................................................. 269

E. Cristiano............................................................ 228-229

I. P. Cintra..................................................................... 265

L. Cook......................................................................... 176

J. Cristóvão................................................................... 258

M. Ciprés...................................................................... 274

J. Cooke........................................................................ 111

V. Crosa........................................................................ 227

J. J. Cirio............................................................... 111, 221

W. Cooper.................................................................... 255

N. Crozzoli..................................................................... 168

M. Cisterna................................................................... 107

J. C. H. Coracini............................................................ 265

C. N. Crudo Norma....................................................... 169

M. Ciszewski................................................................ 102

S. Corali........................................................................ 188

A. Crusitu...................................................................... 200

A. Ciszewski................................................................. 175

S. Coralli........................................................................ 188

H. Cruz.................................................................. 181, 193

L. Citta.......................................................................... 102

F. Corbella............................................................. 239, 255

C. Cruz.......................................................................... 228

N. Citta.......................................................................... 102

M. Corbi........................................................................ 231

M. Cruz......................................................................... 229

M. M. Civetta................................................................ 275

P. Cordeiro................................77, 111, 181, 233, 236-237

F. E. S. F. Cruz....................................................... 252-253

K. Ckarke...................................................................... 168

V. Cordeiro.................................................................... 144

I. Cruz-Gonzalez.................................................... 218, 257

D. Clark......................................................................... 135

A. C. Cordeiro......................................................... 80, 208

D. Cruz-Robles.............................................................. 204

A. M. Clark............................................................ 143, 229

D. Cordero.................................................................... 204

T. Csatay....................................................................... 199

S. C. Clark..................................................................... 138

I. Cordovil..........191-192, 244, 252-254, 264, 266-267, 273

G. Cuberas............................................................ 132, 236

N. C. D. Clementino........................................................ 74

D. Cornalo..................................................................... 189

M. Cudmore................................................................. 256

I. P. Clements............................................................... 105

M. Cornelli.................................................................... 210

F. Cuellar....................................................................... 139

B. Clericus.................................................................... 257

M. L. Coronel...................................................70, 105, 271

R. Cuenca..................................................................... 188

C. R. Clover........................................................... 138, 212

R. Coronel.............................................................. 205-206

A. Cueto........................................................................ 222

M. R. Cobain................................................................... 73

L. Coronel................................................70, 105, 271, 273

A. Cuevas..................................................................... 163

J. F. Codone.................................................................. 223

A. Correa................................................102, 132, 242, 253

H. Cuezo......................................................................... 78

R. Codutti............................................................... 270-271

A. G. Correa.................................................................. 102

G. Cugat........................................................................ 248

L. Coelho...................................................................... 258

M. Correa............................................................... 270-271

C. Culebras................................................................... 183

F. Coelho...................................................................... 191

D. V. Correa.................................................................. 245

S. Cunha............................................................... 202, 258

A. C. Côrrea.................................................................. 221

T. S. Cunha................................................................... 258

M. G. Cohen...........................................138, 212, 225-226

Authors L. Cuniberti................................................................... 259

D. De Backer................................................................. 107

N. Delarche................................................................... 243

F. Cura..............................71, 132, 225, 242, 244-245, 277

D. De Bacquer..........................................73, 107-108, 143

H. Delgadillo-Rodríguez................................................ 205

C. Curato......................................................................... 77

G. De Bacquer.............................................................. 107

M. Delgado Moreno...................................................... 234

A. Curcio....................................................................... 269

L. N. De Barros............................................................. 234

D. Delgado...................................................................... 74

A. Cury.................................................................... 79, 258

L. De Candido............................................................... 142

E. Delgado............................................................. 196-197

G. Cvetanovic............................................................... 251

F. De Cecco.................................................................. 181

J. Delgado..................................................................... 139

B. Cveticanin................................................................. 174

A. De Dios..................................................................... 178

M. Deljanin Ilic...................................................... 166, 214

A. Cypiene.................................................................... 184

A. De Elizari................................................................... 260

R. Della Pasqua............................................................... 72

F. Cyrino......................................................................... 71

U. De Faire...................................................................... 75

D. Deluso.............................................................. 102, 212

E. Czarnowska.............................................................. 134

F. R. De Fazzio.............................................................. 244

D. Demicco................................................................... 183

A. Czerniczyniec........................................................... 197

J. A. De Grazia.............................................................. 137

A. D. Demir................................................................... 110

R. D´agosto................................................................... 168

M. De La Vega.............................................................. 241

B. Demircelik................................................................ 223

C. D´amico.................................................................... 138

J. De La Hera......................................................... 196-197

M. Demkow................................................... 101-102, 136

L. D’angelo................................................................... 106

M. De La Riba................................................111, 221, 255

M. Dencker................................................................... 168

K. Da Correggio............................................................. 179

R. N. De La Fuente..................................76, 138, 234, 253

M. C. Deng................................................................... 104

P. Da Luz....................................................................... 176

M. De La Rosa.............................................................. 260

D. H. Denis Hamel........................................................ 138

M. P. Da Rosa............................................................... 205

M. E. De La Antonia...................................................... 168

D. V. Denizar Vianna..................................................... 209

M. Da Cunha................................................................. 234

L. M. De La Fuente............................................... 140, 218

C. Dennison.................................................................. 196

M. Dabrowski................................................102, 136, 237

R. N. De La Fuente..................................76, 138, 234, 253

R. K. Deo....................................................................... 272

J. Dadoniene................................................................. 184

C. De Larrazabal............................................................ 270

S. Depine.......................................................107, 222, 240

M. D’Aglio..................................................................... 197

G. De León.....................................................132, 236, 238

M. Descalzo.................................................................. 267

R. B. D’Agostino............................................................. 73

J. J. G. De Lima............................................................ 101

H. Deschle.............................................175, 268, 272, 277

V. Daher Vaz................................................................. 208

D. R. S. De Lorenzi........................................................ 228

P. Dessen............................................................... 75, 103

I. Dahlbom...................................................................... 75

A. De Lorenzo................................................110, 142, 210

M. Destro..................................................................... 173

M. Daicz........................................................................ 207

C. De Luca.................................................................... 211

J. L. Dettoni.................................................................. 270

M. Dal Pai-Silva..................................................... 258, 260

R. De Miguel................................................................. 221

A. Dettorre.................................................................... 103

R. Dall’ Alba.................................................................. 233

D. De Mollein................................................................ 214

B. Deveci...................................................................... 233

P. Dall´ago........................................................74, 138, 142

L. De Noronha................................................................. 77

L. Devera...................................................................... 264

P. Dall’Ago.......................................................74, 138, 142

P. S. De Oliveira............................................................ 266

A. Deviggiano................................141, 200, 204, 238, 275

L. A. O. Dallan............................................................... 193

A. De Paola................................................................... 110

F. Devito....................................................................... 261

C. Daltro........................................................................ 215

A. V. De Paola......................................................... 72, 248

S. C. Dharmage............................................................. 164

P. Daluz......................................................................... 111

F. J. De Paula................................................................ 101

G. Di Gesaro................................................................. 106

N. R. T. Damasceno.............................................. 263, 265

J. De Paz....................................................................... 139

F. Di Giovanni................................................................ 179

R. C. Damaso................................................................ 247

S. De Ridder.................................................................. 277

D. Di Nanno...................................................248, 257, 259

C. Damico..................................................................... 277

R. De Rosa.................................................................... 178

B. A. Di Rico.................................................................. 226

S. Damilano.................................................................. 189

M. De Rossi.......................................................... 233, 236

J. Di Siervi..................................................................... 215

J. Damsky Barbosa....................................................... 209

R. De Rossi............................................................. 76, 208

G. Di Tano....................................................................... 70

L. D’Angelo................................................................... 106

T. De Santo..................................................................... 72

F. Di Tomaso................................................................. 189

G. A. Danieli.................................................................. 134

M. De Sena................................................................... 143

F. Di Tommaso............................................................. 220

R. O. Darabont...................................................... 106, 211

L. De Souza................................................................... 137

D. Di Toro...............................................197, 214, 273, 277

V. Daru.......................................................................... 244

C. De Zuloaga............................................................... 102

C. Di Verniero................................................................ 273

V. Darú.......................................................................... 111

P. Debruyne.................................................................. 277

S. Di Yelsi...................................................................... 179

F. Das Neves................................................................ 278

A. Debski.............................................................. 102, 241

J. Diament.................................................................... 109

J. Dassanayake............................................................. 164

J. Decourcey................................................................. 166

S. Diangelo................................................................... 185

G. Datcu........................................................................ 211

D. B. Dedeoglu..................................................... 180, 242

J. M. Dias De Azeredo Bastos...................................... 208

A. Dauria....................................................................... 134

R. Dedrick..................................................................... 104

C. Dias.......................................................................... 108

G. Davey Smith............................................................. 164

M. M. Defeo......................................................... 208, 211

V. Dias.......................................................................... 191 E. Dias.......................................................................... 231

Z. Davicevic.................................................................. 193

J. P. Degaute................................................................ 211

F. David......................................................................... 144

M. Degrange..........................................111, 170, 189, 196

R. Dias.......................................................................... 176

M. David....................................................................... 214

J. A. Degrazia................................................................ 107

P. Diaz Uberti..........................106-107, 201, 208, 236, 238

A. R. Davies.................................................................. 164

V. Dehlaghi........................................................... 142, 212

I. Diaz...................................................................... 80, 244

A. Davila........................................................................ 263

F. Deketele................................................................... 195

M. Diaz......................................................................... 246

V. Davutoglu......................................................... 171, 211

M. Dekleva................................................................... 174

C. Diaz...................................................................... 73, 75

M. De Abreu....................................................70, 100, 238

M. Del Campo....................................................... 214, 222

A. Díaz Redondo........................................................... 186

W. De Andrade............................................................. 185

C. Del Mazo...........................................111, 170, 189, 196

R. Díaz.......................................................................... 137

K. De Angelis................................74, 76-77, 136-138, 239,

M. Del Sueldo......................................................... 78, 261

R. Diaz-Contreras.......................................................... 248

...............................................................249, 254-255, 258

L. A. Del Val.................................................................. 251

S. A. Dib Ashur..................................................... 207, 209

G. De Backer.............................................73, 107-108, 143

A. Del Val.............................................................. 190, 251

M. Dicugno................................................................... 201

Index / 297

Authors M. Diego-Dominguez.....................................207, 218, 257

L. Dragonetti..................................................227, 239, 255

L. Enciso....................................................................... 102

A. Dieterle..................................................................... 176

M. Dragovic.................................................................. 169

J. E. Enders................................................................... 273

G. Dieuzeide................................................................. 240

H. Dreger...................................................................... 140

O. Epstein..................................................................... 175

F. Diez................................................................... 105, 240

A. Drolias...................................................................... 216

A. R. Erbay.................................................................... 110

M. Diez........... 106, 186, 224, 236, 238, 250, 259, 266-267

J. Drozdz........................................................170, 188, 222

P. Erceg.................................................................. 74, 105

P. Digon........................................................................ 240

R. Drwila....................................................................... 230

A. Erdem........................................................180, 194, 205

M. Dikic.......................................................................... 71

A. Drzewiecka-Gerber................................................... 230

G. Erdem...................................................................... 278

C. H. Dina...................................................................... 191

M. Duarte.............................................................. 200-201

M. Erden....................................................................... 186

A. Dini............................................................................. 71

D. Duarte........................................................................ 79

S. Erdine............................................................... 108, 241

R. V. Z. Diniz.................................................. 248-249, 267

T. N. Dube............................................................. 108, 231

I. Erdinler...................................................................... 186

R. Diniz......................................................................... 247

R. Duchonova................................................141, 223, 234

E. Erdogan.................................................................... 197

M. Diniz........................................................................ 201

R. Duchoňová................................................................ 136

M. Eren......................................................................... 171

B. Dinov........................................................................ 206

A. Dudkowska.............................................................. 249

B. Erer........................................................................... 171

L. Diodato............................................................. 244, 247

T. Duffy......................................................................... 250

A. Erglis........................................................................ 255

T. Diogenes........................................................... 264-266

H. Duggirala.................................................................. 110

L. Erhardt...................................................................... 243

P. Diosque.................................................................... 254

A. Dukat........................................................................ 240

C. M. Erley.................................................................... 141

T. Dipp..............212-214, 221-223, 227, 261, 265-266, 269

E. Dulbecco......................73, 107, 205-206, 230, 246, 279

Z. Eroglu......................................................................... 77

M. Disanto.................................................................... 221

L. Dumas...................................................................... 176

C. Erol........................................................................... 192

F. Ditomaso.................................................................. 102

H. Duplain............................................................... 75, 103

N. Erondu................................................................ 75, 166

C. D’Ivernois......................................................... 135, 218

J. Dupont...................................................................... 139

J. Erriest....................................................................... 210

C. Dizeo........................................................................ 189

E. Duronto............................................................ 100, 207

S. Eryilmaz.................................................................... 111

W. Djaballah.................................................................. 110

F. Duru.......................................................................... 246

B. Eryonucu.................................................................. 185

S. Djambazov................................................................ 230

G. Dussaillant................................................................ 141

J. Escalante.................................................................. 260

D. Djordjevic................................................................. 276

N. Dusserre.................................................................. 218

A. S. Escandurra........................................................... 224

A. Djordjevic-Dikic...........................110, 142, 171, 277-278

R. Dutta........................................................................ 232

C. Escarain.................................................................... 259

B. Djukanovic................................................................ 202

H. Duygu....................................................................... 188

A. Escobar.............................................................. 72, 227

L. D. Do................................................................. 143, 275

S. Dzemeshkevich........................................................ 234

J. Escudero................................................................... 185

D. Dobrev..................................................................... 103

V. Dzenkeviciute................................................... 184, 237

E. M. Escudero................................................77, 140, 198

H. Dohmann......................................................... 139, 184

Z. Dzielinska.................................................................. 101

C. Esis........................................................................... 242

N. Doll........................................................................... 182

S. S. Eagle....................................................................... 73

S. Eskenazi................................................................... 218

A. Dombrovskis............................................................ 255

K. A. Eagle.................................................................... 100

M. M. Esnaola......................................................... 78, 111

E. Domenicchini............................................................ 242

M. Ebbing.......................................142, 243, 247-249, 251

A. Esper........................................................................ 265

A. M. Domingos............................................................ 253

A. Ebner........................................................................ 240

A. Esperon.................................................................... 267

R. Dominguez....................................................... 168, 222

R. Ebrahimi................................................................... 144

P. Esperón............................................................ 273, 276

C. Dominguez............................................................... 214

C. Echeverria................................................. 189-190, 215

G. Espersen.................................................................. 166

A. Dominguez-Rodriguez...............................167, 169, 213

H. Ede........................................................................... 192

R. Esporcatte................................................................ 250

M. Dominiak.................................................. 170-171, 188

T. Eftestøl..................................................................... 199

A. Esquivel.................................................................... 240

F. Dominici.................................................................... 274

Z. Egileten..................................................................... 111

A. R. Essop................................................................... 203

S. Donato.........................................................72, 200, 226

E. Egito......................................................................... 258

M. R. Essop.......................................................... 203, 230

P. Donato.............................................................. 204, 224

E. T. Egito....................................................................... 76

J. P. Esteves........................................................... 72, 107

L. Dong Won................................................................. 272

S. Egito......................................................................... 249

P. Esteves........................................................72, 107, 254

I. Donis......................................................................... 190

Y. Ekimova.................................................................... 132

J. Estornell.................................................................... 231

L. Donwon.................................................................... 272

A. Eksik......................................................................... 186

G. Estrade..................................................................... 243

J. P. Donzeau................................................................ 103

C. Elbacha..................................................................... 278

S. J. Eum........................................................................ 79

A. N. Dorelle.........79-80, 176, 178, 219-220, 222-223, 229

R. Elesgaray.......................................................... 169, 211

A. Evangelista............................................................... 252

A. H. Dorigo.................................................................. 262

A. Elhendy.................................................................... 111

P. Evangelista............................................................... 240

M. Dorobantu........................................106, 200, 211, 224

F. Eliaschewitz.............................................................. 227

L. Evlampieva............................................................... 183

D. Dorsey...................................................................... 133

G. Elizalde............................................................. 241, 264

F. Exposito.................................................................... 229

F. Dorticós.................................................................... 210

A. Elizalde....................................................................... 77

E. Eyheremendy........................................................... 255

A. Dos Santos............................................................... 207

M. V. Elizari.................................................... 219-220, 229

H. Ezumi....................................................................... 239

G. Dotto........................................................................ 264

R. El-Kik........................................................................ 175

J. N. Fabiani.................................................................. 179

R. Doughty.................................................................... 136

S. Ellovitch.................................................................... 102

B. Fabricio............................................................. 136, 211

P. Dourado.................................................................... 111

I. Elmadbouh................................................................. 139

L. Fabryova................................................................... 257

H. Doval...........................................................70, 100, 209

H. Eltchaninoff................................................................ 78

G. Facin......................................................................... 100

M. Dowlut..................................................................... 256

L. Elvas......................................................................... 258

S. Fadel......................................................................... 179

G. Doxastakis................................................................ 227

W. T. Emery.................................................................. 165

K. Fagnilli...................................................................... 168

S. Dragnic..................................................................... 167

F. Emperador................................................................ 190

G. E. Fagogenis............................................................. 185

D. D. Drago................................................................... 217

S. Enar.......................................................................... 216

B. Faillace..................................................................... 195

Authors I. Faillace....................................................................... 195

E. O. Fernandes.................................................... 252, 274

A. Ferro......................................................................... 166

D. Faith......................................................................... 226

T. R. Fernandes............................................................. 236

M. Fervenza.................................................................... 72

D. Faivovich.................................................................. 137

E. Fernandes................................................................. 268

G. Feuchtner................................................................. 173

S. A. Fakhouri................................................................ 244

G. S. Fernandes.................................................... 226, 236

Z. Fichino...................................................................... 276

A. S. Fakhouri................................................................ 244

G. M. O. Fernandes...................................................... 274

J. Fiedler............................................................... 223, 237

G. Falbo........................................................................ 228

F. Fernandez Chamorro................................................ 256

J. Figal.......................................................................... 107

S. Falcão....................................................................... 111

C. Fernandez Gomez.................................................... 273

L. Figiel......................................................................... 170

F. Falcón....................................................................... 137

N. Fernandez................................................................ 206

J. Figueira..................................................................... 190

V. Falk........................................................................... 182

G. Fernandez................................................................ 210

A. Figueiredo.................................................108, 250, 272

J. P. Faller..................................................................... 194

E. Fernandez......................................................... 215, 260

J. Figueiredo................................................................. 138

V. Faltus...........................................................72, 132, 200

S. Fernandez......................................................... 169, 240

S. Figueiredo................................................................. 253

R. Falú............................................................132, 236, 238

M. Fernandez.........................................178, 182, 241, 268

J. Figueras.................................................................... 236

R. Falú,...........................................................132, 236, 238

A. Fernandez.........................102, 205, 207, 211, 224, 227,

J. Figueredo.................................................................. 190

S. Fandiño............................................................... 70, 136

...............................................231, 235-237, 240, 248, 254

A. Figueroa................................................................... 240

M. Fanuele.................................................................... 181

R. Fernandez................................................................. 224

M. Fijalkowski............................................................... 249

A. Farah................................................................ 246, 248

H. Fernandez...........................................79, 176, 187, 250

R. D. S. Filho................................................................. 263

S. C. Faria...................................................................... 274

F. Fernandez......................................................... 165, 256

R. Filho.......................................................................... 253

C. Faria.................................................................. 249, 274

E. H. Fernandez............................................................ 176

I. Filibev........................................................................ 194

J. Faría.......................................................................... 263

J. Fernández De La Concha.................................. 213, 239

K. Filipiak....................................................................... 273

E. Farias........................................................................ 141

A. Fernández Meseguer............................................... 174

S. Finella....................................................................... 211

M. F. Farias................................................................... 217

J. M. Fernández............................................................ 209

F. Fini............................................................................ 240

M. Farnier....................................................................... 75

A. Fernández..................................................174, 186, 227

F. Finol........................................................... 247-248, 263

M. Farrall......................................................................... 77

A. R. Fernández............................................................ 273

A. Fiorillo....................................................................... 218

H. Farras............................................................... 171, 181

C. Fernández................................................................... 69

M. Fisberg.................................................................... 265

J. Fassl.................................................................... 73, 182

V. Fernández................................................................. 188

C. H. Fischer....................................................79, 224, 253

L. Fatecha..................................................................... 256

B. Fernández................................................................. 274

C. Fisher....................................................................... 238

A. Fauzi......................................................................... 184

C. Fernández-Cimadevilla............................................. 196

E. Fisman...................................................................... 209

G. Fava............................................205-207, 211, 236, 259

C. Fernández-Labandera............................................... 174

R. Fitaroni..................................................................... 144

C. Fava.............................................................78, 188, 193

J. M. Fernandez-Real.................................................... 188

P. Fitzgeral.................................................................... 257

L. Favaloro...... 106, 186, 224, 236, 238, 250, 259, 266-267

F. L. Fernando Lanas.................................................... 102

G. Fitzgerald.................................................................. 100

R. R. Favaloro.........................186, 205, 211, 230, 246, 266

L. Fernando Tanajura.................................................... 257

P. Flaherty..................................................................... 197

D. Favarato................................................................... 192

S. Ferradas.................................................................... 214

A. Flavio........................................................................ 211

D. Favaratto.................................................................. 172

R. Ferrando............................................................ 269-270

E. Fleck................................................................... 75, 107

G. Fazio......................................................................... 106

D. Ferrante.................................................................... 137

E. Fleitas....................................................................... 177

C. Febres...................................................................... 190

G. M. Ferrari...................................................133, 237, 274

P. Flondor..................................................................... 106

M. Fechner................................................................... 140

G. Ferrari....................................................................... 227

C. Flores Borja.............................................................. 248

R. A. Fedato.................................................................... 75

A. Ferrario............................................................... 78, 256

E. Flores........................................................................ 178

F. L. Federico Lipszyc................................................... 212

C. Ferreira Filho..................................................... 195, 245

D. Flores....................................................................... 107

B. Federico................................................................... 132

J. L. Ferreira.................................................................. 247

M. Flores...................................................................... 190

H. Feier......................................................................... 241

B. Ferreira..................................................................... 180

X. Flores-Ríos................................................................ 198

J. Feijoo........................................................................ 218

C. Ferreira..............................195, 243, 245, 247, 251, 265

J. Floridia........................................................................ 78

M. Feissel..................................................................... 194

M. Ferreira......................110, 142, 204, 217, 247, 253-254

E. Florido....................................................................... 271

A. D. M. Feitosa.................................................... 247, 255

G. M. Ferreira................................................................ 142

L. Florio......................................................................... 199

A. Feitosa...................................................................... 228

A. L. Ferreira................................................................. 106

S. Florit......................................................................... 142

G. S. Feitosa-Filho......................................................... 109

M. A. P. Ferreira............................................................ 108

G. Flory......................................................................... 243

L. Feldman.................................................................... 267

M. J. Ferreira................................................................ 224

K. Flues................................................76-77, 137-138, 258

G. Feldman....................................................141, 180, 187

J. C. A. Ferreira-Filho.................................................... 270

B. Flynn......................................................................... 176

R. Feldman........................................................... 187, 241

M. Ferreiro.................................................................... 275

G. Fodor........................................................................ 240

A. Feldman................................................................... 186

C. R. Ferreiro................................................................... 76

A. Fogel.......................................................................... 76

M. S. Felix..................................................................... 142

L. Ferrer........................... 69, 103, 242, 258, 260, 265, 271

A. Folga......................................................................... 273

A. Fellet........................................................................ 205

M. Ferrer................................................................. 69, 207

S. Folino........................................................................ 274

G. Feltes................................................................ 241-242

A. Ferrer-Antunes................................................. 110, 217

T. Folkestad.................................................................. 247

H. Feng........................................................................... 73

F. M. Ferrero................................................................. 274

A. Y. Y. Fong................................................................. 201

C. Fenili......................................................................... 189

L. Ferrero...................................................................... 239

F. L. Fonseca................................................................ 250

A. L. Fenrich.................................................................. 206

M. Ferrero..................................................................... 274

S. Fonseca................................................77, 233, 236-237

M. Fenucci.................................................................... 229

R. Ferreyra.............................................102, 185, 225, 244

I. Fonseca..................................................................... 213

F. Feres..........................................198, 225, 257, 259, 261

M. Ferriera.................................................................... 245

L. M. B. Fonseca............................................110, 140, 210

E. L. Ferlin............................................................... 74, 106

L. Ferro......................................................................... 176

L. Fonseca.....................................................226, 236, 250

Index / 299

Authors L. H. Fonseca................................................................ 201

E. Fucak........................................................................ 223

E. A. Garcia Gras........................................................... 191

C. Fontana.................................................................... 179

S. Fuchs................................................................ 110, 178

M. A. Garcia.................................................................. 244

P. Forcada......................................................106, 138, 187

F. D. Fuchs.......................................................76, 106, 143

E. Garcia........................................................ 215, 270-271

L. M. A. Forlenza................................................... 102, 132

S. C. Fuchs.......................................................76, 106, 143

W. Garcia...................................................................... 215

M. Forrester.................................................................. 201

F. C. Fuchs.............................................................. 76, 106

R. G. Garcia................................................................... 249

O. Forster.............................................................. 202-203

K. Fuckar....................................................................... 220

R. Garcia........................................224, 235, 254, 264, 271

R. Y. Forte..................................................................... 100

F. Fuertes..................................................................... 248

A. Garcia................................111, 132, 184, 191, 195, 244

E. Forte................................................................. 100, 111

S. Fujii................................................................... 263, 278

M. Garcia................................141, 186-187, 192, 200, 260

A. Fortier....................................................................... 197

H. Fujii............................................................164, 188, 197

C. Garcia............................................................... 177, 207

M. J. Fosco......................................................73, 100, 279

T. Fujisawa.................................................................... 256

S. Garcia....................................................................... 141

J. Fourie........................................................................ 196

S. Fukae................................................................ 195, 209

H. H. Garcia................................................................... 164

R. Fowler...................................................................... 108

H. Fukuda........................................................70, 185, 189

A. García..........................................................69, 174, 188

R. Foye......................................................................... 181

K. Fukuyo...................................................................... 195

J. J. García-Cuerrero..................................................... 213

J. Fracasso.................................................................... 231

M. B. G. Funari.............................................................. 224

A. Garcia-Flores............................................................ 188

J. M. Fragoso......................................................... 204-205

E. Fung......................................................................... 111

M. J. Garcia-Gonzalez....................................167, 169, 213

H. Fraguas.................................................................... 206

T. Furuhashi.....................................................70, 185, 189

R. Garcia’Monaco..................................235, 254, 264, 271

F. Fraige Filho........................................................ 243-244

S. Furuyama.................................................................. 181

J. Garcia-Puig................................................................ 243

R. Frajndlich.................................................................. 109

J. Fuse.................................................................... 80, 244

C. D. Garciarena............................................................ 140

O. França Neto.............................................................. 176

S. Fuse.......................................................................... 167

L. García-Rojas.............................................................. 133

O. R. França Neto........................................................... 77

J. Fuselli................................................................ 102, 209

J. García-Ruiz......................................................... 196-197

F. R. França................................................................... 233

O. Fustinoni.......................................................... 111, 221

J. García-Seara...................................................... 180, 194

O. França................................................................ 77, 176

O. Fustoni....................................................................... 78

J. Gardin................................................................. 73, 179

B. V. França........................................................... 252, 268

J. Gabay........................................................................ 248

N. Garg......................................................................... 198

A. Francesia............................................................ 74, 136

E. Gabbay..................................................................... 108

V. Gariboldi................................................................... 241

J. V. Francica................................................................. 254

E. Gabe..................................................142, 205, 230, 278

L. Gariglio.......................................................181, 193, 239

D. Franco...................................................................... 227

A. Gacek....................................................................... 171

C. Garillo....................................................................... 210

L. François...................................................................... 78

Z. Gaciong..................................................................... 243

S. Garrido...................................................................... 218

T. Francuz..................................................................... 208

F. L. Gadaleta................................................................ 168

A. Garutti...................................................................... 264

A. Frangi................................................................. 79, 201

F. J. Gadea.................................................................... 178

J. Gasparovic................................................................ 257

R. Frank........................................................................ 179

V. Gafarov..............................................108, 138, 177, 272

I. Gasperovich............................................................... 218

P. Y. Frasier................................................................... 212

A. Gafarova............................................108, 138, 177, 272

M. Gassmann............................................................... 240

L. Frazin........................................................................ 202

J. Gagliardi...............................70, 100, 102, 133, 266, 278

E. Gassner.................................................................... 173

P. M. Fredriksen................................................... 103, 223

I. Gagulin............................................................... 138, 272

N. Gastaldello............................................................... 249

N. A. Freedberg............................................................ 186

E. Gainoiu..................................................................... 200

L. Gastaldi..................................................................... 263

B. Freedman................................................................. 100

D. Gainza.........................................................75, 107, 137

J. Gaudiano................................................................... 270

L. Freire........................................................................ 195

M. Gaito.......................................................................... 69

E. Gaui.................................................................. 106, 262

R. Freire........................................................................ 195

R. Galaska..................................................................... 249

M. Gaute....................................................................... 228

E. O. Freitas.................................................................. 260

S. Galatius............................................................. 230, 232

G. Gavrielatos............................................................... 181

J. Freitas......................................................................... 72

R. Galerano................................................................... 264

M. Gayda...................................................................... 197

M. Freitas....................................70, 78-79, 101, 132, 250,

A. Galindo..................................................................... 190

D. S. Gazizova............................................................... 255

.................................252, 254-256, 258-260, 262-263, 268

M. Galli......................................................................... 277

F. Gazoni............................................................... 263, 268

E. V. Freitas................................................................... 250

S. Gallo......................................................................... 240

O. C. E. Gebara............................................................. 277

A. L. R. M. Freitas................................................. 252, 268

P. Gallo...................................141, 206, 209, 246-248, 260

S. Geidel....................................................................... 103

L. Freitas....................................................................... 186

J. Gallo.......................................................................... 243

R. J. Gelpi.............................................................. 227-228

X. Freixa.......................................................................... 69

J. P. Gallo.............................................................. 141, 260

D. Genova..................................................................... 263

J. French....................................................................... 132

A. Galloe..........................................................71, 142, 253

J. A. Genovese..................................................... 172, 212

R. Fretes....................................................................... 222

M. Galovcová................................................................ 166

A. T. Germanos............................................................. 185

B. Frey.......................................................................... 232

M. Galvao..................................................................... 270

T. Gerntholtz................................................................. 107

N. Freyberg................................................................... 143

G. T. Gama.................................................................... 244

R. Geronazzo................................................................ 227

O. Fridman.................................................................... 239

J. Gambarte.....................................................72, 200, 226

L. Gerones.................................................................... 197

S. Friedl......................................................................... 274

S. Gambhir.................................................................... 250

L. Geronés.................................................................... 189

R. A. Friedman.............................................................. 206

R. Gamboa.......................................................76, 165, 224

M. Geronés................................................................... 189

G. Friedrich................................................................... 173

M. Gamen............................................................. 134, 225

C. Geronés.................................................................... 183

C. Froimovich................................................... 80, 242-244

C. Gangana................................................................... 262

M. Geronimo................................................................ 247

J. Frostegård................................................................... 75

I. Gantz........................................................................... 75

H. Ghandehari................................................................. 79

A. G. Fruntelata............................................................. 200

N. Ganugrava................................................................ 235

D. Gherardi................................................................... 240

M. L. Fuantos Delgado................................................. 268

F. Ganzalez................................................................... 193

M. Ghias....................................................................... 163

M. L. Fuantos-Delgado.......................................... 265-266

C. Garcez...................................................................... 234

S. Ghione.............................................................. 190, 251

Authors S. Ghiorghe....................................................106, 211, 224

S. Golitsyn.................................................................... 234

N. Gotcheva.................................................................. 225

G. Ghirardi..................................................................... 242

T. Golitsyna................................................................... 163

D. Gotera...................................................................... 247

F. Ghizzoni.................................................................... 143

A. M. Gomes........................................................ 100, 255

I. Gotlib......................................................................... 136

A. Ghosh....................................................................... 232

R. Gomes........................................190, 252, 259-260, 262

C. Gottschall................................................................. 138

M. Giacomo........................................................... 189-190

I. Gomes....................................................................... 102

G. Gouvea.............................................................. 222-223

J. Giani.......................................................................... 274

G. B. Gomes................................................................... 75

C. M. Gouvêa................................................................ 275

E. Giardina.............................................................. 75, 107

M. A. M. Gomes........................................................... 255

L. H. W. Gowdak...........................................101, 193, 236

A. Gibert....................................................................... 188

C. Gomes...................................................................... 191

V. Grabauskiene............................................................ 210

V. Giga....................................................110, 142, 277-278

L. Gomes...................................................................... 191

N. A. Grablina........................................................ 174, 192

G. Gigena................................................................ 69, 132

R. A. F. Gomes............................................................. 247

M. Grabowski............................................................... 273

G. S. Gill........................................................................ 251

S. Gomes Jr...................................................136, 215, 220

B. Graça........................................................................ 224

J. Gill............................................................................. 179

J. Gomez.................................................71, 139, 228, 248

R. Graebin..................................................................... 257

A. Gillinov...................................................................... 232

C. Gomez................................................................ 73, 266

S. Graf........................................................................... 194

R. H. Gilman.......................................................... 137, 164

K. Gomez...................................................................... 209

S. Grajek............................................................... 225, 251

V. M. L. Gimenes............................................................ 79

S. Gomez.............................................................. 190, 251

N. Gramatnikovski........................................................ 163

L. Gimenez........................................................... 208, 211

L. Gomez...................................................................... 221

D. R. Grana............................106, 109, 138, 141, 197, 201

J. Gimenez.................................................................... 242

R. Gomez.............................................................. 106, 189

B. E. Grand.................................................................... 183

S. Gimenez............................................107, 222, 240, 251

J. Gómez...................................................................... 219

H. Gransar..................................................................... 141

F. Ginés........................................................................ 264

J. Gomez-Mancebo...................................................... 205

I. Graziadei.................................................................... 173

C. Ginghina................................................................... 134

F. Goncalves....... 70, 79, 101, 132, 250, 254-256, 260, 263

A. Graziano................................................................... 227

M. Gingins............................................................ 237, 274

L. Gonçalves..............................................70, 78, 252, 258

F. Graziano.................................................................... 278

A. Giolis........................................................................ 216

F. Gonçalves....................................................78, 252, 258

G. Grazioli..................................................................... 228

S. Gioppato................................................................... 190

C. Gonçalves................................................................. 233

L. Grazioli...................................................................... 141

D. M. A. Giorgi.............................................................. 260

R. Gonçalves........................................................... 76, 190

G. Grecca...................................................................... 240

J. Giorgini...................................................................... 226

B. Gonçalves................................................................. 143

A. Greco.......................................................................... 79

V. Giovinni..................................................................... 261

N. Goncharova...................................................... 204, 274

O. T. Greco................................................................... 213

M. Giraudo.................................................................... 241

A. F. P. Gondar............................................... 191-192, 267

J. P. Greelish................................................................... 73

X. Girerd........................................................................ 243

H. Gonna............................................................... 103, 105

S. B. Greene......................................................... 138, 225

M. Gironacci..................................................256, 262, 274

C. C. Gonzaga......................................................... 80, 208

S. B. Greene......................................................... 138, 225

M. M. Gironacci.................................................... 256, 262

B. Gonzales................................................................... 278

V. Gregorietti................................................................ 259

P. Gitelman..................................................................... 70

D. Gonzales.................................................................... 77

A. Grentzinger............................................................... 194

A. Giuca........................................................................ 180

P. Gonzalez................................................................... 206

K. Griffith...................................................................... 205

G. Giunta........................................................107, 179, 259

R. Gonzalez.............................134, 170, 186-187, 194, 214

J. Grignola..................................................................... 264

E. Gkaliagkousi............................................................. 166

J. L. Gonzalez................................................. 206-207, 259

M. Grigorov................................................................... 230

A. Gkouziouta............................................................... 182

C. D. Gonzalez.............................................................. 166

V. Grigorov.................................................................... 191

A. Glavan.............................................................. 229, 250

F. Gonzalez................................................................... 181

M. Grinberg...................................132, 237, 247, 275, 278

G. Gleim.......................................................................... 75

E. Gonzalez.............................171, 174, 186-187, 192, 194

D. Grinfeld............................................................ 227, 248

D. Glogar............................................................... 100, 110

E. S. Gonzalez....................................................... 205, 262

M. Grippo.............................................................. 221, 252

R. Glowczynska............................................................ 273

J. Gonzalez....................................................180, 190, 256

D. Grisoli....................................................................... 241

J. Gminski..................................................................... 208

S. Gonzalez....................................................184, 205, 262

E. Gromova........................................................... 138, 272

R. N. Gobbi................................................................... 266

C. Gonzalez................................................................... 184

K. Grong................................................................ 143, 272

G. N. Gobbi.....................191-192, 244, 254, 264, 267, 273

G. E. González........................................................ 227-228

H. Grönlund.................................................................... 75

J. H. Goch..................................................................... 210

G. E. González........................................................ 227-228

P. Grosse........................................................................ 78

A. Godomiczer...................................................... 220, 222

T. Gonzalez-Alujas......................................................... 252

O. Grosso..................................................................... 267

L. Godoy............................................................... 189, 197

J. R. Gonzalez-Juanatey................................................ 194

E. Gruenig..................................................................... 225

P. Godoy....................................................................... 269

I. Gonzalez-Mendia....................................................... 207

S. Grujic........................................................................ 105

G. Godoy....................................................................... 183

C. González-Quesada.................................................... 205

H. Grundt................................................................ 75, 178

T. J. S. Goes................................................................. 111

G. Gonzalez-Stawinski.................................................. 232

H. Grunfeldova.................................................72, 132, 200

C. Goh................................................................... 235, 239

M. Good........................................................................ 103

C. J. Grupi..................................................................... 193

Y. Goh........................................................................... 192

J. Goral............................................................ 80, 242-244

M. Grygier..................................................................... 225

P. Goh........................................................................... 192

E. Gorbatenko............................................................... 183

L. Grynberg............................................133, 139, 188, 266

J. Gohil.......................................................................... 235

I. A. Gorbunova............................................................. 210

A. Grzesiak...................................................................... 77

S. Gokaslan................................................................... 223

J. M. Gore..................................................................... 100

P. Grzesiowski.............................................................. 251

R. J. Goldberg............................................................... 100

T. Goren........................................................................ 191

A. Guajardo................................................................... 143

R. C. S. Goldenberg...................................................... 140

S. Gorgulu..................................................................... 171

F. Gual-Capllonch.......................................................... 252

A. Goldsman................................................................. 252

L. Goryunova......................................................... 234-235

L. C. Guarita-Souza....................................................... 218

A. Goldsmit................................................................... 141

M. Goss........................................................................ 208

G. Guarraccino.............................................................. 175

L. Goldstraj................................................................... 228

G. Gossing.................................................................... 238

D. Guastavino............................................................... 197

Index / 301

Authors A. Guedes..................................................................... 273

V. Hachinski.................................................................. 267

G. Heper......................................................................... 72

F. Guerloy..................................................................... 100

M. Hadad.............................................................. 190, 251

H. Herbas...................................................................... 276

R. Guerra...................................................................... 183

A. Haddad............................................................. 139, 184

R. Hermes.................................................................... 244

G. M. Guerra......................................................... 138, 260

C. Hadid.........................................................197, 214, 273

L. Hernandez................................................................ 226

X. Guerra....................................................................... 247

M. P. Haefner............................................................... 142

D. Hernandez................................................................ 271

F. Guerra....................................................................... 190

L. Hagemann................................................................ 109

A. Hernandez................................................................ 163

J. E. Guerra............................................................. 80, 220

P. Hajek........................................................................ 223

E. Hernández......................................................... 196-197

G. M. Guerra......................................................... 138, 260

A. Halabe...................................................................... 107

I. Hernandez-Baldomero....................................... 167, 213

R. Guerreiro.......................................................... 215, 222

A. L. C. Hallal................................................................ 208

M. Herrera.................................................................... 209

F. Guerrero......................................................74, 211, 241

J. Hallén........................................................................ 223

J. Herrera...................................................................... 264

P. Guerrero................................................................... 106

R. Halmosi.................................................................... 202

C. Herrera..................................................................... 214

J. Guerrieri.................................................................... 138

L. Halmy............................................................... 199, 238

D. Herrera..................................................................... 190

E. Guevara....... 73, 186, 205, 207, 211, 224, 231, 236, 246

L. Hamity...................................................................... 173

R. N. Herrera................................................................. 180

A. Guevara............................................................ 260, 270

O. Hamoui.................................................................... 277

L. Herrera-Para.............................................................. 248

R. Guglielmone....................................................... 80, 111

R. Hams................................................................ 247, 268

A. Hershon.................................................................... 179

G. Guglieri......................................................260, 265, 271

S. Han................................................................ 75-77, 144

A. Hershson.......................................................... 206, 225

D. Guidi......................................................................... 143

R. Handrock...........................................106, 196, 198, 221

C. Hesse....................................................................... 225

K. C. Guidini.......................................................... 221, 261

M. Hanna...................................................................... 168

Ø. Hetland.................................................................... 199

R. Guidoin..................................................................... 178

K. N. Hansen....................................................71, 142, 253

F. Heusser.................................................................... 207

S. Guilhon............................................................. 233, 236

A. Hansen..................................................................... 274

P. Hewett..................................................................... 256

A. Guimaraes........................................................ 209, 268

M. Hara......................................................................... 170

S. Heymsfield................................................................. 75

T. Guimaraes................................................................ 253

E. S. Hara...................................................................... 271

F. Hidden-Lucet............................................................ 179

M. Guimarães....................................................... 135, 208

S. Harb.......................................................................... 110

K. Hideg........................................................................ 202

T. Guimarães..........................................139-140, 253, 257

C. Harden...................................................................... 176

C. Higa.....................................................72, 102, 200, 226

J. B. Guimarães............................................................ 190

G. E. Harders.......................................................... 72, 136

M. Higuchi.................................................................... 249

H. Guimarães........................................................ 132, 254

J. M. Hare....................................................................... 77

D. Hilfiker-Kleiner.......................................................... 202

A. Guimarães................................................................ 108

W. S. Harris...............................................75, 206-207, 209

M. N Hill........................................................................ 196

I. C. Guimarães............................................................. 215

W. Harvey............................................................. 134, 170

G. Hillis......................................................................... 136

A. C. Guimarães............................................................ 215

C. Hasdemir.................................................................... 77

M. S. Hiremath............................................................. 132

R. Guindy...................................................................... 108

H. Hasdemýr................................................................. 186

J. C. Hiriart.................................................................... 208

S. Guinjoan................................................................... 138

H. Hase......................................................................... 189

A. Hita......................................79, 102, 106, 138, 187, 189

C. Gul............................................................................ 182

M. Hashemi.................................................................. 211

R. Hitateguy........................................................... 269-270

R. Guleria...................................................................... 103

M. Hashemzadeh......................72, 79, 102, 106, 111, 273

S. P. H. Hjortshoj.......................................................... 166

G. M. Gulnar Mendonça....................................... 210, 213

K. H. Hashemzadeh...................................................... 176

M. Hlawaty............................................170, 173, 185, 193

B. Gumbiner................................................................. 166

S. H. Hashemzadeh...................................................... 176

M. Hochleitner.............................................................. 176

C. Gun............................................................................. 79

C. Hasikidis................................................................... 181

C. Höcht................................................................. 273-274

S. Guneri....................................................................... 170

A. Hasslocher-Moreno.................................................. 140

D. O. Hodge.................................................................. 105

S. Gupta........................................................................ 232

T. Hatano...................................................................... 167

S. J. Hoff......................................................................... 73

R. Gupta................................................................ 108, 231

G. Hatzigeorgiou........................................................... 182

P. Hoffman............................................109, 134, 171, 174

E. P. Gurfinkel............................................................... 100

A. Hauqui...................................................................... 215

R. Hoffman................................................................... 227

F. Gurgel........................................................262, 265, 267

F. Hauqui...................................................................... 215

A. Holden.........................................................73, 107, 143

L. Gurrin........................................................................ 164

K. Hayashi............................................................. 137, 173

R. Holloway.......................................................... 103, 105

T. Gursoy...................................................................... 223

S. Heath........................................................................ 229

G. M. Holmes....................................................... 138, 225

M. Gus.......................................................................... 106

J. L. Hebert................................................................... 179

G. M. Holmes....................................................... 138, 225

R. Gusmão.................................................................... 272

T. G. Heck....................................................................... 74

H. Holmstrøm....................................................... 103, 223

F. Gustafsson............................................................... 104

S. Hecker...................................................................... 274

D. Holownia.................................................................. 265

A. Gustavo.................................................................... 175

B. Hedblad...................................................................... 75

W. Homena................................................... 252, 259-260

B. Gutfilen..................................................................... 140

M. Heeren.......................................................77, 137, 255

A. Homsi-Neto.............................................................. 233

G. Guthman.................................................................... 69

M. Heigert.................................................................... 110

B. Hong.......................................................... 110, 218-219

G. Guthmann................................................................ 271

M. Helguera.................................................................. 135

T. Honìk........................................................................ 237

D. F. Gutierrez......................................................... 76, 165

B. Hellmuth.................................................... 220, 222-223

S. Honsho..................................................................... 235

L. A. Guzman.................................................................. 74

L. Helman..................................................................... 192

A. Hopkins.................................................................... 132

B. Guzman.................................................................... 137

R. Hemetsberger.......................................................... 100

W. Hopman.......................................................... 135, 163

M. L. Guzzo................................................................... 243

M. Heñin....................................................................... 218

B. Horne....................................................................... 208

M. Gyongyosi....................................................... 100, 110

R. L. Henn............................................................... 76, 143

K. Horoba...................................................................... 171

D. Haag................................................................. 111, 255

R. Henquin.................................................................... 104

E. Horowitz.................................................77-78, 233, 236

R. Habib................................................................ 247, 268

H. S. Henrik................................................................... 141

C. Hossri....................................................................... 240

T. Habon....................................................................... 202

H. D. Henrique D`abreu................................................ 210

J. Hou............................................................................. 73

Authors L. Howes...................................................................... 108

M. Isa............................................................................ 102

H. Jiang......................................................................... 163

H. Hreybe..................................................................... 101

M. E. Isasi Capelo......................................................... 207

X. Jiang......................................................................... 202

K. Hristova.................................................................... 194

J. Isea-P........................................................................ 218

H. Jilaihawi............................................................. 73, 256

V. Hsieh........................................................................ 132

J. Isea-Pérez......................................................... 219, 226

M. Jiménez..................................................................... 69

X. R. Hu......................................................................... 163

M. Ishikawa.................................................................. 175

J. R. Jimeno.................................................................. 217

C. X. Huang................................................................... 163

O. Istratoaie.................................................................. 180

M. Joao......................................................................... 211

S. Huang....................................................................... 135

A. Ithuralde....................................................141, 206, 260

N. Jochmann.................................................................. 75

T. Huang....................................................................... 239

A. Ittig........................................................................... 241

S. Joekes........................................................................ 78

J. Huang....................................................................... 202

S. Ivanov........................................................174, 192, 203

A. John......................................................................... 238

J. Huber........................................................................ 109

L. Ivaskeviciene............................................................ 184

S. O. Johnsen............................................................... 110

Z. Huczek...................................................................... 273

S. A. Ivyanskij................................................................ 210

S. P. Johnsen.................................................................. 79

W. Hueb....................................................................... 191

T. Iwao.......................................................................... 170

B. J. Johnson................................................................ 108

M. Huguet.............................................................. 79, 201

Y. U. A. Izachik...................................................... 174, 192

E. S. Johnson................................................................ 243

J. D. Humphreys................................................... 237, 274

A. Izaguirre.................................................................... 141

O. Johnson................................................................... 178

M. Hunn........................................................................ 216

E. Izcovich..................................................................... 244

A. O. Johnson-Levonas................................................... 75

B. K. Huntley........................................................... 72, 136

A. Izcovich.................................................................... 244

N. Joki........................................................................... 189

J. Hurtado..................................................................... 217

R. Izcovich.................................................................... 244

P. Jolivet....................................................................... 110

P. Huschnir................................................................... 111

V. Jacas........................................................................ 231

L. Joly........................................................................... 110

A. Hussain...................................................................... 69

S. Jacob........................................................................ 103

J. Jones...........................................................73, 107, 143

A. Hussein.................................................................... 277

J. L. B. Jacob................................................................ 213

J. L. Jones.................................................................... 107

A. Hvelplund......................................................... 230, 232

M. H. V. M. Jacob......................................................... 201

V. M. Jonke................................................................... 237

L. Hyeongook............................................................... 272

I. Jadavji........................................................................ 165

C. Jordan.............................................................. 226, 277

G. Iacometti.................................................................. 106

F. Jahan.......................................................................... 73

L. Jorge............................................................74, 253, 269

L. E. Ianhez................................................................... 101

F. Jaimes...................................................................... 139

K. Jose.......................................................................... 211

O. Iavicoli...................................................................... 200

G. Jaimovich.......................................................... 238-239

G. Joseph....................................................................... 77

A. Ibañez....................................................................... 213

R. K. Jain............................................................... 108, 231

X. Jouven...................................................................... 180

J. Ibañez....................................................................... 275

O. Jaksic....................................................................... 231

A. Jovelic...................................................................... 190

S. Ibañez....................................................................... 228

M. M. Jamal...............................72, 79, 102, 106, 111, 273

Z. Jovic......................................................................... 193

A. Ibáñez....................................................................... 239

A. Jamalludin................................................................ 184

L. J. Jovovic.......................................................... 187, 202

J. Igland........................................................................ 133

M. A. James......................................................... 103, 105

S. Jozami..................................71, 225, 242, 244-245, 277

D. Iglesias....................................................................... 77

K. D. James.................................................................. 108

T. Jozic.......................................................................... 187

M. Ignjatovic................................................................. 105

J. Janas......................................................................... 172

J. G. Juárez-Rojas......................................................... 133

K. Ihara.................................................................. 188, 197

Y. Jang.......................................................................... 110

C. Juergens.................................................................. 132

R. Ikegami..................................................................... 249

K. Jankowski................................................................. 251

M. Juliano..................................................................... 268

H. Ilarraza...................................................................... 216

D. R. Janner.................................................................. 201

M. Junco....................................................................... 239

M. Ildizli.......................................................................... 77

P. Jansky.........................................................72, 132, 200

S. M. Jung.................................................................... 179

M. Ilea........................................................................... 245

L. Janssens................................................................... 277

L. Jurado............................................................... 210, 254

S. Ilic..................................................................... 166, 214

A. Januszewicz............................................................. 101

S. H. Jurayeva............................................................... 196

M. Ilic............................................................................ 187

P. Jaramillo........................................................... 163, 227

A. Jussipov................................................................... 174

E. Ilkay.................................................................. 110, 233

C. Jardim.............................................................. 257, 259

N. Kabiri........................................................................ 216

G. Illuminati................................................................... 240

F. S. V. Jardim............................................................... 244

A. Kablak-Ziembicka............. 76, 78, 80, 101, 141, 230, 233

O. Ilyinskaya................................................................. 235

M. R. Järvelin.................................................................. 75

F. Kacmaz............................................................. 110, 233

T. Imiela........................................................................ 273

I. Jashi.......................................................................... 235

K. Kadappu.................................................................... 235

O. C. Imventarza..................................................... 79, 219

I. Jatene.................................................................. 76, 240

J. Kado.......................................................................... 103

T. Inada......................................................................... 271

M. Jatene..................................................................... 263

J. Kadziela..................................................................... 102

B. Inan.......................................................................... 111

P. Y. Jayet..................................................................... 103

L. I. Kafarskaya............................................ 74-75, 104-105

A. Incarbone................................................................. 168

T. Jeerakathil................................................................ 267

P. Kairuz........................................................................ 247

C. Ingino..................................................78, 256, 265, 267

S. Jegere...................................................................... 255

L. Kaklamanis.................................................................. 77

A. Innasimuthu............................................................. 168

M. Jelinek..................................................................... 100

T. Kálai.......................................................................... 202

A. Inocenzi.................................................................... 262

S. Jenkins..................................................................... 108

M. Kalaivani.................................................................. 167

J. Insua......................................................................... 181

A. J. W. Jenney............................................................ 103

A. Kalangos................................................................... 142

D. D. Ionescu................................................................ 180

C. S. Jennings............................................................... 107

C. Kalianos.................................................................... 177

J. Iribarren..................................................................... 190

L. O. Jensen......................................71, 79, 110, 142, 253

R. Kalil................................................................... 231, 233

M. C. Irigoyen.......................74, 76-77, 136-138, 234, 239,

J. Jensen...................................................................... 272

H. Kalinic....................................................................... 254

................................................249, 253-255, 258, 269-270

D. Jeon......................................................................... 110

M. Kalousova................................................................ 200

M. Irurita....................................................................... 183

M. H. Jeong.................................................................. 239

A. Kaltoft................................................................. 79, 110

J. Irurita......................................................................... 183

T. Jezewski................................................................... 222

A. Kalvelis..................................................................... 235

I. M. Irurzun.......................................................... 208, 211

J. Jezewski................................................................... 171

S. Kamal-Bahl.................................................................. 79

Index / 303

Authors U. Kamilova................................................................... 196

I. Keles.......................................................................... 187

A. Kocher...................................................................... 218

E. E. Kanaan.................................................................. 244

J. Kempfert................................................................... 182

P. Kociubinski............................................................... 210

A. Kandra...................................................................... 173

S. Kenan....................................................................... 180

M. Koestering....................................................... 104, 270

J. Kang.......................................................................... 163

M. Kenar............................................................... 102, 189

K. Koh.................................................75-77, 111, 144, 272

W. C. Kang............................................................ 111, 272

N. Kenji......................................................................... 233

N. V. Kokosadze.............................................................. 74

N. Kangola............................................................ 109, 243

B. Kennel...................................................................... 218

C. Kolbitsch................................................................... 173

R. Kanthack................................................................... 268

B. M. Kennelly.............................................................. 100

L. Koldas....................................................................... 233

T. Kapadohos................................................................ 181

C. Kepka....................................................................... 175

S. Kole.......................................................................... 232

M. Kapitan............................................................. 269-270

S. Kerbage.....................................................107, 138, 179

K. Kolodziej................................................................... 222

A. Kaplon...................................................................... 273

N. J. Kertesz................................................................. 206

A. Kolosova................................................................... 175

A. Kapoor....................................................... 110, 250-251

R. Kevorkian.................................................................. 142

G. Kolovou.................................................................... 182

M. K. Kapral.................................................................. 267

A. Kevorkov.................................................................. 196

G. Kolunin............................................................. 183, 202

B. Karadag.................................................................... 187

J. Kezen.................................................136, 215, 220, 223

H. Kominsky................................................................. 168

N. Karadag.................................................................... 187

A. Kezerashvili.............................................................. 270

N. Komiya............................................................. 195, 209

A. Karadzic.................................................................... 169

K. Khairi......................................................................... 184

V. Komoliatova.............................................................. 213

A. Karanfýl.................................................................... 195

R. Khalaky..................................................................... 194

V. N. Komolyatova........................................................ 135

G. Kararigas.................................................................. 204

M. Kharlap.................................................................... 234

D. J. Komorowski................................................. 179, 275

S. Karas......................................................................... 201

G. Khaspekov......................................................... 234-235

M. Kondruweit...................................................... 176, 274

M. Karcz................................................................ 102, 237

N. Khavarian.................................................................. 211

K. Koniari....................................................................... 217

D. Kardara..................................................................... 216

K. A. Khmelnitskaya...................................................... 192

M. Konka.............................................................. 136, 174

P. Karki.......................................................................... 272

H. N. Khong.................................................................. 275

A. Konopka................................................................... 252

M. K. Karlsson............................................................... 168

R. Kiamco....................................................................... 69

I. V. Konopka...........................................219-220, 229, 250

R. Karnik....................................................................... 110

M. Kidawa..................................................................... 222

F. O. Kontari.................................................................. 185

N. A. Karoli.................................................................... 103

M. Kilickap.................................................................... 192

D. Kontogianni.............................................................. 181

H. Karpuz.............................................................. 180, 242

R. Killing................................................................. 212-213

G. Kopec....................................................................... 101

V. Karpuz....................................................................... 242

C. Killinger............................................................. 214, 222

J. Kopec........................................................................ 208

G. Karthikeyan.............................................................. 167

B. Kim................................................................... 235, 239

S. Kopecky.................................................................... 107

M. Karynski................................................................... 251

H. Kim........................................................................... 218

C. Kopp......................................................................... 100

P. Karyofillis.................................................................. 177

M. Kim................................................................... 218-219

A. Koprowski................................................................ 249

E. Kaschina..................................................................... 77

H. S. Kim......................................................................... 79

G. E. Kordosis............................................................... 185

J. C. Kaski...............................................165, 168-169, 213

Y. Kinoshita................................................................... 164

N. Koren-Morag............................................................ 209

R. Kasliwal............................................................. 141-142

A. Kirilmaz..................................................................... 163

M. Koretzky...................................................181, 274, 277

J. Kasprzak..................................................... 170-171, 222

B. Kirilmaz..................................................................... 188

H. Korkes...................................................................... 238

A. Katarzynska.............................................................. 225

S. Kiserud....................................................................... 75

M. E. Korkmaz................................................................ 72

R. E. Katholi.................................................................. 142

Y. Kishi.......................................................................... 188

R. Kornowski........................................................ 110, 178

T. Katic.......................................................................... 231

T. Kishmareia................................................................ 230

V. Korpelainen............................................................... 143

S. Katoh........................................................................ 231

G. Y. N. Kiss.................................................................. 197

M. I. Korsunskaya........................................................... 74

V. Katsi.......................................................................... 217

J. Z. Klafke.......................212-214, 222-223, 227, 261, 265

K. Korybalska................................................................ 225

A. Katsume................................................................... 235

S. Klebs..................................................106, 196, 198, 221

A. Korycka..................................................................... 222

M. Katz......................................................................... 247

T. Kleemann.................................................................. 203

O. Korzh................................................................ 186, 214

A. Kavata............................................................... 172, 185

N. Kleiman.................................................................... 258

C. Kosour...................................................................... 133

N. Kawaguchi................................................................ 175

S. Klein.......................................................................... 166

J. Kostic.......................................................................... 71

H. Kawano.................................................................... 164

F. Klein.............................................................73, 266, 279

J. B. Kostis............................................................ 137, 144

A. Kaya........................................................... 195, 198-199

C. Klein................................................................. 106, 262

M. Kostkiewicz......... 76, 101, 170, 173-174, 182, 185, 193

B. Kaya.......................................................................... 111

C. H. Klein..................................................................... 269

E. Kostova..................................................................... 225

M. Kayikcioglu........................................................ 77, 276

M. Klopotowski..................................................... 136, 237

G. Kotchuev.................................................................. 186

H. Kazerani.................................................................... 212

M. Klosinska................................................................. 188

C. Kotliar........................................................106, 138, 187

K. Kazmi.......................................................................... 73

I. Kloszewska................................................................ 188

K. Kotlinski.................................................................... 171

C. Kchmelnitskaya........................................................ 203

M. Knobel......................................................102, 132, 253

V. Kotowicz................................................................... 189

A. Kearney-Schwartz.................................................... 110

E. Knobel.......................................................102, 132, 253

K. Kotseva.................................................73, 107-108, 143

S. Keavey...................................................................... 177

J. Knopfholz.......................................................... 218, 226

T. Kottke............................................................... 226, 277

B. Keavney...................................................................... 77

Y. Kobayashi................................................................. 239

C. Kouanfack................................................................. 211

E. Keba......................................................................... 187

B. Kobulia...................................................................... 235

S. Koulchitsky............................................................... 176

V. Kecskemeti............................................................... 203

M. Koc.......................................................................... 105

N. Koumallos................................................... 69, 216-217

D. L. Keefe.................................................................... 238

V. Koca.......................................................................... 197

A. P. Kourounakis............................................................ 77

R. Keegan..................................................................... 205

S. A. Kocaman...............................172, 180, 185-186, 190,

P. N. Kourounakis........................................................... 77

H. Kelbaek.......................................................71, 142, 253

........................................................219, 231-232, 278-279

P. A. Koustas................................................................ 185

J. F. Kelendjian...............................................245, 247, 265

E. Koch..................................................................... 73, 75

J. Kovac.................................................................. 73, 256

Authors K. Kovacs...................................................................... 202

F. Kuster....................................................................... 276

E. Lataza....................................................................... 264

G. Kovacs...................................................................... 225

S. Kutkiene................................................................... 237

F. Latif........................................................................... 104

M. Kovaite.................................................................... 184

W. Kuzmicz..................................................................... 80

F. Latiff......................................................................... 104

I. Kowalik...................................................................... 135

V. Kuznetsov......................................................... 183, 202

G. Laufer....................................................................... 173

E. Kowalik............................................................. 109, 171

J. T. Kvaløy............................................................ 135, 199

M. Laule.................................................................. 75, 238

M. Kowalski.......................................................... 109, 171

H. Kwon......................................................... 110, 218-219

R. P. Laurino................................................................. 271

I. Kowatsch................................................................... 179

D. A. Kyle...................................................................... 221

D. Lavaggi..................................................................... 225

M. Kowman.................................................................. 188

R. Kyrillos...................................................................... 278

G. Lavall................................................................. 222-223

F. Kozak................................................................ 134, 225

T. Kyryleva.................................................................... 213

M. Lavalle..................................................................... 168

A. Kozanecki..............................................76, 80, 101, 141

N. L’heureux................................................................. 218

T. Lavergne................................................................... 179

N. Kozarevic.................................................................. 171

G. Labakhua.................................................................. 164

P. L. Lavitola................................................................. 132

B. Koziner..................................................................... 140

I. Labanca..................................................................... 241

R. A. Lawrance............................................................. 165

V. Krämer....................................................... 143, 182-183

J. C. Laborde........................................................... 73, 256

J. Lax.................................................................... 242, 249

S. Krasnokutskiy................................................... 186, 214

S. Lacchini............................................................ 234, 251

A. Laynez...................................................................... 231

O. Krasnova.................................................................. 203

C. Lace.................................................................. 262, 265

S. Laza.......................................................................... 267

J. Krauze....................................................................... 230

N. Lachmann................................................................ 182

G. Lazarevic.................................................................. 276

C. Kreutzer.............................................................. 76, 252

C. D. Lacunza................................................................ 254

M. Lazovic.................................................................... 170

E. M. Krieger..................................101, 234, 249, 260, 270

V. R. Lafayette.............................................................. 255

O. Lazzarín...................................................................... 76

L. Krieger...................................................................... 228

N. Laffaye..................................................................... 200

V. Le............................................................................... 79

J. E. Krieger.......................................................... 193, 251

M. V. Lafuente.............................................................. 264

M. Leacche..................................................................... 73

E. Krieger.............................................................. 193, 251

A. Lagioia...................................................................... 225

M. Leal.......................................................................... 189

D. Krinochkin........................................................ 183, 202

N. Lago......................................................................... 139

D. Lebedev................................................................... 276

S. Krishna...................................................................... 258

M. R. Lago.................................................................... 213

Y. Lecarpentier............................................................. 179

A. Krishnarao........................................................ 138, 212

G. Lago......................................................................... 270

D. Lecic-Tosevski.......................................................... 110

A. Krishnaswamy.......................................................... 242

R. Lagos........................................................................ 215

C. Lecot................................................................. 269-270

J. Kriskovich................................................... 228, 260-261

A. Lagrange.......................................................... 135, 218

P. Ledesma................................................................... 169

G. Krljanac..................................................................... 169

S. Lagudis..................................................................... 253

B. Lee................................................................... 235, 239

G. Krogh........................................................................ 183

R. Laguens.............................................186, 205, 211, 259

E. J. Lee.......................................................................... 79

N. Krstic........................................................................ 170

R. Laiño......................................................................... 241

M. Leeman................................................................... 211

M. Kruk......................................................................... 175

J. Laitinen....................................................................... 75

J. H. Leguizamon.......................................................... 176

H. Kruklis...................................................................... 100

A. Lakowsky..................................................175, 215, 272

J. H. Leguizamón.......................................................... 258

M. Krzeminska-Pakula.................................................. 222

T. Laks.......................................................................... 187

M. Leiner...................................................................... 187

K. Ksiazek..................................................................... 225

N. Lakusic..................................................................... 220

F. Leisch....................................................................... 110

M. Kuchta..................................................................... 137

P. Lal............................................................................. 104

M. F. M. P. Leite........................................................... 256

A. Kuchwaha................................................................. 108

S. Lam.......................................................................... 176

R. Leite......................................................................... 268

K. H. Kuck..................................................................... 103

M. C. Lama........................................................... 205, 262

M. Leite........................................................................ 109

N. Kucukarslan.............................................................. 163

M. F. Lambardi.............................................................. 275

V. A. Leite............................................................. 252, 268

C. Kudrle........................................................227, 237, 274

J. R. Lambertucci.......................................................... 217

A. Lejnieks.................................................................... 235

G. Kuhn................................................................. 258, 260

P. A. Lamothe............................................................... 133

M. Lelek........................................................................ 232

K. Kuiper....................................................................... 247

S. M. Lamy................................................................... 227

M. Lelonek.................................................................... 210

K. Kukula............................................................... 102, 237

F. Lanas.................................................132, 163, 215, 227

T. Lelyavina................................................................... 203

L. Kuller......................................................................... 137

C. Lanas................................................................ 163, 227

M. Lemes..................................................................... 195

H. Kultursay............................................................ 77, 276

M. C. Landermann........................................................ 140

G. Lemke...................................................................... 254

S. Kumar.................................................110, 132, 250-251

F. Landeta......................................186, 205, 207, 211, 236

C. Lemos...................................................................... 138

I. Kumsars..................................................................... 255

I. Lang........................................................................... 110

M. Lengyel.................................................................... 220

A. Kundu....................................................................... 232

M. Lanocha........................................................... 225, 251

A. R. Lenhenbauer-Lüdke............................................. 236

F. Kuniyoshi.................................................................. 107

M. Lanzotti.................................................................... 185

A. Leon......................................................................... 227

S. Kunstmann..................................................75, 107, 137

M. F. Larin............................................................. 237, 274

S. Leon.................................................................. 270-271

B. Kuo........................................................................... 135

J. C. Larosa................................................................... 183

M. Leonardi...................................................103, 242, 265

M. Kura................................................................. 265, 267

M. Larroude.................................................................. 229

C. Leonardi................................................................... 241

E. Kuralay...................................................................... 163

L. Lasave.............................................................. 134, 225

V. Leon-Arguero.................................................... 218, 257

M. Kurpesa................................................................... 222

R. Lasica....................................................................... 187

G. V. Lepore.................................................................. 271

I. Kurt............................................................................ 276

C. Laspiur.............................................................. 246, 248

J. Lesage.............................................................. 135, 218

T. Kurum....................................................................... 182

E. Lasry......................................................................... 209

A. Lescano............................................................ 111, 244

I. Kury Nunes................................................................ 164

M. Lass......................................................................... 103

P. M. Lese.................................................................... 221

P. Kuschnir......................................................... 79-80, 201

O. Lassen..................................................................... 264

M. Lesiak...................................................................... 225

B. Kusmierczyk............................................................. 136

J. F. Lassen................................................71, 79, 142, 253

A. Lesniak-Sobelga..........................78, 174, 182, 185, 233

M. Kusmierczyk............................................................ 109

R. Lasserre................................................................... 243

D. Leung............................................................... 132, 235

Index / 305

Authors E. Lev.................................................................... 110, 178

T. Livieratos.................................................................. 185

L. Lovato....................................................................... 233

G. Lev..............................................78, 110, 143, 188, 193

T. H. Livieratos.............................................................. 185

I. Lovera........................................................................ 237

M. J. Levin............................................................ 209, 250

J. Ljubas............................................................... 104, 245

D. L. Lovic Dragan........................................................ 207

G. Levin........................................................................ 273

G. Llamas-Esperon........................................ 265-266, 268

B. Lovic......................................................................... 251

N. Levitt........................................................................ 196

J. M. Llaneza................................................................. 165

M. Lovic........................................................................ 276

G. Levy......................................................................... 209

S. C. Llois...................................................................... 168

D. Lovic......................................................................... 276

M. Lewandowski...............................................76, 80, 135

C. Llorente............................................................ 213, 239

D. Lovric....................................................................... 230

G. Lewy........................................................................ 243

J. Lloveras...................................................................... 79

D. Lowenstein.............................................................. 142

C. Lezon.......................................................................... 77

S. Lluberas............................................................ 232, 267

R. Lowenstein.............................................................. 208

Q. Li................................................................................ 73

R. Lluberas.................................................................... 270

J. Lowenstein............................................................... 111

J. Li......................................................................... 77, 202

A. C. Lo Prete....................................................... 109, 191

I. Lozano........................................................ 165, 196-197

E. Libhaber............................................................ 203, 230

Q. Lo..................................................................... 132, 235

D. Lozano...................................................................... 214

C. Libhaber................................................................... 230

S. Lo..............................................132, 222, 235, 273, 276

Z. B. Lu......................................................................... 163

A. Lichter...................................................................... 228

M. F. Lobo.................................................................... 241

K. Lu............................................................................. 166

J. Lietava...................................................................... 240

B. Lococo.............................................................. 170, 201

F. Lubenieki.................................................................. 275

C. K. Liew..................................................................... 201

D. Lodi.......................................................................... 275

B. Lubiszewska............................................................. 174

H. B. Liew..................................................................... 201

A. Loera-Pinales............................................................ 265

M. R. Luca.................................................................... 211

G. Ligorio........................................................................ 72

E. Logtens.............................................................. 73, 256

L. Lucas.................................................144, 239, 241, 274

W. K. Lim...................................................................... 104

K. H. Loland.................................................................. 248

A. Lucchini.................................................................... 277

M. C. L. Lim.................................................................. 270

K. H. Løland.......................................................... 142, 243

S. Luchese.................................................................... 109

A. R. R. Lima................................................................. 260

R. Lolo.......................................................................... 214

H. Luciardi......................................................141, 187, 220

J. Lima.................................................................. 110, 217

R. Lombardo................................................................. 218

V. Lucini........................................................................ 209

A. B. R. Lima...........................................191-192, 264, 267

F. Lombi........................................................................ 201

M. Luduena.................................................................. 182

S. Lima.......................................................................... 228

B. Lombo...................................................................... 216

S. Ludueña.................................................................... 240

A. B. Lima.............................................................. 252-254

S. Loncar....................................................................... 182

I. Lugones............................................................... 76, 221

L. Lima..............................77, 110, 140, 210, 233, 236-237

S. Loncaric.................................................................... 254

L. Luis........................................................................... 169

R. S. L. Lima..................................................110, 140, 210

G. Longo....................................................................... 179

M. Lujambio........................................................... 269-270

V. Lima................................................................... 139-140

B. Longo-Mbenza..............................76, 78, 109, 220, 243

I. Luksic........................................................................ 272

A. P. Lima-Leopoldo...................................................... 258

R. Lopes.........................................186, 263, 267-268, 276

A. Luongo..................................................................... 184

D. Lindefjeld................................................................. 109

A. C. Lopes........................................................... 263, 268

S. Lupano...................................................................... 275

S. Lindemberg...................................................... 233, 236

A. A. Lopes................................................................... 263

S. Lupi........................................................................... 189

C. Linden...................................................................... 168

H. F. Lopes................................................................... 260

J. C. Luque-Moscoso.................................................... 248

B. Lindsay..................................................................... 179

M. A. Lopez Verrilli........................................................ 262

A. Luz............................................................................ 191

B. Linetzky............................................................. 137-138

C. Lopez........................... 73, 138, 197, 205, 211, 214, 246

T. Lyle........................................................................... 242

J. M. Linhares............................................................... 234

M. L. Lopez................................................................... 207

S. Lynch........................................................................ 259

K. Linhartova......................................................... 234, 253

L. Lopez.........................................183, 207, 248, 257, 259

B. Lytle......................................................................... 232

K. Linhartová......................................................... 136, 237

M. Lopez................................................................ 270-271

P. Maagh.............................................................. 103, 194

G. Liniado...................................................................... 278

V. A. Lopez.................................................................... 137

L. Mabwa...................................................................... 220

A. Linke................................................................... 73, 182

V. Lopez.......................................................................... 75

A. Macedo...................................................................... 72

F. Lino........................................................................... 267

S. Lopez................................................................ 176, 240

R. Macedo.................................................................... 230

R. H. Lins.............................................................. 220, 222

C. E. Lopez.................................................................... 279

R. Machado...........................................204, 233, 265, 267

A. Liœniak-Sobelga....................................................... 193

D. E. Lopez................................................................... 229

P. Machado..................................................................... 78

S. Liotta........................................................................ 250

J. Lopez................................................................ 183, 204

M. Machado................................................................. 234

M. T. Lioy Lupis............................................................ 223

E. Lopez.........................................................184, 229, 279

F. Machado................................................................... 240

G. Y. H. Lip.................................................................... 217

G. F. López Soutric....................................................... 215

L. Machado................................................................... 251

P. Lipiec........................................................................ 222

A. López........................................................................ 107

L. Machado-H............................................................... 219

A. Lipinska.................................................................... 251

P. Lopez-Jaramillo......................................................... 249

S. A. Machnick.............................................................. 223

E. Lira............................................................................ 238

F. López-Jiménez.......................................................... 107

A. Maciag........................................................................ 76

R. Lirola-Liebanas......................................................... 248

M. Lorenz....................................................................... 75

N. Maciel.............................................................. 133, 266

V. Lisboa....................................................................... 240

G. Lorenzi-Filho............................................................. 270

S. M. Macin..............................................70, 219-220, 271

L. F. Lisboa................................................................... 132

M. Lorenzo........................................................... 273, 276

S. Macin................................................................ 214, 234

V. A. Lischouk............................................................... 255

C. C. Lores.....................................................245, 259, 263

O. Macz........................................................................ 185

A. Lismanis................................................................... 255

M. Losano..................................................................... 242

R. Maczynska............................................................... 136

D. Liszewska-Pfejfer..................................................... 251

L. Lotaif................................................................... 80, 208

H. Madani..................................................................... 216

N. Liu.............................................................................. 75

M. J. Loureiro....................................................... 111, 181

O. Maden...................................................................... 110

Q. Liu............................................................................ 216

C. Lourenco.....................................................79, 101, 132

M. Madsen........................................................... 230, 232

J. Liu............................................................................. 216

C. Lourenço.......................................70, 78, 250, 252, 258

J. K. Madsen......................................................... 230, 232

P. Liva........................................................................... 219

E. Lovaglio.............................................................. 75, 209

C. Mady........................................................................ 136

Authors S. Maeda.............................................................. 188, 197

A. J. Mansur................................................................. 208

J. Martinez.............................................................. 74, 108

M. Maeng..........................................71, 79, 110, 142, 253

J. Manterola.................................................................... 78

F. Martinez...............................................74, 108, 258, 260

H. Maffeo..................................................................... 142

O. Manuale........................................................... 227, 237

R. Martinez................................................................... 197

R. B. Magaldi................................................................ 132

O. D. Manuale....................................................... 133, 274

A. Martinez........................................................... 144, 265

M. Magalhaes............................................................... 137

F. Manzano........................................................... 224, 246

L. Martinez..................................................... 185-186, 194

M. E. C. Magalhaes...................................................... 250

S. Manzolillo................................................................. 260

C. Martinez........................................................... 219, 228

L. B. N. C. Magalhaes................................................... 255

G. Marambio......................................................... 178, 246

M. Martinez.......................................................... 189, 234

E. Magalhães................................................................ 201

R. C. Maranhao..............................109, 180, 191, 255, 263

C. D. Martinez............................................................... 214

M. A. Magalhães........................................................... 102

L. Marani....................................................................... 173

I. Martinez..................................................................... 208

C. Magallanes............................................................... 204

R. Marañon................................................................... 215

N. Martinez................................................................... 231

A. Magd........................................................................ 274

V. Marasa...................................................................... 189

H. Martinez................................................................... 261

R. Maggi....................................................................... 134

V. Marathe............................................................ 195, 232

P. F. Martinez........................................................ 258, 260

S. Maggi....................................................................... 137

V. Maravic..................................................................... 202

J. G. Martínez....................................................... 213, 239

L. Maggio...................................................................... 178

C. C. Marboe................................................................. 104

C. Martínez................................................................... 204

A. P. Maggioni.............................................................. 103

M. Marchel................................................................... 273

N. Martínez-Rodríguez.................................................. 205

R. Magliola............................................................ 221, 255

G. Marchetti.................................................................. 225

L. Martinez-Sande................................................. 180, 194

P. Mahia........................................................................ 252

R. Marchioli................................................................... 209

F. Martin-Herrero.................................................. 218, 257

I. Mahmud.................................................................... 243

M. Marcia..................................................................... 211

L. Martinkovicova..........................................141, 223, 234

P. Mahzoni.................................................................... 216

A. Marco....................................................................... 254

H. F. Martino......................................................... 266, 275

P. Mahzouni.................................................................. 216

M. S. Marcolino.............................................................. 74

R. Martins............................................................. 204, 258

J. Maia.................................................................. 259, 261

F. K. Marcondes............................................................ 258

S. M. Martins........................................................ 227, 247

F. Maia.......................................................................... 198

F. Marconetto....................................................... 246, 248

V. M. Martins................................................................ 106

L. Maia.......................................................................... 254

M. A. Marcozzi.............................................................. 274

S. Martins............................................................. 141, 240

A. Maiato...................................................................... 108

R. Marelli.................................183, 189-190, 197, 214-215

V. Martire............................................................... 184-185

G. Maid.......................... 185, 195, 210, 239, 241, 264, 271

D. Marelli...................................................................... 214

B. Martire...................................................................... 172

R. Maier........................................................................ 225

R. Marenchino...................................................... 244, 247

C. Martorano................................................................. 243

A. Maiorana.................................................................. 108

R. Marfisi...................................................................... 209

M. P. Marturano...............................................73, 100, 279

O. H. Majane................................................................. 230

L. Mari.................................................................... 78, 102

E. Marum.............................................................. 144, 225

M. Majsec..................................................................... 220

J. Mariani................................................................ 78, 100

E. Marusic..................................................................... 137

C. R. Majul.................................................................... 133

P. Marichal.................................................................... 269

R. Marzoa-Rivas............................................................ 198

L. Makarov.................................................................... 213

P. Y. Marie.................................................................... 110

C. Mascheroni.............................................................. 263

M. Makdisse......................................................... 102, 132

E. Marijon............................................................. 103, 180

M. J. Maseko................................................................ 230

S. Makhoul.................................................................... 227

F. Marín........................................................................ 217

G. Masina..................................................................... 175

D. Makowiec................................................................ 249

P. Marinho.................................................................... 257

M. Masotti...................................................................... 69

M. Makowiecka-Ciesla................................................. 101

J. A. T. Marinho............................................................ 267

R. Massa....................................................................... 188

A. Malan....................................................................... 185

A. Marini....................................................................... 218

J. Massa....................................................................... 188

G. Maldonado........................................................ 256-259

J. Marinkovic................................................................ 182

J. Massaro...................................................................... 73

L. Malek........................................................................ 237

K. Marinou....................................................... 69, 216-217

H. Massetti................................................................... 181

M. Maletin.................................................................... 183

A. L. C. Marins.............................................................. 250

W. M. Masson.............................................................. 183

C. Malfitano.................................................................. 239

I. A. Markelova.............................................................. 210

L. Mastrocolla........................................................ 110-111

A. F Malheiros............................................................... 267

M. Markman................................................................. 241

F. Mastrogiacomo................................................. 242, 249

A. Mallouhi.................................................................... 173

B. Markman-Filho......................................................... 241

M. O. Masuda............................................................... 245

J. Maloney............................................................ 185, 205

V. Marmol..................................................................... 256

I. Masuda.............................................................. 190, 227

E. Malpica-Miranda....................................................... 205

M. Marona.................................................................... 252

M. Masuelli................................................................... 217

M. Maly........................................................................ 223

E. Marques..................................................................... 72

P. Matafome......................................................... 100, 269

G. Mamaladze............................................................... 230

C. Marques................................................................... 247

R. S. Math..................................................................... 167

S. C. Manchanda........................................................... 140

I. Marques.................................................................... 229

A. Mathavan................................................................. 138

D. M. Mancini............................................................... 104

A. Marques................................................................... 250

N. Mathew.................................................................... 167

L. Mancini..................................................................... 214

S. A. G. Marques.......................................................... 213

W. Mathias Jr....................................................... 111, 179

C. A. Mandarim-De-Lacerda.................................. 198, 202

N. Marquez................................................................... 247

C. Mathieu.............................................................. 75, 103

N. Mangani......................................................78, 102, 189

H. Marrero.................................................................... 183

G. Matic...........................................................74, 105, 169

A. Manginas.................................................................. 177

G. Marrero.................................................................... 207

M. Matic....................................................................... 187

J. Manica...................................................................... 109

F. Marrero-Rodriguez............................................ 167, 213

I. Matko........................................................................ 203

F. Maniero............................................................ 109, 243

N. A. Marsan................................................................. 136

A. Matonia.................................................................... 171

V. G. Manolopoulos........................................................ 77

M. Martin...................................................................... 165

L. Matos....................................................................... 220

L. Manriquez............................................................. 73, 75

F. L. Martin......................................................72, 108, 136

H. Matsubara................................................................ 235

V. Mansilla.................................................................... 275

A. Martín....................................................................... 210

A. Matsui...................................................................... 235

J. Mansur...............................................136, 208, 215, 220

C. Martinengo............................................................... 210

U. Matte....................................................................... 233

Index / 307

Authors P. G. Mattingly...................................................... 172, 185

C. Mendoza.......................................................... 107, 219

L. Miranda-Peats........................................................... 141

A. Mattioli..................................................................... 275

L. Mendoza................................................................... 271

J. Mirat......................................................................... 220

G. Mattioli..................................................................... 275

R. Meneghelo.........................................110-111, 240, 268

R. Miret......................................................................... 168

M. J. Mattioli................................................................. 183

A. Meneghin I............................................................... 245

R. N. Mishra.................................................................. 251

V. Mattos...................................................................... 234

H. Menezes.................................................................. 109

S. Mishra.............................................................. 140, 164

L. A. Mattos.................................................................. 198

E. Mengual.................................................... 247-248, 263

J. Misiura...................................................................... 210

V. Z. Mattos.................................................................. 250

D. Mentzikof................................................................. 216

P. Mitro......................................................................... 257

R. Matunovic................................................................ 193

R. Merbilhaa................................................................. 102

P. Mitrovic...............................................74, 105, 169, 278

M. Matyjaszczyk........................................................... 210

E. Merilind.................................................................... 187

S. I. Miura..................................................................... 181

S. K. Maulik................................................................... 140

P. Merlo........................................................................ 204

A. M. K. Miyadahira...................................................... 245

S. Mavrogeni................................................................ 182

I. Merlo......................................................................... 207

S. Möbius-Winkler.......................................................... 73

R. Max................................................................... 222-223

A. Mesples..................................................................... 80

A. O. Mocumbi............................................................. 180

T. Maximova................................................................. 203

E. Mesquita...........................191, 201, 229, 238, 260, 263

J. Modenesi.................................................................. 217

S. Maybaum................................................................. 270

E. T. Mesquita.................219, 233-234, 236, 253, 262, 270

P. Moffa.......................................................................... 72

O. Mayer............................................................... 166, 173

K. Messlinger................................................................ 176

G. Mohamed................................................................. 214

R. Mayer....................................................................... 179

P. Meszaros.................................................................. 183

N. Mohammadifard....................................................... 211

M. Mayer............................................................... 273-274

D. Metras...................................................................... 241

A. Mohan...................................................................... 103

O. Mayer Jr................................................................... 166

V. Mezzalira.......................................................74, 80, 111

J. Mohan......................................................................... 79

G. Mazina...................................................................... 175

D. Mezzano................................................................... 109

F. Mohr........................................................................... 73

J. Mazucco....................................................134, 170, 212

J. Miano........................................................................ 140

O. Moiseeva......................................................... 204, 274

C. Mazza....................................................................... 240

R. M. Miatello....................................................... 205, 262

V. Moitra....................................................................... 176

G. Mazzini..................................................................... 233

V. Micevski................................................................... 104

E. E. Mola............................................................. 208, 211

P. Mbuilu........................................................................ 78

L. Michea...................................................................... 137

J. C. Molina............................................................. 75, 107

F. McAlister.................................................................. 229

J. B. Michel................................................................... 139

J. Moll................................................................... 229, 272

T. McAllister................................................................. 218

O. Midttun............................................................ 249, 251

R. A. Moller....................................................108, 241, 243

M. McConnell............................................................... 242

Z. Mijailovic................................................................... 193

T. Möller............................................................... 103, 223

N. McHado..................................................................... 74

N. Mijailovsky............................................................... 214

P. Mollon...........................................76, 78, 110, 143, 165

E. McKay...................................................................... 179

D. Mijalkovic................................................................. 276

A. Mollon.............................................................. 188, 193

J. McMillan................................................................... 135

E. Mikhaylov................................................................. 276

F. P. Mollon............................................................. 76, 165

A. Mead...........................................................73, 107, 143

R. Milani................................................................ 135, 208

G. Molon......................................................................... 72

A. Meave...................................................................... 133

L. Milani.......................................................................... 70

V. Moltchanov............................................................... 231

P. Medeiros.......................................................... 220, 222

S. Milanov..................................................................... 194

S. Molteni..................................................................... 278

A. Medeiros.......................................................... 136, 240

D. Milic......................................................................... 170

H. Mon............................................................................ 76

C. Medeiros.......................................................... 141, 227

D. Milicic........................................................104, 230, 245

M. Mongitore................................................................ 201

L. Medesani................................................... 206-207, 259

C. Militaru..................................................................... 180

Z. Monhart.......................................................72, 132, 200

M. Medina.................................................................... 168

J. G. Mill........................................................................ 263

A. Monney.............................................................. 75, 103

G. Medina..................................................................... 219

G. Millet........................................................................ 138

O. Montaña........................................................... 111, 138

M. Medvegy..........................164, 199, 203, 208, 224, 238

M. Milli............................................................................ 70

S. Monte....................................................................... 103

R. S. Meena.......................................................... 108, 231

J. Mills.......................................................................... 177

R. Montecchiesi............................................................ 274

A. Mehra......................................................................... 69

V. Milman..................................................................... 196

S. Monteiro...........................70, 78-79, 100-101, 132, 204,

A. B. Mehta................................................................... 132

C. Miloro....................................................................... 275

............................... 250, 252, 254-256, 258, 260, 263, 269

O. Meilhac.................................................................... 139

P. Milosavljevic............................................................. 166

P. Monteiro...........................70, 78-79, 100-101, 132, 250,

F. Meiller....................................................................... 195

A. Milosevic.................................................................. 169

S. Meiners.................................................................... 140

P. Min............................................................ 110, 218-219

A. Meissner...................................................103, 194, 245

R. Minardi..................................................................... 262

H. Mejias...................................................................... 190

M. Minelli...................................................................... 171

S. Melamed.................................................................. 163

G. S. Mintz.................................................................... 142

A. Mele......................................................................... 210

M. Miragaya.................................................................. 204

R. Melendez................................................................. 218

G. Miramont....................................................74, 211, 241

P. Mello........................................................................ 138

C. Miranda.......................................78, 244, 256, 266, 273

A. P. Q. Mello....................................................... 263, 265

V. Miranda.................................................................... 191

C. S. Melo..................................................................... 244

R. Miranda.................................................................... 181

P. Melor........................................................................ 184

C. S. Miranda..................................191-192, 254, 264, 267

J. Meltzer...................................................................... 176

I. Miranda...................................................................... 209

R. H. Mendes.................................................253, 258, 269

A. Miranda.....................................................175, 259, 272

R. J. Mendez..................................................220, 229, 250

S. Miranda..............................191-192, 254, 264, 267, 269

O. A. Mendiz................................................................... 76

R. D. Miranda................................................................ 255

L. Mendonça................................................................. 229

J. J. Miranda......................................................... 137, 164

.......................................252, 254-256, 258, 260, 263, 269 G. Monteiro.................................................................. 110 S. Montenegro.............................................................. 241 I. Montero..................................................................... 107 A. Montero-Gómez....................................................... 107 C. Montes....................................................................... 76 M. Monteverde............................................................. 250 P. Montoya.................................................... 206-207, 259 H. Moon........................................................................ 218 C. I. Moon............................................................. 111, 272 J. Moon................................................................ 141, 234 J. Mor........................................................................... 216 L. Moraes......................................................244, 247, 268 V. Moraes..................................................................... 205 A. P. Moraes................................................................. 253 R. S. Moraes......................................................... 106, 138

Authors N. Moraes..................................................................... 176

M. S. Moysés Szklo...................................................... 232

A. B. Nargizyan............................................................. 136

M. Moraes.................................................................... 109

I. Mrdovic...................................................................... 187

B. Naronha.................................................................... 168

E. R. F. L. Moraes......................................................... 244

F. B. Muccillo................................................................ 275

J. Narula........................................................................ 141

J. Morais................................................................ 264-266

D. Mugnai..................................................................... 142

O. Nasario-Junior.......................................................... 244

M. Morais............................................................. 109, 134

M. L. O. Mugnaini......................................................... 254

P. Nasca........................................................................ 271

M. A. Morales Lezica............................................ 220, 239

M. F. Muiño.................................................................. 234

D. D. Nascimento......................................................... 244

C. Morales............................................................. 227-228

E. K. Mulholland............................................................ 103

F. F. Nascimento................................................... 227, 256

B. Morales.................................................................... 272

R. E. Müller................................................................... 227

C. A. S. Nascimento....................................... 252-253, 266

G. Moratalla-Cecilia....................................................... 248

R. Müller....................................................................... 256

B. C. G. Nascimento............................................. 172, 180

S. K. Morcos................................................................. 141

M. A. Müller.................................................................. 106

J. H. M. Nascimento............................................. 245, 263

G. Moré.......................................................................... 74

J. Müller........................................................................ 274

A. L. R Nascimento....................................................... 198

D. Moreira...................................76-77, 110, 247, 249, 268

H. Mun.......................................................................... 219

C. Nascimento.............................................................. 102

E. D. Moreira...................................................... 76-77, 249

K. Munakata.................................................................. 175

F. Nascimento...............................................227, 256, 259

R. B. Moreira................................................................. 253

A. Muniz............................................................... 132, 269

T. R. Nasibullin.............................................................. 236

L. F. Moreira................................................................. 237

A. Muñoz...................................................................... 183

J. Nasser....................................................................... 254

P. Moreira............................................................. 108, 278

M. C. Muñoz................................................................. 256

A. Natália...................................................................... 250

A. Moreira.............................................................. 257-259

R. Munoz-Sandoval....................................................... 265

R. Nauwerk................................................................... 237

L. B. Moreira....................................................76, 106, 143

N. Murad....................................................................... 245

A. Nava......................................................................... 271

M. B. Moreira........................................................ 106, 143

N. Murai................................................................ 188, 197

M. Navarrete................................................................. 205

C. M. Moreira................................................................ 106

C. Muratore...................................................185, 205, 277

V. Navarro..................................................................... 217

E. Moreira............................................................. 137, 269

P. Murray........................................................................ 73

C. Navas....................................................................... 139

L. Moreira..................................................................... 108

A. Muryan..................................................................... 201

V. Navega..................................................................... 263

R. C. Moreira......................................................... 139, 184

A. Musacchio.................................................................. 78

D. Navia........................................................................ 142

J. Moreno..................................................................... 244

P. Musialek........................................78, 80, 141, 230, 233

E. Navia...................................106-107, 201, 208, 236, 238

C. Moreno..................................................................... 241

L. Music........................................................................ 167

H. Nawawi............................................................ 133, 201

M. Moreno.......................................................75, 137, 241

B. Musser............................................................... 75, 166

J. Nayee.......................................................................... 75

G. Moreno.............................................111, 221, 226, 255

O. E. Mustafina............................................................. 236

C. Nazzal....................................................................... 132

H. Moreno-Filho............................................................ 270

R. Mvungi..................................................................... 235

I. Nedeljkovic................................................. 110, 277-278

A. Moreyra...................................................................... 69

B. Myasnik.................................................................... 196

M. Nedeljkovic..................................71, 110, 142, 277-278

A. E. Moreyra........................................................ 142, 144

J. Myszor...................................................................... 230

J. A. Neder.................................................................... 187

S. Morhy..................................................79, 224, 238, 253

G. Naccarato........................................................... 79, 224

S. Nedogoda................................................................. 175

A. T. Morikawa.............................................................. 255

J. H. M. Nacimento....................................................... 259

C. E. Negrao...................................................172, 180, 192

D. Morillo...................................................................... 176

J. Nadal......................................................................... 244

C. E. Negrão.................................................................. 138

P. Moriña...................................................................... 209

M. Nadal....................................................................... 231

C. Negrier...............................................255-256, 260, 263

C. Moris........................................................................ 165

S. Nadeem.................................................................... 270

J. Negroni..................................................................... 266

C. Morís................................................................. 196-197

B. Nadinic..................................................................... 217

M. J. Nel....................................................................... 203

T. Morishima................................................................. 167

C. Nagaoka.............................................243-244, 247, 265

K. Nelson........................................................................ 78

D. Morisse................................................80, 229, 242-244

Y. Nagayoshi................................................................. 164

R. Neme................................................................. 69, 132

L. A. Morita.................................................... 222-223, 229

C. Nagel........................................................................ 246

A. Neno......................................................................... 215

M. Moroi..........................................................70, 185, 189

M. Nahin....................................................................... 197

R. Nery.......................................................................... 243

S. Mortaloni...........................................107, 222, 240, 251

G. Naiman......................................................111, 221, 255

I. Nesralla..........................................77, 231, 233, 236-237

G. Moscardi.................................................................. 110

S. Najarian..................................................................... 142

A. Neto................................................................. 231, 254

F. Mosele...................................................................... 236

J. Najjar......................................................................... 103

R. Neto-Ferreira............................................................ 198

A. Moser....................................................................... 226

Y. Naka......................................................................... 104

W. Neuhuber................................................................ 176

C. Mostarda..........76-77, 137-138, 239, 249, 253-254, 269

S. Nakayama................................................................. 164

A. Neujahr..................................................................... 175

P. Mota.......................................................... 139-140, 257

M. Nakayama................................................................ 167

J. Neumann.................................................................. 166

A. Mota......................................................................... 186

R. Nakazato......................................................70, 185, 189

J. Neuwirth....................................................141, 223, 234

D. Motta.................................106-107, 201, 208, 236, 238

K. Nakiri........................................................................ 271

F. Neves................................................................. 76, 108

A. Mouly-Bandini.......................................................... 241

M. Nallar....................................................................... 225

P. Neves............................................................... 183, 273

J. Mountaner................................................................ 220

S. Nanfara..................................................................... 218

J. L. Neyeloff................................................................ 106

S. Moura....................................................................... 213

A. Nanhay..................................................................... 172

D. Nezic........................................................................ 167

L. A. Z. Moura............................................................... 254

A. D. Nanney................................................................. 212

Q. N. Ngoc.................................................................... 275

J. Mouras...................................................................... 139

N. Napoli....................................................................... 189

H. Ngow....................................................................... 184

M. Moutinho................................................................. 191

R. Narang...................................................................... 103

H. L. Nguyen......................................................... 143, 275

M. R. Movahed.................. 72, 79, 102, 106, 111, 144, 273

A. Naranjo..................................................................... 174

Q. N. Nguyen................................................................ 143

M. Moya....................................................................... 205

I. Narbute...................................................................... 255

V. L. Nguyen......................................................... 143, 275

E. Moya........................................................................ 168

J. Nardi......................................................................... 190

H. M. Nguyen............................................................... 275

A. Moyano.................................................................... 173

N. Nardi......................................................................... 231

Z. Ni.............................................................................. 141

Index / 309

Authors P. Nicod.......................................................................... 75

V. Obradovic................................................................. 171

H. Olschewski.............................................................. 225

G. Nicolaidis.................................................................. 233

R. Obregon....................................................134, 170, 212

K. A. Olson............................................................ 138, 212

C. Nicoletti.................................................................... 134

S. Obregon........................................................... 106, 138

J. Olszewski................................................................. 273

L. Nicoloso.................................................................... 109

M. Ocaranza....................................................77, 137, 224

M. Olszowska........................................170, 173, 185, 193

V. Nieto......................................................................... 183

J. Ochoa....................................................................... 141

M. Olteanu.................................................................... 106

A. Nigam....................................................................... 197

R. Ochotny.................................................................... 251

A. Omer........................................................................ 270

S. Niki................................................................... 188, 197

M. Odaira...................................................................... 167

A. Oncul................................................................ 106, 191

N. Nikolaou................................................................... 181

G. O’Driscoll................................................................. 108

T. K. Ong....................................................................... 201

L. Nikolic....................................................................... 166

H. Ogawa...................................................................... 164

Z. Ongen....................................................................... 187

A. Nikolic............................................................... 187, 202

H. Oh............................................................................ 192

G. A. Ontiveros..................................................... 100, 279

D. Nikolic...................................................................... 187

B. Oh................................................................. 75-77, 144

R. Onut......................................................................... 200

A. Nikolopoulou............................................................ 217

N. Okasha..................................................................... 274

T. Ooie.......................................................................... 170

D. T. W. Nilsen...................................................... 178, 199

M. Okigaki.................................................................... 235

J. A. W. Opezzo............................................................ 273

S. T. Nilsen................................................75, 206-207, 209

K. Okoshi.............................................................. 258, 260

G. Opolski..................................................................... 273

Y. Nisanci.............................................................. 106, 191

M. P. Okoshi......................................................... 258, 260

J. Oporto....................................................................... 109

S. Nishikawa................................................................. 235

J. Olagüe.............................................................. 213, 239

K. Orban........................................................................ 134

M. Nishizaki.......................................................... 188, 197

T. Olcer......................................................................... 110

G. Ordoñez................................................................... 144

W. Nishizawa................................................................ 277

F. O. Olejnik.................................................................. 217

S. Ordu.................................................................. 198-199

L. Njord......................................................................... 255

J. Olin........................................................................... 111

M. Orellana................................................................... 206

R. Njord......................................................................... 255

I. Olina.......................................................................... 255

V. Orellana.................................................................... 254

F. Nobre........................................................................ 254

S. Olival...................................................252, 259-260, 262

L. Orellana.................................................................... 182

A. Nobrega................................76, 108, 137-138, 258, 278

A. Olive......................................................................... 178

R. Oren......................................................................... 163

I. Nocetti....................................................................... 204

S. A. Oliveira Júnior...................................................... 258

D. Orlandi.............................................................. 263, 268

R. Noe............................................................................. 71

A. M. R. R. Oliveira....................................................... 267

D. Orlic.................................................................... 71, 142

M. Nofal........................................................................ 189

A. Oliveira........................ 79, 193, 224, 233, 238, 258, 260

D. Ortega.............................................................. 102, 189

G. Nogiene.................................................................... 184

F. M. F. Oliveira............................................................ 240

D. F. Ortega.................................................................... 78

F. Nogueira................................................................... 220

I. S. Oliveira................................................................... 275

F. Ortega......................................................................... 78

C. R. Nogueira............................................................... 260

L. Z. P. Oliveira............................................... 243-247, 265

Y. R. Ortega.................................................................. 164

P. Nogueira............................................................. 79, 267

P. P. M. Oliveira.................................................... 133, 166

R. Ortego...................................................................... 218

M. Nogues.................................................................... 244

V. Oliveira..............................................102, 193, 236, 243

J. Ortellado................................................................... 237

C. Nojec........................................................................ 141

G. Oliveira......................................................106, 215, 262

C. Ortiz.......................................................................... 168

M. B. Nolly.................................................................... 140

T. V. Oliveira.................................................................. 243

L. Ose............................................................................. 75

C. H. Nomura................................................................ 224

C. P. Oliveira................................................................. 198

J. Oses......................................................................... 278

S. Noorfaizan................................................................ 184

N. Oliveira..................................................................... 213

A. Osório....................................................................... 179

M. Nordaby................................................................... 181

F. Oliveira.......................................................132, 191, 240

D. Ostera...................................................................... 240

J. E. Nordrehaug......133, 142-143, 243, 247-249, 251, 272

S. A. Oliveira..........................................193, 238, 258, 260

J. Ostermeyer............................................................... 103

T. Norgaz...................................................................... 186

P. S. Oliveira......................................................... 262, 275

M. Ostojic........... 71, 74, 105, 110, 142, 171, 182, 277-278

L. Noronha.................................................................... 176

E. Oliveira..................................................................... 240

R. K. Osugue................................................................. 253

G. R. Norton.................................................................. 230

M. Oliveira...... 111, 133, 166, 186, 218, 227, 267-269, 276

M. Oteh........................................................................ 184

A. Novakovic................................................................. 167

C. Oliveira..................................................................... 236

F. Otero........................................................................ 227

L. P. Novaretto.............................................................. 189

J. L. M. Oliveira............................................................. 111

J. Otero......................................................................... 207

F. Novo............................................................72, 200, 226

S. Oliveira......................................................176, 262, 275

D. Ott............................................................................ 231

G. Novo......................................................................... 106

F. T. Oliveira.................................................................. 250

G. Ottaviano.................................................................. 106

S. Novo......................................................................... 106

I. Oliveira....................................................................... 253

K. Otter......................................................................... 187

L. Novotny.................................................................... 200

S. A. Oliveira Jr............................................................. 260

R. S. Ovchinnikov.......................................................... 255

M. Nowak..................................................................... 232

W. Oliveira Jr................................................................ 141

C. Oviedo...................................................................... 240

J. U. Nowak.................................................................. 238

W. A. Oliveira.......................................................... 79, 224

D. Oz............................................................................. 186

E. Nowicki..................................................................... 232

S. A. Oliveira..........................................193, 238, 258, 260

B. Oz............................................................................. 163

N. Nranyan.................................................................... 136

V. F. Oliveira.................................................................. 132

E. Ozal.......................................................................... 163

L. Ntyintyane................................................................ 107

C. L. Oliveira................................................................. 234

E. Ozcinar..................................................................... 111

R. B. Nunes..................................................................... 74

A. L. V. Oliveira..................................................... 193, 236

A. O. Ozdemir............................................................... 192

M. C. P. Nunes............................................................... 74

F. M. Oliveira................................................................ 227

O. Ozdemir........................................................... 192, 233

B. Nuñez....................................................................... 226

P. S. Oliveira......................................................... 262, 275

M. Ozdemir................................................................... 279

B. Nuta.......................................................................... 103

G. D. Olivera................................................................. 271

O. Ozer................................................................. 171, 211

O. Nygard............................................................. 249, 251

P. Olivier....................................................................... 110

F. Ozerkan.................................................................... 188

O. Nygård......................................................133, 142, 247

G. Oller......................................................................... 201

H. Ozhan....................................................................... 198

D. Nyhan......................................................................... 77

J. Ollitrault...................................................................... 80

H. Özhan....................................................................... 199

V. Nzuzi......................................................................... 220

J. C. Olmos............................................................. 69, 265

J. Ozores...................................................................... 177

Authors U. Ozyurda.................................................................... 111

E. Parra......................................................................... 190

C. Pellegrini................................................................... 100

G. Pacheco............................................................. 78, 102

R. Parra......................................................................... 207

G. M. M. Pellegrino..........................................78, 102, 189

N. Pacheco........................................................... 216, 270

J. Parras.........................................134, 170, 212, 215, 260

M. P. Pellini........................................................... 110, 210

A. Pacheco.................................................................... 215

C. Parsai........................................................................ 254

M. Pelliza...................................................................... 204

O. Pachinger................................................................. 173

W. Partata..................................................................... 236

R. Peloso...............................................134, 170, 212, 260

L. Padilla.........................................132, 225, 242, 244-245

O. Parysow................................................................... 261

G. Peltz......................................................................... 225

C. R. Padovani............................................................... 258

A. Pasca........................................................................ 227

H. P. M. Pena................................................................ 228

A. F. Padoveze.............................................................. 243

A. Pascua...................................................................... 227

M. Peña........................................................................ 272

T. Paes.................................................................. 263, 268

C. Pasinato.....................................................248, 257, 259

M. A. Peña-Duque........................................................ 205

J. Paes Jr............................................................... 264-266

M. Pasowicz..................................................101, 173, 193

E. Peñaloza................................................................... 140

Z. Pagava...................................................................... 230

M. Pasquale.................................................................. 178

G. Peñaloza................................................................... 111

N. Paglia........................................................................ 138

O. Passarelli Jr........................................................ 80, 208

F. Penhalves................................................................. 186

P. Paglini....................................................................... 222

M. Passauer.................................................................. 195

C. Pensa............................................................... 192, 210

P. Paglini-Oliva.............................................................. 276

R. B. D. Passos............................................................. 224

M. Peradejordi...................................................... 259, 267

J. Paiva......................................................................... 134

T. Patel.......................................................................... 132

M. Perazzoli.................................................................. 137

W. Paiva................................................................ 262, 265

M. Patricio.................................................................... 144

I. Perdomo.................................................................... 168

L. Pál............................................................................. 220

L. Patrucco.................................................................... 229

M. Perea....................................................................... 267

C. Paladino.................................................................... 189

A. L. Patsilinakos........................................................... 185

F. Pereda...................................................................... 190

C. Palaniswamy............................................................ 103

S. Patsilinakos............................................................... 177

L. Pereira.............................................................. 226, 229

A. Palazzo..................................................................... 219

C. Patterson.......................................................... 138, 225

R. Pereira.......................................................213, 222, 244

P. Palazzolo................................................................... 106

J. Paul........................................................................... 211

S. B. Pereira.................................................................. 253

M. Palinsky................................................................... 257

J. Paulini.......................................................74, 76-77, 137

A. M. R. Pereira.................................................... 213, 222

J. Palleiro...................................................................... 228

B. Pausa........................................................................ 232

J. R. M. Pereira...................................................... 252-253

J. A. Palma.................................................................... 205

E. Pautasso........................................................... 181, 274

J. B. Pereira.................................................................. 110

M. Palmeira.................................................................. 195

R. Pavanello.................................................................. 256

T. Pereira...................................................................... 204

T. Palomero.................................................................. 104

L. J. Pavelic................................................................... 220

A. C. Pereira.......................................................... 193, 236

S. A. P. Palomino.......................................................... 249

G. Pavlides.................................................................... 177

G. Pereiro...................................................................... 227

G. Paluzie...................................................................... 188

M. Pavlovic................................................................... 170

V. Pereyra..................................................................... 254

G. Paluzuie.................................................................... 188

K. Pavlovic.................................................................... 183

H. Pereyra..................................................................... 201

A. Panaro.............................................................. 111, 201

S. Pavlovic.................................................................... 171

E. Perez........................................................................ 244

O. Panes....................................................................... 109

N. Pavo......................................................................... 100

R. Perez.................................178, 195, 204, 215, 228, 241

G. Panic........................................................................ 190

I. Pavo Jr....................................................................... 100

H. Perez........................................................................ 267

C. F. Paniga................................................................... 212

R. Paya.......................................................................... 231

A. Perez.............................................................73, 75, 179

T. F. Panigas.....212-214, 221-223, 227, 261, 265-266, 269

W. R. Payne.................................................................. 164

N. Perez.........................................133, 139, 188, 240, 266

C. F. Panigas............212-214, 222-223, 227, 261, 266, 269

S. Payzin......................................................................... 77

J. Perez......................................................................... 231

J. Panini........................................................................ 181

N. Paz........................................................................... 189

M. Perez............................................................... 178, 219

A. A. V. Paola................................................................ 249

A. F. S. Paz.................................................................... 265

R. Pérez........................................................................ 191

F. Paoletti...................................................................... 185

K. Peczalski................................................................... 252

A. Perez-Bueno..................................................... 218, 257

J. F. Paolini...................................................................... 75

E. R. Pedersen...............................................247, 249, 251

R. Perez-Etchepare....................................................... 264

A. Papadopoulos........................................................... 222

K. E. Pedersen.............................................................. 110

N. Pérez-Hernández...................................................... 204

E. Papadopoulou........................................................... 182

L. Pedersen............................................................ 79, 110

M. Peric........................................................................ 167

T. Papafanis.................................................................. 181

E. R. Pedersen...............................................247, 249, 251

M. Perin........................................................................ 102

N. Papageorgiou........................................................... 216

S. F. Pedra...................................................................... 76

C. A. Perings......................................................... 103, 194

A. Papantoniou............................................................. 220

S. Pedrosa.................................................................... 137

M. Peris........................................................................ 225

A. Paragano.................................................................. 204

R. C. Pedrosa................................................................ 140

Z. Perisic....................................................................... 170

A. C. Parameswaran............................................. 166, 172

N. Peer.......................................................................... 196

E. Perna...........................................70, 105, 215, 271, 273

V. Paravati..................................................................... 240

K. Peersen............................................................ 103, 223

D. Peroni....................................................................... 176

E. Pardes...................................................................... 189

J. Pei............................................................................... 73

A. Perrone..................................................................... 229

E. Pardo........................................................................ 274

F. Peidro....................................................................... 208

B. Pertiné........................................................................ 80

O. Paredes.......................................69, 258, 260, 265, 271

J. Peirano...................................................................... 207

J. Z. Peruga................................................................... 222

J. Paredes..................................................................... 256

L. Peixoto........................................................................ 72

J. Perunicic................................................................... 187

M. Paredes............................................................... 73, 75

R. Peixoto..................................................................... 143

A. Pesantes.................................................................. 267

D. Pareira...................................................................... 267

W. Peixoto.................................................................... 267

C. Pesce......................................................................... 77

K. Parikh........................................................................ 132

C. Peixoto..................................................................... 184

G. Pessah............................................................. 241, 260

C. Parisi........................................................................... 70

N. Pejcic........................................................................ 105

L. Pessoa.............................................................. 260, 263

C. E. Parisi..................................................................... 136

E. Pektok...................................................................... 142

A. B. Pestova........................................................ 174, 192

J. L. Parmisano............................................................. 248

L. Pellanda.....................................................231, 272, 275

M. Peterson.................................................................. 187

J. C. Parodi............................................................. 253-254

F. Pellegrini................................................................... 103

M. Petit................................................................... 79, 201

Index / 311

Authors R. Petkowics................................................................. 275

S. Pipitone.................................................................... 106

V. Porto............................................................77, 233, 236

Ö. Petnehazy................................................................ 100

J. L. C. Pippi...................................212, 214, 223, 261, 269

A. Posa......................................................................... 100

M. R. Petracek................................................................ 73

M. Piraino..................................................................... 100

J. Postley.........................................................73, 137, 179

Z. Petrasi....................................................................... 100

P. V. Pires..................................................................... 253

M. Potenzoni................................................................ 239

Z. Petrasinovic...................................................... 171, 277

J. Pirkola......................................................................... 75

S. Potic......................................................................... 105

J. Petriz..........................................................229, 250, 272

O. Pisano....................................................... 189-190, 215

R. Potluri....................................................................... 256

F. Petrolito.................................................................... 259

D. Pisano........................................................................ 79

L. Potocnakova............................................................. 137

D. Petrov....................................................................... 194

A. Pisarevsky................................................................ 106

A. Potosyan.................................................................. 181

V. Petrov....................................................................... 175

R. Pissinis..................................................................... 268

J. Pouso........................................................................ 199

D. Petrovai.................................................................... 245

J. Pitanga...................................................................... 108

A. Pouta.......................................................................... 75

M. Petrovic........................................................... 190, 278

F. J. M. Pitella............................................................... 266

C. Poy........................................................................... 105

D. Petrovic............................................................. 187-188

B. Pitt............................................................................ 108

R. Pozzan.............................................................. 201, 250

O. Petrovic.................................................................... 278

F. J. M. Pittela............................................................... 142

P. Pozzer........................................................215, 219, 273

J. Petrovicova............................................................... 257

R. B. Piveta................................................................... 233

P. L. Pozzer................................................................... 271

D. Petroviè.................................................................... 136

O. Pizzi.......................................................................... 250

F. S. Pozzi..................................................................... 199

O. Petrucci............................................................ 133, 166

M. Plášková.................................................................. 173

N. G. Prado........................................................... 220, 229

Z. Petrulioniene..................................................... 184, 237

M. L. Plastino................................................................ 210

N. Prasad............................................................... 250-251

R. Pettersen.......................................................... 143, 272

J. Plate............................................................................ 69

P. Prates............................................................... 231, 233

E. Pettersen.................................................................. 103

L. Platica....................................................................... 200

S. Prates....................................................................... 175

G. Pettersson................................................................ 232

O. Platonova................................................................. 238

P. Pratesi........................................................................ 79

M. Petti................................................................. 170, 201

G. Plehn.................................................103, 194, 223, 245

D. Précoma......................................................77, 135, 208

B. Pezo-Nikolic...................................................... 104, 245

A. Pleskovic........................................................... 187-188

I. Préda......................................................................... 164

S. Pezzotto.................................................................... 263

A. Pleskoviè.................................................................. 136

J. Pregowski................................................................. 241

A. Pfeferman................................................................ 102

M. Plewka..................................................................... 222

A. Prejbisz..................................................................... 101

L. Pfister....................................................................... 100

J. Poch............................................................................ 79

M. F. Prescott............................................................... 238

H. M. Pham........................................................... 143, 275

A. Pocoví............................................................... 225, 238

H. A. Prezioso...... 79-80, 142, 176, 178, 219-223, 229, 250

O. N. Pham................................................................... 143

Y. A. Pocrovskiy............................................................ 105

J. C. Prieto.................................................................... 132

K. G. Pham............................................................ 143, 275

D. A. Poddubnyy................................................... 103, 224

N. Prieto........................................................................ 273

E. Picabea............................................................. 134, 225

C. Podoleanu................................................................ 134

C. Prim.................................................................... 77, 176

F. Piccinini..................................................................... 142

D. Podoleanu................................................................ 134

C. R. Prim........................................................................ 77

A. Piccoli Jr................................................................... 109

P. Podolec..............................................170, 173, 185, 193

L. Principe..................................................................... 174

V. Piccone..................................................................... 220

E. Podolskaya............................................................... 175

D. Prior.......................................................................... 136

R. Picon........................................................................ 106

G. Podosyan................................................................. 181

J. O. Prior...................................................................... 133

V. Picone....................................................................... 279

J. Poeys........................................................................ 110

Y. Prior.................................................................. 107, 271

L. S. Piegas............................................................. 80, 208

P. Pogonza.................................................................... 176

D. Pritchard................................................................... 178

P. Pieniazek.......................................78, 80, 141, 230, 233

Y. A. Pokrovskiy.............................................................. 74

G. F. Procopio............................................................... 100

P. Pieroni...................................................................... 274

E. Polanco..................................................................... 201

G. Procopio............................................................. 73, 279

M. Pietrani.....................................................234, 264, 271

N. Polat......................................................................... 106

Z. Prohaszka................................................................. 203

R. Pietrobon.................................................................. 250

C. Poliserpi.................................................................... 217

L. Protasio..................................................................... 138

T. Pietrucha................................................................... 210

J. Politei........................................................................ 231

M. Protich..................................................................... 206

M. Pilan........................................................................... 73

D. Polk.......................................................................... 141

V. Proto......................................................................... 215

M. Pilato....................................................................... 184

J. Pollan........................................................................ 137

L. A. Providencia.........................78-79, 100-101, 132, 250,

S. Pilato......................................................................... 184

P. Pollono........................182, 234-235, 248, 254, 264, 271

...............................................254-256, 258, 260, 263, 269

K. Pilichou..................................................................... 134

L. Polonski.................................................................... 238

L. Providência......................................................... 70, 252

C. Pimenta.................................................................... 248

P. Pomerantzeff............................................................ 278

P. Pruszczyk.................................................................. 251

J. Pineda....................................................................... 217

L. Ponce........................................................................ 214

T. Przewlocki............... 76, 78, 80, 101, 141, 170, 230, 233

D. Pineiro...................................................................... 267

K. Ponciano................................................................... 255

A. Przybylski............................................................. 76, 80

A. Pinheiro.................................................................... 234

V. Pönitz..................................................166, 178, 206-207

B. Przybysz................................................................... 273

V. Pinheiro............................................................. 247-248

P. Pons................................................................. 205, 222

B. Psaty........................................................................ 137

E. Pinheiro.................................................................... 247

C. I. Ponte..................................................................... 226

M. Puchta..................................................................... 251

J. Pinheiro Jr................................................................... 79

D. Pop............................................................ 242, 245-246

D. Puente...................................................................... 267

O. A. Pinilla......................................................77, 140, 198

S. Popovic..................................................................... 105

S. E. Puga..................................................................... 220

B. Pinto......................................................................... 132

K. Poppe....................................................................... 136

P. Pujol...........................................................132, 236, 238

I. Pinto.................................................................. 198, 240

R. P. Porcile.................................................................. 239

C. G. Puk............................................................... 109, 191

J. Pinto.................................................................. 179, 226

L. Portela...................................................................... 233

C. Pulz........................................................................... 248

A. Pinzon............................................................... 205, 249

L. Portella...................................................................... 233

Y. Purmah..................................................................... 256

D. Piotrowska-Kownacka.............................................. 174

D. Portillo............................................................... 184-185

K. Putarek..................................................................... 231

W. Piotrowski............................................................... 175

M. Portis............................................................... 183, 215

A. M. Puyó.................................................................... 274

Authors M. Pyda........................................................................ 225

G. Rao........................................................................... 168

M. F. Ribeiro................................................................. 236

O. Querencio........................................................ 215, 260

V. Raos......................................................................... 231

A. L. P. Ribeiro........................................................ 74, 228

M. S. Queroz................................................................. 213

A. Rapaee............................................................. 133, 201

A. Ribeiro.............................................................. 218, 229

S. Quevedo............................................................ 238-239

C. Rapallo...................................................................... 133

G. Ribeiro.......................................................253, 260, 263

J. Quiles........................................................................ 165

J. J. Raposo.................................................................. 249

E. P. Ribeiro.................................................................. 190

M. Quintão............................................................ 219, 270

K. Raslova..................................................................... 257

J. Ribeiro....................................................................... 226

M. P. Quintão........................................................ 234, 236

J. N. Rasmussen................................................... 230, 232

L. Ribeiro................................................................ 79, 267

D. Quintero................................................................... 249

R. Rasmussen....................................................... 260-261

M. F. M. Ribeiro............................................................ 201

F. Quintiero................................................................... 264

S. Rasmussen....................................................... 230, 232

M. Ribeiro..................................................................... 201

C. Quiroga..................................................................... 102

S. Rassi......................................................................... 208

C. Ribeiro...................................................................... 141

L. Quiroga......................................................111, 221, 255

F. Rassi................................................................. 246, 248

A. Riberi........................................................................ 241

P. Quiroga............................................................. 107, 209

A. Rastan...................................................................... 182

R. Ricardo....................................................................... 77

J. Quiroga..................................................................... 269

A. J. Rastan................................................................... 173

E. Ricardo............................................................. 265, 267

C. Quiroz....................................................................... 111

O. Rastelli............................................................. 189, 215

M. Riccitelli............................................................. 70, 139

M. Quon............................................................ 75-77, 144

R. Ratto......................................................................... 267

C. M. Richter.....212-214, 221-223, 227, 261, 265-266, 269

M. Rabrenovic.............................................................. 193

J. Ravkilde.................................................................... 166

D. Ricon........................................................................ 204

J. Racek........................................................................ 253

E. Ravussin................................................................... 166

F. Ridocci-Soriano......................................................... 231

L. J. Radevic................................................................. 170

R. Ray........................................................................... 140

I. Riecansky.................................................................. 137

D. Radlovacky............................................................... 220

E. Raymenants............................................................. 277

E. Riedemann............................................................... 109

N. Radovanoviæ............................................................ 136

A. P. Rebrov.......................................................... 103, 224

A. R. P. Rieira................................................................ 245

M. Radovanovic...............................................74, 105, 169

C. Recuerda Casado..................................................... 234

A. Riera........................................................................... 72

N. Radovanovic.................................74, 105, 169, 187-188

D. P. Redfearn...................................................... 135, 163

M. A. Rieth.................................................................... 143

S. Rafajlovski................................................................ 193

H. J. Redruello.......................................136, 142, 219, 250

I. Rifourcat............................................................ 183, 214

P. Raffaelle................................................................... 206

M. Redruello..........................................133, 139, 261, 266

K. Rigatto.............................................................. 253, 269

H. Raffaelli........................73, 107, 205-206, 225, 230, 279

G. S. Reeder................................................................. 262

A. Righetti....................................................................... 78

A. Rafie......................................................................... 111

H. Refsum.............................................133, 142, 243, 248

P. Rigueiro Veloso................................................. 186, 194

V. Raggio.............................................................. 273, 276

V. Regitz-Zagrosek........................................................ 204

S. Rim............................................................ 110, 218-219

M. Raguz...................................................................... 231

A. Rego......................................................................... 249

S. J. Rim......................................................................... 79

H. Ragy......................................................................... 274

A. Reichert.................................................................... 218

R. E. Rios Mendez.................................................. 76, 165

P. Rahimi...................................................................... 216

R. P. Reidar Pettersen.................................................. 203

A. Ríos.......................................................................... 274

R. Rahmonov................................................................ 196

A. Reina...........................................................70, 224, 246

A. V. Risnenko................................................................ 74

A. Rai.................................................................... 142, 212

A. Reina-Toral............................................................... 248

A. Riso.......................................................................... 263

H. Rai............................................................................ 110

J. Reiner....................................................................... 142

L. Ritt............................................................................ 132

H. Raich........................................................................ 142

S. Reinmets.................................................................. 187

J. Ritter......................................................................... 166

F. Raineri....................................................................... 186

R. Reinoso.................................................................... 166

W. Rivarola....................................................222, 273, 276

T. Rajarajan................................................................... 231

A. Reis.................................................................. 100, 269

H. W. Rivarola....................................................... 273, 276

D. Rajic................................................................... 74, 105

H. Reis.......................................................................... 132

M. Rivarola.................................................................... 209

N. Rajicic....................................................................... 243

M. M. Reis............................................................ 249, 276

E. Rivas Stany............................................................... 228

S. Ramamurthy............................................................. 103

L. S. R Reis................................................................... 198

C. Rivas................................................................. 195, 255

F. Ramello..................................................................... 173

D. Reisner..................................................................... 166

C. A. Rivas............................................................ 220, 239

J. Ramires............................................................. 111, 179

A. Rekhviashvili..................................................... 164, 175

A. Rivera....................................................................... 188

M. Ramirez........................................................... 181, 206

I. Rendon...................................................................... 216

P. Rivera..........................................................77, 137, 224

H. Ramirez.................................................................... 259

J. Rengel....................................................................... 190

M. Rizzatti..................................................................... 226

A. Ramirez.................................................................... 141

N. F. Renna........................................................... 205, 262

N. Rizzo......................................................................... 200

V. Ramirez-Castro..........................................207, 218, 257

E. S. Resende............................................................... 244

Y. Ro............................................................................. 108

J. C. Ramiro Novoa....................................................... 177

P. Resende........................................................... 250, 272

T. Robak........................................................................ 222

R. C. Ramon Corbalan................................................... 102

M. Resnik..................................................................... 178

S. Robert............................................................... 200, 214

R. Ramon...................................................................... 259

D. Reuland.................................................................... 212

C. Roberts..................................................................... 137

R. Ramos........................................................................ 79

A. Reveron.................................................................... 226

F. Robles........................................................205, 230, 278

A. Rampazzo................................................................. 134

M. Rey.......................................................................... 274

L. Robles....................................................................... 271

K. A. Ramsdale............................................................. 179

G. Rey........................................................................... 189

G. Robles...................................................................... 194

D. R. Ramsdale............................................................. 179

I. Reyes......................................................................... 273

M. Robles..................................................................... 141

A. Ramzy...................................................................... 274

P. A. Reyes................................................................... 204

B. Roca......................................................................... 225

R. Raña......................................................................... 206

J. Reynolds................................................................... 169

J. Roca.......................................................................... 224

G. Ranchilio................................................................... 208

K. Rhee......................................................................... 235

G. Rocca....................................................................... 175

C. Rando......................................................................... 71

A. R. Riarte............................................................ 220, 229

L. Rocha Lopes..................................................... 111, 181

M. Rangel..................................................................... 270

A. Ribeiro Langowiski................................................... 218

R. Rocha....................................................................... 209

A. Rao........................................................................... 179

J. P. Ribeiro......................................................74, 106, 138

N. Rocha..........................................76, 108, 198, 219, 278

Index / 313

Authors A. Ruiz.................................................................. 213, 244

M. S. Rocha............................................................ 72, 107

R. Romero.............................................................. 78, 179

A. S. C. Rocha....................................................... 142, 266

T. Romero................................................................. 73, 75

J. M. Ruiz-Nodar........................................................... 217

V. N. Rocha................................................................... 198

M. C. Romero............................................................... 221

M. J. Ruiz-Olgado..........................................207, 218, 257

C. Rochitte............................................................ 136, 141

M. U. Rondon............................................................... 172

A. Ruokonen................................................................... 75

L. Rodas...........................................................80, 242, 244

J. Roosen...................................................................... 277

C. Rus Mansilla............................................................. 234

R. Rodrigo..................................................................... 261

M. Rosa........................................................................ 191

E. Rusak........................................................................ 200

L. F. Rodrigues Jr.................................................. 259, 263

K. Rosa................................................................... 74, 239

P. Ruschel...................................................... 233, 236-237

L. F. Rodrigues Jr.................................................. 259, 263

K. T. Rosa...................................................................... 249

P. Ruschell...................................................................... 77

B. Rodrigues............................................74, 136, 234, 249

D. Rosa......................................................................... 133

U. Rushentsova............................................................ 132

L. M. Rodrigues............................................................ 266

F. Rosa.......................................................................... 108

V. Ruskin....................................................................... 234

A. C. Rodrigues............................................................. 238

L. Rosa.......................................................................... 234

E. Ruslender.......................................................... 253-254

V. Rodrigues......................................................... 110, 204

G. Rosadiez..................................................................... 77

R. Russo............................................................... 144, 225

M. Rodriguez Acuña............................................. 205, 230

A. Rosales..................................................................... 215

M. Russo...................................................................... 178

G. Rodriguez Botta........................................................ 257

A. Rosas Cabral............................................................. 268

C. M. Rutherford........................................................... 139

C. Rodriguez Correa................................................ 73, 224

B. T. Roseguini................................................................ 74

O. Ruyer....................................................................... 194

L. Rodriguez Nande...................................................... 202

R. Rosental................................................................... 214

W. Ruzyllo........................101-102, 136, 174-175, 237, 241

L. Rodriguez Nandez..................................................... 228

P. Rosique.................................................................... 183

A. Rybicka-Musialik....................................................... 230

A. Rodriguez Saavedra.................................................. 181

A. Roslawiecka....................................................... 76, 141

L. Ryliskyte................................................................... 184

L. Rodriguez.............................................69, 202, 207, 228

E. Rosner...................................................................... 186

A. Rynkiewicz............................................................... 249

C. Rodriguez............................................73, 224, 237, 248

H. Ross........................................................................... 74

E. Rzewuska................................................................. 251

A. Rodriguez......................................................... 132, 181

H. J. Ross..................................................................... 104

D. Rzeznik........................................................76, 141, 230

M. Rodriguez.................................................205, 228, 230

J. Ross.......................................................................... 104

A. Sa............................................................................. 201

W. Rodriguez........................................................ 192, 210

M. Rossi........................................................134, 225, 246

A. K. Sá......................................................................... 201

J. Rodriguez.......................................................... 175, 270

A. Rossi................................................................ 136, 247

G. Saatashvili................................................................ 230

D. Rodríguez Ierace...................................................... 169

G. Rossi........................................................................ 264

L. Saavedra................................................................... 107

M. Rodríguez................................................................ 133

F. M. B. Rossi................................................ 243-247, 265

N. Saavedra.................................................................. 215

L. Rodríguez.................................................................. 191

S. Rossi......................................................................... 236

A. Sabanov.................................................................... 175

J. Rodriguez-Collado......................................207, 218, 257

R. Rossi.......................................................................... 78

J. Sabik......................................................................... 232

C. Rodriguez-Correa...................................................... 246

E. A. Rossi.................................................................... 247

M. C. Saccheri...................................79-80, 136, 142, 176,

M. Rodriguez-Elvira............................................... 224, 246

N. Rossi.......................................................................... 76

.......................................................178, 219-223, 229, 250

J. M. Rodríguez-Pérez............................................ 204-205

P. Rossi......................................................................... 189

L. Saclietti..................................................................... 259

H. Rodríguez-Zanella..................................................... 133

L. Rosso.......................................................................... 77

B. Sáenz........................................................................ 207

J. Roesch...................................................................... 176

F. Rotemberg................................................................ 168

D. Y. Sahin.................................................................... 105

D. Roganovic................................................................ 182

S. Rotevatn................................................................... 143

M. Sahin....................................................................... 163

A. Roggerio................................................................... 278

A. Rouge.................................................252, 259-260, 262

A. Sahinarslan.................................172, 185, 219, 231-232

O. Rogowski................................................................. 163

P. Roura...................................................73, 206, 246, 279

S. Sahýn........................................................................ 195

L. E. Rohde................................................................... 233

B. G. Rovai.................................................................... 228

T. Saikawa.................................................................... 170

C. Rojas Matas........................................................ 78, 227

S. K Roy........................................................................ 232

V. Saini.......................................................................... 138

J. Rojas.................................................................. 228-229

G. Roytberg.................................................................. 238

B. Saiz........................................................................... 183

E. Rojas.......................................................... 247-248, 263

J. Rozanski............................................................ 109, 171

S. Sakalli....................................................................... 186

E. Roldos Cuza.............................................................. 228

P. Rozentryt.................................................................. 238

I. Sakic.......................................................................... 223

R. B. Rolf Berge............................................................ 203

A. Rozga....................................................................... 170

K. Saku.......................................................................... 181

C. Rollan....................................................................... 195

A. Rózga....................................................................... 171

J. P. Sala....................................................................... 190

M. Rollin-Ornelas.......................................................... 273

A. Rubinich................................................................... 277

A. Salacata.................................................................... 177

A. L. Rollins................................................................... 212

P. Rubis........................................................................ 101

H. Salazar........................................................................ 69

R. Romaguera............................................................... 231

Y. Rückert..................................................................... 182

L. A. Salazar...................................................163, 215, 227

C. Roman.................................................................. 73, 75

H. Ruda Vega................................................................ 109

A. Salazar...............................................163, 215, 227, 268

M. I. Roman.................................................................... 76

M. Ruffa........................................................................ 178

C. Salazar...................................................................... 169

J. Román García............................................................ 174

G. Ruibal....................................................................... 189

C. Saldarriaga................................................................ 139

A. Romano.................................................................... 220

E. Ruiz De Temiño De Andres...................................... 234

C. Saldivar..................................................................... 256

E. Romano.................................................................... 257

G. Ruiz Deza................................................................. 139

M. Salem.............................................................. 143, 272

M. Romano............................................................ 228-229

E. Ruiz Lascano............................................................. 270

A. Sales........................................................................... 76

E. R. Romano.................................................................. 76

M. Ruiz Moraga............................................................ 174

J. Salgado-Fernández.................................................... 198

L. Romano.................................................................... 141

M. L. Ruiz Morosini....................................................... 184

M. Salguero.......................................................... 195, 269

M. Romanowska.......................................................... 175

E. Ruiz................................................................... 234, 270

J. Saligova..................................................................... 137

L. Romeo........................................................................ 70

G. A. Ruiz...................................................................... 244

J. Salinas....................................................................... 215

M. Romero............................................103, 134, 170, 212

L. P. Ruiz....................................................................... 213

S. Salinger..................................................................... 170

I. Romero...................................................................... 185

M. Ruiz................................................................. 174, 184

F. V. Salis...................................................................... 213

Authors F. Saliva.......................................................................... 74

G. A. Santiago..................................263-264, 266, 269-270

J. Schad........................................................................ 238

A. Salles........................................................................ 207

A. C. Santomauro........................................... 243-247, 265

R. Schaetzl............................................................ 196, 198

J. B. Salles.................................................................... 202

A. T. Santomauro.......................................................... 243

D. Schaf........................................................................ 233

W. Salmhofer................................................................ 225

A. C. Santomauro Jr............................................... 243-247

C. M. Schannwell.................................................. 104, 270

F. Salmo.................................................................. 73, 246

B. S. Santoro.................................................. 243-245, 247

S. Schanz....................................................... 206-207, 259

R. Salomao................................................................... 220

D. Santoro...................................................... 139-140, 253

E. Schapachnik..................................................... 195, 218

C. Salomón................................................................... 214

D. Santos.......................................................238, 242, 249

M. Schapira................................................................... 137

P. R. Salvador................................................................ 244

E. Santos...................................................................... 132

H. Schartum-Hansen............................................ 249, 251

F. Salvaggio.......................................................... 181, 193

I. Santos................................................................ 132, 253

N. Schechtmann........................................................... 201

F. Salvagio.............................................111, 170, 189, 196

M. Santos......................................142, 201, 205, 230, 262

S. Scheidl...................................................................... 225

C. Salvatori.............................................................. 73, 246

B. Santos........................................175, 252, 259-260, 262

P. C. Schenkel............................................................... 233

P. Salvo......................................................................... 257

T. Santos....................................................................... 275

U. Scherrer............................................................. 75, 103

S. Salzberg...................................................................... 70

F. Santos........................................................110, 175, 204

I. T. Schettert................................................................ 193

G. Samaja..................................................................... 181

M. H. H. Santos.................................................... 243, 249

A. G. Schijman.............................................................. 250

R. Samaniego............................................................... 210

J. Santos....................................................................... 278

A. C. Schimidt............................................................... 267

J. Samardzic................................................................. 193

A. A. Santos.................................................................. 226

N. Schimidt................................................................... 175

N. V. Sambiase..................................................... 276, 278

I. Santos-Rodriguez........................................207, 218, 257

T. H. Schindler.............................................................. 133

S. Samimi-Fard..............................................167, 169, 213

O. Sanz................................................................. 213, 239

G. Schipani............................................................ 237, 240

S. Samir........................................................................ 101

S. Sapari........................................................................ 184

J. A. Schirger................................................................ 108

M. Sammartino............................................................. 241

G. Saposnik......................................................78, 111, 267

A. J. Schlichter........................................................ 76, 221

P. P. Sampaio.........................................136, 211, 215, 220

D. J. Saranovic.............................................................. 171

S. Schneck.................................................................... 278

R. O. Sampaio........................................132, 237, 247, 275

S. Saravia............................................................... 246-248

M. Schneider................................................................ 228

D. L. Sampaio............................................................... 256

M. Sardar...................................................................... 270

C. Schneider................................................................. 106

C. Sampaio................................................................... 227

A. Sardella............................................................... 76, 252

J. Schnidt...................................................................... 239

R. M. F. Sampedro........................................................ 214

P. Sareli......................................................................... 230

A. Schott....................................................................... 260

F. Sampedro................................................................. 214

I. Sari..................................................................... 171, 211

M. Schou.............................................................. 108, 241

E. A. Sampó.................................................................. 215

S. Sarikaya.................................................................... 205

I. M. Schou................................................................... 108

H. Sanabria........................................................... 142, 179

R. Sarjanovich................................................................. 74

P. Schreib..................................................................... 200

J. Sanagua............................................................ 218, 261

B. Sarkar....................................................................... 232

V. Schubsky.................................................................. 238

P. Sanches...................................................................... 72

R. A. Sarmiento..........................................70, 80, 221, 229

G. Schuler............................................................... 73, 182

L. B. Sanches................................................................ 265

R. Sarmiento....................................................69, 102, 132

C. Schulte............................................................. 138, 225

I. Sanches..................................................................... 255

D. Sarmiento................................................................. 216

R. Schumiachkin............................................................. 76

F. Sanchez............................................................ 181, 193

M. Sarmiento................................................................ 228

I. Schusterova............................................................... 137

O. Sanchez................................................................... 218

Z. S. Sarszegi................................................................ 197

P. Schvartzman............................................................. 226

R. Sanchez.....................................................183, 215, 259

C. Sarteschi...................................................227, 240, 247

M. Schwab............................................................. 75, 103

V. Sanchez.................................................................... 211

A. Sartori............................................................... 135, 208

O. A. Schwint................................................................ 142

L. Sanchez.................................................................... 183

C. Sartori................................................................. 75, 103

P. Schygiel.................................................................... 171

S. Sanchez.................................................................... 190

M. Sartori...................................................................... 254

R. Sciacca............................................................... 75, 107

A. Sanchez.....................................................190, 205, 213

J. Sasaki........................................................................ 195

G. Scianca..................................................................... 229

L. A. Sanchez................................................................ 205

C. Satizabal................................................................... 216

A. Scicolone.................................................................. 211

M. A. Sánchez Chaparro............................................... 174

L. Satlin......................................................................... 173

G. Scicolone.................................................................. 211

A. Sanchez-Grande....................................................... 167

R. Savanti...................................................................... 227

S. Sclarovsky.................................................102, 167, 178

M. J. Sancho-Tello................................................ 213, 239

N. A. Savelov.................................................................. 74

E. Sclarovsky.......................................................... 72, 143

A. Sancineti................................................................... 103

O. Savenko....................................................141, 249, 252

M. Scofano................................................................... 229

M. Sancineti.................................................................. 103

M. Sawasany................................................................ 274

C. G. Scott.................................................................... 105

S. Sandoval-Navarrete................................... 265-266, 268

S. Saygi......................................................................... 276

E. Scrivano...................................................................... 78

M. Sani......................................................................... 178

B. Saygi........................................................................... 77

C. Seara.........................................................141, 206, 260

C. A. Sanibal.................................................................. 263

T. Sayin......................................................................... 192

C. Seelig....................................................................... 237

M. Sanjurjo............................................................ 270-271

L. V. Sazukina................................................................ 255

C. Segadaes.................................................................. 222

R. Sankaranarayanan............................................ 103, 105

A. Scafa-Udriste............................................................ 200

E. V. Segura.................................................................. 189

R. Sansalone................................................................. 242

J. Scaglia..........................................78, 110, 143, 188, 193

M. Segura..................................................................... 279

M. Santa....................................................................... 208

J. Scaglione.................................................................. 210

R. Seiça................................................................. 100, 269

R. Santa........................................................................ 179

E. Scaiola...................................................................... 240

K. Seidl.......................................................................... 203

W. Santander...................................69, 258, 260, 265, 271

N. Scarin....................................................................... 268

C. Seidler................................................................ 80, 244

P. Santander................................................................... 69

A. Scariot...................................................................... 228

D. Seinhart.................................................................... 137

J. Sant’Anna......................................................... 231, 233

G. B. Scaro...................................................................... 74

D. Selchen.................................................................... 267

R. Sant’Anna................................................................. 231

B. Schaan...................................................................... 226

Y. Selcoki.............................................................. 185, 195

G. Santiago..............................192, 195, 241-242, 260-261

T. Schachner................................................................. 173

V. Selios................................................................. 269-270

Index / 315

Authors M. Sellanes........................................................... 192, 210

A. Shirom...................................................................... 163

J. L. Simon.............................................................. 76, 221

A. Selvi.......................................................................... 223

E. Shlyakhto.................................................................. 203

J. Šimon................................................................ 166, 173

K. A. Selzman........................................................ 138, 225

E. Shlykhto............................................................ 204, 274

T. Simoncek.................................................................. 231

A. Sembaj..................................................................... 264

Z. Shoalimova............................................................... 196

G. Simonyi.............................164, 199, 203, 208, 224, 238

M. Semukhin................................................................ 202

L. Shocron.................................................................... 222

C. S. Simpson....................................................... 135, 163

O. Sen........................................................................... 105

N. Shor.................................................................. 110, 178

S. Singh........................................................................ 167

L. M. Sena.................................................................... 247

A. A. Shoukas................................................................. 77

G. Singh................................................................ 108, 231

M. Senesi............................................................. 210, 222

R. K. Shrivastava................................................... 108, 231

N. Singh........................................................................ 110

K. Senna....................................................................... 262

S. Shukurjanova............................................................ 196

I. Singla......................................................................... 101

D. Sepulveda................................................................ 137

A. Shurman................................................................... 186

N. Sinha..........................................110, 132, 198, 250-251

S. Serafim..................................................................... 211

A. Siciliano.................................................................... 263

A. Sinha........................................................................ 104

A. Serafin...................................................................... 273

S. Sicouri....................................................................... 275

D. A. Siniawski.............................................................. 183 S. Sinigaglia.................................................................. 244

D. F. Serans.......................................................... 220, 250

R. Siddiqui..................................................................... 270

J. Seresi........................................................................ 277

D. Sidi........................................................................... 180

A. Sinisi..............................................74, 79, 201, 211, 241

P. Seron........................................................................ 132

K. Siemianowicz........................................................... 208

P. Sionek....................................................................... 252

I. Seropian..................................................................... 228

I. U. Sigaev.................................................................... 255

P. Siostrzonek............................................................... 110

B. S. Serpa.................................................................... 224

J. Sikic-Vagic................................................................. 231

D. Siqueira.....................................................257, 259, 261

A. Serra......................................................................... 229

J. Sikora................................................................ 171, 238

A. Siqueira-Filho.............................................................. 71

S. Serra........................................................................... 76

E. Silberman.......................................................... 273-274

M. Sirlak........................................................................ 111

O. Serraiocco................................................................ 227

F. J. B. Silva Filho.......................................................... 244

V. Sirotkin..................................................................... 235

D. Serrano..................................................................... 247

E. Silva........................... 138, 240, 242, 259, 269, 272, 275

R. Sirvente.................................................................... 269

E. Serrano..................................................................... 214

J. Silva...............................................................72, 78, 109

A. Sitar-Tautu................................................................ 242

C. Serrano..................................................................... 254

F. Silva...................................................135, 208, 246, 253

M. Sitnikova.................................................................. 203

J. Sertic......................................................................... 230

A. C. Silva...................................................................... 244

B. Sjöberg....................................................................... 75

A. Seth.......................................................................... 132

F. H. Silva...................................................................... 244

D. Skapura.................................................................... 103

K. K. Sethi..................................................................... 132

M. C. C. Silva................................................................ 202

B. D. Skinner......................................................... 138, 212

S. Seto.................................................................. 195, 209

H. Silva.................................................................. 244, 279

S. M. Skinner........................................................ 138, 212

V. Severicha.................................................................. 210

P. Silva....................................137, 139-140, 226, 236, 257

B. Skoric................................................104, 219, 230, 245

L. J. Sevic..................................................................... 174

A. Silva....................................139-141, 164, 183-184, 212,

W. Skorupski................................................................ 225

N. Sewpaul................................................................... 256

...............................................224-225, 227, 257, 265, 273

M. Skwarek.......................................................... 102, 237

T. M. Seydell..................................................109, 191, 243

R. Silva.................................................................. 253, 257

M. Slater....................................................................... 277

A. Shah......................................................................... 166

M. J. L. M. Silva.................................................... 227, 256

B. L. Sleath................................................................... 226

T. P. Shah...................................................................... 172

L. C. S. Silva.................................................................. 217

J. Sleigh.......................................................................... 71

T. Shalganov................................................................. 206

I. T. Silva............................................................... 263, 265

A. Slichter..................................................................... 252

I. Shapira....................................................................... 163

M. A. Silva......................................................212, 227, 265

I. Slimobich............................................................. 70, 248

N. Sharashidze.............................................................. 230

B. Silva.................................................................... 76, 244

E. Slywitch.................................................................... 199

O. Sharkhun.................................................................. 238

I. C. M. Silva.............................................76, 138, 234, 253

P. Smanio........................110-111, 186, 251, 267-268, 276

V. K. Sharma......................................................... 108, 231

V. M. Silva............................................................. 180, 198

P. A. Smars................................................................... 262

S. K. Sharma......................................................... 142, 272

R. B. F. Silva.................................................................. 246

N. Smedira.................................................................... 232

S. Sharma..................................................................... 140

S. A. Silva.............................................................. 139, 184

L. Smeeth............................................................. 137, 164

C. Shaw........................................................................ 163

J. P. Silva.............................................................. 226, 236

L. Smidt.................................................134, 138, 243, 250

M. Silva...................................76, 109, 138, 180, 198, 227,

C. Smith.............................................................4, 219, 225

L. J. Shaw..................................................................... 141 C. Shekhar...................................................................... 79 H. Sheng....................................................................... 202 J. Shepherd.................................................................. 183 H. Shi............................................................................ 241 S. Shigematsu.............................................................. 170 L. S. Shigueoka............................................................... 75 E. O. Shim............................................................. 111, 272 K. Shimomura............................................................... 195 J. Shin........................................................................... 270 E. Shin............................................................... 75-77, 144 M. S. Shin............................................................. 111, 272 E. K. Shin.............................................................. 111, 272 T. Shingo....................................................................... 175 G. Shinzato................................................................... 266 A. Shiozaki.................................................................... 136 J. Shiraishi.................................................................... 192

...............................................................234, 252-253, 256 F. C. S Silva Jr............................................................... 275 I. C. M. Silva.............................................76, 138, 234, 253 C. Silva...................................................202, 244, 252, 268 J. L. Silva....................................................................... 255 P. L. Silva...................................................................... 260 V. M. Silva............................................................. 180, 198 J. P. Silva.............................................................. 226, 236 M. Silvero.............................................................. 169-170 J. Silveyra............................................................. 260, 273 K. H. Sim....................................................................... 201 S. Simas........................................................................ 234 J. C. Simes.................................................................... 205 M. Simoes.................................................................... 220 O. Simoes............................................................. 111, 181 L. Simões.......................................................262, 265, 267

G. Smolyanova.............................................................. 234 T. D. Snyder.................................................................. 212 P. Soares.........................................76, 108, 138, 236, 278 S. Soares...................................................................... 270 A. Soares.......................................................144, 225, 236 C. E. Soares.................................................................. 198 O. E. Soares.................................................................. 266 F. Soares....................................................................... 191 P. P. Soares.................................................................. 236 D. Sobic-Saranovic........................................................ 171 D. Sobolev.................................................................... 238 T. Sobow...................................................................... 188 D. Sobral-Filho.............................................................. 249 M. Socorro.................................................................... 144 H. Soejima.................................................................... 164 F. Sogorb...................................................................... 217

Authors A. Sokolowski....................................................... 101, 230

T. Spyt.................................................................... 73, 256

M. Strumminger........................................................... 220

G. Solari........................................................................ 169

R. Squires..................................................................... 107

C. Strunz............................................................... 237, 247

R. Solerno..................................................................... 229

M. Šrámek.................................................................... 169

K. Stuart........................................................................ 135

E. Z. Soliman................................................................. 200

M. Šramko.................................................................... 169

I. Stukena...................................................................... 235

E. Soloaga..................................................................... 219

I. Srdanovic................................................................... 190

C. Sturgeon................................................................... 229

R. J. Solomon............................................................... 142

M. Srdic........................................................................ 187

A. Sturich........................................................................ 76

H. Solomon................................................................... 137

A. Srinivas..................................................................... 132

M. C. J. M. Sturkenboom............................................. 243

I. Solti.................................................................... 197, 202

R. Staico........................................................198, 257, 259

A. Stuto......................................................................... 186

M. Somera.................................................................... 181

H. Staines.........................................75, 178, 206-207, 209

P. Stuzbach................................................................... 220

D. Sondore.................................................................... 255

G. Stampone................................................................. 206

J. Su................................................................................ 75

S. Sood......................................................................... 103

V. Stangl................................................................. 75, 140

L. Suarez....................................................................... 183

T. Sööt.......................................................................... 187

K. Stangl..........................................................75, 140, 238

E. R. Suarez...........................................243, 245, 247, 265

E. Sophia................................................................ 222-223

C. Staniloae................................................................... 142

R. Suarez-Arias...................................................... 196-197

L. Sorell................................................................. 247, 263

B. Stankova................................................................... 200

V. Suchanek.......................................................... 141, 223

T. Soria.......................................................................... 181

S. Stankovic.................................................................. 187

M. Sucu........................................................................ 171

L. Soriano.............................................................. 206, 259

G. Stankovic............................................................ 71, 142

K. Sugar........................................................................ 259

C. Soriano..................................................................... 231

J. Stanley...................................................................... 176

J. Sugawara.......................................................... 137, 173

P. Sorroche................................................................... 183

S. Stanojevic................................................................. 137

K. Sugi.................................................................... 70, 185

F. Sosa...................................144, 172, 239, 241, 271, 274

R. Stauber..................................................................... 225

M. M. Sugizaki.............................................................. 258

E. Sosa.......................................................................... 102

A. C. Steer.................................................................... 103

M. Sultan...................................................................... 136

R. Sosa......................................................................... 264

E. Stefanadi..................................................... 69, 216-217

M. Sultán................................................................ 80, 111

C. Sosa......................................................................... 271

C. Stefanadis................................................... 69, 216-217

G. Sumay...................................................................... 217

J. E. Sousa.............................................................. 76, 198

A. Stefani.............................................................. 102, 212

B. Sumegi............................................................. 197, 202

E. Sousa...........................................................76, 198, 225

B. Stefanovic...................................................74, 105, 169

V. Sumodi..................................................................... 168

A. Sousa........................................................ 256-259, 261

R. Steffen..................................................................... 207

Y. Sun........................................................................... 135

A. G. M. R. Sousa......................................................... 198

M. Stefuriac.................................................................. 200

C. Sun........................................................................... 222

J. E. Sousa.............................................................. 76, 198

R. Stein............................................74, 106, 138, 187, 226

M. Sun.......................................................................... 214

M. G. Sousa............................................................ 80, 208

S. Steiner.............................................................. 104, 270

V. Sundararajan............................................................. 164

A. C. S Sousa................................................................ 111

S. Steiner-Boker............................................................ 100

J. B. Sundstrom..................................................... 202-203

M. A. C. Sousa.............................................................. 215

V. Stelet.......................................................................... 76

R. Suneja...................................................................... 258

I. Souto......................................................................... 175

J. Stepanovic..........................................110, 142, 277-278

A. Sunil......................................................................... 101

N. A. Souza E. Silva....................................................... 269

J. Stepinska.......................................................... 172, 252

S. Suryawanshi............................................................... 75

O. Souza....................................................................... 229

R. Steponeniene........................................................... 210

L. Sutera....................................................................... 106

A. Souza.........................................................237, 258, 269

G. Sterbakova............................................................... 253

G. Sutherland................................................................ 254

D. Souza....................................................................... 233

M. Sterlinski.................................................................... 76

M. Sutton................................................................ 74, 136

A. S. Souza.....................................................139, 184, 256

A. Sterque..................................................................... 223

O. Suzer........................................................................ 242

S. B. C. Souza............................................................... 270

J. Stertzer..................................................................... 140

O. Süzer........................................................................ 180

F. Souza........................................................................ 228

S. H. Stertzer................................................................ 140

L. Svard......................................................................... 229

M. Souza....................................................................... 138

A. Stevanovic................................................................ 174

L. Svensson.................................................................. 232

E. C. Souza.................................................................... 266

S. Stewart............................................................. 107, 203

G. Svingen............................................................ 247, 251

J. Souza........................................................................ 234

C. Stipp......................................................................... 201

C. Swarzman................................................................ 248

L. C. B. Souza................................................................. 76

V. Stoickov............................................................ 166, 214

S. Swieszkowski........................................................... 215

W. Souza...................................................................... 241

S. Stojkovic...............................................71, 142, 277-278

M. K. Sydnor......................................................... 179, 275

V. R. Souza.................................................................... 250

A. Stojkovic................................................................... 170

P. Syska.......................................................................... 76

S. Soydinc..................................................................... 171

N. Stolf.................................................................. 276, 278

A. Sýsman.................................................................... 170

O. Soylu........................................................................ 186

M. Stoll................................................................. 273, 276

Z. Szabolcs.................................................................... 203

E. Y. Sozmen.......................................................... 77, 276

P. Stoll.......................................................................... 143

M. Szakacs................................................................... 257

C. Spargias.................................................................... 177

T. Stompor.................................................................... 101

K. Szakolczai......................................................... 164, 199

R. Spasic....................................................................... 193

I. Stopa................................................................... 80, 141

J. Szarfer..................................................69, 132, 139, 188

M. Spelta...................................................................... 220

V. Strada....................................................................... 215

A. Szebeni..................................................................... 203

R. Speranza........................................................... 102, 212

L. Strain........................................................................ 143

J. Szlavov...................................................................... 220

F. Spernanzoni........................................................ 79, 219

E. Strand................................................133, 142, 243, 248

S. Szmit........................................................................ 273

J. Spiers........................................................................ 229

B. E. Strauer.......................................................... 104, 270

E. Szûcs........................................................................ 164

A. Spillmann.......................................................... 260, 270

M. Strauß...................................................................... 203

H. Szwed...........................................................76, 80, 135

G. Spina.........................................................132, 237, 247

P. Strebelas.................................................................. 181

F. Szymanski................................................................. 273

A. Spinelli...................................................................... 208

T. Strecker............................................................ 176, 274

A. Szyszka..................................................................... 251

M. Spleta...................................................................... 222

C. Stringi....................................................................... 217

E. Tabak........................................................................ 104

L. A. Sposato.......................................................... 78, 111

M. Strozzi.............................................................. 219, 231

S. Tabares..................................................................... 264

Index / 317

Authors G. Tabidze..................................................................... 235

A. Taylor.................................................................... 73, 75

K. Tjelta......................................................................... 199

G. Tacoy................................................................. 278-279

Y. Tayyareci.......................................................... 106, 191

M. Tobar....................................................................... 178

G. Taçoy................................................................ 172, 186

J. Tazar................................................................. 178, 265

D. Tobing.............................................................. 132, 235

K. Taeik......................................................................... 272

A. S. Tebexreni...................................................... 248-249

J. E. Toblli..................................................................... 138

M. Tafazzoli-Shadpour.................................................. 142

A. Tedeschi................................................................... 143

C. Tobon......................................................................... 79

A. C. Taffarel................................................................. 233

B. Tedeschi................................................................... 143

M. Todorovic-Tirnanic................................................... 171

R. Tagle......................................................................... 182

U. Teibe........................................................................ 235

S. Toker........................................................................ 163

M. S. Tagliari................................................................. 265

R. Teixeira....................................70, 78-79, 101, 110, 132,

C. Toldo........................................................................ 246

C. Taira.......................................................................... 274

.......................................250, 252, 255-256, 258, 260, 263

C. Toledo...................................................................... 207

O. Tairova..................................................................... 228

P. Teixeira..................................................................... 236

I. Tolj............................................................................. 190

N. Tajima....................................................................... 231

G. Teixeira............................................................. 231, 233

J. F. Tolsa...................................................................... 103

N. Takahashi................................................................. 175

E. Tekbas...................................................................... 171

D. Tomar......................................................................... 79

T. Takakura................................................................... 170

L. Tekieli................................................................. 78, 233

P. Tomašov................................................................... 136

D. Takara....................................................................... 193

J. Telayna...................................................................... 278

A. Tomat....................................................................... 211

K. Takazawa.................................................................. 167

L. A. Temming...................................................... 138, 212

C. Tomaz....................................................................... 249

R. T. Takeda.................................................................. 213

P. L. Temporelli............................................................. 136

M. Tomazzi................................................................... 240

K. Takeishi.................................................................... 167

A. Tenenbaum.............................................................. 209

A. Tomek...................................................................... 169

L. Talavera.....................................................142, 221, 259

C. Tentolouris.................................................. 69, 216-217

S. Tomic................................................................ 187, 202

M. L. Talavera....................................................... 142, 221

M. C. Tentori................................................................. 244

H. Tomiyama................................................................ 187

J. A. Talayero................................................................ 133

C. Tentori.............................................................. 205, 244

M. Tonetto...................................................................... 74

C. Talos......................................................................... 246

I. Teplitsky............................................................ 110, 178

O. Topolcan.................................................................. 253

H. Tamagusuku..........................................74, 79, 211, 241

I. Ternouth.............................................................. 71, 179

A. Torino....................................................................... 209

G. Tamashiro.................................................................. 71

C. Terzic........................................................................ 107

P. Tornos...................................................................... 252

A. Tamashiro................................................................... 71

M. Tettamanti............................................................... 224

A. Torrão....................................................................... 234

T. Tammelin.................................................................... 75

S. Tewari........................................................ 110, 250-251

I. Torres........................................................................ 252

Y. Tanaka...................................................................... 164

S. Tewell....................................................................... 144

J. Torres.........................................................260, 265, 271

H. Tanaka.............................................................. 137, 173

S. Tezuka...................................................................... 175

F. Torres....................................................................... 196

C. Tanamati................................................................... 263

E. Thaulow............................................................ 103, 223

E. Torresani........................................................... 237, 240

R. Tandler..................................................................... 176

P. Thayssen.......................................71, 79, 110, 142, 253

C. Torromeo.................................................................. 240

I. Tandogan....................................................180, 194, 205

T. R. Theodoro.............................................................. 245

A. Tors............................................................................ 72

Q. Z. Tang..................................................................... 163

T. Theodoropoulos........................................................ 224

A. Torterola................................................................... 257

A. Tangari.............................................................. 226, 236

G. Thiene...................................................................... 134

M. Toscani.................................................................... 205

D. Tanne....................................................................... 209

A. Thom..........................................110-111, 186, 251, 276

A. Toscano.................................................................... 201

E. Tanus.................................................111, 170, 189, 196

M. Thomas................................................................... 108

I. Toshev....................................................................... 225

P. Tapanainen................................................................. 75

R. Thomas.................................................................... 107

K. Toth.......................................................................... 202

M. Tarán....................................................................... 205

C. Thomas.................................................................... 237

J. L. Tovar..................................................................... 252

E. Tararak...................................................................... 235

M. C. Thomazi....................................................... 266, 268

R. Tracy......................................................................... 137

F. Tarasoutchi........................................132, 237, 247, 275

S. Thomopoulou........................................................... 177

W. Tracz......................................76, 78, 80, 101, 141, 170,

S. Tarasov..................................................................... 175

S. Thompson-Bell........................................................... 75

.......................................173-174, 182, 185, 193, 230, 233

J. C. Tardif..................................................................... 197

O. Thorsson.................................................................. 168

J. Trainini...................................................................... 139

O. Tardin............................................................... 260, 263

L. Thuesen.........................................71, 79, 110, 142, 253

J. C. Trainini.................................................................. 139

J. Tartaglione........................................................ 228, 248

R. Thurler...................................................................... 256

F. Tramontini................................................................. 187

I. Tasic.......................................................................... 276

K. Tibazarwa................................................................. 107

B. Tranchesi Jr.............................................................. 224

A. Tasouli...................................................................... 181

C. Tibbatts...................................................................... 71

G. Trancoso.................................................................. 234

R. Tasoz........................................................................ 111

J. C. Tille....................................................................... 142

D. Trapaidze.................................................................. 175

E. Tassano............................................................. 260-261

H. Tilsted................................................................ 79, 110

H. J. Trappe...........................................103, 194, 223, 245

P. Tassovska................................................................. 225

Y. R. Timasheva............................................................ 236

P. R. Travancas..............................................262, 265, 267

C. P. Tastan................................................................... 191

A. S. Timm.................................................................... 263

S. Traverso.............................................133, 139, 227, 266

H. Tatar......................................................................... 163

M. Timm......................................................................... 77

V. Traykov..................................................................... 206

R. Tataradze.................................................................. 175

A. Timofeeva......................................................... 234-235

N. Trehan............................................................... 141-142

E. Tatli........................................................................... 182

T. Timurkaynak.172, 180, 185-186, 190, 219, 231-232, 278

P. Trejo......................................................................... 206

M. Tatsch...................................................................... 234

E. Tinoco....................................................................... 207

E. Trendafilova.............................................................. 225

S. Taurozzi.................................................................... 178

R. Tinoco....................................................................... 234

P. Trenkwalder...................................................... 196, 198

A. Tavares....................................................................... 74

G. A. Tinoco.................................................................. 234

L. Trentacoste............................................................... 209

L. Tavares..................................................................... 191

E. Tirado................................................................. 270-271

M. Trevisan................................................................... 100

A. M. V. Tavares........................................................... 233

C. Tirziu......................................................................... 224

A. Trigo......................................................................... 231

D. Tavciovski................................................................. 193

G. C. Tiscornia............................................................... 191

E. Trillos........................................................................ 249

A. Tavridou...................................................................... 77

J. Tisnado............................................................. 179, 275

H. Trimarchi.................................................................. 201

Authors E. Trindade............................................................ 263, 278

D. Ugalde...................................................................... 141

D. Vangu Ngoma................................................76, 78, 243

J. Tripolone.............................192, 195, 241-242, 260-261,

M. R. Ugolini.................................................. 243-247, 265

B. Vankelecom.............................................................. 277

........................................................263-264, 266, 269-270

M. Uhlemann................................................................ 182

A. D. Varanda-Rosario................................................... 273

K. Trivedi....................................................................... 270

E. Ulusoy...................................................................... 163

S. Varela Ortiz....................................................... 266, 268

L. J. Trkulja.................................................................... 202

R. Umakanthan............................................................... 73

M. Varela Otero............................................................ 192

I. C. Trombetta...............................................172, 180, 192

B. Umman............................................................ 106, 191

A. Varela Roman........................................................... 194

C. Tron............................................................................ 78

S. Umman..................................................................... 191

J. S. Varela.................................................................... 106

J. Tronge....................................................................... 171

D. Umpierre.................................................................. 106

C. Varela....................................................................... 137

E. Trucco....................................................................... 185

A. Unzueta.................................................................... 144

S. Varela-Ortiz............................................................... 265

T. Tsai................................................................... 135, 231

J. Urban.......................................................................... 75

E. Varella....................................................................... 179

S. Tsao.......................................................................... 135

G. Urcelay..................................................................... 207

L. Vargas....................................................................... 232

H. F. Tse....................................................................... 108

P. Uriarte....................................................................... 178

N. Vargas...................................................................... 219

M. Tsekova................................................................... 230

W. Uribe....................................................................... 205

G. Vargas-Alarcon......................................................... 205

W. Tshani............................................................... 202-203

A. Uribe......................................................................... 242

G. Vargas-Alarcón......................................................... 204

B. Tsinamdzgvrishvili............................................ 164, 175

F. Urinovsky.................................................................. 176

P. Varleta...................................................................... 257

C. Tsioufis..................................................................... 216

T. Ushakova.................................................................. 238

Y. Varma............................................................... 108, 231

A. Tsiskaridze................................................................ 164

H. Uyarel....................................................................... 171

A. Vasile........................................................................ 200

V. Tsoma....................................................................... 175

B. Uz..................................................................... 185, 195

C. Vasiliadou.................................................... 69, 216-217

J. Tsutsui...............................................111, 136, 176, 179

E. Uz............................................................................. 195

Z. Vasiljevic..............................................74, 105, 169, 187

R. Tsuyuki..................................................................... 143

J. Uzunangelov............................................................. 230

B. Vatan........................................................................ 187

M. Tubaldini.................................................................. 254

M. Vääräsmäki................................................................ 75

E. Vavouranakis............................................................ 216

F. A. Tuche............................................................ 139, 184

M. Vaccari..................................................................... 178

M. Vazques Blanco....................................................... 250

A. Tufare....................................................................... 218

G. Vaccarino.................................................................. 142

M. Vazquez Blanco............................................... 109, 214

T. Tuiketei..................................................................... 103

V. Vaghela..................................................................... 235

G. Vazquez.................................................................... 188

K. Tukamoto......................................................... 247, 268

M. Vaidotas........................................................... 102, 132

H. Vazquez.................................................................... 252

L. R. Tumasyan............................................................. 136

S. Vaidya............................................................... 195, 232

S. Vazquez.................................................................... 200

M. Tundybaeva............................................................. 174

N. Vainstein...............................................74, 77, 136, 204

D. Vazquez.................................................................... 215

L. Tunyan...................................................................... 134

F. Vaisbuj.........................................73, 205, 211, 236, 246

C. Vazquez.................................................................... 178

J. O. Tuomilehto........................................................... 231

H. Vaknin Assa...................................................... 110, 178

N. Vázquez-González.................................................... 198

B. Tura.......................................................................... 250

A. M. Valderrama.......................................................... 109

J. M. Vázquez-Rodríguez.............................................. 198

R. G. Turan............................................................ 104, 270

H. Valdes Pino............................................................... 177

H. Vefring...................................................................... 135

Y. Turgeman................................................................. 186

M. Valdés...................................................................... 217

M. Vega Fernandez....................................................... 194

O. O. Turgut.................................................................. 205

G. F. Valdez................................................................... 247

F. Vega.......................................................................... 165

F. H. Turgut................................................................... 195

S. Valdivielso................................................................. 238

G. Vega......................................................................... 251

S. Turhan...................................................................... 192

L. R. Valdivieso Cedeño.................................................. 76

B. Vega................................................................... 76, 270

U. Turk.......................................................................... 188

L. Valdivieso.....................................78, 110, 143, 188, 193

J. Vega.......................................................................... 169

C. Turkoglu................................................................... 188

J. Valencia..................................................................... 217

J. Vegas................................................................. 196-197

S. Türkoglu............................................................ 186, 190

G. Valenzuela................................................................ 176

R. Vegni..................................................252, 259-260, 262

C. Turner....................................................................... 104

G. Valeriano.................................................................. 258

A. B. G. Veiga.................................................................. 74

D. Turri.....................................79, 102, 106, 138, 187, 189

E. Valero............................................................... 210, 254

L. Veiras........................................................................ 211

M. Turski....................................................................... 232

S. Väli............................................................................ 187

E. Veitenheimer............................................................ 175

D. Turyn........................................................................ 256

J. M. Valle..................................................................... 165

O. Velásquez................................................................. 139

V. Tuseth.............................................................. 143, 272

A. Valle.......................................................................... 231

J. Velayo....................................................................... 183

P. Tyczynski.......................................................... 101, 241

R. Valle............................................................................ 70

P. Velazco............................................................. 208, 211

A. Tziovas..................................................................... 185

R. Vallejo....................................................................... 169

H. Velez........................................................................ 246

V. Tzoma....................................................................... 175

J. Vallejos............... 107, 134, 170, 200, 204, 212, 261, 275

A. Velkova..................................................................... 230

O. Ucar......................................................................... 223

G. Vallejos..................................................................... 106

M. Velloso..................................................................... 260

E. Ucer.......................................................................... 171

L. Valtuille..................................................................... 221

H. H. Veloso.................................................................... 72

O. N. Uchevatkina......................................................... 135

L. Van Bortel................................................................. 211

M. M. Veloso................................................................ 233

T. Uchida....................................................................... 175

M. Van Bracht............................................................... 245

M. Veltri........................................................................ 219

A. H. Uchida.................................................................. 195

L. Van Casteren............................................................ 277

A. Venalis...................................................................... 184

A. Uchida...................................................................... 176

P. H. Van De Borne....................................................... 211

L. Vendrame......................................................... 263, 268

M. Uder........................................................................ 176

R. Van Der Vijver........................................................... 132

R. C. Vendramini........................................................... 247

Y. Uehara...................................................................... 181

R. Van Manen............................................................... 110

J. Venegas.................................................................... 209

P. M. Ueland...........................133, 142, 243, 247-249, 251

R. Van Oort................................................................... 103

M. Venere..................................................................... 175

M. Uellendahl............................................................... 141

V. Vanasco.................................................................... 239

N. Vensentini................................................................ 240

K. Ueng......................................................................... 135

M. Vane........................................................................ 249

M. Ventura.................................................................... 258

H. Ugalde...................................................................... 141

A. Vanella........................................................................ 74

M. J. Vera Janavel.......................................................... 70

Index / 319

Authors S. Waldman...................................................138, 192, 206

M. Vera................................................................. 201, 212

E. Villegas...............................................215, 219, 260-261

V. Vera.......................................................................... 178

M. Villegas...................................................................... 71

M. Walker....................................................................... 74

P. J. E. Verdegem......................................................... 255

R. Villela................................................................ 215, 222

B. Walpoth.................................................................... 142

P. Verdegem................................................................. 208

J. L. Viloria.................................................................... 226

T. Walther............................................................... 73, 182

R. Verney.............................................................. 139, 184

C. G. C. Vinagre............................................................ 198

W. Wang....................................................................... 216

V. H. Veronica Heredia.................................................. 226

J. C. M. Vinagre............................................................ 199

T. Wang.......................................................................... 73

V. Verri................................................................... 252-253

C. G. Vinagre......................................................... 199, 255

S. Wang........................................................................ 176

J. Veselka...................... 136, 141, 169, 223, 234, 237, 253

R. Vinueza..................................................................... 109

L. Waqatakirewa........................................................... 103

V. B. Vesna Bisenic....................................................... 134

R. Viotti................................................................. 170, 201

D. D. Waters................................................................. 183

F. F. Vianna................................................................... 106

M. Virgolini.................................................................... 137

H. Watkins...................................................................... 77

A. Vicario............................................................... 204, 214

A. Virgos Lamela........................................................... 186

F. Wayar................................................................ 246-247

R. Vidal Perez..........................................180, 186-187, 194

C. Viscuso......................................................183, 190, 215

T. Wcis£o...................................................................... 171

L. A. Vidal...........................................79-80, 136, 176, 178,

M. F. Visintini Jaime..................................................... 169

T. Wcislo....................................................................... 170

........................................188, 219-220, 222-223, 229, 250

M. Viso......................................................................... 263

L. Wee.......................................................................... 135

L. Vidal.........................69-70, 132-133, 139, 197, 214, 266

J. Visperas.................................................................... 181

X. H. Wehrens.............................................................. 103

M. Vidal......................................................................... 178

M. Visser...................................................................... 273

F. L. Weich Glogier..........................................79, 219, 221

L. A. Vidal...................................79-80, 136, 176, 178, 188,

N. Vita........................................................................... 240

M. R. Weir.................................................................... 238

................................................219-220, 222-223, 229, 250 A. Videla Lynch............................................................. 229 P. R. N. Viecili.................................212-214, 221-223, 227, ...............................................................261, 265-266, 269 C. Viegas....................................................................... 252 R. F. M. Viegas............................................................. 249 T. M. R. F. Viégas.......................................................... 267 F. L. Vieira..................................................................... 244 H. Vieira........................................................................ 258 P. J. C. Vieira....................................................74, 106, 138 R. W. Vieira........................................................... 133, 166 J. Vieira............................................................77, 233, 236 C. Vietti......................................................................... 184 G. Vieyra....................................................................... 274 I. Vigil Torres................................................................. 261 C. Vigliano................................70, 170, 186, 201, 250, 259 G. Vignolo............................................................. 199, 208 G. Vigo.......................................................................... 210 E. Vigueras.....................................................233, 237, 275 V. Vikentyev...................................................141, 249, 252 J. H. Vila........................................................................ 226 J. Vila...................................................................... 78, 256 J. Vilar.................................................................... 269-270 M. Vilaseca................................................................... 188 F. Vilchez...................................................................... 257 F. D. Vilela.........................191-192, 252-254, 266-267, 273 F. P. Vilela..................................................................... 244 F. D. Vilela.........................191-192, 252-254, 266-267, 273 F. Vilela......................................................................... 264 J. Vilkas Anzorena................................................... 79, 219 A. Villa............................................................111, 221, 255 D. M. Villa..................................................................... 165 H. Villacorta................................................................... 207 L. Villagra.........................................78, 110, 143, 188, 193 C. Villalba...................................................................... 264 A. Villamayor................................................................. 256 L. Villano....................................................................... 172 E. Villanueva................................................................. 207 M. A. Villasis................................................................. 144 J. Villasmil..................................................................... 242 R. Villavicencio.............................................................. 134

L. Vitek.......................................................................... 200

L. H. Weitzel......................................................... 236, 266

B. Vitunjski-Englert....................................................... 231

C. Weksler.................................................................... 227

R. Vivacqua..................................................................... 76

H. Z. Wen...................................................................... 163

A. Vizcarra Diaz............................................................. 244

M. Weyand........................................................... 176, 274

G. Vizcarra..................................................................... 197

G. Whalley.................................................................... 136

C. Vlachopoulos............................................................ 217

R. B. Wichi.................................................................... 239

W. Vogel....................................................................... 173

A. Wiecek..................................................................... 101

S. Vogogna................................................................... 184

C. Wiefels..................................................................... 207

B. Vohnout............................................................ 240, 257

K. Wierzbowska-Drabik................................................. 222

M. Vojkoviæ.................................................................. 231

U. Wilczek..................................................................... 238

V. Volberg............................................................. 103, 267

L. Wilensky............................................................ 227-228

V. E. Volgushev............................................................. 255

D. Wilkinson................................................................. 107

A. L. Volkova........................................................... 74, 164

A. Wilson................................................................ 69, 111

S. E. Vollset....................................133, 142, 247, 249, 251

N. Wilson...................................................................... 103

J. A. Volmink................................................................. 165

E. R. Winkelmann........................................................... 74

A. Volschan....................................................201, 229, 234

K. Wita.......................................................................... 232

A. Volshan..................................................................... 229

R. Witjes....................................................................... 135

M. Von Bracht....................................................... 103, 194

A. Witkowski.................................................136, 237, 241

S. Von Heahling............................................................ 238

J. Witowski................................................................... 225

I. Vondermuhl............................................................... 165

T. Wittenberg................................................................ 274

M. Voos................................................................ 171, 181

E. Wittke....................................................................... 106

J. Vormbrock................................................................ 223

E. K. Wlodarska..................................................... 134, 174

L. S. Voto...................................................................... 183

L. Woie.....................................75, 135, 199, 206-207, 209

G. N. Voto..................................................................... 183

D. Wojciechowski......................................................... 252

V. Voudris............................................................. 177, 182

I. Wojtkowska............................................................... 252

J. M. Vrancic................................................................. 142

P. Wollmer.................................................................... 168

O. Vraspir Porenta.................................................. 187-188

H. Wong....................................................................... 135

M. Vrkic Kirhmajer................................................ 223, 231

N. D. Wong..................................73, 75, 79, 137, 141, 179

Z. Vucinic...................................................................... 193

T. W. Wong................................................................... 270

B. Vujisic-Tesic........................................171, 174, 277-278

D. A. Wood................................................................... 107

N. Vukadinovic.............................................................. 251

A. J. Woodiwiss............................................................ 230

V. Vukcevic................................................71, 74, 105, 142

S. Wottrich.................................................................... 233

M. Vukovic............................................................ 187, 202

N. Wouters................................................................... 132

O. Vukovic.................................................................... 110

O. Wozniak........................................................... 134, 174

A. Vukusich................................................................... 137

M. Wraga...................................................................... 222

D. Vulic......................................................................... 182

J. Wrobel...................................................................... 171

B. Vulic.......................................................................... 182

W. Wróbel.................................................................... 232

V. A. Vural..................................................................... 187

S. Wsolova.................................................................... 257

M. Vural........................................................................ 223

Y. Wu............................................................................ 135

K. Wahab...................................................................... 178

V. F. Xavier...................................................................... 74

E. Walczak.................................................................... 174

R. M. A. Xavier...................................................... 227, 256

Authors S. Xavier.................................................................. 76, 140

D. Zamaklar-Trifunovic.................................................. 278

E. Zuanich..................................................................... 100

S. S. Xavier.................................................................... 140

A. Zamora Muciño................................................ 266, 268

C. Zuehlke..................................................................... 223

H. Xiao.......................................................................... 202

A. Zamora......................................................188, 266, 268

M. Zugaib...................................................................... 268

B. Xu............................................................................... 73

R. Zamora............................................................... 78, 111

C. Zukowski.................................................................. 268

S. Xue........................................................................... 136

C. Zamora..................................................................... 209

P. Zuliani....................................................................... 269

P. Xun........................................................................... 202

A. Zamora-Muciño........................................................ 265

C. Zuloaga..................................................................... 212

B. S. Yadav............................................................ 108, 231

N. Zamorano................................................................. 144

R. Zumach.................................................................... 274

S. M. Yala...................................................................... 104

M. Zampach.................................................................. 178

M. Zurru................................................................. 228-229

S. Yala..................................................................... 75, 107

G. Zampi....................................................................... 240

K. Zykov........................................................................ 163

K. Yalta...........................................................180, 194, 205

G. Zapata...................................................................... 220

S. Zymerman................................................................ 214

H. Yamabe.................................................................... 164

J. Zapata....................................................................... 248

H. Yamada.................................................................... 235

A. Zapolanski........................................................ 242, 249

T. Yamaguchi................................................................ 175

B. Zappa........................................................................ 222

M. Yamamoto............................................................... 181

R. Zarate....................................................................... 183

A. Yamamoto................................................................ 175

D. Zaremba................................................................... 175

A. Yamashina........................................................ 167, 187

B. Zarlenga.................................................................... 178

N. Yamawake....................................................... 188, 197

J. G. Zarruk-Serrano...................................................... 249

G. Yanes-Bowden................................................. 167, 213

A. Zarza................................................................. 134, 170

D. Yanez....................................................................... 137

A. D. Zazula............................................................. 75, 100

F. Yañez........................................................................ 143

D. Zdrenghea................................................. 242, 245-246

X. Yang......................................................................... 110

T. Zdrojewski................................................................ 106

J. Yang.......................................................................... 110

M. Zehetgruber............................................................. 232

G. Yannarelli.................................................................. 259

F. Zelaya....................................................................... 102

B. S. Yasumura............................................................. 251

D. Zeltser...................................................................... 163

G. E. Yazici.................................................................... 279

P. Zelveian.................................................................... 181

M. Yazici................................................................ 198-199

D. Zemanek.................................................................. 223

L. Yazicioglu.................................................................. 111

D. Zemánek.................................................................. 136

G. Yentzen.................................................................... 137

S. Zengin....................................................................... 211

T. Yildiran...................................................................... 105

G. Zenker...................................................................... 110

V. Yildirim...................................................................... 163

C. C. Zeno............................................................. 142, 254

C. Yildirim..................................................................... 211

A. Zervoudaki................................................................ 110

A. Yilmaz....................................................................... 205

T. Zeus.................................................................. 104, 270

M. B. Yilmaz...................................................180, 194, 205

Y. Zhan.......................................................................... 202

A. Yip............................................................................ 202

X. L. Zhang.................................................................... 133

T. Yokoi................................................................. 137, 173

L. Zhang...........................................................73, 133, 195

S. Yokus................................................................ 104, 270

B. Zhang....................................................................... 181

M. Yokusoglu................................................................ 163

D. Zhao................................................................. 163, 216

O. C. Yontar...................................................180, 194, 205

J. R. Zhu........................................................................ 216

S. Yoon......................................................................... 218

A. Zichert...................................................................... 168

Y. Yoon.......................................................... 110, 218-219

J. Zidanaviciute............................................................. 184

S. B. Yoon....................................................................... 79

Z. C. Ziella..................................................................... 274

Y. W. Yoon...................................................................... 79

J. Zietek........................................................................ 171

L. Yordi......................................................................... 233

A. Zillo........................................................................... 197

N. Ysturiz...................................................................... 190

T. Zima.......................................................................... 200

J. Yu...................................................................... 135, 231

J. Zimmermann.............................................................. 69

C. Yu............................................................................. 136

P. Zimolova................................................................... 223

C. Yukiko Osato............................................................ 263

P. Zimolová................................................................... 169

S. Yurdakul.................................................................... 106

G. Zini........................................................................... 219

K. Yusoff............................................................... 133, 201

S. Zizzias................................................107, 222, 240, 251

B. Yusuf........................................................................ 178

M. Zlatanovic................................................................ 202

F. Zaanad...................................................................... 108

K. Zmudka........................................................78, 141, 233

M. Zabalza.................................................................... 232

Y. Zocalo........................................................ 231-232, 267

R. Zacca........................................................................ 254

C. R. Zoni...................................................................... 271

B. Zaccara..................................................................... 240

R. Zoni...........................................................260, 271, 273

A. Zak............................................................................ 200

R. Zorc Pleskovic................................................... 187-188

A. Zaki........................................................................... 274

M. Zorc...........................................105, 136, 174, 187-188

A. N. Zakirova................................................................ 236

R. Zorc-Pleskoviè.......................................................... 136

D. Zakrzewski............................................................... 172

L. A. M. Zornoff............................................................ 260

Index / 321

INDEX

Faculty Sharaf Abd El Rahman Abd El Gawad........................... 141

Hugo Baglivo.................................................................. 85

Miguel Bustamante-Labarta......................................... 155

Alia Abdelfattah.................................................... 113, 122

Noel Bairey Merz...........................................114, 128, 152

Jorge Cachero.............................................................. 155

Pasquale Abete............................................................... 91

Victor Balestrini............................................................. 125

Andres Caeiro............................................................... 150

Alexander Abizaid..............................89, 92, 142, 154, 160

Miguel Ballarino............................................................ 160

Arturo Cagide.........................................................4, 34, 68

Mónica Acevedo............................................................... 4

Adrian Baranchuk...............................81, 85, 102, 145, 157

Jaime Calderón Herrer.................................................. 121

Aloyzio Achutti.............................................................. 126

Alejandro Barbagelata............................................. 85, 322

Robert Califf...................................................116, 127, 151

Gustavo Acosta............................................................ 125

Miguel L Barbero Marcial................................................ 82

John Camm................................................87, 93, 285-286

Luis Acosta................................................................... 123

Marcia Barbosa............................................................. 113

Roxana Campisi.................................................... 141, 152

Susan Acosta Castillo................................................... 154

José Luis Barisani................................................... 93, 119

Horacio Capelli................................................................ 64

Harry Acquatella..................................................... 93, 126

Joaquín Barnoya................................................... 118, 121

Riccardo Cappato.............................................93, 112, 150

David Adams........................................................ 113, 121

Carlos Barrero................................................................. 64

Alessandro Capucci........................................................ 98

Miguel Adorno........................................................ 88, 106

Antoni Bayés De Luna.......................................... 149, 162

Jonathan Carapetis........................................................... 4

Carla Agatiello................................................................. 64

Oscar BAzzino................................................................ 84

Oscar Carretero.........................................82, 90, 115, 155

Fernando Aguirre.................................................... 84, 157

Craig T Beam................................................................. 8-9

José Horacio Casabé.................................................... 120

Luis Alcocer.....................................................87, 115, 135

Jorge Belardi......................................................... 154, 283

Marcelo Casey.............................................................. 130

Luis Alday................................................................... 4, 64

George Beller............................................86, 113, 124-125

Ricardo Castro.............................................................. 155

Erick Alexanderson......................................................... 83

Cesar Belziti.................................................................... 88

Christopher Cates............................................92, 117, 120

Adel Allam.............................................................. 83, 128

Mario Bendersky.......................................................... 161

Manuel Cerqueira................................................. 113, 124

Angeles Alonso Garcia.............................97, 108, 114, 162

Francisco Benítez............................................99, 122, 125

Juan Carlos Chachques.......................................... 96, 140

Oscar Alvarado C.......................................................... 117

Daniel Berman................................................................ 95

Antonio Chagas.....................115, 131, 149, 152, 161, 286

Marcelo Alvarez............................................................ 148

Daniel Berrocal........................................92, 114, 142, 283

Sergio Chain................................................................... 19

Giuseppe Ambrosio.............................................. 116, 120

Mario Bey Lombana.......................................107, 126, 149

Beatriz Champagne...................................................... 121

Sebastián Ameriso........................................................ 130

Deepak Bhatt........................................................ 146, 281

Victoria Chaparro Cristaldo............................................ 131

Albert Amoah.................................................................... 8

Eduardo Bianco............................................................. 121

Hilton Chaves............................................................... 162

Celso Amodeo.............................................................. 123

Roberto Blandon Calderon.............................................. 84

John Cheatham...................................................76, 90, 96

Ezra Amsterdam........................................................... 146

Jorge Bluguerman.................................................. 78, 123

Shih-Ann Chen.......................................................... 81, 87

Marcos Amuchastegui.................................................. 158

José Antonio Boggiano................................................. 143

Pablo ChiAle................................................................... 93

Luis María Amuchástegui................................................. 4

Michael Böhm.............................................................. 284

Miguel Chiape............................................................... 123

Claudia Anchique.......................................................... 162

Carlos Boissonet............................................................. 69

Tomás Cianciulli.............................................................. 95

Rosana Andreoli............................................................ 157

Robert Bonow...................................................92, 95, 123

Juan Cimbaro Canella................................................... 157

Octavio Aparicio............................................................ 150

Jeffrey Borer....................................................95, 147, 161

Horacio F. Cingolani................................................ 77, 151

José Luis Araya............................................................. 153

Guillermo Bortman....................................................... 158

Nadine Clausell..................................................... 158, 289

Daniel Areco................................................................. 126

Xavier Bosch................................................................. 129

John Cleland......................................................81, 94, 112

Julio Argentieri................................................................ 96

Bernardo Boskis........................................................... 128

Antonio Coca...................................................85, 115, 126

Virginia Argibay Pitlyk.................................................... 157

Fernando Botto..................................................... 129, 226

Mauricio Cohen...................................................... 85, 127

Dagnovar Aristizabal............................................. 106, 145

Daniel Bracco................................................................ 129

Hernán Cohen Arazi...................................................... 119

Pilar Arnaiz.............................................................. 82, 116

Johannes Brachmann......................................82, 144, 287

William E. Cohn............................................................ 113

Richard Arntz................................................................ 281

Jorge Braguinsky.......................................................... 152

Jay Cohn..........................................94, 112, 119, 126, 162

Cristina Arranz................................................................ 76

Ayrton Brandão........................................................... 4, 64

Roberto Colque............................................................. 151

Víctor Arregui................................................................ 119

Andrea Brandão.............................................................. 85

I. Coma-Canella............................................................... 90

Arturo Arribada............................................................. 152

Nancy Bravo................................................................. 148

Eduardo Conci................................................................ 19

Pablo Aschner................................................................. 86

Günter Breithardt.....................................4, 64, 80, 87, 155

Jose Condado..................................................89, 113, 150

Rene Asenjo......................................................... 144, 156

Raúl Bretal................................................................ 71, 84

Ramon Corbalan................................................... 102, 313

Ademar Atik............................................................ 82, 118

Nancy Brown................................................................ 130

Roque Cordoba............................................................. 114

T. P. Aufderheide............................................................ 91

William J Bryant............................................................ 322

Pedro Cossio.................................................................. 18

Gustavo Avegliano........................................................ 147

AlfonsO Buendia-Hernandez.........................129, 148, 156

Costantino Costantini....................................110, 120, 160

Álvaro Avezum...............................................129, 285, 289

Enio Buffolo............................................................ 94, 129

Ronald Cuellar............................................................... 156

Fernando Bacal....................................................... 93, 116

Matthew Burg.............................................................. 128

Ada Cuevas......................................................86, 153, 160

Ricardo Baeza............................................................... 147

Javier Bustamante................................................ 118, 152

Carlos Cuneo............................................................ 75, 98

Faculty Fernando Cura........................................................ 78, 123

Gilson Feitosa....................................................87, 95, 125

Oscar González............................................................. 124

Donald Cutlip.................................................................. 84

J. Fernandes........................................................... 75, 153

Graciela González Bogado.............................................. 93

Protasio Da Luz......................................125, 137, 159, 161

Manoel Fernandes Canesin............................................ 98

Antonio Gonzalez Hermosillo........................................ 112

Anibal Damonte.............................................................. 91

Alberto Fernández........................................................ 157

Juan Gonzalez Juanatey................................................. 83

Adolfo De Bold.............................................................. 151

Waldo Fernández Durand............................................... 93

Juan Gonzalez Moreno................................................. 150

Luis De La Fuente..................................................... 77, 96

Marcela Ferrada............................................................ 148

Jorge Gonzalez ZUelgaray...................................... 88, 135

Fernando De La Serna.................................................. 128

Carlos Ferrario...........................................82, 90, 151, 286

John Gorcsan III.................................................81, 93, 146

Robert J. De Souza....................................................... 128

Mariano Ferreira........................................................... 123

Hugo Grancelli.......................................................4, 64, 68

Radu Deac.................................................................... 155

Ernesto Ferreiro............................................................ 100

Miguel Granja................................................................. 90

Diego Delgado.........................................88, 117, 151, 159

John Field..................................................................... 129

Liliana Grinfeld............................................................ 4, 64

Hector Delgado OsoriO.................................120, 136, 158

Bartolome Finizola.......................................................... 87

Scott Grundy....................................................86, 117, 152

Hernán Delmonte......................................................... 121

Scott Flamm................................................................. 147

Jose Fernando Guadalajara............................................. 79

Gabriel D’empaire Yanes................................................ 99

Ferenc Follath............................................................... 282

Eduardo Guevara.................................................... 79, 161

Milind Desai............................................................ 95, 125

Francisco Fonseca........................................................ 153

Luiza Guilherme............................................................ 126

Richard Devereux..........................................115, 123, 151

Guy Fontaine........................................................ 119, 157

Victor Gura.................................................................... 151

Rafael Diaz...............................................84, 281, 284, 289

Valmir Fontes................................................................ 115

Enrique Gurfinkel.................................................. 147, 161

Mirta Diez....................................................................... 18

Patricia Frangini............................................................ 148

Pedro Gutierrez Fajardo................................................ 126

Horacio Dinunzio............................................................. 91

Erika S Froelicher............................................................ 83

Tj. Guzik........................................................................ 151

Van Veldhuisen Dirk...................................................... 284

Jean Charles Fruchart..................................................... 86

Luis Guzman......................................................... 111, 114

Alberto Domenech....................................................... 121

Juan José Fuselli.......................................................... 116

Laksmiati A. Hanafiah....................................................... 8

Wistremundo Dones.....................................117, 137, 149

Valentin Fuster................................................4, 8-9, 16, 64

Eduardo Hasbani............................................................. 85

Hernan Doval.......................................................... 87, 145

José Gabay............................................................. 98, 111

Trevor Hassell.......................................................4, 8-9, 64

Luciano Drager............................................................. 161

Juan Gagliardi................................................................. 72

Sergio Hauad................................................................ 146

José Drago Silva........................................................... 131

Javier Galeano.............................................................. 156

Laura Hayman............................................................... 131

Saúl Drajer...................................................................... 93

Nestor Galizio................................................................. 93

Felipe Heusser Risopatró.............................................. 113

Sergio Dubner................................................................. 64

Runlin GaO....................................................................... 4

J. Thomas Heywood..................................................... 289

Carlos Dumont.............................................................. 158

Mario Garcia......................................................92, 95, 122

Ziyad Hijazi...................................................82, 92, 96, 115

Anai Durazzo................................................................. 288

Ernest Garcia.......................................................... 91, 113

Shirish Hiremath..............................................96, 116, 128

Shah Ebrahim............................................................... 160

Carlos García................................................................... 81

Alejandro Hita............................................................... 212

Denise Eldemire Shearer...................................... 128, 143

Santiago García Egüez.......................................... 131, 146

Sun Yee Ho................................................................... 130

Marcelo Elizari........................................................ 93, 285

Mario Garcia-Palmieri................................................ 91, 98

Peter Hollins..................................................................... 8

Uri Elkayam................................................................... 289

Timothy Gardner............................................................. 89

Nancy Houston Miller....................................131, 148, 157

Nabil El-Sheriff.................................................87, 118, 134

Jorge Garguichevich..................................................... 150

Sandrine Huez.............................................................. 288

Ladislao Endrei............................................................. 150

Fabián Gelpi.................................................................... 98

Steen Husted................................................................ 281

Irene Ennis...................................................................... 64

Ricardo Gelpi................................................................ 151

Ricardo Iglesias............................................................... 18

Sabine Ernst......................................................... 150, 157

Gerald Nacarelli............................................................. 285

Hermes Ilarraza-Lomeli....................................83, 108, 159

Diego Esandi................................................................... 97

Mihai Gheorghiade....................................81, 94, 112, 151

Manuel IrarrazAbal................................................ 100, 129

Edgardo Escobar......................................................... 4, 64

Federico Giachello........................................................ 121

Daniel Isaza..................................................................... 99

Eduardo Escudero................................................ 154, 191

Alberto Giniger...........................................72, 80, 156, 226

Mitsuaki Isobe.............................................................. 158

Roberto César Esper..................................................... 145

Mariano Giorgi................................................................ 91

Mariano Ithuralde............................................................ 96

Ricardo Esper........................................................... 75, 89

Alan Goble...................................................................... 83

Jorge Jalil.............................................................. 155, 161

Jaime Espinosa............................................................. 126

Jaime Goich.................................................................... 87

Kenneth Jamerson....................................................... 287

Agustin Lara Esqueda................................................... 286

Michael Gold........................................................81, 88, 93

Loreta Jara...................................................................... 90

GuilleRmo Fabregues........................................... 155, 162

Marcelo Goldstein.......................................83, 91, 95, 141

Alex Javois.............................................................. 82, 129

Horacio Faella...............................................3-4, 34, 64, 68

Alejandro Gómez Monroy............................................. 160

Catriona Jennings......................................................... 131

Robert Fagard........................................................... 86, 95

Miguel Gomez Sanchez.................................120, 146, 288

Daniel W. Jones.................................................... 121, 123

Enrique Fairman............................................................ 127

Gilberto Gonzalez.................................................. 130, 146

Soon Joo Wang................................................... 91, 97-98

Mariano Falconi.............................................................. 64

Rolando Gonzalez......................................................... 150

Ernesto Juaneda............................................................. 97

Roberto Favaloro.......................................................... 129

Miguel Gonzalez........................................................ 93-94

Luis Juncos................................................................... 115

Index / 323

Faculty Juan Justiniano Encina........................................... 84, 114

Nestor Lopez................................................................ 287

Carlos Mendiz..................................................92, 117, 142

Edward L. Kaplan.......................................................... 126

Ricardo López Santi...................................................... 127

Oscar Mendiz............................................................... 283

Wahida Karmally................................................... 145, 159

Jorge Lopez Sosa........................................................... 95

Ivan Mendoza....................................................72, 80, 157

Juan Kaski......................................................127, 145, 151

José Luis López-Sendón....................87, 89, 112, 125, 289

Claudio Meneghetti........................................................ 83

Anthony Keech............................................................. 282

Alberto Lorenzatti................................................. 137, 153

George A. Mensah.................................................. 86, 149

Ulrich Keil...................................................................... 121

Jorge A. Lowenstein..................................................... 154

Luis Mercado........................................................ 127, 145

Roya Kelishadi.............................................................. 116

Hector LUciardi............................................................. 155

Peter A. Meredith......................................................... 281

David T. Kelly............................................................ 92, 96

Sergio Lupo.................................................................... 97

Ricardo Miglino............................................................... 81

Karl B. Kern............................................................. 91, 122

Pedro Lylyk..................................................................... 64

Ricardo Migliore.................................................... 103, 152

Bjoy Khandheria..................................................... 154-155

Carlos Macaya.................................................84, 130, 143

Jose Milei....................................................................... 84

Spencer King III..............................................117, 147, 160

Alejandro Macchia.......................................................... 88

Santiago Miriuka............................................................. 88

Sverre E. Kjeldsen......................................................... 126

Daniel Maggio............................................................... 157

Jorge Mitelman.............................................................. 84

Kwang Koh......................................................82, 140, 148

John Mahmarian........................................................... 124

Kyoichi Mizuno............................................................. 145

Marvin Konstam........................................83, 94, 119, 162

Stella Maimone............................................................. 148

Luis Molina..............................................93, 118, 145, 150

Irina Kovalskys.............................................................. 129

A. A. Shafi Majumder.................................................... 113

Luis Molinary.................................................101, 115, 152

Veronica Kramer................................................... 131, 153

Rafael Maldonado......................................................... 282

Jose Moltedo................................................................ 148

Juan Krauss................................................................ 4, 64

Giuseppe Mancia.............................................90, 281, 284

Marcelo Montera.................................................... 74, 158

Christian Kreutzer........................................................... 82

Fernando Manzur Jattin.............................73, 92, 155, 162

Lorenzo Montserrat................................................ 95, 127

Guillermo Kreutzer........................................................ 115

Mário Maranhão............................................................... 4

James Moon................................................................. 147

Henry Krum...................................................112, 119, 147

Pablo Marantz......................................................... 90, 109

Rosalia Morais Torres..................................................... 84

Anil Kumar........................................................................ 8

V. Mareev............................................................. 119, 145

Eduardo Morales Briceño....................................... 69, 149

Paola Kuschnir................................................................ 64

Alvaro Margoglis........................................................... 156

Eduardo Moreyra...........................................127, 136, 151

EmiliO Kuschnir.............................................................. 64

José Antônio Marin-Neto.............................................. 152

Abel Moreyra................................................................ 155

Rodolfo Daniel La Greca....................................... 107, 116

Javier Marino................................................................ 158

Carlos A Morillo.................................................... 112, 118

Carlos Labadet.................................................81, 102, 195

Flavio Marques............................................................... 91

Luis Moya..................................................................... 150

Mario  Lado........................................................... 122, 131

Ricardo Martellotto....................................................... 146

Bernhard Mumm.................................................. 113, 161

Michael Landzberg........................................115, 129, 148

Felipe Martínez......................................................4, 34, 68

Juan Muntaner............................................................... 19

Hugo Lastiri...................................................................... 4

Marco A. Martínez Ríos................................. 204-205, 307

Francisco Nacinovich.................................................... 120

Aleksandras Laucevicius................................................. 88

Jose Alejandro Martinez Sepulveda........................ 96, 154

Juan Carlos Nadalich..................................................... 124

Aina Lauga.................................................................... 153

Carlos Martinez-Sanchez.............................................. 116

M Nahir................................................................. 129, 146

Jorge Lax...................................................................... 110

Hori Masatsugu............................................................ 112

Takeshi Nakatani..................................................... 92, 154

Trong Phi Le.................................................................... 96

Osvaldo Masoli......................................................... 18, 64

Navin Nanda........................................................86, 92, 99

Jorge Leguizamon................................................ 102, 130

Mònica Masotti......................................................... 72, 90

Andrea Natale....................................................81, 87, 286

Daniel Lemogoum.......................................................... 97

Barry Massie..................................112, 125, 136, 151, 158

Solon Navarrete.................................................... 157, 284

Jorge Lemus................................................................. 124

Wilson Mathias....................................................... 95, 154

Jose Navarro Estrada...................................................... 90

Jorge Lerman............................................................. 4, 64

Akira Matsumori...................................................4, 8-9, 64

José Luis Navia....................................................... 94, 121

Ricardo Levin.................................................................. 88

Alicia MattiazzI................................................................ 82

Daniel Navia.................................................................. 114

Jack Lewin...................................................................... 86

Luiz Piva Mattos........................................................... 161

Jose Navia.................................................................... 160

Peter Libby.................................................... 124, 145-146

Victor Mauro................................................................. 116

Jorge Neira..................................................................... 85

Michael Lim.................................................................. 149

Branco Mautner..................................................... 118-119

Rodolfo Neirotti............................................................ 118

J. C. Linares-Casas....................................................... 156

Bongani Mayosi................................................................ 4

Deborah Nercolini..............................................78, 89, 113

Lars Lindholm........................................................... 82, 95

Jean-Rene M’buyamba................................................... 97

Richard W. Nesto.......................................................... 282

Pedro Lipszyc....................................................... 122, 285

Mabel Medina............................................................... 153

David Newby................................................................ 159

Maria Teresa Lira.....................................75, 107, 137, 306

Felix Medina................................................................. 162

Graham Nichol.............................................................. 284

Peter Liu........................................................120, 127, 158

Roxana Mehran.................................71, 98, 120, 130, 147

Jose Nicolau..............................................90, 99, 116, 160

Shay Livschiz................................................................ 111

Anibal Mele..................................................................... 83

Carlos Nijensohn........................................................... 160

Ricardo Lluberas............................................114, 125, 132

Eduardo Mele................................................18, 34, 64, 68

Sania Nishtar............................................................... 4, 64

Hugo Londero................................................................. 98

Nedina Mendez.............................................................. 91

Carlos Nojek................................................................. 113

Beatriz Londoño.............................................................. 97

Shanthi Mendis..................................................... 121, 128

Daniel Nul............................................................. 136, 151

Faculty Ismael N. Nuno............................................................. 324

Alfredo Piombo..................................................... 122, 169

Eduardo Rivas Estany..............................83, 138, 149, 153

Pablo Oberti.................................................................. 116

Rubén Piraino................................................................. 89

Lyn Roberts...................................................................... 8

Graciela Ocaña.............................................................. 124

Raul Pisabarro......................................................... 79, 128

Rose Marie Robertson.......................................... 114, 159

Robert O’connor........................................................... 284

Daniel Piskorz......................................................... 95, 155

Alfredo Rodriguez......................................................... 129

Jose Andres Octavio..................................................... 156

Rodolfo Pizarro....................................................... 85, 133

Pablo Rodriguez............................................................ 123

Mario Oliveira............................................................... 324

Nelson Pizzano....................................................... 99, 154

José Antonio Rodríguez................................................ 147

Anders G. OlssOn......................................................... 285

Juan Carlos Plana...............................................92, 99, 155

Marco Roffi........................................................... 116, 128

T. Omland..................................................................... 159

Juan A. Plastino................................................................ 4

Florencia Rolandi.......................................................... 130

Churchill Onen............................................................ 4, 64

Antonio Pocovi.............................................................. 117

Carlos Romero.................................................................. 4

Marcelo Orias................................................................. 82

Don Poldermans................................................... 119, 288

Ricardo Ronderos....................................................... 4, 64

Cesare Orlandi................................................................ 83

Horacio Pomes Iparraguirre.....................70, 103, 237, 242

Juan Rosas................................................................... 285

Andres Orlandini........................................................... 127

Piotr Ponikowski........................................................... 288

Stephan Rosenkranz..................................................... 288

Enrique Oropeza........................................................... 157

Carlos I. Ponte N.................................................... 218-219

Diego Rosso................................................................. 147

Oscar Oseroff................................................................. 64

Philip A Poole-Wilson...................................83, 88, 94, 112

Rodolfo Rothlin............................................................... 64

Ali Oto............................................................144, 150, 159

Barry Popkin................................................................. 117

Eduardo Roura...................................................81, 85, 118

Armando Pacher........................................................... 156

Rafael Porcile................................................................ 105

Miguel Rubio................................................................ 120

Jose Carlos Pachon Mateos............................81, 103, 286

Edgar Pozo Valdivia............................................... 119, 125

Luis Ruilope.....................................................82, 123, 126

S. R. K. Padmavati........................................................ 324

Domingo Pozzer............................................................. 19

Frank Thomas Ruschitzka..................................... 115, 147

Dev Pahlajani.............................................................. 4, 64

Palmira Pramparo..........................................107, 117, 152

Joseph F. Sabik III......................................................... 123

Igor Palacios..........................................121, 142, 147, 154

Pekka Puska.............................................................. 4, 8-9

Masood Sadiq............................................................... 118

Alejandro Palacios................................................. 113, 143

Qing Qiao...................................................................... 128

Lawrence B. Sadwin..................................................... 325

Norberto Pallavicini....................................................... 152

Ramón Quesada..................................................... 89, 114

David Sahn................................................................ 82, 90

Julio Palmaz............................................................ 84, 121

Miguel Quiñones...........................................117, 119, 154

Jose Sala...................................................................... 160

Maria Paniagua............................................................. 117

MiGuel Quintana..................................................... 99, 125

Oscar Salomone........................................................... 152

Ernesto Paolasso.......................................................... 122

Fernán Quirós............................................................... 156

Ana Salvati...................................................................... 98

David Paquette............................................................. 287

Rafael Rabinovich......................................................... 112

Eduardo Sampo.............................................................. 74

Gianfranco Parati...........................................145, 151, 161

Ed Racht....................................................................... 284

Ramiro Sánchez...................................................... 95, 161

Manish Parikh................................................................. 92

P. Radke............................................................... 114, 127

María José Sancho Tello......................................... 88, 150

Carlos Pedra................................................................... 96

Jose Antonio Francisco Ramires.......................85, 95, 122

Fabio Sandoli De Brito.................................................. 114

Jairo Pedraza................................................................ 126

Sanchez Ramiro............................................................ 284

Julio Sandoval............................................................... 288

Roberto Peidro...............................................108, 126, 138

Hugo Ramos................................................................. 146

Edgardo Sandoya............................................................ 87

Amparo Peiró........................................................ 143, 148

José Luis Ramos............................................................ 64

Angel Sandrin............................................................... 113

Alejandro Peirone......................................................... 156

Sunil V. Rao................................................................... 281

Patricia Sangenis.......................................................... 116

Fernando Peliche.......................................................... 161

Anis Rassi Jr................................................................. 152

Patricio Sanhueza......................................................... 102

Imelda Perdomo........................................................... 153

Alberto Re....................................................................... 90

Masao Sano.......................................................75, 98, 162

Alfonso Perez................................................................. 97

Patricia Rebaza............................................................. 125

Omar Santaera...................................................... 110, 130

Néstor Gustavo Pérez................................................... 148

Srinath Reddy............................................................ 4, 8-9

Robson Santos............................................................. 286

Néstor Pérez Baliño.................................................... 4, 64

Zeljko Reiner....................................................77, 121, 159

Gines Sanz.............................................................. 89, 116

Diego Pérez De Arenaza................................................. 64

Willem Remme............................................83, 89, 94, 112

Ricardo Sarmiento........................................................ 154

Eduardo Perna.............................................................. 158

Jorge Resk.................................................................... 106

Nizal SarrAf-Zadegan.................................................. 4, 64

Sergio Perrone........................................146, 282, 288-289

Gustavo Restrepo................................................. 150, 154

Shigetake Sasayama............................................. 112, 158

Ricardo Pesce............................................................... 144

Enrique Retyk............................................................... 144

Anita Saxena....................................................97, 118, 129

Leopoldo Piegas........................................................... 269

Ricardo Horacio Rey............................................. 145, 285

Mauricio Scanavacca............................................ 150, 286

Mario Pieroni................................................................ 117

Karina Rey García.................................................... 96, 144

Herman Schargrodsky.......................................... 143, 160

Ileana Piña.....................................................105, 125, 158

Walter Reyes Caorsi................................................. 82, 93

Heinrich Schelbert.........................................120, 125, 146

Daniel Piñeiro.................................................................. 64

Expedito Ribeiro............................................117, 129, 154

Angelique Schiffer................................................ 128, 138

Sergio Pinski........................................................... 87, 145

Arthur Ribeiro............................................................... 286

Andrés Schlichter......................................................... 115

Manuel Pinto................................................................ 154

Leonardo Ribeiro.......................................................... 145

Joanne D Schuijf............................................................. 95

Xavier Pintó................................................................... 282

Roberto Ricca........................................................... 74, 94

Alberto Sciegata..................................................... 76, 118

Index / 325

Faculty Ernesto Sebrie.............................................................. 121

Marcelo Trivi........................................................... 92, 226

Andy Wielgosz............................................................ 8, 16

Martin Seoane................................................................ 97

Tak-Fu Tse.................................................................... 159

William Wijns...........................................................4, 8, 64

José Luis Serra............................................................. 157

Paolo Tucci................................................................... 148

Silvia Wikinski............................................................... 147

César Serra................................................................... 122

Gioia Turitto............................................................ 87, 118

Neil Wilson......................................................96, 113, 115

Satyavan Sharma.......................................85, 89, 114, 159

Alexander Turpie........................................................... 289

Christian Wolpert...................................................... 82, 93

Leslee Shaw..........................................124, 127, 152, 156

Jorge UbaldiNi.............................................................. 146

David Wood.................................................................. 153

Shahryar A. Sheikh.......................................................... 94

Gerardo Uceda.............................................................. 152

Marian Worcester........................................................... 83

Rafael Shuchleib............................................................... 8

Thomas Unger.............................................................. 284

Yunlong Xia............................................................. 81, 119

Joanna Sikkema............................................................ 131

Tudor Vagaonescu........................................................ 155

Cheuk-Man Yu...........................................81, 92, 158, 161

Galvao Silas.................................................................... 81

Gloria S Valdes................................................................ 85

Salim Yusuf....................................................................... 4

Antonio Felipe Simão.................................................... 286

Andre Ricardo Valle....................................................... 147

Carlos Zabal.................................................................. 156

Isaac Sinay............................................................ 128, 285

Frans Van De Werf................................................. 84, 281

Patricio Zaefferer.......................................................... 123

Victor Sinisi............................................................. 80, 119

Hans Van Giezen........................................................... 281

Alberto Zambon............................................................ 282

Karen Sliwa........................................................86, 97, 158

Diego Vanegas................................................................ 88

A. Zampelas.................................................................. 159

Sidney Smith......................................................8-9, 34, 68

Gabriel Vanerio............................................................. 119

Alberto Zanchetti.....................................90, 123, 126, 284

Dario Sobral.....................................................80, 112, 156

Mani Vannan......................................................92, 99, 154

Faiez Zannad........................................................81, 84, 91

Fernando Sokn................................................................ 18

Jesus Vargas Baron...................................................... 161

Barry Zaret.......................................................83, 113, 124

Jane Somerville.................................................... 103, 148

Sergio Varini............................................................ 80, 112

Susana Zeffiro............................................................... 152

Maria Inés Somoza....................................................... 159

Richard Vaughan-Jones................................................ 148

Paulo Zielinsky................................................................ 90

Maria Ines Sosa Liprandi......................................... 97, 282

Horacio Vazquez........................................................... 154

Judith Zilberman........................................................... 152

Álvaro Sosa Liprandi..................................................... 153

Manuel Vazquez-Blanco........................................ 106, 122

Claudio Zin............................................................ 124, 152

Monica Soto Vertchert.................................................. 157

Hector Ventura............................................86, 88, 94, 104

Horacio Zylbersztejn..................................................... 129

Howard Spencer........................................................... 149

Freek Verheugt............................................................. 281

José Spolidoro.............................................................. 138

David Vetcher................................................................. 91

Peter Spooner............................................................... 119

René Vicuña Mariño...................................................... 156

Andrew Steer............................................................... 126

Luis Vidal.......................................................115, 169, 195

P. Gabriel Steg...............................................127, 132, 289

Aurora Vila.................................................................... 283

George Steiner............................................................. 153

Jorge Vilarino.......................................................... 73, 145

Krisela Steyn........................................................... 86, 130

Fabio Vilas-Boas...............................................81, 157, 282

Walter Stoermann........................................................ 122

Alberto Villamil.................................................82, 281, 287

Noedir Groppo Stolf................................................ 94, 118

Fernando Vinuela.................................................... 78, 130

Carlos Eduardo Suaide Silva......................................... 155

Néstor Alejandro Vita............................................ 124, 128

Hisayoshi Suma........................................................ 92, 94

Joao Vitola.............................................................. 83, 113

Robert Superko............................................................. 147

Veronica Ines Volberg................................................... 116

Carlos Tajer......................................................99, 138, 149

Janet Voûte............................................................... 4, 8-9

Ana Tambussi............................................................... 121

C. Vozzi......................................................................... 160

Teruhisa Tanabe................................................... 150, 157

Jose Luis Vukasovic........................................................ 89

Chuwa Tei..................................................................... 158

Norberto VUlcano................................................... 88, 288

Jacques Theron.............................................................. 98

Gabriel D. Waisman.............................................. 149, 284

Jorge Thierer.......................................................... 94, 226

Mauricio Wajngarten.......................................91, 107, 129

Ari Timerman............................................................ 85, 91

Nicholas Wald........................................................... 90, 97

Sergio Timerman.............................................................. 4

Alexander Walker......................................................... 283

Gianni Tognoni........................................................... 97-98

W. Douglas Weaver........................................................ 86

Andrew Tonkin........................................................... 4, 64

Bonnie Weiner.......................................................... 84, 92

Martín Toranzo.............................................................. 153

Ernesto Weinschelbaum................................................ 94

Adam Torbicki................................................120, 146, 288

Matthew Weir.............................................................. 287

Guillermo Torre Amione.....................................81, 88, 112

Rob Welsh.................................................................... 281

Dimitri Tousoulis............................................120, 124, 145

Nanette Wenger..........................................9, 89, 114, 122

Jorge Trainini.......................................................... 96, 139

Beat Widler................................................................... 283

FROM PATIENTS TO POPULATIONS

“See you in Beijing 2010” www.worldcardiocongress.org

Every option considered. Every move confident. Every outcome critical.

More control. Less risk. St. Jude Medical is focused on reducing risk by continuously finding ways to put more control into the hands of those who save lives.

Experience Control. WCC booth 310

©2008 St. Jude Medical. All Rights Reserved. The ST. JUDE MEDICAL logo is a trademark of St. Jude Medical, Inc.